data_1c6s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c6s _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.478 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 68.6 m-20 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.499 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -68.12 -5.37 17.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.59 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.42 -30.54 70.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 2.0 m-20 -72.45 -33.63 67.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -52.13 -60.79 7.21 Favored Glycine 0 C--O 1.201 -1.93 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.654 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -56.53 -26.98 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -1.067 . . . . 0.0 109.871 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -65.41 -35.07 79.83 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.024 -1.047 . . . . 0.0 108.707 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.637 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 14.9 t -88.66 -47.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.287 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 15.4 t80 -64.42 -27.69 69.17 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.804 -1.185 . . . . 0.0 109.435 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 18.7 p -90.93 11.2 23.52 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -141.95 3.53 2.01 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 2.5 m-80 -154.82 -57.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 0.0 109.029 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 11.6 m -65.84 -24.93 66.99 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.744 . . . . 0.0 109.37 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 19' ' ' MET . . . -62.35 -33.55 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 110.359 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.08 13.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.004 . . . . 0.0 110.517 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -138.89 25.6 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.621 ' CE1' HD22 ' A' ' 31' ' ' LEU . 86.0 m-70 -157.07 -69.63 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 108.951 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.52 ' O ' ' O ' ' A' ' 18' ' ' HIS . 1.0 OUTLIER 36.24 102.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.602 0.715 . . . . 0.0 111.207 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 93.59 32.42 7.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.463 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 43.45 36.19 3.09 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -130.51 109.35 0.91 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -44.3 140.82 2.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.0 109.333 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.483 ' CG1' ' O ' ' A' ' 24' ' ' VAL . 58.9 t -107.56 0.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 109.772 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -117.64 -51.3 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.676 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.79 176.27 6.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.72 46.61 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 1.4 p-10 -176.58 -62.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.283 -0.886 . . . . 0.0 108.979 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.589 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -55.18 97.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 t -111.1 -167.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 110.393 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.621 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -107.3 -26.06 11.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.673 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 7.3 mtpt -45.22 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.827 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.578 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 17.5 ttpt -178.74 -26.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.656 -1.278 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -67.83 -53.98 22.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.743 -1.223 . . . . 0.0 110.737 -177.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.547 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -76.05 -51.15 12.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.577 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.663 ' CD1' ' CD1' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -59.7 -22.82 62.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.002 . . . . 0.0 108.852 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.538 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 2.4 tm-20 -112.4 -2.6 14.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.141 -0.975 . . . . 0.0 109.298 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -65.82 -47.05 76.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -85.74 -32.0 22.11 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.281 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 120.93 102.11 1.82 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.623 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 158.57 29.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.702 -0.881 . . . . 0.0 110.823 178.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.663 ' CD1' ' CD1' ' A' ' 36' ' ' LEU . 2.1 t80 -97.11 28.46 3.57 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.077 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 p -106.74 157.58 17.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 110.343 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.581 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -46.05 -62.91 1.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.38 -0.825 . . . . 0.0 109.701 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -54.67 -28.74 49.59 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.94 -1.1 . . . . 0.0 110.637 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.06 -76.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.031 . . . . 0.0 110.247 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.545 HG22 ' CB ' ' A' ' 74' ' ' ALA . 6.5 tt -60.04 -20.99 20.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.462 -0.773 . . . . 0.0 110.047 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 15.6 mt -64.45 -35.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.628 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 26.4 t80 -87.08 -18.12 31.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.54 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -90.38 -1.37 57.91 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 61' ' ' PHE . 78.5 t -109.67 -39.03 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.543 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -71.58 -5.13 31.12 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.169 -0.957 . . . . 0.0 109.016 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.703 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -161.99 26.77 0.12 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 44.51 -133.33 7.1 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER 160.86 126.67 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 121.29 0.567 . . . . 0.0 109.654 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 35.1 m-80 68.98 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -128.12 12.0 6.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.945 -1.097 . . . . 0.0 110.569 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.585 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 14.4 ttt -95.16 138.98 21.88 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.672 -1.267 . . . . 0.0 109.599 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.585 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 29.2 Cg_endo -73.81 117.18 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.964 2.443 . . . . 0.0 113.507 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.63 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.23 165.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.533 -0.73 . . . . 0.0 110.025 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.581 ' CE2' ' O ' ' A' ' 59' ' ' PRO . 48.7 m-85 -146.76 15.59 1.23 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.35 -17.7 2.03 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.37 29.15 0.27 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.518 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -98.85 -41.58 7.56 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 178.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.576 ' CD2' ' CD1' ' A' ' 61' ' ' PHE . 19.3 mt -82.0 -140.71 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 6.1 m -98.62 -57.39 2.2 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.268 -0.895 . . . . 0.0 109.524 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 6.3 t70 153.34 -54.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 16.1 mt-10 -70.79 2.53 4.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.637 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -114.39 -27.42 7.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 65' ' ' LEU . 10.8 mm -58.88 -22.42 21.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 173.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.462 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -97.48 -65.76 0.94 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.993 179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.0 t0 -53.82 -39.93 65.97 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.588 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 1.4 p -60.94 -26.68 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.313 -0.867 . . . . 0.0 109.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.603 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -81.0 -63.48 1.4 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.71 -24.44 3.39 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.383 -1.448 . . . . 0.0 107.24 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.654 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 37.3 t80 -63.91 -47.72 79.43 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.08 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.5 p -67.32 -23.3 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.553 HD23 ' CE1' ' A' ' 42' ' ' TYR . 3.1 mt -79.02 -11.61 60.01 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -35.06 9.67 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.007 0.908 . . . . 0.0 109.709 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.651 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 6.9 mm-40 -77.29 -43.68 32.39 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.313 0.578 . . . . 0.0 110.283 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -76.18 -22.41 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.346 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.71 4.26 22.52 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.549 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -170.59 39.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.587 -1.321 . . . . 0.0 112.309 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 97.29 74.74 1.2 Allowed Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.856 -1.64 . . . . 0.0 110.178 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.651 ' CE3' ' CB ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -40.3 83.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.174 0.511 . . . . 0.0 110.752 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.439 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 5.3 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.516 ' CD2' ' OD1' ' A' ' 72' ' ' ASP . 3.9 mt -72.74 -3.69 26.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.62 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.2 -32.18 73.66 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -71.11 -26.86 63.21 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -60.21 -51.92 55.87 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.674 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -50.2 -19.89 0.89 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.616 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -82.61 -43.44 16.99 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.602 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 5.2 t -62.63 -26.35 40.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.9 t80 -101.29 -22.48 14.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.594 -0.691 . . . . 0.0 110.603 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 62.2 m -88.47 22.45 2.54 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.312 -0.868 . . . . 0.0 109.265 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.29 -23.27 0.02 OUTLIER Glycine 0 N--CA 1.484 1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.342 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -122.96 -7.03 8.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.596 -1.532 . . . . 0.0 110.065 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 6.6 m -127.39 -23.04 3.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.45 75.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.769 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.81 -10.53 13.36 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.229 -0.919 . . . . 0.0 111.77 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 94.7 m -140.64 19.04 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.648 -1.282 . . . . 0.0 110.052 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 89.4 m-70 -158.31 -53.3 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.266 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.486 ' O ' ' O ' ' A' ' 18' ' ' HIS . 5.0 ptt? 35.58 98.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.251 0.548 . . . . 0.0 110.795 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 72.27 52.52 10.66 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.605 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 37.05 83.37 0.01 OUTLIER Glycine 0 N--CA 1.483 1.822 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -161.7 93.74 0.12 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' GLY . 3.8 t-20 -40.72 157.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.577 -0.955 . . . . 0.0 109.823 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.476 HG13 ' CA ' ' A' ' 17' ' ' CYS . 2.3 p -120.87 -20.3 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.73 -68.61 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -58.2 168.83 0.94 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.953 . . . . 0.0 109.936 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -129.39 57.82 1.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 1.7 p30 178.09 -46.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.343 -0.848 . . . . 0.0 109.139 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 58.8 mttt -75.94 101.58 5.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.685 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 35' ' ' ALA . 5.9 m -118.88 173.0 7.14 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.605 ' HB2' ' HA2' ' A' ' 21' ' ' GLY . 1.2 mp -91.9 -19.35 22.57 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.319 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 1.9 ptmt -59.72 179.65 0.12 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.95 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 17.1 ptmt -81.7 -38.52 25.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 2.8 mt-10 -55.89 -33.62 64.79 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 110.499 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.58 -42.0 5.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 110.94 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -66.34 -15.12 63.01 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.573 ' OE2' ' CD1' ' A' ' 42' ' ' TYR . 62.4 mt-10 -114.3 0.41 14.14 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -74.53 -51.91 13.35 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.206 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -87.31 -43.05 12.44 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.364 179.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.94 33.2 0.43 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.023 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -91.01 14.03 15.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.753 -1.439 . . . . 0.0 108.949 179.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.6 ' CD2' ' O ' ' A' ' 42' ' ' TYR . 48.5 t80 -74.03 15.4 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.619 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -106.27 125.75 51.38 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.628 -1.295 . . . . 0.0 110.665 -179.162 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.523 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.6 pt-20 -44.41 -56.71 4.02 Favored 'General case' 0 C--O 1.201 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 108.861 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.65 -41.1 21.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 110.388 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 43' ' ' SER . . . -57.65 -71.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.966 . . . . 0.0 110.122 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 7.4 tt -68.1 -7.86 7.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 110.135 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.534 HG13 ' CB ' ' A' ' 74' ' ' ALA . 3.7 mt -81.54 -31.88 11.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.63 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 41.1 t80 -92.02 -13.19 31.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.558 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.64 -14.28 26.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 53.9 t -101.5 -35.44 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.973 0.892 . . . . 0.0 109.874 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.564 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -74.19 -4.85 38.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.716 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -164.38 32.42 0.07 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.571 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.529 ' HA2' ' CG ' ' A' ' 58' ' ' MET . . . 45.59 -137.31 7.11 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.4 OUTLIER 157.9 128.93 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.937 -0.631 . . . . 0.0 109.311 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 51.9 m-80 62.95 -86.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -123.67 32.47 5.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.947 . . . . 0.0 109.735 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.608 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.1 ttt -111.7 141.92 25.62 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.061 -1.024 . . . . 0.0 109.147 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.608 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 31.0 Cg_endo -76.48 104.06 1.85 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.073 2.515 . . . . 0.0 114.293 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.716 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -52.28 121.97 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.73 -0.606 . . . . 0.0 109.813 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.595 ' CD2' HD12 ' A' ' 65' ' ' LEU . 39.6 m-85 -93.02 -55.66 3.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.96 -1.088 . . . . 0.0 108.558 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.521 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 27.53 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.207 0.527 . . . . 0.0 110.132 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 166.01 -15.53 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.582 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -101.87 -29.34 11.9 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.595 HD12 ' CD2' ' A' ' 61' ' ' PHE . 7.5 mp -94.49 114.12 26.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.552 ' O ' ' O ' ' A' ' 65' ' ' LEU . 3.3 m -43.7 179.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.419 0.628 . . . . 0.0 110.264 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.54 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -75.75 -62.38 1.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.913 -1.117 . . . . 0.0 109.083 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 32.6 mt-10 -61.99 -9.49 7.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.386 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.602 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.6 OUTLIER -94.66 -34.91 12.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CD1' ' CB ' ' A' ' 65' ' ' LEU . 7.0 mm -69.68 -14.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.5 mp0 -97.31 -69.87 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.581 1.181 . . . . 0.0 109.164 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.667 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 42.1 m-20 -52.36 -33.87 44.97 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.393 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.659 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.3 p -69.53 -30.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.619 0.723 . . . . 0.0 109.878 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.534 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -74.68 -57.72 3.74 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.21 -19.16 53.05 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.674 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 61.9 t80 -64.93 -41.89 95.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.606 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 40.7 t -72.95 -24.24 20.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 1.1 mt -85.32 -7.85 58.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 9.8 t0 -99.67 -36.86 9.35 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.183 0.992 . . . . 0.0 109.242 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.59 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 6.5 mm-40 -78.62 -40.15 35.18 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.202 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.58 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -62.62 -37.65 87.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.774 . . . . 0.0 109.891 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.66 13.96 12.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 110.93 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 2.3 ptmt -150.03 30.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.544 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.97 74.06 1.26 Allowed Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.847 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.606 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 1.7 m95 -40.79 84.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.161 -0.611 . . . . 0.0 110.854 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.908 0.385 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 79' ' ' ASP . 1.7 mp -67.06 -7.76 25.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.9 -1.125 . . . . 0.0 109.286 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.76 -31.89 68.77 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -68.6 -36.97 79.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.16 -62.96 5.47 Favored Glycine 0 C--O 1.203 -1.812 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.64 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.55 -30.08 4.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -1.207 . . . . 0.0 109.86 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -64.48 -45.29 88.0 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 108.376 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 41.2 t -75.77 -55.4 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.613 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 7.9 t80 -57.43 -26.11 60.65 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 110.438 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 28.9 t -86.24 19.08 2.84 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -162.16 11.15 0.11 Allowed Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 8.8 m-80 -153.97 -53.16 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.683 -1.481 . . . . 0.0 109.159 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.613 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.3 m -73.38 -26.38 60.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' HA ' ' CA ' ' A' ' 19' ' ' MET . . . -52.1 -41.0 62.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.2 68.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.903 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.583 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 85.8 m -121.55 19.13 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.922 -1.111 . . . . 0.0 110.649 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 93.8 m-70 -158.67 -66.5 0.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.164 -0.96 . . . . 0.0 109.25 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 14.2 ptm 39.48 98.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.531 0.682 . . . . 0.0 110.286 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.45 46.02 80.95 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 51.09 68.19 1.61 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 30' ' ' THR . . . -143.29 88.32 0.17 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.484 ' ND2' ' CE1' ' A' ' 18' ' ' HIS . 1.2 t-20 -61.9 142.25 57.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -1.118 . . . . 0.0 109.778 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 17' ' ' CYS . 17.4 m -102.16 -13.26 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.56 -57.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.92 . . . . 0.0 109.127 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.483 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 9.5 mmt -103.36 93.97 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.845 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.18 -47.55 35.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.733 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -35.62 80.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.192 -0.943 . . . . 0.0 109.885 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 0.0 OUTLIER -84.29 82.68 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 21' ' ' GLY . 24.5 m -122.01 171.97 8.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.052 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.657 ' CD1' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.74 -3.49 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -46.01 173.53 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.142 -0.974 . . . . 0.0 109.964 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -84.17 -27.65 27.94 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.312 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -82.51 -27.12 31.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.96 . . . . 0.0 111.074 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.42 -35.21 7.18 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.292 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.558 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -60.6 -39.7 89.11 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.115 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.557 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -96.93 6.06 49.34 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.503 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -69.33 -47.21 65.1 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.5 -39.04 16.65 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.656 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.52 79.17 0.6 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.437 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.521 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -159.16 25.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -1.098 . . . . 0.0 108.798 179.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.65 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 33.8 t80 -74.68 3.12 8.4 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.518 0.675 . . . . 0.0 109.621 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.46 ' CA ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -103.94 155.59 18.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.707 -1.245 . . . . 0.0 110.999 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 1.3 mp0 -50.44 -64.73 0.72 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.871 -0.518 . . . . 0.0 110.515 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -46.48 -31.57 2.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.77 -1.206 . . . . 0.0 111.437 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 41' ' ' MET . . . -69.65 -73.94 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.784 -1.198 . . . . 0.0 110.658 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.547 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 10.4 tt -60.31 -17.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.25 -0.906 . . . . 0.0 109.622 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 44' ' ' GLU . 21.6 mt -72.31 -34.44 49.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 52.1 t80 -71.64 -29.98 65.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 2.5 pm0 -94.39 -13.2 26.56 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.774 -1.57 . . . . 0.0 109.125 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 60.2 t -87.76 -23.73 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.009 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.566 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -99.39 -7.68 25.85 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.47 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.657 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -147.35 13.6 1.09 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 53.5 -135.33 41.54 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.612 ' N ' ' HB3' ' A' ' 58' ' ' MET . 4.9 mtpt 155.17 127.48 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 16.0 m-80 61.0 -88.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -121.9 29.29 7.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.235 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.612 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 27.8 ttt -107.12 141.89 23.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 37.0 Cg_endo -85.06 99.22 0.69 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.202 2.601 . . . . 0.0 113.879 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.607 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -37.54 158.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 0.0 110.018 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 60' ' ' ALA . 14.4 m-85 -137.03 22.62 3.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -5.07 2.46 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.48 16.74 0.99 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.64 -55.83 2.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.539 ' N ' HD11 ' A' ' 65' ' ' LEU . 4.7 mp -66.52 -157.42 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 1.4 m -99.51 -58.36 1.94 Allowed 'General case' 0 C--N 1.285 -2.236 0 O-C-N 121.246 -0.909 . . . . 0.0 109.259 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 66' ' ' THR . 3.7 m-20 153.72 -53.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 3.7 mt-10 -69.01 -3.77 14.3 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.589 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.88 -25.81 9.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 65' ' ' LEU . 12.3 mm -57.37 -23.13 18.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.9 mp0 -96.37 -70.47 0.71 Allowed 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.515 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 2.8 m-20 -44.66 -46.4 10.2 Favored 'General case' 0 C--O 1.203 -1.394 0 O-C-N 121.857 -0.527 . . . . 0.0 110.026 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.688 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -62.05 -37.02 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.628 0.728 . . . . 0.0 110.005 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.528 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -67.23 -61.84 1.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.1 -18.99 17.03 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.688 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 71.3 t80 -67.14 -44.16 80.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.655 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 85.0 t -71.11 -19.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 75' ' ' ALA . 2.4 mt -84.6 -9.52 58.22 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.293 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.48 ' HB3' ' OE1' ' A' ' 80' ' ' GLN . 7.4 t0 -99.21 -45.87 5.74 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.188 0.994 . . . . 0.0 108.604 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.622 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.1 mm100 -65.59 -50.07 66.44 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.082 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.541 ' CB ' ' CD2' ' A' ' 36' ' ' LEU . . . -74.14 -12.1 60.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.55 -0.719 . . . . 0.0 109.22 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -65.28 -7.46 13.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.53 -0.731 . . . . 0.0 110.023 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -179.9 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.754 -1.217 . . . . 0.0 111.64 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.52 75.9 1.31 Allowed Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.019 -1.562 . . . . 0.0 109.669 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.655 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -39.74 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.39 -0.476 . . . . 0.0 110.551 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.799 . . . . 0.0 109.204 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.498 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 8.6 m-20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.464 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -66.86 -4.91 10.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.554 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.95 -25.41 60.92 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.3 m-20 -77.68 -36.94 50.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.462 ' CA ' ' OD1' ' A' ' 72' ' ' ASP . . . -50.72 -55.98 15.47 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.646 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . -60.31 -24.95 65.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.767 -0.843 . . . . 0.0 109.712 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -68.88 -30.28 68.74 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.838 -1.164 . . . . 0.0 108.331 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 22.8 t -97.73 -23.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.479 -0.763 . . . . 0.0 110.056 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.631 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 t80 -89.17 -25.89 21.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.845 -1.159 . . . . 0.0 109.921 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 17.1 m -78.81 7.34 7.21 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.638 -0.664 . . . . 0.0 110.081 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -156.46 13.02 0.34 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.378 -1.392 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 1.3 m-80 -139.01 -42.4 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.802 -1.411 . . . . 0.0 109.057 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -97.22 -22.76 16.52 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -47.59 -50.37 24.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.716 -0.615 . . . . 0.0 110.455 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.16 71.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 110.776 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 64.4 m -112.94 15.07 19.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.921 -1.112 . . . . 0.0 110.006 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 81.1 m-70 -159.15 -64.45 0.08 Allowed 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 50.24 108.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.497 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.48 57.07 9.76 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 45.99 66.67 1.56 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 30' ' ' THR . . . -144.67 81.78 0.21 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -53.3 153.45 3.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -1.201 . . . . 0.0 109.324 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 m -128.12 5.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 109.997 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.7 t -105.29 -59.57 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 109.31 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.4 mmm -86.38 -173.28 4.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.94 . . . . 0.0 109.369 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -128.67 57.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 1.5 p-10 169.27 -41.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.806 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -71.47 89.02 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 109.876 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.473 HG22 ' HA2' ' A' ' 22' ' ' GLY . 9.6 m -122.43 170.96 9.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.318 -0.863 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.65 ' CD1' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -89.91 -11.71 41.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.997 . . . . 0.0 108.955 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -34.3 -71.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.645 -0.659 . . . . 0.0 111.6 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 1.5 tptm 170.07 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.724 -1.235 . . . . 0.0 110.196 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 32.1 mt-10 -72.2 -46.3 56.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.112 -0.992 . . . . 0.0 111.06 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.597 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.48 -48.41 49.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.029 -1.044 . . . . 0.0 111.132 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -65.97 -14.15 61.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.65 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.541 ' CG ' ' CD2' ' A' ' 42' ' ' TYR . 3.0 mm-40 -119.22 8.4 11.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.773 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.5 tp-100 -87.06 -53.06 5.07 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.25 -40.52 13.59 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.736 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.51 44.35 0.18 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.752 -1.214 . . . . 0.0 110.785 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.483 ' O ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -105.78 9.05 33.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.333 . . . . 0.0 109.187 179.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 27.6 t80 -71.98 13.99 0.25 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 111.449 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.463 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -106.0 136.26 45.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.35 -1.469 . . . . 0.0 110.745 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.56 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 1.4 mt-10 -44.1 -57.51 3.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.297 -0.877 . . . . 0.0 108.83 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -51.41 -38.75 55.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 43' ' ' SER . . . -58.12 -73.82 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.541 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 6.6 tt -64.47 -11.27 10.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 110.083 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 14.8 mt -78.96 -31.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 40.0 t80 -92.32 -14.4 28.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.549 ' OE1' ' CB ' ' A' ' 55' ' ' LYS . 1.4 tp60 -93.93 -14.47 25.95 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 54.2 t -97.32 -44.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.532 ' HB3' ' CD2' ' A' ' 53' ' ' HIS . 0.9 OUTLIER -64.27 -13.94 52.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.582 . . . . 0.0 111.313 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.644 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -147.88 21.54 1.13 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.581 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.36 -130.53 50.56 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.7 137.39 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 58.24 -89.48 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.61 41.46 3.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.614 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 17.5 ttt -113.94 143.97 30.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.614 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.2 Cg_endo -77.39 107.74 2.46 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.334 2.689 . . . . 0.0 114.709 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.644 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.55 159.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 111.039 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.636 ' CD1' ' O ' ' A' ' 60' ' ' ALA . 10.0 m-30 -141.12 16.26 2.26 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.8 -0.562 . . . . 0.0 110.116 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 52' ' ' GLN . . . -66.28 -2.99 4.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.123 178.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.53 17.8 1.13 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.22 -57.49 2.11 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.551 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 36.0 mt -73.51 -149.1 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 1.4 m -99.53 -61.52 1.36 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.9 t70 156.7 -51.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 12.3 tp10 -71.15 4.01 3.08 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.585 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -112.21 -33.24 6.28 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CD1' ' CD1' ' A' ' 65' ' ' LEU . 36.0 mm -58.28 -24.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.421 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -91.6 -73.52 0.54 Allowed 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.713 178.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 15.1 t0 -44.65 -53.7 6.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.731 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 11.5 t -56.09 -39.54 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.362 1.077 . . . . 0.0 108.159 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.429 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -55.77 -59.15 5.28 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.97 -18.77 59.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.731 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 65.0 t80 -67.27 -38.06 84.49 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.607 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 93.7 t -76.78 -23.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -86.41 -6.48 58.91 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -98.2 -52.63 3.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.265 1.031 . . . . 0.0 108.404 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.594 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 45.7 mm-40 -65.16 -46.34 81.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.365 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -70.57 -12.39 61.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.321 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -78.08 -4.45 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.45 -0.781 . . . . 0.0 110.963 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -178.32 57.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.454 -1.404 . . . . 0.0 111.961 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 89.56 75.96 1.3 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 118.947 -1.597 . . . . 0.0 109.339 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.607 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -40.7 84.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.177 0.513 . . . . 0.0 110.826 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.337 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.66 -11.93 61.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 108.588 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -30.42 66.57 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.49 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.43 -37.32 65.93 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -49.72 -59.09 7.62 Favored Glycine 0 C--O 1.201 -1.948 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.626 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -54.06 -35.05 61.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.103 . . . . 0.0 109.79 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 108.995 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.603 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 37.5 t -86.15 -43.08 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 110.563 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 10' ' ' PHE . 7.8 t80 -63.46 -27.68 69.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.726 -1.234 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 p -86.52 18.47 3.29 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 109.473 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.71 6.96 0.66 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.243 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -152.56 -49.76 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.605 -1.527 . . . . 0.0 109.468 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 2.3 m -76.46 -30.69 57.43 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 19' ' ' MET . . . -43.6 -42.45 5.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.679 -0.638 . . . . 0.0 110.294 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -46.96 85.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.944 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.582 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 66.5 m -107.28 29.54 7.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.608 ' CE1' HD22 ' A' ' 31' ' ' LEU . 77.8 m-70 -162.6 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.499 ' O ' ' O ' ' A' ' 18' ' ' HIS . 9.8 ptt? 39.04 100.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.49 0.662 . . . . 0.0 110.777 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 87.26 41.95 6.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 39.32 58.73 1.97 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.449 ' HA2' HG21 ' A' ' 30' ' ' THR . . . -151.64 103.85 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -56.11 162.08 2.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.197 . . . . 0.0 109.05 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.4 -29.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.047 -1.033 . . . . 0.0 109.986 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -79.09 -70.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.099 -1.001 . . . . 0.0 109.337 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.3 mmt -66.48 150.85 48.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.278 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -113.54 60.35 0.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 109.685 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.47 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.8 p30 -178.69 -44.17 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.985 . . . . 0.0 109.364 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' CD ' ' HE3' ' A' ' 41' ' ' MET . 25.0 mttp -81.86 124.37 29.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.121 -0.987 . . . . 0.0 109.071 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.48 ' O ' HD21 ' A' ' 36' ' ' LEU . 2.1 m -121.47 -174.18 2.8 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.274 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.608 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -100.24 -13.93 18.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 81' ' ' ALA . 24.2 mtpt -59.78 -98.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.144 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' HB2' ' CD2' ' A' ' 42' ' ' TYR . 14.7 ptpt -177.25 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -51.47 -29.07 15.02 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.584 ' C ' ' CE2' ' A' ' 39' ' ' PHE . . . -104.48 -71.79 0.73 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.396 -0.815 . . . . 0.0 110.095 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.588 HD13 ' CG ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -40.56 -39.91 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.532 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -82.96 -33.45 26.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.92 -1.112 . . . . 0.0 109.215 179.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -45.79 -44.3 13.91 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CE2' ' C ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -85.83 -72.24 0.5 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.9 89.18 0.07 OUTLIER Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER 179.48 26.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -1.2 . . . . 0.0 110.395 -178.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.588 ' CG ' HD13 ' A' ' 36' ' ' LEU . 3.3 t80 -109.04 23.37 14.64 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 109.473 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 p -107.79 153.42 23.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.546 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -42.52 -65.67 0.44 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 109.858 178.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -52.18 -32.91 38.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.015 . . . . 0.0 110.437 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.503 ' C ' ' NE2' ' A' ' 50' ' ' GLN . . . -62.55 -73.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.28 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.556 HG12 ' CG2' ' A' ' 51' ' ' VAL . 10.6 tt -62.57 -13.8 11.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 32.7 mt -77.22 -28.67 16.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.646 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 25.7 t80 -85.76 -22.22 27.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.338 -0.851 . . . . 0.0 110.026 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.548 ' O ' ' CE ' ' A' ' 58' ' ' MET . 2.3 pm0 -99.47 -15.07 18.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 119.789 -1.819 . . . . 0.0 108.735 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.556 ' CG2' HG12 ' A' ' 47' ' ' ILE . 34.5 t -91.43 -27.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 109.516 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.608 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -86.8 -4.4 59.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.788 -1.195 . . . . 0.0 108.144 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.695 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -158.97 22.37 0.2 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.36 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.581 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 48.8 -138.28 15.09 Favored Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.261 -1.935 . . . . 0.0 108.261 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.609 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.9 OUTLIER 156.43 134.53 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.03 -89.38 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -121.76 41.15 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.507 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.626 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 18.2 ttt -119.76 143.31 34.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 108.726 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.626 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 33.5 Cg_endo -77.31 94.56 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 123.004 2.469 . . . . 0.0 115.347 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.691 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -49.2 112.94 0.7 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.288 -0.882 . . . . 0.0 110.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.675 ' CD2' ' CD2' ' A' ' 65' ' ' LEU . 25.9 m-85 -81.41 -51.2 8.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.11 26.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.384 0.612 . . . . 0.0 109.606 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.85 32.74 0.63 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.645 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -100.29 -48.52 4.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.675 ' CD2' ' CD2' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -64.12 -141.0 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.581 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 3.3 m -98.02 -52.11 3.81 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 121.01 -1.056 . . . . 0.0 109.175 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.7 m-20 150.77 -60.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 35.2 mm-40 -68.22 -2.02 7.31 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.679 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -111.11 -29.82 7.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.534 ' CD1' HD21 ' A' ' 65' ' ' LEU . 9.7 mm -52.47 -24.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.52 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -100.21 -60.42 1.53 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.442 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.679 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 13.9 m-20 -52.69 -47.6 67.13 Favored 'General case' 0 C--O 1.189 -2.114 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.527 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.585 ' C ' ' HB3' ' A' ' 76' ' ' TYR . 6.3 t -54.56 -29.17 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 108.791 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.609 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -77.67 -67.64 0.7 Allowed 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.47 -23.62 2.58 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.012 -1.68 . . . . 0.0 107.515 177.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.626 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 35.6 t80 -64.74 -46.23 83.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.188 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.675 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.4 p -67.74 -23.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.5 mt -78.34 -12.13 59.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 3.6 t0 -100.74 -34.62 9.77 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.793 0.806 . . . . 0.0 109.713 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.593 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 4.2 mm-40 -76.95 -40.63 46.37 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.27 0.557 . . . . 0.0 110.198 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 32' ' ' LYS . . . -69.48 -26.15 64.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 108.952 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.45 11.65 18.71 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 111.036 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -162.53 29.5 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.344 -1.473 . . . . 0.0 112.442 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 92.31 75.7 1.31 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.71 -1.709 . . . . 0.0 109.202 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.675 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.6 OUTLIER -36.9 89.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.532 0.682 . . . . 0.0 110.152 178.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.3 -1.574 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 79' ' ' ASP . 4.8 mt -69.61 -5.28 23.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.133 -0.979 . . . . 0.0 109.449 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.58 68.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.8 -33.95 64.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.85 -61.82 6.71 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.66 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.47 -36.66 15.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.271 . . . . 0.0 109.66 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -58.52 -46.1 87.47 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 42.5 t -75.51 -63.03 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.622 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.1 t80 -46.27 -23.43 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 110.954 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 7' ' ' ALA . 50.3 m -91.49 31.88 1.13 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.24 -0.912 . . . . 0.0 109.168 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.34 -32.73 0.02 OUTLIER Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.896 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.443 ' CG ' HD13 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -118.08 -50.24 2.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.878 -1.366 . . . . 0.0 108.767 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.622 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 6.6 m -70.2 -29.8 66.74 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 10' ' ' PHE . . . -61.14 -38.17 85.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.513 -0.742 . . . . 0.0 110.48 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -11.83 7.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.82 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.576 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 96.9 m -143.01 23.91 1.85 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.869 -1.145 . . . . 0.0 110.082 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 84.8 m-70 -157.9 -68.73 0.09 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.19 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 53.78 110.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.637 -0.664 . . . . 0.0 110.304 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 45.92 62.4 3.39 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 41.64 68.8 0.62 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' HG22 ' A' ' 30' ' ' THR . . . -149.75 87.18 0.15 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -57.85 145.85 33.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -1.107 . . . . 0.0 109.474 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.8 m -97.42 -41.34 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.6 t -83.53 -60.7 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.092 -1.005 . . . . 0.0 109.196 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -86.7 90.19 8.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.77 71.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.713 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -74.16 -39.51 63.19 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.151 -0.968 . . . . 0.0 109.457 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.72 106.79 18.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.366 -0.834 . . . . 0.0 109.425 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.506 ' HB ' ' CD ' ' A' ' 32' ' ' LYS . 7.7 m -126.5 174.81 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.104 -0.998 . . . . 0.0 109.567 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -95.76 -8.83 33.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -34.49 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.573 -178.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.589 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 14.9 ttpp -178.42 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.824 -1.173 . . . . 0.0 110.592 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -80.16 -53.3 6.8 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.082 -1.011 . . . . 0.0 111.63 -178.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.617 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -67.75 -53.84 24.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.937 -1.102 . . . . 0.0 110.521 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -44.84 -23.76 0.16 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.565 -179.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 89.4 mt-10 -95.25 -32.56 12.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 110.307 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 15.5 mm100 -52.17 -39.52 60.19 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.617 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.87 -47.9 8.64 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.33 8.37 5.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.538 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 4.2 ptt? -80.94 11.78 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -1.153 . . . . 0.0 109.98 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.593 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 15.0 t80 -85.11 12.22 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.946 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 p -105.15 149.28 26.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.26 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 48' ' ' ILE . 3.8 tt0 -54.39 -57.4 11.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.849 . . . . 0.0 109.64 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 45' ' ' ASP . 16.0 t0 -51.75 -23.13 4.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.643 -1.286 . . . . 0.0 110.3 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.68 -76.17 0.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 6.7 tt -57.91 -16.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 44' ' ' GLU . 15.1 mt -71.89 -39.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.586 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 28.9 t80 -86.36 -16.88 35.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 108.834 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.522 ' OE1' ' CB ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -86.61 -19.97 28.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.665 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.589 HG11 ' CD2' ' A' ' 61' ' ' PHE . 62.3 t -96.22 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.503 1.144 . . . . 0.0 109.552 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.558 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -71.7 -11.74 60.98 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.272 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.645 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -154.2 23.87 0.49 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.378 -1.451 . . . . 0.0 109.091 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.684 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.42 -148.86 44.51 Favored Glycine 0 C--N 1.285 -2.256 0 N-CA-C 107.627 -2.189 . . . . 0.0 107.627 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.97 117.82 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.9 m-80 63.39 -86.98 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.29 28.32 6.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 108.737 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.647 ' CG ' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.31 141.82 23.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.565 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 31.7 Cg_endo -75.75 105.49 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 123.369 2.713 . . . . 0.0 116.242 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -57.27 117.47 4.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.634 ' CD2' ' CD2' ' A' ' 65' ' ' LEU . 17.7 m-85 -87.9 -45.59 10.12 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.038 -1.039 . . . . 0.0 108.781 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 46.93 19.01 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.39 -0.819 . . . . 0.0 108.906 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 128.65 43.19 0.23 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.555 ' CB ' ' HB3' ' A' ' 61' ' ' PHE . 21.0 ttt180 -101.59 -51.62 3.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.634 ' CD2' ' CD2' ' A' ' 61' ' ' PHE . 2.7 mm? -63.6 -145.13 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 2.5 m -99.0 -56.98 2.28 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 120.896 -1.128 . . . . 0.0 109.642 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER 152.43 -55.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.086 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 24.5 mt-10 -69.75 -1.71 9.96 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.589 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.6 -28.23 8.98 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 65' ' ' LEU . 8.2 mm -56.29 -23.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.482 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.9 mp0 -95.56 -70.31 0.72 Allowed 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.442 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 5.4 m-20 -45.19 -47.29 12.5 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.954 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.715 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -60.45 -36.25 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.74 0.781 . . . . 0.0 110.132 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -68.34 -62.71 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.529 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.19 -19.14 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 82.5 t80 -65.02 -45.27 86.22 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.466 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 42.5 t -68.87 -24.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.429 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.529 ' HG ' ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -83.53 -4.76 58.83 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.908 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.469 ' HB2' HD11 ' A' ' 3' ' ' LEU . 5.0 t0 -97.41 -45.4 6.47 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.774 ' HB3' ' CD2' ' A' ' 85' ' ' TRP . 10.7 mp0 -72.08 -31.75 66.38 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.2 0.524 . . . . 0.0 110.344 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 33' ' ' LYS . . . -58.44 -52.72 64.43 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.73 19.39 4.03 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -131.95 5.57 4.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 111.597 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.5 76.15 1.04 Allowed Glycine 0 C--N 1.296 -1.672 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.774 ' CD2' ' HB3' ' A' ' 80' ' ' GLN . 18.0 m95 -38.28 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.417 0.627 . . . . 0.0 110.804 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 109.824 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.415 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 35.1 t70 . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.471 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.24 -3.98 23.27 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.08 -1.012 . . . . 0.0 108.424 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.92 -31.12 72.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.504 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.2 m-20 -71.6 -26.54 62.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.629 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -60.56 -64.11 4.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.853 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -39.77 -34.24 0.24 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.875 -0.78 . . . . 0.0 109.275 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.17 -52.49 40.82 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.697 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 23.6 t -52.19 -57.29 4.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.715 -0.615 . . . . 0.0 110.349 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.783 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 19.8 t80 -59.37 -33.46 71.21 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.986 -1.072 . . . . 0.0 110.473 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 t -91.1 21.17 4.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.283 -0.885 . . . . 0.0 110.073 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.63 -8.64 0.68 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.483 ' ND2' HD21 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -149.12 3.67 0.6 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.484 -1.598 . . . . 0.0 111.525 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.551 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -132.65 -44.99 0.89 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.564 -1.335 . . . . 0.0 110.979 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . -27.38 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.13 0.491 . . . . 0.0 111.196 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -61.8 -53.48 55.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 110.762 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' HA ' ' CG1' ' A' ' 24' ' ' VAL . 84.4 m -94.85 25.02 4.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 109.628 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.561 ' CE1' ' HG ' ' A' ' 31' ' ' LEU . 28.5 m-70 -157.1 -72.08 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.743 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 2.5 mtp 43.71 100.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.313 0.578 . . . . 0.0 110.631 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 75.72 50.8 7.64 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.471 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 37.98 45.82 1.68 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -127.42 101.0 0.56 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.3 t-20 -46.16 165.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -1.198 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' CG1' ' HA ' ' A' ' 17' ' ' CYS . 1.7 p -111.73 -40.41 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.181 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.404 HG22 HG11 ' A' ' 24' ' ' VAL . 2.7 t -91.72 -70.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.227 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.92 101.18 8.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.55 75.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.641 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 2.2 p-10 -65.8 -44.93 84.23 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.15 -0.969 . . . . 0.0 109.387 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.2 tptt -85.12 79.69 9.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.449 -0.782 . . . . 0.0 109.677 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 6.7 t -101.04 -176.47 3.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.905 . . . . 0.0 109.69 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -97.3 -19.07 18.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.73 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -38.61 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.692 -0.63 . . . . 0.0 111.407 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.582 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 0.6 OUTLIER 174.63 -39.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.019 . . . . 0.0 109.95 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.71 . . . . 0.0 111.103 -178.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.603 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -93.31 -47.24 7.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 110.803 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.67 ' CD1' ' CG ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -58.85 -33.21 70.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.557 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 42' ' ' TYR . 2.0 mm-40 -95.75 -1.28 50.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.568 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -73.69 -57.61 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -88.27 -48.98 7.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.456 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.58 92.84 0.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.525 ' SD ' ' CB ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -172.13 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.048 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.67 ' CG ' ' CD1' ' A' ' 36' ' ' LEU . 2.2 t80 -102.14 21.73 14.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.482 -0.761 . . . . 0.0 109.751 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -107.4 143.78 35.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 0.0 111.216 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -42.42 -62.78 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.47 -0.769 . . . . 0.0 109.588 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -49.01 -37.6 20.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 110.751 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -74.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.995 -1.066 . . . . 0.0 110.44 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.54 HG12 ' CG2' ' A' ' 51' ' ' VAL . 8.0 tt -64.28 -10.51 8.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.528 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 44' ' ' GLU . 10.7 mt -75.4 -37.64 38.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 34.0 t80 -89.5 -15.96 31.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -88.34 -14.48 38.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.54 ' CG2' HG12 ' A' ' 47' ' ' ILE . 54.5 t -97.2 -47.71 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.392 -0.818 . . . . 0.0 110.006 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.534 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -61.34 -9.92 6.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.737 -0.602 . . . . 0.0 110.878 -178.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.64 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.51 23.54 0.4 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 54.01 -133.84 44.66 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.03 120.76 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.208 0.528 . . . . 0.0 109.737 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 2.5 m120 73.85 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.8 29.4 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.195 -0.941 . . . . 0.0 108.859 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.582 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 27.0 ttt -108.23 143.79 28.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 109.346 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 32.9 Cg_endo -79.89 111.98 2.81 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.012 2.475 . . . . 0.0 113.171 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.64 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -37.68 159.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.599 -0.688 . . . . 0.0 110.246 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 60' ' ' ALA . 5.9 m-85 -147.23 21.71 1.21 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.483 -0.76 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.02 -10.8 10.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.03 . . . . 0.0 109.063 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.38 13.12 5.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.581 ' HG3' ' CD1' ' A' ' 61' ' ' PHE . 6.6 mmt85 -104.07 -48.11 3.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.589 ' HG ' ' HB3' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -95.41 124.83 39.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.524 ' O ' ' O ' ' A' ' 65' ' ' LEU . 5.3 m -44.26 178.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.258 0.552 . . . . 0.0 110.049 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.509 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 4.3 m-20 -65.21 -59.38 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.798 -1.189 . . . . 0.0 109.204 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.579 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 4.4 mt-10 -71.1 1.91 5.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.653 -0.654 . . . . 0.0 109.533 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.697 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -102.67 -27.17 12.88 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.53 HD12 ' HG ' ' A' ' 65' ' ' LEU . 25.6 mm -73.01 -31.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.8 mp0 -80.01 -64.64 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.68 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.579 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 40.7 t0 -56.86 -30.41 63.82 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.117 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.679 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 8.7 p -70.52 -29.39 38.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.501 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -70.4 -58.2 3.99 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.411 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -55.97 -23.39 32.11 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.853 ' CE2' ' HA ' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.77 -50.62 68.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.594 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 44.0 t -65.77 -22.66 31.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.89 -1.131 . . . . 0.0 109.489 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.599 HD21 ' CE1' ' A' ' 42' ' ' TYR . 1.9 mt -87.32 -7.19 58.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.038 -1.039 . . . . 0.0 108.876 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -97.77 -40.99 8.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.018 0.913 . . . . 0.0 108.761 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.65 ' CB ' ' CD2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -72.14 -45.14 61.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -76.36 -5.45 47.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -75.35 -13.54 60.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.489 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER 176.3 66.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.702 -1.249 . . . . 0.0 111.076 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 91.82 77.44 1.35 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.65 ' CD2' ' CB ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -40.21 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.389 0.614 . . . . 0.0 110.7 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.875 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 0.8 OUTLIER -69.17 -8.6 47.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.123 -0.986 . . . . 0.0 108.554 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.43 -22.52 54.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -78.86 -37.01 41.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -62.39 -53.2 43.75 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.674 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.15 -24.83 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.016 -1.285 . . . . 0.0 109.368 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.494 ' HE3' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -73.97 -47.24 38.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.662 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 14.8 t -55.38 -65.03 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 122.219 1.009 . . . . 0.0 108.918 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 t80 -60.73 -28.9 69.03 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 33.0 t -89.88 18.05 6.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.556 -1.34 . . . . 0.0 109.513 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -155.56 3.54 0.2 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.88 -1.152 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -155.49 -46.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.604 -1.527 . . . . 0.0 109.56 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.2 m -79.65 -30.38 41.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.61 -41.2 66.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 110.945 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.5 79.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.262 -0.899 . . . . 0.0 111.151 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.537 ' HA ' ' CG1' ' A' ' 24' ' ' VAL . 1.8 m -110.95 20.08 17.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.879 -1.138 . . . . 0.0 110.013 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.592 ' CE1' HD23 ' A' ' 31' ' ' LEU . 89.2 m-70 -155.58 -51.37 0.08 Allowed 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.544 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.0 ptm 42.39 111.07 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.756 0.788 . . . . 0.0 111.556 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 49.95 57.47 9.84 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.36 72.86 0.26 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.539 ' HA2' ' CG2' ' A' ' 30' ' ' THR . . . -153.83 92.49 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 1.1 t-20 -43.85 156.76 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -1.053 . . . . 0.0 109.812 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 17' ' ' CYS . 3.3 p -115.86 -35.67 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 109.633 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.486 ' N ' HG11 ' A' ' 24' ' ' VAL . 13.4 t -91.51 -68.53 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.867 . . . . 0.0 109.651 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.437 ' HE2' ' HD3' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -60.61 161.45 7.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 28' ' ' ASN . . . -117.03 63.83 0.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.905 . . . . 0.0 109.265 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 163.65 -39.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.208 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 2.7 mptt -71.73 83.23 0.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.539 ' CG2' ' HA2' ' A' ' 22' ' ' GLY . 2.1 m -99.38 -168.09 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 108.816 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.592 HD23 ' CE1' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -109.83 -2.8 17.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.677 -1.264 . . . . 0.0 109.651 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.53 ' N ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -60.19 -82.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.993 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 36' ' ' LEU . 3.2 ptmm? 168.75 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.658 -1.276 . . . . 0.0 110.936 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.72 -34.53 5.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.907 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.09 -66.44 1.02 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.84 0.828 . . . . 0.0 110.365 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.609 ' CD1' ' CB ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -44.75 -46.43 10.46 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.927 -0.483 . . . . 0.0 111.846 -178.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.474 ' HA ' ' CD1' ' A' ' 42' ' ' TYR . 43.4 tt0 -60.94 -34.63 75.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.569 -1.332 . . . . 0.0 110.333 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 3.2 mm-40 -73.81 -77.9 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.17 7.57 43.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.524 -0.735 . . . . 0.0 111.851 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 36' ' ' LEU . . . -124.88 -3.62 7.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.691 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.9 mtt 42.57 48.38 4.64 Favored 'General case' 0 C--O 1.196 -1.739 0 O-C-N 121.241 -1.152 . . . . 0.0 109.527 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.609 ' CB ' ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -39.01 -21.81 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 O-C-N 120.912 -1.117 . . . . 0.0 111.368 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -42.45 166.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.773 -1.204 . . . . 0.0 110.508 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.512 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -52.64 -73.18 0.04 OUTLIER 'General case' 0 C--O 1.2 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 110.579 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 44' ' ' GLU . 33.5 t0 -36.72 -51.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.209 -0.932 . . . . 0.0 112.492 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.691 ' CB ' ' O ' ' A' ' 41' ' ' MET . . . -63.35 -73.25 0.12 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 111.204 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 14.0 tt -51.0 -20.55 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.016 -1.052 . . . . 0.0 109.677 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 44' ' ' GLU . 14.0 mt -72.12 -38.25 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.626 -0.671 . . . . 0.0 109.445 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -77.44 -26.79 51.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.5 pm0 -89.13 -18.86 26.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.213 -1.554 . . . . 0.0 108.702 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.535 ' HA ' ' CE ' ' A' ' 58' ' ' MET . 45.3 t -85.78 -44.8 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.942 0.877 . . . . 0.0 109.389 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.559 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -66.74 -10.69 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.821 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -158.65 23.29 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.71 -1.196 . . . . 0.0 108.612 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 55.89 -141.34 39.98 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.586 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 154.23 142.5 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 54.98 -90.56 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.12 49.0 2.33 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.589 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 ttt -121.04 144.6 39.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.9 Cg_endo -82.54 105.21 1.39 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 123.077 2.518 . . . . 0.0 113.67 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.62 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -39.45 154.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 110.677 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD1' HD13 ' A' ' 65' ' ' LEU . 23.0 m-85 -136.72 3.46 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 52' ' ' GLN . . . -44.36 -29.67 0.71 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.76 36.64 0.51 Allowed Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.095 -1.526 . . . . 0.0 109.805 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HB3' HD22 ' A' ' 65' ' ' LEU . 10.7 ttt-85 -102.0 -48.34 4.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.557 HD13 ' CD1' ' A' ' 61' ' ' PHE . 1.6 mt -93.68 -146.03 0.24 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.552 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -84.73 -172.94 4.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 69' ' ' GLN . 3.6 m-20 -93.45 -55.74 3.18 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.9 mt-10 -72.36 5.61 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.662 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -102.34 -31.85 10.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 66' ' ' THR . 2.2 mm -72.24 -26.06 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -66.73 0.86 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.774 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 53.9 t0 -58.61 -28.47 65.65 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.128 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.65 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 7.9 p -69.14 -26.73 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -75.18 -56.75 4.42 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.06 -19.62 53.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.674 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 78.6 t80 -67.85 -41.09 83.46 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 39.9 t -70.04 -22.61 24.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -85.39 -8.46 58.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 1.8 t70 -99.02 -35.52 10.02 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.946 0.879 . . . . 0.0 109.16 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.625 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 7.2 mm-40 -81.96 -34.01 29.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.233 0.54 . . . . 0.0 109.942 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -62.92 -48.16 80.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.852 . . . . 0.0 109.101 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.52 18.54 3.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.445 -0.784 . . . . 0.0 109.358 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -134.86 13.38 3.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 0.0 110.963 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 77.74 75.73 0.93 Allowed Glycine 0 C--N 1.296 -1.694 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.625 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 11.7 m95 -34.76 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.727 0.775 . . . . 0.0 109.417 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 109.969 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 1.7 m-20 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 72' ' ' ASP . 1.8 pp -72.88 2.21 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.074 -1.016 . . . . 0.0 109.613 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.14 70.55 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -62.86 -25.65 68.39 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -59.55 -51.2 60.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.649 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -45.54 -25.45 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.714 -1.463 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -75.0 -47.82 27.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 177.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.638 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 21.1 t -55.44 -64.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 121.948 0.88 . . . . 0.0 109.01 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.598 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 11.6 t80 -59.82 -31.79 70.05 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.768 -0.582 . . . . 0.0 111.11 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 43.1 p -88.53 18.69 4.38 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.788 -1.195 . . . . 0.0 109.653 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -155.7 3.74 0.2 Allowed Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.577 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 9' ' ' VAL . 1.1 m-80 -155.16 -49.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.631 -1.511 . . . . 0.0 109.409 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.4 m -71.96 -34.99 69.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.463 ' O ' ' SD ' ' A' ' 19' ' ' MET . . . -44.99 -42.78 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 110.449 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.87 74.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.187 -0.946 . . . . 0.0 111.706 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.576 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 95.9 m -104.19 27.18 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.885 -1.134 . . . . 0.0 109.87 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 85.7 m-70 -159.89 -67.92 0.07 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.614 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.474 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 55.76 114.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.45 -0.781 . . . . 0.0 110.092 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.32 61.73 1.71 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 44.82 79.62 0.06 OUTLIER Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -160.81 83.35 0.13 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 22' ' ' GLY . 5.1 t-20 -40.51 160.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.611 -0.935 . . . . 0.0 109.586 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.517 ' CG1' ' HA ' ' A' ' 17' ' ' CYS . 14.7 p -116.3 -47.04 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.09 -1.006 . . . . 0.0 110.138 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.497 ' N ' HG12 ' A' ' 24' ' ' VAL . 9.1 p -95.82 -38.52 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -96.56 115.99 28.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.73 -1.231 . . . . 0.0 109.441 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -90.19 71.87 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.6 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER 177.6 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.378 -0.826 . . . . 0.0 109.049 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 5.5 mtmm -93.43 61.56 3.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.283 -0.886 . . . . 0.0 109.311 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.471 HG22 ' HA2' ' A' ' 22' ' ' GLY . 5.1 m -85.17 166.2 16.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.746 . . . . 0.0 109.526 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -94.26 -12.22 28.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.57 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -37.37 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.587 -0.695 . . . . 0.0 111.182 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.607 ' CA ' ' CD2' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -165.74 -43.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.122 . . . . 0.0 110.386 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 mt-10 -67.31 -47.52 70.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.594 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -65.84 -45.97 80.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.675 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.623 ' CB ' ' HG3' ' A' ' 41' ' ' MET . 0.3 OUTLIER -62.63 -36.17 81.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' A' ' 33' ' ' LYS . 8.8 mt-10 -92.28 5.87 48.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.195 -0.941 . . . . 0.0 109.394 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 2.0 tp-100 -90.55 -55.6 3.52 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.594 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.71 -50.7 6.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.031 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.15 33.65 0.15 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.387 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.623 ' HG3' ' CB ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -86.05 -25.85 25.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.647 -1.502 . . . . 0.0 108.562 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 78' ' ' LEU . 8.2 t80 -41.86 -23.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.852 -0.53 . . . . 0.0 110.654 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 41' ' ' MET . 22.8 p -84.42 134.82 34.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.873 -1.142 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.547 ' O ' HG13 ' A' ' 48' ' ' ILE . 2.7 mt-10 -49.02 -54.94 13.59 Favored 'General case' 0 C--O 1.198 -1.627 0 O-C-N 121.51 -0.744 . . . . 0.0 109.524 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -52.26 -32.9 39.33 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.667 -1.27 . . . . 0.0 110.692 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 41' ' ' MET . . . -67.72 -69.66 0.3 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.97 . . . . 0.0 111.152 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.546 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 7.5 tt -66.76 -19.33 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.4 -0.812 . . . . 0.0 109.817 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 44' ' ' GLU . 12.5 mt -68.04 -25.64 32.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.656 ' CD1' ' CD2' ' A' ' 53' ' ' HIS . 63.6 t80 -86.97 -68.65 0.73 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.53 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -44.19 -25.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.515 -1.366 . . . . 0.0 108.825 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 55.8 t -80.36 -46.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 108.669 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.586 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -65.52 -13.23 58.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 111.954 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -154.57 20.02 0.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.446 -1.408 . . . . 0.0 108.515 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 56.41 -140.52 42.86 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.582 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 153.51 133.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 7.7 m-80 60.78 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -129.38 43.32 3.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.611 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 19.9 ttt -117.98 145.95 37.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.482 -0.761 . . . . 0.0 109.498 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.611 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.2 Cg_endo -81.83 101.63 1.18 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 123.373 2.715 . . . . 0.0 114.517 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.636 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.5 156.26 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.61 ' CE1' ' CD1' ' A' ' 65' ' ' LEU . 39.2 m-85 -137.02 3.74 2.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.596 -0.69 . . . . 0.0 109.434 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.39 -25.8 0.16 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.214 -0.929 . . . . 0.0 109.45 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -162.85 33.65 0.31 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -102.4 -46.57 4.74 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.61 ' CD1' ' CE1' ' A' ' 61' ' ' PHE . 73.8 mt -103.25 -145.72 0.37 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.531 ' CG2' ' OE1' ' A' ' 69' ' ' GLN . 9.2 m -98.47 167.41 10.83 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.367 -0.833 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -82.7 -49.9 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.205 -0.934 . . . . 0.0 109.134 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.553 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 4.0 tt0 -64.63 -6.86 8.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.631 -0.668 . . . . 0.0 109.273 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.638 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -96.01 -35.77 11.27 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 61' ' ' PHE . 3.8 mm -72.21 -11.54 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -66.97 0.87 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.296 1.046 . . . . 0.0 108.623 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 48.7 m-20 -53.4 -37.87 62.88 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.371 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 p -67.96 -28.98 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.55 0.691 . . . . 0.0 109.508 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.547 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -74.96 -59.31 2.79 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.47 -21.3 51.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.703 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 88.8 t80 -66.4 -42.49 87.79 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.537 HG12 ' CE ' ' A' ' 41' ' ' MET . 48.8 t -70.35 -22.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.512 ' HG ' ' HA ' ' A' ' 75' ' ' ALA . 2.2 mt -81.26 -7.75 59.63 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.481 ' HB2' HD23 ' A' ' 3' ' ' LEU . 5.6 t0 -99.42 -47.38 5.17 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.069 0.937 . . . . 0.0 108.952 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.634 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 66.7 mm-40 -69.48 -39.89 77.4 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.488 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -59.97 -45.78 91.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 109.187 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.18 13.73 12.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 110.583 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.526 ' CG ' ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -137.26 19.16 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.683 -1.261 . . . . 0.0 111.603 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.98 73.15 1.28 Allowed Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.142 -1.504 . . . . 0.0 109.366 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.634 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 1.9 m95 -40.83 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 122.316 -0.52 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.039 -1.038 . . . . 0.0 109.574 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.438 HD23 ' HB2' ' A' ' 79' ' ' ASP . 1.3 mt -68.28 -5.86 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.153 -0.967 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.3 70.61 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.97 -30.7 62.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -58.97 -59.8 10.09 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.641 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -52.31 -28.86 20.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.761 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.5 OUTLIER -62.51 -43.49 98.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 69' ' ' GLN . 4.1 t -77.92 -49.61 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.444 -0.785 . . . . 0.0 109.815 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 5.1 t80 -60.57 -23.57 64.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.698 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 40.2 p -87.95 19.74 3.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.66 3.95 0.64 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.474 ' ND2' HD21 ' A' ' 65' ' ' LEU . 29.9 m-80 -147.58 -48.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.745 -1.444 . . . . 0.0 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 1.9 m -78.98 -29.52 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 108.692 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.84 -40.11 13.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.655 -0.653 . . . . 0.0 110.009 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -42.42 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.011 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 80.2 m -116.67 32.9 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.425 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.593 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 67.0 m-70 -163.9 -76.83 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 109.153 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 52.04 114.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.493 0.663 . . . . 0.0 110.755 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 50.13 55.42 15.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 40.78 81.58 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -165.44 96.79 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.05 150.33 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -1.107 . . . . 0.0 109.399 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.68 -14.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.602 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.12 -68.68 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mmt -76.75 140.95 40.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.821 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -100.73 62.71 1.03 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.13 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.1 p30 179.24 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.312 -0.867 . . . . 0.0 109.819 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -80.81 75.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.707 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -89.78 175.07 7.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.554 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -102.22 -17.58 15.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.482 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' O ' HD23 ' A' ' 36' ' ' LEU . 2.7 mtpm? -48.18 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.717 -0.615 . . . . 0.0 111.955 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' CD2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -165.08 -45.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.689 -1.257 . . . . 0.0 111.003 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 3.6 mm-40 -61.83 -14.18 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 111.157 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -105.73 -45.74 4.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.969 -1.082 . . . . 0.0 110.695 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.652 ' CB ' ' HG3' ' A' ' 41' ' ' MET . 0.2 OUTLIER -61.9 -33.83 74.94 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.279 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.582 ' OE1' ' CD2' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -89.96 -4.0 57.71 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.619 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.532 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.14 -59.68 2.68 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -87.25 -51.54 5.91 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.995 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 141.18 24.32 0.23 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.948 -1.596 . . . . 0.0 111.672 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.652 ' HG3' ' CB ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -74.91 -20.05 59.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.556 -1.555 . . . . 0.0 108.321 178.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.582 ' CD2' ' OE1' ' A' ' 37' ' ' GLU . 6.9 t80 -46.83 -22.16 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.715 -0.616 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.515 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 50.8 p -90.26 129.79 36.46 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.17 -0.956 . . . . 0.0 110.192 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -43.38 -62.78 0.97 Allowed 'General case' 0 C--O 1.202 -1.425 0 O-C-N 121.624 -0.672 . . . . 0.0 109.361 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -49.23 -35.98 18.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.01 . . . . 0.0 110.855 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.515 ' CB ' ' OG ' ' A' ' 43' ' ' SER . . . -61.73 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 4.2 tt -58.91 -16.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 110.252 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 10.1 mt -70.45 -37.53 70.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 29.5 t80 -83.31 -18.3 39.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -89.49 -10.78 45.03 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 70.1 t -98.56 -50.14 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.864 . . . . 0.0 109.562 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.521 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -58.55 -12.36 3.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 0.0 110.55 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.632 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -146.18 16.27 1.35 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.603 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 52.93 -121.25 14.89 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER 162.24 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.761 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.035 178.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 55' ' ' LYS . 51.8 m-80 -20.02 -49.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.724 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -148.3 20.26 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 109.765 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.586 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 23.5 ttt -102.15 145.16 30.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 108.866 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.586 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.6 Cg_endo -79.7 111.7 2.81 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.824 2.349 . . . . 0.0 113.603 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.603 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -37.58 160.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.525 -0.734 . . . . 0.0 110.25 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 32.4 m-85 -142.44 16.11 2.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 108.98 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.23 -23.05 0.77 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.436 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.47 31.27 0.7 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -103.65 -56.9 2.12 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.574 ' HG ' ' CD1' ' A' ' 61' ' ' PHE . 18.2 mt -61.82 -144.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 14.9 m -99.04 -63.24 1.14 Allowed 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.258 -0.901 . . . . 0.0 109.955 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.5 m-20 152.94 -56.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.6 tt0 -71.4 -0.01 9.27 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.657 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 2.4 mp0 -114.07 -24.32 9.08 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.507 ' CG2' ' OE1' ' A' ' 52' ' ' GLN . 9.8 mm -56.48 -21.74 13.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 172.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.9 mp0 -97.8 -68.3 0.81 Allowed 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.595 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.657 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 3.4 m-20 -51.22 -46.86 62.37 Favored 'General case' 0 C--O 1.199 -1.573 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.99 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.593 ' CG1' ' O ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -56.93 -29.1 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.626 -0.671 . . . . 0.0 110.042 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.581 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -80.15 -64.22 1.24 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.459 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -50.36 -23.05 2.1 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.493 -1.379 . . . . 0.0 107.323 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.641 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 17.1 t80 -66.5 -47.59 72.51 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.581 ' CG1' ' O ' ' A' ' 74' ' ' ALA . 1.8 p -68.11 -16.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.541 HD21 ' N ' ' A' ' 78' ' ' LEU . 5.1 mt -81.52 -15.74 53.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' HB2' HD23 ' A' ' 3' ' ' LEU . 1.2 t70 -97.95 -34.93 10.63 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.948 0.88 . . . . 0.0 108.899 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.714 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 2.3 mm-40 -83.54 -39.04 20.92 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.746 0.784 . . . . 0.0 110.035 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.622 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -51.45 -33.59 31.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.352 -0.842 . . . . 0.0 109.073 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -80.87 -28.79 35.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.543 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER 176.33 -24.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.155 -0.966 . . . . 0.0 111.0 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.709 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -61.18 -13.13 34.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.714 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 2.5 m95 -64.13 89.2 0.06 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.222 -0.924 . . . . 0.0 108.913 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 72' ' ' ASP . 6.5 mt -68.64 -7.19 30.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.182 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.02 67.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -71.94 -39.38 69.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.204 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 5' ' ' ASN . . . -47.39 -56.45 8.15 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.658 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -52.43 -38.66 59.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.264 . . . . 0.0 109.281 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HD2' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -56.82 -40.51 76.14 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.661 ' CG2' ' CG ' ' A' ' 69' ' ' GLN . 38.6 t -80.69 -69.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.496 -0.752 . . . . 0.0 109.485 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 22.7 t80 -41.74 -25.31 0.05 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.389 -0.82 . . . . 0.0 111.257 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 63.7 m -92.1 32.92 1.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.464 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.57 -29.68 0.02 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.123 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.441 ' ND2' HG12 ' A' ' 9' ' ' VAL . 1.6 m-80 -116.75 -48.85 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.919 -1.342 . . . . 0.0 108.702 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -77.39 -27.42 52.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.513 ' CB ' ' HG3' ' A' ' 19' ' ' MET . . . -54.01 -31.35 50.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.563 -0.71 . . . . 0.0 110.163 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.35 85.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 110.99 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.605 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.5 m -111.0 26.31 10.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.413 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.635 ' CE1' HD22 ' A' ' 31' ' ' LEU . 97.8 m-70 -156.94 -74.7 0.09 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.321 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.513 ' HG3' ' CB ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 46.11 105.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.403 0.621 . . . . 0.0 111.096 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 78.13 42.31 15.88 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.488 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 42.25 37.07 2.27 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.92 90.6 0.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.534 ' HB3' ' CG ' ' A' ' 26' ' ' MET . 3.6 t-20 -49.38 168.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -1.075 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.459 ' O ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -144.07 -69.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.033 -1.042 . . . . 0.0 110.35 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.47 ' CG1' ' SG ' ' A' ' 17' ' ' CYS . 1.2 p -44.24 -40.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.053 -1.029 . . . . 0.0 109.837 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.534 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -56.36 -168.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.919 -1.113 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -121.65 4.29 10.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 178.15 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.945 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.587 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -51.79 137.56 25.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.263 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.469 ' O ' HD21 ' A' ' 36' ' ' LEU . 4.0 m -123.64 179.93 4.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.399 -0.813 . . . . 0.0 109.198 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.635 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.66 -15.7 17.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.984 -1.073 . . . . 0.0 109.165 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 5.2 mtpm? -56.45 -92.35 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.897 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 3.9 pttm -179.41 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.946 -1.096 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.611 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 23.1 pt-20 -47.42 -37.16 10.99 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.661 -0.65 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.566 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -108.32 -61.14 1.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.77 -0.581 . . . . 0.0 111.161 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.617 ' CD1' ' CD1' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -40.68 -32.65 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 109.035 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.57 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -93.15 -33.31 14.08 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 120.962 -1.086 . . . . 0.0 108.637 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.611 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 7.0 tp60 -40.73 -31.55 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.5 1.143 . . . . 0.0 108.254 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 29' ' ' LYS . 3.8 m-85 -84.96 -50.99 7.02 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.5 ' C ' ' CG ' ' A' ' 41' ' ' MET . . . 127.68 64.37 0.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.522 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -171.39 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.97 -1.312 . . . . 0.0 110.675 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.66 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 2.5 t80 -92.48 23.48 3.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 108.632 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.3 p -104.58 165.67 10.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.628 -1.295 . . . . 0.0 110.338 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 48' ' ' ILE . 4.3 mt-10 -48.63 -70.51 0.09 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -50.05 -21.42 1.25 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.589 -1.319 . . . . 0.0 110.495 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 41' ' ' MET . . . -75.45 -73.59 0.25 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.204 -0.935 . . . . 0.0 110.39 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.537 HG12 ' CG2' ' A' ' 51' ' ' VAL . 6.3 tt -63.24 -14.1 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.845 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 44' ' ' GLU . 44.4 mt -74.6 -32.52 29.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.582 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 36.0 t80 -94.32 -15.52 24.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 1.5 tp60 -91.14 -10.28 42.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.537 ' CG2' HG12 ' A' ' 47' ' ' ILE . 54.7 t -103.66 -44.97 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.712 0.768 . . . . 0.0 109.275 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.538 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -61.24 -12.23 12.41 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.34 0.591 . . . . 0.0 110.459 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.649 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -151.75 20.55 0.7 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -178.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.601 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.77 -132.44 51.21 Favored Glycine 0 C--N 1.3 -1.42 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.52 139.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 121.388 0.614 . . . . 0.0 109.423 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 53.21 -88.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -127.55 43.29 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.982 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.609 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 11.1 ttt -126.14 143.37 45.48 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 109.367 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.9 Cg_endo -76.64 120.55 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.108 2.539 . . . . 0.0 114.406 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.93 165.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.641 -0.662 . . . . 0.0 109.707 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.625 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 23.5 m-85 -145.77 11.53 1.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.177 -0.952 . . . . 0.0 109.842 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.35 -19.27 5.19 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.095 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.7 24.68 1.49 Allowed Glycine 0 N--CA 1.486 1.993 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.83 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.625 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt180 -101.93 -39.31 7.41 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.591 ' CD2' ' CD1' ' A' ' 61' ' ' PHE . 2.4 mt -102.83 -154.12 0.49 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.496 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.597 ' HB ' ' OE1' ' A' ' 69' ' ' GLN . 51.5 m -101.48 174.12 6.12 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 69' ' ' GLN . 5.6 m-20 -72.6 -57.62 4.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.822 -1.174 . . . . 0.0 108.129 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 33.4 mt-10 -63.59 3.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.661 ' CG ' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -104.51 -42.75 5.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 61' ' ' PHE . 8.7 mm -56.65 -19.14 8.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -95.86 -73.56 0.59 Allowed 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 76' ' ' TYR . 78.5 m-20 -39.63 -53.25 2.17 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.586 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.745 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 t -60.1 -42.28 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.434 1.112 . . . . 0.0 109.069 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 47' ' ' ILE . . . -59.07 -65.85 0.6 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.301 -1.499 . . . . 0.0 107.211 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.579 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.0 -17.94 20.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.745 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 78.2 t80 -65.12 -40.67 94.82 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.604 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 96.8 t -74.65 -24.71 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.594 HD21 ' CE1' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -86.68 -8.8 57.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' HB2' HD11 ' A' ' 3' ' ' LEU . 7.3 t0 -99.54 -36.02 9.67 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.031 0.919 . . . . 0.0 109.186 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.59 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 5.4 mm-40 -79.76 -42.24 24.92 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.43 0.634 . . . . 0.0 109.708 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -74.79 -18.89 60.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.394 -0.816 . . . . 0.0 109.358 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.66 6.52 7.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.626 -0.671 . . . . 0.0 110.587 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.81 48.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.501 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.93 78.26 1.15 Allowed Glycine 0 N--CA 1.481 1.643 0 C-N-CA 118.643 -1.742 . . . . 0.0 109.215 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.604 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -36.02 90.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.578 0.704 . . . . 0.0 109.677 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.3 -1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.669 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.011 0.434 . . . . 0.0 110.027 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.0 mp -70.39 -3.25 16.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.017 -1.052 . . . . 0.0 109.105 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.97 77.09 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.52 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -67.64 -25.43 65.72 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.59 -63.26 4.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.641 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -51.47 -33.13 29.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 0.0 109.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.508 ' NZ ' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.49 -41.78 86.1 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 108.834 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 69' ' ' GLN . 2.7 t -79.05 -51.85 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.581 ' O ' ' CD1' ' A' ' 10' ' ' PHE . 10.4 t80 -54.72 -24.38 21.89 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.045 -1.034 . . . . 0.0 110.455 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -89.8 24.97 2.19 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.443 -0.786 . . . . 0.0 109.367 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.21 11.67 0.19 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.53 ' CB ' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.23 -40.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.78 -1.424 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -93.37 -31.06 14.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 108.827 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . -42.26 -45.77 4.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.32 84.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 110.535 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.602 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 59.6 m -111.44 28.23 8.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.978 -1.076 . . . . 0.0 110.23 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 76.8 m-70 -161.56 -73.81 0.06 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.246 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 55.24 114.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.745 -0.597 . . . . 0.0 110.574 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.19 62.8 1.45 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.62 65.88 1.24 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -150.26 69.37 0.32 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 18' ' ' HIS . 20.7 p30 -48.01 166.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.099 -1.236 . . . . 0.0 109.202 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.493 HG21 ' N ' ' A' ' 25' ' ' VAL . 3.1 m -128.86 -37.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.956 -1.09 . . . . 0.0 109.908 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.493 ' N ' HG21 ' A' ' 24' ' ' VAL . 2.4 t -82.67 -40.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.09 -1.006 . . . . 0.0 109.199 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.493 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 1.2 mpp? -61.23 -56.94 14.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 26' ' ' MET . . . 74.38 27.25 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -179.34 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.479 ' C ' ' ND2' ' A' ' 23' ' ' ASN . 1.3 mtmp? -90.34 57.01 3.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 109.499 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.498 ' HB ' ' HD3' ' A' ' 32' ' ' LYS . 4.9 m -67.51 178.33 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.578 HD23 ' CE1' ' A' ' 18' ' ' HIS . 0.8 OUTLIER -98.99 -8.98 24.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -45.88 -76.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.886 -1.134 . . . . 0.0 110.481 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.578 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER 167.55 -43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 109.844 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.35 -25.99 51.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.216 -0.927 . . . . 0.0 110.415 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.599 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -101.85 -59.65 1.67 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.683 ' CD1' ' CD1' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -48.52 -31.8 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.01 -1.056 . . . . 0.0 109.774 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.578 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 38.5 mt-10 -91.42 -23.62 19.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.536 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.504 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.6 tp-100 -61.67 -42.04 98.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.599 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -89.8 -76.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.873 0.844 . . . . 0.0 109.005 178.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.42 84.92 0.05 OUTLIER Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.471 ' SD ' ' HA ' ' A' ' 36' ' ' LEU . 5.2 ptt? -168.26 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -1.22 . . . . 0.0 109.617 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.683 ' CD1' ' CD1' ' A' ' 36' ' ' LEU . 7.1 t80 -103.2 19.26 19.94 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.151 -0.968 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.475 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -105.77 144.09 32.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 0.0 110.611 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.54 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -45.6 -65.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.778 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -49.4 -31.84 10.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.826 -1.171 . . . . 0.0 110.748 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 43' ' ' SER . . . -64.78 -78.54 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.565 HG12 ' CG2' ' A' ' 51' ' ' VAL . 4.4 tt -57.98 -16.19 6.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.552 0.692 . . . . 0.0 110.211 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 23.2 mt -71.67 -38.53 67.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.615 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 33.3 t80 -86.38 -11.55 51.71 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -95.88 -12.88 24.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.421 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.565 ' CG2' HG12 ' A' ' 47' ' ' ILE . 56.4 t -102.58 -37.19 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.033 0.921 . . . . 0.0 109.474 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.526 ' HB3' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -66.2 -11.17 48.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.714 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -164.93 38.34 0.07 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.681 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.571 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 44.74 -133.42 7.37 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.08 125.95 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.587 -0.807 . . . . 0.0 108.846 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 73.6 m-80 65.04 -85.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.543 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.0 37.58 4.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.619 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 26.6 ttt -116.3 142.28 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 108.796 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.619 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.1 Cg_endo -71.24 103.44 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.873 2.382 . . . . 0.0 113.451 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.693 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -58.79 107.55 0.53 Allowed 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.866 -0.521 . . . . 0.0 110.385 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CD2' HD22 ' A' ' 65' ' ' LEU . 75.5 m-85 -77.1 -41.06 43.6 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.884 -1.135 . . . . 0.0 108.259 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.26 19.14 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.674 -0.641 . . . . 0.0 109.493 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 61' ' ' PHE . . . 122.37 44.28 0.36 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HB3' HD12 ' A' ' 65' ' ' LEU . 15.6 ttt-85 -102.48 -54.0 2.77 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.576 HD22 ' CD2' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -62.07 -146.39 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.541 HG21 ' N ' ' A' ' 67' ' ' ASP . 78.8 m -97.42 154.22 17.61 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.592 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 7.7 t0 -63.24 -53.68 49.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.944 -1.097 . . . . 0.0 108.303 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 tt0 -64.76 1.57 0.85 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.003 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.67 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 2.2 mp0 -115.34 -25.47 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.145 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 67' ' ' ASP . 3.7 mt -59.24 -19.95 17.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' C ' ' A' ' 69' ' ' GLN . 3.1 mp0 -97.51 -67.0 0.87 Allowed 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 114.546 -1.207 . . . . 0.0 108.332 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.67 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 18.4 m-20 -52.74 -46.08 67.29 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.001 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.588 ' CG1' ' O ' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -56.51 -27.88 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.919 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.565 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -81.69 -63.48 1.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -51.23 -22.29 2.59 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.641 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 23.0 t80 -67.93 -46.82 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.826 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.599 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.5 p -68.77 -15.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.548 HD21 ' N ' ' A' ' 78' ' ' LEU . 4.8 mt -84.28 -14.78 48.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -96.91 -39.63 9.3 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.723 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.2 mm-40 -80.02 -38.31 32.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.891 0.853 . . . . 0.0 109.411 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.6 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -52.26 -30.18 26.56 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -87.55 -25.38 23.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 110.153 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.542 ' HD3' ' N ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 176.61 -24.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.077 -1.014 . . . . 0.0 111.059 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.706 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -65.24 -12.47 55.5 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.723 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 3.3 m95 -64.81 88.57 0.07 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.299 -1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.324 -177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.445 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 72' ' ' ASP . 5.9 mt -76.19 -0.67 23.02 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.172 -0.955 . . . . 0.0 109.33 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.479 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -70.1 -27.36 64.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 7' ' ' ALA . . . -59.6 -65.38 3.47 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.643 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -43.13 -33.11 0.82 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -1.161 . . . . 0.0 109.445 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.492 ' HE3' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -65.26 -50.77 64.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.617 HG22 ' HG2' ' A' ' 69' ' ' GLN . 3.2 t -67.54 -59.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.266 -0.896 . . . . 0.0 108.692 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 9.2 t80 -50.28 -26.78 5.15 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 13.1 t -85.87 25.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 109.741 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.39 13.36 0.1 OUTLIER Glycine 0 N--CA 1.484 1.874 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.998 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.512 ' ND2' HD21 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.57 -48.76 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 109.381 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.619 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.3 m -81.97 -28.81 32.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.449 ' HA ' ' CA ' ' A' ' 19' ' ' MET . . . -43.39 -41.29 4.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.476 -0.765 . . . . 0.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.7 -50.32 68.58 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.124 -0.985 . . . . 0.0 111.233 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 7.8 m -109.81 23.92 13.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.168 . . . . 0.0 110.46 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 95.5 m-70 -156.16 -70.32 0.11 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.452 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.518 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.3 ptt? 38.72 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 80.07 49.28 6.04 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 31' ' ' LEU . . . 37.63 36.15 0.26 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.75 95.69 0.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.576 ' OD1' ' CE1' ' A' ' 18' ' ' HIS . 3.7 t-20 -57.71 -176.9 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.273 -1.134 . . . . 0.0 109.441 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -156.93 -78.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 109.793 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' MET . 1.4 p -41.58 -39.99 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 110.044 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.555 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -54.1 -166.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.024 -1.047 . . . . 0.0 109.746 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -126.34 2.15 7.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.013 -1.055 . . . . 0.0 109.919 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 178.89 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.018 . . . . 0.0 110.299 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.62 122.83 14.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' HD21 ' A' ' 36' ' ' LEU . 5.9 m -124.03 175.94 6.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 18' ' ' HIS . 2.1 mp -99.52 -9.92 22.73 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.818 -0.551 . . . . 0.0 111.138 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.557 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -56.38 -102.32 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.292 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.537 ' N ' HD22 ' A' ' 36' ' ' LEU . 19.8 ptmt -155.74 -43.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.48 -1.388 . . . . 0.0 109.803 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 7.2 pt-20 -63.64 -40.51 97.06 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 110.636 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -79.22 -52.17 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 111.482 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.62 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -65.32 -11.48 42.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.718 -1.238 . . . . 0.0 108.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.597 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -119.67 -1.61 10.57 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.273 -0.892 . . . . 0.0 108.777 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.539 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -65.45 -48.32 73.12 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.62 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -86.48 -31.62 21.24 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.22 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 117.29 99.38 2.05 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.648 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.582 ' SD ' ' CE1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 156.42 46.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.852 -0.793 . . . . 0.0 108.987 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.646 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -104.79 18.78 21.68 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.976 0.893 . . . . 0.0 108.853 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.428 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 53.6 p -105.17 166.31 10.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.131 -0.981 . . . . 0.0 110.604 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.556 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 6.8 mt-10 -48.4 -59.9 3.1 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 109.503 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -57.05 -25.94 59.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.588 -1.32 . . . . 0.0 110.976 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 41' ' ' MET . . . -69.31 -70.21 0.29 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.973 -1.079 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.563 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 5.4 tt -63.0 -27.4 43.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 121.859 0.838 . . . . 0.0 109.262 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.561 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 31.2 mt -64.86 -22.38 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.686 -0.634 . . . . 0.0 109.343 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.427 ' O ' ' HD2' ' A' ' 53' ' ' HIS . 38.1 t80 -91.93 -56.7 2.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.912 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.531 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 5.7 pm0 -59.68 -14.46 14.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.201 -1.562 . . . . 0.0 109.186 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.563 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 57.4 t -101.27 -41.09 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.284 -0.885 . . . . 0.0 110.712 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -59.79 -14.69 15.84 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.892 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.651 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -153.72 25.51 0.51 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.586 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 57.91 -140.8 45.76 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.8 135.1 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 26.8 m-80 63.62 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.54 45.38 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.554 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.613 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 10.9 ttt -127.45 144.8 52.19 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 110.107 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.613 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.3 Cg_endo -76.85 116.32 4.22 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.299 2.666 . . . . 0.0 114.261 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.619 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.83 162.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.092 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.682 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 25.8 m-85 -143.61 7.21 1.48 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.245 -0.909 . . . . 0.0 110.053 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.54 -20.41 4.96 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.195 -0.94 . . . . 0.0 108.774 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.45 27.4 1.36 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.682 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 6.0 mmt85 -101.32 -44.73 5.55 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.54 ' CD2' ' CD1' ' A' ' 61' ' ' PHE . 7.9 mt -87.07 -152.93 0.2 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.29 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 67' ' ' ASP . 31.3 m -99.43 164.86 11.92 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.591 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -63.15 -57.37 10.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.443 1.116 . . . . 0.0 108.032 178.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.2 tt0 -64.18 2.92 0.49 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.354 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.617 ' HG2' HG22 ' A' ' 9' ' ' VAL . 1.3 mp0 -115.18 -26.48 7.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.851 -1.156 . . . . 0.0 109.2 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 67' ' ' ASP . 2.6 mt -59.31 -19.53 16.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.5 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.6 mp0 -97.58 -71.28 0.69 Allowed 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.497 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.614 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 24.6 m-20 -47.36 -46.41 25.67 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.979 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.664 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -62.17 -31.26 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.426 0.631 . . . . 0.0 110.546 -178.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -74.67 -62.14 1.64 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.97 -22.07 13.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.664 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 37.6 t80 -62.76 -45.57 92.06 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.629 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 72.4 t -67.29 -27.47 39.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -81.24 -9.32 59.8 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.236 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.0 t70 -100.29 -33.52 10.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.133 0.968 . . . . 0.0 109.714 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.609 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 20.7 mm-40 -77.24 -38.39 51.2 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -71.88 -17.22 62.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.27 10.0 23.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 111.101 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -164.26 37.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.965 -1.494 . . . . 0.0 112.728 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 85.1 77.08 1.19 Allowed Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.764 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.629 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 4.0 m95 -36.08 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.546 0.688 . . . . 0.0 109.185 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.3 -1.578 0 O-C-N 121.603 -0.686 . . . . 0.0 109.841 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.458 HD23 ' HB2' ' A' ' 75' ' ' ALA . 1.5 mp -75.65 -14.77 60.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.21 68.52 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.519 ' O ' ' HE2' ' A' ' 8' ' ' LYS . 1.3 m-20 -80.33 -30.35 38.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -53.86 -48.33 62.49 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.649 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -58.94 -28.27 66.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.82 -0.812 . . . . 0.0 109.8 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -68.59 -28.15 66.68 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.008 -1.058 . . . . 0.0 108.717 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.657 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 41.1 t -100.16 -18.56 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.454 -0.779 . . . . 0.0 110.479 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 12.7 t80 -97.03 -19.93 18.39 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.89 -1.131 . . . . 0.0 109.694 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -99.38 7.46 45.51 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.664 -0.648 . . . . 0.0 109.584 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.499 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -139.18 2.28 2.58 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.515 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -151.04 -62.44 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.129 -1.218 . . . . 0.0 108.742 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 6.8 m -60.89 -34.49 74.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' MET . . . -54.93 -36.21 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 110.124 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.01 -44.74 74.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.392 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 92.8 m -109.0 13.53 24.61 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 91.9 m-70 -160.92 38.94 0.15 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -63.0 141.09 58.9 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.62 45.79 8.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 42.32 68.05 0.79 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -147.61 96.53 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 22' ' ' GLY . 1.2 t-20 -43.9 139.9 2.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -1.142 . . . . 0.0 109.289 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.68 -17.8 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 0.0 110.104 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -98.83 -69.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 0.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 18.4 mmt -84.22 149.79 25.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -107.15 71.91 0.85 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.301 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER 179.6 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.328 -0.857 . . . . 0.0 109.332 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.584 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.5 mptt -89.7 91.28 8.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 0.0 109.312 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.544 ' O ' ' CD2' ' A' ' 36' ' ' LEU . 1.8 m -98.76 -169.46 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 0.0 109.079 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.495 ' HB3' HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -105.69 -6.51 19.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.73 -1.231 . . . . 0.0 109.576 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.591 ' N ' HD23 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -54.38 -88.45 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.371 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HG2' ' CB ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER 167.11 -38.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.844 -1.16 . . . . 0.0 110.692 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HG3' ' HE2' ' A' ' 33' ' ' LYS . 85.9 mt-10 -54.38 -28.25 42.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 110.036 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.565 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -107.43 -57.74 2.05 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.053 0.93 . . . . 0.0 110.495 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.608 HD13 ' CD2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -62.05 -43.5 98.71 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.42 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 56.7 tt0 -69.04 -19.49 64.1 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.529 -1.357 . . . . 0.0 108.868 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 3.0 tp60 -77.83 -83.83 0.08 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.847 0.832 . . . . 0.0 109.389 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CZ ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -91.41 5.1 50.7 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.639 0.733 . . . . 0.0 110.598 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -108.69 -21.21 7.64 Favored Glycine 0 C--N 1.289 -2.062 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.02 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.602 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 51.64 69.32 0.68 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.608 ' CD2' HD13 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -86.29 -3.73 59.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.179 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.422 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -45.35 162.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.252 -0.905 . . . . 0.0 111.013 -179.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.565 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -46.86 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.009 -1.057 . . . . 0.0 109.518 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.496 ' HA ' HD11 ' A' ' 48' ' ' ILE . 29.2 t0 -54.64 -17.04 2.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.786 -1.196 . . . . 0.0 110.66 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' CB ' ' O ' ' A' ' 41' ' ' MET . . . -81.04 -79.76 0.15 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.601 ' HA ' ' HB3' ' A' ' 50' ' ' GLN . 2.7 tt -54.27 -20.76 5.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.73 -1.231 . . . . 0.0 109.656 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.565 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 10.3 mt -59.92 -43.12 91.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.636 ' CE2' ' CE1' ' A' ' 53' ' ' HIS . 20.0 t80 -80.5 -16.89 53.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.601 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -86.47 -8.16 57.82 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.643 -1.286 . . . . 0.0 107.925 178.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 47' ' ' ILE . 42.1 t -108.48 -33.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.532 ' HG3' ' CG2' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -70.22 -7.55 42.93 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.715 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -165.96 38.24 0.05 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.522 -178.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 47.5 -133.67 14.94 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.95 132.75 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 57.6 m-80 62.05 -88.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.92 50.86 2.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 108.971 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.597 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 24.7 ttt -124.43 142.13 39.5 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 109.065 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.597 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 26.4 Cg_endo -68.34 104.17 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.804 2.336 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.715 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -59.22 118.33 5.78 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.588 ' CD2' ' CD ' ' A' ' 64' ' ' ARG . 13.2 m-85 -86.29 -49.41 7.7 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.93 -1.106 . . . . 0.0 108.211 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.58 26.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.22 0.533 . . . . 0.0 109.808 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.51 32.55 0.66 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.588 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.84 -48.69 4.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.581 ' HG ' ' CD2' ' A' ' 61' ' ' PHE . 29.5 mt -62.52 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.574 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 3.0 m -98.3 -54.92 2.91 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.109 -0.995 . . . . 0.0 108.956 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 66' ' ' THR . 2.6 m-20 150.87 -59.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 68.8 mm-40 -67.06 -1.84 4.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.04 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.657 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -112.05 -29.76 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CG2' ' HG3' ' A' ' 52' ' ' GLN . 39.6 mm -57.05 -20.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.492 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -100.15 -64.19 1.06 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.584 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.613 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 34.5 m-20 -52.15 -48.66 64.79 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.089 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 2.2 p -54.53 -27.21 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.918 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.61 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -81.27 -66.41 0.89 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' A' ' 3' ' ' LEU . . . -50.1 -23.77 2.33 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.163 -1.586 . . . . 0.0 107.392 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.649 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 37.1 t80 -63.55 -47.6 80.92 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.686 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.2 p -65.4 -25.59 37.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.513 HD21 ' N ' ' A' ' 78' ' ' LEU . 1.1 mt -77.34 -9.87 59.1 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.964 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.99 -43.73 6.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.051 0.929 . . . . 0.0 109.411 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.577 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 18.4 mm-40 -65.94 -44.82 83.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -68.78 -11.36 60.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.3 7.01 37.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 111.005 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -175.09 46.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.235 -1.541 . . . . 0.0 112.739 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.602 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 88.5 76.7 1.29 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.869 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.686 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -39.93 83.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 109.541 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 25.7 t0 . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.541 ' HA ' ' CB ' ' A' ' 72' ' ' ASP . 2.4 pp -68.83 -0.2 5.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.905 -1.122 . . . . 0.0 108.971 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.7 t-20 -47.63 -28.69 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.51 -57.74 17.89 Favored Glycine 0 C--O 1.199 -2.034 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.621 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -45.93 -28.16 1.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.761 -1.435 . . . . 0.0 110.066 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -68.05 -46.25 71.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.595 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 24.6 t -73.49 -51.76 24.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.819 -0.551 . . . . 0.0 110.115 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.64 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 6.1 t80 -62.5 -28.85 70.12 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.717 -1.239 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 47.0 t -84.09 15.15 3.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.878 . . . . 0.0 109.701 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.472 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -160.95 11.95 0.14 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 9' ' ' VAL . 7.7 m-80 -156.43 -54.08 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.449 . . . . 0.0 108.831 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.64 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -74.06 -26.15 60.24 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.499 0.666 . . . . 0.0 109.287 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.57 -39.51 76.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.574 -0.704 . . . . 0.0 110.393 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.94 62.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.136 -0.977 . . . . 0.0 111.057 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.9 m -124.79 8.81 8.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.826 -1.171 . . . . 0.0 110.691 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.593 ' CG ' HD21 ' A' ' 31' ' ' LEU . 87.8 m-70 -150.12 -65.45 0.21 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.136 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.447 ' O ' ' O ' ' A' ' 18' ' ' HIS . 1.2 ttt 56.25 113.08 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.269 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 39.42 60.35 1.71 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.592 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 49.43 73.33 0.37 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -155.72 81.43 0.17 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 1.6 t-20 -54.61 163.26 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.249 . . . . 0.0 109.223 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.3 m -144.4 17.11 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.041 . . . . 0.0 109.889 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.58 -55.99 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.098 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.47 -172.51 1.82 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -134.39 46.47 2.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.102 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.3 p30 178.2 -44.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 109.366 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.548 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 2.0 mttp -74.18 110.62 8.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.557 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.52 HG21 ' N ' ' A' ' 31' ' ' LEU . 92.3 m -133.43 149.33 51.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.317 -0.865 . . . . 0.0 109.25 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.593 HD21 ' CG ' ' A' ' 18' ' ' HIS . 5.9 mp -74.95 -18.67 60.35 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.848 -0.533 . . . . 0.0 111.096 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -40.61 -82.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.476 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER 174.72 -42.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 3.7 mm-40 -56.1 -34.85 66.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.584 -0.697 . . . . 0.0 109.594 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -99.17 -39.53 8.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.408 -0.808 . . . . 0.0 110.369 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.572 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -69.75 -10.28 57.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.554 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 17.1 mt-10 -118.78 3.78 11.6 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.495 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 tp-100 -83.59 -51.15 7.55 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -86.67 -35.54 19.27 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.779 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.63 51.75 0.24 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.955 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -112.13 8.07 19.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.017 -1.284 . . . . 0.0 108.747 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.608 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 41.0 t80 -69.43 10.78 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.991 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 41' ' ' MET . 3.3 p -105.7 143.85 33.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.548 -1.345 . . . . 0.0 110.179 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 48' ' ' ILE . 5.1 mt-10 -46.28 -58.45 3.68 Favored 'General case' 0 C--O 1.203 -1.355 0 O-C-N 121.379 -0.826 . . . . 0.0 109.29 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 45' ' ' ASP . 9.3 t0 -47.88 -37.19 13.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -0.963 . . . . 0.0 110.829 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.07 -70.27 0.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.557 ' CD1' ' HB ' ' A' ' 77' ' ' VAL . 15.3 tt -66.06 -9.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.891 0.853 . . . . 0.0 109.884 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 44' ' ' GLU . 22.3 mt -87.57 -25.53 6.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 25.6 t80 -88.72 -23.39 22.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.554 ' OE1' ' SD ' ' A' ' 58' ' ' MET . 4.2 pp0? -94.17 -26.45 16.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.438 -1.414 . . . . 0.0 108.289 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.535 ' CG2' ' NE2' ' A' ' 50' ' ' GLN . 2.9 t -75.02 -49.51 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.885 0.85 . . . . 0.0 109.01 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.552 ' HB3' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -64.91 -12.53 50.29 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.809 -0.557 . . . . 0.0 111.525 -177.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.635 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -147.46 13.24 1.06 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.58 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.681 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.19 -136.09 24.81 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 106.754 -2.539 . . . . 0.0 106.754 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 149.94 141.09 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 50.32 -90.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -129.35 49.39 2.25 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.586 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 7.1 ttt -125.2 146.48 54.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.2 Cg_endo -80.97 107.82 1.97 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 123.363 2.709 . . . . 0.0 114.81 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.681 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -40.79 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 111.135 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 59' ' ' PRO . 56.0 m-85 -150.25 14.34 0.79 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.474 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . . . -47.17 -28.49 1.85 Allowed 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.263 -0.898 . . . . 0.0 109.136 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.32 35.05 0.52 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.3 -42.99 6.1 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 61' ' ' PHE . 21.1 mt -77.09 -143.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.572 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 3.0 m -98.22 -59.45 1.75 Allowed 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.5 OUTLIER 153.26 -55.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 12.4 tt0 -68.79 -1.48 7.2 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.595 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -108.35 -31.35 7.89 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 61' ' ' PHE . 23.6 mm -57.54 -20.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.473 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.8 mp0 -99.09 -71.0 0.71 Allowed 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.01 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 87.5 m-20 -45.72 -49.77 14.39 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.176 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.664 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -60.75 -32.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.505 0.669 . . . . 0.0 110.082 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -69.82 -65.51 0.71 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.203 -1.561 . . . . 0.0 106.856 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.05 -21.86 9.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.664 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 62.5 t80 -63.84 -45.1 91.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.603 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.612 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 60.7 t -68.89 -25.22 29.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -82.65 -9.05 59.55 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.037 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 10.9 t0 -99.35 -34.52 10.27 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.624 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 4.4 mm-40 -78.57 -34.57 46.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.377 0.608 . . . . 0.0 110.003 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -65.17 -43.61 91.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.366 -0.834 . . . . 0.0 109.792 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.94 14.83 11.15 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.284 -0.885 . . . . 0.0 110.85 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 12.8 ptmt -142.86 23.57 1.9 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.512 -1.367 . . . . 0.0 111.665 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 87.3 72.6 1.29 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.032 -1.556 . . . . 0.0 109.756 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.624 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 1.1 m95 -40.85 85.06 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.202 -0.587 . . . . 0.0 110.797 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.133 -0.979 . . . . 0.0 109.485 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 5.2 m-20 . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.564 ' CD2' ' O ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -75.69 2.6 11.58 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.308 177.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.542 ' N ' HD11 ' A' ' 3' ' ' LEU . . . -59.92 -42.49 94.05 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.488 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.5 t-20 -51.34 -32.88 27.12 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -54.49 -47.51 69.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.66 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.81 -33.45 10.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.657 -1.496 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.03 -43.99 81.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.687 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 18.3 t -62.43 -72.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 16.0 t80 -49.72 -26.62 3.96 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.703 -0.623 . . . . 0.0 111.237 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 19.6 t -92.35 31.38 1.32 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 109.008 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.33 -46.18 1.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.83 -1.394 . . . . 0.0 109.563 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.5 m -76.48 -25.02 53.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.746 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.469 ' O ' ' HE1' ' A' ' 19' ' ' MET . . . -59.3 -35.49 73.88 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.805 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.87 97.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.35 -0.844 . . . . 0.0 111.64 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.575 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -108.26 26.48 10.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.757 -1.214 . . . . 0.0 109.494 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 92.5 m-70 -160.02 -54.5 0.06 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.234 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.488 ' CG ' ' C ' ' A' ' 18' ' ' HIS . 3.9 ptp 39.41 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.479 0.657 . . . . 0.0 110.794 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 67.6 52.23 31.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 41.72 57.39 3.39 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -147.26 86.63 0.16 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.5 ' HB3' ' CE ' ' A' ' 26' ' ' MET . 2.9 t-20 -51.13 159.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -1.096 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.84 -10.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 26' ' ' MET . 18.1 t -100.2 -62.78 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.074 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.5 ' CE ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -51.53 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.847 . . . . 0.0 109.773 179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.44 -8.53 10.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -153.33 -37.65 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.278 -0.888 . . . . 0.0 109.586 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 39' ' ' PHE . 5.9 tptt -46.21 90.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.485 -0.76 . . . . 0.0 109.804 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 28' ' ' ASN . 7.1 m -117.63 151.55 36.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -78.88 -7.73 58.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.324 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 1.1 mtpt -51.52 162.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.529 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' CA ' ' HB2' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.02 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -61.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 110.733 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.58 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.99 -35.62 69.53 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 111.239 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.598 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -64.74 -43.43 93.39 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.854 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -90.68 13.23 16.65 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.187 -0.946 . . . . 0.0 109.129 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -82.21 -49.82 9.68 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.598 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -87.07 -42.73 12.83 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.333 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.87 82.13 0.4 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.525 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -158.68 24.53 0.23 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.286 -1.126 . . . . 0.0 108.496 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.629 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 43.3 t80 -84.38 15.83 3.42 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.494 0.664 . . . . 0.0 109.225 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.41 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -104.61 134.39 47.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.791 -1.193 . . . . 0.0 111.126 -179.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -45.07 -59.76 2.44 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -48.03 -37.98 16.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.064 -1.022 . . . . 0.0 110.492 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 43' ' ' SER . . . -60.9 -73.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 6.7 tt -65.28 -9.52 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.531 -0.73 . . . . 0.0 110.338 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 44' ' ' GLU . 9.1 mt -78.91 -35.57 18.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 37.0 t80 -91.08 -14.41 31.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' OE1' ' HB2' ' A' ' 55' ' ' LYS . 1.1 tp60 -90.63 -17.57 26.64 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 68.5 t -94.27 -45.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.53 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -62.79 -9.78 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.597 -0.69 . . . . 0.0 110.949 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.98 22.25 0.51 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 54.58 -133.44 47.01 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.75 135.75 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 121.389 0.614 . . . . 0.0 109.545 178.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 54.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.01 55.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.698 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.6 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 9.8 ttt -142.85 142.51 22.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 109.116 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.6 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 29.5 Cg_endo -75.07 117.21 4.82 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 123.385 2.723 . . . . 0.0 115.036 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.657 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -43.07 164.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.641 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 49.4 m-85 -143.12 12.63 1.81 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.44 -0.788 . . . . 0.0 109.433 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.93 -26.09 0.25 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.416 -0.802 . . . . 0.0 108.899 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -151.44 35.31 0.88 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.641 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt85 -103.38 -50.98 3.32 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.549 ' CD2' ' CD1' ' A' ' 61' ' ' PHE . 5.9 mt -86.81 -157.59 0.38 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 69' ' ' GLN . 5.6 m -100.88 -179.09 3.96 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 3.0 m-20 -76.34 -59.51 2.74 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.678 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.556 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 8.0 tt0 -66.22 -7.68 19.76 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.687 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -95.39 -34.94 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.519 HD12 ' CD1' ' A' ' 65' ' ' LEU . 4.3 mm -67.91 -14.47 18.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -98.7 -71.57 0.69 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.465 1.126 . . . . 0.0 109.071 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 58.9 m-20 -47.42 -38.6 13.73 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.89 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.709 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 3.5 p -66.52 -36.79 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.704 0.764 . . . . 0.0 109.885 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HA ' HG22 ' A' ' 47' ' ' ILE . . . -68.35 -60.21 2.61 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 119.949 -1.719 . . . . 0.0 106.401 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.38 -20.63 45.63 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.709 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 84.3 t80 -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.542 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 43.9 t -70.62 -27.02 29.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.546 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -83.63 -8.03 59.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.281 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.517 ' CB ' HD22 ' A' ' 3' ' ' LEU . 3.1 t70 -98.79 -43.38 6.79 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.178 0.989 . . . . 0.0 109.039 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.636 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -70.32 -35.68 73.8 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.951 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.533 ' HB2' ' CA ' ' A' ' 33' ' ' LYS . . . -59.44 -50.91 72.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 108.392 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.84 16.77 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.659 -0.651 . . . . 0.0 109.857 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 26.6 tttm -132.11 13.18 4.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 111.297 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 81.9 72.66 1.24 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.636 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 7.5 m95 -38.71 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.14 0.495 . . . . 0.0 110.508 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.943 . . . . 0.0 109.421 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 6.2 m-20 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 76' ' ' TYR . 2.0 pp -70.62 3.92 2.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.616 ' CA ' ' HD3' ' A' ' 8' ' ' LYS . 1.4 m-20 -75.0 -1.68 23.81 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.458 ' N ' ' HB3' ' A' ' 72' ' ' ASP . . . -86.27 -46.91 5.13 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.57 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -56.14 -46.57 79.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.857 -0.79 . . . . 0.0 108.877 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.616 ' HD3' ' CA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -51.04 -33.44 25.47 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.653 ' CG2' ' HG2' ' A' ' 69' ' ' GLN . 59.6 t -96.62 -15.7 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.215 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 11.0 t80 -84.76 -28.05 26.5 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 117.589 -1.644 . . . . 0.0 109.793 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -86.63 15.09 5.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.808 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -144.34 2.02 1.27 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.844 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.482 ' ND2' ' C ' ' A' ' 12' ' ' GLY . 0.9 OUTLIER -143.51 -50.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.805 -1.409 . . . . 0.0 109.114 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.5 m -77.11 -32.11 56.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.426 -0.797 . . . . 0.0 108.875 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' HA ' ' N ' ' A' ' 19' ' ' MET . . . -45.77 -40.87 10.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.661 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.72 -46.3 77.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.097 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.594 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 80.3 m -116.12 27.81 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 110.33 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.662 ' CE1' HD22 ' A' ' 31' ' ' LEU . 90.5 m-70 -159.93 -76.41 0.07 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.215 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.531 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 55.1 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.595 0.712 . . . . 0.0 110.668 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.95 45.17 9.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.584 ' HA3' ' CD2' ' A' ' 85' ' ' TRP . . . 48.64 68.27 1.35 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.491 ' HA2' ' OG1' ' A' ' 30' ' ' THR . . . -151.78 86.8 0.14 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.8 t-20 -55.33 161.47 1.86 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.976 -1.308 . . . . 0.0 109.305 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 16.4 m -136.5 -52.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' MET . 44.8 t -45.79 -61.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.175 -0.953 . . . . 0.0 108.781 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -53.41 -170.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 109.109 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.71 1.25 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.097 . . . . 0.0 110.289 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.9 -30.83 0.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.038 -1.039 . . . . 0.0 110.729 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 11.9 mttt -75.93 101.16 5.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.969 -1.082 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.578 HG21 ' CD2' ' A' ' 36' ' ' LEU . 10.3 t -93.88 -146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 108.492 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.662 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -118.41 -11.11 10.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.482 -1.386 . . . . 0.0 109.615 179.133 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 5.2 mtpt -50.02 -86.9 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.846 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 165.04 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.984 -1.072 . . . . 0.0 109.956 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -53.14 -27.19 19.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 109.718 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.86 -67.33 0.95 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.273 -0.892 . . . . 0.0 110.532 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.602 HD13 ' CD2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -54.39 -35.85 63.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.645 -0.659 . . . . 0.0 111.335 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 2.0 tt0 -69.33 -30.79 68.9 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.306 -1.496 . . . . 0.0 110.183 -178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.515 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 6.0 mm-40 -78.55 -64.55 1.15 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.245 -0.909 . . . . 0.0 109.925 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 40' ' ' GLY . 2.0 p90 -93.99 -20.19 20.2 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.537 0.684 . . . . 0.0 110.627 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.578 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -89.42 -19.11 50.7 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.031 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.572 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 49.48 71.23 0.4 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -177.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.602 ' CD2' HD13 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -101.69 -6.08 24.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.485 -176.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.514 ' OG ' ' HB1' ' A' ' 46' ' ' ALA . 2.6 p -48.74 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.781 -1.199 . . . . 0.0 110.223 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.533 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -43.61 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.92 -1.112 . . . . 0.0 109.668 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -52.67 -19.78 2.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.891 -1.131 . . . . 0.0 110.286 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 41' ' ' MET . . . -74.37 -82.11 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.395 -0.816 . . . . 0.0 110.262 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.553 HG21 ' N ' ' A' ' 48' ' ' ILE . 12.1 tt -48.77 -33.52 5.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 O-C-N 121.283 -0.886 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.553 ' N ' HG21 ' A' ' 47' ' ' ILE . 74.7 mt -56.31 -41.23 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.596 -0.69 . . . . 0.0 110.058 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.4 ' O ' ' HD2' ' A' ' 53' ' ' HIS . 28.3 t80 -78.69 -25.7 44.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.561 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.531 ' CG ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -93.71 -3.71 51.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.087 -1.633 . . . . 0.0 108.896 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.496 ' HA ' ' CE ' ' A' ' 58' ' ' MET . 25.1 t -94.8 -48.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.554 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -64.49 -8.32 13.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.867 -0.521 . . . . 0.0 110.167 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.615 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.62 21.45 0.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.838 -1.145 . . . . 0.0 108.772 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 51.89 -131.1 36.44 Favored Glycine 0 C--N 1.3 -1.419 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 150.04 142.31 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 53.94 -89.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.53 42.63 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.568 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 21.4 ttt -119.63 142.19 32.39 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.225 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 37.0 Cg_endo -81.26 108.82 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.914 2.409 . . . . 0.0 113.406 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.615 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.7 163.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.761 . . . . 0.0 110.286 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 11.2 m-85 -145.74 14.43 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 52' ' ' GLN . . . -60.22 -10.8 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.907 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.19 -4.34 7.78 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.418 ' CD ' ' CE1' ' A' ' 61' ' ' PHE . 4.2 ttt180 -106.82 -61.64 1.51 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.584 ' CD1' ' CG2' ' A' ' 73' ' ' VAL . 0.6 OUTLIER -64.62 105.8 1.04 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.551 ' O ' ' O ' ' A' ' 65' ' ' LEU . 86.2 m -39.3 166.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.294 0.569 . . . . 0.0 109.564 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 69' ' ' GLN . 15.1 t0 -57.74 -57.75 11.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.989 -1.069 . . . . 0.0 108.42 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.5 mm-40 -65.87 10.81 0.09 Allowed 'General case' 0 C--O 1.193 -1.917 0 O-C-N 121.755 -0.59 . . . . 0.0 109.887 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.653 ' HG2' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -104.4 -44.66 4.87 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.468 HG23 ' NE2' ' A' ' 52' ' ' GLN . 18.9 mm -53.0 -22.09 3.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 mp0 -94.45 -73.34 0.58 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 76' ' ' TYR . 98.2 m-20 -44.82 -64.69 0.65 Allowed 'General case' 0 C--O 1.186 -2.27 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.286 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.584 ' CG2' ' CD1' ' A' ' 65' ' ' LEU . 2.3 t -49.15 -29.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.096 -1.003 . . . . 0.0 110.269 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.626 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -79.94 -74.18 0.31 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.694 -1.254 . . . . 0.0 108.118 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -46.56 -23.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.966 -1.709 . . . . 0.0 107.784 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.622 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 40.9 t80 -60.41 -53.13 61.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.274 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.626 ' CG1' ' O ' ' A' ' 74' ' ' ALA . 1.9 p -64.47 -25.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.574 ' CD2' ' CE2' ' A' ' 42' ' ' TYR . 2.8 mt -78.5 -9.67 59.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.47 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 3.0 t0 -99.57 -41.49 7.32 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.0 0.905 . . . . 0.0 109.059 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.645 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 9.3 mm-40 -69.53 -47.48 63.59 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.381 0.61 . . . . 0.0 109.956 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -68.5 -16.02 63.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.44 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.61 8.68 27.17 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 110.889 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -171.69 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.47 77.27 1.33 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.02 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.645 ' CE3' ' CB ' ' A' ' 80' ' ' GLN . 0.9 OUTLIER -40.36 84.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.319 -0.518 . . . . 0.0 110.596 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.858 -1.151 . . . . 0.0 109.029 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.453 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 9.7 m-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.98 0.419 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 76' ' ' TYR . 1.0 OUTLIER -77.2 7.39 5.17 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.937 -1.102 . . . . 0.0 109.738 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.98 -24.31 59.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.602 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . 68.3 m-20 -84.39 -6.03 59.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.445 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.582 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -87.74 -61.74 1.5 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 106.674 -2.571 . . . . 0.0 106.674 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.862 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -40.67 -37.81 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.128 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.601 ' CE ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -61.84 -48.63 79.71 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.642 ' CG2' ' CG ' ' A' ' 69' ' ' GLN . 87.9 t -63.68 -59.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -0.773 . . . . 0.0 111.814 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.756 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 46.0 t80 -54.92 -42.59 72.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.732 -1.23 . . . . 0.0 112.261 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -84.29 19.58 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.58 -1.325 . . . . 0.0 110.365 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -147.16 0.77 0.72 Allowed Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.541 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -156.23 -48.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.569 -1.548 . . . . 0.0 110.035 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.4 m -71.99 -36.12 69.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.1 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.442 -0.786 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.01 69.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.956 -1.09 . . . . 0.0 109.257 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.569 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 82.3 m -119.43 20.28 12.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.441 -0.787 . . . . 0.0 109.506 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.589 ' CE1' HD22 ' A' ' 31' ' ' LEU . 93.3 m-70 -159.87 21.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.436 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.34 153.36 7.31 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.656 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 43.46 33.53 2.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 46.39 57.99 6.14 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' HA2' ' CG2' ' A' ' 30' ' ' THR . . . -146.76 91.89 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 2.2 t-20 -41.77 142.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.457 -1.026 . . . . 0.0 109.865 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.11 -1.24 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.447 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.54 -66.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mmt -65.39 130.67 44.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.319 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 28' ' ' ASN . . . -85.08 48.32 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 27' ' ' ALA . 1.8 p-10 175.3 -59.7 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HD3' ' CE ' ' A' ' 41' ' ' MET . 7.6 mttp -51.71 102.8 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.213 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.454 ' O ' HD21 ' A' ' 36' ' ' LEU . 3.7 m -113.32 177.44 4.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.589 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -94.71 -18.93 20.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.798 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' C ' ' CD2' ' A' ' 36' ' ' LEU . 14.8 mtpt -58.16 -113.63 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 110.295 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HA ' ' CG ' ' A' ' 36' ' ' LEU . 22.7 ttpt -155.44 -29.61 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.677 -1.264 . . . . 0.0 110.871 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 12.3 pt-20 -59.97 -28.91 68.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.729 -1.232 . . . . 0.0 111.193 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.631 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -102.25 -48.57 4.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.001 -1.062 . . . . 0.0 110.818 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.664 ' CD1' ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -61.07 -34.56 75.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.923 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.502 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.2 mm-40 -93.1 6.02 49.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.5 tp60 -89.74 -51.1 5.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.62 -50.27 6.93 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.486 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.81 91.45 0.48 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.51 ' CE ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -174.12 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.12 . . . . 0.0 109.474 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.664 ' CG ' ' CD1' ' A' ' 36' ' ' LEU . 4.1 t80 -105.62 28.57 7.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 109.816 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.469 ' OG ' ' HB1' ' A' ' 46' ' ' ALA . 29.2 p -106.73 143.11 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.359 -0.838 . . . . 0.0 110.569 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.544 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -50.53 -59.15 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 109.834 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.35 -28.62 8.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.526 -1.359 . . . . 0.0 110.568 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' HB1' ' OG ' ' A' ' 43' ' ' SER . . . -71.61 -73.66 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 110.321 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.535 HG12 ' CG2' ' A' ' 51' ' ' VAL . 3.1 tt -61.16 -13.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 110.358 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 44' ' ' GLU . 14.5 mt -73.41 -35.99 47.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 31.0 t80 -91.11 -14.44 31.21 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.529 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -88.79 -17.07 30.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.535 ' CG2' HG12 ' A' ' 47' ' ' ILE . 72.2 t -93.77 -43.62 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.817 0.818 . . . . 0.0 109.985 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HB3' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -62.72 -10.54 13.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 0.0 110.18 -178.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.661 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -158.36 30.97 0.24 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.357 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.589 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 49.96 -132.99 28.16 Favored Glycine 0 C--N 1.299 -1.524 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 151.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 37.8 m-80 69.05 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.48 14.95 6.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 109.202 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.614 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 27.4 ttt -89.63 142.3 29.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.263 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.614 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 30.3 Cg_endo -74.25 97.2 1.0 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.906 2.404 . . . . 0.0 114.647 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.661 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -46.94 119.16 2.38 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 63' ' ' GLY . 57.1 m-85 -88.24 -49.87 6.71 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.999 -1.063 . . . . 0.0 108.747 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 28.05 40.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.35 0.595 . . . . 0.0 110.376 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 167.61 -24.18 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.502 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -93.83 -30.92 14.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.557 ' CD1' HG13 ' A' ' 9' ' ' VAL . 1.7 mm? -91.45 94.51 9.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.548 ' O ' ' O ' ' A' ' 65' ' ' LEU . 21.0 m -41.03 168.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.524 ' N ' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -57.15 -61.2 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.522 -1.361 . . . . 0.0 108.487 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 mt-10 -60.68 3.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.777 -0.577 . . . . 0.0 110.604 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.642 ' CG ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -102.94 -45.15 5.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.558 ' CG2' ' HG3' ' A' ' 52' ' ' GLN . 33.6 mm -55.34 -22.66 12.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 1.6 mp0 -92.19 -65.71 0.98 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.103 0.954 . . . . 0.0 108.642 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 47.1 m-20 -49.62 -61.5 2.08 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 3.3 p -45.5 -29.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.3 -0.875 . . . . 0.0 109.8 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.58 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -80.68 -71.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -45.52 -25.8 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.554 -1.341 . . . . 0.0 107.508 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.862 ' CE2' ' HA ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -59.08 -56.95 15.61 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.655 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 2.6 p -62.37 -26.14 39.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.99 -1.069 . . . . 0.0 108.647 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.593 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 5.1 mt -76.45 -10.76 59.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 2.0 t0 -99.47 -43.52 6.51 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.929 0.871 . . . . 0.0 109.218 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.67 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 59.6 mm-40 -67.3 -41.55 85.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.88 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -60.9 -47.3 87.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.143 -0.973 . . . . 0.0 109.063 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.11 8.45 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.573 -0.705 . . . . 0.0 109.843 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 6.9 tttm -129.84 12.84 5.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.079 -1.013 . . . . 0.0 110.974 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.0 76.71 0.98 Allowed Glycine 0 C--N 1.296 -1.681 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.67 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 12.8 m95 -34.36 90.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.725 0.774 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 121.386 0.612 . . . . 0.0 109.446 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.495 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 1.2 mp -71.11 -3.36 19.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.053 -1.029 . . . . 0.0 109.454 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.71 -15.82 63.63 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.574 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -86.69 10.26 16.28 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -107.69 -36.33 2.43 Favored Glycine 0 C--O 1.201 -1.919 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.655 ' HA ' ' CZ ' ' A' ' 76' ' ' TYR . . . -59.88 -12.63 8.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.659 -0.906 . . . . 0.0 109.884 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.574 ' CE ' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -87.13 -32.52 19.84 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.65 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 3.4 t -77.31 -29.55 16.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.595 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 32.2 t80 -100.33 -34.53 9.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 3.9 t -85.05 10.76 11.1 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.024 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -142.34 -6.74 0.72 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.173 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.549 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -147.23 -52.93 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.567 -1.549 . . . . 0.0 110.031 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 5.3 m -64.8 -29.31 70.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 110.035 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.84 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.846 -1.159 . . . . 0.0 109.294 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 84.8 m -120.7 14.78 11.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.224 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' HD22 ' A' ' 31' ' ' LEU . 91.0 m-70 -158.63 26.74 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.765 . . . . 0.0 109.033 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -52.49 147.12 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.308 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 46.96 35.86 8.33 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' O ' ' HD2' ' A' ' 32' ' ' LYS . . . 48.47 53.0 17.75 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.73 122.06 2.52 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.429 ' OD1' ' HB2' ' A' ' 26' ' ' MET . 3.7 t-20 -64.43 154.21 36.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -1.127 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 m -122.95 -22.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.12 -0.988 . . . . 0.0 110.244 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.07 -69.54 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.868 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.485 ' HB3' ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -47.62 -37.26 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.42 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . 71.32 40.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 26' ' ' MET . 1.3 p30 177.09 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.371 -0.83 . . . . 0.0 108.915 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.29 77.14 5.83 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.541 ' CG2' ' HG2' ' A' ' 32' ' ' LYS . 9.3 t -83.23 -177.35 6.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.878 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.575 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -100.78 -18.54 16.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 110.758 -179.043 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.541 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 0.0 OUTLIER -61.07 -100.8 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.667 -1.271 . . . . 0.0 109.4 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 11.0 ptmm? -168.32 -38.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.642 -1.286 . . . . 0.0 110.797 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -41.16 -29.46 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 -178.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.636 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -110.25 -59.23 1.97 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 111.644 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -58.98 -7.72 1.16 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.728 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.564 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.4 mm-40 -107.08 -11.79 15.56 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.593 -1.317 . . . . 0.0 109.72 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 6.9 mm100 -82.54 -40.54 20.82 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.636 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -84.96 -45.94 11.71 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.709 177.097 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 41' ' ' MET . . . 121.51 98.19 1.54 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER 170.08 37.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -1.085 . . . . 0.0 109.741 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.607 ' CD1' HD13 ' A' ' 36' ' ' LEU . 6.6 t80 -118.98 33.17 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.486 ' O ' ' HB ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -110.49 176.97 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.568 -0.708 . . . . 0.0 110.938 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.573 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 3.6 mt-10 -69.89 -72.56 0.19 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -54.0 -36.37 62.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.566 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 50' ' ' GLN . . . -64.01 -74.41 0.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.067 -1.021 . . . . 0.0 109.498 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.549 ' HA ' ' CG ' ' A' ' 50' ' ' GLN . 40.9 mt -53.9 -17.56 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.621 0.724 . . . . 0.0 109.264 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.573 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 16.2 mt -80.82 -33.38 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.472 ' OH ' ' HE2' ' A' ' 55' ' ' LYS . 59.7 t80 -73.19 -23.07 60.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 108.536 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.551 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -85.64 -33.65 21.56 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.391 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 10.9 t -79.92 -36.67 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.552 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -72.23 -14.45 61.79 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.344 -0.848 . . . . 0.0 109.968 -178.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.687 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -159.33 31.54 0.2 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.012 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 48.04 -136.86 14.81 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.588 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 151.91 134.1 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.1 m-80 60.25 -88.91 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.473 -0.767 . . . . 0.0 108.978 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.27 41.58 3.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.597 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 21.4 ttt -119.04 143.49 34.01 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 30.3 Cg_endo -75.23 99.76 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.918 2.412 . . . . 0.0 114.27 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.687 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -57.07 118.27 4.84 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.654 -0.654 . . . . 0.0 110.458 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.595 ' CD2' ' CD ' ' A' ' 64' ' ' ARG . 25.1 m-85 -85.37 -52.27 5.99 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 37.58 28.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.424 0.631 . . . . 0.0 109.675 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 126.46 32.8 0.7 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.506 -1.837 . . . . 0.0 108.506 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.595 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 5.5 ttm-85 -101.67 -52.78 3.13 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.59 HD13 ' CD2' ' A' ' 61' ' ' PHE . 6.5 mt -79.92 -143.16 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.576 ' CB ' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -98.62 -166.9 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 121.085 -1.009 . . . . 0.0 109.494 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.37 -62.55 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.596 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.1 tt0 -71.41 2.61 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.65 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 1.1 mp0 -104.08 -32.03 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 65' ' ' LEU . 7.5 mm -72.88 -21.84 19.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.43 -66.13 0.95 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 37.3 t0 -54.59 -36.92 64.94 Favored 'General case' 0 C--O 1.193 -1.902 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.409 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.589 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 9.9 p -61.69 -26.92 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.193 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.588 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -82.12 -59.11 2.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.62 -21.63 11.09 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.655 ' CZ ' ' HA ' ' A' ' 7' ' ' ALA . 36.5 t80 -67.03 -45.12 78.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.366 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.638 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.1 p -69.6 -21.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.577 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 5.4 mt -77.97 -11.82 59.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.504 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 1.8 t0 -99.99 -37.52 8.97 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.888 0.851 . . . . 0.0 109.327 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.619 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 8.5 mm-40 -77.44 -35.28 54.12 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.876 -0.515 . . . . 0.0 110.395 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.52 ' CB ' ' OH ' ' A' ' 42' ' ' TYR . . . -61.0 -48.71 80.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.121 -0.987 . . . . 0.0 108.522 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.8 13.86 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.759 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 1.6 ttmm -130.79 13.69 5.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.96 -1.088 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 82.84 73.6 1.23 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.638 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 5.0 m95 -39.07 83.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.119 0.485 . . . . 0.0 110.592 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.97 0.414 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.503 ' CD2' ' HA ' ' A' ' 72' ' ' ASP . 10.1 mt -69.67 -8.3 46.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.933 -1.105 . . . . 0.0 109.057 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.23 -29.09 63.48 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.3 m-20 -67.91 -41.78 82.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -47.21 -58.83 6.14 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.644 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . -50.67 -37.65 42.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.338 . . . . 0.0 109.286 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -59.4 -41.1 88.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.204 -0.935 . . . . 0.0 108.58 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.575 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 21.9 t -81.23 -67.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 26.9 t80 -41.54 -26.63 0.07 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.288 -0.883 . . . . 0.0 109.851 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 36.6 m -76.71 -48.53 18.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.296 -0.877 . . . . 0.0 111.275 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -101.57 29.84 11.66 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.726 -1.225 . . . . 0.0 111.739 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 23.4 m-80 -155.03 -29.3 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.783 -1.422 . . . . 0.0 110.771 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.612 ' SG ' ' CZ ' ' A' ' 61' ' ' PHE . 79.6 m -127.91 -11.18 5.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.903 -1.123 . . . . 0.0 111.316 -177.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 19' ' ' MET . . . -51.69 -32.04 28.29 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.32 78.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.382 -0.824 . . . . 0.0 110.699 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.63 18.7 18.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.739 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.629 ' CE1' ' CD2' ' A' ' 31' ' ' LEU . 81.8 m-70 -158.61 -64.91 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.929 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.482 ' CG ' ' C ' ' A' ' 18' ' ' HIS . 4.9 ptt? 38.66 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.318 0.58 . . . . 0.0 109.719 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 71.08 57.23 6.37 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 36.74 64.81 0.6 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -141.66 99.05 0.23 Allowed Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.992 -1.299 . . . . 0.0 109.953 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -67.83 138.0 55.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -1.168 . . . . 0.0 109.855 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.22 -3.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -0.827 . . . . 0.0 109.599 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.446 HG22 ' SG ' ' A' ' 17' ' ' CYS . 5.1 t -103.59 -46.96 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mtp -100.45 157.51 16.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -109.77 61.25 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.9 p-10 169.62 -50.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -77.25 91.04 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.47 ' CG2' ' N ' ' A' ' 31' ' ' LEU . 23.2 m -126.17 163.89 22.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.187 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.629 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -88.36 74.48 8.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.133 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -111.83 -85.04 0.57 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.648 -1.283 . . . . 0.0 109.103 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -176.56 -47.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 179.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.59 -33.81 27.87 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.15 -0.968 . . . . 0.0 110.413 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.649 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -70.81 -56.81 5.49 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.056 -1.028 . . . . 0.0 109.688 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -53.42 -33.57 54.48 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.438 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.549 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 3.1 mm-40 -87.14 -17.84 31.82 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.706 0.765 . . . . 0.0 109.242 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 2.1 tp60 -68.33 -50.29 54.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.649 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -85.8 -78.17 0.28 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.427 -0.796 . . . . 0.0 108.926 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.66 86.36 0.06 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.566 ' SD ' ' CE2' ' A' ' 39' ' ' PHE . 2.7 ptt? -167.0 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -1.192 . . . . 0.0 109.511 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.584 ' CD1' ' CD1' ' A' ' 36' ' ' LEU . 38.0 t80 -104.68 12.02 33.39 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.55 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.42 140.41 38.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.537 ' N ' ' CD1' ' A' ' 78' ' ' LEU . 1.2 mt-10 -44.89 -63.05 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.796 . . . . 0.0 109.97 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 29.5 t0 -48.63 -33.53 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.817 -1.177 . . . . 0.0 110.553 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -76.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.556 ' HA ' ' HB3' ' A' ' 50' ' ' GLN . 1.6 tt -65.5 -6.75 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.859 0.838 . . . . 0.0 110.563 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.527 HD13 ' CG ' ' A' ' 44' ' ' GLU . 12.8 mt -77.26 -43.02 31.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 49' ' ' TYR . 58.4 t80 -88.89 -3.83 58.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -100.87 -13.78 18.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 47' ' ' ILE . 26.8 t -92.09 -47.36 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.56 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -58.69 -12.82 4.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.58 -179.239 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.637 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -151.57 21.59 0.71 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 53.09 -131.97 41.55 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 157.08 132.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.437 0 CA-C-O 121.538 0.685 . . . . 0.0 109.728 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 59.9 m-80 63.05 -85.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.53 44.48 2.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.596 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 6.6 ttt -129.05 144.15 51.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.039 -1.038 . . . . 0.0 109.167 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.596 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.6 Cg_endo -71.71 117.27 5.06 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.372 2.715 . . . . 0.0 115.822 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -42.51 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.658 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 26.0 m-85 -139.48 8.64 2.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.42 -19.7 2.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.435 -0.791 . . . . 0.0 109.217 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.54 26.86 0.96 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.658 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 2.4 mmt85 -102.06 -48.59 4.18 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.63 ' CD2' ' CD1' ' A' ' 61' ' ' PHE . 8.4 mt -81.34 -148.57 0.07 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.557 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 1.5 m -98.83 -74.96 0.57 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 122.19 0.995 . . . . 0.0 108.929 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.618 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 23.3 t0 -177.83 -59.34 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.544 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 9.7 tt0 -69.25 5.1 1.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.662 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.618 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -111.21 -33.92 6.31 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.618 ' CD1' ' HA ' ' A' ' 67' ' ' ASP . 2.3 mt -60.28 -18.0 15.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.477 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -96.46 -73.81 0.58 Allowed 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 60.7 m-20 -44.64 -46.34 10.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.833 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.754 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 10.5 t -63.29 -42.25 95.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.623 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -56.19 -63.87 1.05 Allowed 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.268 -1.52 . . . . 0.0 106.951 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.513 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.49 -18.93 32.91 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.754 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 61.4 t80 -65.46 -39.91 92.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.571 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 25.2 t -75.33 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' CD1' ' N ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -88.83 -8.12 54.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.3 t70 -98.54 -36.31 9.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.107 0.956 . . . . 0.0 108.707 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.615 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 5.1 mm-40 -80.9 -36.56 31.02 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.575 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -64.56 -42.88 95.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.435 ' CB ' ' OH ' ' A' ' 42' ' ' TYR . . . -89.12 12.81 14.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 110.829 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 8.3 ptmm? -138.08 18.18 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.494 -1.379 . . . . 0.0 111.22 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 86.49 73.96 1.27 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.615 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 5.6 m95 -36.62 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.41 0.624 . . . . 0.0 109.61 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.301 -1.506 0 O-C-N 121.411 -0.806 . . . . 0.0 109.832 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.478 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 68.6 m-20 -127.95 -26.09 2.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.988 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.499 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -68.12 -5.37 17.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.59 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.42 -30.54 70.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 2.0 m-20 -72.45 -33.63 67.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -52.13 -60.79 7.21 Favored Glycine 0 C--O 1.201 -1.93 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.654 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -56.53 -26.98 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -1.067 . . . . 0.0 109.871 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -65.41 -35.07 79.83 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.024 -1.047 . . . . 0.0 108.707 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.637 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 14.9 t -88.66 -47.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.287 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 15.4 t80 -64.42 -27.69 69.17 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.804 -1.185 . . . . 0.0 109.435 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 18.7 p -90.93 11.2 23.52 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -141.95 3.53 2.01 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 2.5 m-80 -154.82 -57.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 0.0 109.029 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 11.6 m -65.84 -24.93 66.99 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.744 . . . . 0.0 109.37 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 19' ' ' MET . . . -62.35 -33.55 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 110.359 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.08 13.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.004 . . . . 0.0 110.517 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.535 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 0.1 OUTLIER -138.89 25.6 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.621 ' CE1' HD22 ' A' ' 31' ' ' LEU . 86.0 m-70 -157.07 -69.63 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 108.951 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.52 ' O ' ' O ' ' A' ' 18' ' ' HIS . 1.0 OUTLIER 36.24 102.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.602 0.715 . . . . 0.0 111.207 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 93.59 32.42 7.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.463 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 43.45 36.19 3.09 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -130.51 109.35 0.91 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -44.3 140.82 2.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.0 109.333 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.483 ' CG1' ' O ' ' A' ' 24' ' ' VAL . 58.9 t -107.56 0.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 109.772 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.462 HG22 HBC2 ' A' ' 88' ' ' HEC . 90.5 t -117.64 -51.3 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.676 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.79 176.27 6.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.72 46.61 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 1.4 p-10 -176.58 -62.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.283 -0.886 . . . . 0.0 108.979 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.589 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -55.18 97.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 t -111.1 -167.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 110.393 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.621 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -107.3 -26.06 11.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.673 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 7.3 mtpt -45.22 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.827 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.578 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 17.5 ttpt -178.74 -26.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.656 -1.278 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -67.83 -53.98 22.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.743 -1.223 . . . . 0.0 110.737 -177.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.547 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -76.05 -51.15 12.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.577 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.663 ' CD1' ' CD1' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -59.7 -22.82 62.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.002 . . . . 0.0 108.852 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.538 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 2.4 tm-20 -112.4 -2.6 14.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.141 -0.975 . . . . 0.0 109.298 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -65.82 -47.05 76.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -85.74 -32.0 22.11 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.281 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 120.93 102.11 1.82 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.623 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 158.57 29.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.702 -0.881 . . . . 0.0 110.823 178.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.663 ' CD1' ' CD1' ' A' ' 36' ' ' LEU . 2.1 t80 -97.11 28.46 3.57 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.077 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 p -106.74 157.58 17.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 110.343 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.581 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -46.05 -62.91 1.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.38 -0.825 . . . . 0.0 109.701 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -54.67 -28.74 49.59 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.94 -1.1 . . . . 0.0 110.637 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.06 -76.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.031 . . . . 0.0 110.247 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.545 HG22 ' CB ' ' A' ' 74' ' ' ALA . 6.5 tt -60.04 -20.99 20.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.462 -0.773 . . . . 0.0 110.047 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 15.6 mt -64.45 -35.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.628 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 26.4 t80 -87.08 -18.12 31.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.54 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -90.38 -1.37 57.91 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 61' ' ' PHE . 78.5 t -109.67 -39.03 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.543 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -71.58 -5.13 31.12 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.169 -0.957 . . . . 0.0 109.016 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.703 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -161.99 26.77 0.12 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 44.51 -133.33 7.1 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER 160.86 126.67 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 121.29 0.567 . . . . 0.0 109.654 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 35.1 m-80 68.98 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.415 ' O ' HBC3 ' A' ' 88' ' ' HEC . . . -128.12 12.0 6.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.945 -1.097 . . . . 0.0 110.569 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.641 ' HB2' ' C1D' ' A' ' 88' ' ' HEC . 14.4 ttt -95.16 138.98 21.88 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.672 -1.267 . . . . 0.0 109.599 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.601 ' HD2' ' C2C' ' A' ' 88' ' ' HEC . 29.2 Cg_endo -73.81 117.18 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.964 2.443 . . . . 0.0 113.507 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.63 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.23 165.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.533 -0.73 . . . . 0.0 110.025 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.581 ' CE2' ' O ' ' A' ' 59' ' ' PRO . 48.7 m-85 -146.76 15.59 1.23 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.35 -17.7 2.03 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.37 29.15 0.27 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.518 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -98.85 -41.58 7.56 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 178.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.576 ' CD2' ' CD1' ' A' ' 61' ' ' PHE . 19.3 mt -82.0 -140.71 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 6.1 m -98.62 -57.39 2.2 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.268 -0.895 . . . . 0.0 109.524 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 6.3 t70 153.34 -54.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 16.1 mt-10 -70.79 2.53 4.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.637 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -114.39 -27.42 7.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 65' ' ' LEU . 10.8 mm -58.88 -22.42 21.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 173.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.462 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -97.48 -65.76 0.94 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.993 179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.0 t0 -53.82 -39.93 65.97 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.588 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 1.4 p -60.94 -26.68 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.313 -0.867 . . . . 0.0 109.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.603 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -81.0 -63.48 1.4 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.71 -24.44 3.39 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.383 -1.448 . . . . 0.0 107.24 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.654 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 37.3 t80 -63.91 -47.72 79.43 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.08 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.5 p -67.32 -23.3 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.553 HD23 ' CE1' ' A' ' 42' ' ' TYR . 3.1 mt -79.02 -11.61 60.01 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -35.06 9.67 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.007 0.908 . . . . 0.0 109.709 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.651 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 6.9 mm-40 -77.29 -43.68 32.39 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.313 0.578 . . . . 0.0 110.283 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -76.18 -22.41 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.346 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.71 4.26 22.52 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.549 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -170.59 39.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.587 -1.321 . . . . 0.0 112.309 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 97.29 74.74 1.2 Allowed Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.856 -1.64 . . . . 0.0 110.178 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.651 ' CE3' ' CB ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -40.3 83.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.174 0.511 . . . . 0.0 110.752 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 46.43 24.3 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.439 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.486 2.007 0 CA-C-O 117.921 -1.488 . . . . 0.0 109.45 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.641 ' C1D' ' HB2' ' A' ' 58' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 5.3 m-20 -122.22 157.77 30.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.404 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.516 ' CD2' ' OD1' ' A' ' 72' ' ' ASP . 3.9 mt -72.74 -3.69 26.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.62 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.2 -32.18 73.66 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -71.11 -26.86 63.21 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -60.21 -51.92 55.87 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.674 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -50.2 -19.89 0.89 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.616 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -82.61 -43.44 16.99 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.602 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 5.2 t -62.63 -26.35 40.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.9 t80 -101.29 -22.48 14.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.594 -0.691 . . . . 0.0 110.603 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 62.2 m -88.47 22.45 2.54 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.312 -0.868 . . . . 0.0 109.265 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.29 -23.27 0.02 OUTLIER Glycine 0 N--CA 1.484 1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.342 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -122.96 -7.03 8.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.596 -1.532 . . . . 0.0 110.065 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 6.6 m -127.39 -23.04 3.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.45 75.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.769 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.81 -10.53 13.36 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.229 -0.919 . . . . 0.0 111.77 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.57 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 94.7 m -140.64 19.04 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.648 -1.282 . . . . 0.0 110.052 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 89.4 m-70 -158.31 -53.3 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.266 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.486 ' O ' ' O ' ' A' ' 18' ' ' HIS . 5.0 ptt? 35.58 98.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.251 0.548 . . . . 0.0 110.795 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 72.27 52.52 10.66 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.605 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 37.05 83.37 0.01 OUTLIER Glycine 0 N--CA 1.483 1.822 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -161.7 93.74 0.12 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' GLY . 3.8 t-20 -40.72 157.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.577 -0.955 . . . . 0.0 109.823 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.476 HG13 ' CA ' ' A' ' 17' ' ' CYS . 2.3 p -120.87 -20.3 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.412 ' HB ' HMD2 ' A' ' 88' ' ' HEC . 20.8 t -109.73 -68.61 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -58.2 168.83 0.94 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.953 . . . . 0.0 109.936 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -129.39 57.82 1.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 1.7 p30 178.09 -46.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.343 -0.848 . . . . 0.0 109.139 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 58.8 mttt -75.94 101.58 5.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.685 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 35' ' ' ALA . 5.9 m -118.88 173.0 7.14 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.605 ' HB2' ' HA2' ' A' ' 21' ' ' GLY . 1.2 mp -91.9 -19.35 22.57 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.319 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 1.9 ptmt -59.72 179.65 0.12 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.95 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 17.1 ptmt -81.7 -38.52 25.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 2.8 mt-10 -55.89 -33.62 64.79 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 110.499 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.58 -42.0 5.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 110.94 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -66.34 -15.12 63.01 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.573 ' OE2' ' CD1' ' A' ' 42' ' ' TYR . 62.4 mt-10 -114.3 0.41 14.14 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -74.53 -51.91 13.35 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.206 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -87.31 -43.05 12.44 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.364 179.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.94 33.2 0.43 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.023 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -91.01 14.03 15.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.753 -1.439 . . . . 0.0 108.949 179.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.6 ' CD2' ' O ' ' A' ' 42' ' ' TYR . 48.5 t80 -74.03 15.4 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.619 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -106.27 125.75 51.38 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.628 -1.295 . . . . 0.0 110.665 -179.162 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.523 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.6 pt-20 -44.41 -56.71 4.02 Favored 'General case' 0 C--O 1.201 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 108.861 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.65 -41.1 21.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 110.388 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 43' ' ' SER . . . -57.65 -71.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.966 . . . . 0.0 110.122 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 7.4 tt -68.1 -7.86 7.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 110.135 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.534 HG13 ' CB ' ' A' ' 74' ' ' ALA . 3.7 mt -81.54 -31.88 11.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.63 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 41.1 t80 -92.02 -13.19 31.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.558 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.64 -14.28 26.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 53.9 t -101.5 -35.44 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.973 0.892 . . . . 0.0 109.874 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.564 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -74.19 -4.85 38.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.716 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -164.38 32.42 0.07 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.571 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.529 ' HA2' ' CG ' ' A' ' 58' ' ' MET . . . 45.59 -137.31 7.11 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.4 OUTLIER 157.9 128.93 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.937 -0.631 . . . . 0.0 109.311 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 51.9 m-80 62.95 -86.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -123.67 32.47 5.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.947 . . . . 0.0 109.735 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.623 ' HE1' ' C4B' ' A' ' 88' ' ' HEC . 27.1 ttt -111.7 141.92 25.62 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.061 -1.024 . . . . 0.0 109.147 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.608 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 31.0 Cg_endo -76.48 104.06 1.85 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.073 2.515 . . . . 0.0 114.293 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.716 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -52.28 121.97 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.73 -0.606 . . . . 0.0 109.813 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.595 ' CD2' HD12 ' A' ' 65' ' ' LEU . 39.6 m-85 -93.02 -55.66 3.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.96 -1.088 . . . . 0.0 108.558 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.521 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 27.53 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.207 0.527 . . . . 0.0 110.132 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 166.01 -15.53 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.582 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -101.87 -29.34 11.9 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.595 HD12 ' CD2' ' A' ' 61' ' ' PHE . 7.5 mp -94.49 114.12 26.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.552 ' O ' ' O ' ' A' ' 65' ' ' LEU . 3.3 m -43.7 179.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.419 0.628 . . . . 0.0 110.264 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.54 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -75.75 -62.38 1.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.913 -1.117 . . . . 0.0 109.083 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 32.6 mt-10 -61.99 -9.49 7.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.386 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.602 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.6 OUTLIER -94.66 -34.91 12.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CD1' ' CB ' ' A' ' 65' ' ' LEU . 7.0 mm -69.68 -14.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.5 mp0 -97.31 -69.87 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.581 1.181 . . . . 0.0 109.164 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.667 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 42.1 m-20 -52.36 -33.87 44.97 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.393 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.659 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.3 p -69.53 -30.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.619 0.723 . . . . 0.0 109.878 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.534 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -74.68 -57.72 3.74 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.21 -19.16 53.05 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.674 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 61.9 t80 -64.93 -41.89 95.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.606 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 40.7 t -72.95 -24.24 20.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 1.1 mt -85.32 -7.85 58.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 9.8 t0 -99.67 -36.86 9.35 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.183 0.992 . . . . 0.0 109.242 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.59 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 6.5 mm-40 -78.62 -40.15 35.18 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.202 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.58 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -62.62 -37.65 87.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.774 . . . . 0.0 109.891 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.66 13.96 12.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 110.93 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 2.3 ptmt -150.03 30.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.544 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.97 74.06 1.26 Allowed Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.847 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.606 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 1.7 m95 -40.79 84.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.161 -0.611 . . . . 0.0 110.854 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 47.38 23.57 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.531 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.623 ' C4B' ' HE1' ' A' ' 58' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -130.02 -24.32 2.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 79' ' ' ASP . 1.7 mp -67.06 -7.76 25.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.9 -1.125 . . . . 0.0 109.286 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.76 -31.89 68.77 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -68.6 -36.97 79.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.16 -62.96 5.47 Favored Glycine 0 C--O 1.203 -1.812 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.64 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.55 -30.08 4.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -1.207 . . . . 0.0 109.86 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -64.48 -45.29 88.0 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 108.376 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 41.2 t -75.77 -55.4 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.613 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 7.9 t80 -57.43 -26.11 60.65 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 110.438 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 28.9 t -86.24 19.08 2.84 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -162.16 11.15 0.11 Allowed Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 8.8 m-80 -153.97 -53.16 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.683 -1.481 . . . . 0.0 109.159 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.613 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.3 m -73.38 -26.38 60.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.485 ' HA ' ' CA ' ' A' ' 19' ' ' MET . . . -52.1 -41.0 62.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.2 68.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.903 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.583 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 85.8 m -121.55 19.13 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.922 -1.111 . . . . 0.0 110.649 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 93.8 m-70 -158.67 -66.5 0.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.164 -0.96 . . . . 0.0 109.25 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 14.2 ptm 39.48 98.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.531 0.682 . . . . 0.0 110.286 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.45 46.02 80.95 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 51.09 68.19 1.61 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 30' ' ' THR . . . -143.29 88.32 0.17 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.484 ' ND2' ' CE1' ' A' ' 18' ' ' HIS . 1.2 t-20 -61.9 142.25 57.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -1.118 . . . . 0.0 109.778 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 17' ' ' CYS . 17.4 m -102.16 -13.26 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.56 -57.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.92 . . . . 0.0 109.127 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.483 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 9.5 mmt -103.36 93.97 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.845 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.18 -47.55 35.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.733 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -35.62 80.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.192 -0.943 . . . . 0.0 109.885 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 0.0 OUTLIER -84.29 82.68 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 21' ' ' GLY . 24.5 m -122.01 171.97 8.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.052 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.657 ' CD1' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.74 -3.49 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -46.01 173.53 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.142 -0.974 . . . . 0.0 109.964 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -84.17 -27.65 27.94 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.312 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -82.51 -27.12 31.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.96 . . . . 0.0 111.074 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.42 -35.21 7.18 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.292 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.558 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -60.6 -39.7 89.11 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.115 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.557 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -96.93 6.06 49.34 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.503 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -69.33 -47.21 65.1 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.5 -39.04 16.65 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.656 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.52 79.17 0.6 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.437 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.521 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -159.16 25.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -1.098 . . . . 0.0 108.798 179.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.65 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 33.8 t80 -74.68 3.12 8.4 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.518 0.675 . . . . 0.0 109.621 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.46 ' CA ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -103.94 155.59 18.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.707 -1.245 . . . . 0.0 110.999 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 1.3 mp0 -50.44 -64.73 0.72 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.871 -0.518 . . . . 0.0 110.515 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -46.48 -31.57 2.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.77 -1.206 . . . . 0.0 111.437 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 41' ' ' MET . . . -69.65 -73.94 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.784 -1.198 . . . . 0.0 110.658 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.547 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 10.4 tt -60.31 -17.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.25 -0.906 . . . . 0.0 109.622 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 44' ' ' GLU . 21.6 mt -72.31 -34.44 49.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 52.1 t80 -71.64 -29.98 65.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 2.5 pm0 -94.39 -13.2 26.56 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.774 -1.57 . . . . 0.0 109.125 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 60.2 t -87.76 -23.73 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.009 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.566 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -99.39 -7.68 25.85 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.47 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.657 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -147.35 13.6 1.09 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 53.5 -135.33 41.54 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.612 ' N ' ' HB3' ' A' ' 58' ' ' MET . 4.9 mtpt 155.17 127.48 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 16.0 m-80 61.0 -88.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -121.9 29.29 7.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.235 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.612 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 27.8 ttt -107.12 141.89 23.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.582 ' CD ' ' C3C' ' A' ' 88' ' ' HEC . 37.0 Cg_endo -85.06 99.22 0.69 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.202 2.601 . . . . 0.0 113.879 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.607 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -37.54 158.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 0.0 110.018 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 60' ' ' ALA . 14.4 m-85 -137.03 22.62 3.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -5.07 2.46 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.48 16.74 0.99 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.64 -55.83 2.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.539 ' N ' HD11 ' A' ' 65' ' ' LEU . 4.7 mp -66.52 -157.42 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 1.4 m -99.51 -58.36 1.94 Allowed 'General case' 0 C--N 1.285 -2.236 0 O-C-N 121.246 -0.909 . . . . 0.0 109.259 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 66' ' ' THR . 3.7 m-20 153.72 -53.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 3.7 mt-10 -69.01 -3.77 14.3 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.589 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.88 -25.81 9.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 65' ' ' LEU . 12.3 mm -57.37 -23.13 18.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.9 mp0 -96.37 -70.47 0.71 Allowed 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.515 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 2.8 m-20 -44.66 -46.4 10.2 Favored 'General case' 0 C--O 1.203 -1.394 0 O-C-N 121.857 -0.527 . . . . 0.0 110.026 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.688 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -62.05 -37.02 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.628 0.728 . . . . 0.0 110.005 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -67.23 -61.84 1.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.1 -18.99 17.03 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.688 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 71.3 t80 -67.14 -44.16 80.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.655 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 85.0 t -71.11 -19.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 75' ' ' ALA . 2.4 mt -84.6 -9.52 58.22 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.293 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.48 ' HB3' ' OE1' ' A' ' 80' ' ' GLN . 7.4 t0 -99.21 -45.87 5.74 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.188 0.994 . . . . 0.0 108.604 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.622 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.1 mm100 -65.59 -50.07 66.44 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.082 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.541 ' CB ' ' CD2' ' A' ' 36' ' ' LEU . . . -74.14 -12.1 60.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.55 -0.719 . . . . 0.0 109.22 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -65.28 -7.46 13.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.53 -0.731 . . . . 0.0 110.023 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -179.9 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.754 -1.217 . . . . 0.0 111.64 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.52 75.9 1.31 Allowed Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.019 -1.562 . . . . 0.0 109.669 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.655 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -39.74 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.39 -0.476 . . . . 0.0 110.551 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 41.49 29.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.799 . . . . 0.0 109.204 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 85' ' ' TRP . . . . . . . . 0 N--CA 1.487 2.086 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.604 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.621 ' C3A' HD13 ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.498 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 8.6 m-20 -129.98 -25.83 2.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.037 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.464 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -66.86 -4.91 10.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.554 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.95 -25.41 60.92 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.3 m-20 -77.68 -36.94 50.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.462 ' CA ' ' OD1' ' A' ' 72' ' ' ASP . . . -50.72 -55.98 15.47 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.646 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . -60.31 -24.95 65.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.767 -0.843 . . . . 0.0 109.712 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -68.88 -30.28 68.74 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.838 -1.164 . . . . 0.0 108.331 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 22.8 t -97.73 -23.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.479 -0.763 . . . . 0.0 110.056 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.631 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 t80 -89.17 -25.89 21.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.845 -1.159 . . . . 0.0 109.921 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 17.1 m -78.81 7.34 7.21 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.638 -0.664 . . . . 0.0 110.081 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -156.46 13.02 0.34 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.378 -1.392 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 1.3 m-80 -139.01 -42.4 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.802 -1.411 . . . . 0.0 109.057 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -97.22 -22.76 16.52 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -47.59 -50.37 24.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.716 -0.615 . . . . 0.0 110.455 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.16 71.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 110.776 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.612 ' CB ' ' C2C' ' A' ' 88' ' ' HEC . 64.4 m -112.94 15.07 19.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.921 -1.112 . . . . 0.0 110.006 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 81.1 m-70 -159.15 -64.45 0.08 Allowed 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 50.24 108.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.497 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.48 57.07 9.76 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 45.99 66.67 1.56 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 30' ' ' THR . . . -144.67 81.78 0.21 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -53.3 153.45 3.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -1.201 . . . . 0.0 109.324 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 m -128.12 5.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 109.997 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' CG2' ' CBC' ' A' ' 88' ' ' HEC . 27.7 t -105.29 -59.57 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 109.31 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.463 ' HG3' HAD1 ' A' ' 88' ' ' HEC . 4.4 mmm -86.38 -173.28 4.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.94 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -128.67 57.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 1.5 p-10 169.27 -41.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.806 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -71.47 89.02 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 109.876 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.473 HG22 ' HA2' ' A' ' 22' ' ' GLY . 9.6 m -122.43 170.96 9.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.318 -0.863 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.65 ' CD1' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -89.91 -11.71 41.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.997 . . . . 0.0 108.955 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -34.3 -71.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.645 -0.659 . . . . 0.0 111.6 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 1.5 tptm 170.07 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.724 -1.235 . . . . 0.0 110.196 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 32.1 mt-10 -72.2 -46.3 56.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.112 -0.992 . . . . 0.0 111.06 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.597 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.48 -48.41 49.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.029 -1.044 . . . . 0.0 111.132 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -65.97 -14.15 61.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.65 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.541 ' CG ' ' CD2' ' A' ' 42' ' ' TYR . 3.0 mm-40 -119.22 8.4 11.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.773 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.5 tp-100 -87.06 -53.06 5.07 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.25 -40.52 13.59 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.736 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.51 44.35 0.18 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.752 -1.214 . . . . 0.0 110.785 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.483 ' O ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -105.78 9.05 33.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.333 . . . . 0.0 109.187 179.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 27.6 t80 -71.98 13.99 0.25 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 111.449 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.463 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -106.0 136.26 45.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.35 -1.469 . . . . 0.0 110.745 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.56 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 1.4 mt-10 -44.1 -57.51 3.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.297 -0.877 . . . . 0.0 108.83 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -51.41 -38.75 55.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 43' ' ' SER . . . -58.12 -73.82 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.544 HD13 ' HHB' ' A' ' 88' ' ' HEC . 6.6 tt -64.47 -11.27 10.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 110.083 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 14.8 mt -78.96 -31.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 40.0 t80 -92.32 -14.4 28.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.549 ' OE1' ' CB ' ' A' ' 55' ' ' LYS . 1.4 tp60 -93.93 -14.47 25.95 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 54.2 t -97.32 -44.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.532 ' HB3' ' CD2' ' A' ' 53' ' ' HIS . 0.9 OUTLIER -64.27 -13.94 52.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.582 . . . . 0.0 111.313 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.644 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -147.88 21.54 1.13 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.581 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.36 -130.53 50.56 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.7 137.39 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 58.24 -89.48 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.61 41.46 3.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.614 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 17.5 ttt -113.94 143.97 30.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.646 ' CD ' ' C3C' ' A' ' 88' ' ' HEC . 33.2 Cg_endo -77.39 107.74 2.46 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.334 2.689 . . . . 0.0 114.709 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.644 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.55 159.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 111.039 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.636 ' CD1' ' O ' ' A' ' 60' ' ' ALA . 10.0 m-30 -141.12 16.26 2.26 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.8 -0.562 . . . . 0.0 110.116 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 52' ' ' GLN . . . -66.28 -2.99 4.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.123 178.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.53 17.8 1.13 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.22 -57.49 2.11 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.551 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 36.0 mt -73.51 -149.1 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 1.4 m -99.53 -61.52 1.36 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.9 t70 156.7 -51.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 12.3 tp10 -71.15 4.01 3.08 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.585 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -112.21 -33.24 6.28 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CD1' ' CD1' ' A' ' 65' ' ' LEU . 36.0 mm -58.28 -24.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.421 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -91.6 -73.52 0.54 Allowed 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.713 178.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 15.1 t0 -44.65 -53.7 6.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.731 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 11.5 t -56.09 -39.54 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.362 1.077 . . . . 0.0 108.159 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.429 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -55.77 -59.15 5.28 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.97 -18.77 59.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.731 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 65.0 t80 -67.27 -38.06 84.49 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.607 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 93.7 t -76.78 -23.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -86.41 -6.48 58.91 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -98.2 -52.63 3.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.265 1.031 . . . . 0.0 108.404 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.594 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 45.7 mm-40 -65.16 -46.34 81.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.365 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -70.57 -12.39 61.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.321 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -78.08 -4.45 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.45 -0.781 . . . . 0.0 110.963 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -178.32 57.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.454 -1.404 . . . . 0.0 111.961 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 89.56 75.96 1.3 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 118.947 -1.597 . . . . 0.0 109.339 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.607 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -40.7 84.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.177 0.513 . . . . 0.0 110.826 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 55.16 48.51 19.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.337 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.09 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.536 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.657 ' CBC' ' HHD' ' A' ' 88' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -104.17 158.06 16.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 109.52 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.66 -11.93 61.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 108.588 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -30.42 66.57 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.49 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.43 -37.32 65.93 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -49.72 -59.09 7.62 Favored Glycine 0 C--O 1.201 -1.948 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.626 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -54.06 -35.05 61.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.103 . . . . 0.0 109.79 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 108.995 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.603 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 37.5 t -86.15 -43.08 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 110.563 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 10' ' ' PHE . 7.8 t80 -63.46 -27.68 69.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.726 -1.234 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 p -86.52 18.47 3.29 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 109.473 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.71 6.96 0.66 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.243 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -152.56 -49.76 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.605 -1.527 . . . . 0.0 109.468 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 2.3 m -76.46 -30.69 57.43 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 19' ' ' MET . . . -43.6 -42.45 5.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.679 -0.638 . . . . 0.0 110.294 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -46.96 85.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.944 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.582 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 66.5 m -107.28 29.54 7.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.608 ' CE1' HD22 ' A' ' 31' ' ' LEU . 77.8 m-70 -162.6 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.499 ' O ' ' O ' ' A' ' 18' ' ' HIS . 9.8 ptt? 39.04 100.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.49 0.662 . . . . 0.0 110.777 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 87.26 41.95 6.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 39.32 58.73 1.97 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.449 ' HA2' HG21 ' A' ' 30' ' ' THR . . . -151.64 103.85 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.415 HD22 ' C4D' ' A' ' 88' ' ' HEC . 2.5 t-20 -56.11 162.08 2.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.197 . . . . 0.0 109.05 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.4 -29.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.047 -1.033 . . . . 0.0 109.986 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -79.09 -70.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.099 -1.001 . . . . 0.0 109.337 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.522 ' CG ' HAD1 ' A' ' 88' ' ' HEC . 32.3 mmt -66.48 150.85 48.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.278 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -113.54 60.35 0.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 109.685 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.47 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.8 p30 -178.69 -44.17 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.985 . . . . 0.0 109.364 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' CD ' ' HE3' ' A' ' 41' ' ' MET . 25.0 mttp -81.86 124.37 29.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.121 -0.987 . . . . 0.0 109.071 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.48 ' O ' HD21 ' A' ' 36' ' ' LEU . 2.1 m -121.47 -174.18 2.8 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.274 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.608 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -100.24 -13.93 18.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 81' ' ' ALA . 24.2 mtpt -59.78 -98.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.144 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.555 ' HB2' ' CD2' ' A' ' 42' ' ' TYR . 14.7 ptpt -177.25 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -51.47 -29.07 15.02 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.584 ' C ' ' CE2' ' A' ' 39' ' ' PHE . . . -104.48 -71.79 0.73 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.396 -0.815 . . . . 0.0 110.095 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.588 HD13 ' CG ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -40.56 -39.91 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.532 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -82.96 -33.45 26.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.92 -1.112 . . . . 0.0 109.215 179.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -45.79 -44.3 13.91 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CE2' ' C ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -85.83 -72.24 0.5 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.9 89.18 0.07 OUTLIER Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER 179.48 26.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -1.2 . . . . 0.0 110.395 -178.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.588 ' CG ' HD13 ' A' ' 36' ' ' LEU . 3.3 t80 -109.04 23.37 14.64 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 109.473 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 p -107.79 153.42 23.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.546 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -42.52 -65.67 0.44 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 109.858 178.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -52.18 -32.91 38.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.015 . . . . 0.0 110.437 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.503 ' C ' ' NE2' ' A' ' 50' ' ' GLN . . . -62.55 -73.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.28 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.556 HG12 ' CG2' ' A' ' 51' ' ' VAL . 10.6 tt -62.57 -13.8 11.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 32.7 mt -77.22 -28.67 16.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.646 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 25.7 t80 -85.76 -22.22 27.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.338 -0.851 . . . . 0.0 110.026 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.561 ' NE2' HBA2 ' A' ' 88' ' ' HEC . 2.3 pm0 -99.47 -15.07 18.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 119.789 -1.819 . . . . 0.0 108.735 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.556 ' CG2' HG12 ' A' ' 47' ' ' ILE . 34.5 t -91.43 -27.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 109.516 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.608 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -86.8 -4.4 59.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.788 -1.195 . . . . 0.0 108.144 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.695 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -158.97 22.37 0.2 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.36 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.581 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 48.8 -138.28 15.09 Favored Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.261 -1.935 . . . . 0.0 108.261 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.609 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.9 OUTLIER 156.43 134.53 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.03 -89.38 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -121.76 41.15 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.507 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.626 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 18.2 ttt -119.76 143.31 34.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 108.726 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.626 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 33.5 Cg_endo -77.31 94.56 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 123.004 2.469 . . . . 0.0 115.347 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.691 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -49.2 112.94 0.7 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.288 -0.882 . . . . 0.0 110.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.675 ' CD2' ' CD2' ' A' ' 65' ' ' LEU . 25.9 m-85 -81.41 -51.2 8.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.11 26.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.384 0.612 . . . . 0.0 109.606 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.85 32.74 0.63 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.645 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -100.29 -48.52 4.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.675 ' CD2' ' CD2' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -64.12 -141.0 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.581 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 3.3 m -98.02 -52.11 3.81 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 121.01 -1.056 . . . . 0.0 109.175 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.7 m-20 150.77 -60.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 35.2 mm-40 -68.22 -2.02 7.31 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.679 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -111.11 -29.82 7.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.534 ' CD1' HD21 ' A' ' 65' ' ' LEU . 9.7 mm -52.47 -24.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.52 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -100.21 -60.42 1.53 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.442 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.679 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 13.9 m-20 -52.69 -47.6 67.13 Favored 'General case' 0 C--O 1.189 -2.114 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.527 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.585 ' C ' ' HB3' ' A' ' 76' ' ' TYR . 6.3 t -54.56 -29.17 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 108.791 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.609 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -77.67 -67.64 0.7 Allowed 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.47 -23.62 2.58 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.012 -1.68 . . . . 0.0 107.515 177.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.626 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 35.6 t80 -64.74 -46.23 83.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.188 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.675 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.4 p -67.74 -23.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.5 mt -78.34 -12.13 59.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 83' ' ' LYS . 3.6 t0 -100.74 -34.62 9.77 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.793 0.806 . . . . 0.0 109.713 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.593 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 4.2 mm-40 -76.95 -40.63 46.37 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.27 0.557 . . . . 0.0 110.198 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 32' ' ' LYS . . . -69.48 -26.15 64.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 108.952 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.45 11.65 18.71 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 111.036 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -162.53 29.5 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.344 -1.473 . . . . 0.0 112.442 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 92.31 75.7 1.31 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.71 -1.709 . . . . 0.0 109.202 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.675 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.6 OUTLIER -36.9 89.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.532 0.682 . . . . 0.0 110.152 178.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -60.31 -35.87 76.61 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.217 0 CA-C-O 118.028 -1.429 . . . . 0.0 109.722 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.567 ' C4C' ' HG3' ' A' ' 58' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -122.47 -24.53 4.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.849 . . . . 0.0 109.484 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 79' ' ' ASP . 4.8 mt -69.61 -5.28 23.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.133 -0.979 . . . . 0.0 109.449 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.58 68.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.8 -33.95 64.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.85 -61.82 6.71 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.66 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.47 -36.66 15.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.271 . . . . 0.0 109.66 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -58.52 -46.1 87.47 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 42.5 t -75.51 -63.03 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.622 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.1 t80 -46.27 -23.43 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 110.954 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 7' ' ' ALA . 50.3 m -91.49 31.88 1.13 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.24 -0.912 . . . . 0.0 109.168 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.34 -32.73 0.02 OUTLIER Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.896 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.443 ' CG ' HD13 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -118.08 -50.24 2.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.878 -1.366 . . . . 0.0 108.767 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.622 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 6.6 m -70.2 -29.8 66.74 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 10' ' ' PHE . . . -61.14 -38.17 85.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.513 -0.742 . . . . 0.0 110.48 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -11.83 7.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.82 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.576 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 96.9 m -143.01 23.91 1.85 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.869 -1.145 . . . . 0.0 110.082 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 84.8 m-70 -157.9 -68.73 0.09 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.19 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 53.78 110.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.637 -0.664 . . . . 0.0 110.304 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 45.92 62.4 3.39 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 41.64 68.8 0.62 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA2' HG22 ' A' ' 30' ' ' THR . . . -149.75 87.18 0.15 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -57.85 145.85 33.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -1.107 . . . . 0.0 109.474 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.8 m -97.42 -41.34 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.6 t -83.53 -60.7 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.092 -1.005 . . . . 0.0 109.196 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.483 ' CG ' HAD1 ' A' ' 88' ' ' HEC . 0.2 OUTLIER -86.7 90.19 8.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.77 71.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.713 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -74.16 -39.51 63.19 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.151 -0.968 . . . . 0.0 109.457 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.72 106.79 18.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.366 -0.834 . . . . 0.0 109.425 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.506 ' HB ' ' CD ' ' A' ' 32' ' ' LYS . 7.7 m -126.5 174.81 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.104 -0.998 . . . . 0.0 109.567 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -95.76 -8.83 33.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -34.49 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.573 -178.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.589 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 14.9 ttpp -178.42 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.824 -1.173 . . . . 0.0 110.592 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -80.16 -53.3 6.8 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.082 -1.011 . . . . 0.0 111.63 -178.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.617 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -67.75 -53.84 24.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.937 -1.102 . . . . 0.0 110.521 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -44.84 -23.76 0.16 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.565 -179.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 89.4 mt-10 -95.25 -32.56 12.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 110.307 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 15.5 mm100 -52.17 -39.52 60.19 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.617 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.87 -47.9 8.64 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.33 8.37 5.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.538 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 4.2 ptt? -80.94 11.78 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -1.153 . . . . 0.0 109.98 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.593 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 15.0 t80 -85.11 12.22 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.946 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 p -105.15 149.28 26.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.26 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 48' ' ' ILE . 3.8 tt0 -54.39 -57.4 11.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.849 . . . . 0.0 109.64 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 45' ' ' ASP . 16.0 t0 -51.75 -23.13 4.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.643 -1.286 . . . . 0.0 110.3 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.68 -76.17 0.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 6.7 tt -57.91 -16.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 44' ' ' GLU . 15.1 mt -71.89 -39.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.586 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 28.9 t80 -86.36 -16.88 35.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 108.834 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.54 ' NE2' HBA1 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -86.61 -19.97 28.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.665 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.589 HG11 ' CD2' ' A' ' 61' ' ' PHE . 62.3 t -96.22 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.503 1.144 . . . . 0.0 109.552 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.558 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -71.7 -11.74 60.98 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.272 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.645 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -154.2 23.87 0.49 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.378 -1.451 . . . . 0.0 109.091 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.684 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.42 -148.86 44.51 Favored Glycine 0 C--N 1.285 -2.256 0 N-CA-C 107.627 -2.189 . . . . 0.0 107.627 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.97 117.82 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.9 m-80 63.39 -86.98 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -126.29 28.32 6.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 108.737 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.647 ' CG ' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.31 141.82 23.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.634 ' CD ' ' C3C' ' A' ' 88' ' ' HEC . 31.7 Cg_endo -75.75 105.49 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 123.369 2.713 . . . . 0.0 116.242 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -57.27 117.47 4.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.634 ' CD2' ' CD2' ' A' ' 65' ' ' LEU . 17.7 m-85 -87.9 -45.59 10.12 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.038 -1.039 . . . . 0.0 108.781 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 46.93 19.01 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.39 -0.819 . . . . 0.0 108.906 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 128.65 43.19 0.23 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.555 ' CB ' ' HB3' ' A' ' 61' ' ' PHE . 21.0 ttt180 -101.59 -51.62 3.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.634 ' CD2' ' CD2' ' A' ' 61' ' ' PHE . 2.7 mm? -63.6 -145.13 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 2.5 m -99.0 -56.98 2.28 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 120.896 -1.128 . . . . 0.0 109.642 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER 152.43 -55.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.086 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 24.5 mt-10 -69.75 -1.71 9.96 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.589 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.6 -28.23 8.98 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 65' ' ' LEU . 8.2 mm -56.29 -23.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.482 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.9 mp0 -95.56 -70.31 0.72 Allowed 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.442 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 5.4 m-20 -45.19 -47.29 12.5 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.954 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.715 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -60.45 -36.25 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.74 0.781 . . . . 0.0 110.132 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -68.34 -62.71 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.529 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.19 -19.14 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 82.5 t80 -65.02 -45.27 86.22 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.466 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 42.5 t -68.87 -24.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.429 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.529 ' HG ' ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -83.53 -4.76 58.83 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.908 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.469 ' HB2' HD11 ' A' ' 3' ' ' LEU . 5.0 t0 -97.41 -45.4 6.47 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.774 ' HB3' ' CD2' ' A' ' 85' ' ' TRP . 10.7 mp0 -72.08 -31.75 66.38 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.2 0.524 . . . . 0.0 110.344 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 33' ' ' LYS . . . -58.44 -52.72 64.43 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.73 19.39 4.03 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -131.95 5.57 4.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 111.597 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.5 76.15 1.04 Allowed Glycine 0 C--N 1.296 -1.672 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.774 ' CD2' ' HB3' ' A' ' 80' ' ' GLN . 18.0 m95 -38.28 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.417 0.627 . . . . 0.0 110.804 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 44.78 24.84 0.12 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 109.824 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.112 0 CA-C-O 117.971 -1.46 . . . . 0.0 109.499 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.713 ' CBB' ' HHC' ' A' ' 88' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.415 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 35.1 t70 -116.39 150.96 36.9 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.173 -0.954 . . . . 0.0 109.258 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.471 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.24 -3.98 23.27 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.08 -1.012 . . . . 0.0 108.424 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.92 -31.12 72.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.504 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.2 m-20 -71.6 -26.54 62.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.629 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -60.56 -64.11 4.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.853 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -39.77 -34.24 0.24 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.875 -0.78 . . . . 0.0 109.275 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.17 -52.49 40.82 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.697 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 23.6 t -52.19 -57.29 4.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.715 -0.615 . . . . 0.0 110.349 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.783 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 19.8 t80 -59.37 -33.46 71.21 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.986 -1.072 . . . . 0.0 110.473 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 t -91.1 21.17 4.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.283 -0.885 . . . . 0.0 110.073 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.63 -8.64 0.68 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.513 ' O ' ' HAB' ' A' ' 88' ' ' HEC . 0.7 OUTLIER -149.12 3.67 0.6 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.484 -1.598 . . . . 0.0 111.525 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.551 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -132.65 -44.99 0.89 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.564 -1.335 . . . . 0.0 110.979 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . -27.38 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.13 0.491 . . . . 0.0 111.196 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -61.8 -53.48 55.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 110.762 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.572 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 84.4 m -94.85 25.02 4.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 109.628 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.561 ' CE1' ' HG ' ' A' ' 31' ' ' LEU . 28.5 m-70 -157.1 -72.08 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.743 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 2.5 mtp 43.71 100.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.313 0.578 . . . . 0.0 110.631 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 75.72 50.8 7.64 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 37.98 45.82 1.68 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -127.42 101.0 0.56 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.3 t-20 -46.16 165.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -1.198 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' CG1' ' HA ' ' A' ' 17' ' ' CYS . 1.7 p -111.73 -40.41 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.181 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.404 HG22 HG11 ' A' ' 24' ' ' VAL . 2.7 t -91.72 -70.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.227 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.92 101.18 8.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.55 75.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.641 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 2.2 p-10 -65.8 -44.93 84.23 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.15 -0.969 . . . . 0.0 109.387 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.2 tptt -85.12 79.69 9.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.449 -0.782 . . . . 0.0 109.677 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 6.7 t -101.04 -176.47 3.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.905 . . . . 0.0 109.69 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -97.3 -19.07 18.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.73 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -38.61 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.692 -0.63 . . . . 0.0 111.407 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.582 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 0.6 OUTLIER 174.63 -39.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.019 . . . . 0.0 109.95 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.71 . . . . 0.0 111.103 -178.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.603 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -93.31 -47.24 7.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 110.803 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.67 ' CD1' ' CG ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -58.85 -33.21 70.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.557 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 42' ' ' TYR . 2.0 mm-40 -95.75 -1.28 50.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.568 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -73.69 -57.61 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -88.27 -48.98 7.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.456 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.58 92.84 0.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.535 ' CE ' HAA2 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -172.13 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.048 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.67 ' CG ' ' CD1' ' A' ' 36' ' ' LEU . 2.2 t80 -102.14 21.73 14.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.482 -0.761 . . . . 0.0 109.751 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -107.4 143.78 35.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 0.0 111.216 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -42.42 -62.78 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.47 -0.769 . . . . 0.0 109.588 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -49.01 -37.6 20.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 110.751 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -74.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.995 -1.066 . . . . 0.0 110.44 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.54 HG12 ' CG2' ' A' ' 51' ' ' VAL . 8.0 tt -64.28 -10.51 8.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.528 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 44' ' ' GLU . 10.7 mt -75.4 -37.64 38.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 34.0 t80 -89.5 -15.96 31.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.53 ' NE2' HBA1 ' A' ' 88' ' ' HEC . 0.1 OUTLIER -88.34 -14.48 38.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.54 ' CG2' HG12 ' A' ' 47' ' ' ILE . 54.5 t -97.2 -47.71 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.392 -0.818 . . . . 0.0 110.006 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.534 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -61.34 -9.92 6.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.737 -0.602 . . . . 0.0 110.878 -178.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.64 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.51 23.54 0.4 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 54.01 -133.84 44.66 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.03 120.76 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.208 0.528 . . . . 0.0 109.737 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 2.5 m120 73.85 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.8 29.4 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.195 -0.941 . . . . 0.0 108.859 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.582 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 27.0 ttt -108.23 143.79 28.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 109.346 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 32.9 Cg_endo -79.89 111.98 2.81 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.012 2.475 . . . . 0.0 113.171 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.64 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -37.68 159.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.599 -0.688 . . . . 0.0 110.246 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 60' ' ' ALA . 5.9 m-85 -147.23 21.71 1.21 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.483 -0.76 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.02 -10.8 10.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.03 . . . . 0.0 109.063 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.38 13.12 5.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.581 ' HG3' ' CD1' ' A' ' 61' ' ' PHE . 6.6 mmt85 -104.07 -48.11 3.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.589 ' HG ' ' HB3' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -95.41 124.83 39.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.524 ' O ' ' O ' ' A' ' 65' ' ' LEU . 5.3 m -44.26 178.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.258 0.552 . . . . 0.0 110.049 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.509 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 4.3 m-20 -65.21 -59.38 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.798 -1.189 . . . . 0.0 109.204 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.579 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 4.4 mt-10 -71.1 1.91 5.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.653 -0.654 . . . . 0.0 109.533 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.697 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -102.67 -27.17 12.88 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.53 HD12 ' HG ' ' A' ' 65' ' ' LEU . 25.6 mm -73.01 -31.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.8 mp0 -80.01 -64.64 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.68 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.579 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 40.7 t0 -56.86 -30.41 63.82 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.117 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.679 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 8.7 p -70.52 -29.39 38.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.501 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -70.4 -58.2 3.99 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.411 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -55.97 -23.39 32.11 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.853 ' CE2' ' HA ' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.77 -50.62 68.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.594 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 44.0 t -65.77 -22.66 31.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.89 -1.131 . . . . 0.0 109.489 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.599 HD21 ' CE1' ' A' ' 42' ' ' TYR . 1.9 mt -87.32 -7.19 58.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.038 -1.039 . . . . 0.0 108.876 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -97.77 -40.99 8.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.018 0.913 . . . . 0.0 108.761 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.65 ' CB ' ' CD2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -72.14 -45.14 61.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -76.36 -5.45 47.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -75.35 -13.54 60.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.489 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER 176.3 66.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.702 -1.249 . . . . 0.0 111.076 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 91.82 77.44 1.35 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.65 ' CD2' ' CB ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -40.21 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.389 0.614 . . . . 0.0 110.7 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 48.71 21.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.875 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.047 0 CA-C-O 117.977 -1.457 . . . . 0.0 109.573 -179.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.59 HBB2 ' CD2' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.6 OUTLIER -111.87 -28.92 7.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.513 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 0.8 OUTLIER -69.17 -8.6 47.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.123 -0.986 . . . . 0.0 108.554 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.43 -22.52 54.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -78.86 -37.01 41.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -62.39 -53.2 43.75 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.674 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.15 -24.83 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.016 -1.285 . . . . 0.0 109.368 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.494 ' HE3' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -73.97 -47.24 38.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.662 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 14.8 t -55.38 -65.03 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 122.219 1.009 . . . . 0.0 108.918 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 t80 -60.73 -28.9 69.03 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 33.0 t -89.88 18.05 6.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.556 -1.34 . . . . 0.0 109.513 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -155.56 3.54 0.2 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.88 -1.152 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -155.49 -46.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.604 -1.527 . . . . 0.0 109.56 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.2 m -79.65 -30.38 41.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.61 -41.2 66.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 110.945 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.5 79.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.262 -0.899 . . . . 0.0 111.151 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.678 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 1.8 m -110.95 20.08 17.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.879 -1.138 . . . . 0.0 110.013 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.592 ' CE1' HD23 ' A' ' 31' ' ' LEU . 89.2 m-70 -155.58 -51.37 0.08 Allowed 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.544 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.0 ptm 42.39 111.07 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.756 0.788 . . . . 0.0 111.556 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 87' ' ' GLY . . . 49.95 57.47 9.84 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.36 72.86 0.26 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.539 ' HA2' ' CG2' ' A' ' 30' ' ' THR . . . -153.83 92.49 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 1.1 t-20 -43.85 156.76 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -1.053 . . . . 0.0 109.812 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 17' ' ' CYS . 3.3 p -115.86 -35.67 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 109.633 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.486 ' N ' HG11 ' A' ' 24' ' ' VAL . 13.4 t -91.51 -68.53 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.867 . . . . 0.0 109.651 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.437 ' HE2' ' HD3' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -60.61 161.45 7.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 28' ' ' ASN . . . -117.03 63.83 0.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.905 . . . . 0.0 109.265 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 163.65 -39.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.208 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 2.7 mptt -71.73 83.23 0.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.539 ' CG2' ' HA2' ' A' ' 22' ' ' GLY . 2.1 m -99.38 -168.09 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 108.816 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.592 HD23 ' CE1' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -109.83 -2.8 17.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.677 -1.264 . . . . 0.0 109.651 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.53 ' N ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -60.19 -82.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.993 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 36' ' ' LEU . 3.2 ptmm? 168.75 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.658 -1.276 . . . . 0.0 110.936 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.72 -34.53 5.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.907 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.09 -66.44 1.02 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.84 0.828 . . . . 0.0 110.365 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.609 ' CD1' ' CB ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -44.75 -46.43 10.46 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.927 -0.483 . . . . 0.0 111.846 -178.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.474 ' HA ' ' CD1' ' A' ' 42' ' ' TYR . 43.4 tt0 -60.94 -34.63 75.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.569 -1.332 . . . . 0.0 110.333 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 3.2 mm-40 -73.81 -77.9 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.17 7.57 43.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.524 -0.735 . . . . 0.0 111.851 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 36' ' ' LEU . . . -124.88 -3.62 7.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.691 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.9 mtt 42.57 48.38 4.64 Favored 'General case' 0 C--O 1.196 -1.739 0 O-C-N 121.241 -1.152 . . . . 0.0 109.527 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.609 ' CB ' ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -39.01 -21.81 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 O-C-N 120.912 -1.117 . . . . 0.0 111.368 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -42.45 166.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.773 -1.204 . . . . 0.0 110.508 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.512 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -52.64 -73.18 0.04 OUTLIER 'General case' 0 C--O 1.2 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 110.579 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 44' ' ' GLU . 33.5 t0 -36.72 -51.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.209 -0.932 . . . . 0.0 112.492 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.691 ' CB ' ' O ' ' A' ' 41' ' ' MET . . . -63.35 -73.25 0.12 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 111.204 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.541 ' CD1' HMA3 ' A' ' 88' ' ' HEC . 14.0 tt -51.0 -20.55 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.016 -1.052 . . . . 0.0 109.677 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 44' ' ' GLU . 14.0 mt -72.12 -38.25 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.626 -0.671 . . . . 0.0 109.445 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -77.44 -26.79 51.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.5 pm0 -89.13 -18.86 26.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.213 -1.554 . . . . 0.0 108.702 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.535 ' HA ' ' CE ' ' A' ' 58' ' ' MET . 45.3 t -85.78 -44.8 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.942 0.877 . . . . 0.0 109.389 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.559 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -66.74 -10.69 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.821 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -158.65 23.29 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.71 -1.196 . . . . 0.0 108.612 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 55.89 -141.34 39.98 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.586 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 154.23 142.5 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 54.98 -90.56 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.12 49.0 2.33 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.589 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 ttt -121.04 144.6 39.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.9 Cg_endo -82.54 105.21 1.39 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 123.077 2.518 . . . . 0.0 113.67 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.62 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -39.45 154.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 110.677 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD1' HD13 ' A' ' 65' ' ' LEU . 23.0 m-85 -136.72 3.46 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 52' ' ' GLN . . . -44.36 -29.67 0.71 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.76 36.64 0.51 Allowed Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.095 -1.526 . . . . 0.0 109.805 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HB3' HD22 ' A' ' 65' ' ' LEU . 10.7 ttt-85 -102.0 -48.34 4.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.557 HD13 ' CD1' ' A' ' 61' ' ' PHE . 1.6 mt -93.68 -146.03 0.24 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.552 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -84.73 -172.94 4.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 69' ' ' GLN . 3.6 m-20 -93.45 -55.74 3.18 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.9 mt-10 -72.36 5.61 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.662 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -102.34 -31.85 10.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 66' ' ' THR . 2.2 mm -72.24 -26.06 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -66.73 0.86 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.774 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 53.9 t0 -58.61 -28.47 65.65 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.128 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.65 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 7.9 p -69.14 -26.73 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -75.18 -56.75 4.42 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.06 -19.62 53.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.674 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 78.6 t80 -67.85 -41.09 83.46 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 39.9 t -70.04 -22.61 24.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -85.39 -8.46 58.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 1.8 t70 -99.02 -35.52 10.02 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.946 0.879 . . . . 0.0 109.16 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.625 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 7.2 mm-40 -81.96 -34.01 29.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.233 0.54 . . . . 0.0 109.942 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 32' ' ' LYS . . . -62.92 -48.16 80.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.852 . . . . 0.0 109.101 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.52 18.54 3.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.445 -0.784 . . . . 0.0 109.358 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -134.86 13.38 3.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 0.0 110.963 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 77.74 75.73 0.93 Allowed Glycine 0 C--N 1.296 -1.694 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.625 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 11.7 m95 -34.76 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.727 0.775 . . . . 0.0 109.417 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -59.09 -22.78 61.34 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 109.969 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.477 ' CA ' ' HA2' ' A' ' 20' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.678 ' C2C' ' HB2' ' A' ' 17' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 1.7 m-20 73.13 -0.24 3.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.306 -0.871 . . . . 0.0 109.897 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 72' ' ' ASP . 1.8 pp -72.88 2.21 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.074 -1.016 . . . . 0.0 109.613 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.14 70.55 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -62.86 -25.65 68.39 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -59.55 -51.2 60.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.649 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -45.54 -25.45 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.714 -1.463 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -75.0 -47.82 27.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 177.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.638 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 21.1 t -55.44 -64.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 121.948 0.88 . . . . 0.0 109.01 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.598 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 11.6 t80 -59.82 -31.79 70.05 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.768 -0.582 . . . . 0.0 111.11 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 43.1 p -88.53 18.69 4.38 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.788 -1.195 . . . . 0.0 109.653 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -155.7 3.74 0.2 Allowed Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.577 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 9' ' ' VAL . 1.1 m-80 -155.16 -49.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.631 -1.511 . . . . 0.0 109.409 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.4 m -71.96 -34.99 69.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.463 ' O ' ' SD ' ' A' ' 19' ' ' MET . . . -44.99 -42.78 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 110.449 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.87 74.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.187 -0.946 . . . . 0.0 111.706 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.589 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 95.9 m -104.19 27.18 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.885 -1.134 . . . . 0.0 109.87 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 85.7 m-70 -159.89 -67.92 0.07 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.614 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.474 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 55.76 114.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.45 -0.781 . . . . 0.0 110.092 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.32 61.73 1.71 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 44.82 79.62 0.06 OUTLIER Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -160.81 83.35 0.13 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 22' ' ' GLY . 5.1 t-20 -40.51 160.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.611 -0.935 . . . . 0.0 109.586 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.517 ' CG1' ' HA ' ' A' ' 17' ' ' CYS . 14.7 p -116.3 -47.04 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.09 -1.006 . . . . 0.0 110.138 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.497 ' N ' HG12 ' A' ' 24' ' ' VAL . 9.1 p -95.82 -38.52 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.48 ' HG3' HAD1 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -96.56 115.99 28.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.73 -1.231 . . . . 0.0 109.441 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -90.19 71.87 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.6 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER 177.6 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.378 -0.826 . . . . 0.0 109.049 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 5.5 mtmm -93.43 61.56 3.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.283 -0.886 . . . . 0.0 109.311 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.471 HG22 ' HA2' ' A' ' 22' ' ' GLY . 5.1 m -85.17 166.2 16.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.746 . . . . 0.0 109.526 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -94.26 -12.22 28.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.57 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -37.37 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.587 -0.695 . . . . 0.0 111.182 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.607 ' CA ' ' CD2' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -165.74 -43.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.122 . . . . 0.0 110.386 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 mt-10 -67.31 -47.52 70.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.594 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -65.84 -45.97 80.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.675 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.623 ' CB ' ' HG3' ' A' ' 41' ' ' MET . 0.3 OUTLIER -62.63 -36.17 81.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' A' ' 33' ' ' LYS . 8.8 mt-10 -92.28 5.87 48.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.195 -0.941 . . . . 0.0 109.394 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 2.0 tp-100 -90.55 -55.6 3.52 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.594 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.71 -50.7 6.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.031 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.15 33.65 0.15 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.387 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.623 ' HG3' ' CB ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -86.05 -25.85 25.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.647 -1.502 . . . . 0.0 108.562 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 78' ' ' LEU . 8.2 t80 -41.86 -23.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.852 -0.53 . . . . 0.0 110.654 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 41' ' ' MET . 22.8 p -84.42 134.82 34.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.873 -1.142 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.547 ' O ' HG13 ' A' ' 48' ' ' ILE . 2.7 mt-10 -49.02 -54.94 13.59 Favored 'General case' 0 C--O 1.198 -1.627 0 O-C-N 121.51 -0.744 . . . . 0.0 109.524 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -52.26 -32.9 39.33 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.667 -1.27 . . . . 0.0 110.692 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 41' ' ' MET . . . -67.72 -69.66 0.3 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.97 . . . . 0.0 111.152 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.546 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 7.5 tt -66.76 -19.33 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.4 -0.812 . . . . 0.0 109.817 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 44' ' ' GLU . 12.5 mt -68.04 -25.64 32.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.656 ' CD1' ' CD2' ' A' ' 53' ' ' HIS . 63.6 t80 -86.97 -68.65 0.73 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.53 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -44.19 -25.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.515 -1.366 . . . . 0.0 108.825 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 55.8 t -80.36 -46.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 108.669 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.586 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -65.52 -13.23 58.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 111.954 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -154.57 20.02 0.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.446 -1.408 . . . . 0.0 108.515 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 56.41 -140.52 42.86 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 153.51 133.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 7.7 m-80 60.78 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.473 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -129.38 43.32 3.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.611 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 19.9 ttt -117.98 145.95 37.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.482 -0.761 . . . . 0.0 109.498 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.611 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.2 Cg_endo -81.83 101.63 1.18 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 123.373 2.715 . . . . 0.0 114.517 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.636 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.5 156.26 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.689 ' CZ ' HBB1 ' A' ' 88' ' ' HEC . 39.2 m-85 -137.02 3.74 2.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.596 -0.69 . . . . 0.0 109.434 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.39 -25.8 0.16 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.214 -0.929 . . . . 0.0 109.45 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -162.85 33.65 0.31 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -102.4 -46.57 4.74 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.61 ' CD1' ' CE1' ' A' ' 61' ' ' PHE . 73.8 mt -103.25 -145.72 0.37 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.531 ' CG2' ' OE1' ' A' ' 69' ' ' GLN . 9.2 m -98.47 167.41 10.83 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.367 -0.833 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -82.7 -49.9 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.205 -0.934 . . . . 0.0 109.134 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.553 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 4.0 tt0 -64.63 -6.86 8.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.631 -0.668 . . . . 0.0 109.273 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.638 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -96.01 -35.77 11.27 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 61' ' ' PHE . 3.8 mm -72.21 -11.54 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -66.97 0.87 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.296 1.046 . . . . 0.0 108.623 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 48.7 m-20 -53.4 -37.87 62.88 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.371 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 p -67.96 -28.98 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.55 0.691 . . . . 0.0 109.508 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.547 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -74.96 -59.31 2.79 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.47 -21.3 51.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.703 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 88.8 t80 -66.4 -42.49 87.79 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.537 HG12 ' CE ' ' A' ' 41' ' ' MET . 48.8 t -70.35 -22.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.512 ' HG ' ' HA ' ' A' ' 75' ' ' ALA . 2.2 mt -81.26 -7.75 59.63 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.481 ' HB2' HD23 ' A' ' 3' ' ' LEU . 5.6 t0 -99.42 -47.38 5.17 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.069 0.937 . . . . 0.0 108.952 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.634 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 66.7 mm-40 -69.48 -39.89 77.4 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.488 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -59.97 -45.78 91.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 109.187 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.18 13.73 12.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 110.583 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.526 ' CG ' ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -137.26 19.16 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.683 -1.261 . . . . 0.0 111.603 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.98 73.15 1.28 Allowed Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.142 -1.504 . . . . 0.0 109.366 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.634 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 1.9 m95 -40.83 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 122.316 -0.52 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 48.56 34.85 5.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.039 -1.038 . . . . 0.0 109.574 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 CA-C-O 118.009 -1.44 . . . . 0.0 109.584 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.697 ' CBB' ' HHC' ' A' ' 88' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.311 0.576 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.77 -25.17 4.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.438 HD23 ' HB2' ' A' ' 79' ' ' ASP . 1.3 mt -68.28 -5.86 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.153 -0.967 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.3 70.61 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.97 -30.7 62.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -58.97 -59.8 10.09 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.641 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -52.31 -28.86 20.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.761 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.5 OUTLIER -62.51 -43.49 98.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 69' ' ' GLN . 4.1 t -77.92 -49.61 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.444 -0.785 . . . . 0.0 109.815 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 5.1 t80 -60.57 -23.57 64.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.698 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 40.2 p -87.95 19.74 3.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.66 3.95 0.64 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.474 ' ND2' HD21 ' A' ' 65' ' ' LEU . 29.9 m-80 -147.58 -48.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.745 -1.444 . . . . 0.0 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 1.9 m -78.98 -29.52 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 108.692 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.84 -40.11 13.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.655 -0.653 . . . . 0.0 110.009 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -42.42 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.011 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 80.2 m -116.67 32.9 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.425 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.593 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 67.0 m-70 -163.9 -76.83 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 109.153 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 52.04 114.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.493 0.663 . . . . 0.0 110.755 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 50.13 55.42 15.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 40.78 81.58 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -165.44 96.79 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.05 150.33 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -1.107 . . . . 0.0 109.399 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.68 -14.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.602 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.429 ' HB ' HMD1 ' A' ' 88' ' ' HEC . 11.0 t -101.12 -68.68 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mmt -76.75 140.95 40.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.821 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -100.73 62.71 1.03 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.13 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.1 p30 179.24 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.312 -0.867 . . . . 0.0 109.819 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -80.81 75.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.707 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -89.78 175.07 7.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.554 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -102.22 -17.58 15.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.482 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' O ' HD23 ' A' ' 36' ' ' LEU . 2.7 mtpm? -48.18 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.717 -0.615 . . . . 0.0 111.955 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' CD2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -165.08 -45.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.689 -1.257 . . . . 0.0 111.003 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 3.6 mm-40 -61.83 -14.18 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 111.157 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -105.73 -45.74 4.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.969 -1.082 . . . . 0.0 110.695 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.652 ' CB ' ' HG3' ' A' ' 41' ' ' MET . 0.2 OUTLIER -61.9 -33.83 74.94 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.279 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.582 ' OE1' ' CD2' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -89.96 -4.0 57.71 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.619 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.532 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.14 -59.68 2.68 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -87.25 -51.54 5.91 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.995 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 141.18 24.32 0.23 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.948 -1.596 . . . . 0.0 111.672 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.652 ' HG3' ' CB ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -74.91 -20.05 59.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.556 -1.555 . . . . 0.0 108.321 178.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.582 ' CD2' ' OE1' ' A' ' 37' ' ' GLU . 6.9 t80 -46.83 -22.16 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.715 -0.616 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.515 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 50.8 p -90.26 129.79 36.46 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.17 -0.956 . . . . 0.0 110.192 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -43.38 -62.78 0.97 Allowed 'General case' 0 C--O 1.202 -1.425 0 O-C-N 121.624 -0.672 . . . . 0.0 109.361 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -49.23 -35.98 18.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.01 . . . . 0.0 110.855 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.515 ' CB ' ' OG ' ' A' ' 43' ' ' SER . . . -61.73 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 4.2 tt -58.91 -16.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 110.252 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 10.1 mt -70.45 -37.53 70.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 29.5 t80 -83.31 -18.3 39.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -89.49 -10.78 45.03 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 70.1 t -98.56 -50.14 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.864 . . . . 0.0 109.562 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.521 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -58.55 -12.36 3.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 0.0 110.55 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.632 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -146.18 16.27 1.35 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.603 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 52.93 -121.25 14.89 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER 162.24 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.761 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.035 178.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 55' ' ' LYS . 51.8 m-80 -20.02 -49.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.724 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -148.3 20.26 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 109.765 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.622 ' HE1' ' C4B' ' A' ' 88' ' ' HEC . 23.5 ttt -102.15 145.16 30.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 108.866 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.586 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.6 Cg_endo -79.7 111.7 2.81 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.824 2.349 . . . . 0.0 113.603 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.603 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -37.58 160.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.525 -0.734 . . . . 0.0 110.25 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 32.4 m-85 -142.44 16.11 2.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 108.98 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.23 -23.05 0.77 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.436 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.47 31.27 0.7 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -103.65 -56.9 2.12 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.574 ' HG ' ' CD1' ' A' ' 61' ' ' PHE . 18.2 mt -61.82 -144.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 14.9 m -99.04 -63.24 1.14 Allowed 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.258 -0.901 . . . . 0.0 109.955 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.5 m-20 152.94 -56.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.6 tt0 -71.4 -0.01 9.27 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.657 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 2.4 mp0 -114.07 -24.32 9.08 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.507 ' CG2' ' OE1' ' A' ' 52' ' ' GLN . 9.8 mm -56.48 -21.74 13.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 172.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.9 mp0 -97.8 -68.3 0.81 Allowed 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.595 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.657 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 3.4 m-20 -51.22 -46.86 62.37 Favored 'General case' 0 C--O 1.199 -1.573 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.99 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.593 ' CG1' ' O ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -56.93 -29.1 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.626 -0.671 . . . . 0.0 110.042 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.581 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -80.15 -64.22 1.24 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.459 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -50.36 -23.05 2.1 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.493 -1.379 . . . . 0.0 107.323 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.641 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 17.1 t80 -66.5 -47.59 72.51 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.581 ' CG1' ' O ' ' A' ' 74' ' ' ALA . 1.8 p -68.11 -16.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.541 HD21 ' N ' ' A' ' 78' ' ' LEU . 5.1 mt -81.52 -15.74 53.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' HB2' HD23 ' A' ' 3' ' ' LEU . 1.2 t70 -97.95 -34.93 10.63 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.948 0.88 . . . . 0.0 108.899 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.714 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 2.3 mm-40 -83.54 -39.04 20.92 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.746 0.784 . . . . 0.0 110.035 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.622 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -51.45 -33.59 31.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.352 -0.842 . . . . 0.0 109.073 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -80.87 -28.79 35.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.543 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER 176.33 -24.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.155 -0.966 . . . . 0.0 111.0 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.709 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -61.18 -13.13 34.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.714 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 2.5 m95 -64.13 89.2 0.06 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -46.12 -25.92 0.67 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.222 -0.924 . . . . 0.0 108.913 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.067 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.471 179.809 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.622 ' C4B' ' HE1' ' A' ' 58' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -124.37 -22.13 4.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.409 -0.807 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 72' ' ' ASP . 6.5 mt -68.64 -7.19 30.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.182 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.02 67.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -71.94 -39.38 69.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.204 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 5' ' ' ASN . . . -47.39 -56.45 8.15 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.658 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -52.43 -38.66 59.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.264 . . . . 0.0 109.281 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HD2' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -56.82 -40.51 76.14 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.661 ' CG2' ' CG ' ' A' ' 69' ' ' GLN . 38.6 t -80.69 -69.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.496 -0.752 . . . . 0.0 109.485 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 22.7 t80 -41.74 -25.31 0.05 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.389 -0.82 . . . . 0.0 111.257 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 63.7 m -92.1 32.92 1.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.464 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.57 -29.68 0.02 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.123 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.441 ' ND2' HG12 ' A' ' 9' ' ' VAL . 1.6 m-80 -116.75 -48.85 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.919 -1.342 . . . . 0.0 108.702 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -77.39 -27.42 52.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.513 ' CB ' ' HG3' ' A' ' 19' ' ' MET . . . -54.01 -31.35 50.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.563 -0.71 . . . . 0.0 110.163 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.35 85.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 110.99 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.605 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.5 m -111.0 26.31 10.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.413 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.635 ' CE1' HD22 ' A' ' 31' ' ' LEU . 97.8 m-70 -156.94 -74.7 0.09 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.321 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.513 ' HG3' ' CB ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 46.11 105.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.403 0.621 . . . . 0.0 111.096 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 78.13 42.31 15.88 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.488 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 42.25 37.07 2.27 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.92 90.6 0.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.534 ' HB3' ' CG ' ' A' ' 26' ' ' MET . 3.6 t-20 -49.38 168.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -1.075 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.459 ' O ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -144.07 -69.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.033 -1.042 . . . . 0.0 110.35 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.47 ' CG1' ' SG ' ' A' ' 17' ' ' CYS . 1.2 p -44.24 -40.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.053 -1.029 . . . . 0.0 109.837 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.534 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -56.36 -168.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.919 -1.113 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -121.65 4.29 10.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 178.15 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.945 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.587 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -51.79 137.56 25.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.263 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.469 ' O ' HD21 ' A' ' 36' ' ' LEU . 4.0 m -123.64 179.93 4.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.399 -0.813 . . . . 0.0 109.198 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.635 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.66 -15.7 17.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.984 -1.073 . . . . 0.0 109.165 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 5.2 mtpm? -56.45 -92.35 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.897 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 3.9 pttm -179.41 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.946 -1.096 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.611 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 23.1 pt-20 -47.42 -37.16 10.99 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.661 -0.65 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.566 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -108.32 -61.14 1.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.77 -0.581 . . . . 0.0 111.161 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.617 ' CD1' ' CD1' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -40.68 -32.65 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 109.035 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.57 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -93.15 -33.31 14.08 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 120.962 -1.086 . . . . 0.0 108.637 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.611 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 7.0 tp60 -40.73 -31.55 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.5 1.143 . . . . 0.0 108.254 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 29' ' ' LYS . 3.8 m-85 -84.96 -50.99 7.02 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.5 ' C ' ' CG ' ' A' ' 41' ' ' MET . . . 127.68 64.37 0.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.522 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -171.39 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.97 -1.312 . . . . 0.0 110.675 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.66 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 2.5 t80 -92.48 23.48 3.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 108.632 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.3 p -104.58 165.67 10.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.628 -1.295 . . . . 0.0 110.338 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 48' ' ' ILE . 4.3 mt-10 -48.63 -70.51 0.09 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -50.05 -21.42 1.25 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.589 -1.319 . . . . 0.0 110.495 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 41' ' ' MET . . . -75.45 -73.59 0.25 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.204 -0.935 . . . . 0.0 110.39 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.537 HG12 ' CG2' ' A' ' 51' ' ' VAL . 6.3 tt -63.24 -14.1 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.845 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 44' ' ' GLU . 44.4 mt -74.6 -32.52 29.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.582 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 36.0 t80 -94.32 -15.52 24.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 1.5 tp60 -91.14 -10.28 42.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.537 ' CG2' HG12 ' A' ' 47' ' ' ILE . 54.7 t -103.66 -44.97 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.712 0.768 . . . . 0.0 109.275 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.538 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -61.24 -12.23 12.41 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.34 0.591 . . . . 0.0 110.459 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.649 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -151.75 20.55 0.7 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -178.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.601 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.77 -132.44 51.21 Favored Glycine 0 C--N 1.3 -1.42 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.52 139.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 121.388 0.614 . . . . 0.0 109.423 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 53.21 -88.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -127.55 43.29 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.982 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.609 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 11.1 ttt -126.14 143.37 45.48 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 109.367 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.9 Cg_endo -76.64 120.55 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.108 2.539 . . . . 0.0 114.406 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.93 165.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.641 -0.662 . . . . 0.0 109.707 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.625 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 23.5 m-85 -145.77 11.53 1.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.177 -0.952 . . . . 0.0 109.842 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.35 -19.27 5.19 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.095 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.7 24.68 1.49 Allowed Glycine 0 N--CA 1.486 1.993 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.83 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.625 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt180 -101.93 -39.31 7.41 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.591 ' CD2' ' CD1' ' A' ' 61' ' ' PHE . 2.4 mt -102.83 -154.12 0.49 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.496 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.597 ' HB ' ' OE1' ' A' ' 69' ' ' GLN . 51.5 m -101.48 174.12 6.12 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 69' ' ' GLN . 5.6 m-20 -72.6 -57.62 4.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.822 -1.174 . . . . 0.0 108.129 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 33.4 mt-10 -63.59 3.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.661 ' CG ' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -104.51 -42.75 5.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 61' ' ' PHE . 8.7 mm -56.65 -19.14 8.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -95.86 -73.56 0.59 Allowed 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 76' ' ' TYR . 78.5 m-20 -39.63 -53.25 2.17 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.586 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.745 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 t -60.1 -42.28 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.434 1.112 . . . . 0.0 109.069 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 47' ' ' ILE . . . -59.07 -65.85 0.6 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.301 -1.499 . . . . 0.0 107.211 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.579 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.0 -17.94 20.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.745 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 78.2 t80 -65.12 -40.67 94.82 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.604 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 96.8 t -74.65 -24.71 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.594 HD21 ' CE1' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -86.68 -8.8 57.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' HB2' HD11 ' A' ' 3' ' ' LEU . 7.3 t0 -99.54 -36.02 9.67 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.031 0.919 . . . . 0.0 109.186 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.59 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 5.4 mm-40 -79.76 -42.24 24.92 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.43 0.634 . . . . 0.0 109.708 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -74.79 -18.89 60.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.394 -0.816 . . . . 0.0 109.358 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.66 6.52 7.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.626 -0.671 . . . . 0.0 110.587 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.81 48.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.501 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.93 78.26 1.15 Allowed Glycine 0 N--CA 1.481 1.643 0 C-N-CA 118.643 -1.742 . . . . 0.0 109.215 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.604 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -36.02 90.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.578 0.704 . . . . 0.0 109.677 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -63.1 -39.97 96.25 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.669 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.034 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.601 ' C4B' ' HE1' ' A' ' 58' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.12 -20.46 3.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.314 -0.866 . . . . 0.0 110.027 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.0 mp -70.39 -3.25 16.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.017 -1.052 . . . . 0.0 109.105 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.97 77.09 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.52 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -67.64 -25.43 65.72 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.59 -63.26 4.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.641 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -51.47 -33.13 29.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 0.0 109.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.508 ' NZ ' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.49 -41.78 86.1 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 108.834 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 69' ' ' GLN . 2.7 t -79.05 -51.85 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.581 ' O ' ' CD1' ' A' ' 10' ' ' PHE . 10.4 t80 -54.72 -24.38 21.89 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.045 -1.034 . . . . 0.0 110.455 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -89.8 24.97 2.19 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.443 -0.786 . . . . 0.0 109.367 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.21 11.67 0.19 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.53 ' CB ' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.23 -40.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.78 -1.424 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -93.37 -31.06 14.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 108.827 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . -42.26 -45.77 4.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.32 84.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 110.535 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.602 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 59.6 m -111.44 28.23 8.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.978 -1.076 . . . . 0.0 110.23 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 76.8 m-70 -161.56 -73.81 0.06 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.246 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 55.24 114.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.745 -0.597 . . . . 0.0 110.574 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.19 62.8 1.45 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.62 65.88 1.24 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -150.26 69.37 0.32 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 18' ' ' HIS . 20.7 p30 -48.01 166.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.099 -1.236 . . . . 0.0 109.202 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.493 HG21 ' N ' ' A' ' 25' ' ' VAL . 3.1 m -128.86 -37.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.956 -1.09 . . . . 0.0 109.908 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.493 ' N ' HG21 ' A' ' 24' ' ' VAL . 2.4 t -82.67 -40.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.09 -1.006 . . . . 0.0 109.199 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.615 ' CE ' ' CHA' ' A' ' 88' ' ' HEC . 1.2 mpp? -61.23 -56.94 14.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 26' ' ' MET . . . 74.38 27.25 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -179.34 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.479 ' C ' ' ND2' ' A' ' 23' ' ' ASN . 1.3 mtmp? -90.34 57.01 3.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 109.499 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.498 ' HB ' ' HD3' ' A' ' 32' ' ' LYS . 4.9 m -67.51 178.33 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.578 HD23 ' CE1' ' A' ' 18' ' ' HIS . 0.8 OUTLIER -98.99 -8.98 24.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -45.88 -76.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.886 -1.134 . . . . 0.0 110.481 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.578 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER 167.55 -43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 109.844 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.35 -25.99 51.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.216 -0.927 . . . . 0.0 110.415 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.599 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -101.85 -59.65 1.67 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.683 ' CD1' ' CD1' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -48.52 -31.8 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.01 -1.056 . . . . 0.0 109.774 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.578 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 38.5 mt-10 -91.42 -23.62 19.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.536 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.504 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.6 tp-100 -61.67 -42.04 98.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.599 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -89.8 -76.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.873 0.844 . . . . 0.0 109.005 178.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.42 84.92 0.05 OUTLIER Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.496 ' CE ' HAA2 ' A' ' 88' ' ' HEC . 5.2 ptt? -168.26 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -1.22 . . . . 0.0 109.617 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.683 ' CD1' ' CD1' ' A' ' 36' ' ' LEU . 7.1 t80 -103.2 19.26 19.94 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.151 -0.968 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.475 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -105.77 144.09 32.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 0.0 110.611 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.54 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -45.6 -65.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.778 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -49.4 -31.84 10.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.826 -1.171 . . . . 0.0 110.748 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 43' ' ' SER . . . -64.78 -78.54 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.565 HG12 ' CG2' ' A' ' 51' ' ' VAL . 4.4 tt -57.98 -16.19 6.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.552 0.692 . . . . 0.0 110.211 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 23.2 mt -71.67 -38.53 67.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.615 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 33.3 t80 -86.38 -11.55 51.71 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.537 ' NE2' HBA1 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -95.88 -12.88 24.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.421 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.565 ' CG2' HG12 ' A' ' 47' ' ' ILE . 56.4 t -102.58 -37.19 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.033 0.921 . . . . 0.0 109.474 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.526 ' HB3' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -66.2 -11.17 48.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.714 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -164.93 38.34 0.07 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.681 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.571 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 44.74 -133.42 7.37 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.08 125.95 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.587 -0.807 . . . . 0.0 108.846 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 73.6 m-80 65.04 -85.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.543 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.0 37.58 4.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.619 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 26.6 ttt -116.3 142.28 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 108.796 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.619 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.1 Cg_endo -71.24 103.44 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.873 2.382 . . . . 0.0 113.451 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.693 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -58.79 107.55 0.53 Allowed 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.866 -0.521 . . . . 0.0 110.385 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CD2' HD22 ' A' ' 65' ' ' LEU . 75.5 m-85 -77.1 -41.06 43.6 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.884 -1.135 . . . . 0.0 108.259 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.26 19.14 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.674 -0.641 . . . . 0.0 109.493 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 61' ' ' PHE . . . 122.37 44.28 0.36 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HB3' HD12 ' A' ' 65' ' ' LEU . 15.6 ttt-85 -102.48 -54.0 2.77 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.576 HD22 ' CD2' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -62.07 -146.39 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.541 HG21 ' N ' ' A' ' 67' ' ' ASP . 78.8 m -97.42 154.22 17.61 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.592 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 7.7 t0 -63.24 -53.68 49.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.944 -1.097 . . . . 0.0 108.303 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 tt0 -64.76 1.57 0.85 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.003 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.67 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 2.2 mp0 -115.34 -25.47 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.145 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 67' ' ' ASP . 3.7 mt -59.24 -19.95 17.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' C ' ' A' ' 69' ' ' GLN . 3.1 mp0 -97.51 -67.0 0.87 Allowed 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 114.546 -1.207 . . . . 0.0 108.332 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.67 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 18.4 m-20 -52.74 -46.08 67.29 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.001 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.588 ' CG1' ' O ' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -56.51 -27.88 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.919 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.565 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -81.69 -63.48 1.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -51.23 -22.29 2.59 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.641 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 23.0 t80 -67.93 -46.82 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.826 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.599 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.5 p -68.77 -15.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.548 HD21 ' N ' ' A' ' 78' ' ' LEU . 4.8 mt -84.28 -14.78 48.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -96.91 -39.63 9.3 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.723 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.2 mm-40 -80.02 -38.31 32.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.891 0.853 . . . . 0.0 109.411 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.6 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -52.26 -30.18 26.56 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -87.55 -25.38 23.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 110.153 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.542 ' HD3' ' N ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 176.61 -24.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.077 -1.014 . . . . 0.0 111.059 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.706 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -65.24 -12.47 55.5 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.723 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 3.3 m95 -64.81 88.57 0.07 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -48.76 -24.42 1.4 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.324 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.131 0 CA-C-O 117.997 -1.446 . . . . 0.0 109.664 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.615 ' CHA' ' CE ' ' A' ' 26' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.445 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 1.0 OUTLIER 71.52 6.32 5.69 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.24 -0.913 . . . . 0.0 109.461 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 72' ' ' ASP . 5.9 mt -76.19 -0.67 23.02 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.172 -0.955 . . . . 0.0 109.33 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.479 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -70.1 -27.36 64.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 7' ' ' ALA . . . -59.6 -65.38 3.47 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -43.13 -33.11 0.82 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -1.161 . . . . 0.0 109.445 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.492 ' HE3' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -65.26 -50.77 64.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.617 HG22 ' HG2' ' A' ' 69' ' ' GLN . 3.2 t -67.54 -59.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.266 -0.896 . . . . 0.0 108.692 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 9.2 t80 -50.28 -26.78 5.15 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 13.1 t -85.87 25.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 109.741 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.39 13.36 0.1 OUTLIER Glycine 0 N--CA 1.484 1.874 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.998 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.512 ' ND2' HD21 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.57 -48.76 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 109.381 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.619 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.3 m -81.97 -28.81 32.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.449 ' HA ' ' CA ' ' A' ' 19' ' ' MET . . . -43.39 -41.29 4.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.476 -0.765 . . . . 0.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.7 -50.32 68.58 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.124 -0.985 . . . . 0.0 111.233 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.582 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 7.8 m -109.81 23.92 13.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.168 . . . . 0.0 110.46 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 95.5 m-70 -156.16 -70.32 0.11 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.452 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.518 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.3 ptt? 38.72 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' HA2' ' HA3' ' A' ' 87' ' ' GLY . . . 80.07 49.28 6.04 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 31' ' ' LEU . . . 37.63 36.15 0.26 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.75 95.69 0.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.576 ' OD1' ' CE1' ' A' ' 18' ' ' HIS . 3.7 t-20 -57.71 -176.9 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.273 -1.134 . . . . 0.0 109.441 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -156.93 -78.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 109.793 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' MET . 1.4 p -41.58 -39.99 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 110.044 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.555 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -54.1 -166.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.024 -1.047 . . . . 0.0 109.746 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -126.34 2.15 7.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.013 -1.055 . . . . 0.0 109.919 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 178.89 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.018 . . . . 0.0 110.299 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HD3' HAD2 ' A' ' 88' ' ' HEC . 1.0 OUTLIER -58.62 122.83 14.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 -179.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' HD21 ' A' ' 36' ' ' LEU . 5.9 m -124.03 175.94 6.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 18' ' ' HIS . 2.1 mp -99.52 -9.92 22.73 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.818 -0.551 . . . . 0.0 111.138 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.557 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -56.38 -102.32 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.292 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.537 ' N ' HD22 ' A' ' 36' ' ' LEU . 19.8 ptmt -155.74 -43.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.48 -1.388 . . . . 0.0 109.803 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 7.2 pt-20 -63.64 -40.51 97.06 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 110.636 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -79.22 -52.17 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 111.482 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.62 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -65.32 -11.48 42.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.718 -1.238 . . . . 0.0 108.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.597 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -119.67 -1.61 10.57 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.273 -0.892 . . . . 0.0 108.777 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.539 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -65.45 -48.32 73.12 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.62 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -86.48 -31.62 21.24 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.22 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 117.29 99.38 2.05 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.648 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.582 ' SD ' ' CE1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 156.42 46.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.852 -0.793 . . . . 0.0 108.987 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.646 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -104.79 18.78 21.68 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.976 0.893 . . . . 0.0 108.853 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.428 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 53.6 p -105.17 166.31 10.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.131 -0.981 . . . . 0.0 110.604 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.556 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 6.8 mt-10 -48.4 -59.9 3.1 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 109.503 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -57.05 -25.94 59.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.588 -1.32 . . . . 0.0 110.976 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 41' ' ' MET . . . -69.31 -70.21 0.29 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.973 -1.079 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.58 ' CB ' HMA3 ' A' ' 88' ' ' HEC . 5.4 tt -63.0 -27.4 43.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 121.859 0.838 . . . . 0.0 109.262 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.561 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 31.2 mt -64.86 -22.38 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.686 -0.634 . . . . 0.0 109.343 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.427 ' O ' ' HD2' ' A' ' 53' ' ' HIS . 38.1 t80 -91.93 -56.7 2.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.912 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.531 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 5.7 pm0 -59.68 -14.46 14.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.201 -1.562 . . . . 0.0 109.186 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.563 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 57.4 t -101.27 -41.09 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.284 -0.885 . . . . 0.0 110.712 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -59.79 -14.69 15.84 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.892 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.651 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -153.72 25.51 0.51 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.586 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 57.91 -140.8 45.76 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.8 135.1 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 26.8 m-80 63.62 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.54 45.38 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.554 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.613 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 10.9 ttt -127.45 144.8 52.19 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 110.107 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.613 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.3 Cg_endo -76.85 116.32 4.22 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.299 2.666 . . . . 0.0 114.261 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.619 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.83 162.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.092 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.682 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 25.8 m-85 -143.61 7.21 1.48 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.245 -0.909 . . . . 0.0 110.053 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.54 -20.41 4.96 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.195 -0.94 . . . . 0.0 108.774 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.45 27.4 1.36 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.682 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 6.0 mmt85 -101.32 -44.73 5.55 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.54 ' CD2' ' CD1' ' A' ' 61' ' ' PHE . 7.9 mt -87.07 -152.93 0.2 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.29 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 67' ' ' ASP . 31.3 m -99.43 164.86 11.92 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.591 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -63.15 -57.37 10.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.443 1.116 . . . . 0.0 108.032 178.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.2 tt0 -64.18 2.92 0.49 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.354 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.617 ' HG2' HG22 ' A' ' 9' ' ' VAL . 1.3 mp0 -115.18 -26.48 7.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.851 -1.156 . . . . 0.0 109.2 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 67' ' ' ASP . 2.6 mt -59.31 -19.53 16.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.5 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.6 mp0 -97.58 -71.28 0.69 Allowed 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.497 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.614 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 24.6 m-20 -47.36 -46.41 25.67 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.979 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.664 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -62.17 -31.26 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.426 0.631 . . . . 0.0 110.546 -178.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -74.67 -62.14 1.64 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.97 -22.07 13.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.664 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 37.6 t80 -62.76 -45.57 92.06 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.629 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 72.4 t -67.29 -27.47 39.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -81.24 -9.32 59.8 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.236 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.0 t70 -100.29 -33.52 10.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.133 0.968 . . . . 0.0 109.714 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.609 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 20.7 mm-40 -77.24 -38.39 51.2 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -71.88 -17.22 62.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.27 10.0 23.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 111.101 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -164.26 37.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.965 -1.494 . . . . 0.0 112.728 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 85.1 77.08 1.19 Allowed Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.764 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.629 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 4.0 m95 -36.08 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.546 0.688 . . . . 0.0 109.185 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -60.68 -45.26 94.85 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.603 -0.686 . . . . 0.0 109.841 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.477 ' HA3' ' HA2' ' A' ' 20' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.146 0 CA-C-O 117.957 -1.468 . . . . 0.0 109.579 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.595 ' C1D' ' HB2' ' A' ' 58' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -116.34 -28.52 6.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.945 . . . . 0.0 109.279 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.458 HD23 ' HB2' ' A' ' 75' ' ' ALA . 1.5 mp -75.65 -14.77 60.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.21 68.52 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.519 ' O ' ' HE2' ' A' ' 8' ' ' LYS . 1.3 m-20 -80.33 -30.35 38.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -53.86 -48.33 62.49 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.649 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -58.94 -28.27 66.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.82 -0.812 . . . . 0.0 109.8 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -68.59 -28.15 66.68 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.008 -1.058 . . . . 0.0 108.717 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.657 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 41.1 t -100.16 -18.56 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.454 -0.779 . . . . 0.0 110.479 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 12.7 t80 -97.03 -19.93 18.39 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.89 -1.131 . . . . 0.0 109.694 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -99.38 7.46 45.51 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.664 -0.648 . . . . 0.0 109.584 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.499 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -139.18 2.28 2.58 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.515 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -151.04 -62.44 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.129 -1.218 . . . . 0.0 108.742 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.558 ' HA ' HBB3 ' A' ' 88' ' ' HEC . 6.8 m -60.89 -34.49 74.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' MET . . . -54.93 -36.21 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 110.124 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.01 -44.74 74.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.392 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 92.8 m -109.0 13.53 24.61 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.603 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 91.9 m-70 -160.92 38.94 0.15 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -63.0 141.09 58.9 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.62 45.79 8.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 42.32 68.05 0.79 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -147.61 96.53 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 22' ' ' GLY . 1.2 t-20 -43.9 139.9 2.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -1.142 . . . . 0.0 109.289 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.4 m -105.68 -17.8 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 0.0 110.104 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.428 ' HB ' HMD2 ' A' ' 88' ' ' HEC . 39.0 t -98.83 -69.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 0.0 109.469 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 18.4 mmt -84.22 149.79 25.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -107.15 71.91 0.85 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.301 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER 179.6 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.328 -0.857 . . . . 0.0 109.332 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.584 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.5 mptt -89.7 91.28 8.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 0.0 109.312 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.544 ' O ' ' CD2' ' A' ' 36' ' ' LEU . 1.8 m -98.76 -169.46 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 0.0 109.079 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.495 ' HB3' HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -105.69 -6.51 19.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.73 -1.231 . . . . 0.0 109.576 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.591 ' N ' HD23 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -54.38 -88.45 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.371 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HG2' ' CB ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER 167.11 -38.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.844 -1.16 . . . . 0.0 110.692 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HG3' ' HE2' ' A' ' 33' ' ' LYS . 85.9 mt-10 -54.38 -28.25 42.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 110.036 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.565 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -107.43 -57.74 2.05 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.053 0.93 . . . . 0.0 110.495 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.608 HD13 ' CD2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -62.05 -43.5 98.71 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.42 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 56.7 tt0 -69.04 -19.49 64.1 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.529 -1.357 . . . . 0.0 108.868 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 3.0 tp60 -77.83 -83.83 0.08 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.847 0.832 . . . . 0.0 109.389 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CZ ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -91.41 5.1 50.7 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.639 0.733 . . . . 0.0 110.598 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -108.69 -21.21 7.64 Favored Glycine 0 C--N 1.289 -2.062 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.02 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.602 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 51.64 69.32 0.68 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.608 ' CD2' HD13 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -86.29 -3.73 59.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.179 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.422 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -45.35 162.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.252 -0.905 . . . . 0.0 111.013 -179.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.565 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -46.86 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.009 -1.057 . . . . 0.0 109.518 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.496 ' HA ' HD11 ' A' ' 48' ' ' ILE . 29.2 t0 -54.64 -17.04 2.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.786 -1.196 . . . . 0.0 110.66 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' CB ' ' O ' ' A' ' 41' ' ' MET . . . -81.04 -79.76 0.15 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.601 ' HA ' ' HB3' ' A' ' 50' ' ' GLN . 2.7 tt -54.27 -20.76 5.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.73 -1.231 . . . . 0.0 109.656 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.565 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 10.3 mt -59.92 -43.12 91.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.636 ' CE2' ' CE1' ' A' ' 53' ' ' HIS . 20.0 t80 -80.5 -16.89 53.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.601 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -86.47 -8.16 57.82 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.643 -1.286 . . . . 0.0 107.925 178.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 47' ' ' ILE . 42.1 t -108.48 -33.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.532 ' HG3' ' CG2' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -70.22 -7.55 42.93 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.715 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -165.96 38.24 0.05 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.522 -178.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 47.5 -133.67 14.94 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.95 132.75 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 57.6 m-80 62.05 -88.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.92 50.86 2.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 108.971 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.597 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 24.7 ttt -124.43 142.13 39.5 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 109.065 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.597 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 26.4 Cg_endo -68.34 104.17 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.804 2.336 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.715 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -59.22 118.33 5.78 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.655 ' CZ ' HBB1 ' A' ' 88' ' ' HEC . 13.2 m-85 -86.29 -49.41 7.7 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.93 -1.106 . . . . 0.0 108.211 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.58 26.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.22 0.533 . . . . 0.0 109.808 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.51 32.55 0.66 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.588 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.84 -48.69 4.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.581 ' HG ' ' CD2' ' A' ' 61' ' ' PHE . 29.5 mt -62.52 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.574 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 3.0 m -98.3 -54.92 2.91 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.109 -0.995 . . . . 0.0 108.956 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 66' ' ' THR . 2.6 m-20 150.87 -59.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 68.8 mm-40 -67.06 -1.84 4.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.04 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.657 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -112.05 -29.76 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CG2' ' HG3' ' A' ' 52' ' ' GLN . 39.6 mm -57.05 -20.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.492 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -100.15 -64.19 1.06 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.584 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.613 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 34.5 m-20 -52.15 -48.66 64.79 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.089 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 2.2 p -54.53 -27.21 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.918 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.61 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -81.27 -66.41 0.89 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' A' ' 3' ' ' LEU . . . -50.1 -23.77 2.33 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.163 -1.586 . . . . 0.0 107.392 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.649 ' CE1' ' CA ' ' A' ' 7' ' ' ALA . 37.1 t80 -63.55 -47.6 80.92 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.686 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.2 p -65.4 -25.59 37.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.513 HD21 ' N ' ' A' ' 78' ' ' LEU . 1.1 mt -77.34 -9.87 59.1 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.964 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.99 -43.73 6.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.051 0.929 . . . . 0.0 109.411 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.577 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 18.4 mm-40 -65.94 -44.82 83.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -68.78 -11.36 60.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.3 7.01 37.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 111.005 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -175.09 46.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.235 -1.541 . . . . 0.0 112.739 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.602 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 88.5 76.7 1.29 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.869 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.686 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -39.93 83.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 45.87 24.82 0.25 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 109.541 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.956 0 CA-C-O 118.032 -1.427 . . . . 0.0 109.605 -179.887 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.702 ' CBB' ' HHC' ' A' ' 88' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 25.7 t0 -124.22 144.42 49.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.157 -0.965 . . . . 0.0 109.479 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.541 ' HA ' ' CB ' ' A' ' 72' ' ' ASP . 2.4 pp -68.83 -0.2 5.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.905 -1.122 . . . . 0.0 108.971 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.7 t-20 -47.63 -28.69 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.51 -57.74 17.89 Favored Glycine 0 C--O 1.199 -2.034 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.621 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -45.93 -28.16 1.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.761 -1.435 . . . . 0.0 110.066 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -68.05 -46.25 71.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.595 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 24.6 t -73.49 -51.76 24.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.819 -0.551 . . . . 0.0 110.115 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.64 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 6.1 t80 -62.5 -28.85 70.12 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.717 -1.239 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 47.0 t -84.09 15.15 3.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.878 . . . . 0.0 109.701 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.472 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -160.95 11.95 0.14 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 9' ' ' VAL . 7.7 m-80 -156.43 -54.08 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.449 . . . . 0.0 108.831 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.64 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -74.06 -26.15 60.24 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.499 0.666 . . . . 0.0 109.287 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.57 -39.51 76.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.574 -0.704 . . . . 0.0 110.393 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.94 62.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.136 -0.977 . . . . 0.0 111.057 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' HMC1 ' A' ' 88' ' ' HEC . 99.9 m -124.79 8.81 8.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.826 -1.171 . . . . 0.0 110.691 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.593 ' CG ' HD21 ' A' ' 31' ' ' LEU . 87.8 m-70 -150.12 -65.45 0.21 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.136 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.447 ' O ' ' O ' ' A' ' 18' ' ' HIS . 1.2 ttt 56.25 113.08 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.269 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 39.42 60.35 1.71 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.592 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 49.43 73.33 0.37 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -155.72 81.43 0.17 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 1.6 t-20 -54.61 163.26 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.249 . . . . 0.0 109.223 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.3 m -144.4 17.11 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.041 . . . . 0.0 109.889 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.442 ' HB ' HMD1 ' A' ' 88' ' ' HEC . 43.1 t -126.58 -55.99 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.098 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.466 ' HG3' HBD1 ' A' ' 88' ' ' HEC . 3.2 mmt -75.47 -172.51 1.82 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -134.39 46.47 2.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.102 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.3 p30 178.2 -44.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 109.366 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.548 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 2.0 mttp -74.18 110.62 8.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.557 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.52 HG21 ' N ' ' A' ' 31' ' ' LEU . 92.3 m -133.43 149.33 51.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.317 -0.865 . . . . 0.0 109.25 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.608 HD12 ' C4A' ' A' ' 88' ' ' HEC . 5.9 mp -74.95 -18.67 60.35 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.848 -0.533 . . . . 0.0 111.096 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -40.61 -82.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.476 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER 174.72 -42.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 3.7 mm-40 -56.1 -34.85 66.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.584 -0.697 . . . . 0.0 109.594 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -99.17 -39.53 8.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.408 -0.808 . . . . 0.0 110.369 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.572 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -69.75 -10.28 57.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.554 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 17.1 mt-10 -118.78 3.78 11.6 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.495 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.4 tp-100 -83.59 -51.15 7.55 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -86.67 -35.54 19.27 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.779 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.63 51.75 0.24 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.955 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 41' ' ' MET . 0.0 OUTLIER -112.13 8.07 19.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.017 -1.284 . . . . 0.0 108.747 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.608 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 41.0 t80 -69.43 10.78 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.991 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 41' ' ' MET . 3.3 p -105.7 143.85 33.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.548 -1.345 . . . . 0.0 110.179 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 48' ' ' ILE . 5.1 mt-10 -46.28 -58.45 3.68 Favored 'General case' 0 C--O 1.203 -1.355 0 O-C-N 121.379 -0.826 . . . . 0.0 109.29 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 45' ' ' ASP . 9.3 t0 -47.88 -37.19 13.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -0.963 . . . . 0.0 110.829 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.07 -70.27 0.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.557 ' CD1' ' HB ' ' A' ' 77' ' ' VAL . 15.3 tt -66.06 -9.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.891 0.853 . . . . 0.0 109.884 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 44' ' ' GLU . 22.3 mt -87.57 -25.53 6.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 25.6 t80 -88.72 -23.39 22.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.643 ' OE1' ' C1A' ' A' ' 88' ' ' HEC . 4.2 pp0? -94.17 -26.45 16.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.438 -1.414 . . . . 0.0 108.289 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.535 ' CG2' ' NE2' ' A' ' 50' ' ' GLN . 2.9 t -75.02 -49.51 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.885 0.85 . . . . 0.0 109.01 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.552 ' HB3' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -64.91 -12.53 50.29 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.809 -0.557 . . . . 0.0 111.525 -177.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.635 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -147.46 13.24 1.06 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.58 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.681 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.19 -136.09 24.81 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 106.754 -2.539 . . . . 0.0 106.754 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 149.94 141.09 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 50.32 -90.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -129.35 49.39 2.25 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.661 ' HG3' ' C4C' ' A' ' 88' ' ' HEC . 7.1 ttt -125.2 146.48 54.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.644 ' CD ' ' C3C' ' A' ' 88' ' ' HEC . 36.2 Cg_endo -80.97 107.82 1.97 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 123.363 2.709 . . . . 0.0 114.81 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.681 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -40.79 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 111.135 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 59' ' ' PRO . 56.0 m-85 -150.25 14.34 0.79 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.474 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . . . -47.17 -28.49 1.85 Allowed 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.263 -0.898 . . . . 0.0 109.136 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.32 35.05 0.52 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.3 -42.99 6.1 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 61' ' ' PHE . 21.1 mt -77.09 -143.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.572 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 3.0 m -98.22 -59.45 1.75 Allowed 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.5 OUTLIER 153.26 -55.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 12.4 tt0 -68.79 -1.48 7.2 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.595 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -108.35 -31.35 7.89 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 61' ' ' PHE . 23.6 mm -57.54 -20.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.473 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.8 mp0 -99.09 -71.0 0.71 Allowed 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.01 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 87.5 m-20 -45.72 -49.77 14.39 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.176 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.664 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -60.75 -32.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.505 0.669 . . . . 0.0 110.082 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -69.82 -65.51 0.71 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.203 -1.561 . . . . 0.0 106.856 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.05 -21.86 9.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.664 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 62.5 t80 -63.84 -45.1 91.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.603 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.612 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 60.7 t -68.89 -25.22 29.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -82.65 -9.05 59.55 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.037 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 10.9 t0 -99.35 -34.52 10.27 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.624 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 4.4 mm-40 -78.57 -34.57 46.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.377 0.608 . . . . 0.0 110.003 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -65.17 -43.61 91.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.366 -0.834 . . . . 0.0 109.792 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.94 14.83 11.15 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.284 -0.885 . . . . 0.0 110.85 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 12.8 ptmt -142.86 23.57 1.9 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.512 -1.367 . . . . 0.0 111.665 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 87.3 72.6 1.29 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.032 -1.556 . . . . 0.0 109.756 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.624 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 1.1 m95 -40.85 85.06 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.202 -0.587 . . . . 0.0 110.797 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 45.74 26.21 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.133 -0.979 . . . . 0.0 109.485 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.088 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.522 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.661 ' C4C' ' HG3' ' A' ' 58' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.295 0.569 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 5.2 m-20 -109.93 145.29 37.15 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.194 -0.941 . . . . 0.0 109.199 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.564 ' CD2' ' O ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -75.69 2.6 11.58 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.308 177.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.542 ' N ' HD11 ' A' ' 3' ' ' LEU . . . -59.92 -42.49 94.05 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.488 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.5 t-20 -51.34 -32.88 27.12 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -54.49 -47.51 69.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.66 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.81 -33.45 10.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.657 -1.496 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.03 -43.99 81.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.687 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 18.3 t -62.43 -72.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 16.0 t80 -49.72 -26.62 3.96 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.703 -0.623 . . . . 0.0 111.237 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 19.6 t -92.35 31.38 1.32 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 109.008 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.481 ' HB2' HBB1 ' A' ' 88' ' ' HEC . 0.8 OUTLIER -129.33 -46.18 1.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.83 -1.394 . . . . 0.0 109.563 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.5 m -76.48 -25.02 53.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.746 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.469 ' O ' ' HE1' ' A' ' 19' ' ' MET . . . -59.3 -35.49 73.88 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.805 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.87 97.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.35 -0.844 . . . . 0.0 111.64 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.594 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 0.1 OUTLIER -108.26 26.48 10.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.757 -1.214 . . . . 0.0 109.494 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 92.5 m-70 -160.02 -54.5 0.06 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.234 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.488 ' CG ' ' C ' ' A' ' 18' ' ' HIS . 3.9 ptp 39.41 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.479 0.657 . . . . 0.0 110.794 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 67.6 52.23 31.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 41.72 57.39 3.39 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -147.26 86.63 0.16 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.5 ' HB3' ' CE ' ' A' ' 26' ' ' MET . 2.9 t-20 -51.13 159.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -1.096 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.84 -10.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 26' ' ' MET . 18.1 t -100.2 -62.78 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.074 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.5 ' CE ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -51.53 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.847 . . . . 0.0 109.773 179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.44 -8.53 10.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -153.33 -37.65 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.278 -0.888 . . . . 0.0 109.586 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 39' ' ' PHE . 5.9 tptt -46.21 90.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.485 -0.76 . . . . 0.0 109.804 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 28' ' ' ASN . 7.1 m -117.63 151.55 36.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -78.88 -7.73 58.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.324 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 1.1 mtpt -51.52 162.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.529 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' CA ' ' HB2' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.02 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -61.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 110.733 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.58 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.99 -35.62 69.53 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 111.239 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.598 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -64.74 -43.43 93.39 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.854 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -90.68 13.23 16.65 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.187 -0.946 . . . . 0.0 109.129 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -82.21 -49.82 9.68 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.598 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -87.07 -42.73 12.83 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.333 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.87 82.13 0.4 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.567 ' CE ' HAA2 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -158.68 24.53 0.23 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.286 -1.126 . . . . 0.0 108.496 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.629 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 43.3 t80 -84.38 15.83 3.42 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.494 0.664 . . . . 0.0 109.225 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.41 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -104.61 134.39 47.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.791 -1.193 . . . . 0.0 111.126 -179.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -45.07 -59.76 2.44 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -48.03 -37.98 16.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.064 -1.022 . . . . 0.0 110.492 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 43' ' ' SER . . . -60.9 -73.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 6.7 tt -65.28 -9.52 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.531 -0.73 . . . . 0.0 110.338 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 44' ' ' GLU . 9.1 mt -78.91 -35.57 18.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 37.0 t80 -91.08 -14.41 31.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.626 ' NE2' ' CHA' ' A' ' 88' ' ' HEC . 1.1 tp60 -90.63 -17.57 26.64 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 68.5 t -94.27 -45.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.53 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -62.79 -9.78 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.597 -0.69 . . . . 0.0 110.949 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.98 22.25 0.51 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 54.58 -133.44 47.01 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.75 135.75 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 121.389 0.614 . . . . 0.0 109.545 178.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 54.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.01 55.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.698 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.61 ' HB2' ' C1D' ' A' ' 88' ' ' HEC . 9.8 ttt -142.85 142.51 22.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 109.116 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.6 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 29.5 Cg_endo -75.07 117.21 4.82 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 123.385 2.723 . . . . 0.0 115.036 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.657 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -43.07 164.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.752 ' CZ ' HBB2 ' A' ' 88' ' ' HEC . 49.4 m-85 -143.12 12.63 1.81 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.44 -0.788 . . . . 0.0 109.433 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.93 -26.09 0.25 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.416 -0.802 . . . . 0.0 108.899 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -151.44 35.31 0.88 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.641 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt85 -103.38 -50.98 3.32 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.549 ' CD2' ' CD1' ' A' ' 61' ' ' PHE . 5.9 mt -86.81 -157.59 0.38 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 69' ' ' GLN . 5.6 m -100.88 -179.09 3.96 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 3.0 m-20 -76.34 -59.51 2.74 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.678 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.556 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 8.0 tt0 -66.22 -7.68 19.76 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.687 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -95.39 -34.94 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.519 HD12 ' CD1' ' A' ' 65' ' ' LEU . 4.3 mm -67.91 -14.47 18.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -98.7 -71.57 0.69 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.465 1.126 . . . . 0.0 109.071 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 58.9 m-20 -47.42 -38.6 13.73 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.89 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.709 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 3.5 p -66.52 -36.79 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.704 0.764 . . . . 0.0 109.885 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HA ' HG22 ' A' ' 47' ' ' ILE . . . -68.35 -60.21 2.61 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 119.949 -1.719 . . . . 0.0 106.401 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.38 -20.63 45.63 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.709 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 84.3 t80 -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.542 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 43.9 t -70.62 -27.02 29.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.546 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -83.63 -8.03 59.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.281 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.517 ' CB ' HD22 ' A' ' 3' ' ' LEU . 3.1 t70 -98.79 -43.38 6.79 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.178 0.989 . . . . 0.0 109.039 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.636 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -70.32 -35.68 73.8 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.951 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.533 ' HB2' ' CA ' ' A' ' 33' ' ' LYS . . . -59.44 -50.91 72.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 108.392 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.84 16.77 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.659 -0.651 . . . . 0.0 109.857 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 26.6 tttm -132.11 13.18 4.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 111.297 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 81.9 72.66 1.24 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.636 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 7.5 m95 -38.71 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.14 0.495 . . . . 0.0 110.508 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 42.44 26.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.943 . . . . 0.0 109.421 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 85' ' ' TRP . . . . . . . . 0 N--CA 1.487 2.046 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.59 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.752 HBB2 ' CZ ' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 6.2 m-20 79.31 0.93 2.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.481 -0.762 . . . . 0.0 109.912 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 76' ' ' TYR . 2.0 pp -70.62 3.92 2.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.616 ' CA ' ' HD3' ' A' ' 8' ' ' LYS . 1.4 m-20 -75.0 -1.68 23.81 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.458 ' N ' ' HB3' ' A' ' 72' ' ' ASP . . . -86.27 -46.91 5.13 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.57 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -56.14 -46.57 79.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.857 -0.79 . . . . 0.0 108.877 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.616 ' HD3' ' CA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -51.04 -33.44 25.47 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.653 ' CG2' ' HG2' ' A' ' 69' ' ' GLN . 59.6 t -96.62 -15.7 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.215 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 11.0 t80 -84.76 -28.05 26.5 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 117.589 -1.644 . . . . 0.0 109.793 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -86.63 15.09 5.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.808 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -144.34 2.02 1.27 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.844 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.482 ' ND2' ' C ' ' A' ' 12' ' ' GLY . 0.9 OUTLIER -143.51 -50.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.805 -1.409 . . . . 0.0 109.114 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.5 m -77.11 -32.11 56.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.426 -0.797 . . . . 0.0 108.875 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' HA ' ' N ' ' A' ' 19' ' ' MET . . . -45.77 -40.87 10.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.661 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.72 -46.3 77.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.097 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.594 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 80.3 m -116.12 27.81 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 110.33 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.662 ' CE1' HD22 ' A' ' 31' ' ' LEU . 90.5 m-70 -159.93 -76.41 0.07 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.215 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.531 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 55.1 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.595 0.712 . . . . 0.0 110.668 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.95 45.17 9.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.584 ' HA3' ' CD2' ' A' ' 85' ' ' TRP . . . 48.64 68.27 1.35 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.491 ' HA2' ' OG1' ' A' ' 30' ' ' THR . . . -151.78 86.8 0.14 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.8 t-20 -55.33 161.47 1.86 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.976 -1.308 . . . . 0.0 109.305 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 16.4 m -136.5 -52.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' MET . 44.8 t -45.79 -61.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.175 -0.953 . . . . 0.0 108.781 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -53.41 -170.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 109.109 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.71 1.25 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.097 . . . . 0.0 110.289 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.9 -30.83 0.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.038 -1.039 . . . . 0.0 110.729 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HG2' ' CE1' ' A' ' 39' ' ' PHE . 11.9 mttt -75.93 101.16 5.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.969 -1.082 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.578 HG21 ' CD2' ' A' ' 36' ' ' LEU . 10.3 t -93.88 -146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 108.492 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.662 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -118.41 -11.11 10.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.482 -1.386 . . . . 0.0 109.615 179.133 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 5.2 mtpt -50.02 -86.9 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.846 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 165.04 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.984 -1.072 . . . . 0.0 109.956 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -53.14 -27.19 19.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 109.718 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.86 -67.33 0.95 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.273 -0.892 . . . . 0.0 110.532 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.602 HD13 ' CD2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -54.39 -35.85 63.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.645 -0.659 . . . . 0.0 111.335 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 2.0 tt0 -69.33 -30.79 68.9 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.306 -1.496 . . . . 0.0 110.183 -178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.515 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 6.0 mm-40 -78.55 -64.55 1.15 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.245 -0.909 . . . . 0.0 109.925 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 40' ' ' GLY . 2.0 p90 -93.99 -20.19 20.2 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.537 0.684 . . . . 0.0 110.627 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.578 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -89.42 -19.11 50.7 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.031 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.572 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 49.48 71.23 0.4 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -177.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.602 ' CD2' HD13 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -101.69 -6.08 24.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.485 -176.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.514 ' OG ' ' HB1' ' A' ' 46' ' ' ALA . 2.6 p -48.74 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.781 -1.199 . . . . 0.0 110.223 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.533 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -43.61 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.92 -1.112 . . . . 0.0 109.668 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -52.67 -19.78 2.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.891 -1.131 . . . . 0.0 110.286 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 41' ' ' MET . . . -74.37 -82.11 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.395 -0.816 . . . . 0.0 110.262 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.553 HG21 ' N ' ' A' ' 48' ' ' ILE . 12.1 tt -48.77 -33.52 5.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 O-C-N 121.283 -0.886 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.553 ' N ' HG21 ' A' ' 47' ' ' ILE . 74.7 mt -56.31 -41.23 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.596 -0.69 . . . . 0.0 110.058 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.4 ' O ' ' HD2' ' A' ' 53' ' ' HIS . 28.3 t80 -78.69 -25.7 44.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.561 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.531 ' CG ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -93.71 -3.71 51.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.087 -1.633 . . . . 0.0 108.896 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.496 ' HA ' ' CE ' ' A' ' 58' ' ' MET . 25.1 t -94.8 -48.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.554 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -64.49 -8.32 13.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.867 -0.521 . . . . 0.0 110.167 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.615 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.62 21.45 0.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.838 -1.145 . . . . 0.0 108.772 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 51.89 -131.1 36.44 Favored Glycine 0 C--N 1.3 -1.419 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 150.04 142.31 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 53.94 -89.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.53 42.63 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.568 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 21.4 ttt -119.63 142.19 32.39 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.225 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 37.0 Cg_endo -81.26 108.82 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.914 2.409 . . . . 0.0 113.406 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.615 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.7 163.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.761 . . . . 0.0 110.286 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 11.2 m-85 -145.74 14.43 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 52' ' ' GLN . . . -60.22 -10.8 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.907 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.19 -4.34 7.78 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' CD ' ' CE1' ' A' ' 61' ' ' PHE . 4.2 ttt180 -106.82 -61.64 1.51 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.584 ' CD1' ' CG2' ' A' ' 73' ' ' VAL . 0.6 OUTLIER -64.62 105.8 1.04 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.551 ' O ' ' O ' ' A' ' 65' ' ' LEU . 86.2 m -39.3 166.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.294 0.569 . . . . 0.0 109.564 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 69' ' ' GLN . 15.1 t0 -57.74 -57.75 11.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.989 -1.069 . . . . 0.0 108.42 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.5 mm-40 -65.87 10.81 0.09 Allowed 'General case' 0 C--O 1.193 -1.917 0 O-C-N 121.755 -0.59 . . . . 0.0 109.887 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.653 ' HG2' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -104.4 -44.66 4.87 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.468 HG23 ' NE2' ' A' ' 52' ' ' GLN . 18.9 mm -53.0 -22.09 3.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' N ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 mp0 -94.45 -73.34 0.58 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 76' ' ' TYR . 98.2 m-20 -44.82 -64.69 0.65 Allowed 'General case' 0 C--O 1.186 -2.27 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.286 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.584 ' CG2' ' CD1' ' A' ' 65' ' ' LEU . 2.3 t -49.15 -29.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.096 -1.003 . . . . 0.0 110.269 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.626 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -79.94 -74.18 0.31 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.694 -1.254 . . . . 0.0 108.118 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -46.56 -23.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.966 -1.709 . . . . 0.0 107.784 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.622 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 40.9 t80 -60.41 -53.13 61.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.274 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.626 ' CG1' ' O ' ' A' ' 74' ' ' ALA . 1.9 p -64.47 -25.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.574 ' CD2' ' CE2' ' A' ' 42' ' ' TYR . 2.8 mt -78.5 -9.67 59.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.47 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 3.0 t0 -99.57 -41.49 7.32 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.0 0.905 . . . . 0.0 109.059 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.645 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 9.3 mm-40 -69.53 -47.48 63.59 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.381 0.61 . . . . 0.0 109.956 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -68.5 -16.02 63.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.44 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.61 8.68 27.17 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 110.889 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -171.69 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.47 77.27 1.33 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.02 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.645 ' CE3' ' CB ' ' A' ' 80' ' ' GLN . 0.9 OUTLIER -40.36 84.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.319 -0.518 . . . . 0.0 110.596 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 53.63 47.62 23.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.858 -1.151 . . . . 0.0 109.029 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.029 0 CA-C-O 117.951 -1.471 . . . . 0.0 109.529 -179.737 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.565 ' C2C' ' HB2' ' A' ' 17' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 9.7 m-20 72.8 5.02 5.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.301 -0.874 . . . . 0.0 109.961 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 76' ' ' TYR . 1.0 OUTLIER -77.2 7.39 5.17 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.937 -1.102 . . . . 0.0 109.738 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.98 -24.31 59.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.602 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . 68.3 m-20 -84.39 -6.03 59.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.445 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.582 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -87.74 -61.74 1.5 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 106.674 -2.571 . . . . 0.0 106.674 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.862 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -40.67 -37.81 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.128 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.601 ' CE ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -61.84 -48.63 79.71 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.642 ' CG2' ' CG ' ' A' ' 69' ' ' GLN . 87.9 t -63.68 -59.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -0.773 . . . . 0.0 111.814 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.756 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 46.0 t80 -54.92 -42.59 72.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.732 -1.23 . . . . 0.0 112.261 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -84.29 19.58 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.58 -1.325 . . . . 0.0 110.365 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -147.16 0.77 0.72 Allowed Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.541 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -156.23 -48.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.569 -1.548 . . . . 0.0 110.035 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.4 m -71.99 -36.12 69.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.1 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.442 -0.786 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.01 69.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.956 -1.09 . . . . 0.0 109.257 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.569 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 82.3 m -119.43 20.28 12.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.441 -0.787 . . . . 0.0 109.506 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.589 ' CE1' HD22 ' A' ' 31' ' ' LEU . 93.3 m-70 -159.87 21.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.436 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.34 153.36 7.31 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.656 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 43.46 33.53 2.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 46.39 57.99 6.14 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' HA2' ' CG2' ' A' ' 30' ' ' THR . . . -146.76 91.89 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 2.2 t-20 -41.77 142.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.457 -1.026 . . . . 0.0 109.865 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.11 -1.24 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.447 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.402 ' HB ' HMD1 ' A' ' 88' ' ' HEC . 45.3 t -111.54 -66.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mmt -65.39 130.67 44.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.319 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 28' ' ' ASN . . . -85.08 48.32 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 27' ' ' ALA . 1.8 p-10 175.3 -59.7 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HD3' ' CE ' ' A' ' 41' ' ' MET . 7.6 mttp -51.71 102.8 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.213 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.454 ' O ' HD21 ' A' ' 36' ' ' LEU . 3.7 m -113.32 177.44 4.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.589 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -94.71 -18.93 20.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.798 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' C ' ' CD2' ' A' ' 36' ' ' LEU . 14.8 mtpt -58.16 -113.63 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 110.295 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HA ' ' CG ' ' A' ' 36' ' ' LEU . 22.7 ttpt -155.44 -29.61 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.677 -1.264 . . . . 0.0 110.871 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 12.3 pt-20 -59.97 -28.91 68.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.729 -1.232 . . . . 0.0 111.193 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.631 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -102.25 -48.57 4.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.001 -1.062 . . . . 0.0 110.818 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.664 ' CD1' ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -61.07 -34.56 75.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.923 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.502 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.2 mm-40 -93.1 6.02 49.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' A' ' 38' ' ' GLN . 1.5 tp60 -89.74 -51.1 5.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.62 -50.27 6.93 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.486 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.81 91.45 0.48 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.51 ' CE ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -174.12 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.12 . . . . 0.0 109.474 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.664 ' CG ' ' CD1' ' A' ' 36' ' ' LEU . 4.1 t80 -105.62 28.57 7.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 109.816 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.469 ' OG ' ' HB1' ' A' ' 46' ' ' ALA . 29.2 p -106.73 143.11 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.359 -0.838 . . . . 0.0 110.569 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.544 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -50.53 -59.15 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 109.834 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.35 -28.62 8.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.526 -1.359 . . . . 0.0 110.568 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' HB1' ' OG ' ' A' ' 43' ' ' SER . . . -71.61 -73.66 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 110.321 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.535 HG12 ' CG2' ' A' ' 51' ' ' VAL . 3.1 tt -61.16 -13.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 110.358 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 44' ' ' GLU . 14.5 mt -73.41 -35.99 47.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 31.0 t80 -91.11 -14.44 31.21 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.529 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -88.79 -17.07 30.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.535 ' CG2' HG12 ' A' ' 47' ' ' ILE . 72.2 t -93.77 -43.62 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.817 0.818 . . . . 0.0 109.985 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HB3' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -62.72 -10.54 13.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 0.0 110.18 -178.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.661 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -158.36 30.97 0.24 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.357 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.589 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 49.96 -132.99 28.16 Favored Glycine 0 C--N 1.299 -1.524 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 151.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 37.8 m-80 69.05 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.48 14.95 6.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 109.202 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.614 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 27.4 ttt -89.63 142.3 29.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.263 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.614 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 30.3 Cg_endo -74.25 97.2 1.0 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.906 2.404 . . . . 0.0 114.647 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.661 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -46.94 119.16 2.38 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.551 ' CE2' HBB2 ' A' ' 88' ' ' HEC . 57.1 m-85 -88.24 -49.87 6.71 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.999 -1.063 . . . . 0.0 108.747 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 28.05 40.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.35 0.595 . . . . 0.0 110.376 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 167.61 -24.18 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.502 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -93.83 -30.92 14.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.557 ' CD1' HG13 ' A' ' 9' ' ' VAL . 1.7 mm? -91.45 94.51 9.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.548 ' O ' ' O ' ' A' ' 65' ' ' LEU . 21.0 m -41.03 168.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.524 ' N ' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -57.15 -61.2 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.522 -1.361 . . . . 0.0 108.487 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 mt-10 -60.68 3.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.777 -0.577 . . . . 0.0 110.604 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.642 ' CG ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -102.94 -45.15 5.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.558 ' CG2' ' HG3' ' A' ' 52' ' ' GLN . 33.6 mm -55.34 -22.66 12.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 1.6 mp0 -92.19 -65.71 0.98 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.103 0.954 . . . . 0.0 108.642 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 47.1 m-20 -49.62 -61.5 2.08 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 3.3 p -45.5 -29.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.3 -0.875 . . . . 0.0 109.8 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.58 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -80.68 -71.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -45.52 -25.8 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.554 -1.341 . . . . 0.0 107.508 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.862 ' CE2' ' HA ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -59.08 -56.95 15.61 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.655 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 2.6 p -62.37 -26.14 39.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.99 -1.069 . . . . 0.0 108.647 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.593 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 5.1 mt -76.45 -10.76 59.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 2.0 t0 -99.47 -43.52 6.51 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.929 0.871 . . . . 0.0 109.218 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.67 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 59.6 mm-40 -67.3 -41.55 85.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.88 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -60.9 -47.3 87.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.143 -0.973 . . . . 0.0 109.063 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.11 8.45 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.573 -0.705 . . . . 0.0 109.843 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 6.9 tttm -129.84 12.84 5.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.079 -1.013 . . . . 0.0 110.974 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.0 76.71 0.98 Allowed Glycine 0 C--N 1.296 -1.681 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.67 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 12.8 m95 -34.36 90.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.725 0.774 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -54.76 -37.99 66.65 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.386 0.612 . . . . 0.0 109.446 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.085 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.687 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.602 ' C4B' ' HE1' ' A' ' 58' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -119.51 -25.79 5.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 0.0 109.586 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.495 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 1.2 mp -71.11 -3.36 19.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.053 -1.029 . . . . 0.0 109.454 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.71 -15.82 63.63 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.574 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -86.69 10.26 16.28 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -107.69 -36.33 2.43 Favored Glycine 0 C--O 1.201 -1.919 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.655 ' HA ' ' CZ ' ' A' ' 76' ' ' TYR . . . -59.88 -12.63 8.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.659 -0.906 . . . . 0.0 109.884 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.574 ' CE ' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -87.13 -32.52 19.84 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.65 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 3.4 t -77.31 -29.55 16.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.595 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 32.2 t80 -100.33 -34.53 9.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 3.9 t -85.05 10.76 11.1 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.024 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -142.34 -6.74 0.72 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.173 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.549 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -147.23 -52.93 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.567 -1.549 . . . . 0.0 110.031 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 5.3 m -64.8 -29.31 70.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 110.035 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.84 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.846 -1.159 . . . . 0.0 109.294 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.59 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 84.8 m -120.7 14.78 11.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.224 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' HD22 ' A' ' 31' ' ' LEU . 91.0 m-70 -158.63 26.74 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.765 . . . . 0.0 109.033 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -52.49 147.12 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.308 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 46.96 35.86 8.33 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' O ' ' HD2' ' A' ' 32' ' ' LYS . . . 48.47 53.0 17.75 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.73 122.06 2.52 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.429 ' OD1' ' HB2' ' A' ' 26' ' ' MET . 3.7 t-20 -64.43 154.21 36.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -1.127 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 m -122.95 -22.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.12 -0.988 . . . . 0.0 110.244 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.07 -69.54 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.868 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.521 ' CG ' HAD1 ' A' ' 88' ' ' HEC . 0.6 OUTLIER -47.62 -37.26 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.42 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . 71.32 40.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 26' ' ' MET . 1.3 p30 177.09 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.371 -0.83 . . . . 0.0 108.915 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.29 77.14 5.83 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.541 ' CG2' ' HG2' ' A' ' 32' ' ' LYS . 9.3 t -83.23 -177.35 6.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.878 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD22 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -100.78 -18.54 16.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 110.758 -179.043 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.541 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 0.0 OUTLIER -61.07 -100.8 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.667 -1.271 . . . . 0.0 109.4 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 11.0 ptmm? -168.32 -38.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.642 -1.286 . . . . 0.0 110.797 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -41.16 -29.46 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 -178.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.636 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -110.25 -59.23 1.97 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 111.644 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -58.98 -7.72 1.16 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.728 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.564 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.4 mm-40 -107.08 -11.79 15.56 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.593 -1.317 . . . . 0.0 109.72 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 6.9 mm100 -82.54 -40.54 20.82 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.636 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -84.96 -45.94 11.71 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.709 177.097 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 41' ' ' MET . . . 121.51 98.19 1.54 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.506 ' HG3' HBA1 ' A' ' 88' ' ' HEC . 0.0 OUTLIER 170.08 37.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -1.085 . . . . 0.0 109.741 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.607 ' CD1' HD13 ' A' ' 36' ' ' LEU . 6.6 t80 -118.98 33.17 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.486 ' O ' ' HB ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -110.49 176.97 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.568 -0.708 . . . . 0.0 110.938 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.573 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 3.6 mt-10 -69.89 -72.56 0.19 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -54.0 -36.37 62.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.566 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 50' ' ' GLN . . . -64.01 -74.41 0.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.067 -1.021 . . . . 0.0 109.498 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.568 ' CG2' HMA2 ' A' ' 88' ' ' HEC . 40.9 mt -53.9 -17.56 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.621 0.724 . . . . 0.0 109.264 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.573 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 16.2 mt -80.82 -33.38 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.472 ' OH ' ' HE2' ' A' ' 55' ' ' LYS . 59.7 t80 -73.19 -23.07 60.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 108.536 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.551 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -85.64 -33.65 21.56 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.391 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 10.9 t -79.92 -36.67 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.552 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -72.23 -14.45 61.79 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.344 -0.848 . . . . 0.0 109.968 -178.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.687 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -159.33 31.54 0.2 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.012 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 48.04 -136.86 14.81 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.588 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 151.91 134.1 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.1 m-80 60.25 -88.91 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.473 -0.767 . . . . 0.0 108.978 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.27 41.58 3.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.597 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 21.4 ttt -119.04 143.49 34.01 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 30.3 Cg_endo -75.23 99.76 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.918 2.412 . . . . 0.0 114.27 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.687 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -57.07 118.27 4.84 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.654 -0.654 . . . . 0.0 110.458 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.606 ' CZ ' HBB1 ' A' ' 88' ' ' HEC . 25.1 m-85 -85.37 -52.27 5.99 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 37.58 28.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.424 0.631 . . . . 0.0 109.675 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 126.46 32.8 0.7 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.506 -1.837 . . . . 0.0 108.506 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.595 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 5.5 ttm-85 -101.67 -52.78 3.13 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.59 HD13 ' CD2' ' A' ' 61' ' ' PHE . 6.5 mt -79.92 -143.16 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.576 ' CB ' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -98.62 -166.9 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 121.085 -1.009 . . . . 0.0 109.494 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.37 -62.55 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.596 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.1 tt0 -71.41 2.61 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.65 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 1.1 mp0 -104.08 -32.03 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 65' ' ' LEU . 7.5 mm -72.88 -21.84 19.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.43 -66.13 0.95 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 37.3 t0 -54.59 -36.92 64.94 Favored 'General case' 0 C--O 1.193 -1.902 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.409 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.589 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 9.9 p -61.69 -26.92 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.193 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.588 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -82.12 -59.11 2.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.62 -21.63 11.09 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.655 ' CZ ' ' HA ' ' A' ' 7' ' ' ALA . 36.5 t80 -67.03 -45.12 78.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.366 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.638 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.1 p -69.6 -21.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.577 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 5.4 mt -77.97 -11.82 59.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.504 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 1.8 t0 -99.99 -37.52 8.97 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.888 0.851 . . . . 0.0 109.327 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.619 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 8.5 mm-40 -77.44 -35.28 54.12 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.876 -0.515 . . . . 0.0 110.395 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.52 ' CB ' ' OH ' ' A' ' 42' ' ' TYR . . . -61.0 -48.71 80.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.121 -0.987 . . . . 0.0 108.522 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.8 13.86 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.759 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 1.6 ttmm -130.79 13.69 5.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.96 -1.088 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 82.84 73.6 1.23 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.638 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 5.0 m95 -39.07 83.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.119 0.485 . . . . 0.0 110.592 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 42.72 27.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.241 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.627 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.684 ' CBB' ' HHC' ' A' ' 88' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.491 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.2 m-20 74.18 -0.1 3.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.884 . . . . 0.0 109.897 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.503 ' CD2' ' HA ' ' A' ' 72' ' ' ASP . 10.1 mt -69.67 -8.3 46.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.933 -1.105 . . . . 0.0 109.057 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.23 -29.09 63.48 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.3 m-20 -67.91 -41.78 82.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -47.21 -58.83 6.14 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.644 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . -50.67 -37.65 42.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.338 . . . . 0.0 109.286 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -59.4 -41.1 88.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.204 -0.935 . . . . 0.0 108.58 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.575 ' CG2' ' CB ' ' A' ' 69' ' ' GLN . 21.9 t -81.23 -67.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 26.9 t80 -41.54 -26.63 0.07 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.288 -0.883 . . . . 0.0 109.851 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 36.6 m -76.71 -48.53 18.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.296 -0.877 . . . . 0.0 111.275 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -101.57 29.84 11.66 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.726 -1.225 . . . . 0.0 111.739 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 23.4 m-80 -155.03 -29.3 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.783 -1.422 . . . . 0.0 110.771 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.888 ' SG ' ' HHC' ' A' ' 88' ' ' HEC . 79.6 m -127.91 -11.18 5.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.903 -1.123 . . . . 0.0 111.316 -177.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 19' ' ' MET . . . -51.69 -32.04 28.29 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.32 78.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.382 -0.824 . . . . 0.0 110.699 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.63 18.7 18.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.739 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.629 ' CE1' ' CD2' ' A' ' 31' ' ' LEU . 81.8 m-70 -158.61 -64.91 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.929 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.482 ' CG ' ' C ' ' A' ' 18' ' ' HIS . 4.9 ptt? 38.66 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.318 0.58 . . . . 0.0 109.719 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 71.08 57.23 6.37 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 36.74 64.81 0.6 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -141.66 99.05 0.23 Allowed Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.992 -1.299 . . . . 0.0 109.953 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.412 HD22 ' C4D' ' A' ' 88' ' ' HEC . 1.2 t-20 -67.83 138.0 55.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -1.168 . . . . 0.0 109.855 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.22 -3.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -0.827 . . . . 0.0 109.599 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.446 HG22 ' SG ' ' A' ' 17' ' ' CYS . 5.1 t -103.59 -46.96 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mtp -100.45 157.51 16.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -109.77 61.25 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.9 p-10 169.62 -50.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -77.25 91.04 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.47 ' CG2' ' N ' ' A' ' 31' ' ' LEU . 23.2 m -126.17 163.89 22.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.187 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.629 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -88.36 74.48 8.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.133 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -111.83 -85.04 0.57 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.648 -1.283 . . . . 0.0 109.103 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -176.56 -47.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 179.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.59 -33.81 27.87 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.15 -0.968 . . . . 0.0 110.413 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.649 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . -70.81 -56.81 5.49 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.056 -1.028 . . . . 0.0 109.688 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -53.42 -33.57 54.48 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.438 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.549 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 3.1 mm-40 -87.14 -17.84 31.82 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.706 0.765 . . . . 0.0 109.242 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 2.1 tp60 -68.33 -50.29 54.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.649 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -85.8 -78.17 0.28 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.427 -0.796 . . . . 0.0 108.926 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.66 86.36 0.06 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.566 ' SD ' ' CE2' ' A' ' 39' ' ' PHE . 2.7 ptt? -167.0 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -1.192 . . . . 0.0 109.511 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.584 ' CD1' ' CD1' ' A' ' 36' ' ' LEU . 38.0 t80 -104.68 12.02 33.39 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.55 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.42 140.41 38.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.537 ' N ' ' CD1' ' A' ' 78' ' ' LEU . 1.2 mt-10 -44.89 -63.05 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.796 . . . . 0.0 109.97 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 29.5 t0 -48.63 -33.53 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.817 -1.177 . . . . 0.0 110.553 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -76.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.556 ' HA ' ' HB3' ' A' ' 50' ' ' GLN . 1.6 tt -65.5 -6.75 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.859 0.838 . . . . 0.0 110.563 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.527 HD13 ' CG ' ' A' ' 44' ' ' GLU . 12.8 mt -77.26 -43.02 31.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 49' ' ' TYR . 58.4 t80 -88.89 -3.83 58.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.606 ' NE2' ' C4A' ' A' ' 88' ' ' HEC . 0.0 OUTLIER -100.87 -13.78 18.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 47' ' ' ILE . 26.8 t -92.09 -47.36 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.56 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -58.69 -12.82 4.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.58 -179.239 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.637 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -151.57 21.59 0.71 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 53.09 -131.97 41.55 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 157.08 132.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.437 0 CA-C-O 121.538 0.685 . . . . 0.0 109.728 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 59.9 m-80 63.05 -85.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.53 44.48 2.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.601 ' HB2' ' C1D' ' A' ' 88' ' ' HEC . 6.6 ttt -129.05 144.15 51.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.039 -1.038 . . . . 0.0 109.167 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.596 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.6 Cg_endo -71.71 117.27 5.06 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.372 2.715 . . . . 0.0 115.822 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -42.51 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.658 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 26.0 m-85 -139.48 8.64 2.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.42 -19.7 2.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.435 -0.791 . . . . 0.0 109.217 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.54 26.86 0.96 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.658 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 2.4 mmt85 -102.06 -48.59 4.18 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.63 ' CD2' ' CD1' ' A' ' 61' ' ' PHE . 8.4 mt -81.34 -148.57 0.07 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.557 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 1.5 m -98.83 -74.96 0.57 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 122.19 0.995 . . . . 0.0 108.929 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.618 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 23.3 t0 -177.83 -59.34 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.544 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 9.7 tt0 -69.25 5.1 1.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.662 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.618 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -111.21 -33.92 6.31 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.618 ' CD1' ' HA ' ' A' ' 67' ' ' ASP . 2.3 mt -60.28 -18.0 15.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.477 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -96.46 -73.81 0.58 Allowed 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 60.7 m-20 -44.64 -46.34 10.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.833 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.754 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 10.5 t -63.29 -42.25 95.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.623 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -56.19 -63.87 1.05 Allowed 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.268 -1.52 . . . . 0.0 106.951 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.49 -18.93 32.91 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.754 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 61.4 t80 -65.46 -39.91 92.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.571 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 25.2 t -75.33 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' CD1' ' N ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -88.83 -8.12 54.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.3 t70 -98.54 -36.31 9.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.107 0.956 . . . . 0.0 108.707 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.615 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 5.1 mm-40 -80.9 -36.56 31.02 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.575 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -64.56 -42.88 95.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.435 ' CB ' ' OH ' ' A' ' 42' ' ' TYR . . . -89.12 12.81 14.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 110.829 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 8.3 ptmm? -138.08 18.18 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.494 -1.379 . . . . 0.0 111.22 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 86.49 73.96 1.27 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.615 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 5.6 m95 -36.62 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.41 0.624 . . . . 0.0 109.61 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -74.43 -52.47 11.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.411 -0.806 . . . . 0.0 109.832 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.027 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.52 -179.957 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HEC . . . . . 0.888 ' HHC' ' SG ' ' A' ' 14' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.478 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 68.6 m-20 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.503 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -68.12 -5.37 17.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.59 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.42 -30.54 70.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 2.0 m-20 -72.45 -33.63 67.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -52.13 -60.79 7.21 Favored Glycine 0 C--O 1.201 -1.93 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.791 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -56.53 -26.98 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -1.067 . . . . 0.0 109.871 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.77 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -65.41 -35.07 79.83 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.024 -1.047 . . . . 0.0 108.707 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.099 HG21 ' CB ' ' A' ' 69' ' ' GLN . 14.9 t -88.66 -47.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.287 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 15.4 t80 -64.42 -27.69 69.17 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.804 -1.185 . . . . 0.0 109.435 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 18.7 p -90.93 11.2 23.52 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.615 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -141.95 3.53 2.01 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 2.6 m120 -154.82 -57.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 0.0 109.029 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.637 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 11.6 m -65.84 -24.93 66.99 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.744 . . . . 0.0 109.37 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -62.35 -33.55 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 110.359 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.08 13.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.004 . . . . 0.0 110.517 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -138.89 25.6 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' O ' ' A' ' 19' ' ' MET . 62.1 m80 -157.07 -69.63 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 108.951 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.52 ' O ' ' O ' ' A' ' 18' ' ' HIS . 1.0 OUTLIER 36.24 102.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.602 0.715 . . . . 0.0 111.207 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 93.59 32.42 7.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 43.45 36.19 3.09 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -130.51 109.35 0.91 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -44.3 140.82 2.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.0 109.333 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 24' ' ' VAL . 58.9 t -107.56 0.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 109.772 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.462 HG23 ' SG ' ' A' ' 17' ' ' CYS . 90.5 t -117.64 -51.3 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.676 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.79 176.27 6.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.72 46.61 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 1.4 p-10 -176.58 -62.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.283 -0.886 . . . . 0.0 108.979 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.615 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -55.18 97.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 t -111.1 -167.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 110.393 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -107.3 -26.06 11.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.673 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.635 ' C ' HD21 ' A' ' 36' ' ' LEU . 7.3 mtpt -45.22 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.827 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.089 ' N ' HD21 ' A' ' 36' ' ' LEU . 17.5 ttpt -178.74 -26.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.656 -1.278 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -67.83 -53.98 22.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.743 -1.223 . . . . 0.0 110.737 -177.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.547 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -76.05 -51.15 12.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.577 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.089 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -59.7 -22.82 62.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.002 . . . . 0.0 108.852 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 2.4 tm-20 -112.4 -2.6 14.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.141 -0.975 . . . . 0.0 109.298 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 11.8 tp60 -65.82 -47.05 76.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.615 ' CZ ' ' HG3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -85.74 -32.0 22.11 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.281 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 120.93 102.11 1.82 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.623 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 158.57 29.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.702 -0.881 . . . . 0.0 110.823 178.575 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.67 ' CD1' HD11 ' A' ' 36' ' ' LEU . 2.1 t80 -97.11 28.46 3.57 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.077 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 6.9 p -106.74 157.58 17.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 110.343 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.857 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -46.05 -62.91 1.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.38 -0.825 . . . . 0.0 109.701 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.511 ' N ' HD12 ' A' ' 48' ' ' ILE . 39.7 t0 -54.67 -28.74 49.59 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.94 -1.1 . . . . 0.0 110.637 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -66.06 -76.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.031 . . . . 0.0 110.247 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.898 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.5 tt -60.04 -20.99 20.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.462 -0.773 . . . . 0.0 110.047 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.857 HD12 ' C ' ' A' ' 44' ' ' GLU . 15.6 mt -64.45 -35.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.581 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 26.4 t80 -87.08 -18.12 31.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 4.4 tp60 -90.38 -1.37 57.91 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 47' ' ' ILE . 78.5 t -109.67 -39.03 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.835 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -71.58 -5.13 31.12 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.169 -0.957 . . . . 0.0 109.016 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.64 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -161.99 26.77 0.12 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 44.51 -133.33 7.1 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER 160.86 126.67 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 121.29 0.567 . . . . 0.0 109.654 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 17.2 m120 68.98 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -128.12 12.0 6.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.945 -1.097 . . . . 0.0 110.569 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.625 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 14.4 ttt -95.16 138.98 21.88 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.672 -1.267 . . . . 0.0 109.599 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.625 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 29.2 Cg_endo -73.81 117.18 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.964 2.443 . . . . 0.0 113.507 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.64 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.23 165.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.533 -0.73 . . . . 0.0 110.025 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.708 ' CD1' HD21 ' A' ' 65' ' ' LEU . 48.7 m-85 -146.76 15.59 1.23 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.35 -17.7 2.03 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.37 29.15 0.27 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.545 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -98.85 -41.58 7.56 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 178.01 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.994 HD13 HG11 ' A' ' 9' ' ' VAL . 19.3 mt -82.0 -140.71 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 6.1 m -98.62 -57.39 2.2 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.268 -0.895 . . . . 0.0 109.524 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 6.3 t70 153.34 -54.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 16.1 mt-10 -70.79 2.53 4.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 1.099 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -114.39 -27.42 7.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.986 HD13 HD12 ' A' ' 65' ' ' LEU . 10.8 mm -58.88 -22.42 21.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 173.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.462 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.0 mt-30 -97.48 -65.76 0.94 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.993 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.0 t0 -53.82 -39.93 65.97 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 69' ' ' GLN . 1.4 p -60.94 -26.68 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.313 -0.867 . . . . 0.0 109.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -81.0 -63.48 1.4 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.71 -24.44 3.39 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.383 -1.448 . . . . 0.0 107.24 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.791 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.3 t80 -63.91 -47.72 79.43 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.08 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.5 p -67.32 -23.3 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 77' ' ' VAL . 3.1 mt -79.02 -11.61 60.01 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -35.06 9.67 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.007 0.908 . . . . 0.0 109.709 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.651 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 6.9 mm-40 -77.29 -43.68 32.39 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.313 0.578 . . . . 0.0 110.283 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.647 ' HB2' ' NE1' ' A' ' 85' ' ' TRP . . . -76.18 -22.41 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.346 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.71 4.26 22.52 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.549 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -170.59 39.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.587 -1.321 . . . . 0.0 112.309 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 97.29 74.74 1.2 Allowed Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.856 -1.64 . . . . 0.0 110.178 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.652 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -40.3 83.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.174 0.511 . . . . 0.0 110.752 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.439 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 5.3 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.539 HD23 ' OD1' ' A' ' 72' ' ' ASP . 3.9 mt -72.74 -3.69 26.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.62 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.2 -32.18 73.66 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.494 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -71.11 -26.86 63.21 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -60.21 -51.92 55.87 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.694 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -50.2 -19.89 0.89 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.616 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -82.61 -43.44 16.99 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.639 HG22 ' CG ' ' A' ' 69' ' ' GLN . 5.2 t -62.63 -26.35 40.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.9 t80 -101.29 -22.48 14.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.594 -0.691 . . . . 0.0 110.603 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 62.2 m -88.47 22.45 2.54 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.312 -0.868 . . . . 0.0 109.265 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.29 -23.27 0.02 OUTLIER Glycine 0 N--CA 1.484 1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.342 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB3' ' HD3' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -122.96 -7.03 8.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.596 -1.532 . . . . 0.0 110.065 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.627 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 6.6 m -127.39 -23.04 3.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -58.27 -37.45 75.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.769 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.81 -10.53 13.36 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.229 -0.919 . . . . 0.0 111.77 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 94.7 m -140.64 19.04 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.648 -1.282 . . . . 0.0 110.052 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 89.4 m-70 -158.31 -53.3 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.266 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.511 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 5.0 ptt? 35.58 98.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.251 0.548 . . . . 0.0 110.795 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 72.27 52.52 10.66 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.677 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 37.05 83.37 0.01 OUTLIER Glycine 0 N--CA 1.483 1.822 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -161.7 93.74 0.12 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' GLY . 3.8 t-20 -40.72 157.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.577 -0.955 . . . . 0.0 109.823 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.631 HG13 HG23 ' A' ' 25' ' ' VAL . 2.3 p -120.87 -20.3 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.631 HG23 HG13 ' A' ' 24' ' ' VAL . 20.8 t -109.73 -68.61 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -58.2 168.83 0.94 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.953 . . . . 0.0 109.936 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -129.39 57.82 1.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 1.7 p30 178.09 -46.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.343 -0.848 . . . . 0.0 109.139 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.535 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 58.8 mttt -75.94 101.58 5.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.685 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 31' ' ' LEU . 5.9 m -118.88 173.0 7.14 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.2 mp -91.9 -19.35 22.57 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.319 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.9 ptmt -59.72 179.65 0.12 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.95 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.629 ' N ' ' HB1' ' A' ' 81' ' ' ALA . 17.1 ptmt -81.7 -38.52 25.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 2.8 mt-10 -55.89 -33.62 64.79 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 110.499 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.58 -42.0 5.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 110.94 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.92 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -66.34 -15.12 63.01 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.586 ' HG3' ' HG ' ' A' ' 36' ' ' LEU . 62.4 mt-10 -114.3 0.41 14.14 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 15.2 tp60 -74.53 -51.91 13.35 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -87.31 -43.05 12.44 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.364 179.132 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.94 33.2 0.43 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.023 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.771 ' HE3' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -91.01 14.03 15.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.753 -1.439 . . . . 0.0 108.949 179.108 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.882 ' HD1' HD11 ' A' ' 36' ' ' LEU . 48.5 t80 -74.03 15.4 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.619 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -106.27 125.75 51.38 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.628 -1.295 . . . . 0.0 110.665 -179.162 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.6 pt-20 -44.41 -56.71 4.02 Favored 'General case' 0 C--O 1.201 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 108.861 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.65 -41.1 21.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 110.388 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.65 -71.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.966 . . . . 0.0 110.122 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.772 HG23 ' HB1' ' A' ' 74' ' ' ALA . 7.4 tt -68.1 -7.86 7.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 110.135 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.556 HG13 ' CB ' ' A' ' 74' ' ' ALA . 3.7 mt -81.54 -31.88 11.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.732 ' HA ' ' HE1' ' A' ' 53' ' ' HIS . 41.1 t80 -92.02 -13.19 31.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 5.9 tp60 -93.64 -14.28 26.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 47' ' ' ILE . 53.9 t -101.5 -35.44 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.973 0.892 . . . . 0.0 109.874 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 2.6 mt-30 -74.19 -4.85 38.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.733 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -164.38 32.42 0.07 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.571 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.545 ' HA2' ' CG ' ' A' ' 58' ' ' MET . . . 45.59 -137.31 7.11 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.581 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.4 OUTLIER 157.9 128.93 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.937 -0.631 . . . . 0.0 109.311 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 51.9 m-80 62.95 -86.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -123.67 32.47 5.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.947 . . . . 0.0 109.735 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.695 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.1 ttt -111.7 141.92 25.62 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.061 -1.024 . . . . 0.0 109.147 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.695 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 31.0 Cg_endo -76.48 104.06 1.85 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.073 2.515 . . . . 0.0 114.293 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.733 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -52.28 121.97 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.73 -0.606 . . . . 0.0 109.813 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.862 ' CG ' HD13 ' A' ' 65' ' ' LEU . 39.6 m-85 -93.02 -55.66 3.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.96 -1.088 . . . . 0.0 108.558 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 52' ' ' GLN . . . 27.53 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.207 0.527 . . . . 0.0 110.132 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 166.01 -15.53 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.575 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -101.87 -29.34 11.9 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.862 HD13 ' CG ' ' A' ' 61' ' ' PHE . 7.5 mp -94.49 114.12 26.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 67' ' ' ASP . 3.3 m -43.7 179.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.419 0.628 . . . . 0.0 110.264 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.716 ' H ' HG22 ' A' ' 66' ' ' THR . 0.1 OUTLIER -75.75 -62.38 1.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.913 -1.117 . . . . 0.0 109.083 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.544 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 32.6 mt-10 -61.99 -9.49 7.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.386 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.639 ' CG ' HG22 ' A' ' 9' ' ' VAL . 2.1 mp0 -94.66 -34.91 12.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 65' ' ' LEU . 7.0 mm -69.68 -14.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.5 mp0 -97.31 -69.87 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.581 1.181 . . . . 0.0 109.164 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.682 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 42.1 m-20 -52.36 -33.87 44.97 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.393 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.689 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.3 p -69.53 -30.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.619 0.723 . . . . 0.0 109.878 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.772 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.68 -57.72 3.74 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.497 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.21 -19.16 53.05 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.694 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 61.9 t80 -64.93 -41.89 95.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.633 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 40.7 t -72.95 -24.24 20.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.817 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.1 mt -85.32 -7.85 58.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 9.8 t0 -99.67 -36.86 9.35 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.183 0.992 . . . . 0.0 109.242 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.621 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 6.5 mm-40 -78.62 -40.15 35.18 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.202 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.629 ' HB1' ' N ' ' A' ' 33' ' ' LYS . . . -62.62 -37.65 87.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.774 . . . . 0.0 109.891 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.66 13.96 12.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 110.93 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 2.3 ptmt -150.03 30.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.544 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.97 74.06 1.26 Allowed Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.847 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.633 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 1.7 m95 -40.79 84.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.161 -0.611 . . . . 0.0 110.854 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.908 0.385 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 79' ' ' ASP . 1.7 mp -67.06 -7.76 25.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.9 -1.125 . . . . 0.0 109.286 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.76 -31.89 68.77 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -68.6 -36.97 79.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.16 -62.96 5.47 Favored Glycine 0 C--O 1.203 -1.812 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.797 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.55 -30.08 4.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -1.207 . . . . 0.0 109.86 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.761 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -64.48 -45.29 88.0 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 108.376 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.046 HG21 ' CB ' ' A' ' 69' ' ' GLN . 41.2 t -75.77 -55.4 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.633 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 7.9 t80 -57.43 -26.11 60.65 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 110.438 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 28.9 t -86.24 19.08 2.84 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.615 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -162.16 11.15 0.11 Allowed Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 7.4 m120 -153.97 -53.16 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.683 -1.481 . . . . 0.0 109.159 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.3 m -73.38 -26.38 60.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' HA ' ' N ' ' A' ' 19' ' ' MET . . . -52.1 -41.0 62.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.2 68.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.903 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.583 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 85.8 m -121.55 19.13 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.922 -1.111 . . . . 0.0 110.649 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.712 ' CD2' HD21 ' A' ' 31' ' ' LEU . 76.9 m80 -158.67 -66.5 0.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.164 -0.96 . . . . 0.0 109.25 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.506 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 14.2 ptm 39.48 98.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.531 0.682 . . . . 0.0 110.286 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.45 46.02 80.95 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.539 ' O ' HG21 ' A' ' 30' ' ' THR . . . 51.09 68.19 1.61 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -143.29 88.32 0.17 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.644 ' H ' HG23 ' A' ' 30' ' ' THR . 1.2 t-20 -61.9 142.25 57.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -1.118 . . . . 0.0 109.778 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 17' ' ' CYS . 17.4 m -102.16 -13.26 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 24' ' ' VAL . 60.4 t -104.56 -57.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.92 . . . . 0.0 109.127 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.53 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 9.5 mmt -103.36 93.97 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.845 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.18 -47.55 35.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.733 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -66.4 -35.62 80.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.192 -0.943 . . . . 0.0 109.885 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 0.0 OUTLIER -84.29 82.68 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.644 HG23 ' H ' ' A' ' 23' ' ' ASN . 24.5 m -122.01 171.97 8.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.052 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.745 ' HB3' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -84.74 -3.49 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.715 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -46.01 173.53 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.142 -0.974 . . . . 0.0 109.964 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -84.17 -27.65 27.94 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.312 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -82.51 -27.12 31.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.96 . . . . 0.0 111.074 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.42 -35.21 7.18 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.292 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.802 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -60.6 -39.7 89.11 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.115 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.587 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -96.93 6.06 49.34 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 17.0 tp60 -69.33 -47.21 65.1 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.5 -39.04 16.65 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.656 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.52 79.17 0.6 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.437 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.556 ' HE2' HD13 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -159.16 25.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -1.098 . . . . 0.0 108.798 179.047 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.717 ' HB2' HD11 ' A' ' 36' ' ' LEU . 33.8 t80 -74.68 3.12 8.4 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.518 0.675 . . . . 0.0 109.621 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.94 155.59 18.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.707 -1.245 . . . . 0.0 110.999 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 1.3 mp0 -50.44 -64.73 0.72 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.871 -0.518 . . . . 0.0 110.515 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -46.48 -31.57 2.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.77 -1.206 . . . . 0.0 111.437 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 41' ' ' MET . . . -69.65 -73.94 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.784 -1.198 . . . . 0.0 110.658 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.859 ' O ' HG23 ' A' ' 51' ' ' VAL . 10.4 tt -60.31 -17.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.25 -0.906 . . . . 0.0 109.622 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.551 HG13 ' CB ' ' A' ' 74' ' ' ALA . 21.6 mt -72.31 -34.44 49.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.417 ' O ' ' ND1' ' A' ' 53' ' ' HIS . 52.1 t80 -71.64 -29.98 65.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 2.5 pm0 -94.39 -13.2 26.56 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.774 -1.57 . . . . 0.0 109.125 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 47' ' ' ILE . 60.2 t -87.76 -23.73 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.009 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.433 ' CB ' ' CE1' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -99.39 -7.68 25.85 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.47 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -147.35 13.6 1.09 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 53.5 -135.33 41.54 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.629 ' N ' ' HB3' ' A' ' 58' ' ' MET . 4.9 mtpt 155.17 127.48 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 13.3 m120 61.0 -88.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -121.9 29.29 7.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.235 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.629 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 27.8 ttt -107.12 141.89 23.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.595 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 37.0 Cg_endo -85.06 99.22 0.69 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.202 2.601 . . . . 0.0 113.879 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB2' ' HA ' ' A' ' 53' ' ' HIS . . . -37.54 158.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 0.0 110.018 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.661 ' HB3' HD13 ' A' ' 65' ' ' LEU . 14.4 m-85 -137.03 22.62 3.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -5.07 2.46 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.48 16.74 0.99 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.64 -55.83 2.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 61' ' ' PHE . 4.7 mp -66.52 -157.42 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 69' ' ' GLN . 1.4 m -99.51 -58.36 1.94 Allowed 'General case' 0 C--N 1.285 -2.236 0 O-C-N 121.246 -0.909 . . . . 0.0 109.259 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 66' ' ' THR . 3.7 m-20 153.72 -53.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 3.7 mt-10 -69.01 -3.77 14.3 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 1.046 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.88 -25.81 9.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.656 HD11 ' O ' ' A' ' 61' ' ' PHE . 12.3 mm -57.37 -23.13 18.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.9 mp0 -96.37 -70.47 0.71 Allowed 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.515 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 2.8 m-20 -44.66 -46.4 10.2 Favored 'General case' 0 C--O 1.203 -1.394 0 O-C-N 121.857 -0.527 . . . . 0.0 110.026 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -62.05 -37.02 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.628 0.728 . . . . 0.0 110.005 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.551 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -67.23 -61.84 1.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.509 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.1 -18.99 17.03 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.797 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 71.3 t80 -67.14 -44.16 80.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.8 HG21 HD11 ' A' ' 47' ' ' ILE . 85.0 t -71.11 -19.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 2.4 mt -84.6 -9.52 58.22 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.293 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.502 ' HB3' ' OE1' ' A' ' 80' ' ' GLN . 7.4 t0 -99.21 -45.87 5.74 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.188 0.994 . . . . 0.0 108.604 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.641 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.1 mm100 -65.59 -50.07 66.44 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.082 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.766 ' HB2' ' CD1' ' A' ' 85' ' ' TRP . . . -74.14 -12.1 60.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.55 -0.719 . . . . 0.0 109.22 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 78' ' ' LEU . . . -65.28 -7.46 13.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.53 -0.731 . . . . 0.0 110.023 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -179.9 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.754 -1.217 . . . . 0.0 111.64 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.52 75.9 1.31 Allowed Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.019 -1.562 . . . . 0.0 109.669 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.766 ' CD1' ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -39.74 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.39 -0.476 . . . . 0.0 110.551 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.799 . . . . 0.0 109.204 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.498 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 8.6 m-20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.464 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -66.86 -4.91 10.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.554 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.95 -25.41 60.92 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.515 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.3 m-20 -77.68 -36.94 50.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.462 ' CA ' ' OD1' ' A' ' 72' ' ' ASP . . . -50.72 -55.98 15.47 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.762 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -60.31 -24.95 65.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.767 -0.843 . . . . 0.0 109.712 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.726 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.88 -30.28 68.74 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.838 -1.164 . . . . 0.0 108.331 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.051 HG21 ' CB ' ' A' ' 69' ' ' GLN . 22.8 t -97.73 -23.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.479 -0.763 . . . . 0.0 110.056 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.658 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 t80 -89.17 -25.89 21.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.845 -1.159 . . . . 0.0 109.921 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 17.1 m -78.81 7.34 7.21 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.638 -0.664 . . . . 0.0 110.081 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.46 13.02 0.34 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.378 -1.392 . . . . 0.0 111.076 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.503 ' ND2' HD23 ' A' ' 65' ' ' LEU . 5.7 m120 -139.01 -42.4 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.802 -1.411 . . . . 0.0 109.057 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -97.22 -22.76 16.52 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -47.59 -50.37 24.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.716 -0.615 . . . . 0.0 110.455 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.16 71.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 110.776 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.526 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 64.4 m -112.94 15.07 19.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.921 -1.112 . . . . 0.0 110.006 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.756 ' CD2' HD21 ' A' ' 31' ' ' LEU . 57.8 m80 -159.15 -64.45 0.08 Allowed 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 50.24 108.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.497 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.48 57.07 9.76 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.507 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 45.99 66.67 1.56 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -144.67 81.78 0.21 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.775 ' H ' HG23 ' A' ' 30' ' ' THR . 6.5 t-20 -53.3 153.45 3.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -1.201 . . . . 0.0 109.324 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 17' ' ' CYS . 4.1 m -128.12 5.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 109.997 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.7 t -105.29 -59.57 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 109.31 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.4 mmm -86.38 -173.28 4.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.94 . . . . 0.0 109.369 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -128.67 57.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 5.2 p30 169.27 -41.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.806 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HD2' ' CE2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -71.47 89.02 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 109.876 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.775 HG23 ' H ' ' A' ' 23' ' ' ASN . 9.6 m -122.43 170.96 9.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.318 -0.863 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.958 ' HB3' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -89.91 -11.71 41.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.997 . . . . 0.0 108.955 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -34.3 -71.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.645 -0.659 . . . . 0.0 111.6 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.035 ' CA ' HD21 ' A' ' 36' ' ' LEU . 1.5 tptm 170.07 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.724 -1.235 . . . . 0.0 110.196 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 32.1 mt-10 -72.2 -46.3 56.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.112 -0.992 . . . . 0.0 111.06 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.597 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.48 -48.41 49.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.029 -1.044 . . . . 0.0 111.132 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.035 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -65.97 -14.15 61.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.65 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.541 ' CG ' ' CD2' ' A' ' 42' ' ' TYR . 3.0 mm-40 -119.22 8.4 11.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.773 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 20.5 tp60 -87.06 -53.06 5.07 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.25 -40.52 13.59 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.736 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.51 44.35 0.18 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.752 -1.214 . . . . 0.0 110.785 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.514 ' HE3' ' HB2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -105.78 9.05 33.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.333 . . . . 0.0 109.187 179.003 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.599 ' CD2' HD12 ' A' ' 36' ' ' LEU . 27.6 t80 -71.98 13.99 0.25 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 111.449 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -106.0 136.26 45.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.35 -1.469 . . . . 0.0 110.745 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.743 ' C ' HD12 ' A' ' 48' ' ' ILE . 1.4 mt-10 -44.1 -57.51 3.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.297 -0.877 . . . . 0.0 108.83 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' N ' HD12 ' A' ' 48' ' ' ILE . 9.9 t0 -51.41 -38.75 55.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.12 -73.82 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.781 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.6 tt -64.47 -11.27 10.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 110.083 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.743 HD12 ' C ' ' A' ' 44' ' ' GLU . 14.8 mt -78.96 -31.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 40.0 t80 -92.32 -14.4 28.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.549 ' OE1' ' CB ' ' A' ' 55' ' ' LYS . 1.4 tp60 -93.93 -14.47 25.95 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.2 t -97.32 -44.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.973 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -64.27 -13.94 52.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.582 . . . . 0.0 111.313 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.761 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -147.88 21.54 1.13 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.604 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.36 -130.53 50.56 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.7 137.39 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.6 m120 58.24 -89.48 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.61 41.46 3.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.689 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 17.5 ttt -113.94 143.97 30.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.689 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.2 Cg_endo -77.39 107.74 2.46 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.334 2.689 . . . . 0.0 114.709 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.662 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.55 159.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 111.039 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.636 ' CD1' ' O ' ' A' ' 60' ' ' ALA . 10.0 m-30 -141.12 16.26 2.26 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.8 -0.562 . . . . 0.0 110.116 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB2' ' HG2' ' A' ' 52' ' ' GLN . . . -66.28 -2.99 4.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.123 178.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.53 17.8 1.13 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.546 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.22 -57.49 2.11 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.043 HD12 ' CD1' ' A' ' 70' ' ' ILE . 36.0 mt -73.51 -149.1 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.536 ' HB ' ' HG2' ' A' ' 69' ' ' GLN . 1.4 m -99.53 -61.52 1.36 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.9 t70 156.7 -51.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 12.3 tp10 -71.15 4.01 3.08 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 1.051 ' CB ' HG21 ' A' ' 9' ' ' VAL . 1.8 mm-40 -112.21 -33.24 6.28 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.043 ' CD1' HD12 ' A' ' 65' ' ' LEU . 36.0 mm -58.28 -24.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -91.6 -73.52 0.54 Allowed 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.713 178.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.554 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 15.1 t0 -44.65 -53.7 6.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.761 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 11.5 t -56.09 -39.54 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.362 1.077 . . . . 0.0 108.159 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLN . . . -55.77 -59.15 5.28 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.97 -18.77 59.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.762 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 65.0 t80 -67.27 -38.06 84.49 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.958 HG13 ' HB3' ' A' ' 31' ' ' LEU . 93.7 t -76.78 -23.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.809 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -86.41 -6.48 58.91 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -98.2 -52.63 3.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.265 1.031 . . . . 0.0 108.404 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.623 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 45.7 mm-40 -65.16 -46.34 81.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.365 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 31' ' ' LEU . . . -70.57 -12.39 61.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.321 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 78' ' ' LEU . . . -78.08 -4.45 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.45 -0.781 . . . . 0.0 110.963 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -178.32 57.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.454 -1.404 . . . . 0.0 111.961 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 89.56 75.96 1.3 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 118.947 -1.597 . . . . 0.0 109.339 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.641 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -40.7 84.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.177 0.513 . . . . 0.0 110.826 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.337 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.583 HD13 ' OD2' ' A' ' 79' ' ' ASP . 1.0 OUTLIER -70.66 -11.93 61.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 108.588 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -30.42 66.57 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.511 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.43 -37.32 65.93 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -49.72 -59.09 7.62 Favored Glycine 0 C--O 1.201 -1.948 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.842 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -54.06 -35.05 61.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.103 . . . . 0.0 109.79 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.572 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 108.995 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.055 HG21 ' CB ' ' A' ' 69' ' ' GLN . 37.5 t -86.15 -43.08 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 110.563 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.588 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 7.8 t80 -63.46 -27.68 69.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.726 -1.234 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 p -86.52 18.47 3.29 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 109.473 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.513 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -150.71 6.96 0.66 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.243 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 13.2 m120 -152.56 -49.76 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.605 -1.527 . . . . 0.0 109.468 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 2.3 m -76.46 -30.69 57.43 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -43.6 -42.45 5.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.679 -0.638 . . . . 0.0 110.294 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -46.96 85.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.944 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.581 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 66.5 m -107.28 29.54 7.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.586 ' CD2' ' HG ' ' A' ' 31' ' ' LEU . 44.2 m80 -162.6 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.499 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 9.8 ptt? 39.04 100.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.49 0.662 . . . . 0.0 110.777 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 87.26 41.95 6.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 39.32 58.73 1.97 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -151.64 103.85 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -56.11 162.08 2.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.197 . . . . 0.0 109.05 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.4 -29.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.047 -1.033 . . . . 0.0 109.986 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -79.09 -70.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.099 -1.001 . . . . 0.0 109.337 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.3 mmt -66.48 150.85 48.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.278 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -113.54 60.35 0.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 109.685 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.498 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.8 p30 -178.69 -44.17 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.985 . . . . 0.0 109.364 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HG2' ' HE3' ' A' ' 41' ' ' MET . 25.0 mttp -81.86 124.37 29.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.121 -0.987 . . . . 0.0 109.071 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.788 ' O ' HD22 ' A' ' 36' ' ' LEU . 2.1 m -121.47 -174.18 2.8 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.274 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.713 ' H ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -100.24 -13.93 18.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.678 ' C ' HD21 ' A' ' 36' ' ' LEU . 24.2 mtpt -59.78 -98.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.144 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.794 ' N ' HD21 ' A' ' 36' ' ' LEU . 14.7 ptpt -177.25 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -51.47 -29.07 15.02 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.584 ' C ' ' CE2' ' A' ' 39' ' ' PHE . . . -104.48 -71.79 0.73 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.396 -0.815 . . . . 0.0 110.095 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.929 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -40.56 -39.91 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.558 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -82.96 -33.45 26.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.92 -1.112 . . . . 0.0 109.215 179.088 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 9.0 tp60 -45.79 -44.3 13.91 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CE2' ' C ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -85.83 -72.24 0.5 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.9 89.18 0.07 OUTLIER Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER 179.48 26.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -1.2 . . . . 0.0 110.395 -178.505 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.027 ' OH ' ' HB3' ' A' ' 81' ' ' ALA . 3.3 t80 -109.04 23.37 14.64 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 109.473 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 5.6 p -107.79 153.42 23.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.899 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -42.52 -65.67 0.44 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 109.858 178.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.538 ' N ' HD12 ' A' ' 48' ' ' ILE . 50.0 t0 -52.18 -32.91 38.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.015 . . . . 0.0 110.437 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.468 ' O ' ' CD ' ' A' ' 50' ' ' GLN . . . -62.55 -73.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.28 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.74 ' CD1' HG11 ' A' ' 77' ' ' VAL . 10.6 tt -62.57 -13.8 11.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.899 HD12 ' C ' ' A' ' 44' ' ' GLU . 32.7 mt -77.22 -28.67 16.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 25.7 t80 -85.76 -22.22 27.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.338 -0.851 . . . . 0.0 110.026 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.548 ' O ' ' CE ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -99.47 -15.07 18.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 119.789 -1.819 . . . . 0.0 108.735 178.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.589 ' CG2' HG12 ' A' ' 47' ' ' ILE . 34.5 t -91.43 -27.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 109.516 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.864 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.5 OUTLIER -86.8 -4.4 59.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.788 -1.195 . . . . 0.0 108.144 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.864 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -158.97 22.37 0.2 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.36 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 48.8 -138.28 15.09 Favored Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.261 -1.935 . . . . 0.0 108.261 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.626 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.9 OUTLIER 156.43 134.53 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.03 -89.38 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -121.76 41.15 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.507 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.651 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 18.2 ttt -119.76 143.31 34.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 108.726 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.651 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 33.5 Cg_endo -77.31 94.56 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 123.004 2.469 . . . . 0.0 115.347 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.74 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -49.2 112.94 0.7 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.288 -0.882 . . . . 0.0 110.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.675 ' CD2' ' CD2' ' A' ' 65' ' ' LEU . 25.9 m-85 -81.41 -51.2 8.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.11 26.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.384 0.612 . . . . 0.0 109.606 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.85 32.74 0.63 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.645 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -100.29 -48.52 4.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.87 HD23 HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -64.12 -141.0 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.587 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 3.3 m -98.02 -52.11 3.81 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 121.01 -1.056 . . . . 0.0 109.175 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.7 m-20 150.77 -60.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 35.2 mm-40 -68.22 -2.02 7.31 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 1.055 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.11 -29.82 7.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.87 HD13 HD23 ' A' ' 65' ' ' LEU . 9.7 mm -52.47 -24.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.52 ' N ' ' C ' ' A' ' 69' ' ' GLN . 1.6 mt-30 -100.21 -60.42 1.53 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.442 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.703 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 13.9 m-20 -52.69 -47.6 67.13 Favored 'General case' 0 C--O 1.189 -2.114 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.527 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 69' ' ' GLN . 6.3 t -54.56 -29.17 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 108.791 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.747 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -77.67 -67.64 0.7 Allowed 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.47 -23.62 2.58 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.012 -1.68 . . . . 0.0 107.515 177.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.842 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 35.6 t80 -64.74 -46.23 83.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.188 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.4 p -67.74 -23.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.5 mt -78.34 -12.13 59.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.583 ' OD2' HD13 ' A' ' 3' ' ' LEU . 3.6 t0 -100.74 -34.62 9.77 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.793 0.806 . . . . 0.0 109.713 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.609 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 4.2 mm-40 -76.95 -40.63 46.37 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.27 0.557 . . . . 0.0 110.198 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.027 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -69.48 -26.15 64.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 108.952 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.45 11.65 18.71 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 111.036 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -162.53 29.5 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.344 -1.473 . . . . 0.0 112.442 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 92.31 75.7 1.31 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.71 -1.709 . . . . 0.0 109.202 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.706 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.6 OUTLIER -36.9 89.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.532 0.682 . . . . 0.0 110.152 178.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.3 -1.574 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.691 HD23 ' OD1' ' A' ' 72' ' ' ASP . 4.8 mt -69.61 -5.28 23.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.133 -0.979 . . . . 0.0 109.449 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.58 68.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.8 -33.95 64.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.85 -61.82 6.71 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.768 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.47 -36.66 15.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.271 . . . . 0.0 109.66 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.74 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -58.52 -46.1 87.47 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.055 HG21 ' CB ' ' A' ' 69' ' ' GLN . 42.5 t -75.51 -63.03 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.651 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.1 t80 -46.27 -23.43 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 110.954 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m -91.49 31.88 1.13 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.24 -0.912 . . . . 0.0 109.168 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.34 -32.73 0.02 OUTLIER Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.896 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' CB ' HD11 ' A' ' 65' ' ' LEU . 1.3 m120 -118.08 -50.24 2.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.878 -1.366 . . . . 0.0 108.767 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 6.6 m -70.2 -29.8 66.74 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -61.14 -38.17 85.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.513 -0.742 . . . . 0.0 110.48 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -11.83 7.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.82 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 96.9 m -143.01 23.91 1.85 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.869 -1.145 . . . . 0.0 110.082 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.987 ' CD2' HD21 ' A' ' 31' ' ' LEU . 65.8 m80 -157.9 -68.73 0.09 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.19 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 53.78 110.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.637 -0.664 . . . . 0.0 110.304 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 45.92 62.4 3.39 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 41.64 68.8 0.62 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -149.75 87.18 0.15 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.688 ' H ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -57.85 145.85 33.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -1.107 . . . . 0.0 109.474 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.545 HG23 HG23 ' A' ' 25' ' ' VAL . 34.8 m -97.42 -41.34 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG23 HG23 ' A' ' 24' ' ' VAL . 2.6 t -83.53 -60.7 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.092 -1.005 . . . . 0.0 109.196 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -86.7 90.19 8.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.77 71.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.713 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -74.16 -39.51 63.19 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.151 -0.968 . . . . 0.0 109.457 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.72 106.79 18.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.366 -0.834 . . . . 0.0 109.425 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.688 HG23 ' H ' ' A' ' 23' ' ' ASN . 7.7 m -126.5 174.81 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.104 -0.998 . . . . 0.0 109.567 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.987 HD21 ' CD2' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -95.76 -8.83 33.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.675 ' HD2' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -34.49 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.573 -178.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.108 ' N ' HD21 ' A' ' 36' ' ' LEU . 14.9 ttpp -178.42 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.824 -1.173 . . . . 0.0 110.592 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -80.16 -53.3 6.8 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.082 -1.011 . . . . 0.0 111.63 -178.17 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' CZ ' ' A' ' 39' ' ' PHE . . . -67.75 -53.84 24.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.937 -1.102 . . . . 0.0 110.521 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.108 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -44.84 -23.76 0.16 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.565 -179.201 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.562 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 89.4 mt-10 -95.25 -32.56 12.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 110.307 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 65.7 mm-40 -52.17 -39.52 60.19 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.772 ' CZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.87 -47.9 8.64 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.33 8.37 5.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.538 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 4.2 ptt? -80.94 11.78 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -1.153 . . . . 0.0 109.98 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.88 ' HB2' HD12 ' A' ' 36' ' ' LEU . 15.0 t80 -85.11 12.22 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.946 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.5 p -105.15 149.28 26.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.26 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.619 ' HG2' HD11 ' A' ' 48' ' ' ILE . 3.8 tt0 -54.39 -57.4 11.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.849 . . . . 0.0 109.64 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 45' ' ' ASP . 16.0 t0 -51.75 -23.13 4.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.643 -1.286 . . . . 0.0 110.3 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 41' ' ' MET . . . -76.68 -76.17 0.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.909 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.7 tt -57.91 -16.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.619 HD11 ' HG2' ' A' ' 44' ' ' GLU . 15.1 mt -71.89 -39.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.586 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 28.9 t80 -86.36 -16.88 35.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 108.834 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.522 ' OE1' ' CB ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -86.61 -19.97 28.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.665 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 47' ' ' ILE . 62.3 t -96.22 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.503 1.144 . . . . 0.0 109.552 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.744 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 3.1 mt-30 -71.7 -11.74 60.98 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.272 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.744 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -154.2 23.87 0.49 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.378 -1.451 . . . . 0.0 109.091 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.704 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.42 -148.86 44.51 Favored Glycine 0 C--N 1.285 -2.256 0 N-CA-C 107.627 -2.189 . . . . 0.0 107.627 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.97 117.82 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.9 m-80 63.39 -86.98 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.29 28.32 6.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 108.737 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.676 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.31 141.82 23.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 31.7 Cg_endo -75.75 105.49 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 123.369 2.713 . . . . 0.0 116.242 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.704 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -57.27 117.47 4.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.634 ' CD2' ' CD2' ' A' ' 65' ' ' LEU . 17.7 m-85 -87.9 -45.59 10.12 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.038 -1.039 . . . . 0.0 108.781 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 46.93 19.01 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.39 -0.819 . . . . 0.0 108.906 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 128.65 43.19 0.23 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.545 ' CB ' ' HB3' ' A' ' 61' ' ' PHE . 21.0 ttt180 -101.59 -51.62 3.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.704 HD12 HG13 ' A' ' 9' ' ' VAL . 2.7 mm? -63.6 -145.13 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.573 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 2.5 m -99.0 -56.98 2.28 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 120.896 -1.128 . . . . 0.0 109.642 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER 152.43 -55.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.086 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 24.5 mt-10 -69.75 -1.71 9.96 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 1.055 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.6 -28.23 8.98 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.464 ' CG2' ' HG3' ' A' ' 52' ' ' GLN . 8.2 mm -56.29 -23.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.482 ' N ' ' C ' ' A' ' 69' ' ' GLN . 3.2 mp0 -95.56 -70.31 0.72 Allowed 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.442 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.691 ' OD1' HD23 ' A' ' 3' ' ' LEU . 5.4 m-20 -45.19 -47.29 12.5 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.954 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.748 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -60.45 -36.25 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.74 0.781 . . . . 0.0 110.132 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' A' ' 48' ' ' ILE . . . -68.34 -62.71 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.19 -19.14 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.768 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 82.5 t80 -65.02 -45.27 86.22 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 31' ' ' LEU . 42.5 t -68.87 -24.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.429 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.72 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -83.53 -4.76 58.83 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.908 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 5.0 t0 -97.41 -45.4 6.47 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.824 ' HB3' ' CD2' ' A' ' 85' ' ' TRP . 2.3 mp0 -72.08 -31.75 66.38 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.2 0.524 . . . . 0.0 110.344 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 33' ' ' LYS . . . -58.44 -52.72 64.43 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.73 19.39 4.03 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -131.95 5.57 4.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 111.597 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.5 76.15 1.04 Allowed Glycine 0 C--N 1.296 -1.672 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.824 ' CD2' ' HB3' ' A' ' 80' ' ' GLN . 18.0 m95 -38.28 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.417 0.627 . . . . 0.0 110.804 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 109.824 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 4' ' ' ALA . 35.1 t70 . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.24 -3.98 23.27 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.08 -1.012 . . . . 0.0 108.424 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB2' ' OD2' ' A' ' 2' ' ' ASP . . . -63.92 -31.12 72.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.524 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.2 m-20 -71.6 -26.54 62.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.629 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -60.56 -64.11 4.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.851 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -39.77 -34.24 0.24 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.875 -0.78 . . . . 0.0 109.275 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.17 -52.49 40.82 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.77 HG11 ' HB ' ' A' ' 73' ' ' VAL . 23.6 t -52.19 -57.29 4.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.715 -0.615 . . . . 0.0 110.349 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.783 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 19.8 t80 -59.37 -33.46 71.21 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.986 -1.072 . . . . 0.0 110.473 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 t -91.1 21.17 4.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.283 -0.885 . . . . 0.0 110.073 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.63 -8.64 0.68 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.767 ' ND2' HD22 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -149.12 3.67 0.6 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.484 -1.598 . . . . 0.0 111.525 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -132.65 -44.99 0.89 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.564 -1.335 . . . . 0.0 110.979 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . -27.38 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.13 0.491 . . . . 0.0 111.196 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -61.8 -53.48 55.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 110.762 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' HA ' ' CG1' ' A' ' 24' ' ' VAL . 84.4 m -94.85 25.02 4.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 109.628 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.755 ' CD2' ' HG ' ' A' ' 31' ' ' LEU . 11.5 m80 -157.1 -72.08 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.743 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 2.5 mtp 43.71 100.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.313 0.578 . . . . 0.0 110.631 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 75.72 50.8 7.64 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 37.98 45.82 1.68 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -127.42 101.0 0.56 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.3 t-20 -46.16 165.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -1.198 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.682 HG13 HG23 ' A' ' 25' ' ' VAL . 1.7 p -111.73 -40.41 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.181 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 24' ' ' VAL . 2.7 t -91.72 -70.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.227 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.92 101.18 8.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.55 75.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.641 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 2.2 p-10 -65.8 -44.93 84.23 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.15 -0.969 . . . . 0.0 109.387 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.2 tptt -85.12 79.69 9.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.449 -0.782 . . . . 0.0 109.677 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 6.7 t -101.04 -176.47 3.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.905 . . . . 0.0 109.69 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.755 ' HG ' ' CD2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -97.3 -19.07 18.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.73 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.614 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -38.61 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.692 -0.63 . . . . 0.0 111.407 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.063 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.6 OUTLIER 174.63 -39.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.019 . . . . 0.0 109.95 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.71 . . . . 0.0 111.103 -178.261 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.603 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -93.31 -47.24 7.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 110.803 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.063 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -58.85 -33.21 70.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.557 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.492 ' HG2' ' HB2' ' A' ' 42' ' ' TYR . 2.0 mm-40 -95.75 -1.28 50.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -73.69 -57.61 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.34 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -88.27 -48.98 7.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.456 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.58 92.84 0.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.525 ' SD ' ' CB ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -172.13 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.048 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.965 ' CG ' HD12 ' A' ' 36' ' ' LEU . 2.2 t80 -102.14 21.73 14.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.482 -0.761 . . . . 0.0 109.751 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -107.4 143.78 35.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 0.0 111.216 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.532 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -42.42 -62.78 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.47 -0.769 . . . . 0.0 109.588 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -49.01 -37.6 20.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 110.751 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -74.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.995 -1.066 . . . . 0.0 110.44 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 77' ' ' VAL . 8.0 tt -64.28 -10.51 8.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.528 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.532 HD12 ' C ' ' A' ' 44' ' ' GLU . 10.7 mt -75.4 -37.64 38.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 34.0 t80 -89.5 -15.96 31.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 6.9 tp60 -88.34 -14.48 38.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.5 t -97.2 -47.71 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.392 -0.818 . . . . 0.0 110.006 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.763 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -61.34 -9.92 6.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.737 -0.602 . . . . 0.0 110.878 -178.554 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.763 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -155.51 23.54 0.4 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 54.01 -133.84 44.66 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.03 120.76 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.208 0.528 . . . . 0.0 109.737 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 8.6 m-20 73.85 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.8 29.4 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.195 -0.941 . . . . 0.0 108.859 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.658 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.0 ttt -108.23 143.79 28.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 109.346 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.658 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 32.9 Cg_endo -79.89 111.98 2.81 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.012 2.475 . . . . 0.0 113.171 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.654 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -37.68 159.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.599 -0.688 . . . . 0.0 110.246 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.633 ' O ' HD11 ' A' ' 70' ' ' ILE . 5.9 m-85 -147.23 21.71 1.21 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.483 -0.76 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.02 -10.8 10.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.03 . . . . 0.0 109.063 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.38 13.12 5.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.59 ' HG3' ' CD1' ' A' ' 61' ' ' PHE . 6.6 mmt85 -104.07 -48.11 3.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -95.41 124.83 39.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.71 HG22 ' H ' ' A' ' 67' ' ' ASP . 5.3 m -44.26 178.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.258 0.552 . . . . 0.0 110.049 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.71 ' H ' HG22 ' A' ' 66' ' ' THR . 4.3 m-20 -65.21 -59.38 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.798 -1.189 . . . . 0.0 109.204 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.597 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 4.4 mt-10 -71.1 1.91 5.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.653 -0.654 . . . . 0.0 109.533 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.724 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -102.67 -27.17 12.88 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.633 HD11 ' O ' ' A' ' 61' ' ' PHE . 25.6 mm -73.01 -31.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -80.01 -64.64 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.68 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 40.7 t0 -56.86 -30.41 63.82 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.117 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.77 ' HB ' HG11 ' A' ' 9' ' ' VAL . 8.7 p -70.52 -29.39 38.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -70.4 -58.2 3.99 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.97 -23.39 32.11 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.851 ' CE2' ' HA ' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.77 -50.62 68.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.835 HG21 ' CD1' ' A' ' 47' ' ' ILE . 44.0 t -65.77 -22.66 31.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.89 -1.131 . . . . 0.0 109.489 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.714 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.9 mt -87.32 -7.19 58.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.038 -1.039 . . . . 0.0 108.876 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -97.77 -40.99 8.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.018 0.913 . . . . 0.0 108.761 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.672 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -72.14 -45.14 61.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.648 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -76.36 -5.45 47.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.614 ' HB3' ' HD3' ' A' ' 83' ' ' LYS . . . -75.35 -13.54 60.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.489 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.614 ' HD3' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER 176.3 66.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.702 -1.249 . . . . 0.0 111.076 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 91.82 77.44 1.35 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.672 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -40.21 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.389 0.614 . . . . 0.0 110.7 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.625 ' HB2' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.875 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.069 HD13 ' OD1' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -69.17 -8.6 47.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.123 -0.986 . . . . 0.0 108.554 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.43 -22.52 54.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -78.86 -37.01 41.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -62.39 -53.2 43.75 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.674 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.15 -24.83 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.016 -1.285 . . . . 0.0 109.368 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.514 ' HE3' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -73.97 -47.24 38.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.746 HG22 ' HB3' ' A' ' 69' ' ' GLN . 14.8 t -55.38 -65.03 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 122.219 1.009 . . . . 0.0 108.918 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 10.9 t80 -60.73 -28.9 69.03 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 33.0 t -89.88 18.05 6.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.556 -1.34 . . . . 0.0 109.513 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.638 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -155.56 3.54 0.2 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.88 -1.152 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.638 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 1.0 OUTLIER -155.49 -46.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.604 -1.527 . . . . 0.0 109.56 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.2 m -79.65 -30.38 41.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 10' ' ' PHE . . . -53.61 -41.2 66.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 110.945 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.5 79.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.262 -0.899 . . . . 0.0 111.151 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.624 ' HA ' HG11 ' A' ' 24' ' ' VAL . 1.8 m -110.95 20.08 17.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.879 -1.138 . . . . 0.0 110.013 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.003 ' CD2' HD21 ' A' ' 31' ' ' LEU . 68.2 m80 -155.58 -51.37 0.08 Allowed 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.544 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.0 ptm 42.39 111.07 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.756 0.788 . . . . 0.0 111.556 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 49.95 57.47 9.84 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.36 72.86 0.26 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.728 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -153.83 92.49 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.456 ' H ' HG23 ' A' ' 30' ' ' THR . 1.1 t-20 -43.85 156.76 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -1.053 . . . . 0.0 109.812 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.704 HG13 HG23 ' A' ' 25' ' ' VAL . 3.3 p -115.86 -35.67 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 109.633 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.704 HG23 HG13 ' A' ' 24' ' ' VAL . 13.4 t -91.51 -68.53 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.867 . . . . 0.0 109.651 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.418 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -60.61 161.45 7.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -117.03 63.83 0.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.905 . . . . 0.0 109.265 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 27' ' ' ALA . 1.2 p30 163.65 -39.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.208 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 2.7 mptt -71.73 83.23 0.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.938 ' O ' HD22 ' A' ' 36' ' ' LEU . 2.1 m -99.38 -168.09 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 108.816 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.003 HD21 ' CD2' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -109.83 -2.8 17.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.677 -1.264 . . . . 0.0 109.651 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.676 ' HG2' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -60.19 -82.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.993 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.576 ' N ' HD21 ' A' ' 36' ' ' LEU . 3.2 ptmm? 168.75 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.658 -1.276 . . . . 0.0 110.936 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.72 -34.53 5.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.907 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.09 -66.44 1.02 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.84 0.828 . . . . 0.0 110.365 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.095 HD12 ' CB ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -44.75 -46.43 10.46 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.927 -0.483 . . . . 0.0 111.846 -178.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.474 ' HA ' ' CD1' ' A' ' 42' ' ' TYR . 43.4 tt0 -60.94 -34.63 75.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.569 -1.332 . . . . 0.0 110.333 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -73.81 -77.9 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.17 7.57 43.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.524 -0.735 . . . . 0.0 111.851 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 36' ' ' LEU . . . -124.88 -3.62 7.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . 1.051 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.9 mtt 42.57 48.38 4.64 Favored 'General case' 0 C--O 1.196 -1.739 0 O-C-N 121.241 -1.152 . . . . 0.0 109.527 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.095 ' CB ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -39.01 -21.81 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 O-C-N 120.912 -1.117 . . . . 0.0 111.368 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.771 ' O ' HG22 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -42.45 166.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.773 -1.204 . . . . 0.0 110.508 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.567 ' N ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -52.64 -73.18 0.04 OUTLIER 'General case' 0 C--O 1.2 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 110.579 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 44' ' ' GLU . 33.5 t0 -36.72 -51.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.209 -0.932 . . . . 0.0 112.492 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 1.051 ' HB3' ' O ' ' A' ' 41' ' ' MET . . . -63.35 -73.25 0.12 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 111.204 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 43' ' ' SER . 14.0 tt -51.0 -20.55 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.016 -1.052 . . . . 0.0 109.677 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.626 HG23 HE22 ' A' ' 52' ' ' GLN . 14.0 mt -72.12 -38.25 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.626 -0.671 . . . . 0.0 109.445 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -77.44 -26.79 51.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.5 pm0 -89.13 -18.86 26.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.213 -1.554 . . . . 0.0 108.702 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 47' ' ' ILE . 45.3 t -85.78 -44.8 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.942 0.877 . . . . 0.0 109.389 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.771 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -66.74 -10.69 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.821 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.771 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -158.65 23.29 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.71 -1.196 . . . . 0.0 108.612 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.563 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 55.89 -141.34 39.98 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 154.23 142.5 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 54.98 -90.56 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.12 49.0 2.33 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.61 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 ttt -121.04 144.6 39.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.61 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.9 Cg_endo -82.54 105.21 1.39 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 123.077 2.518 . . . . 0.0 113.67 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.622 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -39.45 154.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 110.677 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.781 ' HB3' HD12 ' A' ' 70' ' ' ILE . 23.0 m-85 -136.72 3.46 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 52' ' ' GLN . . . -44.36 -29.67 0.71 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.76 36.64 0.51 Allowed Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.095 -1.526 . . . . 0.0 109.805 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HB3' ' HD1' ' A' ' 61' ' ' PHE . 10.7 ttt-85 -102.0 -48.34 4.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' A' ' 61' ' ' PHE . 1.6 mt -93.68 -146.03 0.24 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.57 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -84.73 -172.94 4.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.415 ' H ' HG22 ' A' ' 66' ' ' THR . 3.6 m-20 -93.45 -55.74 3.18 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.9 mt-10 -72.36 5.61 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.746 ' HB3' HG22 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -102.34 -31.85 10.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 61' ' ' PHE . 2.2 mm -72.24 -26.06 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -84.03 -66.73 0.86 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.774 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 1.069 ' OD1' HD13 ' A' ' 3' ' ' LEU . 53.9 t0 -58.61 -28.47 65.65 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.128 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 7.9 p -69.14 -26.73 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -75.18 -56.75 4.42 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.06 -19.62 53.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.025 ' HA ' HD12 ' A' ' 3' ' ' LEU . 78.6 t80 -67.85 -41.09 83.46 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.571 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 39.9 t -70.04 -22.61 24.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.567 HD11 ' N ' ' A' ' 44' ' ' GLU . 0.9 OUTLIER -85.39 -8.46 58.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 1.8 t70 -99.02 -35.52 10.02 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.946 0.879 . . . . 0.0 109.16 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.661 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -81.96 -34.01 29.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.233 0.54 . . . . 0.0 109.942 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -62.92 -48.16 80.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.852 . . . . 0.0 109.101 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.52 18.54 3.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.445 -0.784 . . . . 0.0 109.358 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -134.86 13.38 3.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 0.0 110.963 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 77.74 75.73 0.93 Allowed Glycine 0 C--N 1.296 -1.694 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.661 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 11.7 m95 -34.76 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.727 0.775 . . . . 0.0 109.417 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 109.969 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 1.7 m-20 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.02 HD13 ' HA ' ' A' ' 76' ' ' TYR . 1.8 pp -72.88 2.21 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.074 -1.016 . . . . 0.0 109.613 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.14 70.55 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -62.86 -25.65 68.39 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -59.55 -51.2 60.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.714 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -45.54 -25.45 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.714 -1.463 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -75.0 -47.82 27.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 177.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.662 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 21.1 t -55.44 -64.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 121.948 0.88 . . . . 0.0 109.01 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.606 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 11.6 t80 -59.82 -31.79 70.05 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.768 -0.582 . . . . 0.0 111.11 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 43.1 p -88.53 18.69 4.38 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.788 -1.195 . . . . 0.0 109.653 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.616 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -155.7 3.74 0.2 Allowed Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.577 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 1.3 m120 -155.16 -49.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.631 -1.511 . . . . 0.0 109.409 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.4 m -71.96 -34.99 69.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -44.99 -42.78 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 110.449 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.87 74.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.187 -0.946 . . . . 0.0 111.706 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.576 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 95.9 m -104.19 27.18 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.885 -1.134 . . . . 0.0 109.87 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.914 ' CE1' HD21 ' A' ' 31' ' ' LEU . 85.7 m-70 -159.89 -67.92 0.07 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.614 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.512 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 55.76 114.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.45 -0.781 . . . . 0.0 110.092 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.32 61.73 1.71 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.491 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 44.82 79.62 0.06 OUTLIER Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -160.81 83.35 0.13 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.772 ' H ' HG23 ' A' ' 30' ' ' THR . 5.1 t-20 -40.51 160.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.611 -0.935 . . . . 0.0 109.586 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.604 HG13 ' N ' ' A' ' 25' ' ' VAL . 14.7 p -116.3 -47.04 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.09 -1.006 . . . . 0.0 110.138 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.604 ' N ' HG13 ' A' ' 24' ' ' VAL . 9.1 p -95.82 -38.52 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -96.56 115.99 28.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.73 -1.231 . . . . 0.0 109.441 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -90.19 71.87 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.6 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER 177.6 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.378 -0.826 . . . . 0.0 109.049 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 5.5 mtmm -93.43 61.56 3.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.283 -0.886 . . . . 0.0 109.311 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.772 HG23 ' H ' ' A' ' 23' ' ' ASN . 5.1 m -85.17 166.2 16.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.746 . . . . 0.0 109.526 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.914 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -94.26 -12.22 28.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.595 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -37.37 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.587 -0.695 . . . . 0.0 111.182 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.074 ' CA ' HD21 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -165.74 -43.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.122 . . . . 0.0 110.386 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 mt-10 -67.31 -47.52 70.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.594 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -65.84 -45.97 80.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.675 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.074 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -62.63 -36.17 81.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' A' ' 33' ' ' LYS . 8.8 mt-10 -92.28 5.87 48.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.195 -0.941 . . . . 0.0 109.394 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -90.55 -55.6 3.52 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.594 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.71 -50.7 6.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.031 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.15 33.65 0.15 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.387 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.864 ' CE ' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -86.05 -25.85 25.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.647 -1.502 . . . . 0.0 108.562 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.786 ' CD2' HD12 ' A' ' 36' ' ' LEU . 8.2 t80 -41.86 -23.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.852 -0.53 . . . . 0.0 110.654 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 41' ' ' MET . 22.8 p -84.42 134.82 34.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.873 -1.142 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 48' ' ' ILE . 2.7 mt-10 -49.02 -54.94 13.59 Favored 'General case' 0 C--O 1.198 -1.627 0 O-C-N 121.51 -0.744 . . . . 0.0 109.524 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -52.26 -32.9 39.33 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.667 -1.27 . . . . 0.0 110.692 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' HB1' ' HA ' ' A' ' 41' ' ' MET . . . -67.72 -69.66 0.3 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.97 . . . . 0.0 111.152 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.65 HG23 ' HB1' ' A' ' 74' ' ' ALA . 7.5 tt -66.76 -19.33 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.4 -0.812 . . . . 0.0 109.817 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.573 HG13 ' CB ' ' A' ' 74' ' ' ALA . 12.5 mt -68.04 -25.64 32.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.61 ' CD1' ' CE1' ' A' ' 53' ' ' HIS . 63.6 t80 -86.97 -68.65 0.73 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.547 ' CG ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -44.19 -25.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.515 -1.366 . . . . 0.0 108.825 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.909 ' CG1' HG23 ' A' ' 70' ' ' ILE . 55.8 t -80.36 -46.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 108.669 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.824 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -65.52 -13.23 58.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 111.954 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.824 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -154.57 20.02 0.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.446 -1.408 . . . . 0.0 108.515 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 56.41 -140.52 42.86 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.598 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 153.51 133.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 7.7 m-80 60.78 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -129.38 43.32 3.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.636 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 19.9 ttt -117.98 145.95 37.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.482 -0.761 . . . . 0.0 109.498 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.636 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.2 Cg_endo -81.83 101.63 1.18 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 123.373 2.715 . . . . 0.0 114.517 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.643 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.5 156.26 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.628 ' CE1' HD11 ' A' ' 65' ' ' LEU . 39.2 m-85 -137.02 3.74 2.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.596 -0.69 . . . . 0.0 109.434 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.39 -25.8 0.16 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.214 -0.929 . . . . 0.0 109.45 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -162.85 33.65 0.31 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -102.4 -46.57 4.74 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.628 HD11 ' CE1' ' A' ' 61' ' ' PHE . 73.8 mt -103.25 -145.72 0.37 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.605 HG21 ' OE1' ' A' ' 69' ' ' GLN . 9.2 m -98.47 167.41 10.83 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.367 -0.833 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 66' ' ' THR . 16.1 m-20 -82.7 -49.9 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.205 -0.934 . . . . 0.0 109.134 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.553 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 4.0 tt0 -64.63 -6.86 8.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.631 -0.668 . . . . 0.0 109.273 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.662 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -96.01 -35.77 11.27 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.909 HG23 ' CG1' ' A' ' 51' ' ' VAL . 3.8 mm -72.21 -11.54 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -66.97 0.87 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.296 1.046 . . . . 0.0 108.623 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.715 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 48.7 m-20 -53.4 -37.87 62.88 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.371 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.671 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 p -67.96 -28.98 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.55 0.691 . . . . 0.0 109.508 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.96 -59.31 2.79 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.47 -21.3 51.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.02 ' HA ' HD13 ' A' ' 3' ' ' LEU . 88.8 t80 -66.4 -42.49 87.79 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.864 HG11 ' CE ' ' A' ' 41' ' ' MET . 48.8 t -70.35 -22.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.719 ' N ' HD23 ' A' ' 78' ' ' LEU . 2.2 mt -81.26 -7.75 59.63 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.606 ' OD2' HD21 ' A' ' 3' ' ' LEU . 5.6 t0 -99.42 -47.38 5.17 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.069 0.937 . . . . 0.0 108.952 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.666 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 66.7 mm-40 -69.48 -39.89 77.4 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -59.97 -45.78 91.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 109.187 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.18 13.73 12.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 110.583 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -137.26 19.16 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.683 -1.261 . . . . 0.0 111.603 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.98 73.15 1.28 Allowed Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.142 -1.504 . . . . 0.0 109.366 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.666 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 1.9 m95 -40.83 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 122.316 -0.52 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.039 -1.038 . . . . 0.0 109.574 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.472 HD13 ' CG ' ' A' ' 79' ' ' ASP . 1.3 mt -68.28 -5.86 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.153 -0.967 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.3 70.61 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.506 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.97 -30.7 62.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -58.97 -59.8 10.09 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.828 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -52.31 -28.86 20.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.761 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.519 ' HE3' ' OE1' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -62.51 -43.49 98.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.92 HG21 ' CB ' ' A' ' 69' ' ' GLN . 4.1 t -77.92 -49.61 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.444 -0.785 . . . . 0.0 109.815 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.609 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 5.1 t80 -60.57 -23.57 64.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.698 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 40.2 p -87.95 19.74 3.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.66 3.95 0.64 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' CB ' ' CD2' ' A' ' 65' ' ' LEU . 19.9 m120 -147.58 -48.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.745 -1.444 . . . . 0.0 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.609 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 1.9 m -78.98 -29.52 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 108.692 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -46.84 -40.11 13.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.655 -0.653 . . . . 0.0 110.009 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -42.42 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.011 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 80.2 m -116.67 32.9 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.425 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.748 ' CD2' ' HG ' ' A' ' 31' ' ' LEU . 31.5 m80 -163.9 -76.83 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 109.153 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 52.04 114.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.493 0.663 . . . . 0.0 110.755 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 50.13 55.42 15.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 40.78 81.58 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -165.44 96.79 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.05 150.33 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -1.107 . . . . 0.0 109.399 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.68 -14.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.602 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.12 -68.68 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mmt -76.75 140.95 40.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.821 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -100.73 62.71 1.03 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.13 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 8.2 p-10 179.24 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.312 -0.867 . . . . 0.0 109.819 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -80.81 75.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.707 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 31' ' ' LEU . 3.0 m -89.78 175.07 7.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.781 ' O ' HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -102.22 -17.58 15.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.482 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.729 ' C ' HD21 ' A' ' 36' ' ' LEU . 2.7 mtpm? -48.18 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.717 -0.615 . . . . 0.0 111.955 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.879 ' CA ' HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -165.08 -45.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.689 -1.257 . . . . 0.0 111.003 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 3.6 mm-40 -61.83 -14.18 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 111.157 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -105.73 -45.74 4.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.969 -1.082 . . . . 0.0 110.695 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.879 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -61.9 -33.83 74.94 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.279 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.582 ' OE1' ' CD2' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -89.96 -4.0 57.71 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.619 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.14 -59.68 2.68 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.004 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -87.25 -51.54 5.91 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.995 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 141.18 24.32 0.23 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.948 -1.596 . . . . 0.0 111.672 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.881 ' CE ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -74.91 -20.05 59.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.556 -1.555 . . . . 0.0 108.321 178.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.83 ' CD2' HD12 ' A' ' 36' ' ' LEU . 6.9 t80 -46.83 -22.16 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.715 -0.616 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.679 ' OG ' ' HB2' ' A' ' 46' ' ' ALA . 50.8 p -90.26 129.79 36.46 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.17 -0.956 . . . . 0.0 110.192 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -43.38 -62.78 0.97 Allowed 'General case' 0 C--O 1.202 -1.425 0 O-C-N 121.624 -0.672 . . . . 0.0 109.361 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -49.23 -35.98 18.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.01 . . . . 0.0 110.855 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB2' ' OG ' ' A' ' 43' ' ' SER . . . -61.73 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.918 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.2 tt -58.91 -16.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 110.252 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 10.1 mt -70.45 -37.53 70.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 29.5 t80 -83.31 -18.3 39.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.702 ' NE2' ' HB2' ' A' ' 55' ' ' LYS . 6.0 tp60 -89.49 -10.78 45.03 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 47' ' ' ILE . 70.1 t -98.56 -50.14 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.864 . . . . 0.0 109.562 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.803 ' OE1' HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -58.55 -12.36 3.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 0.0 110.55 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.753 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -146.18 16.27 1.35 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.084 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.625 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 52.93 -121.25 14.89 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.702 ' HB2' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 162.24 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.761 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.035 178.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 55' ' ' LYS . 51.8 m-80 -20.02 -49.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.724 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -148.3 20.26 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 109.765 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.664 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 23.5 ttt -102.15 145.16 30.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 108.866 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.664 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.6 Cg_endo -79.7 111.7 2.81 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.824 2.349 . . . . 0.0 113.603 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -37.58 160.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.525 -0.734 . . . . 0.0 110.25 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.633 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 32.4 m-85 -142.44 16.11 2.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 108.98 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.23 -23.05 0.77 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.436 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.47 31.27 0.7 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.633 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -103.65 -56.9 2.12 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.781 HD12 HD13 ' A' ' 70' ' ' ILE . 18.2 mt -61.82 -144.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 14.9 m -99.04 -63.24 1.14 Allowed 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.258 -0.901 . . . . 0.0 109.955 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.5 m-20 152.94 -56.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.6 tt0 -71.4 -0.01 9.27 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.92 ' CB ' HG21 ' A' ' 9' ' ' VAL . 2.4 mp0 -114.07 -24.32 9.08 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.803 HG21 ' OE1' ' A' ' 52' ' ' GLN . 9.8 mm -56.48 -21.74 13.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 172.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.9 mp0 -97.8 -68.3 0.81 Allowed 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.595 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.669 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 3.4 m-20 -51.22 -46.86 62.37 Favored 'General case' 0 C--O 1.199 -1.573 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.99 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -56.93 -29.1 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.626 -0.671 . . . . 0.0 110.042 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -80.15 -64.22 1.24 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -50.36 -23.05 2.1 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.493 -1.379 . . . . 0.0 107.323 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.828 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 17.1 t80 -66.5 -47.59 72.51 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.881 HG21 ' CE ' ' A' ' 41' ' ' MET . 1.8 p -68.11 -16.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 42' ' ' TYR . 5.1 mt -81.52 -15.74 53.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.472 ' CG ' HD13 ' A' ' 3' ' ' LEU . 1.2 t70 -97.95 -34.93 10.63 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.948 0.88 . . . . 0.0 108.899 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.749 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 2.3 mm-40 -83.54 -39.04 20.92 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.746 0.784 . . . . 0.0 110.035 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -51.45 -33.59 31.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.352 -0.842 . . . . 0.0 109.073 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -80.87 -28.79 35.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER 176.33 -24.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.155 -0.966 . . . . 0.0 111.0 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.728 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -61.18 -13.13 34.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.749 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 2.5 m95 -64.13 89.2 0.06 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.222 -0.924 . . . . 0.0 108.913 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 72' ' ' ASP . 6.5 mt -68.64 -7.19 30.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.182 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.02 67.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -71.94 -39.38 69.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.204 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 5' ' ' ASN . . . -47.39 -56.45 8.15 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.748 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -52.43 -38.66 59.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.264 . . . . 0.0 109.281 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.804 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -56.82 -40.51 76.14 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.94 HG21 ' CG ' ' A' ' 69' ' ' GLN . 38.6 t -80.69 -69.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.496 -0.752 . . . . 0.0 109.485 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 22.7 t80 -41.74 -25.31 0.05 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.389 -0.82 . . . . 0.0 111.257 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 63.7 m -92.1 32.92 1.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.464 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.57 -29.68 0.02 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.123 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.411 ' OD1' HG13 ' A' ' 9' ' ' VAL . 1.9 m120 -116.75 -48.85 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.919 -1.342 . . . . 0.0 108.702 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -77.39 -27.42 52.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.783 ' HB1' ' HG3' ' A' ' 19' ' ' MET . . . -54.01 -31.35 50.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.563 -0.71 . . . . 0.0 110.163 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.35 85.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 110.99 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.605 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.5 m -111.0 26.31 10.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.413 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 69.2 m80 -156.94 -74.7 0.09 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.321 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.783 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 46.11 105.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.403 0.621 . . . . 0.0 111.096 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 78.13 42.31 15.88 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.522 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 42.25 37.07 2.27 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.92 90.6 0.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' HB3' ' CG ' ' A' ' 26' ' ' MET . 3.6 t-20 -49.38 168.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -1.075 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.703 HG23 ' H ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -144.07 -69.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.033 -1.042 . . . . 0.0 110.35 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.703 ' H ' HG23 ' A' ' 24' ' ' VAL . 1.2 p -44.24 -40.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.053 -1.029 . . . . 0.0 109.837 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.533 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -56.36 -168.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.919 -1.113 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -121.65 4.29 10.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 8.4 p-10 178.15 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.945 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.608 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -51.79 137.56 25.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.263 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.692 HG22 ' H ' ' A' ' 31' ' ' LEU . 4.0 m -123.64 179.93 4.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.399 -0.813 . . . . 0.0 109.198 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.692 ' H ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -100.66 -15.7 17.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.984 -1.073 . . . . 0.0 109.165 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.71 ' C ' HD21 ' A' ' 36' ' ' LEU . 5.2 mtpm? -56.45 -92.35 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.897 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.047 ' N ' HD21 ' A' ' 36' ' ' LEU . 3.9 pttm -179.41 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.946 -1.096 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 23.1 pt-20 -47.42 -37.16 10.99 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.661 -0.65 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.607 ' HA ' ' HB2' ' A' ' 38' ' ' GLN . . . -108.32 -61.14 1.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.77 -0.581 . . . . 0.0 111.161 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.047 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -40.68 -32.65 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 109.035 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.582 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -93.15 -33.31 14.08 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 120.962 -1.086 . . . . 0.0 108.637 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 4.8 tp-100 -40.73 -31.55 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.5 1.143 . . . . 0.0 108.254 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.608 ' CE2' ' HG3' ' A' ' 29' ' ' LYS . 3.8 m-85 -84.96 -50.99 7.02 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.5 ' C ' ' CG ' ' A' ' 41' ' ' MET . . . 127.68 64.37 0.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.616 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -171.39 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.97 -1.312 . . . . 0.0 110.675 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.66 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 2.5 t80 -92.48 23.48 3.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 108.632 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 54.3 p -104.58 165.67 10.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.628 -1.295 . . . . 0.0 110.338 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.523 ' O ' HG13 ' A' ' 48' ' ' ILE . 4.3 mt-10 -48.63 -70.51 0.09 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -50.05 -21.42 1.25 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.589 -1.319 . . . . 0.0 110.495 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -75.45 -73.59 0.25 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.204 -0.935 . . . . 0.0 110.39 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.3 tt -63.24 -14.1 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.845 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 44' ' ' GLU . 44.4 mt -74.6 -32.52 29.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.582 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 36.0 t80 -94.32 -15.52 24.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 1.5 tp60 -91.14 -10.28 42.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.7 t -103.66 -44.97 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.712 0.768 . . . . 0.0 109.275 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.807 ' HG3' HG21 ' A' ' 70' ' ' ILE . 1.5 mt-30 -61.24 -12.23 12.41 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.34 0.591 . . . . 0.0 110.459 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.774 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -151.75 20.55 0.7 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -178.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.62 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.77 -132.44 51.21 Favored Glycine 0 C--N 1.3 -1.42 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.52 139.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 121.388 0.614 . . . . 0.0 109.423 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 53.21 -88.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -127.55 43.29 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.982 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.671 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 11.1 ttt -126.14 143.37 45.48 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 109.367 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.671 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.9 Cg_endo -76.64 120.55 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.108 2.539 . . . . 0.0 114.406 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.93 165.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.641 -0.662 . . . . 0.0 109.707 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.764 ' CD1' HD21 ' A' ' 65' ' ' LEU . 23.5 m-85 -145.77 11.53 1.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.177 -0.952 . . . . 0.0 109.842 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.35 -19.27 5.19 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.095 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.7 24.68 1.49 Allowed Glycine 0 N--CA 1.486 1.993 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.83 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.671 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt180 -101.93 -39.31 7.41 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.842 HD13 HG11 ' A' ' 9' ' ' VAL . 2.4 mt -102.83 -154.12 0.49 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.496 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 67' ' ' ASP . 51.5 m -101.48 174.12 6.12 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.623 ' N ' HG22 ' A' ' 66' ' ' THR . 5.6 m-20 -72.6 -57.62 4.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.822 -1.174 . . . . 0.0 108.129 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 33.4 mt-10 -63.59 3.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.94 ' CG ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -104.51 -42.75 5.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.807 HG21 ' HG3' ' A' ' 52' ' ' GLN . 8.7 mm -56.65 -19.14 8.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.7 mm-40 -95.86 -73.56 0.59 Allowed 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 78.5 m-20 -39.63 -53.25 2.17 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.586 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.789 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 t -60.1 -42.28 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.434 1.112 . . . . 0.0 109.069 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -59.07 -65.85 0.6 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.301 -1.499 . . . . 0.0 107.211 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.581 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.0 -17.94 20.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.789 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 78.2 t80 -65.12 -40.67 94.82 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.684 HG21 HD11 ' A' ' 47' ' ' ILE . 96.8 t -74.65 -24.71 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.727 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -86.68 -8.8 57.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 7.3 t0 -99.54 -36.02 9.67 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.031 0.919 . . . . 0.0 109.186 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.618 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 5.4 mm-40 -79.76 -42.24 24.92 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.43 0.634 . . . . 0.0 109.708 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' HA ' ' A' ' 32' ' ' LYS . . . -74.79 -18.89 60.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.394 -0.816 . . . . 0.0 109.358 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.66 6.52 7.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.626 -0.671 . . . . 0.0 110.587 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.81 48.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.501 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.93 78.26 1.15 Allowed Glycine 0 N--CA 1.481 1.643 0 C-N-CA 118.643 -1.742 . . . . 0.0 109.215 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.631 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -36.02 90.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.578 0.704 . . . . 0.0 109.677 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.3 -1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.669 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.011 0.434 . . . . 0.0 110.027 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 79' ' ' ASP . 2.0 mp -70.39 -3.25 16.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.017 -1.052 . . . . 0.0 109.105 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.97 77.09 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.524 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -67.64 -25.43 65.72 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.59 -63.26 4.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.853 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -51.47 -33.13 29.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 0.0 109.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.49 -41.78 86.1 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 108.834 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.879 HG21 ' CB ' ' A' ' 69' ' ' GLN . 2.7 t -79.05 -51.85 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 10.4 t80 -54.72 -24.38 21.89 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.045 -1.034 . . . . 0.0 110.455 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -89.8 24.97 2.19 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.443 -0.786 . . . . 0.0 109.367 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.21 11.67 0.19 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.502 ' ND2' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -153.23 -40.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.78 -1.424 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -93.37 -31.06 14.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 108.827 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -42.26 -45.77 4.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.32 84.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 110.535 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.574 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 59.6 m -111.44 28.23 8.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.978 -1.076 . . . . 0.0 110.23 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.738 ' NE2' HD21 ' A' ' 31' ' ' LEU . 44.9 m80 -161.56 -73.81 0.06 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.246 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 55.24 114.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.745 -0.597 . . . . 0.0 110.574 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.19 62.8 1.45 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.62 65.88 1.24 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -150.26 69.37 0.32 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.575 HD21 ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -48.01 166.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.099 -1.236 . . . . 0.0 109.202 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 25' ' ' VAL . 3.1 m -128.86 -37.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.956 -1.09 . . . . 0.0 109.908 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.4 ' N ' ' CG2' ' A' ' 24' ' ' VAL . 2.4 t -82.67 -40.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.09 -1.006 . . . . 0.0 109.199 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.661 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.2 mpp? -61.23 -56.94 14.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 26' ' ' MET . . . 74.38 27.25 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 7.8 p-10 -179.34 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 1.3 mtmp? -90.34 57.01 3.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 109.499 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.743 ' C ' HD23 ' A' ' 31' ' ' LEU . 4.9 m -67.51 178.33 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.837 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -98.99 -8.98 24.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.71 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -45.88 -76.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.886 -1.134 . . . . 0.0 110.481 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.06 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 167.55 -43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 109.844 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 21.6 pt-20 -56.35 -25.99 51.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.216 -0.927 . . . . 0.0 110.415 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.853 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -101.85 -59.65 1.67 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.06 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -48.52 -31.8 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.01 -1.056 . . . . 0.0 109.774 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.578 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 38.5 mt-10 -91.42 -23.62 19.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.536 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 21.0 tp60 -61.67 -42.04 98.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.853 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -89.8 -76.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.873 0.844 . . . . 0.0 109.005 178.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.42 84.92 0.05 OUTLIER Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.496 ' HE2' ' HB3' ' A' ' 36' ' ' LEU . 5.2 ptt? -168.26 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -1.22 . . . . 0.0 109.617 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.008 ' HB2' HD12 ' A' ' 36' ' ' LEU . 7.1 t80 -103.2 19.26 19.94 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.151 -0.968 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -105.77 144.09 32.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 0.0 110.611 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.732 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -45.6 -65.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.778 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.463 ' N ' HD12 ' A' ' 48' ' ' ILE . 64.3 t0 -49.4 -31.84 10.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.826 -1.171 . . . . 0.0 110.748 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -64.78 -78.54 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.725 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.4 tt -57.98 -16.19 6.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.552 0.692 . . . . 0.0 110.211 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.732 HD12 ' C ' ' A' ' 44' ' ' GLU . 23.2 mt -71.67 -38.53 67.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.774 ' HA ' ' HE1' ' A' ' 53' ' ' HIS . 33.3 t80 -86.38 -11.55 51.71 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 5.6 tp60 -95.88 -12.88 24.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 47' ' ' ILE . 56.4 t -102.58 -37.19 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.033 0.921 . . . . 0.0 109.474 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.719 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -66.2 -11.17 48.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.774 ' HE1' ' HA ' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -164.93 38.34 0.07 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.681 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 44.74 -133.42 7.37 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.08 125.95 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.587 -0.807 . . . . 0.0 108.846 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 73.6 m-80 65.04 -85.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.543 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.0 37.58 4.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.698 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 26.6 ttt -116.3 142.28 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 108.796 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.698 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.1 Cg_endo -71.24 103.44 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.873 2.382 . . . . 0.0 113.451 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.738 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -58.79 107.55 0.53 Allowed 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.866 -0.521 . . . . 0.0 110.385 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.838 ' CD2' HD21 ' A' ' 65' ' ' LEU . 75.5 m-85 -77.1 -41.06 43.6 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.884 -1.135 . . . . 0.0 108.259 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.26 19.14 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.674 -0.641 . . . . 0.0 109.493 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 61' ' ' PHE . . . 122.37 44.28 0.36 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 65' ' ' LEU . 15.6 ttt-85 -102.48 -54.0 2.77 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.839 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -62.07 -146.39 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 69' ' ' GLN . 78.8 m -97.42 154.22 17.61 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.907 ' HA ' HD12 ' A' ' 70' ' ' ILE . 7.7 t0 -63.24 -53.68 49.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.944 -1.097 . . . . 0.0 108.303 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 tt0 -64.76 1.57 0.85 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.003 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.879 ' CB ' HG21 ' A' ' 9' ' ' VAL . 2.2 mp0 -115.34 -25.47 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.145 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.907 HD12 ' HA ' ' A' ' 67' ' ' ASP . 3.7 mt -59.24 -19.95 17.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.5 mp0 -97.51 -67.0 0.87 Allowed 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 114.546 -1.207 . . . . 0.0 108.332 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.698 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 18.4 m-20 -52.74 -46.08 67.29 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.001 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -56.51 -27.88 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.919 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.655 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -81.69 -63.48 1.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.23 -22.29 2.59 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.853 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 23.0 t80 -67.93 -46.82 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.826 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.669 HG23 ' HZ2' ' A' ' 85' ' ' TRP . 1.5 p -68.77 -15.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.557 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 4.8 mt -84.28 -14.78 48.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.429 ' HB2' HD22 ' A' ' 3' ' ' LEU . 9.4 t0 -96.91 -39.63 9.3 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.763 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.2 mm-40 -80.02 -38.31 32.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.891 0.853 . . . . 0.0 109.411 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -52.26 -30.18 26.56 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -87.55 -25.38 23.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 110.153 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 176.61 -24.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.077 -1.014 . . . . 0.0 111.059 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.733 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -65.24 -12.47 55.5 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.763 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 3.3 m95 -64.81 88.57 0.07 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.299 -1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.324 -177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.445 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 72' ' ' ASP . 5.9 mt -76.19 -0.67 23.02 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.172 -0.955 . . . . 0.0 109.33 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -70.1 -27.36 64.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 7' ' ' ALA . . . -59.6 -65.38 3.47 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -43.13 -33.11 0.82 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -1.161 . . . . 0.0 109.445 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HE3' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -65.26 -50.77 64.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.861 HG21 ' CB ' ' A' ' 69' ' ' GLN . 3.2 t -67.54 -59.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.266 -0.896 . . . . 0.0 108.692 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.639 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 9.2 t80 -50.28 -26.78 5.15 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 13.1 t -85.87 25.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 109.741 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.39 13.36 0.1 OUTLIER Glycine 0 N--CA 1.484 1.874 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.998 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.803 ' CG ' HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.57 -48.76 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 109.381 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.639 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.3 m -81.97 -28.81 32.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -43.39 -41.29 4.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.476 -0.765 . . . . 0.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.7 -50.32 68.58 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.124 -0.985 . . . . 0.0 111.233 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 7.8 m -109.81 23.92 13.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.168 . . . . 0.0 110.46 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.688 ' CD2' ' CD2' ' A' ' 31' ' ' LEU . 71.6 m80 -156.16 -70.32 0.11 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.452 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.518 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.3 ptt? 38.72 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 80.07 49.28 6.04 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB2' ' A' ' 31' ' ' LEU . . . 37.63 36.15 0.26 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.75 95.69 0.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.553 ' HB3' ' CG ' ' A' ' 26' ' ' MET . 3.7 t-20 -57.71 -176.9 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.273 -1.134 . . . . 0.0 109.441 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -156.93 -78.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 109.793 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' MET . 1.4 p -41.58 -39.99 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 110.044 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.553 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -54.1 -166.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.024 -1.047 . . . . 0.0 109.746 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -126.34 2.15 7.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.013 -1.055 . . . . 0.0 109.919 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 9.2 p-10 178.89 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.018 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.62 122.83 14.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 31' ' ' LEU . 5.9 m -124.03 175.94 6.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.688 ' CD2' ' CD2' ' A' ' 18' ' ' HIS . 2.1 mp -99.52 -9.92 22.73 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.818 -0.551 . . . . 0.0 111.138 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.825 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -56.38 -102.32 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.292 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' N ' HD21 ' A' ' 36' ' ' LEU . 19.8 ptmt -155.74 -43.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.48 -1.388 . . . . 0.0 109.803 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 7.2 pt-20 -63.64 -40.51 97.06 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 110.636 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -79.22 -52.17 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 111.482 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -65.32 -11.48 42.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.718 -1.238 . . . . 0.0 108.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.608 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -119.67 -1.61 10.57 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.273 -0.892 . . . . 0.0 108.777 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.539 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 12.8 tp60 -65.45 -48.32 73.12 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.602 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -86.48 -31.62 21.24 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.22 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 117.29 99.38 2.05 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.648 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.582 ' SD ' ' CE1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 156.42 46.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.852 -0.793 . . . . 0.0 108.987 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.8 ' HA ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -104.79 18.78 21.68 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.976 0.893 . . . . 0.0 108.853 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 47' ' ' ILE . 53.6 p -105.17 166.31 10.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.131 -0.981 . . . . 0.0 110.604 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.556 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 6.8 mt-10 -48.4 -59.9 3.1 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 109.503 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -57.05 -25.94 59.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.588 -1.32 . . . . 0.0 110.976 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 41' ' ' MET . . . -69.31 -70.21 0.29 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.973 -1.079 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.69 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.4 tt -63.0 -27.4 43.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 121.859 0.838 . . . . 0.0 109.262 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.569 HG13 ' CB ' ' A' ' 74' ' ' ALA . 31.2 mt -64.86 -22.38 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.686 -0.634 . . . . 0.0 109.343 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -91.93 -56.7 2.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.912 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 5.7 pm0 -59.68 -14.46 14.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.201 -1.562 . . . . 0.0 109.186 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.71 HG12 ' HB2' ' A' ' 61' ' ' PHE . 57.4 t -101.27 -41.09 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.284 -0.885 . . . . 0.0 110.712 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.608 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 1.0 OUTLIER -59.79 -14.69 15.84 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.892 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.625 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.72 25.51 0.51 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.605 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 57.91 -140.8 45.76 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.8 135.1 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 14.8 m120 63.62 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.54 45.38 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.554 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.698 ' HE2' ' HA ' ' A' ' 51' ' ' VAL . 10.9 ttt -127.45 144.8 52.19 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 110.107 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.684 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.3 Cg_endo -76.85 116.32 4.22 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.299 2.666 . . . . 0.0 114.261 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.83 162.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.092 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.722 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 25.8 m-85 -143.61 7.21 1.48 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.245 -0.909 . . . . 0.0 110.053 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.54 -20.41 4.96 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.195 -0.94 . . . . 0.0 108.774 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.45 27.4 1.36 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.722 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 6.0 mmt85 -101.32 -44.73 5.55 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.803 HD22 ' CG ' ' A' ' 13' ' ' ASN . 7.9 mt -87.07 -152.93 0.2 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.29 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.575 HG22 ' N ' ' A' ' 67' ' ' ASP . 31.3 m -99.43 164.86 11.92 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.72 ' HA ' HD12 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -63.15 -57.37 10.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.443 1.116 . . . . 0.0 108.032 178.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.579 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.2 tt0 -64.18 2.92 0.49 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.354 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.861 ' CB ' HG21 ' A' ' 9' ' ' VAL . 1.3 mp0 -115.18 -26.48 7.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.851 -1.156 . . . . 0.0 109.2 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 67' ' ' ASP . 2.6 mt -59.31 -19.53 16.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.5 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.6 mp0 -97.58 -71.28 0.69 Allowed 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.497 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.631 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 24.6 m-20 -47.36 -46.41 25.67 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.979 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.692 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -62.17 -31.26 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.426 0.631 . . . . 0.0 110.546 -178.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.665 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.67 -62.14 1.64 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.97 -22.07 13.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.82 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.6 t80 -62.76 -45.57 92.06 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.716 HG13 ' HZ2' ' A' ' 85' ' ' TRP . 72.4 t -67.29 -27.47 39.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.794 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -81.24 -9.32 59.8 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.236 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.458 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.0 t70 -100.29 -33.52 10.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.133 0.968 . . . . 0.0 109.714 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.637 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 2.8 mm100 -77.24 -38.39 51.2 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -71.88 -17.22 62.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.27 10.0 23.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 111.101 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -164.26 37.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.965 -1.494 . . . . 0.0 112.728 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 85.1 77.08 1.19 Allowed Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.764 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.716 ' HZ2' HG13 ' A' ' 77' ' ' VAL . 4.0 m95 -36.08 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.546 0.688 . . . . 0.0 109.185 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.3 -1.578 0 O-C-N 121.603 -0.686 . . . . 0.0 109.841 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.434 HD23 ' C ' ' A' ' 75' ' ' ALA . 1.5 mp -75.65 -14.77 60.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.21 68.52 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.529 ' O ' ' HE2' ' A' ' 8' ' ' LYS . 1.3 m-20 -80.33 -30.35 38.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.548 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -53.86 -48.33 62.49 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.807 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -58.94 -28.27 66.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.82 -0.812 . . . . 0.0 109.8 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.71 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -68.59 -28.15 66.68 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.008 -1.058 . . . . 0.0 108.717 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.081 HG21 ' CB ' ' A' ' 69' ' ' GLN . 41.1 t -100.16 -18.56 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.454 -0.779 . . . . 0.0 110.479 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.607 ' HE2' HD12 ' A' ' 31' ' ' LEU . 12.7 t80 -97.03 -19.93 18.39 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.89 -1.131 . . . . 0.0 109.694 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -99.38 7.46 45.51 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.664 -0.648 . . . . 0.0 109.584 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.18 2.28 2.58 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.04 -62.44 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.129 -1.218 . . . . 0.0 108.742 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.535 ' SG ' HG21 ' A' ' 73' ' ' VAL . 6.8 m -60.89 -34.49 74.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.626 ' HB1' ' HG2' ' A' ' 19' ' ' MET . . . -54.93 -36.21 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 110.124 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.01 -44.74 74.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.392 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 92.8 m -109.0 13.53 24.61 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.914 ' CD2' HD21 ' A' ' 31' ' ' LEU . 77.6 m80 -160.92 38.94 0.15 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.626 ' HG2' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -63.0 141.09 58.9 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.62 45.79 8.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 42.32 68.05 0.79 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -147.61 96.53 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 22' ' ' GLY . 1.2 t-20 -43.9 139.9 2.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -1.142 . . . . 0.0 109.289 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 4.4 m -105.68 -17.8 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 0.0 110.104 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -98.83 -69.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 0.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 18.4 mmt -84.22 149.79 25.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -107.15 71.91 0.85 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.301 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.824 HD21 ' HE2' ' A' ' 39' ' ' PHE . 11.7 p-10 179.6 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.328 -0.857 . . . . 0.0 109.332 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.588 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.5 mptt -89.7 91.28 8.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 0.0 109.312 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.008 ' C ' HD22 ' A' ' 36' ' ' LEU . 1.8 m -98.76 -169.46 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 0.0 109.079 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.914 HD21 ' CD2' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -105.69 -6.51 19.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.73 -1.231 . . . . 0.0 109.576 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -54.38 -88.45 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.371 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.848 ' HG2' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER 167.11 -38.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.844 -1.16 . . . . 0.0 110.692 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG3' ' HE2' ' A' ' 33' ' ' LYS . 85.9 mt-10 -54.38 -28.25 42.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 110.036 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.565 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -107.43 -57.74 2.05 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.053 0.93 . . . . 0.0 110.495 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.008 HD22 ' C ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -62.05 -43.5 98.71 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.42 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.555 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 56.7 tt0 -69.04 -19.49 64.1 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.529 -1.357 . . . . 0.0 108.868 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 3.8 tp-100 -77.83 -83.83 0.08 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.847 0.832 . . . . 0.0 109.389 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.824 ' HE2' HD21 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -91.41 5.1 50.7 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.639 0.733 . . . . 0.0 110.598 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -108.69 -21.21 7.64 Favored Glycine 0 C--N 1.289 -2.062 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.02 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.94 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 51.64 69.32 0.68 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.742 ' CE2' HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -86.29 -3.73 59.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.179 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.501 ' O ' HG22 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -45.35 162.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.252 -0.905 . . . . 0.0 111.013 -179.004 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.799 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -46.86 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.009 -1.057 . . . . 0.0 109.518 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.551 ' N ' HD12 ' A' ' 48' ' ' ILE . 29.2 t0 -54.64 -17.04 2.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.786 -1.196 . . . . 0.0 110.66 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.94 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -81.04 -79.76 0.15 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.977 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.7 tt -54.27 -20.76 5.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.73 -1.231 . . . . 0.0 109.656 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.799 HD12 ' C ' ' A' ' 44' ' ' GLU . 10.3 mt -59.92 -43.12 91.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.628 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 20.0 t80 -80.5 -16.89 53.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.64 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 4.4 tp60 -86.47 -8.16 57.82 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.643 -1.286 . . . . 0.0 107.925 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 47' ' ' ILE . 42.1 t -108.48 -33.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.848 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -70.22 -7.55 42.93 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.745 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -165.96 38.24 0.05 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.522 -178.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 47.5 -133.67 14.94 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.95 132.75 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 57.6 m-80 62.05 -88.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.92 50.86 2.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 108.971 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.665 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 24.7 ttt -124.43 142.13 39.5 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 109.065 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.665 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 26.4 Cg_endo -68.34 104.17 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.804 2.336 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.745 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -59.22 118.33 5.78 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.78 ' CE2' HD21 ' A' ' 65' ' ' LEU . 13.2 m-85 -86.29 -49.41 7.7 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.93 -1.106 . . . . 0.0 108.211 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.58 26.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.22 0.533 . . . . 0.0 109.808 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.51 32.55 0.66 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.588 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.84 -48.69 4.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.028 HD13 HG11 ' A' ' 9' ' ' VAL . 29.5 mt -62.52 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.574 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 3.0 m -98.3 -54.92 2.91 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.109 -0.995 . . . . 0.0 108.956 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 66' ' ' THR . 2.6 m-20 150.87 -59.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 68.8 mm-40 -67.06 -1.84 4.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.04 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 1.081 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -112.05 -29.76 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.96 HD13 HD12 ' A' ' 65' ' ' LEU . 39.6 mm -57.05 -20.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.492 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.1 mt-30 -100.15 -64.19 1.06 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.584 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.639 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 34.5 m-20 -52.15 -48.66 64.79 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.089 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 69' ' ' GLN . 2.2 p -54.53 -27.21 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.918 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.751 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -81.27 -66.41 0.89 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' C ' HD23 ' A' ' 3' ' ' LEU . . . -50.1 -23.77 2.33 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.163 -1.586 . . . . 0.0 107.392 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.807 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.1 t80 -63.55 -47.6 80.92 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.2 p -65.4 -25.59 37.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.742 HD22 ' CE2' ' A' ' 42' ' ' TYR . 1.1 mt -77.34 -9.87 59.1 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.964 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.99 -43.73 6.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.051 0.929 . . . . 0.0 109.411 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.603 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 18.4 mm-40 -65.94 -44.82 83.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.848 ' HB1' ' HG2' ' A' ' 33' ' ' LYS . . . -68.78 -11.36 60.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.3 7.01 37.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 111.005 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -175.09 46.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.235 -1.541 . . . . 0.0 112.739 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.602 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 88.5 76.7 1.29 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.869 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.714 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -39.93 83.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 109.541 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 25.7 t0 . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.011 HD13 ' HA ' ' A' ' 76' ' ' TYR . 2.4 pp -68.83 -0.2 5.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.905 -1.122 . . . . 0.0 108.971 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.543 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.7 t-20 -47.63 -28.69 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.51 -57.74 17.89 Favored Glycine 0 C--O 1.199 -2.034 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -45.93 -28.16 1.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.761 -1.435 . . . . 0.0 110.066 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.775 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.05 -46.25 71.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.044 HG21 ' CB ' ' A' ' 69' ' ' GLN . 24.6 t -73.49 -51.76 24.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.819 -0.551 . . . . 0.0 110.115 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 6.1 t80 -62.5 -28.85 70.12 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.717 -1.239 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 47.0 t -84.09 15.15 3.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.878 . . . . 0.0 109.701 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.63 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -160.95 11.95 0.14 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 6.7 m120 -156.43 -54.08 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.449 . . . . 0.0 108.831 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.677 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -74.06 -26.15 60.24 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.499 0.666 . . . . 0.0 109.287 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -57.57 -39.51 76.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.574 -0.704 . . . . 0.0 110.393 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.94 62.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.136 -0.977 . . . . 0.0 111.057 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' HA ' HG22 ' A' ' 24' ' ' VAL . 99.9 m -124.79 8.81 8.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.826 -1.171 . . . . 0.0 110.691 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.727 ' CG ' HD22 ' A' ' 31' ' ' LEU . 87.8 m-70 -150.12 -65.45 0.21 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.136 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.478 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 1.2 ttt 56.25 113.08 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.269 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 39.42 60.35 1.71 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.646 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 49.43 73.33 0.37 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -155.72 81.43 0.17 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.643 ' H ' HG23 ' A' ' 30' ' ' THR . 1.6 t-20 -54.61 163.26 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.249 . . . . 0.0 109.223 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 17' ' ' CYS . 6.3 m -144.4 17.11 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.041 . . . . 0.0 109.889 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.58 -55.99 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.098 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.47 -172.51 1.82 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -134.39 46.47 2.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.102 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 9.6 p-10 178.2 -44.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 109.366 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 2.0 mttp -74.18 110.62 8.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.557 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.769 HG22 ' H ' ' A' ' 32' ' ' LYS . 92.3 m -133.43 149.33 51.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.317 -0.865 . . . . 0.0 109.25 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.745 ' HG ' HG11 ' A' ' 77' ' ' VAL . 5.9 mp -74.95 -18.67 60.35 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.848 -0.533 . . . . 0.0 111.096 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.769 ' H ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -40.61 -82.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.476 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.558 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 0.4 OUTLIER 174.72 -42.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.548 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 3.7 mm-40 -56.1 -34.85 66.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.584 -0.697 . . . . 0.0 109.594 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -99.17 -39.53 8.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.408 -0.808 . . . . 0.0 110.369 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.845 HD11 ' HD2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -69.75 -10.28 57.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.554 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 17.1 mt-10 -118.78 3.78 11.6 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 21.0 tp60 -83.59 -51.15 7.55 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.588 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -86.67 -35.54 19.27 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.779 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.63 51.75 0.24 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.955 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.749 ' HE3' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -112.13 8.07 19.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.017 -1.284 . . . . 0.0 108.747 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.845 ' HD2' HD11 ' A' ' 36' ' ' LEU . 41.0 t80 -69.43 10.78 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.991 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.3 p -105.7 143.85 33.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.548 -1.345 . . . . 0.0 110.179 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.539 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 5.1 mt-10 -46.28 -58.45 3.68 Favored 'General case' 0 C--O 1.203 -1.355 0 O-C-N 121.379 -0.826 . . . . 0.0 109.29 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 45' ' ' ASP . 9.3 t0 -47.88 -37.19 13.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -0.963 . . . . 0.0 110.829 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.07 -70.27 0.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.811 HG23 ' HB1' ' A' ' 74' ' ' ALA . 15.3 tt -66.06 -9.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.891 0.853 . . . . 0.0 109.884 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CD1' ' HB3' ' A' ' 44' ' ' GLU . 22.3 mt -87.57 -25.53 6.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.482 ' OH ' ' HE2' ' A' ' 55' ' ' LYS . 25.6 t80 -88.72 -23.39 22.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 1.045 ' NE2' HG23 ' A' ' 51' ' ' VAL . 4.2 pp0? -94.17 -26.45 16.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.438 -1.414 . . . . 0.0 108.289 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.045 HG23 ' NE2' ' A' ' 50' ' ' GLN . 2.9 t -75.02 -49.51 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.885 0.85 . . . . 0.0 109.01 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.789 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.7 OUTLIER -64.91 -12.53 50.29 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.809 -0.557 . . . . 0.0 111.525 -177.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.789 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -147.46 13.24 1.06 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.58 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.703 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.19 -136.09 24.81 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 106.754 -2.539 . . . . 0.0 106.754 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 149.94 141.09 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 50.32 -90.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -129.35 49.39 2.25 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.636 ' HE1' ' HA ' ' A' ' 51' ' ' VAL . 7.1 ttt -125.2 146.48 54.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.596 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.2 Cg_endo -80.97 107.82 1.97 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 123.363 2.709 . . . . 0.0 114.81 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.703 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -40.79 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 111.135 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 59' ' ' PRO . 56.0 m-85 -150.25 14.34 0.79 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . . . -47.17 -28.49 1.85 Allowed 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.263 -0.898 . . . . 0.0 109.136 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.32 35.05 0.52 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.3 -42.99 6.1 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.907 HD12 HD13 ' A' ' 70' ' ' ILE . 21.1 mt -77.09 -143.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.582 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 3.0 m -98.22 -59.45 1.75 Allowed 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.5 OUTLIER 153.26 -55.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 12.4 tt0 -68.79 -1.48 7.2 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 1.044 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -108.35 -31.35 7.89 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 HD12 ' A' ' 65' ' ' LEU . 23.6 mm -57.54 -20.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.473 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.8 mp0 -99.09 -71.0 0.71 Allowed 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.01 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 87.5 m-20 -45.72 -49.77 14.39 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.176 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -60.75 -32.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.505 0.669 . . . . 0.0 110.082 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -69.82 -65.51 0.71 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.203 -1.561 . . . . 0.0 106.856 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.482 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.05 -21.86 9.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.011 ' HA ' HD13 ' A' ' 3' ' ' LEU . 62.5 t80 -63.84 -45.1 91.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.603 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.745 HG11 ' HG ' ' A' ' 31' ' ' LEU . 60.7 t -68.89 -25.22 29.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.823 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -82.65 -9.05 59.55 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.037 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 10.9 t0 -99.35 -34.52 10.27 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.653 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 4.4 mm-40 -78.57 -34.57 46.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.377 0.608 . . . . 0.0 110.003 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.595 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -65.17 -43.61 91.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.366 -0.834 . . . . 0.0 109.792 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.94 14.83 11.15 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.284 -0.885 . . . . 0.0 110.85 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 12.8 ptmt -142.86 23.57 1.9 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.512 -1.367 . . . . 0.0 111.665 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 87.3 72.6 1.29 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.032 -1.556 . . . . 0.0 109.756 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.684 ' HZ2' HG13 ' A' ' 77' ' ' VAL . 1.1 m95 -40.85 85.06 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.202 -0.587 . . . . 0.0 110.797 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.133 -0.979 . . . . 0.0 109.485 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 5.2 m-20 . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.094 HD23 ' HA ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -75.69 2.6 11.58 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.308 177.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.583 ' N ' HD13 ' A' ' 3' ' ' LEU . . . -59.92 -42.49 94.05 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.505 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.5 t-20 -51.34 -32.88 27.12 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -54.49 -47.51 69.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.81 -33.45 10.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.657 -1.496 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.03 -43.99 81.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.65 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.769 ' CG1' HD13 ' A' ' 65' ' ' LEU . 18.3 t -62.43 -72.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.632 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 16.0 t80 -49.72 -26.62 3.96 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.703 -0.623 . . . . 0.0 111.237 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 19.6 t -92.35 31.38 1.32 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 109.008 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.33 -46.18 1.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.83 -1.394 . . . . 0.0 109.563 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.632 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.5 m -76.48 -25.02 53.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.746 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -59.3 -35.49 73.88 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.805 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.87 97.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.35 -0.844 . . . . 0.0 111.64 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.575 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -108.26 26.48 10.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.757 -1.214 . . . . 0.0 109.494 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.707 ' NE2' HD21 ' A' ' 31' ' ' LEU . 76.3 m80 -160.02 -54.5 0.06 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.234 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 18' ' ' HIS . 3.9 ptp 39.41 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.479 0.657 . . . . 0.0 110.794 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 67.6 52.23 31.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 41.72 57.39 3.39 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.644 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -147.26 86.63 0.16 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.512 ' HB3' ' CE ' ' A' ' 26' ' ' MET . 2.9 t-20 -51.13 159.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -1.096 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.84 -10.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 26' ' ' MET . 18.1 t -100.2 -62.78 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.074 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.512 ' CE ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -51.53 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.847 . . . . 0.0 109.773 179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.44 -8.53 10.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -153.33 -37.65 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.278 -0.888 . . . . 0.0 109.586 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 39' ' ' PHE . 5.9 tptt -46.21 90.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.485 -0.76 . . . . 0.0 109.804 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.644 HG23 ' HA2' ' A' ' 22' ' ' GLY . 7.1 m -117.63 151.55 36.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.865 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -78.88 -7.73 58.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.324 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HD3' HG21 ' A' ' 30' ' ' THR . 1.1 mtpt -51.52 162.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.529 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.581 ' CA ' ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.02 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -61.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 110.733 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.58 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.99 -35.62 69.53 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 111.239 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.826 HD23 ' O ' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -64.74 -43.43 93.39 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.854 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.572 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -90.68 13.23 16.65 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.187 -0.946 . . . . 0.0 109.129 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 16.8 tp60 -82.21 -49.82 9.68 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.599 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -87.07 -42.73 12.83 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.333 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.87 82.13 0.4 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.766 ' HE3' ' HA ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -158.68 24.53 0.23 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.286 -1.126 . . . . 0.0 108.496 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.718 ' HB2' HD11 ' A' ' 36' ' ' LEU . 43.3 t80 -84.38 15.83 3.42 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.494 0.664 . . . . 0.0 109.225 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.61 134.39 47.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.791 -1.193 . . . . 0.0 111.126 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -45.07 -59.76 2.44 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -48.03 -37.98 16.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.064 -1.022 . . . . 0.0 110.492 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.9 -73.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.7 tt -65.28 -9.52 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.531 -0.73 . . . . 0.0 110.338 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 44' ' ' GLU . 9.1 mt -78.91 -35.57 18.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 37.0 t80 -91.08 -14.41 31.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 1.1 tp60 -90.63 -17.57 26.64 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 47' ' ' ILE . 68.5 t -94.27 -45.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.763 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -62.79 -9.78 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.597 -0.69 . . . . 0.0 110.949 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.763 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -153.98 22.25 0.51 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.622 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 54.58 -133.44 47.01 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.75 135.75 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 121.389 0.614 . . . . 0.0 109.545 178.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m120 54.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.01 55.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.698 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.656 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 9.8 ttt -142.85 142.51 22.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 109.116 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.656 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 29.5 Cg_endo -75.07 117.21 4.82 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 123.385 2.723 . . . . 0.0 115.036 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.67 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -43.07 164.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.768 ' HB3' HD11 ' A' ' 70' ' ' ILE . 49.4 m-85 -143.12 12.63 1.81 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.44 -0.788 . . . . 0.0 109.433 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.93 -26.09 0.25 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.416 -0.802 . . . . 0.0 108.899 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -151.44 35.31 0.88 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.683 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt85 -103.38 -50.98 3.32 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.781 HD12 HD13 ' A' ' 70' ' ' ILE . 5.9 mt -86.81 -157.59 0.38 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 67' ' ' ASP . 5.6 m -100.88 -179.09 3.96 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.704 ' H ' HG22 ' A' ' 66' ' ' THR . 3.0 m-20 -76.34 -59.51 2.74 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.678 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.556 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 8.0 tt0 -66.22 -7.68 19.76 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.709 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -95.39 -34.94 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.781 HD13 HD12 ' A' ' 65' ' ' LEU . 4.3 mm -67.91 -14.47 18.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.448 ' OE1' HG22 ' A' ' 70' ' ' ILE . 2.3 mp0 -98.7 -71.57 0.69 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.465 1.126 . . . . 0.0 109.071 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.706 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 58.9 m-20 -47.42 -38.6 13.73 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.89 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.74 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 3.5 p -66.52 -36.79 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.704 0.764 . . . . 0.0 109.885 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.728 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -68.35 -60.21 2.61 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 119.949 -1.719 . . . . 0.0 106.401 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.38 -20.63 45.63 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.094 ' HA ' HD23 ' A' ' 3' ' ' LEU . 84.3 t80 -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 31' ' ' LEU . 43.9 t -70.62 -27.02 29.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.786 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -83.63 -8.03 59.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.281 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 3.1 t70 -98.79 -43.38 6.79 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.178 0.989 . . . . 0.0 109.039 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.675 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -70.32 -35.68 73.8 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.951 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.581 ' HB1' ' CA ' ' A' ' 33' ' ' LYS . . . -59.44 -50.91 72.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 108.392 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.84 16.77 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.659 -0.651 . . . . 0.0 109.857 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 26.6 tttm -132.11 13.18 4.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 111.297 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 81.9 72.66 1.24 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.675 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 7.5 m95 -38.71 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.14 0.495 . . . . 0.0 110.508 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.943 . . . . 0.0 109.421 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 6.2 m-20 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.0 HD13 ' HA ' ' A' ' 76' ' ' TYR . 2.0 pp -70.62 3.92 2.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.64 ' CA ' ' HD3' ' A' ' 8' ' ' LYS . 1.4 m-20 -75.0 -1.68 23.81 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.645 ' HA2' HG23 ' A' ' 73' ' ' VAL . . . -86.27 -46.91 5.13 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.919 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -56.14 -46.57 79.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.857 -0.79 . . . . 0.0 108.877 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.798 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -51.04 -33.44 25.47 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.964 HG21 ' HG2' ' A' ' 69' ' ' GLN . 59.6 t -96.62 -15.7 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.215 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 11.0 t80 -84.76 -28.05 26.5 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 117.589 -1.644 . . . . 0.0 109.793 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -86.63 15.09 5.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.808 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.34 2.02 1.27 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.487 HD21 ' HD3' ' A' ' 64' ' ' ARG . 4.8 m120 -143.51 -50.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.805 -1.409 . . . . 0.0 109.114 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.5 m -77.11 -32.11 56.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.426 -0.797 . . . . 0.0 108.875 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HA ' ' N ' ' A' ' 19' ' ' MET . . . -45.77 -40.87 10.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.661 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.72 -46.3 77.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.097 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.594 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 80.3 m -116.12 27.81 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 110.33 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.594 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 60.5 m80 -159.93 -76.41 0.07 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.215 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.55 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 55.1 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.595 0.712 . . . . 0.0 110.668 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.95 45.17 9.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.593 ' HA3' ' CD2' ' A' ' 85' ' ' TRP . . . 48.64 68.27 1.35 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.497 ' HA2' ' OG1' ' A' ' 30' ' ' THR . . . -151.78 86.8 0.14 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.8 t-20 -55.33 161.47 1.86 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.976 -1.308 . . . . 0.0 109.305 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 25' ' ' VAL . 16.4 m -136.5 -52.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.573 ' N ' HG23 ' A' ' 24' ' ' VAL . 44.8 t -45.79 -61.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.175 -0.953 . . . . 0.0 108.781 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -53.41 -170.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 109.109 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.71 1.25 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.097 . . . . 0.0 110.289 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -156.9 -30.83 0.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.038 -1.039 . . . . 0.0 110.729 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 11.9 mttt -75.93 101.16 5.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.969 -1.082 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.91 ' C ' HD22 ' A' ' 36' ' ' LEU . 10.3 t -93.88 -146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 108.492 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.609 ' N ' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -118.41 -11.11 10.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.482 -1.386 . . . . 0.0 109.615 179.133 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.757 ' H ' HG23 ' A' ' 30' ' ' THR . 5.2 mtpt -50.02 -86.9 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.846 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 165.04 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.984 -1.072 . . . . 0.0 109.956 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -53.14 -27.19 19.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 109.718 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.931 ' HB1' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.86 -67.33 0.95 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.273 -0.892 . . . . 0.0 110.532 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.984 HD12 ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -54.39 -35.85 63.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.645 -0.659 . . . . 0.0 111.335 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 2.0 tt0 -69.33 -30.79 68.9 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.306 -1.496 . . . . 0.0 110.183 -178.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -78.55 -64.55 1.15 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.245 -0.909 . . . . 0.0 109.925 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CZ ' ' HB1' ' A' ' 35' ' ' ALA . 2.0 p90 -93.99 -20.19 20.2 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.537 0.684 . . . . 0.0 110.627 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.578 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -89.42 -19.11 50.7 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.031 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . 1.117 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 49.48 71.23 0.4 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -177.101 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.984 ' CG ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -101.69 -6.08 24.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.485 -176.506 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.811 ' N ' ' HB3' ' A' ' 46' ' ' ALA . 2.6 p -48.74 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.781 -1.199 . . . . 0.0 110.223 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.698 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -43.61 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.92 -1.112 . . . . 0.0 109.668 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.416 ' N ' HD12 ' A' ' 48' ' ' ILE . 32.6 t0 -52.67 -19.78 2.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.891 -1.131 . . . . 0.0 110.286 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 1.117 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -74.37 -82.11 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.395 -0.816 . . . . 0.0 110.262 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.813 HD13 HG11 ' A' ' 77' ' ' VAL . 12.1 tt -48.77 -33.52 5.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 O-C-N 121.283 -0.886 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 44' ' ' GLU . 74.7 mt -56.31 -41.23 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.596 -0.69 . . . . 0.0 110.058 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -78.69 -25.7 44.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.561 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.625 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 6.3 pm0 -93.71 -3.71 51.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.087 -1.633 . . . . 0.0 108.896 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 47' ' ' ILE . 25.1 t -94.8 -48.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.779 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 3.0 mt-30 -64.49 -8.32 13.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.867 -0.521 . . . . 0.0 110.167 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.779 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -155.62 21.45 0.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.838 -1.145 . . . . 0.0 108.772 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.592 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 51.89 -131.1 36.44 Favored Glycine 0 C--N 1.3 -1.419 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.582 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 150.04 142.31 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.201 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 53.94 -89.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.53 42.63 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.582 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 21.4 ttt -119.63 142.19 32.39 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.225 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.571 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 37.0 Cg_endo -81.26 108.82 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.914 2.409 . . . . 0.0 113.406 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.634 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.7 163.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.761 . . . . 0.0 110.286 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 11.2 m-85 -145.74 14.43 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.22 -10.8 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.907 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.19 -4.34 7.78 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.487 ' HD3' HD21 ' A' ' 13' ' ' ASN . 4.2 ttt180 -106.82 -61.64 1.51 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.008 ' CD1' HG21 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -64.62 105.8 1.04 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.58 HG22 ' N ' ' A' ' 67' ' ' ASP . 86.2 m -39.3 166.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.294 0.569 . . . . 0.0 109.564 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.58 ' N ' HG22 ' A' ' 66' ' ' THR . 15.1 t0 -57.74 -57.75 11.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.989 -1.069 . . . . 0.0 108.42 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.5 mm-40 -65.87 10.81 0.09 Allowed 'General case' 0 C--O 1.193 -1.917 0 O-C-N 121.755 -0.59 . . . . 0.0 109.887 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.964 ' HG2' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -104.4 -44.66 4.87 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.681 HG22 HG23 ' A' ' 48' ' ' ILE . 18.9 mm -53.0 -22.09 3.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 1.5 mp0 -94.45 -73.34 0.58 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 76' ' ' TYR . 98.2 m-20 -44.82 -64.69 0.65 Allowed 'General case' 0 C--O 1.186 -2.27 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.286 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.008 HG21 ' CD1' ' A' ' 65' ' ' LEU . 2.3 t -49.15 -29.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.096 -1.003 . . . . 0.0 110.269 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.808 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -79.94 -74.18 0.31 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.694 -1.254 . . . . 0.0 108.118 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -46.56 -23.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.966 -1.709 . . . . 0.0 107.784 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.0 ' HA ' HD13 ' A' ' 3' ' ' LEU . 40.9 t80 -60.41 -53.13 61.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.274 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.85 HG22 ' HE2' ' A' ' 42' ' ' TYR . 1.9 p -64.47 -25.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.703 HD23 HG13 ' A' ' 77' ' ' VAL . 2.8 mt -78.5 -9.67 59.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.49 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 3.0 t0 -99.57 -41.49 7.32 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.0 0.905 . . . . 0.0 109.059 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.645 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 9.3 mm-40 -69.53 -47.48 63.59 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.381 0.61 . . . . 0.0 109.956 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -68.5 -16.02 63.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.44 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.61 8.68 27.17 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 110.889 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -171.69 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.47 77.27 1.33 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.02 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.825 ' HZ2' HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -40.36 84.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.319 -0.518 . . . . 0.0 110.596 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.858 -1.151 . . . . 0.0 109.029 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.453 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 9.7 m-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.98 0.419 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.875 HD11 ' HA ' ' A' ' 76' ' ' TYR . 1.0 OUTLIER -77.2 7.39 5.17 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.937 -1.102 . . . . 0.0 109.738 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.98 -24.31 59.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.562 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 68.3 m-20 -84.39 -6.03 59.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.445 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.582 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -87.74 -61.74 1.5 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 106.674 -2.571 . . . . 0.0 106.674 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.865 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -40.67 -37.81 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.128 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.923 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -61.84 -48.63 79.71 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 65' ' ' LEU . 87.9 t -63.68 -59.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -0.773 . . . . 0.0 111.814 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.823 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 46.0 t80 -54.92 -42.59 72.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.732 -1.23 . . . . 0.0 112.261 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -84.29 19.58 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.58 -1.325 . . . . 0.0 110.365 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -147.16 0.77 0.72 Allowed Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.541 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -156.23 -48.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.569 -1.548 . . . . 0.0 110.035 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.4 m -71.99 -36.12 69.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 19' ' ' MET . . . -51.55 -38.1 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.442 -0.786 . . . . 0.0 110.089 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.01 69.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.956 -1.09 . . . . 0.0 109.257 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.569 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 82.3 m -119.43 20.28 12.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.441 -0.787 . . . . 0.0 109.506 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 93.3 m-70 -159.87 21.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.436 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.34 153.36 7.31 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.656 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 43.46 33.53 2.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 46.39 57.99 6.14 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.676 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -146.76 91.89 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 2.2 t-20 -41.77 142.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.457 -1.026 . . . . 0.0 109.865 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.11 -1.24 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.447 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.54 -66.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mmt -65.39 130.67 44.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.319 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 28' ' ' ASN . . . -85.08 48.32 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 27' ' ' ALA . 1.8 p-10 175.3 -59.7 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HD3' ' CE ' ' A' ' 41' ' ' MET . 7.6 mttp -51.71 102.8 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.213 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.698 HG21 ' HD3' ' A' ' 32' ' ' LYS . 3.7 m -113.32 177.44 4.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.688 ' H ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -94.71 -18.93 20.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.798 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 1.004 ' C ' HD21 ' A' ' 36' ' ' LEU . 14.8 mtpt -58.16 -113.63 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 110.295 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.761 ' N ' HD21 ' A' ' 36' ' ' LEU . 22.7 ttpt -155.44 -29.61 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.677 -1.264 . . . . 0.0 110.871 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 12.3 pt-20 -59.97 -28.91 68.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.729 -1.232 . . . . 0.0 111.193 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.631 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -102.25 -48.57 4.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.001 -1.062 . . . . 0.0 110.818 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.004 HD21 ' C ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -61.07 -34.56 75.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.923 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.2 mm-40 -93.1 6.02 49.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 3.0 tp-100 -89.74 -51.1 5.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.62 -50.27 6.93 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.486 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.81 91.45 0.48 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.507 ' CE ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -174.12 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.12 . . . . 0.0 109.474 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.942 ' CG ' HD12 ' A' ' 36' ' ' LEU . 4.1 t80 -105.62 28.57 7.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 109.816 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 p -106.73 143.11 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.359 -0.838 . . . . 0.0 110.569 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.54 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -50.53 -59.15 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 109.834 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.35 -28.62 8.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.526 -1.359 . . . . 0.0 110.568 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.61 -73.66 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 110.321 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.845 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.1 tt -61.16 -13.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 110.358 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.719 HG23 HG22 ' A' ' 70' ' ' ILE . 14.5 mt -73.41 -35.99 47.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 31.0 t80 -91.11 -14.44 31.21 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.565 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 4.5 tp60 -88.79 -17.07 30.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 47' ' ' ILE . 72.2 t -93.77 -43.62 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.817 0.818 . . . . 0.0 109.985 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.808 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -62.72 -10.54 13.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 0.0 110.18 -178.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.808 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -158.36 30.97 0.24 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.357 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.591 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 49.96 -132.99 28.16 Favored Glycine 0 C--N 1.299 -1.524 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 151.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 19.7 m120 69.05 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.48 14.95 6.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 109.202 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.646 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.4 ttt -89.63 142.3 29.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.263 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.646 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.3 Cg_endo -74.25 97.2 1.0 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.906 2.404 . . . . 0.0 114.647 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.664 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -46.94 119.16 2.38 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 63' ' ' GLY . 57.1 m-85 -88.24 -49.87 6.71 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.999 -1.063 . . . . 0.0 108.747 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 28.05 40.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.35 0.595 . . . . 0.0 110.376 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 167.61 -24.18 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.521 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -93.83 -30.92 14.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.95 HD11 HG11 ' A' ' 9' ' ' VAL . 1.7 mm? -91.45 94.51 9.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.666 ' HB ' ' NE2' ' A' ' 69' ' ' GLN . 21.0 m -41.03 168.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.616 ' N ' HG22 ' A' ' 66' ' ' THR . 0.1 OUTLIER -57.15 -61.2 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.522 -1.361 . . . . 0.0 108.487 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 mt-10 -60.68 3.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.777 -0.577 . . . . 0.0 110.604 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.882 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -102.94 -45.15 5.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.719 HG22 HG23 ' A' ' 48' ' ' ILE . 33.6 mm -55.34 -22.66 12.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 1.6 mp0 -92.19 -65.71 0.98 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.103 0.954 . . . . 0.0 108.642 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 47.1 m-20 -49.62 -61.5 2.08 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 69' ' ' GLN . 3.3 p -45.5 -29.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.3 -0.875 . . . . 0.0 109.8 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.813 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -80.68 -71.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -45.52 -25.8 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.554 -1.341 . . . . 0.0 107.508 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.875 ' HA ' HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -59.08 -56.95 15.61 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.329 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 74' ' ' ALA . 2.6 p -62.37 -26.14 39.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.99 -1.069 . . . . 0.0 108.647 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 77' ' ' VAL . 5.1 mt -76.45 -10.76 59.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 2.0 t0 -99.47 -43.52 6.51 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.929 0.871 . . . . 0.0 109.218 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 59.6 mm-40 -67.3 -41.55 85.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.88 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.555 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -60.9 -47.3 87.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.143 -0.973 . . . . 0.0 109.063 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.11 8.45 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.573 -0.705 . . . . 0.0 109.843 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 6.9 tttm -129.84 12.84 5.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.079 -1.013 . . . . 0.0 110.974 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.0 76.71 0.98 Allowed Glycine 0 C--N 1.296 -1.681 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.728 ' HZ2' HG23 ' A' ' 77' ' ' VAL . 12.8 m95 -34.36 90.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.725 0.774 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 121.386 0.612 . . . . 0.0 109.446 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.803 HD13 ' OD2' ' A' ' 79' ' ' ASP . 1.2 mp -71.11 -3.36 19.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.053 -1.029 . . . . 0.0 109.454 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.71 -15.82 63.63 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.596 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -86.69 10.26 16.28 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -107.69 -36.33 2.43 Favored Glycine 0 C--O 1.201 -1.919 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -59.88 -12.63 8.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.659 -0.906 . . . . 0.0 109.884 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.596 ' CE ' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -87.13 -32.52 19.84 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.826 HG13 HD22 ' A' ' 65' ' ' LEU . 3.4 t -77.31 -29.55 16.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.595 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 32.2 t80 -100.33 -34.53 9.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 3.9 t -85.05 10.76 11.1 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.024 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.34 -6.74 0.72 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.173 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.563 ' CG ' HD21 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -147.23 -52.93 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.567 -1.549 . . . . 0.0 110.031 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.613 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 5.3 m -64.8 -29.31 70.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 110.035 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.84 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.846 -1.159 . . . . 0.0 109.294 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 84.8 m -120.7 14.78 11.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.224 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.582 ' CD2' ' CD2' ' A' ' 31' ' ' LEU . 76.9 m80 -158.63 26.74 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.765 . . . . 0.0 109.033 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -52.49 147.12 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.308 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 46.96 35.86 8.33 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 32' ' ' LYS . . . 48.47 53.0 17.75 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.73 122.06 2.52 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 26' ' ' MET . 3.7 t-20 -64.43 154.21 36.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -1.127 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.425 HG23 HG23 ' A' ' 25' ' ' VAL . 4.5 m -122.95 -22.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.12 -0.988 . . . . 0.0 110.244 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.425 HG23 HG23 ' A' ' 24' ' ' VAL . 13.4 t -103.07 -69.54 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.868 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.62 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -47.62 -37.26 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.42 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 26' ' ' MET . . . 71.32 40.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 26' ' ' MET . 1.3 p30 177.09 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.371 -0.83 . . . . 0.0 108.915 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.29 77.14 5.83 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.916 ' O ' HD22 ' A' ' 36' ' ' LEU . 9.3 t -83.23 -177.35 6.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.878 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.621 HD13 HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -100.78 -18.54 16.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 110.758 -179.043 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.597 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -61.07 -100.8 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.667 -1.271 . . . . 0.0 109.4 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.495 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 11.0 ptmm? -168.32 -38.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.642 -1.286 . . . . 0.0 110.797 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -41.16 -29.46 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 -178.76 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.858 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -110.25 -59.23 1.97 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 111.644 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -58.98 -7.72 1.16 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.728 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.598 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.4 mm-40 -107.08 -11.79 15.56 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.593 -1.317 . . . . 0.0 109.72 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 65.0 mm-40 -82.54 -40.54 20.82 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.858 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -84.96 -45.94 11.71 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.709 177.097 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 41' ' ' MET . . . 121.51 98.19 1.54 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER 170.08 37.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -1.085 . . . . 0.0 109.741 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.007 ' OH ' ' HB3' ' A' ' 81' ' ' ALA . 6.6 t80 -118.98 33.17 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.511 ' O ' ' HB ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -110.49 176.97 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.568 -0.708 . . . . 0.0 110.938 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.694 ' C ' HD12 ' A' ' 48' ' ' ILE . 3.6 mt-10 -69.89 -72.56 0.19 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -54.0 -36.37 62.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.566 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 50' ' ' GLN . . . -64.01 -74.41 0.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.067 -1.021 . . . . 0.0 109.498 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.016 ' O ' HG23 ' A' ' 51' ' ' VAL . 40.9 mt -53.9 -17.56 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.621 0.724 . . . . 0.0 109.264 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.694 HD12 ' C ' ' A' ' 44' ' ' GLU . 16.2 mt -80.82 -33.38 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.486 ' OH ' ' HE2' ' A' ' 55' ' ' LYS . 59.7 t80 -73.19 -23.07 60.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 108.536 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.589 ' CG ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -85.64 -33.65 21.56 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.391 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.016 HG23 ' O ' ' A' ' 47' ' ' ILE . 10.9 t -79.92 -36.67 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.779 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -72.23 -14.45 61.79 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.344 -0.848 . . . . 0.0 109.968 -178.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.779 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -159.33 31.54 0.2 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.012 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 48.04 -136.86 14.81 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 151.91 134.1 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.313 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.1 m-80 60.25 -88.91 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.473 -0.767 . . . . 0.0 108.978 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.27 41.58 3.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.615 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 21.4 ttt -119.04 143.49 34.01 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.615 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 30.3 Cg_endo -75.23 99.76 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.918 2.412 . . . . 0.0 114.27 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -57.07 118.27 4.84 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.654 -0.654 . . . . 0.0 110.458 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.602 ' CD2' ' HD2' ' A' ' 64' ' ' ARG . 25.1 m-85 -85.37 -52.27 5.99 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 37.58 28.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.424 0.631 . . . . 0.0 109.675 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 126.46 32.8 0.7 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.506 -1.837 . . . . 0.0 108.506 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.602 ' HD2' ' CD2' ' A' ' 61' ' ' PHE . 5.5 ttm-85 -101.67 -52.78 3.13 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.826 HD22 HG13 ' A' ' 9' ' ' VAL . 6.5 mt -79.92 -143.16 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.591 ' CB ' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -98.62 -166.9 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 121.085 -1.009 . . . . 0.0 109.494 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.37 -62.55 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.621 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.1 tt0 -71.41 2.61 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.668 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 2.6 mp0 -104.08 -32.03 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.623 HG21 ' HG3' ' A' ' 52' ' ' GLN . 7.5 mm -72.88 -21.84 19.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.43 -66.13 0.95 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 37.3 t0 -54.59 -36.92 64.94 Favored 'General case' 0 C--O 1.193 -1.902 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.409 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 9.9 p -61.69 -26.92 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.193 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.588 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -82.12 -59.11 2.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.62 -21.63 11.09 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.697 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 36.5 t80 -67.03 -45.12 78.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.366 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.675 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.1 p -69.6 -21.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.97 HD21 HD12 ' A' ' 47' ' ' ILE . 5.4 mt -77.97 -11.82 59.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.803 ' OD2' HD13 ' A' ' 3' ' ' LEU . 1.8 t0 -99.99 -37.52 8.97 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.888 0.851 . . . . 0.0 109.327 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.646 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 8.5 mm-40 -77.44 -35.28 54.12 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.876 -0.515 . . . . 0.0 110.395 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.007 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -61.0 -48.71 80.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.121 -0.987 . . . . 0.0 108.522 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.8 13.86 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.759 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 1.6 ttmm -130.79 13.69 5.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.96 -1.088 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 82.84 73.6 1.23 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.675 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 5.0 m95 -39.07 83.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.119 0.485 . . . . 0.0 110.592 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.97 0.414 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.505 ' CD2' ' HA ' ' A' ' 72' ' ' ASP . 10.1 mt -69.67 -8.3 46.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.933 -1.105 . . . . 0.0 109.057 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.23 -29.09 63.48 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.518 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.3 m-20 -67.91 -41.78 82.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 73' ' ' VAL . . . -47.21 -58.83 6.14 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.766 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -50.67 -37.65 42.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.338 . . . . 0.0 109.286 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.851 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -59.4 -41.1 88.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.204 -0.935 . . . . 0.0 108.58 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.068 HG21 ' CB ' ' A' ' 69' ' ' GLN . 21.9 t -81.23 -67.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 26.9 t80 -41.54 -26.63 0.07 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.288 -0.883 . . . . 0.0 109.851 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 36.6 m -76.71 -48.53 18.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.296 -0.877 . . . . 0.0 111.275 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.631 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -101.57 29.84 11.66 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.726 -1.225 . . . . 0.0 111.739 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.631 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 13.6 m120 -155.03 -29.3 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.783 -1.422 . . . . 0.0 110.771 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.612 ' SG ' ' CZ ' ' A' ' 61' ' ' PHE . 79.6 m -127.91 -11.18 5.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.903 -1.123 . . . . 0.0 111.316 -177.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -51.69 -32.04 28.29 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.32 78.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.382 -0.824 . . . . 0.0 110.699 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.63 18.7 18.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.739 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.82 ' NE2' HD21 ' A' ' 31' ' ' LEU . 34.7 m80 -158.61 -64.91 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.929 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' A' ' 18' ' ' HIS . 4.9 ptt? 38.66 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.318 0.58 . . . . 0.0 109.719 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 71.08 57.23 6.37 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 31' ' ' LEU . . . 36.74 64.81 0.6 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -141.66 99.05 0.23 Allowed Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.992 -1.299 . . . . 0.0 109.953 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -67.83 138.0 55.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -1.168 . . . . 0.0 109.855 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.22 -3.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -0.827 . . . . 0.0 109.599 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 t -103.59 -46.96 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mtp -100.45 157.51 16.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -109.77 61.25 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.9 p-10 169.62 -50.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -77.25 91.04 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.614 HG21 ' HD2' ' A' ' 32' ' ' LYS . 23.2 m -126.17 163.89 22.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.187 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -88.36 74.48 8.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.133 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.67 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -111.83 -85.04 0.57 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.648 -1.283 . . . . 0.0 109.103 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.044 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -176.56 -47.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 179.471 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.59 -33.81 27.87 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.15 -0.968 . . . . 0.0 110.413 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.65 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -70.81 -56.81 5.49 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.056 -1.028 . . . . 0.0 109.688 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.062 HD12 ' HB2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -53.42 -33.57 54.48 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.438 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.549 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 3.1 mm-40 -87.14 -17.84 31.82 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.706 0.765 . . . . 0.0 109.242 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 3.3 tp-100 -68.33 -50.29 54.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.65 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -85.8 -78.17 0.28 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.427 -0.796 . . . . 0.0 108.926 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.66 86.36 0.06 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.566 ' SD ' ' CE2' ' A' ' 39' ' ' PHE . 2.7 ptt? -167.0 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -1.192 . . . . 0.0 109.511 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 1.062 ' HB2' HD12 ' A' ' 36' ' ' LEU . 38.0 t80 -104.68 12.02 33.39 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.55 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -105.42 140.41 38.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.339 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.792 ' HA ' HD11 ' A' ' 78' ' ' LEU . 1.2 mt-10 -44.89 -63.05 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.796 . . . . 0.0 109.97 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 29.5 t0 -48.63 -33.53 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.817 -1.177 . . . . 0.0 110.553 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -65.39 -76.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.84 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 tt -65.5 -6.75 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.859 0.838 . . . . 0.0 110.563 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.561 HD12 ' C ' ' A' ' 44' ' ' GLU . 12.8 mt -77.26 -43.02 31.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 49' ' ' TYR . 58.4 t80 -88.89 -3.83 58.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.626 ' OE1' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -100.87 -13.78 18.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 47' ' ' ILE . 26.8 t -92.09 -47.36 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.875 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -58.69 -12.82 4.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.58 -179.239 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.8 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -151.57 21.59 0.71 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.093 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.597 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 53.09 -131.97 41.55 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.572 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 157.08 132.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.437 0 CA-C-O 121.538 0.685 . . . . 0.0 109.728 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 59.9 m-80 63.05 -85.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.53 44.48 2.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.642 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 6.6 ttt -129.05 144.15 51.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.039 -1.038 . . . . 0.0 109.167 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.642 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.6 Cg_endo -71.71 117.27 5.06 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.372 2.715 . . . . 0.0 115.822 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.656 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -42.51 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.844 ' CE1' HD21 ' A' ' 65' ' ' LEU . 26.0 m-85 -139.48 8.64 2.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.42 -19.7 2.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.435 -0.791 . . . . 0.0 109.217 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.54 26.86 0.96 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.708 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 2.4 mmt85 -102.06 -48.59 4.18 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 178.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.033 HD13 HG11 ' A' ' 9' ' ' VAL . 8.4 mt -81.34 -148.57 0.07 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.609 HG22 ' N ' ' A' ' 67' ' ' ASP . 1.5 m -98.83 -74.96 0.57 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 122.19 0.995 . . . . 0.0 108.929 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.777 ' HA ' HD12 ' A' ' 70' ' ' ILE . 23.3 t0 -177.83 -59.34 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 9.7 tt0 -69.25 5.1 1.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.662 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 1.068 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -111.21 -33.92 6.31 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.875 HG21 ' HG3' ' A' ' 52' ' ' GLN . 2.3 mt -60.28 -18.0 15.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.477 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -96.46 -73.81 0.58 Allowed 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.019 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 60.7 m-20 -44.64 -46.34 10.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.833 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.787 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 10.5 t -63.29 -42.25 95.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.623 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -56.19 -63.87 1.05 Allowed 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.268 -1.52 . . . . 0.0 106.951 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.49 -18.93 32.91 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.787 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 61.4 t80 -65.46 -39.91 92.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.598 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 25.2 t -75.33 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -88.83 -8.12 54.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.3 t70 -98.54 -36.31 9.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.107 0.956 . . . . 0.0 108.707 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.641 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 5.1 mm-40 -80.9 -36.56 31.02 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.575 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -64.56 -42.88 95.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.837 ' HB2' ' OH ' ' A' ' 42' ' ' TYR . . . -89.12 12.81 14.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 110.829 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 8.3 ptmm? -138.08 18.18 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.494 -1.379 . . . . 0.0 111.22 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 86.49 73.96 1.27 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.641 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 5.6 m95 -36.62 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.41 0.624 . . . . 0.0 109.61 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.301 -1.506 0 O-C-N 121.411 -0.806 . . . . 0.0 109.832 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.478 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 68.6 m-20 -127.95 -26.09 2.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.988 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.503 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -68.12 -5.37 17.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.59 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.42 -30.54 70.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 2.0 m-20 -72.45 -33.63 67.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -52.13 -60.79 7.21 Favored Glycine 0 C--O 1.201 -1.93 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.791 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -56.53 -26.98 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -1.067 . . . . 0.0 109.871 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.77 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -65.41 -35.07 79.83 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.024 -1.047 . . . . 0.0 108.707 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.099 HG21 ' CB ' ' A' ' 69' ' ' GLN . 14.9 t -88.66 -47.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.287 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 15.4 t80 -64.42 -27.69 69.17 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.804 -1.185 . . . . 0.0 109.435 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 18.7 p -90.93 11.2 23.52 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.615 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -141.95 3.53 2.01 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 2.6 m120 -154.82 -57.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 0.0 109.029 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.637 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 11.6 m -65.84 -24.93 66.99 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.744 . . . . 0.0 109.37 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -62.35 -33.55 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 110.359 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.08 13.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.004 . . . . 0.0 110.517 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.553 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 0.1 OUTLIER -138.89 25.6 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' O ' ' A' ' 19' ' ' MET . 86.0 m-70 -157.07 -69.63 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 108.951 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.52 ' O ' ' O ' ' A' ' 18' ' ' HIS . 1.0 OUTLIER 36.24 102.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.602 0.715 . . . . 0.0 111.207 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 93.59 32.42 7.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 43.45 36.19 3.09 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -130.51 109.35 0.91 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -44.3 140.82 2.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.0 109.333 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 24' ' ' VAL . 58.9 t -107.56 0.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 109.772 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.75 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 90.5 t -117.64 -51.3 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.676 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.79 176.27 6.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.72 46.61 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 1.4 p-10 -176.58 -62.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.283 -0.886 . . . . 0.0 108.979 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.615 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -55.18 97.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 t -111.1 -167.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 110.393 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD21 ' C4A' ' A' ' 88' ' ' HEC . 0.1 OUTLIER -107.3 -26.06 11.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.673 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.635 ' C ' HD21 ' A' ' 36' ' ' LEU . 7.3 mtpt -45.22 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.827 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.089 ' N ' HD21 ' A' ' 36' ' ' LEU . 17.5 ttpt -178.74 -26.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.656 -1.278 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -67.83 -53.98 22.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.743 -1.223 . . . . 0.0 110.737 -177.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.547 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -76.05 -51.15 12.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.577 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.089 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -59.7 -22.82 62.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.002 . . . . 0.0 108.852 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 2.4 tm-20 -112.4 -2.6 14.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.141 -0.975 . . . . 0.0 109.298 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 11.8 tp60 -65.82 -47.05 76.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.615 ' CZ ' ' HG3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -85.74 -32.0 22.11 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.281 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 120.93 102.11 1.82 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.623 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 158.57 29.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.702 -0.881 . . . . 0.0 110.823 178.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.67 ' CD1' HD11 ' A' ' 36' ' ' LEU . 2.1 t80 -97.11 28.46 3.57 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.077 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 6.9 p -106.74 157.58 17.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 110.343 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.857 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -46.05 -62.91 1.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.38 -0.825 . . . . 0.0 109.701 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.511 ' N ' HD12 ' A' ' 48' ' ' ILE . 39.7 t0 -54.67 -28.74 49.59 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.94 -1.1 . . . . 0.0 110.637 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -66.06 -76.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.031 . . . . 0.0 110.247 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.898 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.5 tt -60.04 -20.99 20.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.462 -0.773 . . . . 0.0 110.047 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.857 HD12 ' C ' ' A' ' 44' ' ' GLU . 15.6 mt -64.45 -35.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.581 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 26.4 t80 -87.08 -18.12 31.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 4.4 tp60 -90.38 -1.37 57.91 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 47' ' ' ILE . 78.5 t -109.67 -39.03 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.835 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -71.58 -5.13 31.12 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.169 -0.957 . . . . 0.0 109.016 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.64 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -161.99 26.77 0.12 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 44.51 -133.33 7.1 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER 160.86 126.67 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 121.29 0.567 . . . . 0.0 109.654 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 17.2 m120 68.98 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.599 ' HB3' HMD2 ' A' ' 88' ' ' HEC . . . -128.12 12.0 6.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.945 -1.097 . . . . 0.0 110.569 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.643 ' HB2' ' C1D' ' A' ' 88' ' ' HEC . 14.4 ttt -95.16 138.98 21.88 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.672 -1.267 . . . . 0.0 109.599 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.701 ' HG2' HMC2 ' A' ' 88' ' ' HEC . 29.2 Cg_endo -73.81 117.18 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.964 2.443 . . . . 0.0 113.507 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.64 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.23 165.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.533 -0.73 . . . . 0.0 110.025 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.708 ' CD1' HD21 ' A' ' 65' ' ' LEU . 48.7 m-85 -146.76 15.59 1.23 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.35 -17.7 2.03 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.37 29.15 0.27 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.545 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -98.85 -41.58 7.56 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 178.01 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.994 HD13 HG11 ' A' ' 9' ' ' VAL . 19.3 mt -82.0 -140.71 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 6.1 m -98.62 -57.39 2.2 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.268 -0.895 . . . . 0.0 109.524 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 6.3 t70 153.34 -54.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 16.1 mt-10 -70.79 2.53 4.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 1.099 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -114.39 -27.42 7.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.986 HD13 HD12 ' A' ' 65' ' ' LEU . 10.8 mm -58.88 -22.42 21.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 173.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.462 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.0 mt-30 -97.48 -65.76 0.94 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.993 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.0 t0 -53.82 -39.93 65.97 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 69' ' ' GLN . 1.4 p -60.94 -26.68 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.313 -0.867 . . . . 0.0 109.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -81.0 -63.48 1.4 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.71 -24.44 3.39 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.383 -1.448 . . . . 0.0 107.24 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.791 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.3 t80 -63.91 -47.72 79.43 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.08 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.5 p -67.32 -23.3 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 77' ' ' VAL . 3.1 mt -79.02 -11.61 60.01 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -35.06 9.67 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.007 0.908 . . . . 0.0 109.709 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.651 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 6.9 mm-40 -77.29 -43.68 32.39 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.313 0.578 . . . . 0.0 110.283 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.647 ' HB2' ' NE1' ' A' ' 85' ' ' TRP . . . -76.18 -22.41 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.346 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.71 4.26 22.52 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.549 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -170.59 39.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.587 -1.321 . . . . 0.0 112.309 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 97.29 74.74 1.2 Allowed Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.856 -1.64 . . . . 0.0 110.178 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.652 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -40.3 83.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.174 0.511 . . . . 0.0 110.752 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 46.43 24.3 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.439 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.486 2.007 0 CA-C-O 117.921 -1.488 . . . . 0.0 109.45 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.861 HBC2 ' HHD' ' A' ' 88' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 5.3 m-20 -122.22 157.77 30.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.404 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.539 HD23 ' OD1' ' A' ' 72' ' ' ASP . 3.9 mt -72.74 -3.69 26.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.62 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.2 -32.18 73.66 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.494 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -71.11 -26.86 63.21 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -60.21 -51.92 55.87 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.694 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -50.2 -19.89 0.89 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.616 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -82.61 -43.44 16.99 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.639 HG22 ' CG ' ' A' ' 69' ' ' GLN . 5.2 t -62.63 -26.35 40.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.9 t80 -101.29 -22.48 14.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.594 -0.691 . . . . 0.0 110.603 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 62.2 m -88.47 22.45 2.54 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.312 -0.868 . . . . 0.0 109.265 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.29 -23.27 0.02 OUTLIER Glycine 0 N--CA 1.484 1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.342 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB3' ' HD3' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -122.96 -7.03 8.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.596 -1.532 . . . . 0.0 110.065 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.657 ' SG ' HMB1 ' A' ' 88' ' ' HEC . 6.6 m -127.39 -23.04 3.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -58.27 -37.45 75.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.769 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.81 -10.53 13.36 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.229 -0.919 . . . . 0.0 111.77 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.57 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 94.7 m -140.64 19.04 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.648 -1.282 . . . . 0.0 110.052 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 89.4 m-70 -158.31 -53.3 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.266 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.511 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 5.0 ptt? 35.58 98.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.251 0.548 . . . . 0.0 110.795 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 72.27 52.52 10.66 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.677 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 37.05 83.37 0.01 OUTLIER Glycine 0 N--CA 1.483 1.822 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -161.7 93.74 0.12 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' GLY . 3.8 t-20 -40.72 157.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.577 -0.955 . . . . 0.0 109.823 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.631 HG13 HG23 ' A' ' 25' ' ' VAL . 2.3 p -120.87 -20.3 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.631 HG23 HG13 ' A' ' 24' ' ' VAL . 20.8 t -109.73 -68.61 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -58.2 168.83 0.94 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.953 . . . . 0.0 109.936 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -129.39 57.82 1.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 1.7 p30 178.09 -46.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.343 -0.848 . . . . 0.0 109.139 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.535 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 58.8 mttt -75.94 101.58 5.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.685 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 31' ' ' LEU . 5.9 m -118.88 173.0 7.14 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.2 mp -91.9 -19.35 22.57 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.319 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.9 ptmt -59.72 179.65 0.12 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.95 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.629 ' N ' ' HB1' ' A' ' 81' ' ' ALA . 17.1 ptmt -81.7 -38.52 25.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 2.8 mt-10 -55.89 -33.62 64.79 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 110.499 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.58 -42.0 5.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 110.94 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.92 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -66.34 -15.12 63.01 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.586 ' HG3' ' HG ' ' A' ' 36' ' ' LEU . 62.4 mt-10 -114.3 0.41 14.14 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 15.2 tp60 -74.53 -51.91 13.35 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -87.31 -43.05 12.44 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.364 179.132 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.94 33.2 0.43 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.023 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.771 ' HE3' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -91.01 14.03 15.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.753 -1.439 . . . . 0.0 108.949 179.108 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.882 ' HD1' HD11 ' A' ' 36' ' ' LEU . 48.5 t80 -74.03 15.4 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.619 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -106.27 125.75 51.38 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.628 -1.295 . . . . 0.0 110.665 -179.162 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.6 pt-20 -44.41 -56.71 4.02 Favored 'General case' 0 C--O 1.201 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 108.861 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.65 -41.1 21.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 110.388 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.65 -71.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.966 . . . . 0.0 110.122 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.772 HG23 ' HB1' ' A' ' 74' ' ' ALA . 7.4 tt -68.1 -7.86 7.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 110.135 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.556 HG13 ' CB ' ' A' ' 74' ' ' ALA . 3.7 mt -81.54 -31.88 11.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.732 ' HA ' ' HE1' ' A' ' 53' ' ' HIS . 41.1 t80 -92.02 -13.19 31.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 5.9 tp60 -93.64 -14.28 26.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 47' ' ' ILE . 53.9 t -101.5 -35.44 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.973 0.892 . . . . 0.0 109.874 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 2.6 mt-30 -74.19 -4.85 38.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.733 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -164.38 32.42 0.07 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.571 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.545 ' HA2' ' CG ' ' A' ' 58' ' ' MET . . . 45.59 -137.31 7.11 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.581 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.4 OUTLIER 157.9 128.93 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.937 -0.631 . . . . 0.0 109.311 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 51.9 m-80 62.95 -86.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -123.67 32.47 5.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.947 . . . . 0.0 109.735 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.695 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.1 ttt -111.7 141.92 25.62 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.061 -1.024 . . . . 0.0 109.147 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.695 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 31.0 Cg_endo -76.48 104.06 1.85 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.073 2.515 . . . . 0.0 114.293 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.733 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -52.28 121.97 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.73 -0.606 . . . . 0.0 109.813 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.862 ' CG ' HD13 ' A' ' 65' ' ' LEU . 39.6 m-85 -93.02 -55.66 3.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.96 -1.088 . . . . 0.0 108.558 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 52' ' ' GLN . . . 27.53 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.207 0.527 . . . . 0.0 110.132 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 166.01 -15.53 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.575 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -101.87 -29.34 11.9 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.048 HD21 HBB1 ' A' ' 88' ' ' HEC . 7.5 mp -94.49 114.12 26.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 67' ' ' ASP . 3.3 m -43.7 179.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.419 0.628 . . . . 0.0 110.264 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.716 ' H ' HG22 ' A' ' 66' ' ' THR . 0.1 OUTLIER -75.75 -62.38 1.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.913 -1.117 . . . . 0.0 109.083 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.544 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 32.6 mt-10 -61.99 -9.49 7.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.386 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.639 ' CG ' HG22 ' A' ' 9' ' ' VAL . 2.1 mp0 -94.66 -34.91 12.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 65' ' ' LEU . 7.0 mm -69.68 -14.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.5 mp0 -97.31 -69.87 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.581 1.181 . . . . 0.0 109.164 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.682 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 42.1 m-20 -52.36 -33.87 44.97 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.393 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.689 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.3 p -69.53 -30.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.619 0.723 . . . . 0.0 109.878 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.772 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.68 -57.72 3.74 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.497 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.21 -19.16 53.05 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.694 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 61.9 t80 -64.93 -41.89 95.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.633 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 40.7 t -72.95 -24.24 20.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.817 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.1 mt -85.32 -7.85 58.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 9.8 t0 -99.67 -36.86 9.35 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.183 0.992 . . . . 0.0 109.242 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.621 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 6.5 mm-40 -78.62 -40.15 35.18 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.202 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.629 ' HB1' ' N ' ' A' ' 33' ' ' LYS . . . -62.62 -37.65 87.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.774 . . . . 0.0 109.891 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.66 13.96 12.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 110.93 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 2.3 ptmt -150.03 30.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.544 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.97 74.06 1.26 Allowed Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.847 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.633 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 1.7 m95 -40.79 84.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.161 -0.611 . . . . 0.0 110.854 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 47.38 23.57 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.531 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 1.048 HBB1 HD21 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -130.02 -24.32 2.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 79' ' ' ASP . 1.7 mp -67.06 -7.76 25.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.9 -1.125 . . . . 0.0 109.286 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.76 -31.89 68.77 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -68.6 -36.97 79.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.16 -62.96 5.47 Favored Glycine 0 C--O 1.203 -1.812 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.797 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.55 -30.08 4.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -1.207 . . . . 0.0 109.86 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.761 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -64.48 -45.29 88.0 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 108.376 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.046 HG21 ' CB ' ' A' ' 69' ' ' GLN . 41.2 t -75.77 -55.4 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.633 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 7.9 t80 -57.43 -26.11 60.65 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 110.438 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 28.9 t -86.24 19.08 2.84 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.615 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -162.16 11.15 0.11 Allowed Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 7.4 m120 -153.97 -53.16 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.683 -1.481 . . . . 0.0 109.159 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.3 m -73.38 -26.38 60.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' HA ' ' N ' ' A' ' 19' ' ' MET . . . -52.1 -41.0 62.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.2 68.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.903 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.583 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 85.8 m -121.55 19.13 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.922 -1.111 . . . . 0.0 110.649 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 93.8 m-70 -158.67 -66.5 0.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.164 -0.96 . . . . 0.0 109.25 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.506 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 14.2 ptm 39.48 98.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.531 0.682 . . . . 0.0 110.286 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.45 46.02 80.95 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.539 ' O ' HG21 ' A' ' 30' ' ' THR . . . 51.09 68.19 1.61 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -143.29 88.32 0.17 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.644 ' H ' HG23 ' A' ' 30' ' ' THR . 1.2 t-20 -61.9 142.25 57.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -1.118 . . . . 0.0 109.778 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 17' ' ' CYS . 17.4 m -102.16 -13.26 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.588 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 60.4 t -104.56 -57.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.92 . . . . 0.0 109.127 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.53 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 9.5 mmt -103.36 93.97 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.845 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.18 -47.55 35.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.733 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -66.4 -35.62 80.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.192 -0.943 . . . . 0.0 109.885 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 0.0 OUTLIER -84.29 82.68 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.644 HG23 ' H ' ' A' ' 23' ' ' ASN . 24.5 m -122.01 171.97 8.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.052 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.745 ' HB3' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -84.74 -3.49 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.715 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -46.01 173.53 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.142 -0.974 . . . . 0.0 109.964 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -84.17 -27.65 27.94 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.312 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -82.51 -27.12 31.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.96 . . . . 0.0 111.074 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.42 -35.21 7.18 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.292 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.802 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -60.6 -39.7 89.11 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.115 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.587 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -96.93 6.06 49.34 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 17.0 tp60 -69.33 -47.21 65.1 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.5 -39.04 16.65 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.656 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.52 79.17 0.6 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.437 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.705 ' SD ' HMA2 ' A' ' 88' ' ' HEC . 0.3 OUTLIER -159.16 25.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -1.098 . . . . 0.0 108.798 179.047 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.717 ' HB2' HD11 ' A' ' 36' ' ' LEU . 33.8 t80 -74.68 3.12 8.4 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.518 0.675 . . . . 0.0 109.621 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.94 155.59 18.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.707 -1.245 . . . . 0.0 110.999 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 1.3 mp0 -50.44 -64.73 0.72 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.871 -0.518 . . . . 0.0 110.515 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -46.48 -31.57 2.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.77 -1.206 . . . . 0.0 111.437 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 41' ' ' MET . . . -69.65 -73.94 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.784 -1.198 . . . . 0.0 110.658 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.859 ' O ' HG23 ' A' ' 51' ' ' VAL . 10.4 tt -60.31 -17.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.25 -0.906 . . . . 0.0 109.622 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.551 HG13 ' CB ' ' A' ' 74' ' ' ALA . 21.6 mt -72.31 -34.44 49.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.417 ' O ' ' ND1' ' A' ' 53' ' ' HIS . 52.1 t80 -71.64 -29.98 65.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 2.5 pm0 -94.39 -13.2 26.56 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.774 -1.57 . . . . 0.0 109.125 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 47' ' ' ILE . 60.2 t -87.76 -23.73 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.009 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.433 ' CB ' ' CE1' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -99.39 -7.68 25.85 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.47 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -147.35 13.6 1.09 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 53.5 -135.33 41.54 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.629 ' N ' ' HB3' ' A' ' 58' ' ' MET . 4.9 mtpt 155.17 127.48 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 13.3 m120 61.0 -88.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -121.9 29.29 7.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.235 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.629 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 27.8 ttt -107.12 141.89 23.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.595 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 37.0 Cg_endo -85.06 99.22 0.69 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.202 2.601 . . . . 0.0 113.879 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB2' ' HA ' ' A' ' 53' ' ' HIS . . . -37.54 158.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 0.0 110.018 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.774 ' HZ ' HMC2 ' A' ' 88' ' ' HEC . 14.4 m-85 -137.03 22.62 3.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -5.07 2.46 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.48 16.74 0.99 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.64 -55.83 2.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.887 HD21 HBB1 ' A' ' 88' ' ' HEC . 4.7 mp -66.52 -157.42 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 69' ' ' GLN . 1.4 m -99.51 -58.36 1.94 Allowed 'General case' 0 C--N 1.285 -2.236 0 O-C-N 121.246 -0.909 . . . . 0.0 109.259 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 66' ' ' THR . 3.7 m-20 153.72 -53.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 3.7 mt-10 -69.01 -3.77 14.3 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 1.046 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.88 -25.81 9.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.656 HD11 ' O ' ' A' ' 61' ' ' PHE . 12.3 mm -57.37 -23.13 18.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.9 mp0 -96.37 -70.47 0.71 Allowed 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.515 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 2.8 m-20 -44.66 -46.4 10.2 Favored 'General case' 0 C--O 1.203 -1.394 0 O-C-N 121.857 -0.527 . . . . 0.0 110.026 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -62.05 -37.02 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.628 0.728 . . . . 0.0 110.005 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.551 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -67.23 -61.84 1.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.509 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.1 -18.99 17.03 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.797 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 71.3 t80 -67.14 -44.16 80.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.8 HG21 HD11 ' A' ' 47' ' ' ILE . 85.0 t -71.11 -19.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 2.4 mt -84.6 -9.52 58.22 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.293 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.502 ' HB3' ' OE1' ' A' ' 80' ' ' GLN . 7.4 t0 -99.21 -45.87 5.74 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.188 0.994 . . . . 0.0 108.604 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.641 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.1 mm100 -65.59 -50.07 66.44 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.082 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.766 ' HB2' ' CD1' ' A' ' 85' ' ' TRP . . . -74.14 -12.1 60.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.55 -0.719 . . . . 0.0 109.22 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 78' ' ' LEU . . . -65.28 -7.46 13.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.53 -0.731 . . . . 0.0 110.023 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -179.9 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.754 -1.217 . . . . 0.0 111.64 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.52 75.9 1.31 Allowed Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.019 -1.562 . . . . 0.0 109.669 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.766 ' CD1' ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -39.74 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.39 -0.476 . . . . 0.0 110.551 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 41.49 29.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.799 . . . . 0.0 109.204 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 85' ' ' TRP . . . . . . . . 0 N--CA 1.487 2.086 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.604 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.887 HBB1 HD21 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.498 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 8.6 m-20 -129.98 -25.83 2.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.037 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.464 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -66.86 -4.91 10.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.554 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.95 -25.41 60.92 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.515 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.3 m-20 -77.68 -36.94 50.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.462 ' CA ' ' OD1' ' A' ' 72' ' ' ASP . . . -50.72 -55.98 15.47 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.762 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -60.31 -24.95 65.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.767 -0.843 . . . . 0.0 109.712 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.726 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.88 -30.28 68.74 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.838 -1.164 . . . . 0.0 108.331 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.051 HG21 ' CB ' ' A' ' 69' ' ' GLN . 22.8 t -97.73 -23.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.479 -0.763 . . . . 0.0 110.056 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.658 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 t80 -89.17 -25.89 21.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.845 -1.159 . . . . 0.0 109.921 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 17.1 m -78.81 7.34 7.21 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.638 -0.664 . . . . 0.0 110.081 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.46 13.02 0.34 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.378 -1.392 . . . . 0.0 111.076 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.503 ' ND2' HD23 ' A' ' 65' ' ' LEU . 5.7 m120 -139.01 -42.4 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.802 -1.411 . . . . 0.0 109.057 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -97.22 -22.76 16.52 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -47.59 -50.37 24.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.716 -0.615 . . . . 0.0 110.455 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.16 71.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 110.776 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 64.4 m -112.94 15.07 19.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.921 -1.112 . . . . 0.0 110.006 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 81.1 m-70 -159.15 -64.45 0.08 Allowed 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 50.24 108.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.497 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.48 57.07 9.76 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.507 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 45.99 66.67 1.56 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -144.67 81.78 0.21 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.775 ' H ' HG23 ' A' ' 30' ' ' THR . 6.5 t-20 -53.3 153.45 3.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -1.201 . . . . 0.0 109.324 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 17' ' ' CYS . 4.1 m -128.12 5.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 109.997 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.802 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 27.7 t -105.29 -59.57 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 109.31 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.456 ' HG3' HAD1 ' A' ' 88' ' ' HEC . 4.4 mmm -86.38 -173.28 4.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.94 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -128.67 57.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 5.2 p30 169.27 -41.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.806 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HD2' ' CE2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -71.47 89.02 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 109.876 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.775 HG23 ' H ' ' A' ' 23' ' ' ASN . 9.6 m -122.43 170.96 9.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.318 -0.863 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.958 ' HB3' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -89.91 -11.71 41.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.997 . . . . 0.0 108.955 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -34.3 -71.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.645 -0.659 . . . . 0.0 111.6 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.035 ' CA ' HD21 ' A' ' 36' ' ' LEU . 1.5 tptm 170.07 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.724 -1.235 . . . . 0.0 110.196 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 32.1 mt-10 -72.2 -46.3 56.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.112 -0.992 . . . . 0.0 111.06 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.597 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.48 -48.41 49.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.029 -1.044 . . . . 0.0 111.132 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.035 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -65.97 -14.15 61.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.65 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.541 ' CG ' ' CD2' ' A' ' 42' ' ' TYR . 3.0 mm-40 -119.22 8.4 11.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.773 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 20.5 tp60 -87.06 -53.06 5.07 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.25 -40.52 13.59 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.736 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.51 44.35 0.18 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.752 -1.214 . . . . 0.0 110.785 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.844 ' SD ' HMA2 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -105.78 9.05 33.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.333 . . . . 0.0 109.187 179.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.599 ' CD2' HD12 ' A' ' 36' ' ' LEU . 27.6 t80 -71.98 13.99 0.25 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 111.449 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -106.0 136.26 45.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.35 -1.469 . . . . 0.0 110.745 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.743 ' C ' HD12 ' A' ' 48' ' ' ILE . 1.4 mt-10 -44.1 -57.51 3.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.297 -0.877 . . . . 0.0 108.83 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' N ' HD12 ' A' ' 48' ' ' ILE . 9.9 t0 -51.41 -38.75 55.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.12 -73.82 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.781 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.6 tt -64.47 -11.27 10.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 110.083 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.743 HD12 ' C ' ' A' ' 44' ' ' GLU . 14.8 mt -78.96 -31.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 40.0 t80 -92.32 -14.4 28.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.549 ' OE1' ' CB ' ' A' ' 55' ' ' LYS . 1.4 tp60 -93.93 -14.47 25.95 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.2 t -97.32 -44.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.973 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -64.27 -13.94 52.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.582 . . . . 0.0 111.313 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.761 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -147.88 21.54 1.13 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.604 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.36 -130.53 50.56 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.7 137.39 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.6 m120 58.24 -89.48 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.61 41.46 3.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.689 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 17.5 ttt -113.94 143.97 30.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.689 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.2 Cg_endo -77.39 107.74 2.46 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.334 2.689 . . . . 0.0 114.709 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.662 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.55 159.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 111.039 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.76 ' HZ ' HMC2 ' A' ' 88' ' ' HEC . 10.0 m-30 -141.12 16.26 2.26 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.8 -0.562 . . . . 0.0 110.116 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB2' ' HG2' ' A' ' 52' ' ' GLN . . . -66.28 -2.99 4.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.123 178.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.53 17.8 1.13 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.546 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.22 -57.49 2.11 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.043 HD12 ' CD1' ' A' ' 70' ' ' ILE . 36.0 mt -73.51 -149.1 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.536 ' HB ' ' HG2' ' A' ' 69' ' ' GLN . 1.4 m -99.53 -61.52 1.36 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.9 t70 156.7 -51.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 12.3 tp10 -71.15 4.01 3.08 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 1.051 ' CB ' HG21 ' A' ' 9' ' ' VAL . 1.8 mm-40 -112.21 -33.24 6.28 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.043 ' CD1' HD12 ' A' ' 65' ' ' LEU . 36.0 mm -58.28 -24.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -91.6 -73.52 0.54 Allowed 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.713 178.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.554 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 15.1 t0 -44.65 -53.7 6.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.761 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 11.5 t -56.09 -39.54 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.362 1.077 . . . . 0.0 108.159 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLN . . . -55.77 -59.15 5.28 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.97 -18.77 59.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.762 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 65.0 t80 -67.27 -38.06 84.49 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.958 HG13 ' HB3' ' A' ' 31' ' ' LEU . 93.7 t -76.78 -23.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.809 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -86.41 -6.48 58.91 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -98.2 -52.63 3.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.265 1.031 . . . . 0.0 108.404 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.623 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 45.7 mm-40 -65.16 -46.34 81.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.365 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 31' ' ' LEU . . . -70.57 -12.39 61.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.321 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 78' ' ' LEU . . . -78.08 -4.45 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.45 -0.781 . . . . 0.0 110.963 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -178.32 57.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.454 -1.404 . . . . 0.0 111.961 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 89.56 75.96 1.3 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 118.947 -1.597 . . . . 0.0 109.339 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.641 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -40.7 84.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.177 0.513 . . . . 0.0 110.826 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 55.16 48.51 19.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.337 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.09 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.536 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.844 HMA2 ' SD ' ' A' ' 41' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -104.17 158.06 16.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 109.52 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.583 HD13 ' OD2' ' A' ' 79' ' ' ASP . 1.0 OUTLIER -70.66 -11.93 61.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 108.588 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -30.42 66.57 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.511 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.43 -37.32 65.93 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -49.72 -59.09 7.62 Favored Glycine 0 C--O 1.201 -1.948 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.842 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -54.06 -35.05 61.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.103 . . . . 0.0 109.79 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.572 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 108.995 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.055 HG21 ' CB ' ' A' ' 69' ' ' GLN . 37.5 t -86.15 -43.08 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 110.563 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.588 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 7.8 t80 -63.46 -27.68 69.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.726 -1.234 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 p -86.52 18.47 3.29 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 109.473 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.513 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -150.71 6.96 0.66 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.243 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 13.2 m120 -152.56 -49.76 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.605 -1.527 . . . . 0.0 109.468 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 2.3 m -76.46 -30.69 57.43 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -43.6 -42.45 5.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.679 -0.638 . . . . 0.0 110.294 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -46.96 85.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.944 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.582 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 66.5 m -107.28 29.54 7.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.582 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 77.8 m-70 -162.6 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.499 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 9.8 ptt? 39.04 100.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.49 0.662 . . . . 0.0 110.777 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 87.26 41.95 6.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 39.32 58.73 1.97 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -151.64 103.85 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.451 HD21 ' C4D' ' A' ' 88' ' ' HEC . 2.5 t-20 -56.11 162.08 2.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.197 . . . . 0.0 109.05 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.4 -29.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.047 -1.033 . . . . 0.0 109.986 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.532 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 4.7 t -79.09 -70.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.099 -1.001 . . . . 0.0 109.337 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.51 ' CG ' HAD1 ' A' ' 88' ' ' HEC . 32.3 mmt -66.48 150.85 48.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.278 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -113.54 60.35 0.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 109.685 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.498 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.8 p30 -178.69 -44.17 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.985 . . . . 0.0 109.364 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HG3' ' OD1' ' A' ' 28' ' ' ASN . 25.0 mttp -81.86 124.37 29.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.121 -0.987 . . . . 0.0 109.071 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.788 ' O ' HD22 ' A' ' 36' ' ' LEU . 2.1 m -121.47 -174.18 2.8 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.274 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.713 ' H ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -100.24 -13.93 18.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.678 ' C ' HD21 ' A' ' 36' ' ' LEU . 24.2 mtpt -59.78 -98.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.144 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.794 ' N ' HD21 ' A' ' 36' ' ' LEU . 14.7 ptpt -177.25 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -51.47 -29.07 15.02 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.584 ' C ' ' CE2' ' A' ' 39' ' ' PHE . . . -104.48 -71.79 0.73 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.396 -0.815 . . . . 0.0 110.095 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.929 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -40.56 -39.91 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.558 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -82.96 -33.45 26.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.92 -1.112 . . . . 0.0 109.215 179.088 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 9.0 tp60 -45.79 -44.3 13.91 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CE2' ' C ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -85.83 -72.24 0.5 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.9 89.18 0.07 OUTLIER Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER 179.48 26.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -1.2 . . . . 0.0 110.395 -178.505 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.027 ' OH ' ' HB3' ' A' ' 81' ' ' ALA . 3.3 t80 -109.04 23.37 14.64 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 109.473 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 5.6 p -107.79 153.42 23.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.899 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -42.52 -65.67 0.44 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 109.858 178.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' N ' HD12 ' A' ' 48' ' ' ILE . 50.0 t0 -52.18 -32.91 38.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.015 . . . . 0.0 110.437 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' O ' ' CD ' ' A' ' 50' ' ' GLN . . . -62.55 -73.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.28 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.74 ' CD1' HG11 ' A' ' 77' ' ' VAL . 10.6 tt -62.57 -13.8 11.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.899 HD12 ' C ' ' A' ' 44' ' ' GLU . 32.7 mt -77.22 -28.67 16.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 25.7 t80 -85.76 -22.22 27.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.338 -0.851 . . . . 0.0 110.026 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.593 ' O ' ' HE2' ' A' ' 58' ' ' MET . 0.0 OUTLIER -99.47 -15.07 18.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 119.789 -1.819 . . . . 0.0 108.735 178.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.589 ' CG2' HG12 ' A' ' 47' ' ' ILE . 34.5 t -91.43 -27.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 109.516 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.864 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.5 OUTLIER -86.8 -4.4 59.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.788 -1.195 . . . . 0.0 108.144 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.864 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -158.97 22.37 0.2 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.36 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 48.8 -138.28 15.09 Favored Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.261 -1.935 . . . . 0.0 108.261 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.626 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.9 OUTLIER 156.43 134.53 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.03 -89.38 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.803 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -121.76 41.15 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.507 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.651 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 18.2 ttt -119.76 143.31 34.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 108.726 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.651 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 33.5 Cg_endo -77.31 94.56 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 123.004 2.469 . . . . 0.0 115.347 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.74 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -49.2 112.94 0.7 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.288 -0.882 . . . . 0.0 110.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.675 ' CD2' ' CD2' ' A' ' 65' ' ' LEU . 25.9 m-85 -81.41 -51.2 8.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.11 26.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.384 0.612 . . . . 0.0 109.606 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.85 32.74 0.63 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.645 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -100.29 -48.52 4.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.87 HD23 HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -64.12 -141.0 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.587 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 3.3 m -98.02 -52.11 3.81 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 121.01 -1.056 . . . . 0.0 109.175 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.7 m-20 150.77 -60.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 35.2 mm-40 -68.22 -2.02 7.31 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 1.055 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.11 -29.82 7.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.87 HD13 HD23 ' A' ' 65' ' ' LEU . 9.7 mm -52.47 -24.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.52 ' N ' ' C ' ' A' ' 69' ' ' GLN . 1.6 mt-30 -100.21 -60.42 1.53 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.442 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.703 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 13.9 m-20 -52.69 -47.6 67.13 Favored 'General case' 0 C--O 1.189 -2.114 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.527 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 69' ' ' GLN . 6.3 t -54.56 -29.17 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 108.791 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.747 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -77.67 -67.64 0.7 Allowed 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.47 -23.62 2.58 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.012 -1.68 . . . . 0.0 107.515 177.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.842 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 35.6 t80 -64.74 -46.23 83.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.188 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.4 p -67.74 -23.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.5 mt -78.34 -12.13 59.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.583 ' OD2' HD13 ' A' ' 3' ' ' LEU . 3.6 t0 -100.74 -34.62 9.77 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.793 0.806 . . . . 0.0 109.713 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.609 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 4.2 mm-40 -76.95 -40.63 46.37 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.27 0.557 . . . . 0.0 110.198 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.027 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -69.48 -26.15 64.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 108.952 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.45 11.65 18.71 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 111.036 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -162.53 29.5 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.344 -1.473 . . . . 0.0 112.442 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 92.31 75.7 1.31 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.71 -1.709 . . . . 0.0 109.202 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.706 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.6 OUTLIER -36.9 89.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.532 0.682 . . . . 0.0 110.152 178.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -60.31 -35.87 76.61 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.217 0 CA-C-O 118.028 -1.429 . . . . 0.0 109.722 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.803 HMD2 ' O ' ' A' ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -122.47 -24.53 4.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.849 . . . . 0.0 109.484 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.691 HD23 ' OD1' ' A' ' 72' ' ' ASP . 4.8 mt -69.61 -5.28 23.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.133 -0.979 . . . . 0.0 109.449 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.58 68.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.8 -33.95 64.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.85 -61.82 6.71 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.768 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.47 -36.66 15.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.271 . . . . 0.0 109.66 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.74 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -58.52 -46.1 87.47 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.055 HG21 ' CB ' ' A' ' 69' ' ' GLN . 42.5 t -75.51 -63.03 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.651 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.1 t80 -46.27 -23.43 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 110.954 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m -91.49 31.88 1.13 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.24 -0.912 . . . . 0.0 109.168 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.34 -32.73 0.02 OUTLIER Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.896 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' CB ' HD11 ' A' ' 65' ' ' LEU . 1.3 m120 -118.08 -50.24 2.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.878 -1.366 . . . . 0.0 108.767 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 6.6 m -70.2 -29.8 66.74 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -61.14 -38.17 85.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.513 -0.742 . . . . 0.0 110.48 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -11.83 7.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.82 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.578 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 96.9 m -143.01 23.91 1.85 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.869 -1.145 . . . . 0.0 110.082 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.039 ' CE1' HD21 ' A' ' 31' ' ' LEU . 84.8 m-70 -157.9 -68.73 0.09 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.19 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 53.78 110.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.637 -0.664 . . . . 0.0 110.304 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 45.92 62.4 3.39 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 41.64 68.8 0.62 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -149.75 87.18 0.15 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.688 ' H ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -57.85 145.85 33.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -1.107 . . . . 0.0 109.474 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.545 HG23 HG23 ' A' ' 25' ' ' VAL . 34.8 m -97.42 -41.34 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG23 HG23 ' A' ' 24' ' ' VAL . 2.6 t -83.53 -60.7 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.092 -1.005 . . . . 0.0 109.196 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.64 ' SD ' HMD1 ' A' ' 88' ' ' HEC . 0.2 OUTLIER -86.7 90.19 8.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.77 71.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.713 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -74.16 -39.51 63.19 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.151 -0.968 . . . . 0.0 109.457 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.72 106.79 18.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.366 -0.834 . . . . 0.0 109.425 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.688 HG23 ' H ' ' A' ' 23' ' ' ASN . 7.7 m -126.5 174.81 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.104 -0.998 . . . . 0.0 109.567 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.039 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -95.76 -8.83 33.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.675 ' HD2' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -34.49 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.573 -178.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.108 ' N ' HD21 ' A' ' 36' ' ' LEU . 14.9 ttpp -178.42 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.824 -1.173 . . . . 0.0 110.592 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -80.16 -53.3 6.8 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.082 -1.011 . . . . 0.0 111.63 -178.17 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' CZ ' ' A' ' 39' ' ' PHE . . . -67.75 -53.84 24.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.937 -1.102 . . . . 0.0 110.521 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.108 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -44.84 -23.76 0.16 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.565 -179.201 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.562 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 89.4 mt-10 -95.25 -32.56 12.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 110.307 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 65.7 mm-40 -52.17 -39.52 60.19 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.772 ' CZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.87 -47.9 8.64 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.33 8.37 5.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.538 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 4.2 ptt? -80.94 11.78 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -1.153 . . . . 0.0 109.98 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.88 ' HB2' HD12 ' A' ' 36' ' ' LEU . 15.0 t80 -85.11 12.22 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.946 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.5 p -105.15 149.28 26.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.26 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.619 ' HG2' HD11 ' A' ' 48' ' ' ILE . 3.8 tt0 -54.39 -57.4 11.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.849 . . . . 0.0 109.64 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 45' ' ' ASP . 16.0 t0 -51.75 -23.13 4.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.643 -1.286 . . . . 0.0 110.3 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 41' ' ' MET . . . -76.68 -76.17 0.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.909 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.7 tt -57.91 -16.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.619 HD11 ' HG2' ' A' ' 44' ' ' GLU . 15.1 mt -71.89 -39.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.586 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 28.9 t80 -86.36 -16.88 35.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 108.834 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.522 ' OE1' ' CB ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -86.61 -19.97 28.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.665 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 47' ' ' ILE . 62.3 t -96.22 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.503 1.144 . . . . 0.0 109.552 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.744 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 3.1 mt-30 -71.7 -11.74 60.98 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.272 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.744 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -154.2 23.87 0.49 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.378 -1.451 . . . . 0.0 109.091 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.704 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.42 -148.86 44.51 Favored Glycine 0 C--N 1.285 -2.256 0 N-CA-C 107.627 -2.189 . . . . 0.0 107.627 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.97 117.82 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.9 m-80 63.39 -86.98 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.716 ' C ' HMD2 ' A' ' 88' ' ' HEC . . . -126.29 28.32 6.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 108.737 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.676 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.31 141.82 23.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.634 ' CD ' ' C3C' ' A' ' 88' ' ' HEC . 31.7 Cg_endo -75.75 105.49 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 123.369 2.713 . . . . 0.0 116.242 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.704 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -57.27 117.47 4.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.678 ' CZ ' HBB3 ' A' ' 88' ' ' HEC . 17.7 m-85 -87.9 -45.59 10.12 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.038 -1.039 . . . . 0.0 108.781 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 46.93 19.01 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.39 -0.819 . . . . 0.0 108.906 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 128.65 43.19 0.23 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.545 ' CB ' ' HB3' ' A' ' 61' ' ' PHE . 21.0 ttt180 -101.59 -51.62 3.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.704 HD12 HG13 ' A' ' 9' ' ' VAL . 2.7 mm? -63.6 -145.13 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.573 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 2.5 m -99.0 -56.98 2.28 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 120.896 -1.128 . . . . 0.0 109.642 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER 152.43 -55.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.086 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 24.5 mt-10 -69.75 -1.71 9.96 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 1.055 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.6 -28.23 8.98 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.464 ' CG2' ' HG3' ' A' ' 52' ' ' GLN . 8.2 mm -56.29 -23.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.482 ' N ' ' C ' ' A' ' 69' ' ' GLN . 3.2 mp0 -95.56 -70.31 0.72 Allowed 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.442 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.691 ' OD1' HD23 ' A' ' 3' ' ' LEU . 5.4 m-20 -45.19 -47.29 12.5 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.954 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.748 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -60.45 -36.25 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.74 0.781 . . . . 0.0 110.132 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' A' ' 48' ' ' ILE . . . -68.34 -62.71 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.19 -19.14 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.768 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 82.5 t80 -65.02 -45.27 86.22 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 31' ' ' LEU . 42.5 t -68.87 -24.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.429 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.72 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -83.53 -4.76 58.83 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.908 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 5.0 t0 -97.41 -45.4 6.47 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.824 ' HB3' ' CD2' ' A' ' 85' ' ' TRP . 2.3 mp0 -72.08 -31.75 66.38 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.2 0.524 . . . . 0.0 110.344 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 33' ' ' LYS . . . -58.44 -52.72 64.43 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.73 19.39 4.03 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -131.95 5.57 4.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 111.597 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.5 76.15 1.04 Allowed Glycine 0 C--N 1.296 -1.672 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.824 ' CD2' ' HB3' ' A' ' 80' ' ' GLN . 18.0 m95 -38.28 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.417 0.627 . . . . 0.0 110.804 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 44.78 24.84 0.12 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 109.824 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.112 0 CA-C-O 117.971 -1.46 . . . . 0.0 109.499 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.734 HMA1 HD12 ' A' ' 47' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 4' ' ' ALA . 35.1 t70 -116.39 150.96 36.9 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.173 -0.954 . . . . 0.0 109.258 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.24 -3.98 23.27 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.08 -1.012 . . . . 0.0 108.424 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB2' ' OD2' ' A' ' 2' ' ' ASP . . . -63.92 -31.12 72.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.524 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.2 m-20 -71.6 -26.54 62.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.629 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -60.56 -64.11 4.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.851 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -39.77 -34.24 0.24 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.875 -0.78 . . . . 0.0 109.275 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.17 -52.49 40.82 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.77 HG11 ' HB ' ' A' ' 73' ' ' VAL . 23.6 t -52.19 -57.29 4.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.715 -0.615 . . . . 0.0 110.349 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.783 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 19.8 t80 -59.37 -33.46 71.21 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.986 -1.072 . . . . 0.0 110.473 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 t -91.1 21.17 4.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.283 -0.885 . . . . 0.0 110.073 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.63 -8.64 0.68 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.767 ' ND2' HD22 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -149.12 3.67 0.6 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.484 -1.598 . . . . 0.0 111.525 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -132.65 -44.99 0.89 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.564 -1.335 . . . . 0.0 110.979 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . -27.38 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.13 0.491 . . . . 0.0 111.196 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -61.8 -53.48 55.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 110.762 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.603 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 84.4 m -94.85 25.02 4.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 109.628 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.564 ' CE1' ' HG ' ' A' ' 31' ' ' LEU . 28.5 m-70 -157.1 -72.08 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.743 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 2.5 mtp 43.71 100.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.313 0.578 . . . . 0.0 110.631 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 75.72 50.8 7.64 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 37.98 45.82 1.68 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -127.42 101.0 0.56 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.3 t-20 -46.16 165.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -1.198 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.682 HG13 HG23 ' A' ' 25' ' ' VAL . 1.7 p -111.73 -40.41 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.181 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 24' ' ' VAL . 2.7 t -91.72 -70.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.227 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.92 101.18 8.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.55 75.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.641 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 2.2 p-10 -65.8 -44.93 84.23 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.15 -0.969 . . . . 0.0 109.387 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.2 tptt -85.12 79.69 9.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.449 -0.782 . . . . 0.0 109.677 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 6.7 t -101.04 -176.47 3.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.905 . . . . 0.0 109.69 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD22 HMA3 ' A' ' 88' ' ' HEC . 0.3 OUTLIER -97.3 -19.07 18.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.73 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.614 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -38.61 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.692 -0.63 . . . . 0.0 111.407 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.063 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.6 OUTLIER 174.63 -39.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.019 . . . . 0.0 109.95 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.71 . . . . 0.0 111.103 -178.261 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.603 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -93.31 -47.24 7.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 110.803 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.063 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -58.85 -33.21 70.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.557 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.492 ' HG2' ' HB2' ' A' ' 42' ' ' TYR . 2.0 mm-40 -95.75 -1.28 50.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -73.69 -57.61 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -88.27 -48.98 7.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.456 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.58 92.84 0.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.595 ' HE1' HAA2 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -172.13 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.048 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.965 ' CG ' HD12 ' A' ' 36' ' ' LEU . 2.2 t80 -102.14 21.73 14.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.482 -0.761 . . . . 0.0 109.751 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -107.4 143.78 35.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 0.0 111.216 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.532 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -42.42 -62.78 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.47 -0.769 . . . . 0.0 109.588 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -49.01 -37.6 20.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 110.751 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -74.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.995 -1.066 . . . . 0.0 110.44 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 77' ' ' VAL . 8.0 tt -64.28 -10.51 8.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.528 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.532 HD12 ' C ' ' A' ' 44' ' ' GLU . 10.7 mt -75.4 -37.64 38.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 34.0 t80 -89.5 -15.96 31.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 6.9 tp60 -88.34 -14.48 38.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.5 t -97.2 -47.71 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.392 -0.818 . . . . 0.0 110.006 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.763 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -61.34 -9.92 6.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.737 -0.602 . . . . 0.0 110.878 -178.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.763 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -155.51 23.54 0.4 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 54.01 -133.84 44.66 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.03 120.76 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.208 0.528 . . . . 0.0 109.737 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.48 ' HB2' HBD2 ' A' ' 88' ' ' HEC . 2.5 m120 73.85 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -135.8 29.4 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.195 -0.941 . . . . 0.0 108.859 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.658 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.0 ttt -108.23 143.79 28.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 109.346 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.658 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 32.9 Cg_endo -79.89 111.98 2.81 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.012 2.475 . . . . 0.0 113.171 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.654 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -37.68 159.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.599 -0.688 . . . . 0.0 110.246 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.685 ' CD2' HBB2 ' A' ' 88' ' ' HEC . 5.9 m-85 -147.23 21.71 1.21 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.483 -0.76 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.02 -10.8 10.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.03 . . . . 0.0 109.063 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.38 13.12 5.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.59 ' HG3' ' CD1' ' A' ' 61' ' ' PHE . 6.6 mmt85 -104.07 -48.11 3.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -95.41 124.83 39.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.71 HG22 ' H ' ' A' ' 67' ' ' ASP . 5.3 m -44.26 178.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.258 0.552 . . . . 0.0 110.049 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.71 ' H ' HG22 ' A' ' 66' ' ' THR . 4.3 m-20 -65.21 -59.38 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.798 -1.189 . . . . 0.0 109.204 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.597 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 4.4 mt-10 -71.1 1.91 5.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.653 -0.654 . . . . 0.0 109.533 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.724 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -102.67 -27.17 12.88 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.633 HD11 ' O ' ' A' ' 61' ' ' PHE . 25.6 mm -73.01 -31.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -80.01 -64.64 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.68 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 40.7 t0 -56.86 -30.41 63.82 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.117 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.77 ' HB ' HG11 ' A' ' 9' ' ' VAL . 8.7 p -70.52 -29.39 38.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -70.4 -58.2 3.99 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.97 -23.39 32.11 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.851 ' CE2' ' HA ' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.77 -50.62 68.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.835 HG21 ' CD1' ' A' ' 47' ' ' ILE . 44.0 t -65.77 -22.66 31.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.89 -1.131 . . . . 0.0 109.489 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.714 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.9 mt -87.32 -7.19 58.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.038 -1.039 . . . . 0.0 108.876 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -97.77 -40.99 8.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.018 0.913 . . . . 0.0 108.761 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.672 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -72.14 -45.14 61.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.648 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -76.36 -5.45 47.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.614 ' HB3' ' HD3' ' A' ' 83' ' ' LYS . . . -75.35 -13.54 60.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.489 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.614 ' HD3' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER 176.3 66.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.702 -1.249 . . . . 0.0 111.076 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 91.82 77.44 1.35 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.672 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -40.21 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.389 0.614 . . . . 0.0 110.7 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.625 ' HB2' ' OE1' ' A' ' 80' ' ' GLN . . . 48.71 21.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.875 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.047 0 CA-C-O 117.977 -1.457 . . . . 0.0 109.573 -179.861 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.685 HBB2 ' CD2' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.6 OUTLIER -111.87 -28.92 7.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.513 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.069 HD13 ' OD1' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -69.17 -8.6 47.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.123 -0.986 . . . . 0.0 108.554 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.43 -22.52 54.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -78.86 -37.01 41.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -62.39 -53.2 43.75 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.674 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.15 -24.83 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.016 -1.285 . . . . 0.0 109.368 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.514 ' HE3' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -73.97 -47.24 38.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.746 HG22 ' HB3' ' A' ' 69' ' ' GLN . 14.8 t -55.38 -65.03 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 122.219 1.009 . . . . 0.0 108.918 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 10.9 t80 -60.73 -28.9 69.03 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 33.0 t -89.88 18.05 6.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.556 -1.34 . . . . 0.0 109.513 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.638 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -155.56 3.54 0.2 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.88 -1.152 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.638 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 1.0 OUTLIER -155.49 -46.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.604 -1.527 . . . . 0.0 109.56 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.2 m -79.65 -30.38 41.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 10' ' ' PHE . . . -53.61 -41.2 66.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 110.945 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.5 79.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.262 -0.899 . . . . 0.0 111.151 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.709 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 1.8 m -110.95 20.08 17.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.879 -1.138 . . . . 0.0 110.013 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.889 ' CE1' HD21 ' A' ' 31' ' ' LEU . 89.2 m-70 -155.58 -51.37 0.08 Allowed 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.544 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.0 ptm 42.39 111.07 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.756 0.788 . . . . 0.0 111.556 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.5 ' HA2' ' CA ' ' A' ' 87' ' ' GLY . . . 49.95 57.47 9.84 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.36 72.86 0.26 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.728 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -153.83 92.49 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.456 ' H ' HG23 ' A' ' 30' ' ' THR . 1.1 t-20 -43.85 156.76 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -1.053 . . . . 0.0 109.812 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.704 HG13 HG23 ' A' ' 25' ' ' VAL . 3.3 p -115.86 -35.67 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 109.633 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.704 HG23 HG13 ' A' ' 24' ' ' VAL . 13.4 t -91.51 -68.53 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.867 . . . . 0.0 109.651 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.418 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -60.61 161.45 7.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -117.03 63.83 0.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.905 . . . . 0.0 109.265 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 27' ' ' ALA . 1.2 p30 163.65 -39.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.208 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 2.7 mptt -71.73 83.23 0.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.938 ' O ' HD22 ' A' ' 36' ' ' LEU . 2.1 m -99.38 -168.09 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 108.816 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.936 HD23 ' C ' ' A' ' 30' ' ' THR . 0.6 OUTLIER -109.83 -2.8 17.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.677 -1.264 . . . . 0.0 109.651 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.676 ' HG2' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -60.19 -82.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.993 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.576 ' N ' HD21 ' A' ' 36' ' ' LEU . 3.2 ptmm? 168.75 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.658 -1.276 . . . . 0.0 110.936 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.72 -34.53 5.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.907 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.09 -66.44 1.02 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.84 0.828 . . . . 0.0 110.365 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.095 HD12 ' CB ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -44.75 -46.43 10.46 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.927 -0.483 . . . . 0.0 111.846 -178.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.474 ' HA ' ' CD1' ' A' ' 42' ' ' TYR . 43.4 tt0 -60.94 -34.63 75.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.569 -1.332 . . . . 0.0 110.333 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -73.81 -77.9 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.17 7.57 43.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.524 -0.735 . . . . 0.0 111.851 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 36' ' ' LEU . . . -124.88 -3.62 7.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . 1.051 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.9 mtt 42.57 48.38 4.64 Favored 'General case' 0 C--O 1.196 -1.739 0 O-C-N 121.241 -1.152 . . . . 0.0 109.527 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.095 ' CB ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -39.01 -21.81 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 O-C-N 120.912 -1.117 . . . . 0.0 111.368 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.771 ' O ' HG22 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -42.45 166.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.773 -1.204 . . . . 0.0 110.508 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' N ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -52.64 -73.18 0.04 OUTLIER 'General case' 0 C--O 1.2 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 110.579 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 44' ' ' GLU . 33.5 t0 -36.72 -51.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.209 -0.932 . . . . 0.0 112.492 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.051 ' HB3' ' O ' ' A' ' 41' ' ' MET . . . -63.35 -73.25 0.12 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 111.204 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.801 HD12 HMA1 ' A' ' 88' ' ' HEC . 14.0 tt -51.0 -20.55 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.016 -1.052 . . . . 0.0 109.677 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.626 HG23 HE22 ' A' ' 52' ' ' GLN . 14.0 mt -72.12 -38.25 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.626 -0.671 . . . . 0.0 109.445 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -77.44 -26.79 51.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.607 ' O ' ' HE2' ' A' ' 58' ' ' MET . 0.0 OUTLIER -89.13 -18.86 26.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.213 -1.554 . . . . 0.0 108.702 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 47' ' ' ILE . 45.3 t -85.78 -44.8 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.942 0.877 . . . . 0.0 109.389 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.771 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -66.74 -10.69 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.821 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.771 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -158.65 23.29 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.71 -1.196 . . . . 0.0 108.612 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.563 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 55.89 -141.34 39.98 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 154.23 142.5 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 54.98 -90.56 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.12 49.0 2.33 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.61 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 ttt -121.04 144.6 39.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.61 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.9 Cg_endo -82.54 105.21 1.39 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 123.077 2.518 . . . . 0.0 113.67 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.622 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -39.45 154.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 110.677 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.781 ' HB3' HD12 ' A' ' 70' ' ' ILE . 23.0 m-85 -136.72 3.46 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 52' ' ' GLN . . . -44.36 -29.67 0.71 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.76 36.64 0.51 Allowed Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.095 -1.526 . . . . 0.0 109.805 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HB3' ' HD1' ' A' ' 61' ' ' PHE . 10.7 ttt-85 -102.0 -48.34 4.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' A' ' 61' ' ' PHE . 1.6 mt -93.68 -146.03 0.24 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.57 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -84.73 -172.94 4.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' H ' HG22 ' A' ' 66' ' ' THR . 3.6 m-20 -93.45 -55.74 3.18 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.9 mt-10 -72.36 5.61 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.746 ' HB3' HG22 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -102.34 -31.85 10.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 61' ' ' PHE . 2.2 mm -72.24 -26.06 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -84.03 -66.73 0.86 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.774 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 1.069 ' OD1' HD13 ' A' ' 3' ' ' LEU . 53.9 t0 -58.61 -28.47 65.65 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.128 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 7.9 p -69.14 -26.73 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -75.18 -56.75 4.42 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.06 -19.62 53.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.025 ' HA ' HD12 ' A' ' 3' ' ' LEU . 78.6 t80 -67.85 -41.09 83.46 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.571 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 39.9 t -70.04 -22.61 24.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.567 HD11 ' N ' ' A' ' 44' ' ' GLU . 0.9 OUTLIER -85.39 -8.46 58.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 1.8 t70 -99.02 -35.52 10.02 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.946 0.879 . . . . 0.0 109.16 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.661 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -81.96 -34.01 29.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.233 0.54 . . . . 0.0 109.942 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -62.92 -48.16 80.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.852 . . . . 0.0 109.101 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.52 18.54 3.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.445 -0.784 . . . . 0.0 109.358 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -134.86 13.38 3.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 0.0 110.963 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 77.74 75.73 0.93 Allowed Glycine 0 C--N 1.296 -1.694 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.661 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 11.7 m95 -34.76 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.727 0.775 . . . . 0.0 109.417 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -59.09 -22.78 61.34 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 109.969 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.5 ' CA ' ' HA2' ' A' ' 20' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.801 HMA1 HD12 ' A' ' 47' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 1.7 m-20 73.13 -0.24 3.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.306 -0.871 . . . . 0.0 109.897 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.02 HD13 ' HA ' ' A' ' 76' ' ' TYR . 1.8 pp -72.88 2.21 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.074 -1.016 . . . . 0.0 109.613 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.14 70.55 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -62.86 -25.65 68.39 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -59.55 -51.2 60.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.714 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -45.54 -25.45 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.714 -1.463 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -75.0 -47.82 27.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 177.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.662 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 21.1 t -55.44 -64.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 121.948 0.88 . . . . 0.0 109.01 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.606 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 11.6 t80 -59.82 -31.79 70.05 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.768 -0.582 . . . . 0.0 111.11 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 43.1 p -88.53 18.69 4.38 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.788 -1.195 . . . . 0.0 109.653 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.616 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -155.7 3.74 0.2 Allowed Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.577 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 1.3 m120 -155.16 -49.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.631 -1.511 . . . . 0.0 109.409 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.65 ' SG ' HMB1 ' A' ' 88' ' ' HEC . 3.4 m -71.96 -34.99 69.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -44.99 -42.78 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 110.449 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.87 74.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.187 -0.946 . . . . 0.0 111.706 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.627 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 95.9 m -104.19 27.18 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.885 -1.134 . . . . 0.0 109.87 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.914 ' CE1' HD21 ' A' ' 31' ' ' LEU . 85.7 m-70 -159.89 -67.92 0.07 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.614 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.512 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 55.76 114.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.45 -0.781 . . . . 0.0 110.092 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.32 61.73 1.71 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.491 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 44.82 79.62 0.06 OUTLIER Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -160.81 83.35 0.13 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.772 ' H ' HG23 ' A' ' 30' ' ' THR . 5.1 t-20 -40.51 160.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.611 -0.935 . . . . 0.0 109.586 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.604 HG13 ' N ' ' A' ' 25' ' ' VAL . 14.7 p -116.3 -47.04 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.09 -1.006 . . . . 0.0 110.138 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.786 ' CG1' HMD3 ' A' ' 88' ' ' HEC . 9.1 p -95.82 -38.52 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -96.56 115.99 28.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.73 -1.231 . . . . 0.0 109.441 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -90.19 71.87 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.6 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER 177.6 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.378 -0.826 . . . . 0.0 109.049 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 5.5 mtmm -93.43 61.56 3.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.283 -0.886 . . . . 0.0 109.311 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.772 HG23 ' H ' ' A' ' 23' ' ' ASN . 5.1 m -85.17 166.2 16.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.746 . . . . 0.0 109.526 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.914 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -94.26 -12.22 28.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.595 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -37.37 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.587 -0.695 . . . . 0.0 111.182 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.074 ' CA ' HD21 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -165.74 -43.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.122 . . . . 0.0 110.386 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 mt-10 -67.31 -47.52 70.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.594 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -65.84 -45.97 80.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.675 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.074 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -62.63 -36.17 81.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' A' ' 33' ' ' LYS . 8.8 mt-10 -92.28 5.87 48.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.195 -0.941 . . . . 0.0 109.394 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -90.55 -55.6 3.52 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.594 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.71 -50.7 6.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.031 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.15 33.65 0.15 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.387 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.864 ' CE ' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -86.05 -25.85 25.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.647 -1.502 . . . . 0.0 108.562 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.786 ' CD2' HD12 ' A' ' 36' ' ' LEU . 8.2 t80 -41.86 -23.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.852 -0.53 . . . . 0.0 110.654 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 41' ' ' MET . 22.8 p -84.42 134.82 34.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.873 -1.142 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 48' ' ' ILE . 2.7 mt-10 -49.02 -54.94 13.59 Favored 'General case' 0 C--O 1.198 -1.627 0 O-C-N 121.51 -0.744 . . . . 0.0 109.524 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -52.26 -32.9 39.33 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.667 -1.27 . . . . 0.0 110.692 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' HB1' ' HA ' ' A' ' 41' ' ' MET . . . -67.72 -69.66 0.3 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.97 . . . . 0.0 111.152 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.672 ' CD1' HMA1 ' A' ' 88' ' ' HEC . 7.5 tt -66.76 -19.33 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.4 -0.812 . . . . 0.0 109.817 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.573 HG13 ' CB ' ' A' ' 74' ' ' ALA . 12.5 mt -68.04 -25.64 32.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.61 ' CD1' ' CE1' ' A' ' 53' ' ' HIS . 63.6 t80 -86.97 -68.65 0.73 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.547 ' CG ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -44.19 -25.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.515 -1.366 . . . . 0.0 108.825 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.909 ' CG1' HG23 ' A' ' 70' ' ' ILE . 55.8 t -80.36 -46.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 108.669 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.824 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -65.52 -13.23 58.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 111.954 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.824 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -154.57 20.02 0.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.446 -1.408 . . . . 0.0 108.515 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 56.41 -140.52 42.86 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.598 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 153.51 133.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 7.7 m-80 60.78 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.808 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -129.38 43.32 3.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.657 ' HE2' ' HA ' ' A' ' 51' ' ' VAL . 19.9 ttt -117.98 145.95 37.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.482 -0.761 . . . . 0.0 109.498 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.636 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.2 Cg_endo -81.83 101.63 1.18 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 123.373 2.715 . . . . 0.0 114.517 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.643 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.5 156.26 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.79 ' CZ ' HBB3 ' A' ' 88' ' ' HEC . 39.2 m-85 -137.02 3.74 2.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.596 -0.69 . . . . 0.0 109.434 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.39 -25.8 0.16 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.214 -0.929 . . . . 0.0 109.45 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -162.85 33.65 0.31 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -102.4 -46.57 4.74 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.628 HD11 ' CE1' ' A' ' 61' ' ' PHE . 73.8 mt -103.25 -145.72 0.37 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.605 HG21 ' OE1' ' A' ' 69' ' ' GLN . 9.2 m -98.47 167.41 10.83 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.367 -0.833 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 66' ' ' THR . 16.1 m-20 -82.7 -49.9 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.205 -0.934 . . . . 0.0 109.134 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.553 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 4.0 tt0 -64.63 -6.86 8.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.631 -0.668 . . . . 0.0 109.273 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.662 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -96.01 -35.77 11.27 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.909 HG23 ' CG1' ' A' ' 51' ' ' VAL . 3.8 mm -72.21 -11.54 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -66.97 0.87 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.296 1.046 . . . . 0.0 108.623 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.715 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 48.7 m-20 -53.4 -37.87 62.88 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.371 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.671 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 p -67.96 -28.98 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.55 0.691 . . . . 0.0 109.508 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.96 -59.31 2.79 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.47 -21.3 51.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.02 ' HA ' HD13 ' A' ' 3' ' ' LEU . 88.8 t80 -66.4 -42.49 87.79 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.864 HG11 ' CE ' ' A' ' 41' ' ' MET . 48.8 t -70.35 -22.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.719 ' N ' HD23 ' A' ' 78' ' ' LEU . 2.2 mt -81.26 -7.75 59.63 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.606 ' OD2' HD21 ' A' ' 3' ' ' LEU . 5.6 t0 -99.42 -47.38 5.17 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.069 0.937 . . . . 0.0 108.952 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.666 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 66.7 mm-40 -69.48 -39.89 77.4 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -59.97 -45.78 91.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 109.187 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.18 13.73 12.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 110.583 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -137.26 19.16 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.683 -1.261 . . . . 0.0 111.603 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.98 73.15 1.28 Allowed Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.142 -1.504 . . . . 0.0 109.366 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.666 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 1.9 m95 -40.83 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 122.316 -0.52 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 48.56 34.85 5.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.039 -1.038 . . . . 0.0 109.574 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 CA-C-O 118.009 -1.44 . . . . 0.0 109.584 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.808 HMD2 ' O ' ' A' ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.311 0.576 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.77 -25.17 4.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.472 HD13 ' CG ' ' A' ' 79' ' ' ASP . 1.3 mt -68.28 -5.86 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.153 -0.967 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.3 70.61 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.506 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.97 -30.7 62.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -58.97 -59.8 10.09 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.828 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -52.31 -28.86 20.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.761 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.519 ' HE3' ' OE1' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -62.51 -43.49 98.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.92 HG21 ' CB ' ' A' ' 69' ' ' GLN . 4.1 t -77.92 -49.61 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.444 -0.785 . . . . 0.0 109.815 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.609 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 5.1 t80 -60.57 -23.57 64.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.698 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 40.2 p -87.95 19.74 3.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.66 3.95 0.64 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' CB ' ' CD2' ' A' ' 65' ' ' LEU . 19.9 m120 -147.58 -48.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.745 -1.444 . . . . 0.0 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.609 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 1.9 m -78.98 -29.52 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 108.692 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -46.84 -40.11 13.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.655 -0.653 . . . . 0.0 110.009 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -42.42 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.011 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 80.2 m -116.67 32.9 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.425 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.593 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 67.0 m-70 -163.9 -76.83 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 109.153 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 52.04 114.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.493 0.663 . . . . 0.0 110.755 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 50.13 55.42 15.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 40.78 81.58 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -165.44 96.79 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.05 150.33 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -1.107 . . . . 0.0 109.399 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.68 -14.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.602 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.481 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 11.0 t -101.12 -68.68 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mmt -76.75 140.95 40.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.821 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -100.73 62.71 1.03 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.13 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 8.2 p-10 179.24 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.312 -0.867 . . . . 0.0 109.819 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HD3' HAD2 ' A' ' 88' ' ' HEC . 2.7 mttt -80.81 75.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.707 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 31' ' ' LEU . 3.0 m -89.78 175.07 7.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.781 ' O ' HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -102.22 -17.58 15.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.482 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.729 ' C ' HD21 ' A' ' 36' ' ' LEU . 2.7 mtpm? -48.18 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.717 -0.615 . . . . 0.0 111.955 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.879 ' CA ' HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -165.08 -45.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.689 -1.257 . . . . 0.0 111.003 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 3.6 mm-40 -61.83 -14.18 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 111.157 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -105.73 -45.74 4.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.969 -1.082 . . . . 0.0 110.695 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.879 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -61.9 -33.83 74.94 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.279 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.582 ' OE1' ' CD2' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -89.96 -4.0 57.71 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.619 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.14 -59.68 2.68 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.004 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -87.25 -51.54 5.91 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.995 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 141.18 24.32 0.23 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.948 -1.596 . . . . 0.0 111.672 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.881 ' CE ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -74.91 -20.05 59.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.556 -1.555 . . . . 0.0 108.321 178.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.83 ' CD2' HD12 ' A' ' 36' ' ' LEU . 6.9 t80 -46.83 -22.16 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.715 -0.616 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.679 ' OG ' ' HB2' ' A' ' 46' ' ' ALA . 50.8 p -90.26 129.79 36.46 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.17 -0.956 . . . . 0.0 110.192 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -43.38 -62.78 0.97 Allowed 'General case' 0 C--O 1.202 -1.425 0 O-C-N 121.624 -0.672 . . . . 0.0 109.361 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -49.23 -35.98 18.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.01 . . . . 0.0 110.855 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB2' ' OG ' ' A' ' 43' ' ' SER . . . -61.73 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.918 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.2 tt -58.91 -16.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 110.252 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 10.1 mt -70.45 -37.53 70.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 29.5 t80 -83.31 -18.3 39.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.702 ' NE2' ' HB2' ' A' ' 55' ' ' LYS . 6.0 tp60 -89.49 -10.78 45.03 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 47' ' ' ILE . 70.1 t -98.56 -50.14 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.864 . . . . 0.0 109.562 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.803 ' OE1' HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -58.55 -12.36 3.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 0.0 110.55 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.753 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -146.18 16.27 1.35 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.084 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.625 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 52.93 -121.25 14.89 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.702 ' HB2' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 162.24 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.761 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.035 178.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 55' ' ' LYS . 51.8 m-80 -20.02 -49.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.724 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -148.3 20.26 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 109.765 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.673 ' HE2' ' HA ' ' A' ' 51' ' ' VAL . 23.5 ttt -102.15 145.16 30.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 108.866 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.664 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.6 Cg_endo -79.7 111.7 2.81 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.824 2.349 . . . . 0.0 113.603 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -37.58 160.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.525 -0.734 . . . . 0.0 110.25 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.633 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 32.4 m-85 -142.44 16.11 2.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 108.98 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.23 -23.05 0.77 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.436 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.47 31.27 0.7 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.633 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -103.65 -56.9 2.12 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.025 HD11 HBB1 ' A' ' 88' ' ' HEC . 18.2 mt -61.82 -144.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 14.9 m -99.04 -63.24 1.14 Allowed 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.258 -0.901 . . . . 0.0 109.955 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.5 m-20 152.94 -56.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.6 tt0 -71.4 -0.01 9.27 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.92 ' CB ' HG21 ' A' ' 9' ' ' VAL . 2.4 mp0 -114.07 -24.32 9.08 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.803 HG21 ' OE1' ' A' ' 52' ' ' GLN . 9.8 mm -56.48 -21.74 13.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 172.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.9 mp0 -97.8 -68.3 0.81 Allowed 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.595 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.669 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 3.4 m-20 -51.22 -46.86 62.37 Favored 'General case' 0 C--O 1.199 -1.573 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.99 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -56.93 -29.1 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.626 -0.671 . . . . 0.0 110.042 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -80.15 -64.22 1.24 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -50.36 -23.05 2.1 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.493 -1.379 . . . . 0.0 107.323 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.828 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 17.1 t80 -66.5 -47.59 72.51 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.881 HG21 ' CE ' ' A' ' 41' ' ' MET . 1.8 p -68.11 -16.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 42' ' ' TYR . 5.1 mt -81.52 -15.74 53.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.472 ' CG ' HD13 ' A' ' 3' ' ' LEU . 1.2 t70 -97.95 -34.93 10.63 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.948 0.88 . . . . 0.0 108.899 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.749 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 2.3 mm-40 -83.54 -39.04 20.92 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.746 0.784 . . . . 0.0 110.035 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -51.45 -33.59 31.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.352 -0.842 . . . . 0.0 109.073 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -80.87 -28.79 35.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER 176.33 -24.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.155 -0.966 . . . . 0.0 111.0 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.728 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -61.18 -13.13 34.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.749 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 2.5 m95 -64.13 89.2 0.06 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -46.12 -25.92 0.67 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.222 -0.924 . . . . 0.0 108.913 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.067 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.471 179.809 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 1.025 HBB1 HD11 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -124.37 -22.13 4.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.409 -0.807 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 72' ' ' ASP . 6.5 mt -68.64 -7.19 30.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.182 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.02 67.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -71.94 -39.38 69.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.204 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 5' ' ' ASN . . . -47.39 -56.45 8.15 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.748 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -52.43 -38.66 59.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.264 . . . . 0.0 109.281 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.804 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -56.82 -40.51 76.14 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.94 HG21 ' CG ' ' A' ' 69' ' ' GLN . 38.6 t -80.69 -69.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.496 -0.752 . . . . 0.0 109.485 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 22.7 t80 -41.74 -25.31 0.05 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.389 -0.82 . . . . 0.0 111.257 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 63.7 m -92.1 32.92 1.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.464 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.57 -29.68 0.02 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.123 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.411 ' OD1' HG13 ' A' ' 9' ' ' VAL . 1.9 m120 -116.75 -48.85 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.919 -1.342 . . . . 0.0 108.702 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -77.39 -27.42 52.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.783 ' HB1' ' HG3' ' A' ' 19' ' ' MET . . . -54.01 -31.35 50.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.563 -0.71 . . . . 0.0 110.163 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.35 85.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 110.99 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.605 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.5 m -111.0 26.31 10.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.413 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 97.8 m-70 -156.94 -74.7 0.09 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.321 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.783 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 46.11 105.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.403 0.621 . . . . 0.0 111.096 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 78.13 42.31 15.88 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.522 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 42.25 37.07 2.27 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.92 90.6 0.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' HB3' ' CG ' ' A' ' 26' ' ' MET . 3.6 t-20 -49.38 168.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -1.075 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.703 HG23 ' H ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -144.07 -69.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.033 -1.042 . . . . 0.0 110.35 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.885 HG13 HMD3 ' A' ' 88' ' ' HEC . 1.2 p -44.24 -40.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.053 -1.029 . . . . 0.0 109.837 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.533 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -56.36 -168.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.919 -1.113 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -121.65 4.29 10.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 8.4 p-10 178.15 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.945 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.608 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -51.79 137.56 25.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.263 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.692 HG22 ' H ' ' A' ' 31' ' ' LEU . 4.0 m -123.64 179.93 4.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.399 -0.813 . . . . 0.0 109.198 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.692 ' H ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -100.66 -15.7 17.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.984 -1.073 . . . . 0.0 109.165 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.71 ' C ' HD21 ' A' ' 36' ' ' LEU . 5.2 mtpm? -56.45 -92.35 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.897 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.047 ' N ' HD21 ' A' ' 36' ' ' LEU . 3.9 pttm -179.41 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.946 -1.096 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 23.1 pt-20 -47.42 -37.16 10.99 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.661 -0.65 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.607 ' HA ' ' HB2' ' A' ' 38' ' ' GLN . . . -108.32 -61.14 1.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.77 -0.581 . . . . 0.0 111.161 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.047 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -40.68 -32.65 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 109.035 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.582 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -93.15 -33.31 14.08 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 120.962 -1.086 . . . . 0.0 108.637 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 4.8 tp-100 -40.73 -31.55 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.5 1.143 . . . . 0.0 108.254 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.608 ' CE2' ' HG3' ' A' ' 29' ' ' LYS . 3.8 m-85 -84.96 -50.99 7.02 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.5 ' C ' ' CG ' ' A' ' 41' ' ' MET . . . 127.68 64.37 0.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.616 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -171.39 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.97 -1.312 . . . . 0.0 110.675 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.66 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 2.5 t80 -92.48 23.48 3.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 108.632 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 54.3 p -104.58 165.67 10.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.628 -1.295 . . . . 0.0 110.338 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.523 ' O ' HG13 ' A' ' 48' ' ' ILE . 4.3 mt-10 -48.63 -70.51 0.09 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -50.05 -21.42 1.25 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.589 -1.319 . . . . 0.0 110.495 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -75.45 -73.59 0.25 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.204 -0.935 . . . . 0.0 110.39 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.3 tt -63.24 -14.1 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.845 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 44' ' ' GLU . 44.4 mt -74.6 -32.52 29.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.582 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 36.0 t80 -94.32 -15.52 24.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 1.5 tp60 -91.14 -10.28 42.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.7 t -103.66 -44.97 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.712 0.768 . . . . 0.0 109.275 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.807 ' HG3' HG21 ' A' ' 70' ' ' ILE . 1.5 mt-30 -61.24 -12.23 12.41 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.34 0.591 . . . . 0.0 110.459 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.774 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -151.75 20.55 0.7 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -178.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.62 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.77 -132.44 51.21 Favored Glycine 0 C--N 1.3 -1.42 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.52 139.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 121.388 0.614 . . . . 0.0 109.423 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 53.21 -88.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -127.55 43.29 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.982 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.671 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 11.1 ttt -126.14 143.37 45.48 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 109.367 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.793 ' HD3' HBC3 ' A' ' 88' ' ' HEC . 30.9 Cg_endo -76.64 120.55 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.108 2.539 . . . . 0.0 114.406 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.93 165.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.641 -0.662 . . . . 0.0 109.707 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.764 ' CD1' HD21 ' A' ' 65' ' ' LEU . 23.5 m-85 -145.77 11.53 1.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.177 -0.952 . . . . 0.0 109.842 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.35 -19.27 5.19 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.095 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.7 24.68 1.49 Allowed Glycine 0 N--CA 1.486 1.993 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.83 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.671 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt180 -101.93 -39.31 7.41 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.987 HD11 HBB1 ' A' ' 88' ' ' HEC . 2.4 mt -102.83 -154.12 0.49 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.496 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 67' ' ' ASP . 51.5 m -101.48 174.12 6.12 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.623 ' N ' HG22 ' A' ' 66' ' ' THR . 5.6 m-20 -72.6 -57.62 4.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.822 -1.174 . . . . 0.0 108.129 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 33.4 mt-10 -63.59 3.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.94 ' CG ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -104.51 -42.75 5.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.807 HG21 ' HG3' ' A' ' 52' ' ' GLN . 8.7 mm -56.65 -19.14 8.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.7 mm-40 -95.86 -73.56 0.59 Allowed 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 78.5 m-20 -39.63 -53.25 2.17 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.586 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.789 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 t -60.1 -42.28 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.434 1.112 . . . . 0.0 109.069 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -59.07 -65.85 0.6 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.301 -1.499 . . . . 0.0 107.211 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.581 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.0 -17.94 20.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.789 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 78.2 t80 -65.12 -40.67 94.82 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.684 HG21 HD11 ' A' ' 47' ' ' ILE . 96.8 t -74.65 -24.71 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.727 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -86.68 -8.8 57.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 7.3 t0 -99.54 -36.02 9.67 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.031 0.919 . . . . 0.0 109.186 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.618 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 5.4 mm-40 -79.76 -42.24 24.92 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.43 0.634 . . . . 0.0 109.708 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' HA ' ' A' ' 32' ' ' LYS . . . -74.79 -18.89 60.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.394 -0.816 . . . . 0.0 109.358 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.66 6.52 7.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.626 -0.671 . . . . 0.0 110.587 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.81 48.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.501 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.93 78.26 1.15 Allowed Glycine 0 N--CA 1.481 1.643 0 C-N-CA 118.643 -1.742 . . . . 0.0 109.215 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.631 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -36.02 90.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.578 0.704 . . . . 0.0 109.677 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -63.1 -39.97 96.25 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.669 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.034 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.987 HBB1 HD11 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.12 -20.46 3.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.314 -0.866 . . . . 0.0 110.027 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 79' ' ' ASP . 2.0 mp -70.39 -3.25 16.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.017 -1.052 . . . . 0.0 109.105 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.97 77.09 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.524 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -67.64 -25.43 65.72 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.59 -63.26 4.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.853 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -51.47 -33.13 29.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 0.0 109.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.49 -41.78 86.1 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 108.834 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.879 HG21 ' CB ' ' A' ' 69' ' ' GLN . 2.7 t -79.05 -51.85 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 10.4 t80 -54.72 -24.38 21.89 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.045 -1.034 . . . . 0.0 110.455 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -89.8 24.97 2.19 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.443 -0.786 . . . . 0.0 109.367 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.21 11.67 0.19 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.502 ' ND2' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -153.23 -40.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.78 -1.424 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -93.37 -31.06 14.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 108.827 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -42.26 -45.77 4.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.32 84.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 110.535 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.602 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 59.6 m -111.44 28.23 8.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.978 -1.076 . . . . 0.0 110.23 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.93 ' CE1' HD21 ' A' ' 31' ' ' LEU . 76.8 m-70 -161.56 -73.81 0.06 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.246 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 55.24 114.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.745 -0.597 . . . . 0.0 110.574 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.19 62.8 1.45 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.62 65.88 1.24 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -150.26 69.37 0.32 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.575 HD21 ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -48.01 166.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.099 -1.236 . . . . 0.0 109.202 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 25' ' ' VAL . 3.1 m -128.86 -37.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.956 -1.09 . . . . 0.0 109.908 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.532 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 2.4 t -82.67 -40.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.09 -1.006 . . . . 0.0 109.199 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.661 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.2 mpp? -61.23 -56.94 14.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 26' ' ' MET . . . 74.38 27.25 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 7.8 p-10 -179.34 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 1.3 mtmp? -90.34 57.01 3.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 109.499 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.743 ' C ' HD23 ' A' ' 31' ' ' LEU . 4.9 m -67.51 178.33 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.93 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.8 OUTLIER -98.99 -8.98 24.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.71 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -45.88 -76.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.886 -1.134 . . . . 0.0 110.481 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.06 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 167.55 -43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 109.844 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 21.6 pt-20 -56.35 -25.99 51.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.216 -0.927 . . . . 0.0 110.415 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.853 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -101.85 -59.65 1.67 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.06 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -48.52 -31.8 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.01 -1.056 . . . . 0.0 109.774 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.578 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 38.5 mt-10 -91.42 -23.62 19.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.536 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 21.0 tp60 -61.67 -42.04 98.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.853 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -89.8 -76.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.873 0.844 . . . . 0.0 109.005 178.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.42 84.92 0.05 OUTLIER Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.498 ' CE ' HAA2 ' A' ' 88' ' ' HEC . 5.2 ptt? -168.26 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -1.22 . . . . 0.0 109.617 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.008 ' HB2' HD12 ' A' ' 36' ' ' LEU . 7.1 t80 -103.2 19.26 19.94 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.151 -0.968 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -105.77 144.09 32.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 0.0 110.611 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.732 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -45.6 -65.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.778 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.463 ' N ' HD12 ' A' ' 48' ' ' ILE . 64.3 t0 -49.4 -31.84 10.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.826 -1.171 . . . . 0.0 110.748 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -64.78 -78.54 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.725 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.4 tt -57.98 -16.19 6.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.552 0.692 . . . . 0.0 110.211 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.732 HD12 ' C ' ' A' ' 44' ' ' GLU . 23.2 mt -71.67 -38.53 67.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.774 ' HA ' ' HE1' ' A' ' 53' ' ' HIS . 33.3 t80 -86.38 -11.55 51.71 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 5.6 tp60 -95.88 -12.88 24.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 47' ' ' ILE . 56.4 t -102.58 -37.19 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.033 0.921 . . . . 0.0 109.474 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.719 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -66.2 -11.17 48.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.774 ' HE1' ' HA ' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -164.93 38.34 0.07 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.681 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 44.74 -133.42 7.37 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.08 125.95 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.587 -0.807 . . . . 0.0 108.846 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 73.6 m-80 65.04 -85.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.543 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.629 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -126.0 37.58 4.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 0.0 109.594 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.698 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 26.6 ttt -116.3 142.28 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 108.796 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.698 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.1 Cg_endo -71.24 103.44 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.873 2.382 . . . . 0.0 113.451 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.738 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -58.79 107.55 0.53 Allowed 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.866 -0.521 . . . . 0.0 110.385 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.838 ' CD2' HD21 ' A' ' 65' ' ' LEU . 75.5 m-85 -77.1 -41.06 43.6 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.884 -1.135 . . . . 0.0 108.259 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.26 19.14 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.674 -0.641 . . . . 0.0 109.493 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 61' ' ' PHE . . . 122.37 44.28 0.36 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 65' ' ' LEU . 15.6 ttt-85 -102.48 -54.0 2.77 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.839 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -62.07 -146.39 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 69' ' ' GLN . 78.8 m -97.42 154.22 17.61 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.907 ' HA ' HD12 ' A' ' 70' ' ' ILE . 7.7 t0 -63.24 -53.68 49.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.944 -1.097 . . . . 0.0 108.303 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 tt0 -64.76 1.57 0.85 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.003 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.879 ' CB ' HG21 ' A' ' 9' ' ' VAL . 2.2 mp0 -115.34 -25.47 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.145 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.907 HD12 ' HA ' ' A' ' 67' ' ' ASP . 3.7 mt -59.24 -19.95 17.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.5 mp0 -97.51 -67.0 0.87 Allowed 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 114.546 -1.207 . . . . 0.0 108.332 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.698 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 18.4 m-20 -52.74 -46.08 67.29 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.001 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -56.51 -27.88 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.919 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.655 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -81.69 -63.48 1.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.23 -22.29 2.59 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.853 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 23.0 t80 -67.93 -46.82 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.826 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.669 HG23 ' HZ2' ' A' ' 85' ' ' TRP . 1.5 p -68.77 -15.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.557 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 4.8 mt -84.28 -14.78 48.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.429 ' HB2' HD22 ' A' ' 3' ' ' LEU . 9.4 t0 -96.91 -39.63 9.3 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.763 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.2 mm-40 -80.02 -38.31 32.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.891 0.853 . . . . 0.0 109.411 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -52.26 -30.18 26.56 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -87.55 -25.38 23.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 110.153 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 176.61 -24.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.077 -1.014 . . . . 0.0 111.059 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.733 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -65.24 -12.47 55.5 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.763 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 3.3 m95 -64.81 88.57 0.07 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -48.76 -24.42 1.4 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.324 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.131 0 CA-C-O 117.997 -1.446 . . . . 0.0 109.664 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.629 HMD2 ' O ' ' A' ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.445 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 1.0 OUTLIER 71.52 6.32 5.69 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.24 -0.913 . . . . 0.0 109.461 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 72' ' ' ASP . 5.9 mt -76.19 -0.67 23.02 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.172 -0.955 . . . . 0.0 109.33 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -70.1 -27.36 64.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 7' ' ' ALA . . . -59.6 -65.38 3.47 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -43.13 -33.11 0.82 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -1.161 . . . . 0.0 109.445 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HE3' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -65.26 -50.77 64.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.861 HG21 ' CB ' ' A' ' 69' ' ' GLN . 3.2 t -67.54 -59.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.266 -0.896 . . . . 0.0 108.692 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.639 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 9.2 t80 -50.28 -26.78 5.15 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 13.1 t -85.87 25.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 109.741 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.39 13.36 0.1 OUTLIER Glycine 0 N--CA 1.484 1.874 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.998 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.803 ' CG ' HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.57 -48.76 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 109.381 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.639 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.3 m -81.97 -28.81 32.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -43.39 -41.29 4.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.476 -0.765 . . . . 0.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.7 -50.32 68.58 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.124 -0.985 . . . . 0.0 111.233 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 7.8 m -109.81 23.92 13.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.168 . . . . 0.0 110.46 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 95.5 m-70 -156.16 -70.32 0.11 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.452 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.518 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.3 ptt? 38.72 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.514 ' HA2' ' HA3' ' A' ' 87' ' ' GLY . . . 80.07 49.28 6.04 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB2' ' A' ' 31' ' ' LEU . . . 37.63 36.15 0.26 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.75 95.69 0.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.576 ' OD1' ' CE1' ' A' ' 18' ' ' HIS . 3.7 t-20 -57.71 -176.9 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.273 -1.134 . . . . 0.0 109.441 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -156.93 -78.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 109.793 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.894 HG13 HMD3 ' A' ' 88' ' ' HEC . 1.4 p -41.58 -39.99 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 110.044 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.553 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -54.1 -166.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.024 -1.047 . . . . 0.0 109.746 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -126.34 2.15 7.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.013 -1.055 . . . . 0.0 109.919 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 9.2 p-10 178.89 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.018 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' HD3' HAD2 ' A' ' 88' ' ' HEC . 1.0 OUTLIER -58.62 122.83 14.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 -179.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 31' ' ' LEU . 5.9 m -124.03 175.94 6.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.679 ' H ' HG22 ' A' ' 30' ' ' THR . 2.1 mp -99.52 -9.92 22.73 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.818 -0.551 . . . . 0.0 111.138 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.825 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -56.38 -102.32 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.292 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' N ' HD21 ' A' ' 36' ' ' LEU . 19.8 ptmt -155.74 -43.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.48 -1.388 . . . . 0.0 109.803 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 7.2 pt-20 -63.64 -40.51 97.06 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 110.636 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -79.22 -52.17 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 111.482 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -65.32 -11.48 42.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.718 -1.238 . . . . 0.0 108.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.608 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -119.67 -1.61 10.57 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.273 -0.892 . . . . 0.0 108.777 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.539 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 12.8 tp60 -65.45 -48.32 73.12 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.602 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -86.48 -31.62 21.24 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.22 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 117.29 99.38 2.05 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.648 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.582 ' SD ' ' CE1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 156.42 46.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.852 -0.793 . . . . 0.0 108.987 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.8 ' HA ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -104.79 18.78 21.68 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.976 0.893 . . . . 0.0 108.853 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 47' ' ' ILE . 53.6 p -105.17 166.31 10.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.131 -0.981 . . . . 0.0 110.604 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.556 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 6.8 mt-10 -48.4 -59.9 3.1 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 109.503 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -57.05 -25.94 59.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.588 -1.32 . . . . 0.0 110.976 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 41' ' ' MET . . . -69.31 -70.21 0.29 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.973 -1.079 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.72 HD12 HMA1 ' A' ' 88' ' ' HEC . 5.4 tt -63.0 -27.4 43.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 121.859 0.838 . . . . 0.0 109.262 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.569 HG13 ' CB ' ' A' ' 74' ' ' ALA . 31.2 mt -64.86 -22.38 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.686 -0.634 . . . . 0.0 109.343 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -91.93 -56.7 2.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.912 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.54 HE21 HMA2 ' A' ' 88' ' ' HEC . 5.7 pm0 -59.68 -14.46 14.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.201 -1.562 . . . . 0.0 109.186 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.71 HG12 ' HB2' ' A' ' 61' ' ' PHE . 57.4 t -101.27 -41.09 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.284 -0.885 . . . . 0.0 110.712 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.608 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 1.0 OUTLIER -59.79 -14.69 15.84 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.892 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.625 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.72 25.51 0.51 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.605 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 57.91 -140.8 45.76 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.8 135.1 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 14.8 m120 63.62 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.54 45.38 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.554 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.684 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 10.9 ttt -127.45 144.8 52.19 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 110.107 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.852 ' HD3' HBC3 ' A' ' 88' ' ' HEC . 30.3 Cg_endo -76.85 116.32 4.22 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.299 2.666 . . . . 0.0 114.261 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.83 162.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.092 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.722 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 25.8 m-85 -143.61 7.21 1.48 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.245 -0.909 . . . . 0.0 110.053 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.54 -20.41 4.96 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.195 -0.94 . . . . 0.0 108.774 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.45 27.4 1.36 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.722 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 6.0 mmt85 -101.32 -44.73 5.55 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.007 HD11 HBB1 ' A' ' 88' ' ' HEC . 7.9 mt -87.07 -152.93 0.2 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.29 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.575 HG22 ' N ' ' A' ' 67' ' ' ASP . 31.3 m -99.43 164.86 11.92 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.72 ' HA ' HD12 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -63.15 -57.37 10.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.443 1.116 . . . . 0.0 108.032 178.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.579 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.2 tt0 -64.18 2.92 0.49 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.354 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.861 ' CB ' HG21 ' A' ' 9' ' ' VAL . 1.3 mp0 -115.18 -26.48 7.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.851 -1.156 . . . . 0.0 109.2 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 67' ' ' ASP . 2.6 mt -59.31 -19.53 16.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.5 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.6 mp0 -97.58 -71.28 0.69 Allowed 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.497 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.631 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 24.6 m-20 -47.36 -46.41 25.67 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.979 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.692 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -62.17 -31.26 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.426 0.631 . . . . 0.0 110.546 -178.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.665 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.67 -62.14 1.64 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.97 -22.07 13.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.82 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.6 t80 -62.76 -45.57 92.06 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.716 HG13 ' HZ2' ' A' ' 85' ' ' TRP . 72.4 t -67.29 -27.47 39.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.794 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -81.24 -9.32 59.8 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.236 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.458 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.0 t70 -100.29 -33.52 10.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.133 0.968 . . . . 0.0 109.714 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.637 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 2.8 mm100 -77.24 -38.39 51.2 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -71.88 -17.22 62.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.27 10.0 23.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 111.101 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -164.26 37.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.965 -1.494 . . . . 0.0 112.728 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 85.1 77.08 1.19 Allowed Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.764 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.716 ' HZ2' HG13 ' A' ' 77' ' ' VAL . 4.0 m95 -36.08 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.546 0.688 . . . . 0.0 109.185 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -60.68 -45.26 94.85 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.603 -0.686 . . . . 0.0 109.841 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.514 ' HA3' ' HA2' ' A' ' 20' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.146 0 CA-C-O 117.957 -1.468 . . . . 0.0 109.579 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 1.007 HBB1 HD11 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -116.34 -28.52 6.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.945 . . . . 0.0 109.279 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.434 HD23 ' C ' ' A' ' 75' ' ' ALA . 1.5 mp -75.65 -14.77 60.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.21 68.52 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.529 ' O ' ' HE2' ' A' ' 8' ' ' LYS . 1.3 m-20 -80.33 -30.35 38.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.548 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -53.86 -48.33 62.49 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.807 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -58.94 -28.27 66.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.82 -0.812 . . . . 0.0 109.8 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.71 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -68.59 -28.15 66.68 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.008 -1.058 . . . . 0.0 108.717 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.081 HG21 ' CB ' ' A' ' 69' ' ' GLN . 41.1 t -100.16 -18.56 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.454 -0.779 . . . . 0.0 110.479 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.607 ' HE2' HD12 ' A' ' 31' ' ' LEU . 12.7 t80 -97.03 -19.93 18.39 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.89 -1.131 . . . . 0.0 109.694 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -99.38 7.46 45.51 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.664 -0.648 . . . . 0.0 109.584 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.18 2.28 2.58 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.04 -62.44 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.129 -1.218 . . . . 0.0 108.742 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.653 ' SG ' HMB1 ' A' ' 88' ' ' HEC . 6.8 m -60.89 -34.49 74.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.626 ' HB1' ' HG2' ' A' ' 19' ' ' MET . . . -54.93 -36.21 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 110.124 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.01 -44.74 74.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.392 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 92.8 m -109.0 13.53 24.61 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.715 ' ND1' HD21 ' A' ' 31' ' ' LEU . 91.9 m-70 -160.92 38.94 0.15 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.626 ' HG2' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -63.0 141.09 58.9 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.62 45.79 8.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 42.32 68.05 0.79 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -147.61 96.53 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 22' ' ' GLY . 1.2 t-20 -43.9 139.9 2.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -1.142 . . . . 0.0 109.289 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 4.4 m -105.68 -17.8 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 0.0 110.104 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.552 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 39.0 t -98.83 -69.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 0.0 109.469 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 18.4 mmt -84.22 149.79 25.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -107.15 71.91 0.85 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.301 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.824 HD21 ' HE2' ' A' ' 39' ' ' PHE . 11.7 p-10 179.6 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.328 -0.857 . . . . 0.0 109.332 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.588 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.5 mptt -89.7 91.28 8.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 0.0 109.312 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.008 ' C ' HD22 ' A' ' 36' ' ' LEU . 1.8 m -98.76 -169.46 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 0.0 109.079 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.715 HD21 ' ND1' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -105.69 -6.51 19.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.73 -1.231 . . . . 0.0 109.576 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -54.38 -88.45 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.371 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.848 ' HG2' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER 167.11 -38.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.844 -1.16 . . . . 0.0 110.692 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG3' ' HE2' ' A' ' 33' ' ' LYS . 85.9 mt-10 -54.38 -28.25 42.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 110.036 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.565 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -107.43 -57.74 2.05 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.053 0.93 . . . . 0.0 110.495 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.008 HD22 ' C ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -62.05 -43.5 98.71 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.42 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.555 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 56.7 tt0 -69.04 -19.49 64.1 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.529 -1.357 . . . . 0.0 108.868 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 3.8 tp-100 -77.83 -83.83 0.08 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.847 0.832 . . . . 0.0 109.389 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.824 ' HE2' HD21 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -91.41 5.1 50.7 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.639 0.733 . . . . 0.0 110.598 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -108.69 -21.21 7.64 Favored Glycine 0 C--N 1.289 -2.062 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.02 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.94 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 51.64 69.32 0.68 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.742 ' CE2' HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -86.29 -3.73 59.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.179 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.501 ' O ' HG22 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -45.35 162.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.252 -0.905 . . . . 0.0 111.013 -179.004 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.799 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -46.86 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.009 -1.057 . . . . 0.0 109.518 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.551 ' N ' HD12 ' A' ' 48' ' ' ILE . 29.2 t0 -54.64 -17.04 2.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.786 -1.196 . . . . 0.0 110.66 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.94 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -81.04 -79.76 0.15 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.977 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.7 tt -54.27 -20.76 5.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.73 -1.231 . . . . 0.0 109.656 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.799 HD12 ' C ' ' A' ' 44' ' ' GLU . 10.3 mt -59.92 -43.12 91.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.628 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 20.0 t80 -80.5 -16.89 53.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.64 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 4.4 tp60 -86.47 -8.16 57.82 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.643 -1.286 . . . . 0.0 107.925 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 47' ' ' ILE . 42.1 t -108.48 -33.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.848 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -70.22 -7.55 42.93 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.745 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -165.96 38.24 0.05 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.522 -178.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 47.5 -133.67 14.94 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.95 132.75 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 57.6 m-80 62.05 -88.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.918 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -130.92 50.86 2.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 108.971 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.665 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 24.7 ttt -124.43 142.13 39.5 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 109.065 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.665 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 26.4 Cg_endo -68.34 104.17 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.804 2.336 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.745 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -59.22 118.33 5.78 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.78 ' CE2' HD21 ' A' ' 65' ' ' LEU . 13.2 m-85 -86.29 -49.41 7.7 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.93 -1.106 . . . . 0.0 108.211 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.58 26.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.22 0.533 . . . . 0.0 109.808 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.51 32.55 0.66 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.588 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.84 -48.69 4.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.028 HD13 HG11 ' A' ' 9' ' ' VAL . 29.5 mt -62.52 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.574 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 3.0 m -98.3 -54.92 2.91 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.109 -0.995 . . . . 0.0 108.956 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 66' ' ' THR . 2.6 m-20 150.87 -59.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 68.8 mm-40 -67.06 -1.84 4.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.04 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 1.081 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -112.05 -29.76 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.96 HD13 HD12 ' A' ' 65' ' ' LEU . 39.6 mm -57.05 -20.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.492 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.1 mt-30 -100.15 -64.19 1.06 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.584 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.639 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 34.5 m-20 -52.15 -48.66 64.79 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.089 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 69' ' ' GLN . 2.2 p -54.53 -27.21 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.918 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.751 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -81.27 -66.41 0.89 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' C ' HD23 ' A' ' 3' ' ' LEU . . . -50.1 -23.77 2.33 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.163 -1.586 . . . . 0.0 107.392 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.807 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.1 t80 -63.55 -47.6 80.92 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.2 p -65.4 -25.59 37.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.742 HD22 ' CE2' ' A' ' 42' ' ' TYR . 1.1 mt -77.34 -9.87 59.1 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.964 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.99 -43.73 6.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.051 0.929 . . . . 0.0 109.411 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.603 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 18.4 mm-40 -65.94 -44.82 83.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.848 ' HB1' ' HG2' ' A' ' 33' ' ' LYS . . . -68.78 -11.36 60.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.3 7.01 37.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 111.005 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -175.09 46.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.235 -1.541 . . . . 0.0 112.739 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.602 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 88.5 76.7 1.29 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.869 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.714 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -39.93 83.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 45.87 24.82 0.25 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 109.541 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.956 0 CA-C-O 118.032 -1.427 . . . . 0.0 109.605 -179.887 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.918 HMD2 ' O ' ' A' ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 25.7 t0 -124.22 144.42 49.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.157 -0.965 . . . . 0.0 109.479 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.011 HD13 ' HA ' ' A' ' 76' ' ' TYR . 2.4 pp -68.83 -0.2 5.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.905 -1.122 . . . . 0.0 108.971 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.543 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.7 t-20 -47.63 -28.69 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.51 -57.74 17.89 Favored Glycine 0 C--O 1.199 -2.034 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -45.93 -28.16 1.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.761 -1.435 . . . . 0.0 110.066 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.775 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.05 -46.25 71.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.044 HG21 ' CB ' ' A' ' 69' ' ' GLN . 24.6 t -73.49 -51.76 24.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.819 -0.551 . . . . 0.0 110.115 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 6.1 t80 -62.5 -28.85 70.12 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.717 -1.239 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 47.0 t -84.09 15.15 3.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.878 . . . . 0.0 109.701 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.63 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -160.95 11.95 0.14 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 6.7 m120 -156.43 -54.08 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.449 . . . . 0.0 108.831 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.677 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -74.06 -26.15 60.24 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.499 0.666 . . . . 0.0 109.287 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -57.57 -39.51 76.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.574 -0.704 . . . . 0.0 110.393 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.94 62.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.136 -0.977 . . . . 0.0 111.057 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 99.9 m -124.79 8.81 8.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.826 -1.171 . . . . 0.0 110.691 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.727 ' CG ' HD22 ' A' ' 31' ' ' LEU . 87.8 m-70 -150.12 -65.45 0.21 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.136 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.478 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 1.2 ttt 56.25 113.08 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.269 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 39.42 60.35 1.71 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.646 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 49.43 73.33 0.37 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -155.72 81.43 0.17 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.643 ' H ' HG23 ' A' ' 30' ' ' THR . 1.6 t-20 -54.61 163.26 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.249 . . . . 0.0 109.223 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 17' ' ' CYS . 6.3 m -144.4 17.11 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.041 . . . . 0.0 109.889 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.618 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 43.1 t -126.58 -55.99 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.098 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.528 ' HE2' HBD2 ' A' ' 88' ' ' HEC . 3.2 mmt -75.47 -172.51 1.82 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -134.39 46.47 2.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.102 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 9.6 p-10 178.2 -44.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 109.366 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 2.0 mttp -74.18 110.62 8.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.557 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.769 HG22 ' H ' ' A' ' 32' ' ' LYS . 92.3 m -133.43 149.33 51.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.317 -0.865 . . . . 0.0 109.25 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.967 HD11 ' C3A' ' A' ' 88' ' ' HEC . 5.9 mp -74.95 -18.67 60.35 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.848 -0.533 . . . . 0.0 111.096 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.769 ' H ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -40.61 -82.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.476 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.558 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 0.4 OUTLIER 174.72 -42.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.548 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 3.7 mm-40 -56.1 -34.85 66.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.584 -0.697 . . . . 0.0 109.594 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -99.17 -39.53 8.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.408 -0.808 . . . . 0.0 110.369 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.845 HD11 ' HD2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -69.75 -10.28 57.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.554 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 17.1 mt-10 -118.78 3.78 11.6 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 21.0 tp60 -83.59 -51.15 7.55 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.588 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -86.67 -35.54 19.27 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.779 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.63 51.75 0.24 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.955 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.775 ' SD ' HMA2 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -112.13 8.07 19.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.017 -1.284 . . . . 0.0 108.747 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.845 ' HD2' HD11 ' A' ' 36' ' ' LEU . 41.0 t80 -69.43 10.78 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.991 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.3 p -105.7 143.85 33.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.548 -1.345 . . . . 0.0 110.179 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.539 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 5.1 mt-10 -46.28 -58.45 3.68 Favored 'General case' 0 C--O 1.203 -1.355 0 O-C-N 121.379 -0.826 . . . . 0.0 109.29 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 45' ' ' ASP . 9.3 t0 -47.88 -37.19 13.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -0.963 . . . . 0.0 110.829 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.07 -70.27 0.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.812 ' CD1' HMA1 ' A' ' 88' ' ' HEC . 15.3 tt -66.06 -9.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.891 0.853 . . . . 0.0 109.884 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CD1' ' HB3' ' A' ' 44' ' ' GLU . 22.3 mt -87.57 -25.53 6.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.482 ' OH ' ' HE2' ' A' ' 55' ' ' LYS . 25.6 t80 -88.72 -23.39 22.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 1.045 ' NE2' HG23 ' A' ' 51' ' ' VAL . 4.2 pp0? -94.17 -26.45 16.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.438 -1.414 . . . . 0.0 108.289 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.045 HG23 ' NE2' ' A' ' 50' ' ' GLN . 2.9 t -75.02 -49.51 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.885 0.85 . . . . 0.0 109.01 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.789 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.7 OUTLIER -64.91 -12.53 50.29 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.809 -0.557 . . . . 0.0 111.525 -177.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.789 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -147.46 13.24 1.06 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.58 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.703 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.19 -136.09 24.81 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 106.754 -2.539 . . . . 0.0 106.754 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 149.94 141.09 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 50.32 -90.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -129.35 49.39 2.25 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.712 ' HE1' ' HA ' ' A' ' 51' ' ' VAL . 7.1 ttt -125.2 146.48 54.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.644 ' CD ' ' C3C' ' A' ' 88' ' ' HEC . 36.2 Cg_endo -80.97 107.82 1.97 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 123.363 2.709 . . . . 0.0 114.81 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.703 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -40.79 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 111.135 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.738 ' HZ ' HMC2 ' A' ' 88' ' ' HEC . 56.0 m-85 -150.25 14.34 0.79 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . . . -47.17 -28.49 1.85 Allowed 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.263 -0.898 . . . . 0.0 109.136 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.32 35.05 0.52 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.3 -42.99 6.1 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.11 HD11 HBB1 ' A' ' 88' ' ' HEC . 21.1 mt -77.09 -143.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.582 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 3.0 m -98.22 -59.45 1.75 Allowed 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.5 OUTLIER 153.26 -55.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 12.4 tt0 -68.79 -1.48 7.2 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 1.044 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -108.35 -31.35 7.89 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 HD12 ' A' ' 65' ' ' LEU . 23.6 mm -57.54 -20.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.473 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.8 mp0 -99.09 -71.0 0.71 Allowed 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.01 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 87.5 m-20 -45.72 -49.77 14.39 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.176 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -60.75 -32.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.505 0.669 . . . . 0.0 110.082 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -69.82 -65.51 0.71 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.203 -1.561 . . . . 0.0 106.856 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.482 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.05 -21.86 9.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.011 ' HA ' HD13 ' A' ' 3' ' ' LEU . 62.5 t80 -63.84 -45.1 91.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.603 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.745 HG11 ' HG ' ' A' ' 31' ' ' LEU . 60.7 t -68.89 -25.22 29.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.823 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -82.65 -9.05 59.55 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.037 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 10.9 t0 -99.35 -34.52 10.27 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.653 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 4.4 mm-40 -78.57 -34.57 46.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.377 0.608 . . . . 0.0 110.003 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.595 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -65.17 -43.61 91.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.366 -0.834 . . . . 0.0 109.792 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.94 14.83 11.15 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.284 -0.885 . . . . 0.0 110.85 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 12.8 ptmt -142.86 23.57 1.9 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.512 -1.367 . . . . 0.0 111.665 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 87.3 72.6 1.29 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.032 -1.556 . . . . 0.0 109.756 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.684 ' HZ2' HG13 ' A' ' 77' ' ' VAL . 1.1 m95 -40.85 85.06 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.202 -0.587 . . . . 0.0 110.797 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 45.74 26.21 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.133 -0.979 . . . . 0.0 109.485 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.088 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.522 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 1.11 HBB1 HD11 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.295 0.569 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 5.2 m-20 -109.93 145.29 37.15 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.194 -0.941 . . . . 0.0 109.199 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.094 HD23 ' HA ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -75.69 2.6 11.58 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.308 177.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.583 ' N ' HD13 ' A' ' 3' ' ' LEU . . . -59.92 -42.49 94.05 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.505 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.5 t-20 -51.34 -32.88 27.12 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -54.49 -47.51 69.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.81 -33.45 10.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.657 -1.496 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.03 -43.99 81.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.65 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.769 ' CG1' HD13 ' A' ' 65' ' ' LEU . 18.3 t -62.43 -72.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.632 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 16.0 t80 -49.72 -26.62 3.96 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.703 -0.623 . . . . 0.0 111.237 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 19.6 t -92.35 31.38 1.32 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 109.008 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.554 ' HB2' HBB1 ' A' ' 88' ' ' HEC . 1.0 OUTLIER -129.33 -46.18 1.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.83 -1.394 . . . . 0.0 109.563 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.734 ' SG ' HMB1 ' A' ' 88' ' ' HEC . 3.5 m -76.48 -25.02 53.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.746 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -59.3 -35.49 73.88 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.805 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.87 97.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.35 -0.844 . . . . 0.0 111.64 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.618 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 0.1 OUTLIER -108.26 26.48 10.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.757 -1.214 . . . . 0.0 109.494 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.894 ' CE1' HD21 ' A' ' 31' ' ' LEU . 92.5 m-70 -160.02 -54.5 0.06 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.234 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 18' ' ' HIS . 3.9 ptp 39.41 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.479 0.657 . . . . 0.0 110.794 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 67.6 52.23 31.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 41.72 57.39 3.39 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.644 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -147.26 86.63 0.16 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.512 ' HB3' ' CE ' ' A' ' 26' ' ' MET . 2.9 t-20 -51.13 159.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -1.096 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.84 -10.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 26' ' ' MET . 18.1 t -100.2 -62.78 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.074 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.512 ' CE ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -51.53 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.847 . . . . 0.0 109.773 179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.44 -8.53 10.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -153.33 -37.65 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.278 -0.888 . . . . 0.0 109.586 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 39' ' ' PHE . 5.9 tptt -46.21 90.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.485 -0.76 . . . . 0.0 109.804 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.644 HG23 ' HA2' ' A' ' 22' ' ' GLY . 7.1 m -117.63 151.55 36.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.894 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -78.88 -7.73 58.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.324 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HD3' HG21 ' A' ' 30' ' ' THR . 1.1 mtpt -51.52 162.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.529 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.581 ' CA ' ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.02 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -61.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 110.733 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.58 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.99 -35.62 69.53 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 111.239 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.826 HD23 ' O ' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -64.74 -43.43 93.39 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.854 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.572 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -90.68 13.23 16.65 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.187 -0.946 . . . . 0.0 109.129 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 16.8 tp60 -82.21 -49.82 9.68 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.599 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -87.07 -42.73 12.83 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.333 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.87 82.13 0.4 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.675 ' HE3' ' HA ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -158.68 24.53 0.23 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.286 -1.126 . . . . 0.0 108.496 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.718 ' HB2' HD11 ' A' ' 36' ' ' LEU . 43.3 t80 -84.38 15.83 3.42 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.494 0.664 . . . . 0.0 109.225 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.61 134.39 47.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.791 -1.193 . . . . 0.0 111.126 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -45.07 -59.76 2.44 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -48.03 -37.98 16.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.064 -1.022 . . . . 0.0 110.492 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.9 -73.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.7 tt -65.28 -9.52 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.531 -0.73 . . . . 0.0 110.338 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 44' ' ' GLU . 9.1 mt -78.91 -35.57 18.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 37.0 t80 -91.08 -14.41 31.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.626 ' NE2' ' CHA' ' A' ' 88' ' ' HEC . 1.1 tp60 -90.63 -17.57 26.64 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 47' ' ' ILE . 68.5 t -94.27 -45.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.763 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -62.79 -9.78 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.597 -0.69 . . . . 0.0 110.949 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.763 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -153.98 22.25 0.51 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.622 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 54.58 -133.44 47.01 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.75 135.75 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 121.389 0.614 . . . . 0.0 109.545 178.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m120 54.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.862 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -126.01 55.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.698 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.671 ' HE2' ' HA ' ' A' ' 51' ' ' VAL . 9.8 ttt -142.85 142.51 22.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 109.116 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.656 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 29.5 Cg_endo -75.07 117.21 4.82 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 123.385 2.723 . . . . 0.0 115.036 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.67 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -43.07 164.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.794 ' CZ ' HBB3 ' A' ' 88' ' ' HEC . 49.4 m-85 -143.12 12.63 1.81 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.44 -0.788 . . . . 0.0 109.433 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.93 -26.09 0.25 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.416 -0.802 . . . . 0.0 108.899 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -151.44 35.31 0.88 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.683 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt85 -103.38 -50.98 3.32 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.781 HD12 HD13 ' A' ' 70' ' ' ILE . 5.9 mt -86.81 -157.59 0.38 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 67' ' ' ASP . 5.6 m -100.88 -179.09 3.96 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.704 ' H ' HG22 ' A' ' 66' ' ' THR . 3.0 m-20 -76.34 -59.51 2.74 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.678 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.556 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 8.0 tt0 -66.22 -7.68 19.76 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.709 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -95.39 -34.94 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.781 HD13 HD12 ' A' ' 65' ' ' LEU . 4.3 mm -67.91 -14.47 18.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.448 ' OE1' HG22 ' A' ' 70' ' ' ILE . 2.3 mp0 -98.7 -71.57 0.69 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.465 1.126 . . . . 0.0 109.071 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.706 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 58.9 m-20 -47.42 -38.6 13.73 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.89 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.74 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 3.5 p -66.52 -36.79 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.704 0.764 . . . . 0.0 109.885 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.728 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -68.35 -60.21 2.61 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 119.949 -1.719 . . . . 0.0 106.401 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.38 -20.63 45.63 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.094 ' HA ' HD23 ' A' ' 3' ' ' LEU . 84.3 t80 -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 31' ' ' LEU . 43.9 t -70.62 -27.02 29.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.786 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -83.63 -8.03 59.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.281 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 3.1 t70 -98.79 -43.38 6.79 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.178 0.989 . . . . 0.0 109.039 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.675 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -70.32 -35.68 73.8 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.951 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.581 ' HB1' ' CA ' ' A' ' 33' ' ' LYS . . . -59.44 -50.91 72.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 108.392 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.84 16.77 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.659 -0.651 . . . . 0.0 109.857 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 26.6 tttm -132.11 13.18 4.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 111.297 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 81.9 72.66 1.24 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.675 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 7.5 m95 -38.71 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.14 0.495 . . . . 0.0 110.508 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 42.44 26.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.943 . . . . 0.0 109.421 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 85' ' ' TRP . . . . . . . . 0 N--CA 1.487 2.046 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.59 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.89 HBC2 ' HHD' ' A' ' 88' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 6.2 m-20 79.31 0.93 2.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.481 -0.762 . . . . 0.0 109.912 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.0 HD13 ' HA ' ' A' ' 76' ' ' TYR . 2.0 pp -70.62 3.92 2.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.64 ' CA ' ' HD3' ' A' ' 8' ' ' LYS . 1.4 m-20 -75.0 -1.68 23.81 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.645 ' HA2' HG23 ' A' ' 73' ' ' VAL . . . -86.27 -46.91 5.13 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.919 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -56.14 -46.57 79.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.857 -0.79 . . . . 0.0 108.877 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.798 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -51.04 -33.44 25.47 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.964 HG21 ' HG2' ' A' ' 69' ' ' GLN . 59.6 t -96.62 -15.7 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.215 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 11.0 t80 -84.76 -28.05 26.5 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 117.589 -1.644 . . . . 0.0 109.793 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -86.63 15.09 5.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.808 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.34 2.02 1.27 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.487 HD21 ' HD3' ' A' ' 64' ' ' ARG . 4.8 m120 -143.51 -50.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.805 -1.409 . . . . 0.0 109.114 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.5 m -77.11 -32.11 56.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.426 -0.797 . . . . 0.0 108.875 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HA ' ' N ' ' A' ' 19' ' ' MET . . . -45.77 -40.87 10.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.661 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.72 -46.3 77.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.097 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 80.3 m -116.12 27.81 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 110.33 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.594 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 90.5 m-70 -159.93 -76.41 0.07 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.215 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.55 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 55.1 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.595 0.712 . . . . 0.0 110.668 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.95 45.17 9.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.593 ' HA3' ' CD2' ' A' ' 85' ' ' TRP . . . 48.64 68.27 1.35 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.497 ' HA2' ' OG1' ' A' ' 30' ' ' THR . . . -151.78 86.8 0.14 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.8 t-20 -55.33 161.47 1.86 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.976 -1.308 . . . . 0.0 109.305 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 25' ' ' VAL . 16.4 m -136.5 -52.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.573 ' N ' HG23 ' A' ' 24' ' ' VAL . 44.8 t -45.79 -61.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.175 -0.953 . . . . 0.0 108.781 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -53.41 -170.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 109.109 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.71 1.25 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.097 . . . . 0.0 110.289 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -156.9 -30.83 0.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.038 -1.039 . . . . 0.0 110.729 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 11.9 mttt -75.93 101.16 5.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.969 -1.082 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.91 ' C ' HD22 ' A' ' 36' ' ' LEU . 10.3 t -93.88 -146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 108.492 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.609 ' N ' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -118.41 -11.11 10.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.482 -1.386 . . . . 0.0 109.615 179.133 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.757 ' H ' HG23 ' A' ' 30' ' ' THR . 5.2 mtpt -50.02 -86.9 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.846 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 165.04 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.984 -1.072 . . . . 0.0 109.956 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -53.14 -27.19 19.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 109.718 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.931 ' HB1' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.86 -67.33 0.95 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.273 -0.892 . . . . 0.0 110.532 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.984 HD12 ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -54.39 -35.85 63.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.645 -0.659 . . . . 0.0 111.335 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 2.0 tt0 -69.33 -30.79 68.9 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.306 -1.496 . . . . 0.0 110.183 -178.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -78.55 -64.55 1.15 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.245 -0.909 . . . . 0.0 109.925 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CZ ' ' HB1' ' A' ' 35' ' ' ALA . 2.0 p90 -93.99 -20.19 20.2 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.537 0.684 . . . . 0.0 110.627 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.578 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -89.42 -19.11 50.7 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.031 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . 1.117 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 49.48 71.23 0.4 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -177.101 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.984 ' CG ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -101.69 -6.08 24.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.485 -176.506 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.811 ' N ' ' HB3' ' A' ' 46' ' ' ALA . 2.6 p -48.74 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.781 -1.199 . . . . 0.0 110.223 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.698 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -43.61 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.92 -1.112 . . . . 0.0 109.668 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.416 ' N ' HD12 ' A' ' 48' ' ' ILE . 32.6 t0 -52.67 -19.78 2.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.891 -1.131 . . . . 0.0 110.286 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.117 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -74.37 -82.11 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.395 -0.816 . . . . 0.0 110.262 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.813 HD13 HG11 ' A' ' 77' ' ' VAL . 12.1 tt -48.77 -33.52 5.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 O-C-N 121.283 -0.886 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 44' ' ' GLU . 74.7 mt -56.31 -41.23 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.596 -0.69 . . . . 0.0 110.058 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -78.69 -25.7 44.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.561 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.625 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 6.3 pm0 -93.71 -3.71 51.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.087 -1.633 . . . . 0.0 108.896 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' HA ' ' HE2' ' A' ' 58' ' ' MET . 25.1 t -94.8 -48.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.779 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 3.0 mt-30 -64.49 -8.32 13.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.867 -0.521 . . . . 0.0 110.167 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.779 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -155.62 21.45 0.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.838 -1.145 . . . . 0.0 108.772 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.592 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 51.89 -131.1 36.44 Favored Glycine 0 C--N 1.3 -1.419 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 150.04 142.31 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.201 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 53.94 -89.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.591 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -126.53 42.63 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.582 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 21.4 ttt -119.63 142.19 32.39 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.225 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.571 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 37.0 Cg_endo -81.26 108.82 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.914 2.409 . . . . 0.0 113.406 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.634 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.7 163.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.761 . . . . 0.0 110.286 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.886 ' CD2' HBB2 ' A' ' 88' ' ' HEC . 11.2 m-85 -145.74 14.43 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.22 -10.8 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.907 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.19 -4.34 7.78 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.487 ' HD3' HD21 ' A' ' 13' ' ' ASN . 4.2 ttt180 -106.82 -61.64 1.51 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.008 ' CD1' HG21 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -64.62 105.8 1.04 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.58 HG22 ' N ' ' A' ' 67' ' ' ASP . 86.2 m -39.3 166.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.294 0.569 . . . . 0.0 109.564 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.58 ' N ' HG22 ' A' ' 66' ' ' THR . 15.1 t0 -57.74 -57.75 11.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.989 -1.069 . . . . 0.0 108.42 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.5 mm-40 -65.87 10.81 0.09 Allowed 'General case' 0 C--O 1.193 -1.917 0 O-C-N 121.755 -0.59 . . . . 0.0 109.887 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.964 ' HG2' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -104.4 -44.66 4.87 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.681 HG22 HG23 ' A' ' 48' ' ' ILE . 18.9 mm -53.0 -22.09 3.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 1.5 mp0 -94.45 -73.34 0.58 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 76' ' ' TYR . 98.2 m-20 -44.82 -64.69 0.65 Allowed 'General case' 0 C--O 1.186 -2.27 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.286 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.008 HG21 ' CD1' ' A' ' 65' ' ' LEU . 2.3 t -49.15 -29.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.096 -1.003 . . . . 0.0 110.269 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.808 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -79.94 -74.18 0.31 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.694 -1.254 . . . . 0.0 108.118 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -46.56 -23.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.966 -1.709 . . . . 0.0 107.784 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.0 ' HA ' HD13 ' A' ' 3' ' ' LEU . 40.9 t80 -60.41 -53.13 61.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.274 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.85 HG22 ' HE2' ' A' ' 42' ' ' TYR . 1.9 p -64.47 -25.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.703 HD23 HG13 ' A' ' 77' ' ' VAL . 2.8 mt -78.5 -9.67 59.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.49 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 3.0 t0 -99.57 -41.49 7.32 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.0 0.905 . . . . 0.0 109.059 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.645 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 9.3 mm-40 -69.53 -47.48 63.59 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.381 0.61 . . . . 0.0 109.956 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -68.5 -16.02 63.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.44 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.61 8.68 27.17 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 110.889 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -171.69 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.47 77.27 1.33 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.02 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.825 ' HZ2' HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -40.36 84.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.319 -0.518 . . . . 0.0 110.596 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 53.63 47.62 23.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.858 -1.151 . . . . 0.0 109.029 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.029 0 CA-C-O 117.951 -1.471 . . . . 0.0 109.529 -179.737 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.886 HBB2 ' CD2' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.444 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.453 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 9.7 m-20 72.8 5.02 5.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.301 -0.874 . . . . 0.0 109.961 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.875 HD11 ' HA ' ' A' ' 76' ' ' TYR . 1.0 OUTLIER -77.2 7.39 5.17 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.937 -1.102 . . . . 0.0 109.738 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.98 -24.31 59.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.562 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 68.3 m-20 -84.39 -6.03 59.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.445 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.582 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -87.74 -61.74 1.5 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 106.674 -2.571 . . . . 0.0 106.674 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.865 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -40.67 -37.81 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.128 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.923 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -61.84 -48.63 79.71 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 65' ' ' LEU . 87.9 t -63.68 -59.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -0.773 . . . . 0.0 111.814 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.823 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 46.0 t80 -54.92 -42.59 72.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.732 -1.23 . . . . 0.0 112.261 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -84.29 19.58 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.58 -1.325 . . . . 0.0 110.365 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -147.16 0.77 0.72 Allowed Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.541 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -156.23 -48.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.569 -1.548 . . . . 0.0 110.035 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.4 m -71.99 -36.12 69.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 19' ' ' MET . . . -51.55 -38.1 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.442 -0.786 . . . . 0.0 110.089 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.01 69.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.956 -1.09 . . . . 0.0 109.257 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.569 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 82.3 m -119.43 20.28 12.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.441 -0.787 . . . . 0.0 109.506 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 93.3 m-70 -159.87 21.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.436 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.34 153.36 7.31 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.656 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 43.46 33.53 2.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 46.39 57.99 6.14 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.676 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -146.76 91.89 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 2.2 t-20 -41.77 142.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.457 -1.026 . . . . 0.0 109.865 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.11 -1.24 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.447 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.671 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 45.3 t -111.54 -66.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mmt -65.39 130.67 44.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.319 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 28' ' ' ASN . . . -85.08 48.32 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 27' ' ' ALA . 1.8 p-10 175.3 -59.7 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HD3' ' CE ' ' A' ' 41' ' ' MET . 7.6 mttp -51.71 102.8 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.213 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.698 HG21 ' HD3' ' A' ' 32' ' ' LYS . 3.7 m -113.32 177.44 4.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.688 ' H ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -94.71 -18.93 20.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.798 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 1.004 ' C ' HD21 ' A' ' 36' ' ' LEU . 14.8 mtpt -58.16 -113.63 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 110.295 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.761 ' N ' HD21 ' A' ' 36' ' ' LEU . 22.7 ttpt -155.44 -29.61 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.677 -1.264 . . . . 0.0 110.871 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 12.3 pt-20 -59.97 -28.91 68.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.729 -1.232 . . . . 0.0 111.193 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.631 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -102.25 -48.57 4.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.001 -1.062 . . . . 0.0 110.818 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.004 HD21 ' C ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -61.07 -34.56 75.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.923 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.2 mm-40 -93.1 6.02 49.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 3.0 tp-100 -89.74 -51.1 5.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.62 -50.27 6.93 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.486 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.81 91.45 0.48 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.507 ' CE ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -174.12 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.12 . . . . 0.0 109.474 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.942 ' CG ' HD12 ' A' ' 36' ' ' LEU . 4.1 t80 -105.62 28.57 7.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 109.816 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 p -106.73 143.11 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.359 -0.838 . . . . 0.0 110.569 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.54 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -50.53 -59.15 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 109.834 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.35 -28.62 8.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.526 -1.359 . . . . 0.0 110.568 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.61 -73.66 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 110.321 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.845 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.1 tt -61.16 -13.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 110.358 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.719 HG23 HG22 ' A' ' 70' ' ' ILE . 14.5 mt -73.41 -35.99 47.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 31.0 t80 -91.11 -14.44 31.21 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.565 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 4.5 tp60 -88.79 -17.07 30.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 47' ' ' ILE . 72.2 t -93.77 -43.62 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.817 0.818 . . . . 0.0 109.985 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.808 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -62.72 -10.54 13.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 0.0 110.18 -178.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.808 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -158.36 30.97 0.24 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.357 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.591 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 49.96 -132.99 28.16 Favored Glycine 0 C--N 1.299 -1.524 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 151.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 19.7 m120 69.05 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' HB3' HMD2 ' A' ' 88' ' ' HEC . . . -129.48 14.95 6.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 109.202 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.702 ' HE2' ' HA ' ' A' ' 51' ' ' VAL . 27.4 ttt -89.63 142.3 29.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.263 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.646 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.3 Cg_endo -74.25 97.2 1.0 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.906 2.404 . . . . 0.0 114.647 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.664 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -46.94 119.16 2.38 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 63' ' ' GLY . 57.1 m-85 -88.24 -49.87 6.71 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.999 -1.063 . . . . 0.0 108.747 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 28.05 40.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.35 0.595 . . . . 0.0 110.376 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 167.61 -24.18 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.521 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -93.83 -30.92 14.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.95 HD11 HG11 ' A' ' 9' ' ' VAL . 1.7 mm? -91.45 94.51 9.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.666 ' HB ' ' NE2' ' A' ' 69' ' ' GLN . 21.0 m -41.03 168.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.616 ' N ' HG22 ' A' ' 66' ' ' THR . 0.1 OUTLIER -57.15 -61.2 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.522 -1.361 . . . . 0.0 108.487 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 mt-10 -60.68 3.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.777 -0.577 . . . . 0.0 110.604 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.882 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -102.94 -45.15 5.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.719 HG22 HG23 ' A' ' 48' ' ' ILE . 33.6 mm -55.34 -22.66 12.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 1.6 mp0 -92.19 -65.71 0.98 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.103 0.954 . . . . 0.0 108.642 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 47.1 m-20 -49.62 -61.5 2.08 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 69' ' ' GLN . 3.3 p -45.5 -29.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.3 -0.875 . . . . 0.0 109.8 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.813 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -80.68 -71.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -45.52 -25.8 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.554 -1.341 . . . . 0.0 107.508 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.875 ' HA ' HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -59.08 -56.95 15.61 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 74' ' ' ALA . 2.6 p -62.37 -26.14 39.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.99 -1.069 . . . . 0.0 108.647 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 77' ' ' VAL . 5.1 mt -76.45 -10.76 59.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 2.0 t0 -99.47 -43.52 6.51 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.929 0.871 . . . . 0.0 109.218 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 59.6 mm-40 -67.3 -41.55 85.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.88 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.555 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -60.9 -47.3 87.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.143 -0.973 . . . . 0.0 109.063 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.11 8.45 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.573 -0.705 . . . . 0.0 109.843 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 6.9 tttm -129.84 12.84 5.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.079 -1.013 . . . . 0.0 110.974 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.0 76.71 0.98 Allowed Glycine 0 C--N 1.296 -1.681 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.728 ' HZ2' HG23 ' A' ' 77' ' ' VAL . 12.8 m95 -34.36 90.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.725 0.774 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -54.76 -37.99 66.65 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.386 0.612 . . . . 0.0 109.446 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.085 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.687 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.671 HMD3 ' HB ' ' A' ' 25' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -119.51 -25.79 5.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 0.0 109.586 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.803 HD13 ' OD2' ' A' ' 79' ' ' ASP . 1.2 mp -71.11 -3.36 19.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.053 -1.029 . . . . 0.0 109.454 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.71 -15.82 63.63 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.596 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -86.69 10.26 16.28 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -107.69 -36.33 2.43 Favored Glycine 0 C--O 1.201 -1.919 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -59.88 -12.63 8.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.659 -0.906 . . . . 0.0 109.884 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.596 ' CE ' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -87.13 -32.52 19.84 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.826 HG13 HD22 ' A' ' 65' ' ' LEU . 3.4 t -77.31 -29.55 16.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.595 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 32.2 t80 -100.33 -34.53 9.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 3.9 t -85.05 10.76 11.1 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.024 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.34 -6.74 0.72 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.173 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.563 ' CG ' HD21 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -147.23 -52.93 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.567 -1.549 . . . . 0.0 110.031 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.711 ' SG ' HMB1 ' A' ' 88' ' ' HEC . 5.3 m -64.8 -29.31 70.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 110.035 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.84 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.846 -1.159 . . . . 0.0 109.294 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 84.8 m -120.7 14.78 11.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.224 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.506 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 91.0 m-70 -158.63 26.74 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.765 . . . . 0.0 109.033 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -52.49 147.12 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.308 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 46.96 35.86 8.33 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 32' ' ' LYS . . . 48.47 53.0 17.75 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.73 122.06 2.52 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 26' ' ' MET . 3.7 t-20 -64.43 154.21 36.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -1.127 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.425 HG23 HG23 ' A' ' 25' ' ' VAL . 4.5 m -122.95 -22.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.12 -0.988 . . . . 0.0 110.244 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.425 HG23 HG23 ' A' ' 24' ' ' VAL . 13.4 t -103.07 -69.54 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.868 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.62 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -47.62 -37.26 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.42 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 26' ' ' MET . . . 71.32 40.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 26' ' ' MET . 1.3 p30 177.09 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.371 -0.83 . . . . 0.0 108.915 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.29 77.14 5.83 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.916 ' O ' HD22 ' A' ' 36' ' ' LEU . 9.3 t -83.23 -177.35 6.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.878 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.705 HD11 HMB3 ' A' ' 88' ' ' HEC . 0.1 OUTLIER -100.78 -18.54 16.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 110.758 -179.043 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.597 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -61.07 -100.8 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.667 -1.271 . . . . 0.0 109.4 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.495 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 11.0 ptmm? -168.32 -38.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.642 -1.286 . . . . 0.0 110.797 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -41.16 -29.46 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 -178.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.858 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -110.25 -59.23 1.97 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 111.644 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -58.98 -7.72 1.16 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.728 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.598 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.4 mm-40 -107.08 -11.79 15.56 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.593 -1.317 . . . . 0.0 109.72 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 65.0 mm-40 -82.54 -40.54 20.82 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.858 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -84.96 -45.94 11.71 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.709 177.097 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 41' ' ' MET . . . 121.51 98.19 1.54 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.508 ' HG3' HBA2 ' A' ' 88' ' ' HEC . 0.0 OUTLIER 170.08 37.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -1.085 . . . . 0.0 109.741 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.007 ' OH ' ' HB3' ' A' ' 81' ' ' ALA . 6.6 t80 -118.98 33.17 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.511 ' O ' ' HB ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -110.49 176.97 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.568 -0.708 . . . . 0.0 110.938 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.694 ' C ' HD12 ' A' ' 48' ' ' ILE . 3.6 mt-10 -69.89 -72.56 0.19 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -54.0 -36.37 62.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.566 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 50' ' ' GLN . . . -64.01 -74.41 0.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.067 -1.021 . . . . 0.0 109.498 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.016 ' O ' HG23 ' A' ' 51' ' ' VAL . 40.9 mt -53.9 -17.56 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.621 0.724 . . . . 0.0 109.264 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.694 HD12 ' C ' ' A' ' 44' ' ' GLU . 16.2 mt -80.82 -33.38 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.486 ' OH ' ' HE2' ' A' ' 55' ' ' LYS . 59.7 t80 -73.19 -23.07 60.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 108.536 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.627 ' O ' ' HE2' ' A' ' 58' ' ' MET . 0.0 OUTLIER -85.64 -33.65 21.56 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.391 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.016 HG23 ' O ' ' A' ' 47' ' ' ILE . 10.9 t -79.92 -36.67 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.779 ' HB3' ' CE1' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -72.23 -14.45 61.79 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.344 -0.848 . . . . 0.0 109.968 -178.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.779 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -159.33 31.54 0.2 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.012 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 48.04 -136.86 14.81 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 151.91 134.1 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.313 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.1 m-80 60.25 -88.91 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.473 -0.767 . . . . 0.0 108.978 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.814 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -126.27 41.58 3.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.627 ' HE2' ' O ' ' A' ' 50' ' ' GLN . 21.4 ttt -119.04 143.49 34.01 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.615 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 30.3 Cg_endo -75.23 99.76 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.918 2.412 . . . . 0.0 114.27 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -57.07 118.27 4.84 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.654 -0.654 . . . . 0.0 110.458 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.657 ' CZ ' HBB3 ' A' ' 88' ' ' HEC . 25.1 m-85 -85.37 -52.27 5.99 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 37.58 28.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.424 0.631 . . . . 0.0 109.675 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 126.46 32.8 0.7 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.506 -1.837 . . . . 0.0 108.506 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.602 ' HD2' ' CD2' ' A' ' 61' ' ' PHE . 5.5 ttm-85 -101.67 -52.78 3.13 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.826 HD22 HG13 ' A' ' 9' ' ' VAL . 6.5 mt -79.92 -143.16 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.591 ' CB ' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -98.62 -166.9 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 121.085 -1.009 . . . . 0.0 109.494 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.37 -62.55 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.621 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.1 tt0 -71.41 2.61 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.668 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 2.6 mp0 -104.08 -32.03 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.623 HG21 ' HG3' ' A' ' 52' ' ' GLN . 7.5 mm -72.88 -21.84 19.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.43 -66.13 0.95 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 37.3 t0 -54.59 -36.92 64.94 Favored 'General case' 0 C--O 1.193 -1.902 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.409 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 9.9 p -61.69 -26.92 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.193 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.588 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -82.12 -59.11 2.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.62 -21.63 11.09 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.697 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 36.5 t80 -67.03 -45.12 78.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.366 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.675 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.1 p -69.6 -21.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.97 HD21 HD12 ' A' ' 47' ' ' ILE . 5.4 mt -77.97 -11.82 59.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.803 ' OD2' HD13 ' A' ' 3' ' ' LEU . 1.8 t0 -99.99 -37.52 8.97 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.888 0.851 . . . . 0.0 109.327 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.646 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 8.5 mm-40 -77.44 -35.28 54.12 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.876 -0.515 . . . . 0.0 110.395 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.007 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -61.0 -48.71 80.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.121 -0.987 . . . . 0.0 108.522 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.8 13.86 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.759 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 1.6 ttmm -130.79 13.69 5.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.96 -1.088 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 82.84 73.6 1.23 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.675 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 5.0 m95 -39.07 83.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.119 0.485 . . . . 0.0 110.592 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 42.72 27.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.241 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.627 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.918 ' CMA' HG23 ' A' ' 47' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.491 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.2 m-20 74.18 -0.1 3.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.884 . . . . 0.0 109.897 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.505 ' CD2' ' HA ' ' A' ' 72' ' ' ASP . 10.1 mt -69.67 -8.3 46.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.933 -1.105 . . . . 0.0 109.057 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.23 -29.09 63.48 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.518 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.3 m-20 -67.91 -41.78 82.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 73' ' ' VAL . . . -47.21 -58.83 6.14 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.766 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -50.67 -37.65 42.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.338 . . . . 0.0 109.286 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.851 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -59.4 -41.1 88.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.204 -0.935 . . . . 0.0 108.58 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.068 HG21 ' CB ' ' A' ' 69' ' ' GLN . 21.9 t -81.23 -67.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 26.9 t80 -41.54 -26.63 0.07 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.288 -0.883 . . . . 0.0 109.851 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 36.6 m -76.71 -48.53 18.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.296 -0.877 . . . . 0.0 111.275 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.631 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -101.57 29.84 11.66 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.726 -1.225 . . . . 0.0 111.739 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.631 ' ND2' ' O ' ' A' ' 12' ' ' GLY . 13.6 m120 -155.03 -29.3 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.783 -1.422 . . . . 0.0 110.771 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.907 ' SG ' ' HHC' ' A' ' 88' ' ' HEC . 79.6 m -127.91 -11.18 5.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.903 -1.123 . . . . 0.0 111.316 -177.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -51.69 -32.04 28.29 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.32 78.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.382 -0.824 . . . . 0.0 110.699 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.63 18.7 18.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.739 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.019 ' CE1' HD21 ' A' ' 31' ' ' LEU . 81.8 m-70 -158.61 -64.91 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.929 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' A' ' 18' ' ' HIS . 4.9 ptt? 38.66 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.318 0.58 . . . . 0.0 109.719 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 71.08 57.23 6.37 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 31' ' ' LEU . . . 36.74 64.81 0.6 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -141.66 99.05 0.23 Allowed Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.992 -1.299 . . . . 0.0 109.953 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.445 HD21 ' C4D' ' A' ' 88' ' ' HEC . 1.2 t-20 -67.83 138.0 55.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -1.168 . . . . 0.0 109.855 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.22 -3.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -0.827 . . . . 0.0 109.599 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.832 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 5.1 t -103.59 -46.96 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.494 ' HG3' HMD1 ' A' ' 88' ' ' HEC . 3.2 mtp -100.45 157.51 16.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -109.77 61.25 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.9 p-10 169.62 -50.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -77.25 91.04 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.614 HG21 ' HD2' ' A' ' 32' ' ' LYS . 23.2 m -126.17 163.89 22.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.187 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.019 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -88.36 74.48 8.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.133 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.67 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -111.83 -85.04 0.57 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.648 -1.283 . . . . 0.0 109.103 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.044 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -176.56 -47.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 179.471 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.59 -33.81 27.87 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.15 -0.968 . . . . 0.0 110.413 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.65 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -70.81 -56.81 5.49 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.056 -1.028 . . . . 0.0 109.688 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.062 HD12 ' HB2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -53.42 -33.57 54.48 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.438 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.549 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 3.1 mm-40 -87.14 -17.84 31.82 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.706 0.765 . . . . 0.0 109.242 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 3.3 tp-100 -68.33 -50.29 54.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.65 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -85.8 -78.17 0.28 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.427 -0.796 . . . . 0.0 108.926 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.66 86.36 0.06 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.566 ' SD ' ' CE2' ' A' ' 39' ' ' PHE . 2.7 ptt? -167.0 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -1.192 . . . . 0.0 109.511 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 1.062 ' HB2' HD12 ' A' ' 36' ' ' LEU . 38.0 t80 -104.68 12.02 33.39 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.55 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -105.42 140.41 38.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.339 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.792 ' HA ' HD11 ' A' ' 78' ' ' LEU . 1.2 mt-10 -44.89 -63.05 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.796 . . . . 0.0 109.97 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 29.5 t0 -48.63 -33.53 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.817 -1.177 . . . . 0.0 110.553 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -65.39 -76.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.84 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 tt -65.5 -6.75 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.859 0.838 . . . . 0.0 110.563 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.561 HD12 ' C ' ' A' ' 44' ' ' GLU . 12.8 mt -77.26 -43.02 31.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 49' ' ' TYR . 58.4 t80 -88.89 -3.83 58.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.626 ' OE1' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -100.87 -13.78 18.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 47' ' ' ILE . 26.8 t -92.09 -47.36 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.875 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -58.69 -12.82 4.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.58 -179.239 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.8 ' CE1' ' HB3' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -151.57 21.59 0.71 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.093 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.597 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 53.09 -131.97 41.55 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.572 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 157.08 132.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.437 0 CA-C-O 121.538 0.685 . . . . 0.0 109.728 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 59.9 m-80 63.05 -85.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.475 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -131.53 44.48 2.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.642 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 6.6 ttt -129.05 144.15 51.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.039 -1.038 . . . . 0.0 109.167 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.642 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.6 Cg_endo -71.71 117.27 5.06 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.372 2.715 . . . . 0.0 115.822 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.656 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -42.51 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.922 ' CE2' HBB2 ' A' ' 88' ' ' HEC . 26.0 m-85 -139.48 8.64 2.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.42 -19.7 2.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.435 -0.791 . . . . 0.0 109.217 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.54 26.86 0.96 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.708 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 2.4 mmt85 -102.06 -48.59 4.18 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 178.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.033 HD13 HG11 ' A' ' 9' ' ' VAL . 8.4 mt -81.34 -148.57 0.07 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.609 HG22 ' N ' ' A' ' 67' ' ' ASP . 1.5 m -98.83 -74.96 0.57 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 122.19 0.995 . . . . 0.0 108.929 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.777 ' HA ' HD12 ' A' ' 70' ' ' ILE . 23.3 t0 -177.83 -59.34 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 9.7 tt0 -69.25 5.1 1.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.662 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 1.068 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -111.21 -33.92 6.31 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.875 HG21 ' HG3' ' A' ' 52' ' ' GLN . 2.3 mt -60.28 -18.0 15.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.477 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -96.46 -73.81 0.58 Allowed 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.019 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 60.7 m-20 -44.64 -46.34 10.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.833 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.787 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 10.5 t -63.29 -42.25 95.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.623 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -56.19 -63.87 1.05 Allowed 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.268 -1.52 . . . . 0.0 106.951 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.49 -18.93 32.91 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.787 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 61.4 t80 -65.46 -39.91 92.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.598 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 25.2 t -75.33 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -88.83 -8.12 54.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.3 t70 -98.54 -36.31 9.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.107 0.956 . . . . 0.0 108.707 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.641 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 5.1 mm-40 -80.9 -36.56 31.02 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.575 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -64.56 -42.88 95.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.837 ' HB2' ' OH ' ' A' ' 42' ' ' TYR . . . -89.12 12.81 14.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 110.829 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 8.3 ptmm? -138.08 18.18 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.494 -1.379 . . . . 0.0 111.22 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 86.49 73.96 1.27 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.641 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 5.6 m95 -36.62 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.41 0.624 . . . . 0.0 109.61 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -74.43 -52.47 11.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.411 -0.806 . . . . 0.0 109.832 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.027 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.52 -179.957 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HEC . . . . . 0.922 HBB2 ' CE2' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.478 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 68.6 m-20 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.503 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -68.12 -5.37 17.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.59 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.42 -30.54 70.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 2.0 m-20 -72.45 -33.63 67.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -52.13 -60.79 7.21 Favored Glycine 0 C--O 1.201 -1.93 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.791 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -56.53 -26.98 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -1.067 . . . . 0.0 109.871 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.77 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -65.41 -35.07 79.83 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.024 -1.047 . . . . 0.0 108.707 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.099 HG21 ' CB ' ' A' ' 69' ' ' GLN . 14.9 t -88.66 -47.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.287 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 15.4 t80 -64.42 -27.69 69.17 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.804 -1.185 . . . . 0.0 109.435 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 18.7 p -90.93 11.2 23.52 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -141.95 3.53 2.01 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.553 HD22 HG13 ' A' ' 9' ' ' VAL . 2.5 m-80 -154.82 -57.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 0.0 109.029 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.637 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 11.6 m -65.84 -24.93 66.99 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.744 . . . . 0.0 109.37 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -62.35 -33.55 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 110.359 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.08 13.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.004 . . . . 0.0 110.517 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -138.89 25.6 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' O ' ' A' ' 19' ' ' MET . 86.0 m-70 -157.07 -69.63 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 108.951 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.52 ' O ' ' O ' ' A' ' 18' ' ' HIS . 1.0 OUTLIER 36.24 102.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.602 0.715 . . . . 0.0 111.207 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 93.59 32.42 7.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 43.45 36.19 3.09 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -130.51 109.35 0.91 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -44.3 140.82 2.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.0 109.333 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 24' ' ' VAL . 58.9 t -107.56 0.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 109.772 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.462 HG23 ' SG ' ' A' ' 17' ' ' CYS . 90.5 t -117.64 -51.3 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.676 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.79 176.27 6.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.72 46.61 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 1.4 p-10 -176.58 -62.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.283 -0.886 . . . . 0.0 108.979 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.615 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -55.18 97.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 t -111.1 -167.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 110.393 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -107.3 -26.06 11.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.673 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.635 ' C ' HD21 ' A' ' 36' ' ' LEU . 7.3 mtpt -45.22 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.827 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.089 ' N ' HD21 ' A' ' 36' ' ' LEU . 17.5 ttpt -178.74 -26.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.656 -1.278 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -67.83 -53.98 22.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.743 -1.223 . . . . 0.0 110.737 -177.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.547 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -76.05 -51.15 12.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.577 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.089 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -59.7 -22.82 62.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.002 . . . . 0.0 108.852 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 2.4 tm-20 -112.4 -2.6 14.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.141 -0.975 . . . . 0.0 109.298 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -65.82 -47.05 76.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.615 ' CZ ' ' HG3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -85.74 -32.0 22.11 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.281 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 120.93 102.11 1.82 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.623 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 158.57 29.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.702 -0.881 . . . . 0.0 110.823 178.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.67 ' CD1' HD11 ' A' ' 36' ' ' LEU . 2.1 t80 -97.11 28.46 3.57 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.077 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 6.9 p -106.74 157.58 17.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 110.343 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.857 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -46.05 -62.91 1.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.38 -0.825 . . . . 0.0 109.701 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.511 ' N ' HD12 ' A' ' 48' ' ' ILE . 39.7 t0 -54.67 -28.74 49.59 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.94 -1.1 . . . . 0.0 110.637 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -66.06 -76.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.031 . . . . 0.0 110.247 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.898 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.5 tt -60.04 -20.99 20.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.462 -0.773 . . . . 0.0 110.047 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.857 HD12 ' C ' ' A' ' 44' ' ' GLU . 15.6 mt -64.45 -35.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.628 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 26.4 t80 -87.08 -18.12 31.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -90.38 -1.37 57.91 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 47' ' ' ILE . 78.5 t -109.67 -39.03 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.835 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -71.58 -5.13 31.12 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.169 -0.957 . . . . 0.0 109.016 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.703 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -161.99 26.77 0.12 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 44.51 -133.33 7.1 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.558 ' HB2' ' NE2' ' A' ' 50' ' ' GLN . 0.3 OUTLIER 160.86 126.67 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 121.29 0.567 . . . . 0.0 109.654 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 35.1 m-80 68.98 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -128.12 12.0 6.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.945 -1.097 . . . . 0.0 110.569 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.625 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 14.4 ttt -95.16 138.98 21.88 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.672 -1.267 . . . . 0.0 109.599 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.625 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 29.2 Cg_endo -73.81 117.18 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.964 2.443 . . . . 0.0 113.507 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.64 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.23 165.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.533 -0.73 . . . . 0.0 110.025 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.708 ' CD1' HD21 ' A' ' 65' ' ' LEU . 48.7 m-85 -146.76 15.59 1.23 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.35 -17.7 2.03 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.37 29.15 0.27 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.545 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -98.85 -41.58 7.56 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 178.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.994 HD13 HG11 ' A' ' 9' ' ' VAL . 19.3 mt -82.0 -140.71 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 6.1 m -98.62 -57.39 2.2 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.268 -0.895 . . . . 0.0 109.524 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 6.3 t70 153.34 -54.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 16.1 mt-10 -70.79 2.53 4.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 1.099 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -114.39 -27.42 7.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.986 HD13 HD12 ' A' ' 65' ' ' LEU . 10.8 mm -58.88 -22.42 21.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 173.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.462 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -97.48 -65.76 0.94 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.993 179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.0 t0 -53.82 -39.93 65.97 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 69' ' ' GLN . 1.4 p -60.94 -26.68 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.313 -0.867 . . . . 0.0 109.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -81.0 -63.48 1.4 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.71 -24.44 3.39 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.383 -1.448 . . . . 0.0 107.24 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.791 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.3 t80 -63.91 -47.72 79.43 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.08 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.5 p -67.32 -23.3 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 77' ' ' VAL . 3.1 mt -79.02 -11.61 60.01 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -35.06 9.67 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.007 0.908 . . . . 0.0 109.709 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.651 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 6.9 mm-40 -77.29 -43.68 32.39 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.313 0.578 . . . . 0.0 110.283 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.647 ' HB2' ' NE1' ' A' ' 85' ' ' TRP . . . -76.18 -22.41 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.346 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.71 4.26 22.52 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.549 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -170.59 39.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.587 -1.321 . . . . 0.0 112.309 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 97.29 74.74 1.2 Allowed Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.856 -1.64 . . . . 0.0 110.178 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.652 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -40.3 83.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.174 0.511 . . . . 0.0 110.752 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.439 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 5.3 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.539 HD23 ' OD1' ' A' ' 72' ' ' ASP . 3.9 mt -72.74 -3.69 26.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.62 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.2 -32.18 73.66 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.494 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -71.11 -26.86 63.21 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -60.21 -51.92 55.87 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.694 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -50.2 -19.89 0.89 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.616 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -82.61 -43.44 16.99 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.639 HG22 ' CG ' ' A' ' 69' ' ' GLN . 5.2 t -62.63 -26.35 40.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.9 t80 -101.29 -22.48 14.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.594 -0.691 . . . . 0.0 110.603 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 62.2 m -88.47 22.45 2.54 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.312 -0.868 . . . . 0.0 109.265 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.29 -23.27 0.02 OUTLIER Glycine 0 N--CA 1.484 1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.342 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB3' ' HD3' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -122.96 -7.03 8.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.596 -1.532 . . . . 0.0 110.065 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.627 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 6.6 m -127.39 -23.04 3.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -58.27 -37.45 75.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.769 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.81 -10.53 13.36 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.229 -0.919 . . . . 0.0 111.77 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 94.7 m -140.64 19.04 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.648 -1.282 . . . . 0.0 110.052 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 89.4 m-70 -158.31 -53.3 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.266 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.511 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 5.0 ptt? 35.58 98.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.251 0.548 . . . . 0.0 110.795 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 72.27 52.52 10.66 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.677 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 37.05 83.37 0.01 OUTLIER Glycine 0 N--CA 1.483 1.822 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -161.7 93.74 0.12 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' GLY . 3.8 t-20 -40.72 157.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.577 -0.955 . . . . 0.0 109.823 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.631 HG13 HG23 ' A' ' 25' ' ' VAL . 2.3 p -120.87 -20.3 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.631 HG23 HG13 ' A' ' 24' ' ' VAL . 20.8 t -109.73 -68.61 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -58.2 168.83 0.94 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.953 . . . . 0.0 109.936 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -129.39 57.82 1.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 1.7 p30 178.09 -46.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.343 -0.848 . . . . 0.0 109.139 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.535 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 58.8 mttt -75.94 101.58 5.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.685 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 31' ' ' LEU . 5.9 m -118.88 173.0 7.14 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.2 mp -91.9 -19.35 22.57 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.319 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.9 ptmt -59.72 179.65 0.12 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.95 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.629 ' N ' ' HB1' ' A' ' 81' ' ' ALA . 17.1 ptmt -81.7 -38.52 25.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 2.8 mt-10 -55.89 -33.62 64.79 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 110.499 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.58 -42.0 5.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 110.94 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.92 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -66.34 -15.12 63.01 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.586 ' HG3' ' HG ' ' A' ' 36' ' ' LEU . 62.4 mt-10 -114.3 0.41 14.14 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.52 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -74.53 -51.91 13.35 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.206 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -87.31 -43.05 12.44 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.364 179.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.94 33.2 0.43 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.023 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.771 ' HE3' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -91.01 14.03 15.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.753 -1.439 . . . . 0.0 108.949 179.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.882 ' HD1' HD11 ' A' ' 36' ' ' LEU . 48.5 t80 -74.03 15.4 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.619 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -106.27 125.75 51.38 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.628 -1.295 . . . . 0.0 110.665 -179.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.6 pt-20 -44.41 -56.71 4.02 Favored 'General case' 0 C--O 1.201 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 108.861 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.65 -41.1 21.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 110.388 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.65 -71.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.966 . . . . 0.0 110.122 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.772 HG23 ' HB1' ' A' ' 74' ' ' ALA . 7.4 tt -68.1 -7.86 7.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 110.135 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.556 HG13 ' CB ' ' A' ' 74' ' ' ALA . 3.7 mt -81.54 -31.88 11.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.63 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 41.1 t80 -92.02 -13.19 31.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -93.64 -14.28 26.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 47' ' ' ILE . 53.9 t -101.5 -35.44 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.973 0.892 . . . . 0.0 109.874 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -74.19 -4.85 38.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.733 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -164.38 32.42 0.07 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.571 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.545 ' HA2' ' CG ' ' A' ' 58' ' ' MET . . . 45.59 -137.31 7.11 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.581 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.4 OUTLIER 157.9 128.93 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.937 -0.631 . . . . 0.0 109.311 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 51.9 m-80 62.95 -86.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -123.67 32.47 5.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.947 . . . . 0.0 109.735 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.695 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.1 ttt -111.7 141.92 25.62 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.061 -1.024 . . . . 0.0 109.147 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.695 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 31.0 Cg_endo -76.48 104.06 1.85 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.073 2.515 . . . . 0.0 114.293 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.733 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -52.28 121.97 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.73 -0.606 . . . . 0.0 109.813 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.862 ' CG ' HD13 ' A' ' 65' ' ' LEU . 39.6 m-85 -93.02 -55.66 3.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.96 -1.088 . . . . 0.0 108.558 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 52' ' ' GLN . . . 27.53 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.207 0.527 . . . . 0.0 110.132 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 166.01 -15.53 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.575 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -101.87 -29.34 11.9 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.862 HD13 ' CG ' ' A' ' 61' ' ' PHE . 7.5 mp -94.49 114.12 26.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 67' ' ' ASP . 3.3 m -43.7 179.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.419 0.628 . . . . 0.0 110.264 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.716 ' H ' HG22 ' A' ' 66' ' ' THR . 0.1 OUTLIER -75.75 -62.38 1.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.913 -1.117 . . . . 0.0 109.083 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.545 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 32.6 mt-10 -61.99 -9.49 7.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.386 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.639 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -94.66 -34.91 12.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 65' ' ' LEU . 7.0 mm -69.68 -14.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.5 mp0 -97.31 -69.87 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.581 1.181 . . . . 0.0 109.164 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.682 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 42.1 m-20 -52.36 -33.87 44.97 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.393 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.689 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.3 p -69.53 -30.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.619 0.723 . . . . 0.0 109.878 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.772 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.68 -57.72 3.74 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.497 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.21 -19.16 53.05 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.694 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 61.9 t80 -64.93 -41.89 95.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.633 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 40.7 t -72.95 -24.24 20.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.817 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.1 mt -85.32 -7.85 58.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 9.8 t0 -99.67 -36.86 9.35 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.183 0.992 . . . . 0.0 109.242 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.621 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 6.5 mm-40 -78.62 -40.15 35.18 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.202 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.629 ' HB1' ' N ' ' A' ' 33' ' ' LYS . . . -62.62 -37.65 87.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.774 . . . . 0.0 109.891 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.66 13.96 12.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 110.93 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 2.3 ptmt -150.03 30.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.544 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.97 74.06 1.26 Allowed Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.847 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.633 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 1.7 m95 -40.79 84.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.161 -0.611 . . . . 0.0 110.854 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.908 0.385 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 79' ' ' ASP . 1.7 mp -67.06 -7.76 25.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.9 -1.125 . . . . 0.0 109.286 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.76 -31.89 68.77 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -68.6 -36.97 79.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.16 -62.96 5.47 Favored Glycine 0 C--O 1.203 -1.812 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.797 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.55 -30.08 4.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -1.207 . . . . 0.0 109.86 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.761 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -64.48 -45.29 88.0 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 108.376 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.046 HG21 ' CB ' ' A' ' 69' ' ' GLN . 41.2 t -75.77 -55.4 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.633 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 7.9 t80 -57.43 -26.11 60.65 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 110.438 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 28.9 t -86.24 19.08 2.84 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -162.16 11.15 0.11 Allowed Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.497 HD22 HG13 ' A' ' 9' ' ' VAL . 8.8 m-80 -153.97 -53.16 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.683 -1.481 . . . . 0.0 109.159 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.3 m -73.38 -26.38 60.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' HA ' ' N ' ' A' ' 19' ' ' MET . . . -52.1 -41.0 62.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.2 68.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.903 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.583 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 85.8 m -121.55 19.13 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.922 -1.111 . . . . 0.0 110.649 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 93.8 m-70 -158.67 -66.5 0.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.164 -0.96 . . . . 0.0 109.25 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.506 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 14.2 ptm 39.48 98.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.531 0.682 . . . . 0.0 110.286 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.45 46.02 80.95 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.539 ' O ' HG21 ' A' ' 30' ' ' THR . . . 51.09 68.19 1.61 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -143.29 88.32 0.17 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.644 ' H ' HG23 ' A' ' 30' ' ' THR . 1.2 t-20 -61.9 142.25 57.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -1.118 . . . . 0.0 109.778 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 17' ' ' CYS . 17.4 m -102.16 -13.26 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 24' ' ' VAL . 60.4 t -104.56 -57.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.92 . . . . 0.0 109.127 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.53 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 9.5 mmt -103.36 93.97 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.845 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.18 -47.55 35.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.733 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -35.62 80.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.192 -0.943 . . . . 0.0 109.885 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 0.0 OUTLIER -84.29 82.68 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.644 HG23 ' H ' ' A' ' 23' ' ' ASN . 24.5 m -122.01 171.97 8.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.052 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.745 ' HB3' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -84.74 -3.49 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.715 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -46.01 173.53 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.142 -0.974 . . . . 0.0 109.964 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -84.17 -27.65 27.94 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.312 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -82.51 -27.12 31.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.96 . . . . 0.0 111.074 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.42 -35.21 7.18 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.292 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.802 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -60.6 -39.7 89.11 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.115 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.587 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -96.93 6.06 49.34 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -69.33 -47.21 65.1 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.5 -39.04 16.65 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.656 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.52 79.17 0.6 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.437 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.556 ' HE2' HD13 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -159.16 25.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -1.098 . . . . 0.0 108.798 179.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.717 ' HB2' HD11 ' A' ' 36' ' ' LEU . 33.8 t80 -74.68 3.12 8.4 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.518 0.675 . . . . 0.0 109.621 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.94 155.59 18.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.707 -1.245 . . . . 0.0 110.999 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 1.3 mp0 -50.44 -64.73 0.72 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.871 -0.518 . . . . 0.0 110.515 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -46.48 -31.57 2.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.77 -1.206 . . . . 0.0 111.437 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 41' ' ' MET . . . -69.65 -73.94 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.784 -1.198 . . . . 0.0 110.658 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.859 ' O ' HG23 ' A' ' 51' ' ' VAL . 10.4 tt -60.31 -17.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.25 -0.906 . . . . 0.0 109.622 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.551 HG13 ' CB ' ' A' ' 74' ' ' ALA . 21.6 mt -72.31 -34.44 49.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 52.1 t80 -71.64 -29.98 65.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 2.5 pm0 -94.39 -13.2 26.56 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.774 -1.57 . . . . 0.0 109.125 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 47' ' ' ILE . 60.2 t -87.76 -23.73 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.009 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.566 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -99.39 -7.68 25.85 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.47 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.657 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -147.35 13.6 1.09 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 53.5 -135.33 41.54 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.629 ' N ' ' HB3' ' A' ' 58' ' ' MET . 4.9 mtpt 155.17 127.48 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 16.0 m-80 61.0 -88.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -121.9 29.29 7.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.235 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.629 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 27.8 ttt -107.12 141.89 23.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.595 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 37.0 Cg_endo -85.06 99.22 0.69 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.202 2.601 . . . . 0.0 113.879 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB2' ' HA ' ' A' ' 53' ' ' HIS . . . -37.54 158.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 0.0 110.018 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.661 ' HB3' HD13 ' A' ' 65' ' ' LEU . 14.4 m-85 -137.03 22.62 3.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -5.07 2.46 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.48 16.74 0.99 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.64 -55.83 2.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 61' ' ' PHE . 4.7 mp -66.52 -157.42 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 69' ' ' GLN . 1.4 m -99.51 -58.36 1.94 Allowed 'General case' 0 C--N 1.285 -2.236 0 O-C-N 121.246 -0.909 . . . . 0.0 109.259 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 66' ' ' THR . 3.7 m-20 153.72 -53.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 3.7 mt-10 -69.01 -3.77 14.3 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 1.046 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.88 -25.81 9.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.656 HD11 ' O ' ' A' ' 61' ' ' PHE . 12.3 mm -57.37 -23.13 18.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.9 mp0 -96.37 -70.47 0.71 Allowed 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.515 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 2.8 m-20 -44.66 -46.4 10.2 Favored 'General case' 0 C--O 1.203 -1.394 0 O-C-N 121.857 -0.527 . . . . 0.0 110.026 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -62.05 -37.02 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.628 0.728 . . . . 0.0 110.005 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.551 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -67.23 -61.84 1.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.509 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.1 -18.99 17.03 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.797 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 71.3 t80 -67.14 -44.16 80.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.8 HG21 HD11 ' A' ' 47' ' ' ILE . 85.0 t -71.11 -19.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 2.4 mt -84.6 -9.52 58.22 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.293 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.502 ' HB3' ' OE1' ' A' ' 80' ' ' GLN . 7.4 t0 -99.21 -45.87 5.74 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.188 0.994 . . . . 0.0 108.604 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.641 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.1 mm100 -65.59 -50.07 66.44 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.082 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.766 ' HB2' ' CD1' ' A' ' 85' ' ' TRP . . . -74.14 -12.1 60.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.55 -0.719 . . . . 0.0 109.22 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 78' ' ' LEU . . . -65.28 -7.46 13.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.53 -0.731 . . . . 0.0 110.023 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -179.9 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.754 -1.217 . . . . 0.0 111.64 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.52 75.9 1.31 Allowed Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.019 -1.562 . . . . 0.0 109.669 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.766 ' CD1' ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -39.74 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.39 -0.476 . . . . 0.0 110.551 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.799 . . . . 0.0 109.204 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.498 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 8.6 m-20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.464 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -66.86 -4.91 10.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.554 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.95 -25.41 60.92 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.515 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.3 m-20 -77.68 -36.94 50.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.462 ' CA ' ' OD1' ' A' ' 72' ' ' ASP . . . -50.72 -55.98 15.47 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.762 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -60.31 -24.95 65.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.767 -0.843 . . . . 0.0 109.712 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.726 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.88 -30.28 68.74 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.838 -1.164 . . . . 0.0 108.331 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.051 HG21 ' CB ' ' A' ' 69' ' ' GLN . 22.8 t -97.73 -23.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.479 -0.763 . . . . 0.0 110.056 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.658 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 t80 -89.17 -25.89 21.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.845 -1.159 . . . . 0.0 109.921 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 17.1 m -78.81 7.34 7.21 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.638 -0.664 . . . . 0.0 110.081 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -156.46 13.02 0.34 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.378 -1.392 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 1.3 m-80 -139.01 -42.4 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.802 -1.411 . . . . 0.0 109.057 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -97.22 -22.76 16.52 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -47.59 -50.37 24.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.716 -0.615 . . . . 0.0 110.455 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.16 71.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 110.776 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 64.4 m -112.94 15.07 19.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.921 -1.112 . . . . 0.0 110.006 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 81.1 m-70 -159.15 -64.45 0.08 Allowed 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 50.24 108.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.497 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.48 57.07 9.76 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.507 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 45.99 66.67 1.56 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -144.67 81.78 0.21 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.775 ' H ' HG23 ' A' ' 30' ' ' THR . 6.5 t-20 -53.3 153.45 3.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -1.201 . . . . 0.0 109.324 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 17' ' ' CYS . 4.1 m -128.12 5.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 109.997 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.7 t -105.29 -59.57 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 109.31 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.4 mmm -86.38 -173.28 4.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.94 . . . . 0.0 109.369 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -128.67 57.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 1.5 p-10 169.27 -41.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.806 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HD2' ' CE2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -71.47 89.02 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 109.876 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.775 HG23 ' H ' ' A' ' 23' ' ' ASN . 9.6 m -122.43 170.96 9.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.318 -0.863 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.958 ' HB3' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -89.91 -11.71 41.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.997 . . . . 0.0 108.955 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -34.3 -71.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.645 -0.659 . . . . 0.0 111.6 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.035 ' CA ' HD21 ' A' ' 36' ' ' LEU . 1.5 tptm 170.07 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.724 -1.235 . . . . 0.0 110.196 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 32.1 mt-10 -72.2 -46.3 56.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.112 -0.992 . . . . 0.0 111.06 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.597 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.48 -48.41 49.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.029 -1.044 . . . . 0.0 111.132 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.035 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -65.97 -14.15 61.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.65 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.541 ' CG ' ' CD2' ' A' ' 42' ' ' TYR . 3.0 mm-40 -119.22 8.4 11.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.773 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.533 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.5 tp-100 -87.06 -53.06 5.07 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.25 -40.52 13.59 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.736 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.51 44.35 0.18 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.752 -1.214 . . . . 0.0 110.785 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.514 ' HE3' ' HB2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -105.78 9.05 33.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.333 . . . . 0.0 109.187 179.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.599 ' CD2' HD12 ' A' ' 36' ' ' LEU . 27.6 t80 -71.98 13.99 0.25 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 111.449 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -106.0 136.26 45.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.35 -1.469 . . . . 0.0 110.745 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.743 ' C ' HD12 ' A' ' 48' ' ' ILE . 1.4 mt-10 -44.1 -57.51 3.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.297 -0.877 . . . . 0.0 108.83 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' N ' HD12 ' A' ' 48' ' ' ILE . 9.9 t0 -51.41 -38.75 55.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.12 -73.82 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.781 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.6 tt -64.47 -11.27 10.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 110.083 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.743 HD12 ' C ' ' A' ' 44' ' ' GLU . 14.8 mt -78.96 -31.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 40.0 t80 -92.32 -14.4 28.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.549 ' OE1' ' CB ' ' A' ' 55' ' ' LYS . 1.4 tp60 -93.93 -14.47 25.95 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.2 t -97.32 -44.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.973 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -64.27 -13.94 52.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.582 . . . . 0.0 111.313 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.662 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -147.88 21.54 1.13 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.604 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.36 -130.53 50.56 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.7 137.39 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 58.24 -89.48 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.61 41.46 3.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.689 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 17.5 ttt -113.94 143.97 30.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.689 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.2 Cg_endo -77.39 107.74 2.46 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.334 2.689 . . . . 0.0 114.709 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.662 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.55 159.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 111.039 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.636 ' CD1' ' O ' ' A' ' 60' ' ' ALA . 10.0 m-30 -141.12 16.26 2.26 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.8 -0.562 . . . . 0.0 110.116 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB2' ' HG2' ' A' ' 52' ' ' GLN . . . -66.28 -2.99 4.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.123 178.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.53 17.8 1.13 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.546 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.22 -57.49 2.11 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.043 HD12 ' CD1' ' A' ' 70' ' ' ILE . 36.0 mt -73.51 -149.1 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.536 ' HB ' ' HG2' ' A' ' 69' ' ' GLN . 1.4 m -99.53 -61.52 1.36 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.9 t70 156.7 -51.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 12.3 tp10 -71.15 4.01 3.08 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 1.051 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -112.21 -33.24 6.28 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.043 ' CD1' HD12 ' A' ' 65' ' ' LEU . 36.0 mm -58.28 -24.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -91.6 -73.52 0.54 Allowed 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.713 178.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.554 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 15.1 t0 -44.65 -53.7 6.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.761 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 11.5 t -56.09 -39.54 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.362 1.077 . . . . 0.0 108.159 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLN . . . -55.77 -59.15 5.28 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.97 -18.77 59.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.762 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 65.0 t80 -67.27 -38.06 84.49 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.958 HG13 ' HB3' ' A' ' 31' ' ' LEU . 93.7 t -76.78 -23.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.809 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -86.41 -6.48 58.91 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -98.2 -52.63 3.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.265 1.031 . . . . 0.0 108.404 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.623 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 45.7 mm-40 -65.16 -46.34 81.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.365 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 31' ' ' LEU . . . -70.57 -12.39 61.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.321 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 78' ' ' LEU . . . -78.08 -4.45 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.45 -0.781 . . . . 0.0 110.963 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -178.32 57.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.454 -1.404 . . . . 0.0 111.961 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 89.56 75.96 1.3 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 118.947 -1.597 . . . . 0.0 109.339 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.641 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -40.7 84.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.177 0.513 . . . . 0.0 110.826 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.337 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.583 HD13 ' OD2' ' A' ' 79' ' ' ASP . 1.0 OUTLIER -70.66 -11.93 61.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 108.588 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -30.42 66.57 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.511 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.43 -37.32 65.93 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -49.72 -59.09 7.62 Favored Glycine 0 C--O 1.201 -1.948 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.842 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -54.06 -35.05 61.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.103 . . . . 0.0 109.79 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.572 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 108.995 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.055 HG21 ' CB ' ' A' ' 69' ' ' GLN . 37.5 t -86.15 -43.08 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 110.563 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.588 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 7.8 t80 -63.46 -27.68 69.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.726 -1.234 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 p -86.52 18.47 3.29 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 109.473 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.71 6.96 0.66 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.243 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.513 HD22 HG13 ' A' ' 9' ' ' VAL . 17.8 m-80 -152.56 -49.76 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.605 -1.527 . . . . 0.0 109.468 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 2.3 m -76.46 -30.69 57.43 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -43.6 -42.45 5.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.679 -0.638 . . . . 0.0 110.294 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -46.96 85.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.944 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.582 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 66.5 m -107.28 29.54 7.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.582 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 77.8 m-70 -162.6 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.499 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 9.8 ptt? 39.04 100.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.49 0.662 . . . . 0.0 110.777 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 87.26 41.95 6.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 39.32 58.73 1.97 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -151.64 103.85 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -56.11 162.08 2.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.197 . . . . 0.0 109.05 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.4 -29.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.047 -1.033 . . . . 0.0 109.986 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -79.09 -70.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.099 -1.001 . . . . 0.0 109.337 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.3 mmt -66.48 150.85 48.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.278 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -113.54 60.35 0.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 109.685 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.498 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.8 p30 -178.69 -44.17 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.985 . . . . 0.0 109.364 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HG2' ' HE3' ' A' ' 41' ' ' MET . 25.0 mttp -81.86 124.37 29.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.121 -0.987 . . . . 0.0 109.071 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.788 ' O ' HD22 ' A' ' 36' ' ' LEU . 2.1 m -121.47 -174.18 2.8 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.274 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.713 ' H ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -100.24 -13.93 18.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.678 ' C ' HD21 ' A' ' 36' ' ' LEU . 24.2 mtpt -59.78 -98.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.144 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.794 ' N ' HD21 ' A' ' 36' ' ' LEU . 14.7 ptpt -177.25 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -51.47 -29.07 15.02 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.584 ' C ' ' CE2' ' A' ' 39' ' ' PHE . . . -104.48 -71.79 0.73 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.396 -0.815 . . . . 0.0 110.095 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.929 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -40.56 -39.91 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.558 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -82.96 -33.45 26.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.92 -1.112 . . . . 0.0 109.215 179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -45.79 -44.3 13.91 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CE2' ' C ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -85.83 -72.24 0.5 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.9 89.18 0.07 OUTLIER Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER 179.48 26.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -1.2 . . . . 0.0 110.395 -178.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.027 ' OH ' ' HB3' ' A' ' 81' ' ' ALA . 3.3 t80 -109.04 23.37 14.64 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 109.473 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 5.6 p -107.79 153.42 23.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.899 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -42.52 -65.67 0.44 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 109.858 178.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.538 ' N ' HD12 ' A' ' 48' ' ' ILE . 50.0 t0 -52.18 -32.91 38.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.015 . . . . 0.0 110.437 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.503 ' C ' ' NE2' ' A' ' 50' ' ' GLN . . . -62.55 -73.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.28 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.74 ' CD1' HG11 ' A' ' 77' ' ' VAL . 10.6 tt -62.57 -13.8 11.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.899 HD12 ' C ' ' A' ' 44' ' ' GLU . 32.7 mt -77.22 -28.67 16.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.646 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 25.7 t80 -85.76 -22.22 27.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.338 -0.851 . . . . 0.0 110.026 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.548 ' O ' ' CE ' ' A' ' 58' ' ' MET . 2.3 pm0 -99.47 -15.07 18.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 119.789 -1.819 . . . . 0.0 108.735 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.589 ' CG2' HG12 ' A' ' 47' ' ' ILE . 34.5 t -91.43 -27.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 109.516 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.659 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -86.8 -4.4 59.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.788 -1.195 . . . . 0.0 108.144 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.74 ' HA ' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -158.97 22.37 0.2 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.36 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 48.8 -138.28 15.09 Favored Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.261 -1.935 . . . . 0.0 108.261 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.626 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.9 OUTLIER 156.43 134.53 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.03 -89.38 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -121.76 41.15 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.507 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.651 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 18.2 ttt -119.76 143.31 34.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 108.726 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.651 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 33.5 Cg_endo -77.31 94.56 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 123.004 2.469 . . . . 0.0 115.347 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.74 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -49.2 112.94 0.7 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.288 -0.882 . . . . 0.0 110.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.675 ' CD2' ' CD2' ' A' ' 65' ' ' LEU . 25.9 m-85 -81.41 -51.2 8.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.11 26.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.384 0.612 . . . . 0.0 109.606 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.85 32.74 0.63 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.645 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -100.29 -48.52 4.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.87 HD23 HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -64.12 -141.0 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.587 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 3.3 m -98.02 -52.11 3.81 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 121.01 -1.056 . . . . 0.0 109.175 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.7 m-20 150.77 -60.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 35.2 mm-40 -68.22 -2.02 7.31 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 1.055 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.11 -29.82 7.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.87 HD13 HD23 ' A' ' 65' ' ' LEU . 9.7 mm -52.47 -24.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.52 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -100.21 -60.42 1.53 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.442 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.703 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 13.9 m-20 -52.69 -47.6 67.13 Favored 'General case' 0 C--O 1.189 -2.114 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.527 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 69' ' ' GLN . 6.3 t -54.56 -29.17 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 108.791 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.747 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -77.67 -67.64 0.7 Allowed 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.47 -23.62 2.58 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.012 -1.68 . . . . 0.0 107.515 177.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.842 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 35.6 t80 -64.74 -46.23 83.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.188 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.4 p -67.74 -23.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.5 mt -78.34 -12.13 59.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.583 ' OD2' HD13 ' A' ' 3' ' ' LEU . 3.6 t0 -100.74 -34.62 9.77 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.793 0.806 . . . . 0.0 109.713 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.609 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 4.2 mm-40 -76.95 -40.63 46.37 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.27 0.557 . . . . 0.0 110.198 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.027 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -69.48 -26.15 64.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 108.952 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.45 11.65 18.71 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 111.036 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -162.53 29.5 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.344 -1.473 . . . . 0.0 112.442 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 92.31 75.7 1.31 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.71 -1.709 . . . . 0.0 109.202 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.706 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.6 OUTLIER -36.9 89.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.532 0.682 . . . . 0.0 110.152 178.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.3 -1.574 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.691 HD23 ' OD1' ' A' ' 72' ' ' ASP . 4.8 mt -69.61 -5.28 23.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.133 -0.979 . . . . 0.0 109.449 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.58 68.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.8 -33.95 64.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.85 -61.82 6.71 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.768 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.47 -36.66 15.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.271 . . . . 0.0 109.66 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.74 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -58.52 -46.1 87.47 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.055 HG21 ' CB ' ' A' ' 69' ' ' GLN . 42.5 t -75.51 -63.03 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.651 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.1 t80 -46.27 -23.43 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 110.954 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m -91.49 31.88 1.13 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.24 -0.912 . . . . 0.0 109.168 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.34 -32.73 0.02 OUTLIER Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.896 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' CB ' HD11 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -118.08 -50.24 2.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.878 -1.366 . . . . 0.0 108.767 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 6.6 m -70.2 -29.8 66.74 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -61.14 -38.17 85.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.513 -0.742 . . . . 0.0 110.48 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -11.83 7.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.82 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.576 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 96.9 m -143.01 23.91 1.85 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.869 -1.145 . . . . 0.0 110.082 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.039 ' CE1' HD21 ' A' ' 31' ' ' LEU . 84.8 m-70 -157.9 -68.73 0.09 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.19 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 53.78 110.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.637 -0.664 . . . . 0.0 110.304 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 45.92 62.4 3.39 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 41.64 68.8 0.62 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -149.75 87.18 0.15 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.688 ' H ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -57.85 145.85 33.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -1.107 . . . . 0.0 109.474 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.545 HG23 HG23 ' A' ' 25' ' ' VAL . 34.8 m -97.42 -41.34 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG23 HG23 ' A' ' 24' ' ' VAL . 2.6 t -83.53 -60.7 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.092 -1.005 . . . . 0.0 109.196 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -86.7 90.19 8.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.77 71.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.713 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -74.16 -39.51 63.19 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.151 -0.968 . . . . 0.0 109.457 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.72 106.79 18.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.366 -0.834 . . . . 0.0 109.425 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.688 HG23 ' H ' ' A' ' 23' ' ' ASN . 7.7 m -126.5 174.81 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.104 -0.998 . . . . 0.0 109.567 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.039 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -95.76 -8.83 33.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.675 ' HD2' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -34.49 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.573 -178.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.108 ' N ' HD21 ' A' ' 36' ' ' LEU . 14.9 ttpp -178.42 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.824 -1.173 . . . . 0.0 110.592 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -80.16 -53.3 6.8 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.082 -1.011 . . . . 0.0 111.63 -178.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' CZ ' ' A' ' 39' ' ' PHE . . . -67.75 -53.84 24.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.937 -1.102 . . . . 0.0 110.521 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.108 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -44.84 -23.76 0.16 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.565 -179.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.562 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 89.4 mt-10 -95.25 -32.56 12.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 110.307 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.566 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 15.5 mm100 -52.17 -39.52 60.19 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.772 ' CZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.87 -47.9 8.64 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.33 8.37 5.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.538 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 4.2 ptt? -80.94 11.78 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -1.153 . . . . 0.0 109.98 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.88 ' HB2' HD12 ' A' ' 36' ' ' LEU . 15.0 t80 -85.11 12.22 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.946 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.5 p -105.15 149.28 26.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.26 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.619 ' HG2' HD11 ' A' ' 48' ' ' ILE . 3.8 tt0 -54.39 -57.4 11.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.849 . . . . 0.0 109.64 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 45' ' ' ASP . 16.0 t0 -51.75 -23.13 4.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.643 -1.286 . . . . 0.0 110.3 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 41' ' ' MET . . . -76.68 -76.17 0.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.909 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.7 tt -57.91 -16.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.619 HD11 ' HG2' ' A' ' 44' ' ' GLU . 15.1 mt -71.89 -39.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.586 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 28.9 t80 -86.36 -16.88 35.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 108.834 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.522 ' OE1' ' CB ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -86.61 -19.97 28.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.665 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 47' ' ' ILE . 62.3 t -96.22 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.503 1.144 . . . . 0.0 109.552 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.558 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -71.7 -11.74 60.98 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.272 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.645 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -154.2 23.87 0.49 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.378 -1.451 . . . . 0.0 109.091 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.704 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.42 -148.86 44.51 Favored Glycine 0 C--N 1.285 -2.256 0 N-CA-C 107.627 -2.189 . . . . 0.0 107.627 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.97 117.82 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.9 m-80 63.39 -86.98 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.29 28.32 6.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 108.737 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.676 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.31 141.82 23.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 31.7 Cg_endo -75.75 105.49 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 123.369 2.713 . . . . 0.0 116.242 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.704 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -57.27 117.47 4.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.634 ' CD2' ' CD2' ' A' ' 65' ' ' LEU . 17.7 m-85 -87.9 -45.59 10.12 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.038 -1.039 . . . . 0.0 108.781 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 46.93 19.01 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.39 -0.819 . . . . 0.0 108.906 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 128.65 43.19 0.23 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.545 ' CB ' ' HB3' ' A' ' 61' ' ' PHE . 21.0 ttt180 -101.59 -51.62 3.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.704 HD12 HG13 ' A' ' 9' ' ' VAL . 2.7 mm? -63.6 -145.13 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.573 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 2.5 m -99.0 -56.98 2.28 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 120.896 -1.128 . . . . 0.0 109.642 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER 152.43 -55.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.086 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 24.5 mt-10 -69.75 -1.71 9.96 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 1.055 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.6 -28.23 8.98 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.464 ' CG2' ' HG3' ' A' ' 52' ' ' GLN . 8.2 mm -56.29 -23.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.482 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.9 mp0 -95.56 -70.31 0.72 Allowed 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.442 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.691 ' OD1' HD23 ' A' ' 3' ' ' LEU . 5.4 m-20 -45.19 -47.29 12.5 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.954 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.748 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -60.45 -36.25 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.74 0.781 . . . . 0.0 110.132 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' A' ' 48' ' ' ILE . . . -68.34 -62.71 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.19 -19.14 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.768 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 82.5 t80 -65.02 -45.27 86.22 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 31' ' ' LEU . 42.5 t -68.87 -24.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.429 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.72 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -83.53 -4.76 58.83 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.908 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 5.0 t0 -97.41 -45.4 6.47 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.824 ' HB3' ' CD2' ' A' ' 85' ' ' TRP . 10.7 mp0 -72.08 -31.75 66.38 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.2 0.524 . . . . 0.0 110.344 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 33' ' ' LYS . . . -58.44 -52.72 64.43 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.73 19.39 4.03 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -131.95 5.57 4.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 111.597 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.5 76.15 1.04 Allowed Glycine 0 C--N 1.296 -1.672 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.824 ' CD2' ' HB3' ' A' ' 80' ' ' GLN . 18.0 m95 -38.28 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.417 0.627 . . . . 0.0 110.804 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 109.824 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 4' ' ' ALA . 35.1 t70 . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.24 -3.98 23.27 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.08 -1.012 . . . . 0.0 108.424 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB2' ' OD2' ' A' ' 2' ' ' ASP . . . -63.92 -31.12 72.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.524 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.2 m-20 -71.6 -26.54 62.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.629 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -60.56 -64.11 4.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.851 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -39.77 -34.24 0.24 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.875 -0.78 . . . . 0.0 109.275 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.17 -52.49 40.82 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.77 HG11 ' HB ' ' A' ' 73' ' ' VAL . 23.6 t -52.19 -57.29 4.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.715 -0.615 . . . . 0.0 110.349 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.783 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 19.8 t80 -59.37 -33.46 71.21 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.986 -1.072 . . . . 0.0 110.473 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 t -91.1 21.17 4.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.283 -0.885 . . . . 0.0 110.073 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.63 -8.64 0.68 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.767 ' ND2' HD22 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -149.12 3.67 0.6 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.484 -1.598 . . . . 0.0 111.525 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -132.65 -44.99 0.89 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.564 -1.335 . . . . 0.0 110.979 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . -27.38 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.13 0.491 . . . . 0.0 111.196 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -61.8 -53.48 55.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 110.762 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' HA ' ' CG1' ' A' ' 24' ' ' VAL . 84.4 m -94.85 25.02 4.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 109.628 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.564 ' CE1' ' HG ' ' A' ' 31' ' ' LEU . 28.5 m-70 -157.1 -72.08 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.743 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 2.5 mtp 43.71 100.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.313 0.578 . . . . 0.0 110.631 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 75.72 50.8 7.64 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 37.98 45.82 1.68 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -127.42 101.0 0.56 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.3 t-20 -46.16 165.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -1.198 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.682 HG13 HG23 ' A' ' 25' ' ' VAL . 1.7 p -111.73 -40.41 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.181 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 24' ' ' VAL . 2.7 t -91.72 -70.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.227 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.92 101.18 8.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.55 75.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.641 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 2.2 p-10 -65.8 -44.93 84.23 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.15 -0.969 . . . . 0.0 109.387 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.2 tptt -85.12 79.69 9.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.449 -0.782 . . . . 0.0 109.677 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 6.7 t -101.04 -176.47 3.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.905 . . . . 0.0 109.69 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -97.3 -19.07 18.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.73 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.614 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -38.61 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.692 -0.63 . . . . 0.0 111.407 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.063 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.6 OUTLIER 174.63 -39.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.019 . . . . 0.0 109.95 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.71 . . . . 0.0 111.103 -178.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.603 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -93.31 -47.24 7.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 110.803 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.063 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -58.85 -33.21 70.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.557 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.492 ' HG2' ' HB2' ' A' ' 42' ' ' TYR . 2.0 mm-40 -95.75 -1.28 50.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.589 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -73.69 -57.61 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -88.27 -48.98 7.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.456 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.58 92.84 0.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.525 ' SD ' ' CB ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -172.13 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.048 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.965 ' CG ' HD12 ' A' ' 36' ' ' LEU . 2.2 t80 -102.14 21.73 14.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.482 -0.761 . . . . 0.0 109.751 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -107.4 143.78 35.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 0.0 111.216 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.532 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -42.42 -62.78 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.47 -0.769 . . . . 0.0 109.588 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -49.01 -37.6 20.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 110.751 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -74.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.995 -1.066 . . . . 0.0 110.44 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 77' ' ' VAL . 8.0 tt -64.28 -10.51 8.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.528 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.532 HD12 ' C ' ' A' ' 44' ' ' GLU . 10.7 mt -75.4 -37.64 38.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 34.0 t80 -89.5 -15.96 31.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -88.34 -14.48 38.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.5 t -97.2 -47.71 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.392 -0.818 . . . . 0.0 110.006 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.563 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -61.34 -9.92 6.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.737 -0.602 . . . . 0.0 110.878 -178.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.654 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.51 23.54 0.4 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 54.01 -133.84 44.66 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.03 120.76 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.208 0.528 . . . . 0.0 109.737 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 2.5 m120 73.85 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.8 29.4 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.195 -0.941 . . . . 0.0 108.859 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.658 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.0 ttt -108.23 143.79 28.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 109.346 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.658 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 32.9 Cg_endo -79.89 111.98 2.81 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.012 2.475 . . . . 0.0 113.171 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.654 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -37.68 159.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.599 -0.688 . . . . 0.0 110.246 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.633 ' O ' HD11 ' A' ' 70' ' ' ILE . 5.9 m-85 -147.23 21.71 1.21 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.483 -0.76 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.02 -10.8 10.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.03 . . . . 0.0 109.063 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.38 13.12 5.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.59 ' HG3' ' CD1' ' A' ' 61' ' ' PHE . 6.6 mmt85 -104.07 -48.11 3.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -95.41 124.83 39.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.71 HG22 ' H ' ' A' ' 67' ' ' ASP . 5.3 m -44.26 178.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.258 0.552 . . . . 0.0 110.049 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.71 ' H ' HG22 ' A' ' 66' ' ' THR . 4.3 m-20 -65.21 -59.38 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.798 -1.189 . . . . 0.0 109.204 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.597 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 4.4 mt-10 -71.1 1.91 5.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.653 -0.654 . . . . 0.0 109.533 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.724 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -102.67 -27.17 12.88 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.633 HD11 ' O ' ' A' ' 61' ' ' PHE . 25.6 mm -73.01 -31.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.8 mp0 -80.01 -64.64 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.68 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 40.7 t0 -56.86 -30.41 63.82 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.117 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.77 ' HB ' HG11 ' A' ' 9' ' ' VAL . 8.7 p -70.52 -29.39 38.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -70.4 -58.2 3.99 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.97 -23.39 32.11 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.851 ' CE2' ' HA ' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.77 -50.62 68.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.835 HG21 ' CD1' ' A' ' 47' ' ' ILE . 44.0 t -65.77 -22.66 31.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.89 -1.131 . . . . 0.0 109.489 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.714 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.9 mt -87.32 -7.19 58.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.038 -1.039 . . . . 0.0 108.876 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -97.77 -40.99 8.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.018 0.913 . . . . 0.0 108.761 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.672 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -72.14 -45.14 61.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.648 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -76.36 -5.45 47.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.614 ' HB3' ' HD3' ' A' ' 83' ' ' LYS . . . -75.35 -13.54 60.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.489 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.614 ' HD3' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER 176.3 66.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.702 -1.249 . . . . 0.0 111.076 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 91.82 77.44 1.35 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.672 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -40.21 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.389 0.614 . . . . 0.0 110.7 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.625 ' HB2' ' OE1' ' A' ' 80' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.875 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.069 HD13 ' OD1' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -69.17 -8.6 47.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.123 -0.986 . . . . 0.0 108.554 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.43 -22.52 54.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -78.86 -37.01 41.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -62.39 -53.2 43.75 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.674 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.15 -24.83 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.016 -1.285 . . . . 0.0 109.368 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.514 ' HE3' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -73.97 -47.24 38.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.746 HG22 ' HB3' ' A' ' 69' ' ' GLN . 14.8 t -55.38 -65.03 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 122.219 1.009 . . . . 0.0 108.918 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 10.9 t80 -60.73 -28.9 69.03 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 33.0 t -89.88 18.05 6.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.556 -1.34 . . . . 0.0 109.513 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -155.56 3.54 0.2 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.88 -1.152 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -155.49 -46.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.604 -1.527 . . . . 0.0 109.56 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.2 m -79.65 -30.38 41.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 10' ' ' PHE . . . -53.61 -41.2 66.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 110.945 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.5 79.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.262 -0.899 . . . . 0.0 111.151 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.624 ' HA ' HG11 ' A' ' 24' ' ' VAL . 1.8 m -110.95 20.08 17.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.879 -1.138 . . . . 0.0 110.013 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.889 ' CE1' HD21 ' A' ' 31' ' ' LEU . 89.2 m-70 -155.58 -51.37 0.08 Allowed 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.544 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.0 ptm 42.39 111.07 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.756 0.788 . . . . 0.0 111.556 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 49.95 57.47 9.84 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.36 72.86 0.26 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.728 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -153.83 92.49 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.456 ' H ' HG23 ' A' ' 30' ' ' THR . 1.1 t-20 -43.85 156.76 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -1.053 . . . . 0.0 109.812 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.704 HG13 HG23 ' A' ' 25' ' ' VAL . 3.3 p -115.86 -35.67 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 109.633 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.704 HG23 HG13 ' A' ' 24' ' ' VAL . 13.4 t -91.51 -68.53 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.867 . . . . 0.0 109.651 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.418 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -60.61 161.45 7.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 28' ' ' ASN . . . -117.03 63.83 0.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.905 . . . . 0.0 109.265 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 163.65 -39.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.208 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 2.7 mptt -71.73 83.23 0.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.938 ' O ' HD22 ' A' ' 36' ' ' LEU . 2.1 m -99.38 -168.09 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 108.816 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.936 HD23 ' C ' ' A' ' 30' ' ' THR . 0.6 OUTLIER -109.83 -2.8 17.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.677 -1.264 . . . . 0.0 109.651 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.676 ' HG2' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -60.19 -82.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.993 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.576 ' N ' HD21 ' A' ' 36' ' ' LEU . 3.2 ptmm? 168.75 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.658 -1.276 . . . . 0.0 110.936 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.72 -34.53 5.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.907 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.09 -66.44 1.02 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.84 0.828 . . . . 0.0 110.365 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.095 HD12 ' CB ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -44.75 -46.43 10.46 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.927 -0.483 . . . . 0.0 111.846 -178.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.474 ' HA ' ' CD1' ' A' ' 42' ' ' TYR . 43.4 tt0 -60.94 -34.63 75.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.569 -1.332 . . . . 0.0 110.333 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 3.2 mm-40 -73.81 -77.9 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.17 7.57 43.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.524 -0.735 . . . . 0.0 111.851 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 36' ' ' LEU . . . -124.88 -3.62 7.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 1.051 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.9 mtt 42.57 48.38 4.64 Favored 'General case' 0 C--O 1.196 -1.739 0 O-C-N 121.241 -1.152 . . . . 0.0 109.527 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.095 ' CB ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -39.01 -21.81 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 O-C-N 120.912 -1.117 . . . . 0.0 111.368 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.771 ' O ' HG22 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -42.45 166.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.773 -1.204 . . . . 0.0 110.508 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.567 ' N ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -52.64 -73.18 0.04 OUTLIER 'General case' 0 C--O 1.2 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 110.579 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 44' ' ' GLU . 33.5 t0 -36.72 -51.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.209 -0.932 . . . . 0.0 112.492 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 1.051 ' HB3' ' O ' ' A' ' 41' ' ' MET . . . -63.35 -73.25 0.12 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 111.204 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 43' ' ' SER . 14.0 tt -51.0 -20.55 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.016 -1.052 . . . . 0.0 109.677 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.626 HG23 HE22 ' A' ' 52' ' ' GLN . 14.0 mt -72.12 -38.25 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.626 -0.671 . . . . 0.0 109.445 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -77.44 -26.79 51.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.5 pm0 -89.13 -18.86 26.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.213 -1.554 . . . . 0.0 108.702 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 47' ' ' ILE . 45.3 t -85.78 -44.8 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.942 0.877 . . . . 0.0 109.389 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.626 HE22 HG23 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -66.74 -10.69 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.821 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.622 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -158.65 23.29 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.71 -1.196 . . . . 0.0 108.612 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.563 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 55.89 -141.34 39.98 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 154.23 142.5 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 54.98 -90.56 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.12 49.0 2.33 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.61 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 ttt -121.04 144.6 39.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.61 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.9 Cg_endo -82.54 105.21 1.39 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 123.077 2.518 . . . . 0.0 113.67 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.622 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -39.45 154.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 110.677 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.781 ' HB3' HD12 ' A' ' 70' ' ' ILE . 23.0 m-85 -136.72 3.46 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 52' ' ' GLN . . . -44.36 -29.67 0.71 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.76 36.64 0.51 Allowed Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.095 -1.526 . . . . 0.0 109.805 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HB3' ' HD1' ' A' ' 61' ' ' PHE . 10.7 ttt-85 -102.0 -48.34 4.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' A' ' 61' ' ' PHE . 1.6 mt -93.68 -146.03 0.24 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.57 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -84.73 -172.94 4.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.415 ' H ' HG22 ' A' ' 66' ' ' THR . 3.6 m-20 -93.45 -55.74 3.18 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.9 mt-10 -72.36 5.61 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.746 ' HB3' HG22 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -102.34 -31.85 10.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 61' ' ' PHE . 2.2 mm -72.24 -26.06 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -66.73 0.86 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.774 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 1.069 ' OD1' HD13 ' A' ' 3' ' ' LEU . 53.9 t0 -58.61 -28.47 65.65 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.128 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 7.9 p -69.14 -26.73 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -75.18 -56.75 4.42 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.06 -19.62 53.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.025 ' HA ' HD12 ' A' ' 3' ' ' LEU . 78.6 t80 -67.85 -41.09 83.46 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.571 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 39.9 t -70.04 -22.61 24.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.567 HD11 ' N ' ' A' ' 44' ' ' GLU . 0.9 OUTLIER -85.39 -8.46 58.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 1.8 t70 -99.02 -35.52 10.02 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.946 0.879 . . . . 0.0 109.16 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.661 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 7.2 mm-40 -81.96 -34.01 29.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.233 0.54 . . . . 0.0 109.942 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -62.92 -48.16 80.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.852 . . . . 0.0 109.101 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.52 18.54 3.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.445 -0.784 . . . . 0.0 109.358 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -134.86 13.38 3.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 0.0 110.963 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 77.74 75.73 0.93 Allowed Glycine 0 C--N 1.296 -1.694 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.661 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 11.7 m95 -34.76 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.727 0.775 . . . . 0.0 109.417 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 109.969 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 1.7 m-20 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.02 HD13 ' HA ' ' A' ' 76' ' ' TYR . 1.8 pp -72.88 2.21 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.074 -1.016 . . . . 0.0 109.613 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.14 70.55 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -62.86 -25.65 68.39 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -59.55 -51.2 60.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.714 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -45.54 -25.45 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.714 -1.463 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -75.0 -47.82 27.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 177.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.662 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 21.1 t -55.44 -64.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 121.948 0.88 . . . . 0.0 109.01 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.606 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 11.6 t80 -59.82 -31.79 70.05 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.768 -0.582 . . . . 0.0 111.11 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 43.1 p -88.53 18.69 4.38 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.788 -1.195 . . . . 0.0 109.653 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -155.7 3.74 0.2 Allowed Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.577 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 9' ' ' VAL . 1.1 m-80 -155.16 -49.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.631 -1.511 . . . . 0.0 109.409 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.4 m -71.96 -34.99 69.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -44.99 -42.78 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 110.449 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.87 74.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.187 -0.946 . . . . 0.0 111.706 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.576 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 95.9 m -104.19 27.18 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.885 -1.134 . . . . 0.0 109.87 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.914 ' CE1' HD21 ' A' ' 31' ' ' LEU . 85.7 m-70 -159.89 -67.92 0.07 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.614 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.512 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 55.76 114.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.45 -0.781 . . . . 0.0 110.092 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.32 61.73 1.71 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.491 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 44.82 79.62 0.06 OUTLIER Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -160.81 83.35 0.13 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.772 ' H ' HG23 ' A' ' 30' ' ' THR . 5.1 t-20 -40.51 160.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.611 -0.935 . . . . 0.0 109.586 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.604 HG13 ' N ' ' A' ' 25' ' ' VAL . 14.7 p -116.3 -47.04 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.09 -1.006 . . . . 0.0 110.138 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.604 ' N ' HG13 ' A' ' 24' ' ' VAL . 9.1 p -95.82 -38.52 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -96.56 115.99 28.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.73 -1.231 . . . . 0.0 109.441 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -90.19 71.87 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.6 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER 177.6 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.378 -0.826 . . . . 0.0 109.049 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 5.5 mtmm -93.43 61.56 3.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.283 -0.886 . . . . 0.0 109.311 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.772 HG23 ' H ' ' A' ' 23' ' ' ASN . 5.1 m -85.17 166.2 16.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.746 . . . . 0.0 109.526 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.914 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -94.26 -12.22 28.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.595 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -37.37 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.587 -0.695 . . . . 0.0 111.182 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.074 ' CA ' HD21 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -165.74 -43.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.122 . . . . 0.0 110.386 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 mt-10 -67.31 -47.52 70.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.594 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -65.84 -45.97 80.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.675 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.074 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -62.63 -36.17 81.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' A' ' 33' ' ' LYS . 8.8 mt-10 -92.28 5.87 48.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.195 -0.941 . . . . 0.0 109.394 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.0 tp-100 -90.55 -55.6 3.52 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.594 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.71 -50.7 6.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.031 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.15 33.65 0.15 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.387 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.864 ' CE ' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -86.05 -25.85 25.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.647 -1.502 . . . . 0.0 108.562 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.786 ' CD2' HD12 ' A' ' 36' ' ' LEU . 8.2 t80 -41.86 -23.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.852 -0.53 . . . . 0.0 110.654 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 41' ' ' MET . 22.8 p -84.42 134.82 34.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.873 -1.142 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 48' ' ' ILE . 2.7 mt-10 -49.02 -54.94 13.59 Favored 'General case' 0 C--O 1.198 -1.627 0 O-C-N 121.51 -0.744 . . . . 0.0 109.524 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -52.26 -32.9 39.33 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.667 -1.27 . . . . 0.0 110.692 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' HB1' ' HA ' ' A' ' 41' ' ' MET . . . -67.72 -69.66 0.3 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.97 . . . . 0.0 111.152 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.65 HG23 ' HB1' ' A' ' 74' ' ' ALA . 7.5 tt -66.76 -19.33 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.4 -0.812 . . . . 0.0 109.817 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.573 HG13 ' CB ' ' A' ' 74' ' ' ALA . 12.5 mt -68.04 -25.64 32.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.656 ' CD1' ' CD2' ' A' ' 53' ' ' HIS . 63.6 t80 -86.97 -68.65 0.73 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.547 ' CG ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -44.19 -25.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.515 -1.366 . . . . 0.0 108.825 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.909 ' CG1' HG23 ' A' ' 70' ' ' ILE . 55.8 t -80.36 -46.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 108.669 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.624 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -65.52 -13.23 58.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 111.954 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -154.57 20.02 0.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.446 -1.408 . . . . 0.0 108.515 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 56.41 -140.52 42.86 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.598 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 153.51 133.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 7.7 m-80 60.78 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -129.38 43.32 3.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.636 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 19.9 ttt -117.98 145.95 37.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.482 -0.761 . . . . 0.0 109.498 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.636 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.2 Cg_endo -81.83 101.63 1.18 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 123.373 2.715 . . . . 0.0 114.517 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.643 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.5 156.26 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.628 ' CE1' HD11 ' A' ' 65' ' ' LEU . 39.2 m-85 -137.02 3.74 2.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.596 -0.69 . . . . 0.0 109.434 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.39 -25.8 0.16 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.214 -0.929 . . . . 0.0 109.45 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -162.85 33.65 0.31 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -102.4 -46.57 4.74 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.628 HD11 ' CE1' ' A' ' 61' ' ' PHE . 73.8 mt -103.25 -145.72 0.37 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.605 HG21 ' OE1' ' A' ' 69' ' ' GLN . 9.2 m -98.47 167.41 10.83 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.367 -0.833 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 66' ' ' THR . 16.1 m-20 -82.7 -49.9 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.205 -0.934 . . . . 0.0 109.134 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.553 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 4.0 tt0 -64.63 -6.86 8.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.631 -0.668 . . . . 0.0 109.273 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.662 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -96.01 -35.77 11.27 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.909 HG23 ' CG1' ' A' ' 51' ' ' VAL . 3.8 mm -72.21 -11.54 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -66.97 0.87 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.296 1.046 . . . . 0.0 108.623 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.715 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 48.7 m-20 -53.4 -37.87 62.88 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.371 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.671 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 p -67.96 -28.98 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.55 0.691 . . . . 0.0 109.508 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.96 -59.31 2.79 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.47 -21.3 51.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.02 ' HA ' HD13 ' A' ' 3' ' ' LEU . 88.8 t80 -66.4 -42.49 87.79 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.864 HG11 ' CE ' ' A' ' 41' ' ' MET . 48.8 t -70.35 -22.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.719 ' N ' HD23 ' A' ' 78' ' ' LEU . 2.2 mt -81.26 -7.75 59.63 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.606 ' OD2' HD21 ' A' ' 3' ' ' LEU . 5.6 t0 -99.42 -47.38 5.17 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.069 0.937 . . . . 0.0 108.952 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.666 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 66.7 mm-40 -69.48 -39.89 77.4 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -59.97 -45.78 91.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 109.187 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.18 13.73 12.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 110.583 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -137.26 19.16 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.683 -1.261 . . . . 0.0 111.603 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.98 73.15 1.28 Allowed Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.142 -1.504 . . . . 0.0 109.366 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.666 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 1.9 m95 -40.83 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 122.316 -0.52 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.039 -1.038 . . . . 0.0 109.574 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.472 HD13 ' CG ' ' A' ' 79' ' ' ASP . 1.3 mt -68.28 -5.86 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.153 -0.967 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.3 70.61 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.506 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.97 -30.7 62.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -58.97 -59.8 10.09 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.828 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -52.31 -28.86 20.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.761 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.519 ' HE3' ' OE1' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -62.51 -43.49 98.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.92 HG21 ' CB ' ' A' ' 69' ' ' GLN . 4.1 t -77.92 -49.61 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.444 -0.785 . . . . 0.0 109.815 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.609 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 5.1 t80 -60.57 -23.57 64.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.698 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 40.2 p -87.95 19.74 3.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.66 3.95 0.64 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.456 ' ND2' HD22 ' A' ' 65' ' ' LEU . 29.9 m-80 -147.58 -48.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.745 -1.444 . . . . 0.0 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.609 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 1.9 m -78.98 -29.52 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 108.692 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -46.84 -40.11 13.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.655 -0.653 . . . . 0.0 110.009 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -42.42 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.011 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 80.2 m -116.67 32.9 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.425 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.593 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 67.0 m-70 -163.9 -76.83 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 109.153 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 52.04 114.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.493 0.663 . . . . 0.0 110.755 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 50.13 55.42 15.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 40.78 81.58 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -165.44 96.79 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.05 150.33 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -1.107 . . . . 0.0 109.399 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.68 -14.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.602 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -101.12 -68.68 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mmt -76.75 140.95 40.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.821 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -100.73 62.71 1.03 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.13 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.1 p30 179.24 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.312 -0.867 . . . . 0.0 109.819 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -80.81 75.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.707 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 31' ' ' LEU . 3.0 m -89.78 175.07 7.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.781 ' O ' HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -102.22 -17.58 15.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.482 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.729 ' C ' HD21 ' A' ' 36' ' ' LEU . 2.7 mtpm? -48.18 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.717 -0.615 . . . . 0.0 111.955 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.879 ' CA ' HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -165.08 -45.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.689 -1.257 . . . . 0.0 111.003 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 3.6 mm-40 -61.83 -14.18 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 111.157 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -105.73 -45.74 4.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.969 -1.082 . . . . 0.0 110.695 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.879 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -61.9 -33.83 74.94 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.279 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.582 ' OE1' ' CD2' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -89.96 -4.0 57.71 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.619 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.551 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.14 -59.68 2.68 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -87.25 -51.54 5.91 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.995 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 141.18 24.32 0.23 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.948 -1.596 . . . . 0.0 111.672 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.881 ' CE ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -74.91 -20.05 59.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.556 -1.555 . . . . 0.0 108.321 178.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.83 ' CD2' HD12 ' A' ' 36' ' ' LEU . 6.9 t80 -46.83 -22.16 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.715 -0.616 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.679 ' OG ' ' HB2' ' A' ' 46' ' ' ALA . 50.8 p -90.26 129.79 36.46 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.17 -0.956 . . . . 0.0 110.192 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -43.38 -62.78 0.97 Allowed 'General case' 0 C--O 1.202 -1.425 0 O-C-N 121.624 -0.672 . . . . 0.0 109.361 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -49.23 -35.98 18.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.01 . . . . 0.0 110.855 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB2' ' OG ' ' A' ' 43' ' ' SER . . . -61.73 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.918 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.2 tt -58.91 -16.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 110.252 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 10.1 mt -70.45 -37.53 70.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 29.5 t80 -83.31 -18.3 39.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -89.49 -10.78 45.03 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 47' ' ' ILE . 70.1 t -98.56 -50.14 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.864 . . . . 0.0 109.562 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.803 ' OE1' HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -58.55 -12.36 3.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 0.0 110.55 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.632 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -146.18 16.27 1.35 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.625 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 52.93 -121.25 14.89 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HB2' ' OE1' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 162.24 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.761 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.035 178.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 55' ' ' LYS . 51.8 m-80 -20.02 -49.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.724 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -148.3 20.26 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 109.765 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.664 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 23.5 ttt -102.15 145.16 30.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 108.866 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.664 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.6 Cg_endo -79.7 111.7 2.81 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.824 2.349 . . . . 0.0 113.603 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -37.58 160.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.525 -0.734 . . . . 0.0 110.25 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.633 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 32.4 m-85 -142.44 16.11 2.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 108.98 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.23 -23.05 0.77 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.436 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.47 31.27 0.7 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.633 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -103.65 -56.9 2.12 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.781 HD12 HD13 ' A' ' 70' ' ' ILE . 18.2 mt -61.82 -144.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 14.9 m -99.04 -63.24 1.14 Allowed 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.258 -0.901 . . . . 0.0 109.955 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.5 m-20 152.94 -56.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.6 tt0 -71.4 -0.01 9.27 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.92 ' CB ' HG21 ' A' ' 9' ' ' VAL . 2.4 mp0 -114.07 -24.32 9.08 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.803 HG21 ' OE1' ' A' ' 52' ' ' GLN . 9.8 mm -56.48 -21.74 13.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 172.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.9 mp0 -97.8 -68.3 0.81 Allowed 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.595 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.669 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 3.4 m-20 -51.22 -46.86 62.37 Favored 'General case' 0 C--O 1.199 -1.573 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.99 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -56.93 -29.1 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.626 -0.671 . . . . 0.0 110.042 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -80.15 -64.22 1.24 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -50.36 -23.05 2.1 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.493 -1.379 . . . . 0.0 107.323 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.828 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 17.1 t80 -66.5 -47.59 72.51 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.881 HG21 ' CE ' ' A' ' 41' ' ' MET . 1.8 p -68.11 -16.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 42' ' ' TYR . 5.1 mt -81.52 -15.74 53.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.472 ' CG ' HD13 ' A' ' 3' ' ' LEU . 1.2 t70 -97.95 -34.93 10.63 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.948 0.88 . . . . 0.0 108.899 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.749 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 2.3 mm-40 -83.54 -39.04 20.92 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.746 0.784 . . . . 0.0 110.035 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -51.45 -33.59 31.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.352 -0.842 . . . . 0.0 109.073 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -80.87 -28.79 35.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER 176.33 -24.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.155 -0.966 . . . . 0.0 111.0 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.728 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -61.18 -13.13 34.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.749 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 2.5 m95 -64.13 89.2 0.06 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.222 -0.924 . . . . 0.0 108.913 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 72' ' ' ASP . 6.5 mt -68.64 -7.19 30.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.182 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.02 67.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -71.94 -39.38 69.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.204 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 5' ' ' ASN . . . -47.39 -56.45 8.15 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.748 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -52.43 -38.66 59.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.264 . . . . 0.0 109.281 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.804 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -56.82 -40.51 76.14 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.94 HG21 ' CG ' ' A' ' 69' ' ' GLN . 38.6 t -80.69 -69.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.496 -0.752 . . . . 0.0 109.485 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 22.7 t80 -41.74 -25.31 0.05 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.389 -0.82 . . . . 0.0 111.257 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 63.7 m -92.1 32.92 1.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.464 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.57 -29.68 0.02 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.123 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.552 ' ND2' HG13 ' A' ' 9' ' ' VAL . 1.6 m-80 -116.75 -48.85 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.919 -1.342 . . . . 0.0 108.702 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -77.39 -27.42 52.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.783 ' HB1' ' HG3' ' A' ' 19' ' ' MET . . . -54.01 -31.35 50.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.563 -0.71 . . . . 0.0 110.163 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.35 85.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 110.99 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.605 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.5 m -111.0 26.31 10.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.413 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 97.8 m-70 -156.94 -74.7 0.09 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.321 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.783 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 46.11 105.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.403 0.621 . . . . 0.0 111.096 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 78.13 42.31 15.88 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.522 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 42.25 37.07 2.27 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.92 90.6 0.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' HB3' ' CG ' ' A' ' 26' ' ' MET . 3.6 t-20 -49.38 168.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -1.075 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.703 HG23 ' H ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -144.07 -69.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.033 -1.042 . . . . 0.0 110.35 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.703 ' H ' HG23 ' A' ' 24' ' ' VAL . 1.2 p -44.24 -40.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.053 -1.029 . . . . 0.0 109.837 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.533 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -56.36 -168.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.919 -1.113 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -121.65 4.29 10.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 178.15 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.945 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.608 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -51.79 137.56 25.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.263 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.692 HG22 ' H ' ' A' ' 31' ' ' LEU . 4.0 m -123.64 179.93 4.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.399 -0.813 . . . . 0.0 109.198 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.692 ' H ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -100.66 -15.7 17.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.984 -1.073 . . . . 0.0 109.165 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.71 ' C ' HD21 ' A' ' 36' ' ' LEU . 5.2 mtpm? -56.45 -92.35 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.897 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.047 ' N ' HD21 ' A' ' 36' ' ' LEU . 3.9 pttm -179.41 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.946 -1.096 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 23.1 pt-20 -47.42 -37.16 10.99 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.661 -0.65 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.607 ' HA ' ' HB2' ' A' ' 38' ' ' GLN . . . -108.32 -61.14 1.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.77 -0.581 . . . . 0.0 111.161 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.047 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -40.68 -32.65 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 109.035 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.582 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -93.15 -33.31 14.08 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 120.962 -1.086 . . . . 0.0 108.637 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 7.0 tp60 -40.73 -31.55 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.5 1.143 . . . . 0.0 108.254 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.608 ' CE2' ' HG3' ' A' ' 29' ' ' LYS . 3.8 m-85 -84.96 -50.99 7.02 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.5 ' C ' ' CG ' ' A' ' 41' ' ' MET . . . 127.68 64.37 0.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.616 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -171.39 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.97 -1.312 . . . . 0.0 110.675 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.66 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 2.5 t80 -92.48 23.48 3.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 108.632 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 54.3 p -104.58 165.67 10.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.628 -1.295 . . . . 0.0 110.338 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.523 ' O ' HG13 ' A' ' 48' ' ' ILE . 4.3 mt-10 -48.63 -70.51 0.09 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -50.05 -21.42 1.25 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.589 -1.319 . . . . 0.0 110.495 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -75.45 -73.59 0.25 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.204 -0.935 . . . . 0.0 110.39 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.3 tt -63.24 -14.1 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.845 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 44' ' ' GLU . 44.4 mt -74.6 -32.52 29.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.582 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 36.0 t80 -94.32 -15.52 24.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 1.5 tp60 -91.14 -10.28 42.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.7 t -103.66 -44.97 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.712 0.768 . . . . 0.0 109.275 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.807 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -61.24 -12.23 12.41 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.34 0.591 . . . . 0.0 110.459 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.649 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -151.75 20.55 0.7 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -178.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.62 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.77 -132.44 51.21 Favored Glycine 0 C--N 1.3 -1.42 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.52 139.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 121.388 0.614 . . . . 0.0 109.423 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 53.21 -88.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -127.55 43.29 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.982 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.671 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 11.1 ttt -126.14 143.37 45.48 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 109.367 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.671 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.9 Cg_endo -76.64 120.55 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.108 2.539 . . . . 0.0 114.406 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.93 165.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.641 -0.662 . . . . 0.0 109.707 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.764 ' CD1' HD21 ' A' ' 65' ' ' LEU . 23.5 m-85 -145.77 11.53 1.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.177 -0.952 . . . . 0.0 109.842 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.35 -19.27 5.19 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.095 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.7 24.68 1.49 Allowed Glycine 0 N--CA 1.486 1.993 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.83 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.671 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt180 -101.93 -39.31 7.41 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.842 HD13 HG11 ' A' ' 9' ' ' VAL . 2.4 mt -102.83 -154.12 0.49 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.496 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 67' ' ' ASP . 51.5 m -101.48 174.12 6.12 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.623 ' N ' HG22 ' A' ' 66' ' ' THR . 5.6 m-20 -72.6 -57.62 4.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.822 -1.174 . . . . 0.0 108.129 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 33.4 mt-10 -63.59 3.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.94 ' CG ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -104.51 -42.75 5.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.807 HG21 ' HG3' ' A' ' 52' ' ' GLN . 8.7 mm -56.65 -19.14 8.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -95.86 -73.56 0.59 Allowed 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 78.5 m-20 -39.63 -53.25 2.17 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.586 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.789 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 t -60.1 -42.28 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.434 1.112 . . . . 0.0 109.069 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -59.07 -65.85 0.6 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.301 -1.499 . . . . 0.0 107.211 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.581 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.0 -17.94 20.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.789 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 78.2 t80 -65.12 -40.67 94.82 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.684 HG21 HD11 ' A' ' 47' ' ' ILE . 96.8 t -74.65 -24.71 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.727 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -86.68 -8.8 57.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 7.3 t0 -99.54 -36.02 9.67 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.031 0.919 . . . . 0.0 109.186 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.618 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 5.4 mm-40 -79.76 -42.24 24.92 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.43 0.634 . . . . 0.0 109.708 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' HA ' ' A' ' 32' ' ' LYS . . . -74.79 -18.89 60.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.394 -0.816 . . . . 0.0 109.358 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.66 6.52 7.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.626 -0.671 . . . . 0.0 110.587 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.81 48.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.501 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.93 78.26 1.15 Allowed Glycine 0 N--CA 1.481 1.643 0 C-N-CA 118.643 -1.742 . . . . 0.0 109.215 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.631 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -36.02 90.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.578 0.704 . . . . 0.0 109.677 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.3 -1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.669 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.011 0.434 . . . . 0.0 110.027 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 79' ' ' ASP . 2.0 mp -70.39 -3.25 16.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.017 -1.052 . . . . 0.0 109.105 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.97 77.09 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.524 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -67.64 -25.43 65.72 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.59 -63.26 4.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.853 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -51.47 -33.13 29.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 0.0 109.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.49 -41.78 86.1 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 108.834 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.879 HG21 ' CB ' ' A' ' 69' ' ' GLN . 2.7 t -79.05 -51.85 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 10.4 t80 -54.72 -24.38 21.89 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.045 -1.034 . . . . 0.0 110.455 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -89.8 24.97 2.19 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.443 -0.786 . . . . 0.0 109.367 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.21 11.67 0.19 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.502 ' ND2' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -153.23 -40.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.78 -1.424 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -93.37 -31.06 14.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 108.827 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -42.26 -45.77 4.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.32 84.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 110.535 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.602 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 59.6 m -111.44 28.23 8.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.978 -1.076 . . . . 0.0 110.23 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.93 ' CE1' HD21 ' A' ' 31' ' ' LEU . 76.8 m-70 -161.56 -73.81 0.06 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.246 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 55.24 114.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.745 -0.597 . . . . 0.0 110.574 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.19 62.8 1.45 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.62 65.88 1.24 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -150.26 69.37 0.32 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' HB3' ' HE1' ' A' ' 26' ' ' MET . 20.7 p30 -48.01 166.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.099 -1.236 . . . . 0.0 109.202 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 25' ' ' VAL . 3.1 m -128.86 -37.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.956 -1.09 . . . . 0.0 109.908 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.4 ' N ' ' CG2' ' A' ' 24' ' ' VAL . 2.4 t -82.67 -40.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.09 -1.006 . . . . 0.0 109.199 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.661 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.2 mpp? -61.23 -56.94 14.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 26' ' ' MET . . . 74.38 27.25 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -179.34 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 1.3 mtmp? -90.34 57.01 3.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 109.499 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.743 ' C ' HD23 ' A' ' 31' ' ' LEU . 4.9 m -67.51 178.33 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.93 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.8 OUTLIER -98.99 -8.98 24.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.71 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -45.88 -76.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.886 -1.134 . . . . 0.0 110.481 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.06 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 167.55 -43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 109.844 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 21.6 pt-20 -56.35 -25.99 51.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.216 -0.927 . . . . 0.0 110.415 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.853 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -101.85 -59.65 1.67 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.06 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -48.52 -31.8 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.01 -1.056 . . . . 0.0 109.774 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.578 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 38.5 mt-10 -91.42 -23.62 19.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.536 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.548 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.6 tp-100 -61.67 -42.04 98.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.853 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -89.8 -76.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.873 0.844 . . . . 0.0 109.005 178.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.42 84.92 0.05 OUTLIER Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.496 ' HE2' ' HB3' ' A' ' 36' ' ' LEU . 5.2 ptt? -168.26 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -1.22 . . . . 0.0 109.617 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.008 ' HB2' HD12 ' A' ' 36' ' ' LEU . 7.1 t80 -103.2 19.26 19.94 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.151 -0.968 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -105.77 144.09 32.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 0.0 110.611 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.732 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -45.6 -65.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.778 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.463 ' N ' HD12 ' A' ' 48' ' ' ILE . 64.3 t0 -49.4 -31.84 10.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.826 -1.171 . . . . 0.0 110.748 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -64.78 -78.54 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.725 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.4 tt -57.98 -16.19 6.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.552 0.692 . . . . 0.0 110.211 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.732 HD12 ' C ' ' A' ' 44' ' ' GLU . 23.2 mt -71.67 -38.53 67.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.615 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 33.3 t80 -86.38 -11.55 51.71 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -95.88 -12.88 24.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 47' ' ' ILE . 56.4 t -102.58 -37.19 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.033 0.921 . . . . 0.0 109.474 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.719 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -66.2 -11.17 48.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.738 ' HA ' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -164.93 38.34 0.07 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.681 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 44.74 -133.42 7.37 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.08 125.95 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.587 -0.807 . . . . 0.0 108.846 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 73.6 m-80 65.04 -85.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.543 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.0 37.58 4.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.698 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 26.6 ttt -116.3 142.28 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 108.796 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.698 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.1 Cg_endo -71.24 103.44 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.873 2.382 . . . . 0.0 113.451 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.738 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -58.79 107.55 0.53 Allowed 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.866 -0.521 . . . . 0.0 110.385 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.838 ' CD2' HD21 ' A' ' 65' ' ' LEU . 75.5 m-85 -77.1 -41.06 43.6 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.884 -1.135 . . . . 0.0 108.259 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.26 19.14 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.674 -0.641 . . . . 0.0 109.493 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 61' ' ' PHE . . . 122.37 44.28 0.36 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 65' ' ' LEU . 15.6 ttt-85 -102.48 -54.0 2.77 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.839 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -62.07 -146.39 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 69' ' ' GLN . 78.8 m -97.42 154.22 17.61 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.907 ' HA ' HD12 ' A' ' 70' ' ' ILE . 7.7 t0 -63.24 -53.68 49.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.944 -1.097 . . . . 0.0 108.303 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 tt0 -64.76 1.57 0.85 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.003 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.879 ' CB ' HG21 ' A' ' 9' ' ' VAL . 2.2 mp0 -115.34 -25.47 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.145 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.907 HD12 ' HA ' ' A' ' 67' ' ' ASP . 3.7 mt -59.24 -19.95 17.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' C ' ' A' ' 69' ' ' GLN . 3.1 mp0 -97.51 -67.0 0.87 Allowed 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 114.546 -1.207 . . . . 0.0 108.332 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.698 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 18.4 m-20 -52.74 -46.08 67.29 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.001 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -56.51 -27.88 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.919 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.655 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -81.69 -63.48 1.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.23 -22.29 2.59 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.853 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 23.0 t80 -67.93 -46.82 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.826 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.669 HG23 ' HZ2' ' A' ' 85' ' ' TRP . 1.5 p -68.77 -15.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.557 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 4.8 mt -84.28 -14.78 48.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.429 ' HB2' HD22 ' A' ' 3' ' ' LEU . 9.4 t0 -96.91 -39.63 9.3 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.763 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.2 mm-40 -80.02 -38.31 32.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.891 0.853 . . . . 0.0 109.411 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -52.26 -30.18 26.56 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -87.55 -25.38 23.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 110.153 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 176.61 -24.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.077 -1.014 . . . . 0.0 111.059 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.733 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -65.24 -12.47 55.5 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.763 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 3.3 m95 -64.81 88.57 0.07 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.299 -1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.324 -177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.445 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 72' ' ' ASP . 5.9 mt -76.19 -0.67 23.02 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.172 -0.955 . . . . 0.0 109.33 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -70.1 -27.36 64.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 7' ' ' ALA . . . -59.6 -65.38 3.47 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -43.13 -33.11 0.82 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -1.161 . . . . 0.0 109.445 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HE3' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -65.26 -50.77 64.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.861 HG21 ' CB ' ' A' ' 69' ' ' GLN . 3.2 t -67.54 -59.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.266 -0.896 . . . . 0.0 108.692 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.639 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 9.2 t80 -50.28 -26.78 5.15 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 13.1 t -85.87 25.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 109.741 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.39 13.36 0.1 OUTLIER Glycine 0 N--CA 1.484 1.874 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.998 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.803 ' CG ' HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.57 -48.76 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 109.381 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.639 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.3 m -81.97 -28.81 32.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -43.39 -41.29 4.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.476 -0.765 . . . . 0.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.7 -50.32 68.58 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.124 -0.985 . . . . 0.0 111.233 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 7.8 m -109.81 23.92 13.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.168 . . . . 0.0 110.46 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 95.5 m-70 -156.16 -70.32 0.11 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.452 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.518 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.3 ptt? 38.72 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 80.07 49.28 6.04 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB2' ' A' ' 31' ' ' LEU . . . 37.63 36.15 0.26 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.75 95.69 0.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.576 ' OD1' ' CE1' ' A' ' 18' ' ' HIS . 3.7 t-20 -57.71 -176.9 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.273 -1.134 . . . . 0.0 109.441 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -156.93 -78.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 109.793 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' MET . 1.4 p -41.58 -39.99 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 110.044 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.553 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -54.1 -166.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.024 -1.047 . . . . 0.0 109.746 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -126.34 2.15 7.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.013 -1.055 . . . . 0.0 109.919 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 178.89 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.018 . . . . 0.0 110.299 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.62 122.83 14.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 31' ' ' LEU . 5.9 m -124.03 175.94 6.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.679 ' H ' HG22 ' A' ' 30' ' ' THR . 2.1 mp -99.52 -9.92 22.73 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.818 -0.551 . . . . 0.0 111.138 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.825 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -56.38 -102.32 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.292 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' N ' HD21 ' A' ' 36' ' ' LEU . 19.8 ptmt -155.74 -43.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.48 -1.388 . . . . 0.0 109.803 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 7.2 pt-20 -63.64 -40.51 97.06 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 110.636 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -79.22 -52.17 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 111.482 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -65.32 -11.48 42.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.718 -1.238 . . . . 0.0 108.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.608 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -119.67 -1.61 10.57 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.273 -0.892 . . . . 0.0 108.777 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.539 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -65.45 -48.32 73.12 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.602 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -86.48 -31.62 21.24 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.22 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 117.29 99.38 2.05 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.648 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.582 ' SD ' ' CE1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 156.42 46.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.852 -0.793 . . . . 0.0 108.987 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.8 ' HA ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -104.79 18.78 21.68 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.976 0.893 . . . . 0.0 108.853 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 47' ' ' ILE . 53.6 p -105.17 166.31 10.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.131 -0.981 . . . . 0.0 110.604 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.556 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 6.8 mt-10 -48.4 -59.9 3.1 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 109.503 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -57.05 -25.94 59.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.588 -1.32 . . . . 0.0 110.976 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 41' ' ' MET . . . -69.31 -70.21 0.29 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.973 -1.079 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.69 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.4 tt -63.0 -27.4 43.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 121.859 0.838 . . . . 0.0 109.262 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.569 HG13 ' CB ' ' A' ' 74' ' ' ALA . 31.2 mt -64.86 -22.38 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.686 -0.634 . . . . 0.0 109.343 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.44 ' O ' ' HD2' ' A' ' 53' ' ' HIS . 38.1 t80 -91.93 -56.7 2.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.912 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 5.7 pm0 -59.68 -14.46 14.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.201 -1.562 . . . . 0.0 109.186 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.71 HG12 ' HB2' ' A' ' 61' ' ' PHE . 57.4 t -101.27 -41.09 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.284 -0.885 . . . . 0.0 110.712 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.569 ' HG2' HG21 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -59.79 -14.69 15.84 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.892 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.651 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -153.72 25.51 0.51 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.605 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 57.91 -140.8 45.76 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.8 135.1 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 26.8 m-80 63.62 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.54 45.38 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.554 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.698 ' HE2' ' HA ' ' A' ' 51' ' ' VAL . 10.9 ttt -127.45 144.8 52.19 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 110.107 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.684 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.3 Cg_endo -76.85 116.32 4.22 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.299 2.666 . . . . 0.0 114.261 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.83 162.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.092 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.722 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 25.8 m-85 -143.61 7.21 1.48 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.245 -0.909 . . . . 0.0 110.053 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.54 -20.41 4.96 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.195 -0.94 . . . . 0.0 108.774 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.45 27.4 1.36 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.722 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 6.0 mmt85 -101.32 -44.73 5.55 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.803 HD22 ' CG ' ' A' ' 13' ' ' ASN . 7.9 mt -87.07 -152.93 0.2 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.29 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.575 HG22 ' N ' ' A' ' 67' ' ' ASP . 31.3 m -99.43 164.86 11.92 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.72 ' HA ' HD12 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -63.15 -57.37 10.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.443 1.116 . . . . 0.0 108.032 178.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.579 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.2 tt0 -64.18 2.92 0.49 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.354 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.861 ' CB ' HG21 ' A' ' 9' ' ' VAL . 1.3 mp0 -115.18 -26.48 7.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.851 -1.156 . . . . 0.0 109.2 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 67' ' ' ASP . 2.6 mt -59.31 -19.53 16.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.5 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.6 mp0 -97.58 -71.28 0.69 Allowed 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.497 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.631 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 24.6 m-20 -47.36 -46.41 25.67 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.979 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.692 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -62.17 -31.26 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.426 0.631 . . . . 0.0 110.546 -178.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.665 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.67 -62.14 1.64 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.97 -22.07 13.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.82 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.6 t80 -62.76 -45.57 92.06 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.716 HG13 ' HZ2' ' A' ' 85' ' ' TRP . 72.4 t -67.29 -27.47 39.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.794 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -81.24 -9.32 59.8 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.236 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.458 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.0 t70 -100.29 -33.52 10.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.133 0.968 . . . . 0.0 109.714 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.637 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 20.7 mm-40 -77.24 -38.39 51.2 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -71.88 -17.22 62.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.27 10.0 23.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 111.101 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -164.26 37.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.965 -1.494 . . . . 0.0 112.728 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 85.1 77.08 1.19 Allowed Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.764 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.716 ' HZ2' HG13 ' A' ' 77' ' ' VAL . 4.0 m95 -36.08 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.546 0.688 . . . . 0.0 109.185 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.3 -1.578 0 O-C-N 121.603 -0.686 . . . . 0.0 109.841 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.434 HD23 ' C ' ' A' ' 75' ' ' ALA . 1.5 mp -75.65 -14.77 60.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.21 68.52 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.529 ' O ' ' HE2' ' A' ' 8' ' ' LYS . 1.3 m-20 -80.33 -30.35 38.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.548 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -53.86 -48.33 62.49 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.807 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -58.94 -28.27 66.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.82 -0.812 . . . . 0.0 109.8 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.71 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -68.59 -28.15 66.68 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.008 -1.058 . . . . 0.0 108.717 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.081 HG21 ' CB ' ' A' ' 69' ' ' GLN . 41.1 t -100.16 -18.56 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.454 -0.779 . . . . 0.0 110.479 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.607 ' HE2' HD12 ' A' ' 31' ' ' LEU . 12.7 t80 -97.03 -19.93 18.39 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.89 -1.131 . . . . 0.0 109.694 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -99.38 7.46 45.51 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.664 -0.648 . . . . 0.0 109.584 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.499 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -139.18 2.28 2.58 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.515 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -151.04 -62.44 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.129 -1.218 . . . . 0.0 108.742 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.535 ' SG ' HG21 ' A' ' 73' ' ' VAL . 6.8 m -60.89 -34.49 74.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.626 ' HB1' ' HG2' ' A' ' 19' ' ' MET . . . -54.93 -36.21 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 110.124 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.01 -44.74 74.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.392 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 92.8 m -109.0 13.53 24.61 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.715 ' ND1' HD21 ' A' ' 31' ' ' LEU . 91.9 m-70 -160.92 38.94 0.15 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.626 ' HG2' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -63.0 141.09 58.9 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.62 45.79 8.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 42.32 68.05 0.79 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -147.61 96.53 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 22' ' ' GLY . 1.2 t-20 -43.9 139.9 2.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -1.142 . . . . 0.0 109.289 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 4.4 m -105.68 -17.8 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 0.0 110.104 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -98.83 -69.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 0.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 18.4 mmt -84.22 149.79 25.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -107.15 71.91 0.85 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.301 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER 179.6 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.328 -0.857 . . . . 0.0 109.332 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.588 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.5 mptt -89.7 91.28 8.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 0.0 109.312 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.008 ' C ' HD22 ' A' ' 36' ' ' LEU . 1.8 m -98.76 -169.46 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 0.0 109.079 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.715 HD21 ' ND1' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -105.69 -6.51 19.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.73 -1.231 . . . . 0.0 109.576 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -54.38 -88.45 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.371 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.848 ' HG2' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER 167.11 -38.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.844 -1.16 . . . . 0.0 110.692 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG3' ' HE2' ' A' ' 33' ' ' LYS . 85.9 mt-10 -54.38 -28.25 42.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 110.036 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.565 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -107.43 -57.74 2.05 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.053 0.93 . . . . 0.0 110.495 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.008 HD22 ' C ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -62.05 -43.5 98.71 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.42 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.555 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 56.7 tt0 -69.04 -19.49 64.1 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.529 -1.357 . . . . 0.0 108.868 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.529 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 3.0 tp60 -77.83 -83.83 0.08 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.847 0.832 . . . . 0.0 109.389 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.588 ' CZ ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -91.41 5.1 50.7 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.639 0.733 . . . . 0.0 110.598 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -108.69 -21.21 7.64 Favored Glycine 0 C--N 1.289 -2.062 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.02 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.94 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 51.64 69.32 0.68 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.742 ' CE2' HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -86.29 -3.73 59.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.179 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.501 ' O ' HG22 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -45.35 162.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.252 -0.905 . . . . 0.0 111.013 -179.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.799 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -46.86 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.009 -1.057 . . . . 0.0 109.518 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.551 ' N ' HD12 ' A' ' 48' ' ' ILE . 29.2 t0 -54.64 -17.04 2.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.786 -1.196 . . . . 0.0 110.66 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.94 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -81.04 -79.76 0.15 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.977 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.7 tt -54.27 -20.76 5.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.73 -1.231 . . . . 0.0 109.656 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.799 HD12 ' C ' ' A' ' 44' ' ' GLU . 10.3 mt -59.92 -43.12 91.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.636 ' CE2' ' CE1' ' A' ' 53' ' ' HIS . 20.0 t80 -80.5 -16.89 53.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.64 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -86.47 -8.16 57.82 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.643 -1.286 . . . . 0.0 107.925 178.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 47' ' ' ILE . 42.1 t -108.48 -33.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.848 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -70.22 -7.55 42.93 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.745 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -165.96 38.24 0.05 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.522 -178.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 47.5 -133.67 14.94 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.95 132.75 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 57.6 m-80 62.05 -88.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.92 50.86 2.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 108.971 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.665 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 24.7 ttt -124.43 142.13 39.5 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 109.065 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.665 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 26.4 Cg_endo -68.34 104.17 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.804 2.336 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.745 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -59.22 118.33 5.78 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.78 ' CE2' HD21 ' A' ' 65' ' ' LEU . 13.2 m-85 -86.29 -49.41 7.7 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.93 -1.106 . . . . 0.0 108.211 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.58 26.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.22 0.533 . . . . 0.0 109.808 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.51 32.55 0.66 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.588 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.84 -48.69 4.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.028 HD13 HG11 ' A' ' 9' ' ' VAL . 29.5 mt -62.52 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.574 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 3.0 m -98.3 -54.92 2.91 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.109 -0.995 . . . . 0.0 108.956 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 66' ' ' THR . 2.6 m-20 150.87 -59.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 68.8 mm-40 -67.06 -1.84 4.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.04 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 1.081 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -112.05 -29.76 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.96 HD13 HD12 ' A' ' 65' ' ' LEU . 39.6 mm -57.05 -20.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.492 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -100.15 -64.19 1.06 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.584 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.639 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 34.5 m-20 -52.15 -48.66 64.79 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.089 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 69' ' ' GLN . 2.2 p -54.53 -27.21 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.918 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.751 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -81.27 -66.41 0.89 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' C ' HD23 ' A' ' 3' ' ' LEU . . . -50.1 -23.77 2.33 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.163 -1.586 . . . . 0.0 107.392 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.807 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.1 t80 -63.55 -47.6 80.92 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.2 p -65.4 -25.59 37.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.742 HD22 ' CE2' ' A' ' 42' ' ' TYR . 1.1 mt -77.34 -9.87 59.1 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.964 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.99 -43.73 6.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.051 0.929 . . . . 0.0 109.411 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.603 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 18.4 mm-40 -65.94 -44.82 83.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.848 ' HB1' ' HG2' ' A' ' 33' ' ' LYS . . . -68.78 -11.36 60.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.3 7.01 37.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 111.005 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -175.09 46.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.235 -1.541 . . . . 0.0 112.739 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.602 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 88.5 76.7 1.29 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.869 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.714 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -39.93 83.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 109.541 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 25.7 t0 . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.011 HD13 ' HA ' ' A' ' 76' ' ' TYR . 2.4 pp -68.83 -0.2 5.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.905 -1.122 . . . . 0.0 108.971 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.543 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.7 t-20 -47.63 -28.69 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.51 -57.74 17.89 Favored Glycine 0 C--O 1.199 -2.034 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -45.93 -28.16 1.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.761 -1.435 . . . . 0.0 110.066 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.775 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.05 -46.25 71.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.044 HG21 ' CB ' ' A' ' 69' ' ' GLN . 24.6 t -73.49 -51.76 24.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.819 -0.551 . . . . 0.0 110.115 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 6.1 t80 -62.5 -28.85 70.12 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.717 -1.239 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 47.0 t -84.09 15.15 3.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.878 . . . . 0.0 109.701 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.472 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -160.95 11.95 0.14 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.527 HD22 HG13 ' A' ' 9' ' ' VAL . 7.7 m-80 -156.43 -54.08 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.449 . . . . 0.0 108.831 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.677 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -74.06 -26.15 60.24 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.499 0.666 . . . . 0.0 109.287 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -57.57 -39.51 76.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.574 -0.704 . . . . 0.0 110.393 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.94 62.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.136 -0.977 . . . . 0.0 111.057 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' HA ' HG22 ' A' ' 24' ' ' VAL . 99.9 m -124.79 8.81 8.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.826 -1.171 . . . . 0.0 110.691 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.727 ' CG ' HD22 ' A' ' 31' ' ' LEU . 87.8 m-70 -150.12 -65.45 0.21 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.136 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.478 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 1.2 ttt 56.25 113.08 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.269 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 39.42 60.35 1.71 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.646 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 49.43 73.33 0.37 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -155.72 81.43 0.17 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.643 ' H ' HG23 ' A' ' 30' ' ' THR . 1.6 t-20 -54.61 163.26 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.249 . . . . 0.0 109.223 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 17' ' ' CYS . 6.3 m -144.4 17.11 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.041 . . . . 0.0 109.889 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.58 -55.99 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.098 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.47 -172.51 1.82 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -134.39 46.47 2.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.102 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.3 p30 178.2 -44.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 109.366 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 2.0 mttp -74.18 110.62 8.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.557 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.769 HG22 ' H ' ' A' ' 32' ' ' LYS . 92.3 m -133.43 149.33 51.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.317 -0.865 . . . . 0.0 109.25 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.745 ' HG ' HG11 ' A' ' 77' ' ' VAL . 5.9 mp -74.95 -18.67 60.35 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.848 -0.533 . . . . 0.0 111.096 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.769 ' H ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -40.61 -82.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.476 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.558 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 0.4 OUTLIER 174.72 -42.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.548 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 3.7 mm-40 -56.1 -34.85 66.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.584 -0.697 . . . . 0.0 109.594 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -99.17 -39.53 8.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.408 -0.808 . . . . 0.0 110.369 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.845 HD11 ' HD2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -69.75 -10.28 57.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.554 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 17.1 mt-10 -118.78 3.78 11.6 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 tp-100 -83.59 -51.15 7.55 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.588 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -86.67 -35.54 19.27 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.779 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.63 51.75 0.24 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.955 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.749 ' HE3' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -112.13 8.07 19.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.017 -1.284 . . . . 0.0 108.747 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.845 ' HD2' HD11 ' A' ' 36' ' ' LEU . 41.0 t80 -69.43 10.78 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.991 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.3 p -105.7 143.85 33.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.548 -1.345 . . . . 0.0 110.179 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.539 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 5.1 mt-10 -46.28 -58.45 3.68 Favored 'General case' 0 C--O 1.203 -1.355 0 O-C-N 121.379 -0.826 . . . . 0.0 109.29 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 45' ' ' ASP . 9.3 t0 -47.88 -37.19 13.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -0.963 . . . . 0.0 110.829 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.07 -70.27 0.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.811 HG23 ' HB1' ' A' ' 74' ' ' ALA . 15.3 tt -66.06 -9.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.891 0.853 . . . . 0.0 109.884 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.551 HG23 ' NE2' ' A' ' 52' ' ' GLN . 22.3 mt -87.57 -25.53 6.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 25.6 t80 -88.72 -23.39 22.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 1.045 ' NE2' HG23 ' A' ' 51' ' ' VAL . 4.2 pp0? -94.17 -26.45 16.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.438 -1.414 . . . . 0.0 108.289 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.045 HG23 ' NE2' ' A' ' 50' ' ' GLN . 2.9 t -75.02 -49.51 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.885 0.85 . . . . 0.0 109.01 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.638 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -64.91 -12.53 50.29 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.809 -0.557 . . . . 0.0 111.525 -177.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.635 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -147.46 13.24 1.06 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.58 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.703 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.19 -136.09 24.81 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 106.754 -2.539 . . . . 0.0 106.754 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 149.94 141.09 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 50.32 -90.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -129.35 49.39 2.25 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.636 ' HE1' ' HA ' ' A' ' 51' ' ' VAL . 7.1 ttt -125.2 146.48 54.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.596 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.2 Cg_endo -80.97 107.82 1.97 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 123.363 2.709 . . . . 0.0 114.81 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.703 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -40.79 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 111.135 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 59' ' ' PRO . 56.0 m-85 -150.25 14.34 0.79 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . . . -47.17 -28.49 1.85 Allowed 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.263 -0.898 . . . . 0.0 109.136 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.32 35.05 0.52 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.3 -42.99 6.1 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.907 HD12 HD13 ' A' ' 70' ' ' ILE . 21.1 mt -77.09 -143.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.582 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 3.0 m -98.22 -59.45 1.75 Allowed 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.5 OUTLIER 153.26 -55.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 12.4 tt0 -68.79 -1.48 7.2 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 1.044 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -108.35 -31.35 7.89 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 HD12 ' A' ' 65' ' ' LEU . 23.6 mm -57.54 -20.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.473 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.8 mp0 -99.09 -71.0 0.71 Allowed 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.01 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 87.5 m-20 -45.72 -49.77 14.39 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.176 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -60.75 -32.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.505 0.669 . . . . 0.0 110.082 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -69.82 -65.51 0.71 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.203 -1.561 . . . . 0.0 106.856 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.482 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.05 -21.86 9.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.011 ' HA ' HD13 ' A' ' 3' ' ' LEU . 62.5 t80 -63.84 -45.1 91.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.603 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.745 HG11 ' HG ' ' A' ' 31' ' ' LEU . 60.7 t -68.89 -25.22 29.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.823 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -82.65 -9.05 59.55 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.037 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 10.9 t0 -99.35 -34.52 10.27 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.653 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 4.4 mm-40 -78.57 -34.57 46.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.377 0.608 . . . . 0.0 110.003 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.595 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -65.17 -43.61 91.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.366 -0.834 . . . . 0.0 109.792 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.94 14.83 11.15 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.284 -0.885 . . . . 0.0 110.85 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 12.8 ptmt -142.86 23.57 1.9 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.512 -1.367 . . . . 0.0 111.665 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 87.3 72.6 1.29 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.032 -1.556 . . . . 0.0 109.756 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.684 ' HZ2' HG13 ' A' ' 77' ' ' VAL . 1.1 m95 -40.85 85.06 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.202 -0.587 . . . . 0.0 110.797 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.133 -0.979 . . . . 0.0 109.485 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 5.2 m-20 . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.094 HD23 ' HA ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -75.69 2.6 11.58 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.308 177.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.583 ' N ' HD13 ' A' ' 3' ' ' LEU . . . -59.92 -42.49 94.05 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.505 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.5 t-20 -51.34 -32.88 27.12 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -54.49 -47.51 69.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.81 -33.45 10.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.657 -1.496 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.03 -43.99 81.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.769 ' CG1' HD13 ' A' ' 65' ' ' LEU . 18.3 t -62.43 -72.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.632 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 16.0 t80 -49.72 -26.62 3.96 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.703 -0.623 . . . . 0.0 111.237 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 19.6 t -92.35 31.38 1.32 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 109.008 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.33 -46.18 1.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.83 -1.394 . . . . 0.0 109.563 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.632 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.5 m -76.48 -25.02 53.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.746 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -59.3 -35.49 73.88 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.805 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.87 97.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.35 -0.844 . . . . 0.0 111.64 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.575 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -108.26 26.48 10.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.757 -1.214 . . . . 0.0 109.494 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.894 ' CE1' HD21 ' A' ' 31' ' ' LEU . 92.5 m-70 -160.02 -54.5 0.06 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.234 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 18' ' ' HIS . 3.9 ptp 39.41 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.479 0.657 . . . . 0.0 110.794 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 67.6 52.23 31.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 41.72 57.39 3.39 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.644 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -147.26 86.63 0.16 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.512 ' HB3' ' CE ' ' A' ' 26' ' ' MET . 2.9 t-20 -51.13 159.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -1.096 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.84 -10.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 26' ' ' MET . 18.1 t -100.2 -62.78 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.074 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.512 ' CE ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -51.53 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.847 . . . . 0.0 109.773 179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.44 -8.53 10.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -153.33 -37.65 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.278 -0.888 . . . . 0.0 109.586 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 39' ' ' PHE . 5.9 tptt -46.21 90.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.485 -0.76 . . . . 0.0 109.804 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.644 HG23 ' HA2' ' A' ' 22' ' ' GLY . 7.1 m -117.63 151.55 36.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.894 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -78.88 -7.73 58.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.324 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HD3' HG21 ' A' ' 30' ' ' THR . 1.1 mtpt -51.52 162.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.529 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.581 ' CA ' ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.02 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -61.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 110.733 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.58 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.99 -35.62 69.53 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 111.239 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.826 HD23 ' O ' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -64.74 -43.43 93.39 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.854 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.572 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -90.68 13.23 16.65 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.187 -0.946 . . . . 0.0 109.129 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.52 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -82.21 -49.82 9.68 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.599 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -87.07 -42.73 12.83 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.333 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.87 82.13 0.4 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.766 ' HE3' ' HA ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -158.68 24.53 0.23 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.286 -1.126 . . . . 0.0 108.496 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.718 ' HB2' HD11 ' A' ' 36' ' ' LEU . 43.3 t80 -84.38 15.83 3.42 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.494 0.664 . . . . 0.0 109.225 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.61 134.39 47.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.791 -1.193 . . . . 0.0 111.126 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -45.07 -59.76 2.44 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -48.03 -37.98 16.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.064 -1.022 . . . . 0.0 110.492 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.9 -73.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.7 tt -65.28 -9.52 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.531 -0.73 . . . . 0.0 110.338 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 44' ' ' GLU . 9.1 mt -78.91 -35.57 18.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 37.0 t80 -91.08 -14.41 31.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 1.1 tp60 -90.63 -17.57 26.64 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 47' ' ' ILE . 68.5 t -94.27 -45.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.563 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -62.79 -9.78 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.597 -0.69 . . . . 0.0 110.949 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.67 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.98 22.25 0.51 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.622 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 54.58 -133.44 47.01 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.75 135.75 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 121.389 0.614 . . . . 0.0 109.545 178.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 54.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.01 55.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.698 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.656 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 9.8 ttt -142.85 142.51 22.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 109.116 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.656 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 29.5 Cg_endo -75.07 117.21 4.82 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 123.385 2.723 . . . . 0.0 115.036 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.67 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -43.07 164.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.768 ' HB3' HD11 ' A' ' 70' ' ' ILE . 49.4 m-85 -143.12 12.63 1.81 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.44 -0.788 . . . . 0.0 109.433 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.93 -26.09 0.25 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.416 -0.802 . . . . 0.0 108.899 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -151.44 35.31 0.88 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.683 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt85 -103.38 -50.98 3.32 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.781 HD12 HD13 ' A' ' 70' ' ' ILE . 5.9 mt -86.81 -157.59 0.38 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 67' ' ' ASP . 5.6 m -100.88 -179.09 3.96 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.704 ' H ' HG22 ' A' ' 66' ' ' THR . 3.0 m-20 -76.34 -59.51 2.74 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.678 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.556 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 8.0 tt0 -66.22 -7.68 19.76 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.709 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -95.39 -34.94 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.781 HD13 HD12 ' A' ' 65' ' ' LEU . 4.3 mm -67.91 -14.47 18.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.448 ' OE1' HG22 ' A' ' 70' ' ' ILE . 2.3 mp0 -98.7 -71.57 0.69 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.465 1.126 . . . . 0.0 109.071 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.706 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 58.9 m-20 -47.42 -38.6 13.73 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.89 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.74 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 3.5 p -66.52 -36.79 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.704 0.764 . . . . 0.0 109.885 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.728 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -68.35 -60.21 2.61 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 119.949 -1.719 . . . . 0.0 106.401 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.38 -20.63 45.63 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.094 ' HA ' HD23 ' A' ' 3' ' ' LEU . 84.3 t80 -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 31' ' ' LEU . 43.9 t -70.62 -27.02 29.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.786 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -83.63 -8.03 59.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.281 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 3.1 t70 -98.79 -43.38 6.79 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.178 0.989 . . . . 0.0 109.039 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.675 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -70.32 -35.68 73.8 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.951 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.581 ' HB1' ' CA ' ' A' ' 33' ' ' LYS . . . -59.44 -50.91 72.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 108.392 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.84 16.77 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.659 -0.651 . . . . 0.0 109.857 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 26.6 tttm -132.11 13.18 4.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 111.297 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 81.9 72.66 1.24 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.675 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 7.5 m95 -38.71 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.14 0.495 . . . . 0.0 110.508 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.943 . . . . 0.0 109.421 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 6.2 m-20 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.0 HD13 ' HA ' ' A' ' 76' ' ' TYR . 2.0 pp -70.62 3.92 2.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.64 ' CA ' ' HD3' ' A' ' 8' ' ' LYS . 1.4 m-20 -75.0 -1.68 23.81 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.645 ' HA2' HG23 ' A' ' 73' ' ' VAL . . . -86.27 -46.91 5.13 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.919 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -56.14 -46.57 79.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.857 -0.79 . . . . 0.0 108.877 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.798 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -51.04 -33.44 25.47 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.964 HG21 ' HG2' ' A' ' 69' ' ' GLN . 59.6 t -96.62 -15.7 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.215 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 11.0 t80 -84.76 -28.05 26.5 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 117.589 -1.644 . . . . 0.0 109.793 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -86.63 15.09 5.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.808 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -144.34 2.02 1.27 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.844 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.482 ' ND2' ' C ' ' A' ' 12' ' ' GLY . 0.9 OUTLIER -143.51 -50.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.805 -1.409 . . . . 0.0 109.114 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.5 m -77.11 -32.11 56.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.426 -0.797 . . . . 0.0 108.875 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HA ' ' N ' ' A' ' 19' ' ' MET . . . -45.77 -40.87 10.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.661 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.72 -46.3 77.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.097 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.594 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 80.3 m -116.12 27.81 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 110.33 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.594 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 90.5 m-70 -159.93 -76.41 0.07 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.215 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.55 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 55.1 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.595 0.712 . . . . 0.0 110.668 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.95 45.17 9.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.593 ' HA3' ' CD2' ' A' ' 85' ' ' TRP . . . 48.64 68.27 1.35 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.497 ' HA2' ' OG1' ' A' ' 30' ' ' THR . . . -151.78 86.8 0.14 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.8 t-20 -55.33 161.47 1.86 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.976 -1.308 . . . . 0.0 109.305 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 25' ' ' VAL . 16.4 m -136.5 -52.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.573 ' N ' HG23 ' A' ' 24' ' ' VAL . 44.8 t -45.79 -61.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.175 -0.953 . . . . 0.0 108.781 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -53.41 -170.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 109.109 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.71 1.25 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.097 . . . . 0.0 110.289 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.9 -30.83 0.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.038 -1.039 . . . . 0.0 110.729 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 11.9 mttt -75.93 101.16 5.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.969 -1.082 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.91 ' C ' HD22 ' A' ' 36' ' ' LEU . 10.3 t -93.88 -146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 108.492 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.609 ' N ' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -118.41 -11.11 10.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.482 -1.386 . . . . 0.0 109.615 179.133 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.757 ' H ' HG23 ' A' ' 30' ' ' THR . 5.2 mtpt -50.02 -86.9 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.846 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 165.04 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.984 -1.072 . . . . 0.0 109.956 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -53.14 -27.19 19.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 109.718 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.931 ' HB1' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.86 -67.33 0.95 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.273 -0.892 . . . . 0.0 110.532 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.984 HD12 ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -54.39 -35.85 63.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.645 -0.659 . . . . 0.0 111.335 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 2.0 tt0 -69.33 -30.79 68.9 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.306 -1.496 . . . . 0.0 110.183 -178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.509 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.0 mm-40 -78.55 -64.55 1.15 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.245 -0.909 . . . . 0.0 109.925 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CZ ' ' HB1' ' A' ' 35' ' ' ALA . 2.0 p90 -93.99 -20.19 20.2 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.537 0.684 . . . . 0.0 110.627 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.578 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -89.42 -19.11 50.7 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.031 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 1.117 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 49.48 71.23 0.4 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -177.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.984 ' CG ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -101.69 -6.08 24.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.485 -176.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.811 ' N ' ' HB3' ' A' ' 46' ' ' ALA . 2.6 p -48.74 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.781 -1.199 . . . . 0.0 110.223 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.698 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -43.61 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.92 -1.112 . . . . 0.0 109.668 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.416 ' N ' HD12 ' A' ' 48' ' ' ILE . 32.6 t0 -52.67 -19.78 2.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.891 -1.131 . . . . 0.0 110.286 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 1.117 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -74.37 -82.11 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.395 -0.816 . . . . 0.0 110.262 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.813 HD13 HG11 ' A' ' 77' ' ' VAL . 12.1 tt -48.77 -33.52 5.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 O-C-N 121.283 -0.886 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 44' ' ' GLU . 74.7 mt -56.31 -41.23 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.596 -0.69 . . . . 0.0 110.058 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.408 ' O ' ' HD2' ' A' ' 53' ' ' HIS . 28.3 t80 -78.69 -25.7 44.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.561 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.559 ' CG ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -93.71 -3.71 51.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.087 -1.633 . . . . 0.0 108.896 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 47' ' ' ILE . 25.1 t -94.8 -48.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.584 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -64.49 -8.32 13.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.867 -0.521 . . . . 0.0 110.167 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.634 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.62 21.45 0.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.838 -1.145 . . . . 0.0 108.772 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.592 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 51.89 -131.1 36.44 Favored Glycine 0 C--N 1.3 -1.419 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.582 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 150.04 142.31 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 53.94 -89.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.53 42.63 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.582 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 21.4 ttt -119.63 142.19 32.39 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.225 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.571 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 37.0 Cg_endo -81.26 108.82 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.914 2.409 . . . . 0.0 113.406 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.634 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.7 163.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.761 . . . . 0.0 110.286 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 11.2 m-85 -145.74 14.43 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.22 -10.8 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.907 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.19 -4.34 7.78 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HD2' ' CE1' ' A' ' 61' ' ' PHE . 4.2 ttt180 -106.82 -61.64 1.51 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.008 ' CD1' HG21 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -64.62 105.8 1.04 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.58 HG22 ' N ' ' A' ' 67' ' ' ASP . 86.2 m -39.3 166.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.294 0.569 . . . . 0.0 109.564 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.58 ' N ' HG22 ' A' ' 66' ' ' THR . 15.1 t0 -57.74 -57.75 11.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.989 -1.069 . . . . 0.0 108.42 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.5 mm-40 -65.87 10.81 0.09 Allowed 'General case' 0 C--O 1.193 -1.917 0 O-C-N 121.755 -0.59 . . . . 0.0 109.887 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.964 ' HG2' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -104.4 -44.66 4.87 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.681 HG22 HG23 ' A' ' 48' ' ' ILE . 18.9 mm -53.0 -22.09 3.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 1.5 mp0 -94.45 -73.34 0.58 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 76' ' ' TYR . 98.2 m-20 -44.82 -64.69 0.65 Allowed 'General case' 0 C--O 1.186 -2.27 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.286 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.008 HG21 ' CD1' ' A' ' 65' ' ' LEU . 2.3 t -49.15 -29.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.096 -1.003 . . . . 0.0 110.269 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.808 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -79.94 -74.18 0.31 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.694 -1.254 . . . . 0.0 108.118 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -46.56 -23.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.966 -1.709 . . . . 0.0 107.784 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.0 ' HA ' HD13 ' A' ' 3' ' ' LEU . 40.9 t80 -60.41 -53.13 61.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.274 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.85 HG22 ' HE2' ' A' ' 42' ' ' TYR . 1.9 p -64.47 -25.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.703 HD23 HG13 ' A' ' 77' ' ' VAL . 2.8 mt -78.5 -9.67 59.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.49 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 3.0 t0 -99.57 -41.49 7.32 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.0 0.905 . . . . 0.0 109.059 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.645 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 9.3 mm-40 -69.53 -47.48 63.59 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.381 0.61 . . . . 0.0 109.956 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -68.5 -16.02 63.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.44 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.61 8.68 27.17 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 110.889 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -171.69 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.47 77.27 1.33 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.02 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.825 ' HZ2' HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -40.36 84.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.319 -0.518 . . . . 0.0 110.596 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.858 -1.151 . . . . 0.0 109.029 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.453 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 9.7 m-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.98 0.419 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.875 HD11 ' HA ' ' A' ' 76' ' ' TYR . 1.0 OUTLIER -77.2 7.39 5.17 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.937 -1.102 . . . . 0.0 109.738 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.98 -24.31 59.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.637 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . 68.3 m-20 -84.39 -6.03 59.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.445 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.582 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -87.74 -61.74 1.5 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 106.674 -2.571 . . . . 0.0 106.674 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.865 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -40.67 -37.81 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.128 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.923 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -61.84 -48.63 79.71 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 65' ' ' LEU . 87.9 t -63.68 -59.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -0.773 . . . . 0.0 111.814 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.823 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 46.0 t80 -54.92 -42.59 72.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.732 -1.23 . . . . 0.0 112.261 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -84.29 19.58 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.58 -1.325 . . . . 0.0 110.365 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -147.16 0.77 0.72 Allowed Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.541 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -156.23 -48.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.569 -1.548 . . . . 0.0 110.035 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.4 m -71.99 -36.12 69.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 19' ' ' MET . . . -51.55 -38.1 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.442 -0.786 . . . . 0.0 110.089 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.01 69.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.956 -1.09 . . . . 0.0 109.257 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.569 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 82.3 m -119.43 20.28 12.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.441 -0.787 . . . . 0.0 109.506 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 93.3 m-70 -159.87 21.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.436 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.34 153.36 7.31 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.656 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 43.46 33.53 2.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 46.39 57.99 6.14 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.676 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -146.76 91.89 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 2.2 t-20 -41.77 142.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.457 -1.026 . . . . 0.0 109.865 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.11 -1.24 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.447 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.54 -66.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mmt -65.39 130.67 44.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.319 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 28' ' ' ASN . . . -85.08 48.32 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 27' ' ' ALA . 1.8 p-10 175.3 -59.7 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HD3' ' CE ' ' A' ' 41' ' ' MET . 7.6 mttp -51.71 102.8 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.213 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.698 HG21 ' HD3' ' A' ' 32' ' ' LYS . 3.7 m -113.32 177.44 4.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.688 ' H ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -94.71 -18.93 20.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.798 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 1.004 ' C ' HD21 ' A' ' 36' ' ' LEU . 14.8 mtpt -58.16 -113.63 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 110.295 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.761 ' N ' HD21 ' A' ' 36' ' ' LEU . 22.7 ttpt -155.44 -29.61 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.677 -1.264 . . . . 0.0 110.871 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 12.3 pt-20 -59.97 -28.91 68.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.729 -1.232 . . . . 0.0 111.193 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.631 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -102.25 -48.57 4.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.001 -1.062 . . . . 0.0 110.818 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.004 HD21 ' C ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -61.07 -34.56 75.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.923 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.2 mm-40 -93.1 6.02 49.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.477 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.5 tp60 -89.74 -51.1 5.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.62 -50.27 6.93 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.486 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.81 91.45 0.48 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.507 ' CE ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -174.12 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.12 . . . . 0.0 109.474 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.942 ' CG ' HD12 ' A' ' 36' ' ' LEU . 4.1 t80 -105.62 28.57 7.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 109.816 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 p -106.73 143.11 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.359 -0.838 . . . . 0.0 110.569 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.54 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -50.53 -59.15 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 109.834 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.35 -28.62 8.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.526 -1.359 . . . . 0.0 110.568 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.61 -73.66 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 110.321 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.845 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.1 tt -61.16 -13.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 110.358 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.719 HG23 HG22 ' A' ' 70' ' ' ILE . 14.5 mt -73.41 -35.99 47.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 31.0 t80 -91.11 -14.44 31.21 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.565 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -88.79 -17.07 30.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 47' ' ' ILE . 72.2 t -93.77 -43.62 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.817 0.818 . . . . 0.0 109.985 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.646 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -62.72 -10.54 13.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 0.0 110.18 -178.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.664 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -158.36 30.97 0.24 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.357 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.591 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 49.96 -132.99 28.16 Favored Glycine 0 C--N 1.299 -1.524 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 151.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 37.8 m-80 69.05 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.48 14.95 6.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 109.202 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.646 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.4 ttt -89.63 142.3 29.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.263 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.646 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.3 Cg_endo -74.25 97.2 1.0 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.906 2.404 . . . . 0.0 114.647 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.664 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -46.94 119.16 2.38 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 63' ' ' GLY . 57.1 m-85 -88.24 -49.87 6.71 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.999 -1.063 . . . . 0.0 108.747 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 28.05 40.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.35 0.595 . . . . 0.0 110.376 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 167.61 -24.18 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.521 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -93.83 -30.92 14.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.95 HD11 HG11 ' A' ' 9' ' ' VAL . 1.7 mm? -91.45 94.51 9.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 67' ' ' ASP . 21.0 m -41.03 168.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.616 ' N ' HG22 ' A' ' 66' ' ' THR . 0.1 OUTLIER -57.15 -61.2 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.522 -1.361 . . . . 0.0 108.487 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 mt-10 -60.68 3.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.777 -0.577 . . . . 0.0 110.604 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.882 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -102.94 -45.15 5.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.719 HG22 HG23 ' A' ' 48' ' ' ILE . 33.6 mm -55.34 -22.66 12.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 1.6 mp0 -92.19 -65.71 0.98 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.103 0.954 . . . . 0.0 108.642 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 47.1 m-20 -49.62 -61.5 2.08 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 69' ' ' GLN . 3.3 p -45.5 -29.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.3 -0.875 . . . . 0.0 109.8 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.813 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -80.68 -71.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -45.52 -25.8 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.554 -1.341 . . . . 0.0 107.508 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.875 ' HA ' HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -59.08 -56.95 15.61 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 74' ' ' ALA . 2.6 p -62.37 -26.14 39.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.99 -1.069 . . . . 0.0 108.647 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 77' ' ' VAL . 5.1 mt -76.45 -10.76 59.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 2.0 t0 -99.47 -43.52 6.51 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.929 0.871 . . . . 0.0 109.218 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 59.6 mm-40 -67.3 -41.55 85.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.88 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.555 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -60.9 -47.3 87.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.143 -0.973 . . . . 0.0 109.063 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.11 8.45 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.573 -0.705 . . . . 0.0 109.843 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 6.9 tttm -129.84 12.84 5.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.079 -1.013 . . . . 0.0 110.974 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.0 76.71 0.98 Allowed Glycine 0 C--N 1.296 -1.681 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.728 ' HZ2' HG23 ' A' ' 77' ' ' VAL . 12.8 m95 -34.36 90.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.725 0.774 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 121.386 0.612 . . . . 0.0 109.446 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.803 HD13 ' OD2' ' A' ' 79' ' ' ASP . 1.2 mp -71.11 -3.36 19.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.053 -1.029 . . . . 0.0 109.454 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.71 -15.82 63.63 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.596 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -86.69 10.26 16.28 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -107.69 -36.33 2.43 Favored Glycine 0 C--O 1.201 -1.919 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -59.88 -12.63 8.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.659 -0.906 . . . . 0.0 109.884 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.596 ' CE ' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -87.13 -32.52 19.84 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.826 HG13 HD22 ' A' ' 65' ' ' LEU . 3.4 t -77.31 -29.55 16.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.595 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 32.2 t80 -100.33 -34.53 9.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 3.9 t -85.05 10.76 11.1 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.024 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -142.34 -6.74 0.72 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.173 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.563 ' CG ' HD21 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -147.23 -52.93 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.567 -1.549 . . . . 0.0 110.031 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.613 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 5.3 m -64.8 -29.31 70.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 110.035 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.84 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.846 -1.159 . . . . 0.0 109.294 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 84.8 m -120.7 14.78 11.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.224 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.506 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 91.0 m-70 -158.63 26.74 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.765 . . . . 0.0 109.033 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -52.49 147.12 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.308 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 46.96 35.86 8.33 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 32' ' ' LYS . . . 48.47 53.0 17.75 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.73 122.06 2.52 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 26' ' ' MET . 3.7 t-20 -64.43 154.21 36.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -1.127 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.425 HG23 HG23 ' A' ' 25' ' ' VAL . 4.5 m -122.95 -22.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.12 -0.988 . . . . 0.0 110.244 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.425 HG23 HG23 ' A' ' 24' ' ' VAL . 13.4 t -103.07 -69.54 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.868 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.62 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -47.62 -37.26 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.42 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 26' ' ' MET . . . 71.32 40.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 26' ' ' MET . 1.3 p30 177.09 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.371 -0.83 . . . . 0.0 108.915 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.29 77.14 5.83 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.916 ' O ' HD22 ' A' ' 36' ' ' LEU . 9.3 t -83.23 -177.35 6.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.878 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.621 HD13 HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -100.78 -18.54 16.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 110.758 -179.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.597 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -61.07 -100.8 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.667 -1.271 . . . . 0.0 109.4 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.495 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 11.0 ptmm? -168.32 -38.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.642 -1.286 . . . . 0.0 110.797 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -41.16 -29.46 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 -178.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.858 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -110.25 -59.23 1.97 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 111.644 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -58.98 -7.72 1.16 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.728 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.598 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.4 mm-40 -107.08 -11.79 15.56 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.593 -1.317 . . . . 0.0 109.72 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 6.9 mm100 -82.54 -40.54 20.82 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.858 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -84.96 -45.94 11.71 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.709 177.097 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 41' ' ' MET . . . 121.51 98.19 1.54 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER 170.08 37.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -1.085 . . . . 0.0 109.741 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.007 ' OH ' ' HB3' ' A' ' 81' ' ' ALA . 6.6 t80 -118.98 33.17 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.511 ' O ' ' HB ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -110.49 176.97 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.568 -0.708 . . . . 0.0 110.938 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.694 ' C ' HD12 ' A' ' 48' ' ' ILE . 3.6 mt-10 -69.89 -72.56 0.19 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -54.0 -36.37 62.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.566 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 50' ' ' GLN . . . -64.01 -74.41 0.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.067 -1.021 . . . . 0.0 109.498 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.016 ' O ' HG23 ' A' ' 51' ' ' VAL . 40.9 mt -53.9 -17.56 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.621 0.724 . . . . 0.0 109.264 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.694 HD12 ' C ' ' A' ' 44' ' ' GLU . 16.2 mt -80.82 -33.38 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.486 ' OH ' ' HE2' ' A' ' 55' ' ' LYS . 59.7 t80 -73.19 -23.07 60.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 108.536 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.589 ' CG ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -85.64 -33.65 21.56 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.391 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.016 HG23 ' O ' ' A' ' 47' ' ' ILE . 10.9 t -79.92 -36.67 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.623 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -72.23 -14.45 61.79 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.344 -0.848 . . . . 0.0 109.968 -178.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.694 ' HA ' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -159.33 31.54 0.2 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.012 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 48.04 -136.86 14.81 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 151.91 134.1 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.1 m-80 60.25 -88.91 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.473 -0.767 . . . . 0.0 108.978 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -126.27 41.58 3.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.615 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 21.4 ttt -119.04 143.49 34.01 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.615 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 30.3 Cg_endo -75.23 99.76 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.918 2.412 . . . . 0.0 114.27 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -57.07 118.27 4.84 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.654 -0.654 . . . . 0.0 110.458 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.602 ' CD2' ' HD2' ' A' ' 64' ' ' ARG . 25.1 m-85 -85.37 -52.27 5.99 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 37.58 28.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.424 0.631 . . . . 0.0 109.675 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 126.46 32.8 0.7 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.506 -1.837 . . . . 0.0 108.506 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.602 ' HD2' ' CD2' ' A' ' 61' ' ' PHE . 5.5 ttm-85 -101.67 -52.78 3.13 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.826 HD22 HG13 ' A' ' 9' ' ' VAL . 6.5 mt -79.92 -143.16 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.591 ' CB ' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -98.62 -166.9 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 121.085 -1.009 . . . . 0.0 109.494 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.37 -62.55 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.621 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.1 tt0 -71.41 2.61 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.668 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 1.1 mp0 -104.08 -32.03 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.623 HG21 ' HG3' ' A' ' 52' ' ' GLN . 7.5 mm -72.88 -21.84 19.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.43 -66.13 0.95 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 37.3 t0 -54.59 -36.92 64.94 Favored 'General case' 0 C--O 1.193 -1.902 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.409 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 9.9 p -61.69 -26.92 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.193 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.588 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -82.12 -59.11 2.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.62 -21.63 11.09 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.697 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 36.5 t80 -67.03 -45.12 78.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.366 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.675 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.1 p -69.6 -21.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.97 HD21 HD12 ' A' ' 47' ' ' ILE . 5.4 mt -77.97 -11.82 59.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.803 ' OD2' HD13 ' A' ' 3' ' ' LEU . 1.8 t0 -99.99 -37.52 8.97 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.888 0.851 . . . . 0.0 109.327 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.646 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 8.5 mm-40 -77.44 -35.28 54.12 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.876 -0.515 . . . . 0.0 110.395 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.007 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -61.0 -48.71 80.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.121 -0.987 . . . . 0.0 108.522 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.8 13.86 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.759 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 1.6 ttmm -130.79 13.69 5.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.96 -1.088 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 82.84 73.6 1.23 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.675 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 5.0 m95 -39.07 83.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.119 0.485 . . . . 0.0 110.592 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.97 0.414 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.505 ' CD2' ' HA ' ' A' ' 72' ' ' ASP . 10.1 mt -69.67 -8.3 46.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.933 -1.105 . . . . 0.0 109.057 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.23 -29.09 63.48 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.518 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.3 m-20 -67.91 -41.78 82.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 73' ' ' VAL . . . -47.21 -58.83 6.14 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.766 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -50.67 -37.65 42.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.338 . . . . 0.0 109.286 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.851 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -59.4 -41.1 88.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.204 -0.935 . . . . 0.0 108.58 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.068 HG21 ' CB ' ' A' ' 69' ' ' GLN . 21.9 t -81.23 -67.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 26.9 t80 -41.54 -26.63 0.07 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.288 -0.883 . . . . 0.0 109.851 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 36.6 m -76.71 -48.53 18.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.296 -0.877 . . . . 0.0 111.275 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -101.57 29.84 11.66 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.726 -1.225 . . . . 0.0 111.739 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.472 HD22 HG13 ' A' ' 9' ' ' VAL . 23.4 m-80 -155.03 -29.3 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.783 -1.422 . . . . 0.0 110.771 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.612 ' SG ' ' CZ ' ' A' ' 61' ' ' PHE . 79.6 m -127.91 -11.18 5.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.903 -1.123 . . . . 0.0 111.316 -177.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -51.69 -32.04 28.29 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.32 78.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.382 -0.824 . . . . 0.0 110.699 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.63 18.7 18.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.739 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.019 ' CE1' HD21 ' A' ' 31' ' ' LEU . 81.8 m-70 -158.61 -64.91 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.929 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' A' ' 18' ' ' HIS . 4.9 ptt? 38.66 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.318 0.58 . . . . 0.0 109.719 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 71.08 57.23 6.37 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 31' ' ' LEU . . . 36.74 64.81 0.6 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -141.66 99.05 0.23 Allowed Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.992 -1.299 . . . . 0.0 109.953 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -67.83 138.0 55.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -1.168 . . . . 0.0 109.855 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.22 -3.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -0.827 . . . . 0.0 109.599 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 t -103.59 -46.96 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mtp -100.45 157.51 16.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -109.77 61.25 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.9 p-10 169.62 -50.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -77.25 91.04 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.614 HG21 ' HD2' ' A' ' 32' ' ' LYS . 23.2 m -126.17 163.89 22.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.187 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.019 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -88.36 74.48 8.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.133 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.67 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -111.83 -85.04 0.57 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.648 -1.283 . . . . 0.0 109.103 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.044 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -176.56 -47.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 179.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.59 -33.81 27.87 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.15 -0.968 . . . . 0.0 110.413 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.65 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -70.81 -56.81 5.49 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.056 -1.028 . . . . 0.0 109.688 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.062 HD12 ' HB2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -53.42 -33.57 54.48 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.438 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.549 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 3.1 mm-40 -87.14 -17.84 31.82 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.706 0.765 . . . . 0.0 109.242 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.484 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.1 tp60 -68.33 -50.29 54.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.65 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -85.8 -78.17 0.28 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.427 -0.796 . . . . 0.0 108.926 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.66 86.36 0.06 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.566 ' SD ' ' CE2' ' A' ' 39' ' ' PHE . 2.7 ptt? -167.0 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -1.192 . . . . 0.0 109.511 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 1.062 ' HB2' HD12 ' A' ' 36' ' ' LEU . 38.0 t80 -104.68 12.02 33.39 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.55 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -105.42 140.41 38.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.792 ' HA ' HD11 ' A' ' 78' ' ' LEU . 1.2 mt-10 -44.89 -63.05 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.796 . . . . 0.0 109.97 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 29.5 t0 -48.63 -33.53 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.817 -1.177 . . . . 0.0 110.553 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -65.39 -76.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.84 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 tt -65.5 -6.75 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.859 0.838 . . . . 0.0 110.563 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.561 HD12 ' C ' ' A' ' 44' ' ' GLU . 12.8 mt -77.26 -43.02 31.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 49' ' ' TYR . 58.4 t80 -88.89 -3.83 58.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.626 ' OE1' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -100.87 -13.78 18.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 47' ' ' ILE . 26.8 t -92.09 -47.36 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.875 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -58.69 -12.82 4.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.58 -179.239 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.656 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -151.57 21.59 0.71 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.597 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 53.09 -131.97 41.55 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.572 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 157.08 132.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.437 0 CA-C-O 121.538 0.685 . . . . 0.0 109.728 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 59.9 m-80 63.05 -85.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.53 44.48 2.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.642 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 6.6 ttt -129.05 144.15 51.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.039 -1.038 . . . . 0.0 109.167 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.642 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.6 Cg_endo -71.71 117.27 5.06 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.372 2.715 . . . . 0.0 115.822 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.656 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -42.51 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.844 ' CE1' HD21 ' A' ' 65' ' ' LEU . 26.0 m-85 -139.48 8.64 2.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.42 -19.7 2.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.435 -0.791 . . . . 0.0 109.217 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.54 26.86 0.96 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.708 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 2.4 mmt85 -102.06 -48.59 4.18 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 178.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.033 HD13 HG11 ' A' ' 9' ' ' VAL . 8.4 mt -81.34 -148.57 0.07 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.609 HG22 ' N ' ' A' ' 67' ' ' ASP . 1.5 m -98.83 -74.96 0.57 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 122.19 0.995 . . . . 0.0 108.929 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.777 ' HA ' HD12 ' A' ' 70' ' ' ILE . 23.3 t0 -177.83 -59.34 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 9.7 tt0 -69.25 5.1 1.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.662 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 1.068 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.21 -33.92 6.31 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.875 HG21 ' HG3' ' A' ' 52' ' ' GLN . 2.3 mt -60.28 -18.0 15.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.477 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -96.46 -73.81 0.58 Allowed 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 60.7 m-20 -44.64 -46.34 10.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.833 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.787 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 10.5 t -63.29 -42.25 95.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.623 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -56.19 -63.87 1.05 Allowed 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.268 -1.52 . . . . 0.0 106.951 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.49 -18.93 32.91 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.787 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 61.4 t80 -65.46 -39.91 92.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.598 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 25.2 t -75.33 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -88.83 -8.12 54.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.3 t70 -98.54 -36.31 9.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.107 0.956 . . . . 0.0 108.707 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.641 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 5.1 mm-40 -80.9 -36.56 31.02 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.575 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -64.56 -42.88 95.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.837 ' HB2' ' OH ' ' A' ' 42' ' ' TYR . . . -89.12 12.81 14.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 110.829 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 8.3 ptmm? -138.08 18.18 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.494 -1.379 . . . . 0.0 111.22 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 86.49 73.96 1.27 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.641 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 5.6 m95 -36.62 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.41 0.624 . . . . 0.0 109.61 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . . . . . . 0 C--N 1.301 -1.506 0 O-C-N 121.411 -0.806 . . . . 0.0 109.832 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.478 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 68.6 m-20 -127.95 -26.09 2.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.988 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.503 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -68.12 -5.37 17.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.59 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.42 -30.54 70.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 2.0 m-20 -72.45 -33.63 67.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -52.13 -60.79 7.21 Favored Glycine 0 C--O 1.201 -1.93 0 N-CA-C 107.952 -2.059 . . . . 0.0 107.952 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.791 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -56.53 -26.98 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -1.067 . . . . 0.0 109.871 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.77 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -65.41 -35.07 79.83 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.024 -1.047 . . . . 0.0 108.707 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.099 HG21 ' CB ' ' A' ' 69' ' ' GLN . 14.9 t -88.66 -47.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.287 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 15.4 t80 -64.42 -27.69 69.17 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.804 -1.185 . . . . 0.0 109.435 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 18.7 p -90.93 11.2 23.52 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -141.95 3.53 2.01 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.553 HD22 HG13 ' A' ' 9' ' ' VAL . 2.5 m-80 -154.82 -57.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 0.0 109.029 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.637 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 11.6 m -65.84 -24.93 66.99 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.744 . . . . 0.0 109.37 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -62.35 -33.55 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.466 -0.771 . . . . 0.0 110.359 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.08 13.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.004 . . . . 0.0 110.517 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.553 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 0.1 OUTLIER -138.89 25.6 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' O ' ' A' ' 19' ' ' MET . 86.0 m-70 -157.07 -69.63 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 108.951 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.52 ' O ' ' O ' ' A' ' 18' ' ' HIS . 1.0 OUTLIER 36.24 102.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.602 0.715 . . . . 0.0 111.207 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 93.59 32.42 7.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 43.45 36.19 3.09 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' ASN . . . -130.51 109.35 0.91 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -44.3 140.82 2.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.0 109.333 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 24' ' ' VAL . 58.9 t -107.56 0.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 109.772 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.75 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 90.5 t -117.64 -51.3 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.676 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.79 176.27 6.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.72 46.61 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 1.4 p-10 -176.58 -62.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.283 -0.886 . . . . 0.0 108.979 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.615 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -55.18 97.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 t -111.1 -167.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.996 . . . . 0.0 110.393 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD21 ' C4A' ' A' ' 88' ' ' HEC . 0.1 OUTLIER -107.3 -26.06 11.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.673 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.635 ' C ' HD21 ' A' ' 36' ' ' LEU . 7.3 mtpt -45.22 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.109 -0.994 . . . . 0.0 109.827 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.089 ' N ' HD21 ' A' ' 36' ' ' LEU . 17.5 ttpt -178.74 -26.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.656 -1.278 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -67.83 -53.98 22.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.743 -1.223 . . . . 0.0 110.737 -177.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.547 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -76.05 -51.15 12.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.577 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.089 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -59.7 -22.82 62.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.096 -1.002 . . . . 0.0 108.852 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 2.4 tm-20 -112.4 -2.6 14.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.141 -0.975 . . . . 0.0 109.298 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -65.82 -47.05 76.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 178.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.615 ' CZ ' ' HG3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -85.74 -32.0 22.11 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.281 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 120.93 102.11 1.82 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.623 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.598 ' SD ' ' CD1' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 158.57 29.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.702 -0.881 . . . . 0.0 110.823 178.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.67 ' CD1' HD11 ' A' ' 36' ' ' LEU . 2.1 t80 -97.11 28.46 3.57 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.077 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 6.9 p -106.74 157.58 17.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 110.343 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.857 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -46.05 -62.91 1.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.38 -0.825 . . . . 0.0 109.701 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.511 ' N ' HD12 ' A' ' 48' ' ' ILE . 39.7 t0 -54.67 -28.74 49.59 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.94 -1.1 . . . . 0.0 110.637 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -66.06 -76.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.031 . . . . 0.0 110.247 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.898 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.5 tt -60.04 -20.99 20.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.462 -0.773 . . . . 0.0 110.047 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.857 HD12 ' C ' ' A' ' 44' ' ' GLU . 15.6 mt -64.45 -35.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.628 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 26.4 t80 -87.08 -18.12 31.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -90.38 -1.37 57.91 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 47' ' ' ILE . 78.5 t -109.67 -39.03 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.835 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -71.58 -5.13 31.12 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.169 -0.957 . . . . 0.0 109.016 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.703 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -161.99 26.77 0.12 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 44.51 -133.33 7.1 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.558 ' HB2' ' NE2' ' A' ' 50' ' ' GLN . 0.3 OUTLIER 160.86 126.67 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 121.29 0.567 . . . . 0.0 109.654 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 35.1 m-80 68.98 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.599 ' HB3' HMD2 ' A' ' 88' ' ' HEC . . . -128.12 12.0 6.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.945 -1.097 . . . . 0.0 110.569 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.643 ' HB2' ' C1D' ' A' ' 88' ' ' HEC . 14.4 ttt -95.16 138.98 21.88 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.672 -1.267 . . . . 0.0 109.599 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.701 ' HG2' HMC2 ' A' ' 88' ' ' HEC . 29.2 Cg_endo -73.81 117.18 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.964 2.443 . . . . 0.0 113.507 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.64 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.23 165.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.533 -0.73 . . . . 0.0 110.025 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.708 ' CD1' HD21 ' A' ' 65' ' ' LEU . 48.7 m-85 -146.76 15.59 1.23 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.35 -17.7 2.03 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.37 29.15 0.27 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.545 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -98.85 -41.58 7.56 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 178.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.994 HD13 HG11 ' A' ' 9' ' ' VAL . 19.3 mt -82.0 -140.71 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 6.1 m -98.62 -57.39 2.2 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.268 -0.895 . . . . 0.0 109.524 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 6.3 t70 153.34 -54.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 16.1 mt-10 -70.79 2.53 4.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 1.099 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -114.39 -27.42 7.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.986 HD13 HD12 ' A' ' 65' ' ' LEU . 10.8 mm -58.88 -22.42 21.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 173.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.462 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -97.48 -65.76 0.94 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.993 179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 25.0 t0 -53.82 -39.93 65.97 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 69' ' ' GLN . 1.4 p -60.94 -26.68 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.313 -0.867 . . . . 0.0 109.338 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -81.0 -63.48 1.4 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.71 -24.44 3.39 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.383 -1.448 . . . . 0.0 107.24 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.791 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.3 t80 -63.91 -47.72 79.43 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.08 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.5 p -67.32 -23.3 30.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 77' ' ' VAL . 3.1 mt -79.02 -11.61 60.01 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -35.06 9.67 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.007 0.908 . . . . 0.0 109.709 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.651 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 6.9 mm-40 -77.29 -43.68 32.39 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.313 0.578 . . . . 0.0 110.283 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.647 ' HB2' ' NE1' ' A' ' 85' ' ' TRP . . . -76.18 -22.41 55.38 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.346 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.71 4.26 22.52 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.549 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -170.59 39.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.587 -1.321 . . . . 0.0 112.309 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 97.29 74.74 1.2 Allowed Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.856 -1.64 . . . . 0.0 110.178 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.652 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -40.3 83.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.174 0.511 . . . . 0.0 110.752 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 46.43 24.3 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.439 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.486 2.007 0 CA-C-O 117.921 -1.488 . . . . 0.0 109.45 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.861 HBC2 ' HHD' ' A' ' 88' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.472 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 5.3 m-20 -122.22 157.77 30.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.404 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.539 HD23 ' OD1' ' A' ' 72' ' ' ASP . 3.9 mt -72.74 -3.69 26.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.62 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.2 -32.18 73.66 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.494 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -71.11 -26.86 63.21 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -60.21 -51.92 55.87 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.694 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -50.2 -19.89 0.89 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.616 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -82.61 -43.44 16.99 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.639 HG22 ' CG ' ' A' ' 69' ' ' GLN . 5.2 t -62.63 -26.35 40.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.9 t80 -101.29 -22.48 14.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.594 -0.691 . . . . 0.0 110.603 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 62.2 m -88.47 22.45 2.54 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.312 -0.868 . . . . 0.0 109.265 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.29 -23.27 0.02 OUTLIER Glycine 0 N--CA 1.484 1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.342 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB3' ' HD3' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -122.96 -7.03 8.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.596 -1.532 . . . . 0.0 110.065 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.657 ' SG ' HMB1 ' A' ' 88' ' ' HEC . 6.6 m -127.39 -23.04 3.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -58.27 -37.45 75.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.769 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.81 -10.53 13.36 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.229 -0.919 . . . . 0.0 111.77 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.57 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 94.7 m -140.64 19.04 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.648 -1.282 . . . . 0.0 110.052 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 89.4 m-70 -158.31 -53.3 0.07 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.266 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.511 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 5.0 ptt? 35.58 98.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.251 0.548 . . . . 0.0 110.795 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 72.27 52.52 10.66 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.677 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 37.05 83.37 0.01 OUTLIER Glycine 0 N--CA 1.483 1.822 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -161.7 93.74 0.12 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' GLY . 3.8 t-20 -40.72 157.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.577 -0.955 . . . . 0.0 109.823 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.631 HG13 HG23 ' A' ' 25' ' ' VAL . 2.3 p -120.87 -20.3 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.732 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.631 HG23 HG13 ' A' ' 24' ' ' VAL . 20.8 t -109.73 -68.61 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.0 mmt -58.2 168.83 0.94 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.953 . . . . 0.0 109.936 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -129.39 57.82 1.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 1.7 p30 178.09 -46.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.343 -0.848 . . . . 0.0 109.139 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.535 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 58.8 mttt -75.94 101.58 5.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.685 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 31' ' ' LEU . 5.9 m -118.88 173.0 7.14 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.193 -0.942 . . . . 0.0 110.464 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.888 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.2 mp -91.9 -19.35 22.57 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.319 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.9 ptmt -59.72 179.65 0.12 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.95 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.629 ' N ' ' HB1' ' A' ' 81' ' ' ALA . 17.1 ptmt -81.7 -38.52 25.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 2.8 mt-10 -55.89 -33.62 64.79 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 110.499 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.58 -42.0 5.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 110.94 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.92 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -66.34 -15.12 63.01 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.586 ' HG3' ' HG ' ' A' ' 36' ' ' LEU . 62.4 mt-10 -114.3 0.41 14.14 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.52 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -74.53 -51.91 13.35 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.206 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -87.31 -43.05 12.44 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.364 179.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.94 33.2 0.43 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.023 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.771 ' HE3' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -91.01 14.03 15.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.753 -1.439 . . . . 0.0 108.949 179.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.882 ' HD1' HD11 ' A' ' 36' ' ' LEU . 48.5 t80 -74.03 15.4 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.619 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -106.27 125.75 51.38 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.628 -1.295 . . . . 0.0 110.665 -179.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 1.6 pt-20 -44.41 -56.71 4.02 Favored 'General case' 0 C--O 1.201 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 108.861 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.65 -41.1 21.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 110.388 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.65 -71.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.966 . . . . 0.0 110.122 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.772 HG23 ' HB1' ' A' ' 74' ' ' ALA . 7.4 tt -68.1 -7.86 7.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 110.135 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.556 HG13 ' CB ' ' A' ' 74' ' ' ALA . 3.7 mt -81.54 -31.88 11.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.63 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 41.1 t80 -92.02 -13.19 31.36 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -93.64 -14.28 26.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 47' ' ' ILE . 53.9 t -101.5 -35.44 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.973 0.892 . . . . 0.0 109.874 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -74.19 -4.85 38.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.733 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -164.38 32.42 0.07 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.571 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.545 ' HA2' ' CG ' ' A' ' 58' ' ' MET . . . 45.59 -137.31 7.11 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.581 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.4 OUTLIER 157.9 128.93 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.937 -0.631 . . . . 0.0 109.311 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 51.9 m-80 62.95 -86.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -123.67 32.47 5.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.947 . . . . 0.0 109.735 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.695 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.1 ttt -111.7 141.92 25.62 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.061 -1.024 . . . . 0.0 109.147 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.695 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 31.0 Cg_endo -76.48 104.06 1.85 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.073 2.515 . . . . 0.0 114.293 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.733 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -52.28 121.97 7.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.73 -0.606 . . . . 0.0 109.813 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.862 ' CG ' HD13 ' A' ' 65' ' ' LEU . 39.6 m-85 -93.02 -55.66 3.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.96 -1.088 . . . . 0.0 108.558 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 52' ' ' GLN . . . 27.53 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.207 0.527 . . . . 0.0 110.132 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 166.01 -15.53 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.766 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.575 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -101.87 -29.34 11.9 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.048 HD21 HBB1 ' A' ' 88' ' ' HEC . 7.5 mp -94.49 114.12 26.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 67' ' ' ASP . 3.3 m -43.7 179.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.419 0.628 . . . . 0.0 110.264 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.716 ' H ' HG22 ' A' ' 66' ' ' THR . 0.1 OUTLIER -75.75 -62.38 1.6 Allowed 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.913 -1.117 . . . . 0.0 109.083 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.545 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 32.6 mt-10 -61.99 -9.49 7.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.386 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.639 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -94.66 -34.91 12.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 65' ' ' LEU . 7.0 mm -69.68 -14.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.5 mp0 -97.31 -69.87 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.581 1.181 . . . . 0.0 109.164 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.682 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 42.1 m-20 -52.36 -33.87 44.97 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.393 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.689 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.3 p -69.53 -30.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.619 0.723 . . . . 0.0 109.878 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.772 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.68 -57.72 3.74 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.497 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.21 -19.16 53.05 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.694 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 61.9 t80 -64.93 -41.89 95.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.633 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 40.7 t -72.95 -24.24 20.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.817 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.1 mt -85.32 -7.85 58.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 9.8 t0 -99.67 -36.86 9.35 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.183 0.992 . . . . 0.0 109.242 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.621 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 6.5 mm-40 -78.62 -40.15 35.18 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.202 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.629 ' HB1' ' N ' ' A' ' 33' ' ' LYS . . . -62.62 -37.65 87.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.774 . . . . 0.0 109.891 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.66 13.96 12.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 110.93 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 2.3 ptmt -150.03 30.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.544 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.97 74.06 1.26 Allowed Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.083 -1.532 . . . . 0.0 109.847 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.633 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 1.7 m95 -40.79 84.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.161 -0.611 . . . . 0.0 110.854 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 47.38 23.57 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 0.0 109.593 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.531 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 1.048 HBB1 HD21 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -130.02 -24.32 2.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 79' ' ' ASP . 1.7 mp -67.06 -7.76 25.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.9 -1.125 . . . . 0.0 109.286 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.76 -31.89 68.77 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -68.6 -36.97 79.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.16 -62.96 5.47 Favored Glycine 0 C--O 1.203 -1.812 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.797 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.55 -30.08 4.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -1.207 . . . . 0.0 109.86 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.761 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -64.48 -45.29 88.0 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 108.376 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.046 HG21 ' CB ' ' A' ' 69' ' ' GLN . 41.2 t -75.77 -55.4 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.633 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 7.9 t80 -57.43 -26.11 60.65 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 110.438 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 28.9 t -86.24 19.08 2.84 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -162.16 11.15 0.11 Allowed Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.497 HD22 HG13 ' A' ' 9' ' ' VAL . 8.8 m-80 -153.97 -53.16 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.683 -1.481 . . . . 0.0 109.159 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.3 m -73.38 -26.38 60.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' HA ' ' N ' ' A' ' 19' ' ' MET . . . -52.1 -41.0 62.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.2 68.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.903 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.583 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 85.8 m -121.55 19.13 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.922 -1.111 . . . . 0.0 110.649 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 93.8 m-70 -158.67 -66.5 0.08 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.164 -0.96 . . . . 0.0 109.25 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.506 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 14.2 ptm 39.48 98.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.531 0.682 . . . . 0.0 110.286 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.45 46.02 80.95 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.539 ' O ' HG21 ' A' ' 30' ' ' THR . . . 51.09 68.19 1.61 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -143.29 88.32 0.17 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.644 ' H ' HG23 ' A' ' 30' ' ' THR . 1.2 t-20 -61.9 142.25 57.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -1.118 . . . . 0.0 109.778 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 17' ' ' CYS . 17.4 m -102.16 -13.26 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.588 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 60.4 t -104.56 -57.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.92 . . . . 0.0 109.127 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.53 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 9.5 mmt -103.36 93.97 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.845 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.18 -47.55 35.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.733 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -35.62 80.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.192 -0.943 . . . . 0.0 109.885 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 0.0 OUTLIER -84.29 82.68 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.644 HG23 ' H ' ' A' ' 23' ' ' ASN . 24.5 m -122.01 171.97 8.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.052 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.745 ' HB3' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -84.74 -3.49 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.715 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -46.01 173.53 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.142 -0.974 . . . . 0.0 109.964 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -84.17 -27.65 27.94 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.312 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -82.51 -27.12 31.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.165 -0.96 . . . . 0.0 111.074 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.42 -35.21 7.18 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.292 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.802 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -60.6 -39.7 89.11 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.373 -1.331 . . . . 0.0 108.115 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.587 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -96.93 6.06 49.34 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -69.33 -47.21 65.1 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.5 -39.04 16.65 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.656 178.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.52 79.17 0.6 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.437 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.705 ' SD ' HMA2 ' A' ' 88' ' ' HEC . 0.3 OUTLIER -159.16 25.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -1.098 . . . . 0.0 108.798 179.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.717 ' HB2' HD11 ' A' ' 36' ' ' LEU . 33.8 t80 -74.68 3.12 8.4 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.518 0.675 . . . . 0.0 109.621 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.94 155.59 18.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.707 -1.245 . . . . 0.0 110.999 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.537 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 1.3 mp0 -50.44 -64.73 0.72 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.871 -0.518 . . . . 0.0 110.515 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -46.48 -31.57 2.79 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.77 -1.206 . . . . 0.0 111.437 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 41' ' ' MET . . . -69.65 -73.94 0.15 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.784 -1.198 . . . . 0.0 110.658 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.859 ' O ' HG23 ' A' ' 51' ' ' VAL . 10.4 tt -60.31 -17.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.25 -0.906 . . . . 0.0 109.622 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.551 HG13 ' CB ' ' A' ' 74' ' ' ALA . 21.6 mt -72.31 -34.44 49.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 52.1 t80 -71.64 -29.98 65.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.828 -0.545 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 47' ' ' ILE . 2.5 pm0 -94.39 -13.2 26.56 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.774 -1.57 . . . . 0.0 109.125 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 47' ' ' ILE . 60.2 t -87.76 -23.73 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.009 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.566 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -99.39 -7.68 25.85 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.47 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.657 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -147.35 13.6 1.09 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 55' ' ' LYS . . . 53.5 -135.33 41.54 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.629 ' N ' ' HB3' ' A' ' 58' ' ' MET . 4.9 mtpt 155.17 127.48 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 16.0 m-80 61.0 -88.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -121.9 29.29 7.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.235 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.629 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 27.8 ttt -107.12 141.89 23.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.25 -0.906 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.595 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 37.0 Cg_endo -85.06 99.22 0.69 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 123.202 2.601 . . . . 0.0 113.879 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB2' ' HA ' ' A' ' 53' ' ' HIS . . . -37.54 158.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 0.0 110.018 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.774 ' HZ ' HMC2 ' A' ' 88' ' ' HEC . 14.4 m-85 -137.03 22.62 3.04 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -5.07 2.46 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.48 16.74 0.99 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.64 -55.83 2.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.887 HD21 HBB1 ' A' ' 88' ' ' HEC . 4.7 mp -66.52 -157.42 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 69' ' ' GLN . 1.4 m -99.51 -58.36 1.94 Allowed 'General case' 0 C--N 1.285 -2.236 0 O-C-N 121.246 -0.909 . . . . 0.0 109.259 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 66' ' ' THR . 3.7 m-20 153.72 -53.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 3.7 mt-10 -69.01 -3.77 14.3 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 1.046 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.88 -25.81 9.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.656 HD11 ' O ' ' A' ' 61' ' ' PHE . 12.3 mm -57.37 -23.13 18.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.9 mp0 -96.37 -70.47 0.71 Allowed 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.515 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 2.8 m-20 -44.66 -46.4 10.2 Favored 'General case' 0 C--O 1.203 -1.394 0 O-C-N 121.857 -0.527 . . . . 0.0 110.026 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -62.05 -37.02 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.628 0.728 . . . . 0.0 110.005 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.551 ' CB ' HG13 ' A' ' 48' ' ' ILE . . . -67.23 -61.84 1.72 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.509 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.1 -18.99 17.03 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.797 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 71.3 t80 -67.14 -44.16 80.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.8 HG21 HD11 ' A' ' 47' ' ' ILE . 85.0 t -71.11 -19.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 2.4 mt -84.6 -9.52 58.22 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.155 -1.018 . . . . 0.0 108.293 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.502 ' HB3' ' OE1' ' A' ' 80' ' ' GLN . 7.4 t0 -99.21 -45.87 5.74 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.188 0.994 . . . . 0.0 108.604 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.641 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.1 mm100 -65.59 -50.07 66.44 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.082 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.766 ' HB2' ' CD1' ' A' ' 85' ' ' TRP . . . -74.14 -12.1 60.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.55 -0.719 . . . . 0.0 109.22 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 78' ' ' LEU . . . -65.28 -7.46 13.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.53 -0.731 . . . . 0.0 110.023 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -179.9 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.754 -1.217 . . . . 0.0 111.64 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.52 75.9 1.31 Allowed Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.019 -1.562 . . . . 0.0 109.669 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.766 ' CD1' ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -39.74 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.39 -0.476 . . . . 0.0 110.551 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 41.49 29.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.799 . . . . 0.0 109.204 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 85' ' ' TRP . . . . . . . . 0 N--CA 1.487 2.086 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.604 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.887 HBB1 HD21 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.498 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 8.6 m-20 -129.98 -25.83 2.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.037 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.464 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -66.86 -4.91 10.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 0.0 109.554 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.95 -25.41 60.92 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.515 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.3 m-20 -77.68 -36.94 50.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.462 ' CA ' ' OD1' ' A' ' 72' ' ' ASP . . . -50.72 -55.98 15.47 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.762 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -60.31 -24.95 65.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.767 -0.843 . . . . 0.0 109.712 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.726 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.88 -30.28 68.74 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.838 -1.164 . . . . 0.0 108.331 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.051 HG21 ' CB ' ' A' ' 69' ' ' GLN . 22.8 t -97.73 -23.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.479 -0.763 . . . . 0.0 110.056 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.658 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 t80 -89.17 -25.89 21.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.845 -1.159 . . . . 0.0 109.921 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 17.1 m -78.81 7.34 7.21 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.638 -0.664 . . . . 0.0 110.081 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -156.46 13.02 0.34 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.378 -1.392 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 1.3 m-80 -139.01 -42.4 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.802 -1.411 . . . . 0.0 109.057 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -97.22 -22.76 16.52 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -47.59 -50.37 24.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.716 -0.615 . . . . 0.0 110.455 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -30.16 71.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 110.776 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 64.4 m -112.94 15.07 19.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.921 -1.112 . . . . 0.0 110.006 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 81.1 m-70 -159.15 -64.45 0.08 Allowed 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 50.24 108.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.459 0.647 . . . . 0.0 110.497 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.48 57.07 9.76 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.507 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 45.99 66.67 1.56 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -144.67 81.78 0.21 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.775 ' H ' HG23 ' A' ' 30' ' ' THR . 6.5 t-20 -53.3 153.45 3.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -1.201 . . . . 0.0 109.324 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 17' ' ' CYS . 4.1 m -128.12 5.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 109.997 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.802 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 27.7 t -105.29 -59.57 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 109.31 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.456 ' HG3' HAD1 ' A' ' 88' ' ' HEC . 4.4 mmm -86.38 -173.28 4.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.94 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -128.67 57.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 1.5 p-10 169.27 -41.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.806 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HD2' ' CE2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -71.47 89.02 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 109.876 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.775 HG23 ' H ' ' A' ' 23' ' ' ASN . 9.6 m -122.43 170.96 9.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.318 -0.863 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.958 ' HB3' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -89.91 -11.71 41.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.997 . . . . 0.0 108.955 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -34.3 -71.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.645 -0.659 . . . . 0.0 111.6 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.035 ' CA ' HD21 ' A' ' 36' ' ' LEU . 1.5 tptm 170.07 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.724 -1.235 . . . . 0.0 110.196 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 32.1 mt-10 -72.2 -46.3 56.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.112 -0.992 . . . . 0.0 111.06 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.597 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.48 -48.41 49.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.029 -1.044 . . . . 0.0 111.132 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.035 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -65.97 -14.15 61.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.65 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.541 ' CG ' ' CD2' ' A' ' 42' ' ' TYR . 3.0 mm-40 -119.22 8.4 11.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.773 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.533 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.5 tp-100 -87.06 -53.06 5.07 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.25 -40.52 13.59 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.736 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.51 44.35 0.18 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.752 -1.214 . . . . 0.0 110.785 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.844 ' SD ' HMA2 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -105.78 9.05 33.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.333 . . . . 0.0 109.187 179.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.599 ' CD2' HD12 ' A' ' 36' ' ' LEU . 27.6 t80 -71.98 13.99 0.25 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.264 -0.897 . . . . 0.0 111.449 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -106.0 136.26 45.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.35 -1.469 . . . . 0.0 110.745 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.743 ' C ' HD12 ' A' ' 48' ' ' ILE . 1.4 mt-10 -44.1 -57.51 3.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.297 -0.877 . . . . 0.0 108.83 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' N ' HD12 ' A' ' 48' ' ' ILE . 9.9 t0 -51.41 -38.75 55.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.12 -73.82 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.781 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.6 tt -64.47 -11.27 10.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 110.083 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.743 HD12 ' C ' ' A' ' 44' ' ' GLU . 14.8 mt -78.96 -31.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 40.0 t80 -92.32 -14.4 28.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.549 ' OE1' ' CB ' ' A' ' 55' ' ' LYS . 1.4 tp60 -93.93 -14.47 25.95 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.2 t -97.32 -44.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.973 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -64.27 -13.94 52.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.582 . . . . 0.0 111.313 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.662 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -147.88 21.54 1.13 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.604 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.36 -130.53 50.56 Favored Glycine 0 C--N 1.296 -1.645 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.7 137.39 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 58.24 -89.48 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.61 41.46 3.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.689 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 17.5 ttt -113.94 143.97 30.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.689 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.2 Cg_endo -77.39 107.74 2.46 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.334 2.689 . . . . 0.0 114.709 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.662 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.55 159.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.752 . . . . 0.0 111.039 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.76 ' HZ ' HMC2 ' A' ' 88' ' ' HEC . 10.0 m-30 -141.12 16.26 2.26 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.8 -0.562 . . . . 0.0 110.116 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB2' ' HG2' ' A' ' 52' ' ' GLN . . . -66.28 -2.99 4.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.123 178.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.53 17.8 1.13 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.546 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -108.22 -57.49 2.11 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.043 HD12 ' CD1' ' A' ' 70' ' ' ILE . 36.0 mt -73.51 -149.1 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.536 ' HB ' ' HG2' ' A' ' 69' ' ' GLN . 1.4 m -99.53 -61.52 1.36 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.9 t70 156.7 -51.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 12.3 tp10 -71.15 4.01 3.08 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 1.051 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -112.21 -33.24 6.28 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.043 ' CD1' HD12 ' A' ' 65' ' ' LEU . 36.0 mm -58.28 -24.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -91.6 -73.52 0.54 Allowed 'General case' 0 C--O 1.207 -1.135 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.713 178.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.554 ' HB3' ' HA ' ' A' ' 69' ' ' GLN . 15.1 t0 -44.65 -53.7 6.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.761 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 11.5 t -56.09 -39.54 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.362 1.077 . . . . 0.0 108.159 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLN . . . -55.77 -59.15 5.28 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.97 -18.77 59.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.762 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 65.0 t80 -67.27 -38.06 84.49 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.958 HG13 ' HB3' ' A' ' 31' ' ' LEU . 93.7 t -76.78 -23.29 15.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.809 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -86.41 -6.48 58.91 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -98.2 -52.63 3.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.265 1.031 . . . . 0.0 108.404 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.623 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 45.7 mm-40 -65.16 -46.34 81.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.365 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 31' ' ' LEU . . . -70.57 -12.39 61.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.321 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 78' ' ' LEU . . . -78.08 -4.45 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.45 -0.781 . . . . 0.0 110.963 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -178.32 57.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.454 -1.404 . . . . 0.0 111.961 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 89.56 75.96 1.3 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 118.947 -1.597 . . . . 0.0 109.339 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.641 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -40.7 84.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.177 0.513 . . . . 0.0 110.826 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 55.16 48.51 19.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.337 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.09 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.536 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.844 HMA2 ' SD ' ' A' ' 41' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -104.17 158.06 16.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 109.52 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.583 HD13 ' OD2' ' A' ' 79' ' ' ASP . 1.0 OUTLIER -70.66 -11.93 61.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 108.588 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -30.42 66.57 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.511 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.43 -37.32 65.93 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -49.72 -59.09 7.62 Favored Glycine 0 C--O 1.201 -1.948 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.842 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -54.06 -35.05 61.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.103 . . . . 0.0 109.79 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.572 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 108.995 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.055 HG21 ' CB ' ' A' ' 69' ' ' GLN . 37.5 t -86.15 -43.08 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 110.563 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.588 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 7.8 t80 -63.46 -27.68 69.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.726 -1.234 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 p -86.52 18.47 3.29 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 109.473 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.71 6.96 0.66 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.243 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.513 HD22 HG13 ' A' ' 9' ' ' VAL . 17.8 m-80 -152.56 -49.76 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.605 -1.527 . . . . 0.0 109.468 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 2.3 m -76.46 -30.69 57.43 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -43.6 -42.45 5.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.679 -0.638 . . . . 0.0 110.294 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -46.96 85.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.944 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.582 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 66.5 m -107.28 29.54 7.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.05 -1.031 . . . . 0.0 109.923 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.582 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 77.8 m-70 -162.6 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.499 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 9.8 ptt? 39.04 100.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.49 0.662 . . . . 0.0 110.777 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 87.26 41.95 6.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 39.32 58.73 1.97 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -151.64 103.85 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.451 HD21 ' C4D' ' A' ' 88' ' ' HEC . 2.5 t-20 -56.11 162.08 2.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.197 . . . . 0.0 109.05 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.4 -29.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.047 -1.033 . . . . 0.0 109.986 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.532 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 4.7 t -79.09 -70.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.099 -1.001 . . . . 0.0 109.337 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.51 ' CG ' HAD1 ' A' ' 88' ' ' HEC . 32.3 mmt -66.48 150.85 48.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.278 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -113.54 60.35 0.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 109.685 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.498 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.8 p30 -178.69 -44.17 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.985 . . . . 0.0 109.364 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HG3' ' OD1' ' A' ' 28' ' ' ASN . 25.0 mttp -81.86 124.37 29.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.121 -0.987 . . . . 0.0 109.071 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.788 ' O ' HD22 ' A' ' 36' ' ' LEU . 2.1 m -121.47 -174.18 2.8 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.274 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.713 ' H ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -100.24 -13.93 18.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.678 ' C ' HD21 ' A' ' 36' ' ' LEU . 24.2 mtpt -59.78 -98.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.144 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.794 ' N ' HD21 ' A' ' 36' ' ' LEU . 14.7 ptpt -177.25 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -51.47 -29.07 15.02 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.683 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.584 ' C ' ' CE2' ' A' ' 39' ' ' PHE . . . -104.48 -71.79 0.73 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.396 -0.815 . . . . 0.0 110.095 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.929 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -40.56 -39.91 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.246 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.558 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -82.96 -33.45 26.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.92 -1.112 . . . . 0.0 109.215 179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -45.79 -44.3 13.91 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CE2' ' C ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -85.83 -72.24 0.5 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.9 89.18 0.07 OUTLIER Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER 179.48 26.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -1.2 . . . . 0.0 110.395 -178.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.027 ' OH ' ' HB3' ' A' ' 81' ' ' ALA . 3.3 t80 -109.04 23.37 14.64 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 109.473 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 5.6 p -107.79 153.42 23.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.899 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -42.52 -65.67 0.44 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 109.858 178.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' N ' HD12 ' A' ' 48' ' ' ILE . 50.0 t0 -52.18 -32.91 38.3 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.015 . . . . 0.0 110.437 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.503 ' C ' ' NE2' ' A' ' 50' ' ' GLN . . . -62.55 -73.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.28 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.74 ' CD1' HG11 ' A' ' 77' ' ' VAL . 10.6 tt -62.57 -13.8 11.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.899 HD12 ' C ' ' A' ' 44' ' ' GLU . 32.7 mt -77.22 -28.67 16.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.646 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 25.7 t80 -85.76 -22.22 27.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.338 -0.851 . . . . 0.0 110.026 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.593 ' O ' ' HE2' ' A' ' 58' ' ' MET . 2.3 pm0 -99.47 -15.07 18.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 119.789 -1.819 . . . . 0.0 108.735 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.589 ' CG2' HG12 ' A' ' 47' ' ' ILE . 34.5 t -91.43 -27.66 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 109.516 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.659 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -86.8 -4.4 59.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.788 -1.195 . . . . 0.0 108.144 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.74 ' HA ' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -158.97 22.37 0.2 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.36 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 48.8 -138.28 15.09 Favored Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.261 -1.935 . . . . 0.0 108.261 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.626 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.9 OUTLIER 156.43 134.53 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.03 -89.38 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.803 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -121.76 41.15 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.507 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.651 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 18.2 ttt -119.76 143.31 34.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 108.726 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.651 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 33.5 Cg_endo -77.31 94.56 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 123.004 2.469 . . . . 0.0 115.347 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.74 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -49.2 112.94 0.7 Allowed 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.288 -0.882 . . . . 0.0 110.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.675 ' CD2' ' CD2' ' A' ' 65' ' ' LEU . 25.9 m-85 -81.41 -51.2 8.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.11 26.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.384 0.612 . . . . 0.0 109.606 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.85 32.74 0.63 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.645 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -100.29 -48.52 4.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.87 HD23 HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -64.12 -141.0 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.587 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 3.3 m -98.02 -52.11 3.81 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 121.01 -1.056 . . . . 0.0 109.175 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 66' ' ' THR . 5.7 m-20 150.77 -60.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 35.2 mm-40 -68.22 -2.02 7.31 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 1.055 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.11 -29.82 7.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.87 HD13 HD23 ' A' ' 65' ' ' LEU . 9.7 mm -52.47 -24.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.52 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -100.21 -60.42 1.53 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.442 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.703 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 13.9 m-20 -52.69 -47.6 67.13 Favored 'General case' 0 C--O 1.189 -2.114 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.527 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 69' ' ' GLN . 6.3 t -54.56 -29.17 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 108.791 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.747 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -77.67 -67.64 0.7 Allowed 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -50.47 -23.62 2.58 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.012 -1.68 . . . . 0.0 107.515 177.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.842 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 35.6 t80 -64.74 -46.23 83.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.188 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.4 p -67.74 -23.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.5 mt -78.34 -12.13 59.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.583 ' OD2' HD13 ' A' ' 3' ' ' LEU . 3.6 t0 -100.74 -34.62 9.77 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.793 0.806 . . . . 0.0 109.713 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.609 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 4.2 mm-40 -76.95 -40.63 46.37 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.27 0.557 . . . . 0.0 110.198 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.027 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -69.48 -26.15 64.42 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 108.952 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.45 11.65 18.71 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 111.036 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -162.53 29.5 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.344 -1.473 . . . . 0.0 112.442 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 92.31 75.7 1.31 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.71 -1.709 . . . . 0.0 109.202 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.706 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.6 OUTLIER -36.9 89.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.532 0.682 . . . . 0.0 110.152 178.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -60.31 -35.87 76.61 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.217 0 CA-C-O 118.028 -1.429 . . . . 0.0 109.722 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.803 HMD2 ' O ' ' A' ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -122.47 -24.53 4.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.849 . . . . 0.0 109.484 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.691 HD23 ' OD1' ' A' ' 72' ' ' ASP . 4.8 mt -69.61 -5.28 23.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.133 -0.979 . . . . 0.0 109.449 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.58 68.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.8 -33.95 64.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.85 -61.82 6.71 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.768 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.47 -36.66 15.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.271 . . . . 0.0 109.66 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.74 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -58.52 -46.1 87.47 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.055 HG21 ' CB ' ' A' ' 69' ' ' GLN . 42.5 t -75.51 -63.03 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.651 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 13.1 t80 -46.27 -23.43 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 110.954 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m -91.49 31.88 1.13 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.24 -0.912 . . . . 0.0 109.168 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.34 -32.73 0.02 OUTLIER Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.896 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' CB ' HD11 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -118.08 -50.24 2.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.878 -1.366 . . . . 0.0 108.767 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 6.6 m -70.2 -29.8 66.74 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -61.14 -38.17 85.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.513 -0.742 . . . . 0.0 110.48 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.41 -11.83 7.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.219 -0.926 . . . . 0.0 110.82 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.578 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 96.9 m -143.01 23.91 1.85 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.869 -1.145 . . . . 0.0 110.082 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.039 ' CE1' HD21 ' A' ' 31' ' ' LEU . 84.8 m-70 -157.9 -68.73 0.09 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.19 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 53.78 110.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.637 -0.664 . . . . 0.0 110.304 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 45.92 62.4 3.39 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 41.64 68.8 0.62 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -149.75 87.18 0.15 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.688 ' H ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -57.85 145.85 33.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -1.107 . . . . 0.0 109.474 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.545 HG23 HG23 ' A' ' 25' ' ' VAL . 34.8 m -97.42 -41.34 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG23 HG23 ' A' ' 24' ' ' VAL . 2.6 t -83.53 -60.7 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.092 -1.005 . . . . 0.0 109.196 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.64 ' SD ' HMD1 ' A' ' 88' ' ' HEC . 0.2 OUTLIER -86.7 90.19 8.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.77 71.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.713 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -74.16 -39.51 63.19 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.151 -0.968 . . . . 0.0 109.457 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.72 106.79 18.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.366 -0.834 . . . . 0.0 109.425 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.688 HG23 ' H ' ' A' ' 23' ' ' ASN . 7.7 m -126.5 174.81 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.104 -0.998 . . . . 0.0 109.567 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.039 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -95.76 -8.83 33.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.675 ' HD2' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -34.49 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.573 -178.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.108 ' N ' HD21 ' A' ' 36' ' ' LEU . 14.9 ttpp -178.42 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.824 -1.173 . . . . 0.0 110.592 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -80.16 -53.3 6.8 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.082 -1.011 . . . . 0.0 111.63 -178.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' CZ ' ' A' ' 39' ' ' PHE . . . -67.75 -53.84 24.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.937 -1.102 . . . . 0.0 110.521 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.108 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -44.84 -23.76 0.16 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.565 -179.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.562 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 89.4 mt-10 -95.25 -32.56 12.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 110.307 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.566 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 15.5 mm100 -52.17 -39.52 60.19 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.772 ' CZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.87 -47.9 8.64 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.33 8.37 5.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.538 ' SD ' ' CD2' ' A' ' 39' ' ' PHE . 4.2 ptt? -80.94 11.78 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -1.153 . . . . 0.0 109.98 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.88 ' HB2' HD12 ' A' ' 36' ' ' LEU . 15.0 t80 -85.11 12.22 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.946 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.5 p -105.15 149.28 26.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.26 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.619 ' HG2' HD11 ' A' ' 48' ' ' ILE . 3.8 tt0 -54.39 -57.4 11.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.849 . . . . 0.0 109.64 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 45' ' ' ASP . 16.0 t0 -51.75 -23.13 4.19 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.643 -1.286 . . . . 0.0 110.3 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 41' ' ' MET . . . -76.68 -76.17 0.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.909 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.7 tt -57.91 -16.77 6.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.619 HD11 ' HG2' ' A' ' 44' ' ' GLU . 15.1 mt -71.89 -39.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.586 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 28.9 t80 -86.36 -16.88 35.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 108.834 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.522 ' OE1' ' CB ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -86.61 -19.97 28.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.665 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 47' ' ' ILE . 62.3 t -96.22 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.503 1.144 . . . . 0.0 109.552 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.558 ' C ' ' CD2' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -71.7 -11.74 60.98 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.272 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.645 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -154.2 23.87 0.49 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.378 -1.451 . . . . 0.0 109.091 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.704 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.42 -148.86 44.51 Favored Glycine 0 C--N 1.285 -2.256 0 N-CA-C 107.627 -2.189 . . . . 0.0 107.627 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.97 117.82 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.9 m-80 63.39 -86.98 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.716 ' C ' HMD2 ' A' ' 88' ' ' HEC . . . -126.29 28.32 6.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 108.737 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.676 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.31 141.82 23.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.634 ' CD ' ' C3C' ' A' ' 88' ' ' HEC . 31.7 Cg_endo -75.75 105.49 2.09 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 123.369 2.713 . . . . 0.0 116.242 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.704 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -57.27 117.47 4.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.678 ' CZ ' HBB3 ' A' ' 88' ' ' HEC . 17.7 m-85 -87.9 -45.59 10.12 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.038 -1.039 . . . . 0.0 108.781 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 46.93 19.01 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.39 -0.819 . . . . 0.0 108.906 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 128.65 43.19 0.23 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.545 ' CB ' ' HB3' ' A' ' 61' ' ' PHE . 21.0 ttt180 -101.59 -51.62 3.41 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.704 HD12 HG13 ' A' ' 9' ' ' VAL . 2.7 mm? -63.6 -145.13 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.573 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 2.5 m -99.0 -56.98 2.28 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 120.896 -1.128 . . . . 0.0 109.642 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER 152.43 -55.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.086 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 24.5 mt-10 -69.75 -1.71 9.96 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 1.055 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.6 -28.23 8.98 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.464 ' CG2' ' HG3' ' A' ' 52' ' ' GLN . 8.2 mm -56.29 -23.06 15.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 174.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.482 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.9 mp0 -95.56 -70.31 0.72 Allowed 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.442 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.691 ' OD1' HD23 ' A' ' 3' ' ' LEU . 5.4 m-20 -45.19 -47.29 12.5 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.954 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.748 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -60.45 -36.25 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.74 0.781 . . . . 0.0 110.132 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' A' ' 48' ' ' ILE . . . -68.34 -62.71 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.19 -19.14 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.768 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 82.5 t80 -65.02 -45.27 86.22 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 31' ' ' LEU . 42.5 t -68.87 -24.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.429 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.72 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -83.53 -4.76 58.83 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.908 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 5.0 t0 -97.41 -45.4 6.47 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.824 ' HB3' ' CD2' ' A' ' 85' ' ' TRP . 10.7 mp0 -72.08 -31.75 66.38 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.2 0.524 . . . . 0.0 110.344 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 33' ' ' LYS . . . -58.44 -52.72 64.43 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.73 19.39 4.03 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -131.95 5.57 4.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 111.597 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.5 76.15 1.04 Allowed Glycine 0 C--N 1.296 -1.672 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.824 ' CD2' ' HB3' ' A' ' 80' ' ' GLN . 18.0 m95 -38.28 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.417 0.627 . . . . 0.0 110.804 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 44.78 24.84 0.12 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 109.824 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.112 0 CA-C-O 117.971 -1.46 . . . . 0.0 109.499 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.734 HMA1 HD12 ' A' ' 47' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 4' ' ' ALA . 35.1 t70 -116.39 150.96 36.9 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.173 -0.954 . . . . 0.0 109.258 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.24 -3.98 23.27 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.08 -1.012 . . . . 0.0 108.424 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB2' ' OD2' ' A' ' 2' ' ' ASP . . . -63.92 -31.12 72.2 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.524 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.2 m-20 -71.6 -26.54 62.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.629 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -60.56 -64.11 4.4 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.851 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -39.77 -34.24 0.24 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.875 -0.78 . . . . 0.0 109.275 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.17 -52.49 40.82 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.77 HG11 ' HB ' ' A' ' 73' ' ' VAL . 23.6 t -52.19 -57.29 4.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.715 -0.615 . . . . 0.0 110.349 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.783 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 19.8 t80 -59.37 -33.46 71.21 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.986 -1.072 . . . . 0.0 110.473 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 t -91.1 21.17 4.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.283 -0.885 . . . . 0.0 110.073 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.63 -8.64 0.68 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.767 ' ND2' HD22 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -149.12 3.67 0.6 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.484 -1.598 . . . . 0.0 111.525 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -132.65 -44.99 0.89 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.564 -1.335 . . . . 0.0 110.979 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . -27.38 -44.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.13 0.491 . . . . 0.0 111.196 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -61.8 -53.48 55.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 110.762 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.603 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 84.4 m -94.85 25.02 4.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 109.628 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.564 ' CE1' ' HG ' ' A' ' 31' ' ' LEU . 28.5 m-70 -157.1 -72.08 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.743 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 18' ' ' HIS . 2.5 mtp 43.71 100.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.313 0.578 . . . . 0.0 110.631 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 75.72 50.8 7.64 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 37.98 45.82 1.68 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -127.42 101.0 0.56 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.3 t-20 -46.16 165.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -1.198 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.682 HG13 HG23 ' A' ' 25' ' ' VAL . 1.7 p -111.73 -40.41 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.181 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 24' ' ' VAL . 2.7 t -91.72 -70.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.227 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.1 mmt -79.92 101.18 8.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.55 75.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.641 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 2.2 p-10 -65.8 -44.93 84.23 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.15 -0.969 . . . . 0.0 109.387 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.2 tptt -85.12 79.69 9.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.449 -0.782 . . . . 0.0 109.677 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 6.7 t -101.04 -176.47 3.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.905 . . . . 0.0 109.69 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD22 HMA3 ' A' ' 88' ' ' HEC . 0.3 OUTLIER -97.3 -19.07 18.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 109.73 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.614 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -38.61 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.692 -0.63 . . . . 0.0 111.407 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.063 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.6 OUTLIER 174.63 -39.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.019 . . . . 0.0 109.95 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.565 -0.71 . . . . 0.0 111.103 -178.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.603 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -93.31 -47.24 7.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 110.803 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.063 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -58.85 -33.21 70.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.557 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.492 ' HG2' ' HB2' ' A' ' 42' ' ' TYR . 2.0 mm-40 -95.75 -1.28 50.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.168 -0.957 . . . . 0.0 109.797 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.589 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -73.69 -57.61 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -88.27 -48.98 7.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.456 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.58 92.84 0.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.595 ' HE1' HAA2 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -172.13 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.048 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.965 ' CG ' HD12 ' A' ' 36' ' ' LEU . 2.2 t80 -102.14 21.73 14.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.482 -0.761 . . . . 0.0 109.751 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -107.4 143.78 35.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 0.0 111.216 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.532 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -42.42 -62.78 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.47 -0.769 . . . . 0.0 109.588 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -49.01 -37.6 20.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 110.751 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -74.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.995 -1.066 . . . . 0.0 110.44 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 77' ' ' VAL . 8.0 tt -64.28 -10.51 8.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.528 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.532 HD12 ' C ' ' A' ' 44' ' ' GLU . 10.7 mt -75.4 -37.64 38.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 34.0 t80 -89.5 -15.96 31.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -88.34 -14.48 38.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.5 t -97.2 -47.71 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.392 -0.818 . . . . 0.0 110.006 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.563 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -61.34 -9.92 6.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.737 -0.602 . . . . 0.0 110.878 -178.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.654 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.51 23.54 0.4 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 54.01 -133.84 44.66 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.912 -2.475 . . . . 0.0 106.912 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.03 120.76 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.208 0.528 . . . . 0.0 109.737 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.48 ' HB2' HBD2 ' A' ' 88' ' ' HEC . 2.5 m120 73.85 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -135.8 29.4 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.195 -0.941 . . . . 0.0 108.859 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.658 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 27.0 ttt -108.23 143.79 28.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 109.346 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.658 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 32.9 Cg_endo -79.89 111.98 2.81 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.012 2.475 . . . . 0.0 113.171 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.654 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -37.68 159.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.599 -0.688 . . . . 0.0 110.246 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.685 ' CD2' HBB2 ' A' ' 88' ' ' HEC . 5.9 m-85 -147.23 21.71 1.21 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.483 -0.76 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.02 -10.8 10.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.03 . . . . 0.0 109.063 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.38 13.12 5.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.59 ' HG3' ' CD1' ' A' ' 61' ' ' PHE . 6.6 mmt85 -104.07 -48.11 3.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -95.41 124.83 39.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.71 HG22 ' H ' ' A' ' 67' ' ' ASP . 5.3 m -44.26 178.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.258 0.552 . . . . 0.0 110.049 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.71 ' H ' HG22 ' A' ' 66' ' ' THR . 4.3 m-20 -65.21 -59.38 4.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.798 -1.189 . . . . 0.0 109.204 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.597 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 4.4 mt-10 -71.1 1.91 5.2 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.653 -0.654 . . . . 0.0 109.533 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.724 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -102.67 -27.17 12.88 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.633 HD11 ' O ' ' A' ' 61' ' ' PHE . 25.6 mm -73.01 -31.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 2.8 mp0 -80.01 -64.64 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.68 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 40.7 t0 -56.86 -30.41 63.82 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.117 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.77 ' HB ' HG11 ' A' ' 9' ' ' VAL . 8.7 p -70.52 -29.39 38.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -70.4 -58.2 3.99 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.97 -23.39 32.11 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.851 ' CE2' ' HA ' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.77 -50.62 68.32 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.835 HG21 ' CD1' ' A' ' 47' ' ' ILE . 44.0 t -65.77 -22.66 31.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.89 -1.131 . . . . 0.0 109.489 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.714 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.9 mt -87.32 -7.19 58.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.038 -1.039 . . . . 0.0 108.876 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -97.77 -40.99 8.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.018 0.913 . . . . 0.0 108.761 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.672 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -72.14 -45.14 61.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.648 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -76.36 -5.45 47.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.614 ' HB3' ' HD3' ' A' ' 83' ' ' LYS . . . -75.35 -13.54 60.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 110.489 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.614 ' HD3' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER 176.3 66.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.702 -1.249 . . . . 0.0 111.076 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 91.82 77.44 1.35 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.672 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -40.21 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.389 0.614 . . . . 0.0 110.7 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.625 ' HB2' ' OE1' ' A' ' 80' ' ' GLN . . . 48.71 21.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.875 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.047 0 CA-C-O 117.977 -1.457 . . . . 0.0 109.573 -179.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.685 HBB2 ' CD2' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 0.6 OUTLIER -111.87 -28.92 7.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.513 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.069 HD13 ' OD1' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -69.17 -8.6 47.1 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.123 -0.986 . . . . 0.0 108.554 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.43 -22.52 54.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -78.86 -37.01 41.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -62.39 -53.2 43.75 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.674 ' CA ' ' CE1' ' A' ' 76' ' ' TYR . . . -48.15 -24.83 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.016 -1.285 . . . . 0.0 109.368 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.514 ' HE3' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -73.97 -47.24 38.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.746 HG22 ' HB3' ' A' ' 69' ' ' GLN . 14.8 t -55.38 -65.03 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 122.219 1.009 . . . . 0.0 108.918 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 10.9 t80 -60.73 -28.9 69.03 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 33.0 t -89.88 18.05 6.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.556 -1.34 . . . . 0.0 109.513 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -155.56 3.54 0.2 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.88 -1.152 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -155.49 -46.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.604 -1.527 . . . . 0.0 109.56 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 3.2 m -79.65 -30.38 41.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 10' ' ' PHE . . . -53.61 -41.2 66.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.564 -0.71 . . . . 0.0 110.945 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.25 -35.5 79.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.262 -0.899 . . . . 0.0 111.151 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.709 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 1.8 m -110.95 20.08 17.87 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.879 -1.138 . . . . 0.0 110.013 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.889 ' CE1' HD21 ' A' ' 31' ' ' LEU . 89.2 m-70 -155.58 -51.37 0.08 Allowed 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.544 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.0 ptm 42.39 111.07 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.756 0.788 . . . . 0.0 111.556 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.5 ' HA2' ' CA ' ' A' ' 87' ' ' GLY . . . 49.95 57.47 9.84 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.36 72.86 0.26 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.728 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -153.83 92.49 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.456 ' H ' HG23 ' A' ' 30' ' ' THR . 1.1 t-20 -43.85 156.76 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -1.053 . . . . 0.0 109.812 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.704 HG13 HG23 ' A' ' 25' ' ' VAL . 3.3 p -115.86 -35.67 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 109.633 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.704 HG23 HG13 ' A' ' 24' ' ' VAL . 13.4 t -91.51 -68.53 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.867 . . . . 0.0 109.651 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.418 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -60.61 161.45 7.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 28' ' ' ASN . . . -117.03 63.83 0.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.905 . . . . 0.0 109.265 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 163.65 -39.47 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.208 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 2.7 mptt -71.73 83.23 0.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.938 ' O ' HD22 ' A' ' 36' ' ' LEU . 2.1 m -99.38 -168.09 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 108.816 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.936 HD23 ' C ' ' A' ' 30' ' ' THR . 0.6 OUTLIER -109.83 -2.8 17.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.677 -1.264 . . . . 0.0 109.651 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.676 ' HG2' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -60.19 -82.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.993 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.576 ' N ' HD21 ' A' ' 36' ' ' LEU . 3.2 ptmm? 168.75 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.658 -1.276 . . . . 0.0 110.936 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.72 -34.53 5.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.907 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.09 -66.44 1.02 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.84 0.828 . . . . 0.0 110.365 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.095 HD12 ' CB ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -44.75 -46.43 10.46 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.927 -0.483 . . . . 0.0 111.846 -178.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.474 ' HA ' ' CD1' ' A' ' 42' ' ' TYR . 43.4 tt0 -60.94 -34.63 75.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.569 -1.332 . . . . 0.0 110.333 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 3.2 mm-40 -73.81 -77.9 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -93.17 7.57 43.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.524 -0.735 . . . . 0.0 111.851 -177.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 36' ' ' LEU . . . -124.88 -3.62 7.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 1.051 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 2.9 mtt 42.57 48.38 4.64 Favored 'General case' 0 C--O 1.196 -1.739 0 O-C-N 121.241 -1.152 . . . . 0.0 109.527 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.095 ' CB ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -39.01 -21.81 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 O-C-N 120.912 -1.117 . . . . 0.0 111.368 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.771 ' O ' HG22 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -42.45 166.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.773 -1.204 . . . . 0.0 110.508 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' N ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -52.64 -73.18 0.04 OUTLIER 'General case' 0 C--O 1.2 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 110.579 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 44' ' ' GLU . 33.5 t0 -36.72 -51.33 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.209 -0.932 . . . . 0.0 112.492 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.051 ' HB3' ' O ' ' A' ' 41' ' ' MET . . . -63.35 -73.25 0.12 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.762 -1.211 . . . . 0.0 111.204 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.801 HD12 HMA1 ' A' ' 88' ' ' HEC . 14.0 tt -51.0 -20.55 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.016 -1.052 . . . . 0.0 109.677 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.626 HG23 HE22 ' A' ' 52' ' ' GLN . 14.0 mt -72.12 -38.25 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.626 -0.671 . . . . 0.0 109.445 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -77.44 -26.79 51.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.607 ' O ' ' HE2' ' A' ' 58' ' ' MET . 3.5 pm0 -89.13 -18.86 26.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.213 -1.554 . . . . 0.0 108.702 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 47' ' ' ILE . 45.3 t -85.78 -44.8 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.942 0.877 . . . . 0.0 109.389 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.626 HE22 HG23 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -66.74 -10.69 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.821 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.622 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -158.65 23.29 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.71 -1.196 . . . . 0.0 108.612 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.563 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 55.89 -141.34 39.98 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 154.23 142.5 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 54.98 -90.56 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -130.12 49.0 2.33 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.61 ' CG ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 ttt -121.04 144.6 39.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.61 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.9 Cg_endo -82.54 105.21 1.39 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 123.077 2.518 . . . . 0.0 113.67 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.622 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -39.45 154.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 110.677 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.781 ' HB3' HD12 ' A' ' 70' ' ' ILE . 23.0 m-85 -136.72 3.46 2.74 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 52' ' ' GLN . . . -44.36 -29.67 0.71 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.76 36.64 0.51 Allowed Glycine 0 N--CA 1.486 1.971 0 C-N-CA 119.095 -1.526 . . . . 0.0 109.805 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HB3' ' HD1' ' A' ' 61' ' ' PHE . 10.7 ttt-85 -102.0 -48.34 4.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' A' ' 61' ' ' PHE . 1.6 mt -93.68 -146.03 0.24 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.57 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -84.73 -172.94 4.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' H ' HG22 ' A' ' 66' ' ' THR . 3.6 m-20 -93.45 -55.74 3.18 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.9 mt-10 -72.36 5.61 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.746 ' HB3' HG22 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -102.34 -31.85 10.31 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 61' ' ' PHE . 2.2 mm -72.24 -26.06 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -66.73 0.86 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.774 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 1.069 ' OD1' HD13 ' A' ' 3' ' ' LEU . 53.9 t0 -58.61 -28.47 65.65 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.128 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 7.9 p -69.14 -26.73 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -75.18 -56.75 4.42 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -60.06 -19.62 53.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.025 ' HA ' HD12 ' A' ' 3' ' ' LEU . 78.6 t80 -67.85 -41.09 83.46 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.571 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 39.9 t -70.04 -22.61 24.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.567 HD11 ' N ' ' A' ' 44' ' ' GLU . 0.9 OUTLIER -85.39 -8.46 58.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 1.8 t70 -99.02 -35.52 10.02 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.946 0.879 . . . . 0.0 109.16 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.661 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 7.2 mm-40 -81.96 -34.01 29.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.233 0.54 . . . . 0.0 109.942 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -62.92 -48.16 80.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.852 . . . . 0.0 109.101 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.52 18.54 3.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.445 -0.784 . . . . 0.0 109.358 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -134.86 13.38 3.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 0.0 110.963 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 77.74 75.73 0.93 Allowed Glycine 0 C--N 1.296 -1.694 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.661 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 11.7 m95 -34.76 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.727 0.775 . . . . 0.0 109.417 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -59.09 -22.78 61.34 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 109.969 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.5 ' CA ' ' HA2' ' A' ' 20' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.801 HMA1 HD12 ' A' ' 47' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 1.7 m-20 73.13 -0.24 3.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.306 -0.871 . . . . 0.0 109.897 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.02 HD13 ' HA ' ' A' ' 76' ' ' TYR . 1.8 pp -72.88 2.21 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.074 -1.016 . . . . 0.0 109.613 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.14 70.55 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -62.86 -25.65 68.39 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -59.55 -51.2 60.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.714 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -45.54 -25.45 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.714 -1.463 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -75.0 -47.82 27.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 177.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.662 ' CG2' ' HG3' ' A' ' 69' ' ' GLN . 21.1 t -55.44 -64.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 121.948 0.88 . . . . 0.0 109.01 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.606 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 11.6 t80 -59.82 -31.79 70.05 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.768 -0.582 . . . . 0.0 111.11 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 43.1 p -88.53 18.69 4.38 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.788 -1.195 . . . . 0.0 109.653 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -155.7 3.74 0.2 Allowed Glycine 0 N--CA 1.485 1.918 0 C-N-CA 119.769 -1.205 . . . . 0.0 111.577 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 9' ' ' VAL . 1.1 m-80 -155.16 -49.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.631 -1.511 . . . . 0.0 109.409 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.65 ' SG ' HMB1 ' A' ' 88' ' ' HEC . 3.4 m -71.96 -34.99 69.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -44.99 -42.78 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 110.449 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.87 74.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.187 -0.946 . . . . 0.0 111.706 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.627 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 95.9 m -104.19 27.18 7.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.885 -1.134 . . . . 0.0 109.87 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.914 ' CE1' HD21 ' A' ' 31' ' ' LEU . 85.7 m-70 -159.89 -67.92 0.07 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.614 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.512 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 55.76 114.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.45 -0.781 . . . . 0.0 110.092 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.32 61.73 1.71 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.491 ' O ' ' HD3' ' A' ' 32' ' ' LYS . . . 44.82 79.62 0.06 OUTLIER Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -160.81 83.35 0.13 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.772 ' H ' HG23 ' A' ' 30' ' ' THR . 5.1 t-20 -40.51 160.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.611 -0.935 . . . . 0.0 109.586 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.604 HG13 ' N ' ' A' ' 25' ' ' VAL . 14.7 p -116.3 -47.04 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.09 -1.006 . . . . 0.0 110.138 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.786 ' CG1' HMD3 ' A' ' 88' ' ' HEC . 9.1 p -95.82 -38.52 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -96.56 115.99 28.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.73 -1.231 . . . . 0.0 109.441 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -90.19 71.87 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.6 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER 177.6 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.378 -0.826 . . . . 0.0 109.049 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 5.5 mtmm -93.43 61.56 3.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.283 -0.886 . . . . 0.0 109.311 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.772 HG23 ' H ' ' A' ' 23' ' ' ASN . 5.1 m -85.17 166.2 16.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.507 -0.746 . . . . 0.0 109.526 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.914 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -94.26 -12.22 28.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.595 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -37.37 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.587 -0.695 . . . . 0.0 111.182 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.074 ' CA ' HD21 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -165.74 -43.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.122 . . . . 0.0 110.386 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 mt-10 -67.31 -47.52 70.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.594 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -65.84 -45.97 80.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.675 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.074 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -62.63 -36.17 81.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' A' ' 33' ' ' LYS . 8.8 mt-10 -92.28 5.87 48.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.195 -0.941 . . . . 0.0 109.394 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.0 tp-100 -90.55 -55.6 3.52 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.594 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.71 -50.7 6.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.031 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.15 33.65 0.15 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.387 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.864 ' CE ' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -86.05 -25.85 25.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.647 -1.502 . . . . 0.0 108.562 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.786 ' CD2' HD12 ' A' ' 36' ' ' LEU . 8.2 t80 -41.86 -23.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.852 -0.53 . . . . 0.0 110.654 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 41' ' ' MET . 22.8 p -84.42 134.82 34.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.873 -1.142 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 48' ' ' ILE . 2.7 mt-10 -49.02 -54.94 13.59 Favored 'General case' 0 C--O 1.198 -1.627 0 O-C-N 121.51 -0.744 . . . . 0.0 109.524 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -52.26 -32.9 39.33 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.667 -1.27 . . . . 0.0 110.692 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' HB1' ' HA ' ' A' ' 41' ' ' MET . . . -67.72 -69.66 0.3 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.97 . . . . 0.0 111.152 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.672 ' CD1' HMA1 ' A' ' 88' ' ' HEC . 7.5 tt -66.76 -19.33 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.4 -0.812 . . . . 0.0 109.817 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.573 HG13 ' CB ' ' A' ' 74' ' ' ALA . 12.5 mt -68.04 -25.64 32.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.656 ' CD1' ' CD2' ' A' ' 53' ' ' HIS . 63.6 t80 -86.97 -68.65 0.73 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.547 ' CG ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -44.19 -25.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.515 -1.366 . . . . 0.0 108.825 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.909 ' CG1' HG23 ' A' ' 70' ' ' ILE . 55.8 t -80.36 -46.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 108.669 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.624 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -65.52 -13.23 58.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 111.954 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -154.57 20.02 0.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.446 -1.408 . . . . 0.0 108.515 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 56.41 -140.52 42.86 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.598 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 153.51 133.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 7.7 m-80 60.78 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.808 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -129.38 43.32 3.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.657 ' HE2' ' HA ' ' A' ' 51' ' ' VAL . 19.9 ttt -117.98 145.95 37.95 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.482 -0.761 . . . . 0.0 109.498 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.636 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 36.2 Cg_endo -81.83 101.63 1.18 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 123.373 2.715 . . . . 0.0 114.517 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.643 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.5 156.26 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.79 ' CZ ' HBB3 ' A' ' 88' ' ' HEC . 39.2 m-85 -137.02 3.74 2.68 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.596 -0.69 . . . . 0.0 109.434 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.39 -25.8 0.16 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.214 -0.929 . . . . 0.0 109.45 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -162.85 33.65 0.31 Allowed Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -102.4 -46.57 4.74 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.628 HD11 ' CE1' ' A' ' 61' ' ' PHE . 73.8 mt -103.25 -145.72 0.37 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.605 HG21 ' OE1' ' A' ' 69' ' ' GLN . 9.2 m -98.47 167.41 10.83 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.367 -0.833 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 66' ' ' THR . 16.1 m-20 -82.7 -49.9 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.205 -0.934 . . . . 0.0 109.134 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.553 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 4.0 tt0 -64.63 -6.86 8.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.631 -0.668 . . . . 0.0 109.273 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.662 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -96.01 -35.77 11.27 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.909 HG23 ' CG1' ' A' ' 51' ' ' VAL . 3.8 mm -72.21 -11.54 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -66.97 0.87 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.296 1.046 . . . . 0.0 108.623 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.715 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 48.7 m-20 -53.4 -37.87 62.88 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.371 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.671 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 p -67.96 -28.98 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.55 0.691 . . . . 0.0 109.508 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.96 -59.31 2.79 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.47 -21.3 51.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.02 ' HA ' HD13 ' A' ' 3' ' ' LEU . 88.8 t80 -66.4 -42.49 87.79 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.864 HG11 ' CE ' ' A' ' 41' ' ' MET . 48.8 t -70.35 -22.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.719 ' N ' HD23 ' A' ' 78' ' ' LEU . 2.2 mt -81.26 -7.75 59.63 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.606 ' OD2' HD21 ' A' ' 3' ' ' LEU . 5.6 t0 -99.42 -47.38 5.17 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.069 0.937 . . . . 0.0 108.952 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.666 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 66.7 mm-40 -69.48 -39.89 77.4 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -59.97 -45.78 91.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 109.187 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.18 13.73 12.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 110.583 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -137.26 19.16 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.683 -1.261 . . . . 0.0 111.603 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.98 73.15 1.28 Allowed Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.142 -1.504 . . . . 0.0 109.366 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.666 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 1.9 m95 -40.83 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 122.316 -0.52 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 48.56 34.85 5.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.039 -1.038 . . . . 0.0 109.574 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 CA-C-O 118.009 -1.44 . . . . 0.0 109.584 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.808 HMD2 ' O ' ' A' ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.311 0.576 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.77 -25.17 4.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.472 HD13 ' CG ' ' A' ' 79' ' ' ASP . 1.3 mt -68.28 -5.86 20.82 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.153 -0.967 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.3 70.61 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.506 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -73.97 -30.7 62.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -58.97 -59.8 10.09 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.828 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -52.31 -28.86 20.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.761 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.519 ' HE3' ' OE1' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -62.51 -43.49 98.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.92 HG21 ' CB ' ' A' ' 69' ' ' GLN . 4.1 t -77.92 -49.61 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.444 -0.785 . . . . 0.0 109.815 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.609 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 5.1 t80 -60.57 -23.57 64.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.698 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 40.2 p -87.95 19.74 3.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.66 3.95 0.64 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.83 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.456 ' ND2' HD22 ' A' ' 65' ' ' LEU . 29.9 m-80 -147.58 -48.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.745 -1.444 . . . . 0.0 109.535 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.609 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 1.9 m -78.98 -29.52 43.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 0.0 108.692 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -46.84 -40.11 13.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.655 -0.653 . . . . 0.0 110.009 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -42.42 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.011 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 80.2 m -116.67 32.9 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.425 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.593 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 67.0 m-70 -163.9 -76.83 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.257 -0.902 . . . . 0.0 109.153 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.501 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 52.04 114.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.493 0.663 . . . . 0.0 110.755 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 50.13 55.42 15.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 40.78 81.58 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -165.44 96.79 0.13 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.05 150.33 25.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -1.107 . . . . 0.0 109.399 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 m -118.68 -14.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.602 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.481 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 11.0 t -101.12 -68.68 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.7 mmt -76.75 140.95 40.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.821 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -100.73 62.71 1.03 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.13 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.1 p30 179.24 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.312 -0.867 . . . . 0.0 109.819 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HD3' HAD2 ' A' ' 88' ' ' HEC . 2.7 mttt -80.81 75.06 7.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.707 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 31' ' ' LEU . 3.0 m -89.78 175.07 7.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.781 ' O ' HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -102.22 -17.58 15.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.482 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.729 ' C ' HD21 ' A' ' 36' ' ' LEU . 2.7 mtpm? -48.18 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.717 -0.615 . . . . 0.0 111.955 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.879 ' CA ' HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -165.08 -45.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.689 -1.257 . . . . 0.0 111.003 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 3.6 mm-40 -61.83 -14.18 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 111.157 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -105.73 -45.74 4.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.969 -1.082 . . . . 0.0 110.695 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.879 HD21 ' CA ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -61.9 -33.83 74.94 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.279 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.582 ' OE1' ' CD2' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -89.96 -4.0 57.71 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.619 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.551 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -77.14 -59.68 2.68 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -87.25 -51.54 5.91 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.995 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 46' ' ' ALA . . . 141.18 24.32 0.23 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.948 -1.596 . . . . 0.0 111.672 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.881 ' CE ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -74.91 -20.05 59.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.556 -1.555 . . . . 0.0 108.321 178.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.83 ' CD2' HD12 ' A' ' 36' ' ' LEU . 6.9 t80 -46.83 -22.16 0.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.715 -0.616 . . . . 0.0 109.519 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.679 ' OG ' ' HB2' ' A' ' 46' ' ' ALA . 50.8 p -90.26 129.79 36.46 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.17 -0.956 . . . . 0.0 110.192 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -43.38 -62.78 0.97 Allowed 'General case' 0 C--O 1.202 -1.425 0 O-C-N 121.624 -0.672 . . . . 0.0 109.361 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -49.23 -35.98 18.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.01 . . . . 0.0 110.855 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB2' ' OG ' ' A' ' 43' ' ' SER . . . -61.73 -78.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.918 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.2 tt -58.91 -16.68 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 O-C-N 121.423 -0.798 . . . . 0.0 110.252 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 44' ' ' GLU . 10.1 mt -70.45 -37.53 70.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 29.5 t80 -83.31 -18.3 39.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -89.49 -10.78 45.03 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 47' ' ' ILE . 70.1 t -98.56 -50.14 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.864 . . . . 0.0 109.562 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.803 ' OE1' HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -58.55 -12.36 3.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.649 -0.657 . . . . 0.0 110.55 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.632 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -146.18 16.27 1.35 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.625 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 52.93 -121.25 14.89 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HB2' ' OE1' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 162.24 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.761 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.035 178.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 55' ' ' LYS . 51.8 m-80 -20.02 -49.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.724 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -148.3 20.26 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 109.765 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.673 ' HE2' ' HA ' ' A' ' 51' ' ' VAL . 23.5 ttt -102.15 145.16 30.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 108.866 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.664 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 33.6 Cg_endo -79.7 111.7 2.81 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.824 2.349 . . . . 0.0 113.603 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -37.58 160.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.525 -0.734 . . . . 0.0 110.25 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.633 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 32.4 m-85 -142.44 16.11 2.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 108.98 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.23 -23.05 0.77 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.436 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.47 31.27 0.7 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.633 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -103.65 -56.9 2.12 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.025 HD11 HBB1 ' A' ' 88' ' ' HEC . 18.2 mt -61.82 -144.64 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 14.9 m -99.04 -63.24 1.14 Allowed 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.258 -0.901 . . . . 0.0 109.955 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.5 m-20 152.94 -56.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.6 tt0 -71.4 -0.01 9.27 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.92 ' CB ' HG21 ' A' ' 9' ' ' VAL . 2.4 mp0 -114.07 -24.32 9.08 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.803 HG21 ' OE1' ' A' ' 52' ' ' GLN . 9.8 mm -56.48 -21.74 13.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 172.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.9 mp0 -97.8 -68.3 0.81 Allowed 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.595 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.669 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 3.4 m-20 -51.22 -46.86 62.37 Favored 'General case' 0 C--O 1.199 -1.573 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.99 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -56.93 -29.1 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.626 -0.671 . . . . 0.0 110.042 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -80.15 -64.22 1.24 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -50.36 -23.05 2.1 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.493 -1.379 . . . . 0.0 107.323 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.828 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 17.1 t80 -66.5 -47.59 72.51 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.881 HG21 ' CE ' ' A' ' 41' ' ' MET . 1.8 p -68.11 -16.98 21.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 42' ' ' TYR . 5.1 mt -81.52 -15.74 53.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.472 ' CG ' HD13 ' A' ' 3' ' ' LEU . 1.2 t70 -97.95 -34.93 10.63 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.948 0.88 . . . . 0.0 108.899 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.749 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 2.3 mm-40 -83.54 -39.04 20.92 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.746 0.784 . . . . 0.0 110.035 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -51.45 -33.59 31.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.352 -0.842 . . . . 0.0 109.073 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -80.87 -28.79 35.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER 176.33 -24.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.155 -0.966 . . . . 0.0 111.0 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.728 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -61.18 -13.13 34.04 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.749 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 2.5 m95 -64.13 89.2 0.06 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -46.12 -25.92 0.67 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.222 -0.924 . . . . 0.0 108.913 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.067 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.471 179.809 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 1.025 HBB1 HD11 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -124.37 -22.13 4.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.409 -0.807 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 72' ' ' ASP . 6.5 mt -68.64 -7.19 30.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.182 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.02 67.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -71.94 -39.38 69.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.204 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 5' ' ' ASN . . . -47.39 -56.45 8.15 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.748 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -52.43 -38.66 59.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.264 . . . . 0.0 109.281 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.804 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -56.82 -40.51 76.14 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.94 HG21 ' CG ' ' A' ' 69' ' ' GLN . 38.6 t -80.69 -69.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.496 -0.752 . . . . 0.0 109.485 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 22.7 t80 -41.74 -25.31 0.05 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.389 -0.82 . . . . 0.0 111.257 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 63.7 m -92.1 32.92 1.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.02 -1.05 . . . . 0.0 109.464 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.57 -29.68 0.02 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.123 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.552 ' ND2' HG13 ' A' ' 9' ' ' VAL . 1.6 m-80 -116.75 -48.85 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.919 -1.342 . . . . 0.0 108.702 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -77.39 -27.42 52.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.783 ' HB1' ' HG3' ' A' ' 19' ' ' MET . . . -54.01 -31.35 50.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.563 -0.71 . . . . 0.0 110.163 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.35 85.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 110.99 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.605 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.5 m -111.0 26.31 10.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 110.413 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 97.8 m-70 -156.94 -74.7 0.09 Allowed 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.321 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.783 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 46.11 105.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.403 0.621 . . . . 0.0 111.096 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 78.13 42.31 15.88 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.522 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 42.25 37.07 2.27 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.92 90.6 0.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' HB3' ' CG ' ' A' ' 26' ' ' MET . 3.6 t-20 -49.38 168.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -1.075 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.703 HG23 ' H ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -144.07 -69.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.033 -1.042 . . . . 0.0 110.35 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.885 HG13 HMD3 ' A' ' 88' ' ' HEC . 1.2 p -44.24 -40.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.053 -1.029 . . . . 0.0 109.837 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.533 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -56.36 -168.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.919 -1.113 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -121.65 4.29 10.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.471 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 178.15 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.945 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.608 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -51.79 137.56 25.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.263 -179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.692 HG22 ' H ' ' A' ' 31' ' ' LEU . 4.0 m -123.64 179.93 4.6 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.399 -0.813 . . . . 0.0 109.198 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.692 ' H ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -100.66 -15.7 17.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.984 -1.073 . . . . 0.0 109.165 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.71 ' C ' HD21 ' A' ' 36' ' ' LEU . 5.2 mtpm? -56.45 -92.35 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.897 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.047 ' N ' HD21 ' A' ' 36' ' ' LEU . 3.9 pttm -179.41 -31.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.946 -1.096 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 23.1 pt-20 -47.42 -37.16 10.99 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.661 -0.65 . . . . 0.0 109.914 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.607 ' HA ' ' HB2' ' A' ' 38' ' ' GLN . . . -108.32 -61.14 1.63 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.77 -0.581 . . . . 0.0 111.161 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.047 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -40.68 -32.65 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.335 -0.853 . . . . 0.0 109.035 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.582 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -93.15 -33.31 14.08 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 120.962 -1.086 . . . . 0.0 108.637 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 7.0 tp60 -40.73 -31.55 0.17 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.5 1.143 . . . . 0.0 108.254 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.608 ' CE2' ' HG3' ' A' ' 29' ' ' LYS . 3.8 m-85 -84.96 -50.99 7.02 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.5 ' C ' ' CG ' ' A' ' 41' ' ' MET . . . 127.68 64.37 0.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.616 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -171.39 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.97 -1.312 . . . . 0.0 110.675 -178.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.66 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 2.5 t80 -92.48 23.48 3.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.02 . . . . 0.0 108.632 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 54.3 p -104.58 165.67 10.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.628 -1.295 . . . . 0.0 110.338 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.523 ' O ' HG13 ' A' ' 48' ' ' ILE . 4.3 mt-10 -48.63 -70.51 0.09 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -50.05 -21.42 1.25 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.589 -1.319 . . . . 0.0 110.495 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -75.45 -73.59 0.25 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.204 -0.935 . . . . 0.0 110.39 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.3 tt -63.24 -14.1 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.845 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 44' ' ' GLU . 44.4 mt -74.6 -32.52 29.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.582 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 36.0 t80 -94.32 -15.52 24.36 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 1.5 tp60 -91.14 -10.28 42.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 47' ' ' ILE . 54.7 t -103.66 -44.97 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.712 0.768 . . . . 0.0 109.275 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.807 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -61.24 -12.23 12.41 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.34 0.591 . . . . 0.0 110.459 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.649 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -151.75 20.55 0.7 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -178.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.62 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 59.77 -132.44 51.21 Favored Glycine 0 C--N 1.3 -1.42 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.52 139.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 121.388 0.614 . . . . 0.0 109.423 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 53.21 -88.52 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -127.55 43.29 3.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.982 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.671 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 11.1 ttt -126.14 143.37 45.48 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 0.0 109.367 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.793 ' HD3' HBC3 ' A' ' 88' ' ' HEC . 30.9 Cg_endo -76.64 120.55 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.108 2.539 . . . . 0.0 114.406 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -40.93 165.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.641 -0.662 . . . . 0.0 109.707 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.764 ' CD1' HD21 ' A' ' 65' ' ' LEU . 23.5 m-85 -145.77 11.53 1.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.177 -0.952 . . . . 0.0 109.842 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.35 -19.27 5.19 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.095 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.7 24.68 1.49 Allowed Glycine 0 N--CA 1.486 1.993 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.83 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.671 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt180 -101.93 -39.31 7.41 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.987 HD11 HBB1 ' A' ' 88' ' ' HEC . 2.4 mt -102.83 -154.12 0.49 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.496 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 67' ' ' ASP . 51.5 m -101.48 174.12 6.12 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.623 ' N ' HG22 ' A' ' 66' ' ' THR . 5.6 m-20 -72.6 -57.62 4.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.822 -1.174 . . . . 0.0 108.129 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 33.4 mt-10 -63.59 3.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.94 ' CG ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -104.51 -42.75 5.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.807 HG21 ' HG3' ' A' ' 52' ' ' GLN . 8.7 mm -56.65 -19.14 8.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -95.86 -73.56 0.59 Allowed 'General case' 0 C--O 1.205 -1.246 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 78.5 m-20 -39.63 -53.25 2.17 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.586 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.789 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 4.0 t -60.1 -42.28 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 122.434 1.112 . . . . 0.0 109.069 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -59.07 -65.85 0.6 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.301 -1.499 . . . . 0.0 107.211 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.581 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.0 -17.94 20.65 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.789 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 78.2 t80 -65.12 -40.67 94.82 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.684 HG21 HD11 ' A' ' 47' ' ' ILE . 96.8 t -74.65 -24.71 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.727 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -86.68 -8.8 57.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 7.3 t0 -99.54 -36.02 9.67 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.031 0.919 . . . . 0.0 109.186 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.618 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 5.4 mm-40 -79.76 -42.24 24.92 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.43 0.634 . . . . 0.0 109.708 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' HA ' ' A' ' 32' ' ' LYS . . . -74.79 -18.89 60.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.394 -0.816 . . . . 0.0 109.358 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.66 6.52 7.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.626 -0.671 . . . . 0.0 110.587 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.81 48.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.501 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 84.93 78.26 1.15 Allowed Glycine 0 N--CA 1.481 1.643 0 C-N-CA 118.643 -1.742 . . . . 0.0 109.215 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.631 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -36.02 90.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.578 0.704 . . . . 0.0 109.677 178.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -63.1 -39.97 96.25 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.669 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.034 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.987 HBB1 HD11 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.12 -20.46 3.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.314 -0.866 . . . . 0.0 110.027 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 79' ' ' ASP . 2.0 mp -70.39 -3.25 16.65 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.017 -1.052 . . . . 0.0 109.105 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.78 -33.97 77.09 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.524 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -67.64 -25.43 65.72 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.59 -63.26 4.6 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.853 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -51.47 -33.13 29.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 0.0 109.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.472 ' NZ ' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.49 -41.78 86.1 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 108.834 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.879 HG21 ' CB ' ' A' ' 69' ' ' GLN . 2.7 t -79.05 -51.85 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 10.4 t80 -54.72 -24.38 21.89 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.045 -1.034 . . . . 0.0 110.455 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -89.8 24.97 2.19 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.443 -0.786 . . . . 0.0 109.367 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.21 11.67 0.19 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.887 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.502 ' ND2' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -153.23 -40.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.78 -1.424 . . . . 0.0 109.236 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -93.37 -31.06 14.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 108.827 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -42.26 -45.77 4.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.32 84.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 110.535 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.602 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 59.6 m -111.44 28.23 8.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.978 -1.076 . . . . 0.0 110.23 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.93 ' CE1' HD21 ' A' ' 31' ' ' LEU . 76.8 m-70 -161.56 -73.81 0.06 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.246 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 55.24 114.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.745 -0.597 . . . . 0.0 110.574 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 40.19 62.8 1.45 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 42.62 65.88 1.24 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -150.26 69.37 0.32 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 20.7 p30 -48.01 166.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.099 -1.236 . . . . 0.0 109.202 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 25' ' ' VAL . 3.1 m -128.86 -37.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.956 -1.09 . . . . 0.0 109.908 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.532 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 2.4 t -82.67 -40.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.09 -1.006 . . . . 0.0 109.199 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.661 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.2 mpp? -61.23 -56.94 14.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.353 -0.842 . . . . 0.0 109.524 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 26' ' ' MET . . . 74.38 27.25 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -179.34 -35.92 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HG2' ' CE2' ' A' ' 39' ' ' PHE . 1.3 mtmp? -90.34 57.01 3.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 109.499 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.743 ' C ' HD23 ' A' ' 31' ' ' LEU . 4.9 m -67.51 178.33 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.93 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.8 OUTLIER -98.99 -8.98 24.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.71 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -45.88 -76.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.886 -1.134 . . . . 0.0 110.481 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.06 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 167.55 -43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 109.844 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 21.6 pt-20 -56.35 -25.99 51.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.216 -0.927 . . . . 0.0 110.415 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.853 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -101.85 -59.65 1.67 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.06 HD21 ' N ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -48.52 -31.8 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.01 -1.056 . . . . 0.0 109.774 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.578 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 38.5 mt-10 -91.42 -23.62 19.98 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.536 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.548 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.6 tp-100 -61.67 -42.04 98.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.853 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -89.8 -76.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.873 0.844 . . . . 0.0 109.005 178.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.42 84.92 0.05 OUTLIER Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.498 ' CE ' HAA2 ' A' ' 88' ' ' HEC . 5.2 ptt? -168.26 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -1.22 . . . . 0.0 109.617 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.008 ' HB2' HD12 ' A' ' 36' ' ' LEU . 7.1 t80 -103.2 19.26 19.94 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.151 -0.968 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -105.77 144.09 32.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.217 -0.927 . . . . 0.0 110.611 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.732 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -45.6 -65.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.778 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.463 ' N ' HD12 ' A' ' 48' ' ' ILE . 64.3 t0 -49.4 -31.84 10.41 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.826 -1.171 . . . . 0.0 110.748 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -64.78 -78.54 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.725 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.4 tt -57.98 -16.19 6.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.552 0.692 . . . . 0.0 110.211 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.732 HD12 ' C ' ' A' ' 44' ' ' GLU . 23.2 mt -71.67 -38.53 67.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.615 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 33.3 t80 -86.38 -11.55 51.71 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -95.88 -12.88 24.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 47' ' ' ILE . 56.4 t -102.58 -37.19 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.033 0.921 . . . . 0.0 109.474 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.719 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -66.2 -11.17 48.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.738 ' HA ' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -164.93 38.34 0.07 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.681 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 44.74 -133.42 7.37 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.08 125.95 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.587 -0.807 . . . . 0.0 108.846 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 73.6 m-80 65.04 -85.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.543 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.629 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -126.0 37.58 4.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 0.0 109.594 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.698 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 26.6 ttt -116.3 142.28 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 108.796 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.698 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.1 Cg_endo -71.24 103.44 1.4 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.873 2.382 . . . . 0.0 113.451 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.738 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -58.79 107.55 0.53 Allowed 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.866 -0.521 . . . . 0.0 110.385 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.838 ' CD2' HD21 ' A' ' 65' ' ' LEU . 75.5 m-85 -77.1 -41.06 43.6 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.884 -1.135 . . . . 0.0 108.259 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.26 19.14 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.674 -0.641 . . . . 0.0 109.493 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 61' ' ' PHE . . . 122.37 44.28 0.36 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 65' ' ' LEU . 15.6 ttt-85 -102.48 -54.0 2.77 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.839 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -62.07 -146.39 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 69' ' ' GLN . 78.8 m -97.42 154.22 17.61 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.907 ' HA ' HD12 ' A' ' 70' ' ' ILE . 7.7 t0 -63.24 -53.68 49.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.944 -1.097 . . . . 0.0 108.303 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 tt0 -64.76 1.57 0.85 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.003 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.879 ' CB ' HG21 ' A' ' 9' ' ' VAL . 2.2 mp0 -115.34 -25.47 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.145 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.907 HD12 ' HA ' ' A' ' 67' ' ' ASP . 3.7 mt -59.24 -19.95 17.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' C ' ' A' ' 69' ' ' GLN . 3.1 mp0 -97.51 -67.0 0.87 Allowed 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 114.546 -1.207 . . . . 0.0 108.332 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.698 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 18.4 m-20 -52.74 -46.08 67.29 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.001 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -56.51 -27.88 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 109.919 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.655 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -81.69 -63.48 1.38 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.23 -22.29 2.59 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.853 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 23.0 t80 -67.93 -46.82 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.826 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.669 HG23 ' HZ2' ' A' ' 85' ' ' TRP . 1.5 p -68.77 -15.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.557 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 4.8 mt -84.28 -14.78 48.89 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.429 ' HB2' HD22 ' A' ' 3' ' ' LEU . 9.4 t0 -96.91 -39.63 9.3 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.763 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 1.2 mm-40 -80.02 -38.31 32.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.891 0.853 . . . . 0.0 109.411 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 32' ' ' LYS . . . -52.26 -30.18 26.56 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . -87.55 -25.38 23.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 110.153 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 176.61 -24.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.077 -1.014 . . . . 0.0 111.059 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.733 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . -65.24 -12.47 55.5 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.763 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 3.3 m95 -64.81 88.57 0.07 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -48.76 -24.42 1.4 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.324 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.131 0 CA-C-O 117.997 -1.446 . . . . 0.0 109.664 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.629 HMD2 ' O ' ' A' ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.445 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 1.0 OUTLIER 71.52 6.32 5.69 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.24 -0.913 . . . . 0.0 109.461 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 72' ' ' ASP . 5.9 mt -76.19 -0.67 23.02 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.172 -0.955 . . . . 0.0 109.33 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.1 t-20 -70.1 -27.36 64.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 7' ' ' ALA . . . -59.6 -65.38 3.47 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -43.13 -33.11 0.82 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -1.161 . . . . 0.0 109.445 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HE3' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -65.26 -50.77 64.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.861 HG21 ' CB ' ' A' ' 69' ' ' GLN . 3.2 t -67.54 -59.89 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.266 -0.896 . . . . 0.0 108.692 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.639 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 9.2 t80 -50.28 -26.78 5.15 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 13.1 t -85.87 25.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.241 -0.912 . . . . 0.0 109.741 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.39 13.36 0.1 OUTLIER Glycine 0 N--CA 1.484 1.874 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.998 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.803 ' CG ' HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.57 -48.76 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 109.381 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.639 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.3 m -81.97 -28.81 32.47 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.531 -0.73 . . . . 0.0 109.429 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -43.39 -41.29 4.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.476 -0.765 . . . . 0.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.7 -50.32 68.58 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.124 -0.985 . . . . 0.0 111.233 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 7.8 m -109.81 23.92 13.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.831 -1.168 . . . . 0.0 110.46 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 95.5 m-70 -156.16 -70.32 0.11 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.452 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.518 ' O ' ' O ' ' A' ' 18' ' ' HIS . 15.3 ptt? 38.72 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.514 ' HA2' ' HA3' ' A' ' 87' ' ' GLY . . . 80.07 49.28 6.04 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB2' ' A' ' 31' ' ' LEU . . . 37.63 36.15 0.26 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.75 95.69 0.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.576 ' OD1' ' CE1' ' A' ' 18' ' ' HIS . 3.7 t-20 -57.71 -176.9 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.273 -1.134 . . . . 0.0 109.441 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -156.93 -78.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 109.793 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.894 HG13 HMD3 ' A' ' 88' ' ' HEC . 1.4 p -41.58 -39.99 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 110.044 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.553 ' CG ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -54.1 -166.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.024 -1.047 . . . . 0.0 109.746 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -126.34 2.15 7.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.013 -1.055 . . . . 0.0 109.919 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 178.89 -31.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.07 -1.018 . . . . 0.0 110.299 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' HD3' HAD2 ' A' ' 88' ' ' HEC . 1.0 OUTLIER -58.62 122.83 14.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 -179.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 31' ' ' LEU . 5.9 m -124.03 175.94 6.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.679 ' H ' HG22 ' A' ' 30' ' ' THR . 2.1 mp -99.52 -9.92 22.73 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.818 -0.551 . . . . 0.0 111.138 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.825 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -56.38 -102.32 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.292 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' N ' HD21 ' A' ' 36' ' ' LEU . 19.8 ptmt -155.74 -43.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.48 -1.388 . . . . 0.0 109.803 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 7.2 pt-20 -63.64 -40.51 97.06 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 110.636 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.582 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -79.22 -52.17 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 111.482 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -65.32 -11.48 42.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.718 -1.238 . . . . 0.0 108.468 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.608 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -119.67 -1.61 10.57 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.273 -0.892 . . . . 0.0 108.777 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.539 ' CB ' ' O ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -65.45 -48.32 73.12 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.602 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -86.48 -31.62 21.24 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.22 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.561 ' O ' ' CB ' ' A' ' 41' ' ' MET . . . 117.29 99.38 2.05 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.648 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.582 ' SD ' ' CE1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 156.42 46.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.852 -0.793 . . . . 0.0 108.987 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.8 ' HA ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -104.79 18.78 21.68 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.976 0.893 . . . . 0.0 108.853 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 47' ' ' ILE . 53.6 p -105.17 166.31 10.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.131 -0.981 . . . . 0.0 110.604 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.556 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 6.8 mt-10 -48.4 -59.9 3.1 Favored 'General case' 0 C--O 1.199 -1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 109.503 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -57.05 -25.94 59.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.588 -1.32 . . . . 0.0 110.976 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 41' ' ' MET . . . -69.31 -70.21 0.29 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.973 -1.079 . . . . 0.0 110.466 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.72 HD12 HMA1 ' A' ' 88' ' ' HEC . 5.4 tt -63.0 -27.4 43.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 121.859 0.838 . . . . 0.0 109.262 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.569 HG13 ' CB ' ' A' ' 74' ' ' ALA . 31.2 mt -64.86 -22.38 31.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.686 -0.634 . . . . 0.0 109.343 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.44 ' O ' ' HD2' ' A' ' 53' ' ' HIS . 38.1 t80 -91.93 -56.7 2.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.912 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.54 HE21 HMA2 ' A' ' 88' ' ' HEC . 5.7 pm0 -59.68 -14.46 14.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.201 -1.562 . . . . 0.0 109.186 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.71 HG12 ' HB2' ' A' ' 61' ' ' PHE . 57.4 t -101.27 -41.09 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.284 -0.885 . . . . 0.0 110.712 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.569 ' HG2' HG21 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -59.79 -14.69 15.84 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.892 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.651 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -153.72 25.51 0.51 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.605 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 57.91 -140.8 45.76 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 153.8 135.1 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 26.8 m-80 63.62 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.54 45.38 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.554 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.684 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 10.9 ttt -127.45 144.8 52.19 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 110.107 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.852 ' HD3' HBC3 ' A' ' 88' ' ' HEC . 30.3 Cg_endo -76.85 116.32 4.22 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.299 2.666 . . . . 0.0 114.261 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.83 162.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.092 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.722 ' HA ' ' HB2' ' A' ' 64' ' ' ARG . 25.8 m-85 -143.61 7.21 1.48 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.245 -0.909 . . . . 0.0 110.053 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.54 -20.41 4.96 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.195 -0.94 . . . . 0.0 108.774 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.45 27.4 1.36 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.722 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 6.0 mmt85 -101.32 -44.73 5.55 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.007 HD11 HBB1 ' A' ' 88' ' ' HEC . 7.9 mt -87.07 -152.93 0.2 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.29 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.575 HG22 ' N ' ' A' ' 67' ' ' ASP . 31.3 m -99.43 164.86 11.92 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.72 ' HA ' HD12 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -63.15 -57.37 10.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.443 1.116 . . . . 0.0 108.032 178.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.579 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.2 tt0 -64.18 2.92 0.49 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.354 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.861 ' CB ' HG21 ' A' ' 9' ' ' VAL . 1.3 mp0 -115.18 -26.48 7.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.851 -1.156 . . . . 0.0 109.2 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 67' ' ' ASP . 2.6 mt -59.31 -19.53 16.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.5 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.6 mp0 -97.58 -71.28 0.69 Allowed 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.497 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.631 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 24.6 m-20 -47.36 -46.41 25.67 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.979 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.692 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -62.17 -31.26 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.426 0.631 . . . . 0.0 110.546 -178.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.665 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -74.67 -62.14 1.64 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.97 -22.07 13.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.82 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.6 t80 -62.76 -45.57 92.06 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.716 HG13 ' HZ2' ' A' ' 85' ' ' TRP . 72.4 t -67.29 -27.47 39.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.794 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -81.24 -9.32 59.8 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.236 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.458 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.0 t70 -100.29 -33.52 10.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.133 0.968 . . . . 0.0 109.714 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.637 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 20.7 mm-40 -77.24 -38.39 51.2 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -71.88 -17.22 62.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.27 10.0 23.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 111.101 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -164.26 37.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.965 -1.494 . . . . 0.0 112.728 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 85.1 77.08 1.19 Allowed Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.764 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.716 ' HZ2' HG13 ' A' ' 77' ' ' VAL . 4.0 m95 -36.08 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.546 0.688 . . . . 0.0 109.185 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -60.68 -45.26 94.85 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.603 -0.686 . . . . 0.0 109.841 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.514 ' HA3' ' HA2' ' A' ' 20' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.146 0 CA-C-O 117.957 -1.468 . . . . 0.0 109.579 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 1.007 HBB1 HD11 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -116.34 -28.52 6.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.945 . . . . 0.0 109.279 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.434 HD23 ' C ' ' A' ' 75' ' ' ALA . 1.5 mp -75.65 -14.77 60.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.21 68.52 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.529 ' O ' ' HE2' ' A' ' 8' ' ' LYS . 1.3 m-20 -80.33 -30.35 38.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.548 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -53.86 -48.33 62.49 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.807 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -58.94 -28.27 66.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.82 -0.812 . . . . 0.0 109.8 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.71 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -68.59 -28.15 66.68 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.008 -1.058 . . . . 0.0 108.717 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.081 HG21 ' CB ' ' A' ' 69' ' ' GLN . 41.1 t -100.16 -18.56 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.454 -0.779 . . . . 0.0 110.479 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.607 ' HE2' HD12 ' A' ' 31' ' ' LEU . 12.7 t80 -97.03 -19.93 18.39 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.89 -1.131 . . . . 0.0 109.694 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -99.38 7.46 45.51 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.664 -0.648 . . . . 0.0 109.584 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.499 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -139.18 2.28 2.58 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.515 ' ND2' ' N ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -151.04 -62.44 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.129 -1.218 . . . . 0.0 108.742 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.653 ' SG ' HMB1 ' A' ' 88' ' ' HEC . 6.8 m -60.89 -34.49 74.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.626 ' HB1' ' HG2' ' A' ' 19' ' ' MET . . . -54.93 -36.21 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 110.124 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.01 -44.74 74.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.392 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.603 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 92.8 m -109.0 13.53 24.61 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.715 ' ND1' HD21 ' A' ' 31' ' ' LEU . 91.9 m-70 -160.92 38.94 0.15 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.922 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.626 ' HG2' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -63.0 141.09 58.9 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.115 -0.99 . . . . 0.0 109.704 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.62 45.79 8.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' GLY . . . 42.32 68.05 0.79 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -147.61 96.53 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 22' ' ' GLY . 1.2 t-20 -43.9 139.9 2.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -1.142 . . . . 0.0 109.289 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 4.4 m -105.68 -17.8 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.01 -1.056 . . . . 0.0 110.104 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.552 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 39.0 t -98.83 -69.13 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 0.0 109.469 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 18.4 mmt -84.22 149.79 25.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -107.15 71.91 0.85 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.301 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER 179.6 -40.4 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.328 -0.857 . . . . 0.0 109.332 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.588 ' HD2' ' CZ ' ' A' ' 39' ' ' PHE . 1.5 mptt -89.7 91.28 8.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 0.0 109.312 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.008 ' C ' HD22 ' A' ' 36' ' ' LEU . 1.8 m -98.76 -169.46 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 0.0 109.079 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.715 HD21 ' ND1' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -105.69 -6.51 19.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.73 -1.231 . . . . 0.0 109.576 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -54.38 -88.45 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.371 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.848 ' HG2' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER 167.11 -38.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.844 -1.16 . . . . 0.0 110.692 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG3' ' HE2' ' A' ' 33' ' ' LYS . 85.9 mt-10 -54.38 -28.25 42.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.074 -1.016 . . . . 0.0 110.036 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.565 ' O ' ' CD1' ' A' ' 39' ' ' PHE . . . -107.43 -57.74 2.05 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.053 0.93 . . . . 0.0 110.495 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.008 HD22 ' C ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -62.05 -43.5 98.71 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.42 -178.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.555 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 56.7 tt0 -69.04 -19.49 64.1 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.529 -1.357 . . . . 0.0 108.868 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.529 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 3.0 tp60 -77.83 -83.83 0.08 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.847 0.832 . . . . 0.0 109.389 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.588 ' CZ ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -91.41 5.1 50.7 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.639 0.733 . . . . 0.0 110.598 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -108.69 -21.21 7.64 Favored Glycine 0 C--N 1.289 -2.062 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.02 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.94 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 51.64 69.32 0.68 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.742 ' CE2' HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -86.29 -3.73 59.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.179 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.501 ' O ' HG22 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -45.35 162.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.252 -0.905 . . . . 0.0 111.013 -179.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.799 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -46.86 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.009 -1.057 . . . . 0.0 109.518 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.551 ' N ' HD12 ' A' ' 48' ' ' ILE . 29.2 t0 -54.64 -17.04 2.88 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.786 -1.196 . . . . 0.0 110.66 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.94 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -81.04 -79.76 0.15 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.977 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.7 tt -54.27 -20.76 5.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 120.73 -1.231 . . . . 0.0 109.656 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.799 HD12 ' C ' ' A' ' 44' ' ' GLU . 10.3 mt -59.92 -43.12 91.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.636 ' CE2' ' CE1' ' A' ' 53' ' ' HIS . 20.0 t80 -80.5 -16.89 53.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.64 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -86.47 -8.16 57.82 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 120.643 -1.286 . . . . 0.0 107.925 178.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 47' ' ' ILE . 42.1 t -108.48 -33.5 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.848 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -70.22 -7.55 42.93 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.745 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -165.96 38.24 0.05 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.522 -178.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 47.5 -133.67 14.94 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 154.95 132.75 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 57.6 m-80 62.05 -88.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.918 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -130.92 50.86 2.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 108.971 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.665 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 24.7 ttt -124.43 142.13 39.5 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.412 -0.805 . . . . 0.0 109.065 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.665 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 26.4 Cg_endo -68.34 104.17 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.804 2.336 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.745 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -59.22 118.33 5.78 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.732 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.78 ' CE2' HD21 ' A' ' 65' ' ' LEU . 13.2 m-85 -86.29 -49.41 7.7 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.93 -1.106 . . . . 0.0 108.211 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 39.58 26.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.22 0.533 . . . . 0.0 109.808 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 127.51 32.55 0.66 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.588 ' CD ' ' CD2' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.84 -48.69 4.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.028 HD13 HG11 ' A' ' 9' ' ' VAL . 29.5 mt -62.52 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.574 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 3.0 m -98.3 -54.92 2.91 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.109 -0.995 . . . . 0.0 108.956 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 66' ' ' THR . 2.6 m-20 150.87 -59.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 68.8 mm-40 -67.06 -1.84 4.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.04 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 1.081 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -112.05 -29.76 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.96 HD13 HD12 ' A' ' 65' ' ' LEU . 39.6 mm -57.05 -20.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.492 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -100.15 -64.19 1.06 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.584 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.639 ' HB2' ' HA ' ' A' ' 69' ' ' GLN . 34.5 m-20 -52.15 -48.66 64.79 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.089 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 69' ' ' GLN . 2.2 p -54.53 -27.21 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 109.918 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.751 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -81.27 -66.41 0.89 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' C ' HD23 ' A' ' 3' ' ' LEU . . . -50.1 -23.77 2.33 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.163 -1.586 . . . . 0.0 107.392 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.807 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 37.1 t80 -63.55 -47.6 80.92 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 74' ' ' ALA . 1.2 p -65.4 -25.59 37.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.742 HD22 ' CE2' ' A' ' 42' ' ' TYR . 1.1 mt -77.34 -9.87 59.1 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.964 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.99 -43.73 6.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.051 0.929 . . . . 0.0 109.411 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.603 ' HB3' ' CE3' ' A' ' 85' ' ' TRP . 18.4 mm-40 -65.94 -44.82 83.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.848 ' HB1' ' HG2' ' A' ' 33' ' ' LYS . . . -68.78 -11.36 60.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.297 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.3 7.01 37.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 111.005 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -175.09 46.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.235 -1.541 . . . . 0.0 112.739 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.602 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 88.5 76.7 1.29 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.869 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.714 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -39.93 83.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 45.87 24.82 0.25 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 109.541 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.956 0 CA-C-O 118.032 -1.427 . . . . 0.0 109.605 -179.887 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.918 HMD2 ' O ' ' A' ' 57' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 25.7 t0 -124.22 144.42 49.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.157 -0.965 . . . . 0.0 109.479 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.011 HD13 ' HA ' ' A' ' 76' ' ' TYR . 2.4 pp -68.83 -0.2 5.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.905 -1.122 . . . . 0.0 108.971 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.543 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.7 t-20 -47.63 -28.69 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.51 -57.74 17.89 Favored Glycine 0 C--O 1.199 -2.034 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -45.93 -28.16 1.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.761 -1.435 . . . . 0.0 110.066 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.775 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.05 -46.25 71.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.044 HG21 ' CB ' ' A' ' 69' ' ' GLN . 24.6 t -73.49 -51.76 24.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.819 -0.551 . . . . 0.0 110.115 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 6.1 t80 -62.5 -28.85 70.12 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.717 -1.239 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 47.0 t -84.09 15.15 3.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.878 . . . . 0.0 109.701 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.472 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -160.95 11.95 0.14 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.527 HD22 HG13 ' A' ' 9' ' ' VAL . 7.7 m-80 -156.43 -54.08 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.449 . . . . 0.0 108.831 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.677 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 4.3 m -74.06 -26.15 60.24 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.499 0.666 . . . . 0.0 109.287 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -57.57 -39.51 76.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.574 -0.704 . . . . 0.0 110.393 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.94 62.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.136 -0.977 . . . . 0.0 111.057 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 99.9 m -124.79 8.81 8.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.826 -1.171 . . . . 0.0 110.691 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.727 ' CG ' HD22 ' A' ' 31' ' ' LEU . 87.8 m-70 -150.12 -65.45 0.21 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.136 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.478 ' H ' ' HA ' ' A' ' 15' ' ' ALA . 1.2 ttt 56.25 113.08 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.269 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 39.42 60.35 1.71 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.646 ' HA2' ' HB2' ' A' ' 31' ' ' LEU . . . 49.43 73.33 0.37 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' HIS . . . -155.72 81.43 0.17 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.643 ' H ' HG23 ' A' ' 30' ' ' THR . 1.6 t-20 -54.61 163.26 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.249 . . . . 0.0 109.223 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 17' ' ' CYS . 6.3 m -144.4 17.11 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.041 . . . . 0.0 109.889 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.618 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 43.1 t -126.58 -55.99 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.098 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.528 ' HE2' HBD2 ' A' ' 88' ' ' HEC . 3.2 mmt -75.47 -172.51 1.82 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -134.39 46.47 2.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.102 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.3 p30 178.2 -44.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 109.366 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 2.0 mttp -74.18 110.62 8.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.557 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.769 HG22 ' H ' ' A' ' 32' ' ' LYS . 92.3 m -133.43 149.33 51.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.317 -0.865 . . . . 0.0 109.25 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.967 HD11 ' C3A' ' A' ' 88' ' ' HEC . 5.9 mp -74.95 -18.67 60.35 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.848 -0.533 . . . . 0.0 111.096 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.769 ' H ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -40.61 -82.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.476 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.558 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 0.4 OUTLIER 174.72 -42.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.548 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 3.7 mm-40 -56.1 -34.85 66.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.584 -0.697 . . . . 0.0 109.594 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -99.17 -39.53 8.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.408 -0.808 . . . . 0.0 110.369 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.845 HD11 ' HD2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -69.75 -10.28 57.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.554 ' OE2' ' CD2' ' A' ' 42' ' ' TYR . 17.1 mt-10 -118.78 3.78 11.6 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 tp-100 -83.59 -51.15 7.55 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.588 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -86.67 -35.54 19.27 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.779 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.63 51.75 0.24 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.955 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.775 ' SD ' HMA2 ' A' ' 88' ' ' HEC . 0.0 OUTLIER -112.13 8.07 19.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.017 -1.284 . . . . 0.0 108.747 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.845 ' HD2' HD11 ' A' ' 36' ' ' LEU . 41.0 t80 -69.43 10.78 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.991 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.3 p -105.7 143.85 33.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.548 -1.345 . . . . 0.0 110.179 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.539 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 5.1 mt-10 -46.28 -58.45 3.68 Favored 'General case' 0 C--O 1.203 -1.355 0 O-C-N 121.379 -0.826 . . . . 0.0 109.29 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 45' ' ' ASP . 9.3 t0 -47.88 -37.19 13.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -0.963 . . . . 0.0 110.829 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.07 -70.27 0.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.812 ' CD1' HMA1 ' A' ' 88' ' ' HEC . 15.3 tt -66.06 -9.58 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-O 121.891 0.853 . . . . 0.0 109.884 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.551 HG23 ' NE2' ' A' ' 52' ' ' GLN . 22.3 mt -87.57 -25.53 6.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' A' ' 53' ' ' HIS . 25.6 t80 -88.72 -23.39 22.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.682 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 1.045 ' NE2' HG23 ' A' ' 51' ' ' VAL . 4.2 pp0? -94.17 -26.45 16.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.438 -1.414 . . . . 0.0 108.289 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.045 HG23 ' NE2' ' A' ' 50' ' ' GLN . 2.9 t -75.02 -49.51 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.885 0.85 . . . . 0.0 109.01 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.638 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -64.91 -12.53 50.29 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.809 -0.557 . . . . 0.0 111.525 -177.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.635 ' N ' ' CD2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -147.46 13.24 1.06 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.58 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.703 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 71.19 -136.09 24.81 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 106.754 -2.539 . . . . 0.0 106.754 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 149.94 141.09 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 50.32 -90.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 55' ' ' LYS . . . -129.35 49.39 2.25 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.712 ' HE1' ' HA ' ' A' ' 51' ' ' VAL . 7.1 ttt -125.2 146.48 54.11 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 110.006 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.644 ' CD ' ' C3C' ' A' ' 88' ' ' HEC . 36.2 Cg_endo -80.97 107.82 1.97 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 123.363 2.709 . . . . 0.0 114.81 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.703 ' HA ' ' N ' ' A' ' 54' ' ' GLY . . . -40.79 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 111.135 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.738 ' HZ ' HMC2 ' A' ' 88' ' ' HEC . 56.0 m-85 -150.25 14.34 0.79 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . . . -47.17 -28.49 1.85 Allowed 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.263 -0.898 . . . . 0.0 109.136 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.32 35.05 0.52 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 61' ' ' PHE . 1.9 ttm-85 -101.3 -42.99 6.1 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.11 HD11 HBB1 ' A' ' 88' ' ' HEC . 21.1 mt -77.09 -143.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.582 ' HB ' ' CG ' ' A' ' 69' ' ' GLN . 3.0 m -98.22 -59.45 1.75 Allowed 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 66' ' ' THR . 0.5 OUTLIER 153.26 -55.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 12.4 tt0 -68.79 -1.48 7.2 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 1.044 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -108.35 -31.35 7.89 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 HD12 ' A' ' 65' ' ' LEU . 23.6 mm -57.54 -20.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.473 ' N ' ' C ' ' A' ' 69' ' ' GLN . 2.8 mp0 -99.09 -71.0 0.71 Allowed 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.01 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 87.5 m-20 -45.72 -49.77 14.39 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.176 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -60.75 -32.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.505 0.669 . . . . 0.0 110.082 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -69.82 -65.51 0.71 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.203 -1.561 . . . . 0.0 106.856 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.482 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.05 -21.86 9.39 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.011 ' HA ' HD13 ' A' ' 3' ' ' LEU . 62.5 t80 -63.84 -45.1 91.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.603 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.745 HG11 ' HG ' ' A' ' 31' ' ' LEU . 60.7 t -68.89 -25.22 29.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.823 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -82.65 -9.05 59.55 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.037 179.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 10.9 t0 -99.35 -34.52 10.27 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.653 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 4.4 mm-40 -78.57 -34.57 46.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.377 0.608 . . . . 0.0 110.003 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.595 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . . . -65.17 -43.61 91.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.366 -0.834 . . . . 0.0 109.792 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.94 14.83 11.15 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.284 -0.885 . . . . 0.0 110.85 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 12.8 ptmt -142.86 23.57 1.9 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.512 -1.367 . . . . 0.0 111.665 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 87.3 72.6 1.29 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.032 -1.556 . . . . 0.0 109.756 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.684 ' HZ2' HG13 ' A' ' 77' ' ' VAL . 1.1 m95 -40.85 85.06 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.202 -0.587 . . . . 0.0 110.797 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 45.74 26.21 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.133 -0.979 . . . . 0.0 109.485 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.088 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.522 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 1.11 HBB1 HD11 ' A' ' 65' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.295 0.569 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 5.2 m-20 -109.93 145.29 37.15 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.194 -0.941 . . . . 0.0 109.199 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.094 HD23 ' HA ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -75.69 2.6 11.58 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.308 177.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.583 ' N ' HD13 ' A' ' 3' ' ' LEU . . . -59.92 -42.49 94.05 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.505 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 1.5 t-20 -51.34 -32.88 27.12 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' VAL . . . -54.49 -47.51 69.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -48.81 -33.45 10.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.657 -1.496 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HE3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -67.03 -43.99 81.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.769 ' CG1' HD13 ' A' ' 65' ' ' LEU . 18.3 t -62.43 -72.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.632 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 16.0 t80 -49.72 -26.62 3.96 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.703 -0.623 . . . . 0.0 111.237 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 19.6 t -92.35 31.38 1.32 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 109.008 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.69 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.484 1.878 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.554 ' HB2' HBB1 ' A' ' 88' ' ' HEC . 0.8 OUTLIER -129.33 -46.18 1.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.83 -1.394 . . . . 0.0 109.563 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.734 ' SG ' HMB1 ' A' ' 88' ' ' HEC . 3.5 m -76.48 -25.02 53.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.746 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -59.3 -35.49 73.88 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.805 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.87 97.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.35 -0.844 . . . . 0.0 111.64 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.618 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 0.1 OUTLIER -108.26 26.48 10.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.757 -1.214 . . . . 0.0 109.494 -179.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.894 ' CE1' HD21 ' A' ' 31' ' ' LEU . 92.5 m-70 -160.02 -54.5 0.06 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.234 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 18' ' ' HIS . 3.9 ptp 39.41 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.479 0.657 . . . . 0.0 110.794 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 67.6 52.23 31.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 30' ' ' THR . . . 41.72 57.39 3.39 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.644 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -147.26 86.63 0.16 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.512 ' HB3' ' CE ' ' A' ' 26' ' ' MET . 2.9 t-20 -51.13 159.3 0.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -1.096 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.84 -10.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 109.62 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 26' ' ' MET . 18.1 t -100.2 -62.78 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.074 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.512 ' CE ' ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -51.53 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.847 . . . . 0.0 109.773 179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.44 -8.53 10.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -153.33 -37.65 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.278 -0.888 . . . . 0.0 109.586 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 39' ' ' PHE . 5.9 tptt -46.21 90.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.485 -0.76 . . . . 0.0 109.804 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.644 HG23 ' HA2' ' A' ' 22' ' ' GLY . 7.1 m -117.63 151.55 36.97 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.894 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -78.88 -7.73 58.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.324 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HD3' HG21 ' A' ' 30' ' ' THR . 1.1 mtpt -51.52 162.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.529 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.581 ' CA ' ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.02 . . . . 0.0 110.191 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -61.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 110.733 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.58 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . . . -71.99 -35.62 69.53 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 111.239 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.826 HD23 ' O ' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -64.74 -43.43 93.39 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 117.881 -1.528 . . . . 0.0 107.854 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.572 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -90.68 13.23 16.65 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.187 -0.946 . . . . 0.0 109.129 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.52 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -82.21 -49.82 9.68 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.599 ' CE1' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -87.07 -42.73 12.83 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.333 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.87 82.13 0.4 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.675 ' HE3' ' HA ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -158.68 24.53 0.23 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.286 -1.126 . . . . 0.0 108.496 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.718 ' HB2' HD11 ' A' ' 36' ' ' LEU . 43.3 t80 -84.38 15.83 3.42 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.494 0.664 . . . . 0.0 109.225 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.61 134.39 47.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.791 -1.193 . . . . 0.0 111.126 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -45.07 -59.76 2.44 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -48.03 -37.98 16.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.064 -1.022 . . . . 0.0 110.492 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.9 -73.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.7 tt -65.28 -9.52 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.531 -0.73 . . . . 0.0 110.338 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 44' ' ' GLU . 9.1 mt -78.91 -35.57 18.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 37.0 t80 -91.08 -14.41 31.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.626 ' NE2' ' CHA' ' A' ' 88' ' ' HEC . 1.1 tp60 -90.63 -17.57 26.64 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 47' ' ' ILE . 68.5 t -94.27 -45.9 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.563 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.0 OUTLIER -62.79 -9.78 10.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.597 -0.69 . . . . 0.0 110.949 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.67 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.98 22.25 0.51 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.622 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 54.58 -133.44 47.01 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 155.75 135.75 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-O 121.389 0.614 . . . . 0.0 109.545 178.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 54.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.862 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -126.01 55.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.698 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.671 ' HE2' ' HA ' ' A' ' 51' ' ' VAL . 9.8 ttt -142.85 142.51 22.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 109.116 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.656 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 29.5 Cg_endo -75.07 117.21 4.82 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 123.385 2.723 . . . . 0.0 115.036 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.67 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -43.07 164.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.794 ' CZ ' HBB3 ' A' ' 88' ' ' HEC . 49.4 m-85 -143.12 12.63 1.81 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.44 -0.788 . . . . 0.0 109.433 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . -43.93 -26.09 0.25 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.416 -0.802 . . . . 0.0 108.899 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -151.44 35.31 0.88 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.683 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 4.5 mmt85 -103.38 -50.98 3.32 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.781 HD12 HD13 ' A' ' 70' ' ' ILE . 5.9 mt -86.81 -157.59 0.38 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 67' ' ' ASP . 5.6 m -100.88 -179.09 3.96 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.704 ' H ' HG22 ' A' ' 66' ' ' THR . 3.0 m-20 -76.34 -59.51 2.74 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.638 -1.289 . . . . 0.0 108.678 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.556 ' C ' ' NE2' ' A' ' 69' ' ' GLN . 8.0 tt0 -66.22 -7.68 19.76 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.709 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -95.39 -34.94 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.781 HD13 HD12 ' A' ' 65' ' ' LEU . 4.3 mm -67.91 -14.47 18.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.448 ' OE1' HG22 ' A' ' 70' ' ' ILE . 2.3 mp0 -98.7 -71.57 0.69 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.465 1.126 . . . . 0.0 109.071 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.706 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 58.9 m-20 -47.42 -38.6 13.73 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.89 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.74 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 3.5 p -66.52 -36.79 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.704 0.764 . . . . 0.0 109.885 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.728 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -68.35 -60.21 2.61 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 119.949 -1.719 . . . . 0.0 106.401 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.38 -20.63 45.63 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.094 ' HA ' HD23 ' A' ' 3' ' ' LEU . 84.3 t80 -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 31' ' ' LEU . 43.9 t -70.62 -27.02 29.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.786 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -83.63 -8.03 59.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.281 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 3.1 t70 -98.79 -43.38 6.79 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.178 0.989 . . . . 0.0 109.039 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.675 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 19.5 mm-40 -70.32 -35.68 73.8 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.951 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.581 ' HB1' ' CA ' ' A' ' 33' ' ' LYS . . . -59.44 -50.91 72.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.152 -0.967 . . . . 0.0 108.392 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.84 16.77 6.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.659 -0.651 . . . . 0.0 109.857 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 26.6 tttm -132.11 13.18 4.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 111.297 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 81.9 72.66 1.24 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.675 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 7.5 m95 -38.71 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.14 0.495 . . . . 0.0 110.508 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 42.44 26.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.943 . . . . 0.0 109.421 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 85' ' ' TRP . . . . . . . . 0 N--CA 1.487 2.046 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.59 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.89 HBC2 ' HHD' ' A' ' 88' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 6.2 m-20 79.31 0.93 2.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.481 -0.762 . . . . 0.0 109.912 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.0 HD13 ' HA ' ' A' ' 76' ' ' TYR . 2.0 pp -70.62 3.92 2.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.64 ' CA ' ' HD3' ' A' ' 8' ' ' LYS . 1.4 m-20 -75.0 -1.68 23.81 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.645 ' HA2' HG23 ' A' ' 73' ' ' VAL . . . -86.27 -46.91 5.13 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.919 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -56.14 -46.57 79.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.857 -0.79 . . . . 0.0 108.877 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.798 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -51.04 -33.44 25.47 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.964 HG21 ' HG2' ' A' ' 69' ' ' GLN . 59.6 t -96.62 -15.7 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.215 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 11.0 t80 -84.76 -28.05 26.5 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 117.589 -1.644 . . . . 0.0 109.793 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -86.63 15.09 5.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 0.0 109.808 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -144.34 2.02 1.27 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.844 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.482 ' ND2' ' C ' ' A' ' 12' ' ' GLY . 0.9 OUTLIER -143.51 -50.35 0.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.805 -1.409 . . . . 0.0 109.114 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 2.5 m -77.11 -32.11 56.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.426 -0.797 . . . . 0.0 108.875 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HA ' ' N ' ' A' ' 19' ' ' MET . . . -45.77 -40.87 10.11 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.661 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.72 -46.3 77.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.097 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 80.3 m -116.12 27.81 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 110.33 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.594 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 90.5 m-70 -159.93 -76.41 0.07 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.215 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.55 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 55.1 127.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.595 0.712 . . . . 0.0 110.668 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 44.95 45.17 9.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.593 ' HA3' ' CD2' ' A' ' 85' ' ' TRP . . . 48.64 68.27 1.35 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.497 ' HA2' ' OG1' ' A' ' 30' ' ' THR . . . -151.78 86.8 0.14 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.576 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 6.8 t-20 -55.33 161.47 1.86 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.976 -1.308 . . . . 0.0 109.305 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 25' ' ' VAL . 16.4 m -136.5 -52.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.573 ' N ' HG23 ' A' ' 24' ' ' VAL . 44.8 t -45.79 -61.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.175 -0.953 . . . . 0.0 108.781 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -53.41 -170.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 109.109 179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.71 1.25 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.097 . . . . 0.0 110.289 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.9 -30.83 0.09 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.038 -1.039 . . . . 0.0 110.729 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 11.9 mttt -75.93 101.16 5.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.969 -1.082 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.91 ' C ' HD22 ' A' ' 36' ' ' LEU . 10.3 t -93.88 -146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 108.492 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.609 ' N ' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -118.41 -11.11 10.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.482 -1.386 . . . . 0.0 109.615 179.133 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.757 ' H ' HG23 ' A' ' 30' ' ' THR . 5.2 mtpt -50.02 -86.9 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.846 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 165.04 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.984 -1.072 . . . . 0.0 109.956 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -53.14 -27.19 19.72 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 109.718 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.931 ' HB1' ' CZ ' ' A' ' 39' ' ' PHE . . . -106.86 -67.33 0.95 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.273 -0.892 . . . . 0.0 110.532 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.984 HD12 ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -54.39 -35.85 63.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.645 -0.659 . . . . 0.0 111.335 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . 2.0 tt0 -69.33 -30.79 68.9 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.306 -1.496 . . . . 0.0 110.183 -178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.509 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 6.0 mm-40 -78.55 -64.55 1.15 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.245 -0.909 . . . . 0.0 109.925 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CZ ' ' HB1' ' A' ' 35' ' ' ALA . 2.0 p90 -93.99 -20.19 20.2 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.537 0.684 . . . . 0.0 110.627 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.578 ' CA ' ' O ' ' A' ' 36' ' ' LEU . . . -89.42 -19.11 50.7 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.031 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 1.117 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER 49.48 71.23 0.4 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -177.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.984 ' CG ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -101.69 -6.08 24.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.485 -176.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.811 ' N ' ' HB3' ' A' ' 46' ' ' ALA . 2.6 p -48.74 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.781 -1.199 . . . . 0.0 110.223 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.698 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -43.61 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.92 -1.112 . . . . 0.0 109.668 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.416 ' N ' HD12 ' A' ' 48' ' ' ILE . 32.6 t0 -52.67 -19.78 2.63 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.891 -1.131 . . . . 0.0 110.286 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.117 ' HB1' ' O ' ' A' ' 41' ' ' MET . . . -74.37 -82.11 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.395 -0.816 . . . . 0.0 110.262 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.813 HD13 HG11 ' A' ' 77' ' ' VAL . 12.1 tt -48.77 -33.52 5.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 O-C-N 121.283 -0.886 . . . . 0.0 109.796 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 44' ' ' GLU . 74.7 mt -56.31 -41.23 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.596 -0.69 . . . . 0.0 110.058 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.408 ' O ' ' HD2' ' A' ' 53' ' ' HIS . 28.3 t80 -78.69 -25.7 44.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 110.561 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.559 ' CG ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -93.71 -3.71 51.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.087 -1.633 . . . . 0.0 108.896 179.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' HA ' ' HE2' ' A' ' 58' ' ' MET . 25.1 t -94.8 -48.77 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.584 ' HB3' ' NE2' ' A' ' 53' ' ' HIS . 0.1 OUTLIER -64.49 -8.32 13.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.867 -0.521 . . . . 0.0 110.167 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.634 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.62 21.45 0.4 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.838 -1.145 . . . . 0.0 108.772 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.592 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 51.89 -131.1 36.44 Favored Glycine 0 C--N 1.3 -1.419 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 150.04 142.31 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 53.94 -89.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.591 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -126.53 42.63 3.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.582 ' HB3' ' N ' ' A' ' 55' ' ' LYS . 21.4 ttt -119.63 142.19 32.39 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.499 -0.751 . . . . 0.0 109.225 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.571 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 37.0 Cg_endo -81.26 108.82 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.914 2.409 . . . . 0.0 113.406 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.634 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -38.7 163.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.482 -0.761 . . . . 0.0 110.286 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.886 ' CD2' HBB2 ' A' ' 88' ' ' HEC . 11.2 m-85 -145.74 14.43 1.37 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.22 -10.8 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.907 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.19 -4.34 7.78 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HD2' ' CE1' ' A' ' 61' ' ' PHE . 4.2 ttt180 -106.82 -61.64 1.51 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.008 ' CD1' HG21 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -64.62 105.8 1.04 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.58 HG22 ' N ' ' A' ' 67' ' ' ASP . 86.2 m -39.3 166.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.294 0.569 . . . . 0.0 109.564 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.58 ' N ' HG22 ' A' ' 66' ' ' THR . 15.1 t0 -57.74 -57.75 11.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.989 -1.069 . . . . 0.0 108.42 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.573 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.5 mm-40 -65.87 10.81 0.09 Allowed 'General case' 0 C--O 1.193 -1.917 0 O-C-N 121.755 -0.59 . . . . 0.0 109.887 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.964 ' HG2' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -104.4 -44.66 4.87 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.681 HG22 HG23 ' A' ' 48' ' ' ILE . 18.9 mm -53.0 -22.09 3.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 1.5 mp0 -94.45 -73.34 0.58 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 76' ' ' TYR . 98.2 m-20 -44.82 -64.69 0.65 Allowed 'General case' 0 C--O 1.186 -2.27 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.286 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.008 HG21 ' CD1' ' A' ' 65' ' ' LEU . 2.3 t -49.15 -29.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.096 -1.003 . . . . 0.0 110.269 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.808 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -79.94 -74.18 0.31 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.694 -1.254 . . . . 0.0 108.118 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -46.56 -23.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.966 -1.709 . . . . 0.0 107.784 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.0 ' HA ' HD13 ' A' ' 3' ' ' LEU . 40.9 t80 -60.41 -53.13 61.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.274 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.85 HG22 ' HE2' ' A' ' 42' ' ' TYR . 1.9 p -64.47 -25.72 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.703 HD23 HG13 ' A' ' 77' ' ' VAL . 2.8 mt -78.5 -9.67 59.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.49 ' HB3' ' NE2' ' A' ' 80' ' ' GLN . 3.0 t0 -99.57 -41.49 7.32 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.0 0.905 . . . . 0.0 109.059 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.645 ' CB ' ' CE3' ' A' ' 85' ' ' TRP . 9.3 mm-40 -69.53 -47.48 63.59 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.381 0.61 . . . . 0.0 109.956 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -68.5 -16.02 63.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.44 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.61 8.68 27.17 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 110.889 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -171.69 41.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.362 -1.461 . . . . 0.0 112.518 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 90.47 77.27 1.33 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.02 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.825 ' HZ2' HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -40.36 84.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.319 -0.518 . . . . 0.0 110.596 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 53.63 47.62 23.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.858 -1.151 . . . . 0.0 109.029 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.029 0 CA-C-O 117.951 -1.471 . . . . 0.0 109.529 -179.737 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.886 HBB2 ' CD2' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.444 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.453 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 9.7 m-20 72.8 5.02 5.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.301 -0.874 . . . . 0.0 109.961 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.875 HD11 ' HA ' ' A' ' 76' ' ' TYR . 1.0 OUTLIER -77.2 7.39 5.17 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.937 -1.102 . . . . 0.0 109.738 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.98 -24.31 59.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.637 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . 68.3 m-20 -84.39 -6.03 59.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.445 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.582 ' C ' ' CD2' ' A' ' 76' ' ' TYR . . . -87.74 -61.74 1.5 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 106.674 -2.571 . . . . 0.0 106.674 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.865 ' HA ' ' CE2' ' A' ' 76' ' ' TYR . . . -40.67 -37.81 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.872 -0.781 . . . . 0.0 109.128 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.923 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -61.84 -48.63 79.71 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 65' ' ' LEU . 87.9 t -63.68 -59.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -0.773 . . . . 0.0 111.814 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.823 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 46.0 t80 -54.92 -42.59 72.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.732 -1.23 . . . . 0.0 112.261 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -84.29 19.58 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.58 -1.325 . . . . 0.0 110.365 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -147.16 0.77 0.72 Allowed Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.541 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -156.23 -48.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.569 -1.548 . . . . 0.0 110.035 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 10' ' ' PHE . 3.4 m -71.99 -36.12 69.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 19' ' ' MET . . . -51.55 -38.1 52.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.442 -0.786 . . . . 0.0 110.089 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.01 69.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.956 -1.09 . . . . 0.0 109.257 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.569 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 82.3 m -119.43 20.28 12.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.441 -0.787 . . . . 0.0 109.506 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 93.3 m-70 -159.87 21.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.436 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.34 153.36 7.31 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.656 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 43.46 33.53 2.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 46.39 57.99 6.14 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.676 ' HA2' HG23 ' A' ' 30' ' ' THR . . . -146.76 91.89 0.15 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 2.2 t-20 -41.77 142.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.457 -1.026 . . . . 0.0 109.865 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.11 -1.24 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.447 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.671 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 45.3 t -111.54 -66.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mmt -65.39 130.67 44.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.319 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' C ' ' OD1' ' A' ' 28' ' ' ASN . . . -85.08 48.32 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 27' ' ' ALA . 1.8 p-10 175.3 -59.7 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HD3' ' CE ' ' A' ' 41' ' ' MET . 7.6 mttp -51.71 102.8 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.213 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.698 HG21 ' HD3' ' A' ' 32' ' ' LYS . 3.7 m -113.32 177.44 4.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.688 ' H ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -94.71 -18.93 20.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.827 . . . . 0.0 109.798 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 1.004 ' C ' HD21 ' A' ' 36' ' ' LEU . 14.8 mtpt -58.16 -113.63 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 110.295 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.761 ' N ' HD21 ' A' ' 36' ' ' LEU . 22.7 ttpt -155.44 -29.61 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.677 -1.264 . . . . 0.0 110.871 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 38' ' ' GLN . 12.3 pt-20 -59.97 -28.91 68.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.729 -1.232 . . . . 0.0 111.193 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.631 ' O ' ' CE1' ' A' ' 39' ' ' PHE . . . -102.25 -48.57 4.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.001 -1.062 . . . . 0.0 110.818 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.004 HD21 ' C ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -61.07 -34.56 75.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.923 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.2 mm-40 -93.1 6.02 49.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.477 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 1.5 tp60 -89.74 -51.1 5.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -86.62 -50.27 6.93 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.486 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.81 91.45 0.48 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.507 ' CE ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -174.12 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.12 . . . . 0.0 109.474 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.942 ' CG ' HD12 ' A' ' 36' ' ' LEU . 4.1 t80 -105.62 28.57 7.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 109.816 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 p -106.73 143.11 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.359 -0.838 . . . . 0.0 110.569 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.54 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -50.53 -59.15 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 109.834 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.35 -28.62 8.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.526 -1.359 . . . . 0.0 110.568 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.61 -73.66 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 110.321 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.845 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.1 tt -61.16 -13.84 8.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 110.358 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.719 HG23 HG22 ' A' ' 70' ' ' ILE . 14.5 mt -73.41 -35.99 47.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 31.0 t80 -91.11 -14.44 31.21 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.565 ' HB3' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -88.79 -17.07 30.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 47' ' ' ILE . 72.2 t -93.77 -43.62 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.817 0.818 . . . . 0.0 109.985 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.646 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -62.72 -10.54 13.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 0.0 110.18 -178.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.664 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -158.36 30.97 0.24 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.357 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.591 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . 49.96 -132.99 28.16 Favored Glycine 0 C--N 1.299 -1.524 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 151.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 37.8 m-80 69.05 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' HB3' HMD2 ' A' ' 88' ' ' HEC . . . -129.48 14.95 6.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 109.202 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.702 ' HE2' ' HA ' ' A' ' 51' ' ' VAL . 27.4 ttt -89.63 142.3 29.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.263 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.646 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 30.3 Cg_endo -74.25 97.2 1.0 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.906 2.404 . . . . 0.0 114.647 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.664 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -46.94 119.16 2.38 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 63' ' ' GLY . 57.1 m-85 -88.24 -49.87 6.71 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.999 -1.063 . . . . 0.0 108.747 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 28.05 40.34 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.35 0.595 . . . . 0.0 110.376 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 167.61 -24.18 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.521 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -93.83 -30.92 14.58 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.95 HD11 HG11 ' A' ' 9' ' ' VAL . 1.7 mm? -91.45 94.51 9.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 67' ' ' ASP . 21.0 m -41.03 168.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.616 ' N ' HG22 ' A' ' 66' ' ' THR . 0.1 OUTLIER -57.15 -61.2 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.522 -1.361 . . . . 0.0 108.487 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 mt-10 -60.68 3.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.777 -0.577 . . . . 0.0 110.604 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.882 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -102.94 -45.15 5.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.719 HG22 HG23 ' A' ' 48' ' ' ILE . 33.6 mm -55.34 -22.66 12.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 67' ' ' ASP . 1.6 mp0 -92.19 -65.71 0.98 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.103 0.954 . . . . 0.0 108.642 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 47.1 m-20 -49.62 -61.5 2.08 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 69' ' ' GLN . 3.3 p -45.5 -29.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.3 -0.875 . . . . 0.0 109.8 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.813 ' O ' HG12 ' A' ' 77' ' ' VAL . . . -80.68 -71.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . -45.52 -25.8 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.554 -1.341 . . . . 0.0 107.508 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.875 ' HA ' HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -59.08 -56.95 15.61 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 74' ' ' ALA . 2.6 p -62.37 -26.14 39.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.99 -1.069 . . . . 0.0 108.647 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 77' ' ' VAL . 5.1 mt -76.45 -10.76 59.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 83' ' ' LYS . 2.0 t0 -99.47 -43.52 6.51 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.929 0.871 . . . . 0.0 109.218 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 59.6 mm-40 -67.3 -41.55 85.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.88 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.555 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -60.9 -47.3 87.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.143 -0.973 . . . . 0.0 109.063 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.11 8.45 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.573 -0.705 . . . . 0.0 109.843 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 6.9 tttm -129.84 12.84 5.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.079 -1.013 . . . . 0.0 110.974 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 80.0 76.71 0.98 Allowed Glycine 0 C--N 1.296 -1.681 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.728 ' HZ2' HG23 ' A' ' 77' ' ' VAL . 12.8 m95 -34.36 90.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.725 0.774 . . . . 0.0 109.07 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -54.76 -37.99 66.65 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.386 0.612 . . . . 0.0 109.446 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.487 2.085 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.687 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.671 HMD3 ' HB ' ' A' ' 25' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -119.51 -25.79 5.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 0.0 109.586 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.803 HD13 ' OD2' ' A' ' 79' ' ' ASP . 1.2 mp -71.11 -3.36 19.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.053 -1.029 . . . . 0.0 109.454 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.71 -15.82 63.63 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.596 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -86.69 10.26 16.28 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 76' ' ' TYR . . . -107.69 -36.33 2.43 Favored Glycine 0 C--O 1.201 -1.919 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -59.88 -12.63 8.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.659 -0.906 . . . . 0.0 109.884 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.596 ' CE ' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -87.13 -32.52 19.84 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.826 HG13 HD22 ' A' ' 65' ' ' LEU . 3.4 t -77.31 -29.55 16.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.595 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 14' ' ' CYS . 32.2 t80 -100.33 -34.53 9.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 3.9 t -85.05 10.76 11.1 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.024 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' C ' ' ND2' ' A' ' 13' ' ' ASN . . . -142.34 -6.74 0.72 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.173 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.563 ' CG ' HD21 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -147.23 -52.93 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.567 -1.549 . . . . 0.0 110.031 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.711 ' SG ' HMB1 ' A' ' 88' ' ' HEC . 5.3 m -64.8 -29.31 70.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.91 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 110.035 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.84 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.846 -1.159 . . . . 0.0 109.294 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB2' ' C2C' ' A' ' 88' ' ' HEC . 84.8 m -120.7 14.78 11.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.224 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.506 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 91.0 m-70 -158.63 26.74 0.23 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.765 . . . . 0.0 109.033 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -52.49 147.12 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.961 . . . . 0.0 109.308 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 19' ' ' MET . . . 46.96 35.86 8.33 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 32' ' ' LYS . . . 48.47 53.0 17.75 Favored Glycine 0 N--CA 1.483 1.804 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.73 122.06 2.52 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 26' ' ' MET . 3.7 t-20 -64.43 154.21 36.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -1.127 . . . . 0.0 109.434 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.425 HG23 HG23 ' A' ' 25' ' ' VAL . 4.5 m -122.95 -22.17 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.12 -0.988 . . . . 0.0 110.244 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.425 HG23 HG23 ' A' ' 24' ' ' VAL . 13.4 t -103.07 -69.54 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.868 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.62 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -47.62 -37.26 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.42 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 26' ' ' MET . . . 71.32 40.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 26' ' ' MET . 1.3 p30 177.09 -37.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.371 -0.83 . . . . 0.0 108.915 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.29 77.14 5.83 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.916 ' O ' HD22 ' A' ' 36' ' ' LEU . 9.3 t -83.23 -177.35 6.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 109.878 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.705 HD11 HMB3 ' A' ' 88' ' ' HEC . 0.1 OUTLIER -100.78 -18.54 16.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 110.758 -179.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.597 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -61.07 -100.8 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.667 -1.271 . . . . 0.0 109.4 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.495 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 11.0 ptmm? -168.32 -38.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.642 -1.286 . . . . 0.0 110.797 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -41.16 -29.46 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 -178.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.858 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -110.25 -59.23 1.97 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.483 -0.761 . . . . 0.0 111.644 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -58.98 -7.72 1.16 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.728 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.598 ' HG2' ' CB ' ' A' ' 42' ' ' TYR . 1.4 mm-40 -107.08 -11.79 15.56 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.593 -1.317 . . . . 0.0 109.72 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 6.9 mm100 -82.54 -40.54 20.82 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.858 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -84.96 -45.94 11.71 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.709 177.097 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 41' ' ' MET . . . 121.51 98.19 1.54 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.508 ' HG3' HBA2 ' A' ' 88' ' ' HEC . 0.0 OUTLIER 170.08 37.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -1.085 . . . . 0.0 109.741 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.007 ' OH ' ' HB3' ' A' ' 81' ' ' ALA . 6.6 t80 -118.98 33.17 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.511 ' O ' ' HB ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -110.49 176.97 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.568 -0.708 . . . . 0.0 110.938 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.694 ' C ' HD12 ' A' ' 48' ' ' ILE . 3.6 mt-10 -69.89 -72.56 0.19 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -54.0 -36.37 62.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.566 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 50' ' ' GLN . . . -64.01 -74.41 0.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.067 -1.021 . . . . 0.0 109.498 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.016 ' O ' HG23 ' A' ' 51' ' ' VAL . 40.9 mt -53.9 -17.56 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.621 0.724 . . . . 0.0 109.264 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.694 HD12 ' C ' ' A' ' 44' ' ' GLU . 16.2 mt -80.82 -33.38 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.486 ' OH ' ' HE2' ' A' ' 55' ' ' LYS . 59.7 t80 -73.19 -23.07 60.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 108.536 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.627 ' O ' ' HE2' ' A' ' 58' ' ' MET . 0.0 OUTLIER -85.64 -33.65 21.56 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.391 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.016 HG23 ' O ' ' A' ' 47' ' ' ILE . 10.9 t -79.92 -36.67 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.623 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -72.23 -14.45 61.79 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.344 -0.848 . . . . 0.0 109.968 -178.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.694 ' HA ' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -159.33 31.54 0.2 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.012 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 48.04 -136.86 14.81 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER 151.91 134.1 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 41.1 m-80 60.25 -88.91 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.473 -0.767 . . . . 0.0 108.978 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.814 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -126.27 41.58 3.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.096 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.627 ' HE2' ' O ' ' A' ' 50' ' ' GLN . 21.4 ttt -119.04 143.49 34.01 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.615 ' HD2' ' CG ' ' A' ' 58' ' ' MET . 30.3 Cg_endo -75.23 99.76 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.918 2.412 . . . . 0.0 114.27 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 53' ' ' HIS . . . -57.07 118.27 4.84 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.654 -0.654 . . . . 0.0 110.458 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.657 ' CZ ' HBB3 ' A' ' 88' ' ' HEC . 25.1 m-85 -85.37 -52.27 5.99 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 61' ' ' PHE . . . 37.58 28.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.424 0.631 . . . . 0.0 109.675 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . 126.46 32.8 0.7 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.506 -1.837 . . . . 0.0 108.506 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.602 ' HD2' ' CD2' ' A' ' 61' ' ' PHE . 5.5 ttm-85 -101.67 -52.78 3.13 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.826 HD22 HG13 ' A' ' 9' ' ' VAL . 6.5 mt -79.92 -143.16 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.591 ' CB ' ' HB2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -98.62 -166.9 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 121.085 -1.009 . . . . 0.0 109.494 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.37 -62.55 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.621 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 14.1 tt0 -71.41 2.61 4.68 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.668 ' HG3' ' CG2' ' A' ' 9' ' ' VAL . 1.1 mp0 -104.08 -32.03 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.623 HG21 ' HG3' ' A' ' 52' ' ' GLN . 7.5 mm -72.88 -21.84 19.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.43 -66.13 0.95 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.216 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 37.3 t0 -54.59 -36.92 64.94 Favored 'General case' 0 C--O 1.193 -1.902 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.409 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 9.9 p -61.69 -26.92 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.193 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.588 ' O ' ' CG1' ' A' ' 77' ' ' VAL . . . -82.12 -59.11 2.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -54.62 -21.63 11.09 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.697 ' HE1' ' HB2' ' A' ' 7' ' ' ALA . 36.5 t80 -67.03 -45.12 78.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.366 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.675 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 1.1 p -69.6 -21.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.97 HD21 HD12 ' A' ' 47' ' ' ILE . 5.4 mt -77.97 -11.82 59.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.803 ' OD2' HD13 ' A' ' 3' ' ' LEU . 1.8 t0 -99.99 -37.52 8.97 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.888 0.851 . . . . 0.0 109.327 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.646 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 8.5 mm-40 -77.44 -35.28 54.12 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.876 -0.515 . . . . 0.0 110.395 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.007 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . . . -61.0 -48.71 80.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.121 -0.987 . . . . 0.0 108.522 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.8 13.86 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.509 -0.744 . . . . 0.0 109.759 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 1.6 ttmm -130.79 13.69 5.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.96 -1.088 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 82.84 73.6 1.23 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.675 ' CZ2' ' HA ' ' A' ' 77' ' ' VAL . 5.0 m95 -39.07 83.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.119 0.485 . . . . 0.0 110.592 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . 42.72 27.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.241 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.627 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.918 ' CMA' HG23 ' A' ' 47' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.491 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.2 m-20 74.18 -0.1 3.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.884 . . . . 0.0 109.897 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.505 ' CD2' ' HA ' ' A' ' 72' ' ' ASP . 10.1 mt -69.67 -8.3 46.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.933 -1.105 . . . . 0.0 109.057 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.23 -29.09 63.48 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.518 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.3 m-20 -67.91 -41.78 82.13 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 73' ' ' VAL . . . -47.21 -58.83 6.14 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.766 ' HB2' ' HE1' ' A' ' 76' ' ' TYR . . . -50.67 -37.65 42.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.338 . . . . 0.0 109.286 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.851 ' HD2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -59.4 -41.1 88.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.204 -0.935 . . . . 0.0 108.58 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.068 HG21 ' CB ' ' A' ' 69' ' ' GLN . 21.9 t -81.23 -67.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 10' ' ' PHE . 26.9 t80 -41.54 -26.63 0.07 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.288 -0.883 . . . . 0.0 109.851 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 36.6 m -76.71 -48.53 18.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.296 -0.877 . . . . 0.0 111.275 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 13' ' ' ASN . . . -101.57 29.84 11.66 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.726 -1.225 . . . . 0.0 111.739 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.472 HD22 HG13 ' A' ' 9' ' ' VAL . 23.4 m-80 -155.03 -29.3 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.783 -1.422 . . . . 0.0 110.771 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.907 ' SG ' ' HHC' ' A' ' 88' ' ' HEC . 79.6 m -127.91 -11.18 5.42 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.903 -1.123 . . . . 0.0 111.316 -177.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HA ' ' H ' ' A' ' 19' ' ' MET . . . -51.69 -32.04 28.29 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.055 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.32 78.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.382 -0.824 . . . . 0.0 110.699 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.63 18.7 18.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.739 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.019 ' CE1' HD21 ' A' ' 31' ' ' LEU . 81.8 m-70 -158.61 -64.91 0.08 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.929 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' A' ' 18' ' ' HIS . 4.9 ptt? 38.66 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.318 0.58 . . . . 0.0 109.719 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . 71.08 57.23 6.37 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 31' ' ' LEU . . . 36.74 64.81 0.6 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 18' ' ' HIS . . . -141.66 99.05 0.23 Allowed Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.992 -1.299 . . . . 0.0 109.953 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.445 HD21 ' C4D' ' A' ' 88' ' ' HEC . 1.2 t-20 -67.83 138.0 55.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -1.168 . . . . 0.0 109.855 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.22 -3.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -0.827 . . . . 0.0 109.599 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.832 ' HB ' HMD3 ' A' ' 88' ' ' HEC . 5.1 t -103.59 -46.96 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.494 ' HG3' HMD1 ' A' ' 88' ' ' HEC . 3.2 mtp -100.45 157.51 16.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 28' ' ' ASN . . . -109.77 61.25 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.439 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 2.9 p-10 169.62 -50.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -77.25 91.04 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.614 HG21 ' HD2' ' A' ' 32' ' ' LYS . 23.2 m -126.17 163.89 22.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.187 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.019 HD21 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -88.36 74.48 8.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.133 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.67 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -111.83 -85.04 0.57 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.648 -1.283 . . . . 0.0 109.103 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.044 ' N ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -176.56 -47.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 179.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.59 -33.81 27.87 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.15 -0.968 . . . . 0.0 110.413 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.65 ' HB1' ' HZ ' ' A' ' 39' ' ' PHE . . . -70.81 -56.81 5.49 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.056 -1.028 . . . . 0.0 109.688 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.062 HD12 ' HB2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -53.42 -33.57 54.48 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.489 -0.757 . . . . 0.0 109.438 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.549 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 3.1 mm-40 -87.14 -17.84 31.82 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.706 0.765 . . . . 0.0 109.242 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.484 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 2.1 tp60 -68.33 -50.29 54.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.65 ' HZ ' ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -85.8 -78.17 0.28 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.427 -0.796 . . . . 0.0 108.926 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.66 86.36 0.06 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.566 ' SD ' ' CE2' ' A' ' 39' ' ' PHE . 2.7 ptt? -167.0 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -1.192 . . . . 0.0 109.511 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 1.062 ' HB2' HD12 ' A' ' 36' ' ' LEU . 38.0 t80 -104.68 12.02 33.39 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.386 -0.821 . . . . 0.0 109.55 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -105.42 140.41 38.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.792 ' HA ' HD11 ' A' ' 78' ' ' LEU . 1.2 mt-10 -44.89 -63.05 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.796 . . . . 0.0 109.97 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 29.5 t0 -48.63 -33.53 10.07 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.817 -1.177 . . . . 0.0 110.553 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . -65.39 -76.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.904 . . . . 0.0 110.187 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.84 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 tt -65.5 -6.75 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.859 0.838 . . . . 0.0 110.563 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.561 HD12 ' C ' ' A' ' 44' ' ' GLU . 12.8 mt -77.26 -43.02 31.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 49' ' ' TYR . 58.4 t80 -88.89 -3.83 58.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.626 ' OE1' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -100.87 -13.78 18.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 47' ' ' ILE . 26.8 t -92.09 -47.36 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.875 ' HG3' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -58.69 -12.82 4.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.58 -179.239 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.656 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -151.57 21.59 0.71 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.597 ' N ' ' HA ' ' A' ' 60' ' ' ALA . . . 53.09 -131.97 41.55 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.572 ' HD2' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 157.08 132.86 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.437 0 CA-C-O 121.538 0.685 . . . . 0.0 109.728 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 59.9 m-80 63.05 -85.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.475 ' O ' HMD2 ' A' ' 88' ' ' HEC . . . -131.53 44.48 2.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.642 ' HG3' ' HD2' ' A' ' 59' ' ' PRO . 6.6 ttt -129.05 144.15 51.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.039 -1.038 . . . . 0.0 109.167 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.642 ' HD2' ' HG3' ' A' ' 58' ' ' MET . 28.6 Cg_endo -71.71 117.27 5.06 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.372 2.715 . . . . 0.0 115.822 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.656 ' CB ' ' HA ' ' A' ' 53' ' ' HIS . . . -42.51 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.922 ' CE2' HBB2 ' A' ' 88' ' ' HEC . 26.0 m-85 -139.48 8.64 2.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.42 -19.7 2.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.435 -0.791 . . . . 0.0 109.217 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.54 26.86 0.96 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.708 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 2.4 mmt85 -102.06 -48.59 4.18 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 178.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.033 HD13 HG11 ' A' ' 9' ' ' VAL . 8.4 mt -81.34 -148.57 0.07 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.609 HG22 ' N ' ' A' ' 67' ' ' ASP . 1.5 m -98.83 -74.96 0.57 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 122.19 0.995 . . . . 0.0 108.929 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.777 ' HA ' HD12 ' A' ' 70' ' ' ILE . 23.3 t0 -177.83 -59.34 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 9.7 tt0 -69.25 5.1 1.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.662 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 1.068 ' CB ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.21 -33.92 6.31 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.875 HG21 ' HG3' ' A' ' 52' ' ' GLN . 2.3 mt -60.28 -18.0 15.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.477 ' N ' ' C ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -96.46 -73.81 0.58 Allowed 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 60.7 m-20 -44.64 -46.34 10.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.833 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.787 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 10.5 t -63.29 -42.25 95.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.623 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 47' ' ' ILE . . . -56.19 -63.87 1.05 Allowed 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.268 -1.52 . . . . 0.0 106.951 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -58.49 -18.93 32.91 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.787 ' HB3' ' O ' ' A' ' 73' ' ' VAL . 61.4 t80 -65.46 -39.91 92.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.598 ' HA ' ' CZ2' ' A' ' 85' ' ' TRP . 25.2 t -75.33 -24.18 17.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -88.83 -8.12 54.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HD2' ' A' ' 83' ' ' LYS . 2.3 t70 -98.54 -36.31 9.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.107 0.956 . . . . 0.0 108.707 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.641 ' HB2' ' CE2' ' A' ' 85' ' ' TRP . 5.1 mm-40 -80.9 -36.56 31.02 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.575 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 32' ' ' LYS . . . -64.56 -42.88 95.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.837 ' HB2' ' OH ' ' A' ' 42' ' ' TYR . . . -89.12 12.81 14.69 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 110.829 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 8.3 ptmm? -138.08 18.18 2.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.494 -1.379 . . . . 0.0 111.22 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 86.49 73.96 1.27 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.641 ' CE2' ' HB2' ' A' ' 80' ' ' GLN . 5.6 m95 -36.62 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.41 0.624 . . . . 0.0 109.61 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 84' ' ' GLY . . . -74.43 -52.47 11.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.411 -0.806 . . . . 0.0 109.832 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.027 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.52 -179.957 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HEC . . . . . 0.922 HBB2 ' CE2' ' A' ' 61' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_